Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2026-06-02
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| 5_8S_rRNA | -1.3629867 |
| A1BG | -0.2722585 |
| A1BG-AS1 | 0.1518126 |
| A1CF | 1.8976343 |
| A2M | -0.6716824 |
| A2M-AS1 | -1.0775417 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10454 |
| num_genes_in_profile | 21870 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 13943 |
| num_profile_genes_not_in_sets | 7927 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets:| Gene sets metrics | |
|---|---|
| num_genesets | 10454 |
| num_genesets_excluded | 3933 |
| num_genesets_included | 6521 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are
FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown
irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP LIPOXYGENASE PATHWAY | 9 | 4.40e-06 | -0.884 | 2.82e-04 |
| GOBP LIPOXIN METABOLIC PROCESS | 5 | 6.38e-04 | -0.882 | 1.61e-02 |
| GOMF COMPLEMENT COMPONENT C3B BINDING | 5 | 1.34e-03 | -0.828 | 2.85e-02 |
| GOMF ICOSANOID BINDING | 7 | 2.33e-04 | -0.803 | 7.56e-03 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB | 5 | 2.49e-03 | -0.781 | 4.41e-02 |
| GOMF LIPID ANTIGEN BINDING | 5 | 2.49e-03 | -0.781 | 4.41e-02 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 1.39e-04 | 0.778 | 5.05e-03 |
| GOMF DNA RNA HYBRID BINDING | 5 | 2.72e-03 | 0.774 | 4.68e-02 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 3.90e-04 | 0.774 | 1.11e-02 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 10 | 2.27e-05 | -0.773 | 1.16e-03 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 2.78e-03 | 0.772 | 4.76e-02 |
| GOMF ANKYRIN REPEAT BINDING | 6 | 1.11e-03 | 0.769 | 2.45e-02 |
| GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 6 | 1.25e-03 | -0.761 | 2.70e-02 |
| GOMF NERVE GROWTH FACTOR BINDING | 6 | 1.73e-03 | -0.738 | 3.45e-02 |
| GOBP SYNAPSE PRUNING | 9 | 1.34e-04 | -0.735 | 4.93e-03 |
| GOCC PHAGOCYTIC VESICLE LUMEN | 5 | 4.45e-03 | -0.735 | 6.68e-02 |
| GOBP PROTEIN REPAIR | 7 | 8.97e-04 | -0.725 | 2.12e-02 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 5.13e-03 | -0.723 | 7.38e-02 |
| GOBP INNATE IMMUNE RESPONSE IN MUCOSA | 17 | 2.88e-07 | -0.719 | 2.61e-05 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 7 | 1.02e-03 | -0.717 | 2.32e-02 |
| GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION | 5 | 5.82e-03 | 0.712 | 8.06e-02 |
| GOBP PEPTIDOGLYCAN METABOLIC PROCESS | 5 | 5.92e-03 | -0.711 | 8.15e-02 |
| GOMF HISTONE H3K9 TRIMETHYLTRANSFERASE ACTIVITY | 5 | 6.06e-03 | 0.709 | 8.25e-02 |
| GOMF MHC CLASS I PROTEIN COMPLEX BINDING | 7 | 1.19e-03 | 0.707 | 2.61e-02 |
| GOBP HEPOXILIN METABOLIC PROCESS | 7 | 1.22e-03 | -0.706 | 2.66e-02 |
| GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION | 5 | 6.43e-03 | 0.704 | 8.51e-02 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 7 | 1.32e-03 | -0.701 | 2.81e-02 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 7 | 1.34e-03 | 0.700 | 2.85e-02 |
| GOCC RDNA HETEROCHROMATIN | 5 | 6.95e-03 | 0.697 | 8.93e-02 |
| GOBP RESPONSE TO CORTICOSTERONE | 11 | 6.50e-05 | -0.695 | 2.69e-03 |
| GOBP REGULATION OF INTESTINAL ABSORPTION | 6 | 3.20e-03 | 0.695 | 5.28e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 9 | 3.28e-04 | -0.691 | 9.85e-03 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 7.47e-03 | -0.691 | 9.32e-02 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 5 | 7.99e-03 | 0.685 | 9.85e-02 |
| GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL | 5 | 8.28e-03 | 0.682 | 1.01e-01 |
| GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 5 | 8.80e-03 | -0.676 | 1.05e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 8 | 1.11e-03 | -0.666 | 2.45e-02 |
| GOBP ANTERIOR COMMISSURE MORPHOGENESIS | 5 | 1.05e-02 | 0.660 | 1.18e-01 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 2.53e-03 | 0.659 | 4.46e-02 |
| GOBP ANTIBACTERIAL PEPTIDE PRODUCTION | 5 | 1.08e-02 | -0.658 | 1.20e-01 |
| GOBP ANTIMICROBIAL PEPTIDE PRODUCTION | 5 | 1.08e-02 | -0.658 | 1.20e-01 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 1.11e-02 | -0.656 | 1.21e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 18 | 1.59e-06 | 0.653 | 1.13e-04 |
| GOMF PRIMARY AMINE OXIDASE ACTIVITY | 6 | 5.92e-03 | -0.649 | 8.15e-02 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 6 | 6.03e-03 | 0.647 | 8.23e-02 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION | 6 | 6.17e-03 | -0.646 | 8.34e-02 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 6 | 6.23e-03 | -0.645 | 8.37e-02 |
| GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT | 7 | 3.39e-03 | 0.639 | 5.50e-02 |
| GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 1.34e-02 | -0.638 | 1.36e-01 |
| GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 10 | 4.75e-04 | 0.638 | 1.29e-02 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP LIPOXYGENASE PATHWAY | 9 | 4.40e-06 | -8.84e-01 | 2.82e-04 |
| GOBP LIPOXIN METABOLIC PROCESS | 5 | 6.38e-04 | -8.82e-01 | 1.61e-02 |
| GOMF COMPLEMENT COMPONENT C3B BINDING | 5 | 1.34e-03 | -8.28e-01 | 2.85e-02 |
| GOMF ICOSANOID BINDING | 7 | 2.33e-04 | -8.03e-01 | 7.56e-03 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB | 5 | 2.49e-03 | -7.81e-01 | 4.41e-02 |
| GOMF LIPID ANTIGEN BINDING | 5 | 2.49e-03 | -7.81e-01 | 4.41e-02 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 1.39e-04 | 7.78e-01 | 5.05e-03 |
| GOMF DNA RNA HYBRID BINDING | 5 | 2.72e-03 | 7.74e-01 | 4.68e-02 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 3.90e-04 | 7.74e-01 | 1.11e-02 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 10 | 2.27e-05 | -7.73e-01 | 1.16e-03 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 2.78e-03 | 7.72e-01 | 4.76e-02 |
| GOMF ANKYRIN REPEAT BINDING | 6 | 1.11e-03 | 7.69e-01 | 2.45e-02 |
| GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 6 | 1.25e-03 | -7.61e-01 | 2.70e-02 |
| GOMF NERVE GROWTH FACTOR BINDING | 6 | 1.73e-03 | -7.38e-01 | 3.45e-02 |
| GOBP SYNAPSE PRUNING | 9 | 1.34e-04 | -7.35e-01 | 4.93e-03 |
| GOCC PHAGOCYTIC VESICLE LUMEN | 5 | 4.45e-03 | -7.35e-01 | 6.68e-02 |
| GOBP PROTEIN REPAIR | 7 | 8.97e-04 | -7.25e-01 | 2.12e-02 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 5.13e-03 | -7.23e-01 | 7.38e-02 |
| GOBP INNATE IMMUNE RESPONSE IN MUCOSA | 17 | 2.88e-07 | -7.19e-01 | 2.61e-05 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 7 | 1.02e-03 | -7.17e-01 | 2.32e-02 |
| GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION | 5 | 5.82e-03 | 7.12e-01 | 8.06e-02 |
| GOBP PEPTIDOGLYCAN METABOLIC PROCESS | 5 | 5.92e-03 | -7.11e-01 | 8.15e-02 |
| GOMF HISTONE H3K9 TRIMETHYLTRANSFERASE ACTIVITY | 5 | 6.06e-03 | 7.09e-01 | 8.25e-02 |
| GOMF MHC CLASS I PROTEIN COMPLEX BINDING | 7 | 1.19e-03 | 7.07e-01 | 2.61e-02 |
| GOBP HEPOXILIN METABOLIC PROCESS | 7 | 1.22e-03 | -7.06e-01 | 2.66e-02 |
| GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION | 5 | 6.43e-03 | 7.04e-01 | 8.51e-02 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 7 | 1.32e-03 | -7.01e-01 | 2.81e-02 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 7 | 1.34e-03 | 7.00e-01 | 2.85e-02 |
| GOCC RDNA HETEROCHROMATIN | 5 | 6.95e-03 | 6.97e-01 | 8.93e-02 |
| GOBP RESPONSE TO CORTICOSTERONE | 11 | 6.50e-05 | -6.95e-01 | 2.69e-03 |
| GOBP REGULATION OF INTESTINAL ABSORPTION | 6 | 3.20e-03 | 6.95e-01 | 5.28e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 9 | 3.28e-04 | -6.91e-01 | 9.85e-03 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 7.47e-03 | -6.91e-01 | 9.32e-02 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 5 | 7.99e-03 | 6.85e-01 | 9.85e-02 |
| GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL | 5 | 8.28e-03 | 6.82e-01 | 1.01e-01 |
| GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 5 | 8.80e-03 | -6.76e-01 | 1.05e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 8 | 1.11e-03 | -6.66e-01 | 2.45e-02 |
| GOBP ANTERIOR COMMISSURE MORPHOGENESIS | 5 | 1.05e-02 | 6.60e-01 | 1.18e-01 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 2.53e-03 | 6.59e-01 | 4.46e-02 |
| GOBP ANTIBACTERIAL PEPTIDE PRODUCTION | 5 | 1.08e-02 | -6.58e-01 | 1.20e-01 |
| GOBP ANTIMICROBIAL PEPTIDE PRODUCTION | 5 | 1.08e-02 | -6.58e-01 | 1.20e-01 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 1.11e-02 | -6.56e-01 | 1.21e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 18 | 1.59e-06 | 6.53e-01 | 1.13e-04 |
| GOMF PRIMARY AMINE OXIDASE ACTIVITY | 6 | 5.92e-03 | -6.49e-01 | 8.15e-02 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 6 | 6.03e-03 | 6.47e-01 | 8.23e-02 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION | 6 | 6.17e-03 | -6.46e-01 | 8.34e-02 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 6 | 6.23e-03 | -6.45e-01 | 8.37e-02 |
| GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT | 7 | 3.39e-03 | 6.39e-01 | 5.50e-02 |
| GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 1.34e-02 | -6.38e-01 | 1.36e-01 |
| GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 10 | 4.75e-04 | 6.38e-01 | 1.29e-02 |
| GOCC NADPH OXIDASE COMPLEX | 14 | 4.20e-05 | -6.32e-01 | 1.91e-03 |
| GOBP RESPONSE TO FOLIC ACID | 7 | 3.98e-03 | -6.29e-01 | 6.16e-02 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 7 | 4.05e-03 | -6.27e-01 | 6.24e-02 |
| GOMF NEUROTROPHIN BINDING | 8 | 2.17e-03 | -6.26e-01 | 4.00e-02 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 7 | 4.30e-03 | -6.23e-01 | 6.55e-02 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 7 | 4.45e-03 | 6.21e-01 | 6.68e-02 |
| GOBP POSITIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 5 | 1.65e-02 | -6.19e-01 | 1.53e-01 |
| GOMF D LOOP DNA BINDING | 5 | 1.66e-02 | 6.19e-01 | 1.53e-01 |
| GOMF L PROLINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.67e-02 | 6.18e-01 | 1.53e-01 |
| GOMF PEPTIDOGLYCAN MURALYTIC ACTIVITY | 6 | 8.90e-03 | -6.17e-01 | 1.06e-01 |
| GOCC NURF COMPLEX | 7 | 4.93e-03 | 6.14e-01 | 7.19e-02 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 5 | 1.78e-02 | -6.12e-01 | 1.58e-01 |
| GOBP SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION | 6 | 9.53e-03 | 6.11e-01 | 1.09e-01 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 1.83e-02 | 6.09e-01 | 1.60e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY | 5 | 1.84e-02 | -6.09e-01 | 1.60e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 5 | 1.85e-02 | -6.08e-01 | 1.60e-01 |
| GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 7 | 5.38e-03 | -6.07e-01 | 7.69e-02 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 10 | 9.42e-04 | 6.04e-01 | 2.20e-02 |
| GOMF PROSTANOID RECEPTOR ACTIVITY | 10 | 1.00e-03 | -6.01e-01 | 2.30e-02 |
| GOBP RECEPTOR DIFFUSION TRAPPING | 5 | 2.01e-02 | -6.00e-01 | 1.67e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 11 | 5.77e-04 | 5.99e-01 | 1.50e-02 |
| GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY | 5 | 2.04e-02 | -5.99e-01 | 1.69e-01 |
| GOBP NOTOCHORD DEVELOPMENT | 13 | 1.92e-04 | 5.97e-01 | 6.45e-03 |
| GOBP VESTIBULOCOCHLEAR NERVE MORPHOGENESIS | 5 | 2.13e-02 | 5.95e-01 | 1.72e-01 |
| GOBP GLYCOSYLCERAMIDE CATABOLIC PROCESS | 5 | 2.14e-02 | -5.94e-01 | 1.72e-01 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 2.19e-02 | 5.92e-01 | 1.75e-01 |
| GOBP SEROTONIN SECRETION | 7 | 6.74e-03 | -5.91e-01 | 8.75e-02 |
| GOBP RESPONSE TO CORTISOL | 5 | 2.23e-02 | -5.90e-01 | 1.76e-01 |
| GOMF BH3 DOMAIN BINDING | 6 | 1.23e-02 | -5.90e-01 | 1.29e-01 |
| GOBP POSITIVE REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 5 | 2.25e-02 | -5.89e-01 | 1.77e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 1.28e-02 | 5.87e-01 | 1.32e-01 |
| GOMF CXCR CHEMOKINE RECEPTOR BINDING | 12 | 4.33e-04 | -5.87e-01 | 1.20e-02 |
| GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION | 7 | 7.22e-03 | -5.86e-01 | 9.14e-02 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 7.38e-03 | 5.85e-01 | 9.24e-02 |
| GOMF C X3 C CHEMOKINE BINDING | 5 | 2.38e-02 | -5.84e-01 | 1.84e-01 |
| GOMF RAGE RECEPTOR BINDING | 9 | 2.52e-03 | -5.81e-01 | 4.46e-02 |
| GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY | 6 | 1.37e-02 | 5.81e-01 | 1.38e-01 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 1.48e-03 | -5.80e-01 | 3.08e-02 |
| GOBP SIALYLATION | 7 | 8.05e-03 | 5.78e-01 | 9.89e-02 |
| GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.42e-02 | 5.78e-01 | 1.40e-01 |
| GOBP METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT | 6 | 1.42e-02 | -5.78e-01 | 1.40e-01 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 1.43e-02 | 5.77e-01 | 1.41e-01 |
| GOBP DETOXIFICATION OF NITROGEN COMPOUND | 5 | 2.54e-02 | -5.77e-01 | 1.91e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 14 | 1.85e-04 | -5.77e-01 | 6.31e-03 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 6 | 1.45e-02 | -5.76e-01 | 1.42e-01 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 1.63e-03 | 5.75e-01 | 3.31e-02 |
| GOBP SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION | 5 | 2.62e-02 | -5.74e-01 | 1.95e-01 |
| GOCC CDC73 PAF1 COMPLEX | 6 | 1.49e-02 | 5.74e-01 | 1.44e-01 |
| GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR | 9 | 2.88e-03 | -5.74e-01 | 4.90e-02 |
| GOBP GLIAL CELL FATE COMMITMENT | 7 | 8.59e-03 | -5.74e-01 | 1.04e-01 |
| GOMF GALACTOSIDASE ACTIVITY | 6 | 1.50e-02 | -5.73e-01 | 1.45e-01 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 5 | 2.65e-02 | -5.73e-01 | 1.96e-01 |
| GOMF ATP DEPENDENT DNA DNA ANNEALING ACTIVITY | 5 | 2.72e-02 | 5.70e-01 | 1.99e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS | 6 | 1.57e-02 | -5.69e-01 | 1.49e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 19 | 1.80e-05 | -5.68e-01 | 9.49e-04 |
| GOCC MITOTIC COHESIN COMPLEX | 7 | 9.30e-03 | 5.68e-01 | 1.09e-01 |
| GOMF MUTLALPHA COMPLEX BINDING | 7 | 9.37e-03 | 5.67e-01 | 1.09e-01 |
| GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 6 | 1.63e-02 | 5.66e-01 | 1.53e-01 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 7 | 9.65e-03 | -5.65e-01 | 1.11e-01 |
| GOBP TRANS SYNAPTIC SIGNALING BY LIPID | 6 | 1.66e-02 | -5.64e-01 | 1.53e-01 |
| GOMF MYOSIN LIGHT CHAIN BINDING | 5 | 2.92e-02 | -5.63e-01 | 2.08e-01 |
| GOBP CGMP BIOSYNTHETIC PROCESS | 6 | 1.69e-02 | -5.63e-01 | 1.54e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST | 5 | 2.93e-02 | -5.63e-01 | 2.08e-01 |
| GOBP SEQUESTERING OF IRON ION | 5 | 2.96e-02 | -5.62e-01 | 2.09e-01 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 10 | 2.17e-03 | 5.60e-01 | 4.00e-02 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 6 | 1.76e-02 | -5.60e-01 | 1.57e-01 |
| GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL | 9 | 3.70e-03 | -5.59e-01 | 5.84e-02 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 11 | 1.35e-03 | -5.58e-01 | 2.85e-02 |
| GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 5 | 3.07e-02 | -5.58e-01 | 2.13e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 9 | 3.75e-03 | 5.58e-01 | 5.92e-02 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 12 | 8.49e-04 | 5.56e-01 | 2.03e-02 |
| GOBP MALE GENITALIA DEVELOPMENT | 11 | 1.43e-03 | -5.55e-01 | 3.01e-02 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 5 | 3.16e-02 | -5.55e-01 | 2.15e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 1.44e-03 | 5.55e-01 | 3.01e-02 |
| GOBP VESTIBULOCOCHLEAR NERVE DEVELOPMENT | 7 | 1.10e-02 | 5.55e-01 | 1.21e-01 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 3.96e-03 | 5.55e-01 | 6.15e-02 |
| GOMF BH DOMAIN BINDING | 10 | 2.42e-03 | -5.54e-01 | 4.34e-02 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 2.04e-04 | 5.54e-01 | 6.83e-03 |
| GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY | 5 | 3.21e-02 | 5.53e-01 | 2.17e-01 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.76e-03 | -5.53e-01 | 8.75e-02 |
| GOBP CORNEA DEVELOPMENT IN CAMERA TYPE EYE | 6 | 1.90e-02 | -5.53e-01 | 1.64e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 8 | 6.82e-03 | 5.52e-01 | 8.81e-02 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 16 | 1.31e-04 | -5.52e-01 | 4.88e-03 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 11 | 1.53e-03 | -5.52e-01 | 3.15e-02 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 15 | 2.21e-04 | -5.51e-01 | 7.29e-03 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 5 | 3.31e-02 | 5.50e-01 | 2.20e-01 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 7 | 1.17e-02 | -5.50e-01 | 1.25e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 1.97e-02 | 5.50e-01 | 1.66e-01 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 1.60e-03 | 5.49e-01 | 3.27e-02 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT | 6 | 1.98e-02 | 5.49e-01 | 1.66e-01 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 8 | 7.16e-03 | -5.49e-01 | 9.09e-02 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 6 | 1.99e-02 | -5.49e-01 | 1.66e-01 |
| GOBP CORPUS CALLOSUM MORPHOGENESIS | 6 | 1.99e-02 | 5.49e-01 | 1.66e-01 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 10 | 2.65e-03 | -5.49e-01 | 4.60e-02 |
| GOBP POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 5 | 3.38e-02 | -5.48e-01 | 2.22e-01 |
| GOMF GDP PHOSPHATASE ACTIVITY | 7 | 1.20e-02 | 5.48e-01 | 1.28e-01 |
| GOBP LONG CHAIN FATTY ACID CATABOLIC PROCESS | 7 | 1.22e-02 | -5.47e-01 | 1.28e-01 |
| GOBP ENDOTHELIAL CELL MATRIX ADHESION | 5 | 3.46e-02 | -5.46e-01 | 2.25e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN | 5 | 3.46e-02 | -5.46e-01 | 2.25e-01 |
| GOBP POSITIVE REGULATION OF FEVER GENERATION | 7 | 1.26e-02 | -5.45e-01 | 1.31e-01 |
| GOMF NITRITE REDUCTASE ACTIVITY | 6 | 2.10e-02 | -5.44e-01 | 1.71e-01 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 1.31e-02 | 5.41e-01 | 1.34e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION | 5 | 3.60e-02 | 5.41e-01 | 2.30e-01 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 7 | 1.33e-02 | 5.40e-01 | 1.35e-01 |
| GOCC AXON HILLOCK | 7 | 1.33e-02 | 5.40e-01 | 1.35e-01 |
| GOMF SUMO POLYMER BINDING | 6 | 2.20e-02 | 5.40e-01 | 1.75e-01 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 11 | 1.95e-03 | 5.39e-01 | 3.71e-02 |
| GOMF TELOMERASE ACTIVITY | 6 | 2.28e-02 | 5.37e-01 | 1.79e-01 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 3.79e-02 | -5.36e-01 | 2.36e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING BY LIPID | 5 | 3.79e-02 | -5.36e-01 | 2.36e-01 |
| GOCC IGA IMMUNOGLOBULIN COMPLEX | 8 | 8.78e-03 | -5.35e-01 | 1.05e-01 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 9 | 5.50e-03 | 5.34e-01 | 7.74e-02 |
| GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 6 | 2.34e-02 | 5.34e-01 | 1.82e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ASSEMBLY | 5 | 3.87e-02 | 5.34e-01 | 2.39e-01 |
| GOBP PRIMITIVE ERYTHROCYTE DIFFERENTIATION | 5 | 3.90e-02 | -5.33e-01 | 2.40e-01 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 7 | 1.46e-02 | 5.33e-01 | 1.43e-01 |
| GOMF PHOSPHATIDYLSERINE FLIPPASE ACTIVITY | 5 | 3.91e-02 | 5.33e-01 | 2.40e-01 |
| GOBP LUNG SACCULE DEVELOPMENT | 6 | 2.39e-02 | 5.33e-01 | 1.84e-01 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 7 | 1.49e-02 | -5.31e-01 | 1.44e-01 |
| GOCC TRAMP COMPLEX | 5 | 3.99e-02 | 5.30e-01 | 2.43e-01 |
| GOBP REGULATION OF BLOOD VESSEL REMODELING | 6 | 2.46e-02 | -5.30e-01 | 1.87e-01 |
| GOBP DETECTION OF VIRUS | 5 | 4.05e-02 | 5.29e-01 | 2.45e-01 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 5 | 4.07e-02 | 5.28e-01 | 2.45e-01 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 16 | 2.59e-04 | -5.27e-01 | 8.26e-03 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 53 | 3.06e-11 | -5.27e-01 | 7.63e-09 |
| GOBP MONOCYTE ACTIVATION | 10 | 3.90e-03 | -5.27e-01 | 6.09e-02 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 9 | 6.25e-03 | -5.26e-01 | 8.38e-02 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 20 | 4.67e-05 | -5.26e-01 | 2.07e-03 |
| GOCC FASCIA ADHERENS | 5 | 4.20e-02 | -5.25e-01 | 2.49e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY | 5 | 4.24e-02 | 5.24e-01 | 2.51e-01 |
| GOMF PORIN ACTIVITY | 6 | 2.65e-02 | -5.23e-01 | 1.96e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 6 | 2.65e-02 | -5.23e-01 | 1.96e-01 |
| GOBP OXIDATIVE DEMETHYLATION | 7 | 1.66e-02 | 5.23e-01 | 1.53e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 18 | 1.22e-04 | -5.23e-01 | 4.66e-03 |
| GOBP CANNABINOID SIGNALING PATHWAY | 7 | 1.66e-02 | -5.23e-01 | 1.53e-01 |
| GOBP TELOMERE LOCALIZATION | 7 | 1.70e-02 | 5.21e-01 | 1.54e-01 |
| GOBP CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 7 | 1.70e-02 | 5.21e-01 | 1.54e-01 |
| GOBP BONE TRABECULA FORMATION | 8 | 1.08e-02 | -5.20e-01 | 1.20e-01 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 7 | 1.75e-02 | -5.18e-01 | 1.56e-01 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 6 | 2.79e-02 | 5.18e-01 | 2.02e-01 |
| GOMF HISTONE H3K36 TRIMETHYLTRANSFERASE ACTIVITY | 5 | 4.48e-02 | 5.18e-01 | 2.59e-01 |
| GOCC SPERM PLASMA MEMBRANE | 7 | 1.77e-02 | 5.18e-01 | 1.57e-01 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 4.61e-03 | -5.17e-01 | 6.85e-02 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 6 | 2.82e-02 | 5.17e-01 | 2.04e-01 |
| GOMF LONG CHAIN FATTY ACID BINDING | 12 | 1.92e-03 | -5.17e-01 | 3.67e-02 |
| GOMF OPSONIN RECEPTOR ACTIVITY | 5 | 4.57e-02 | -5.16e-01 | 2.61e-01 |
| GOBP PLASMA CELL DIFFERENTIATION | 8 | 1.15e-02 | -5.16e-01 | 1.24e-01 |
| GOBP HISTIDINE METABOLIC PROCESS | 8 | 1.17e-02 | -5.15e-01 | 1.25e-01 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 7 | 1.83e-02 | -5.15e-01 | 1.60e-01 |
| GOBP RESPONSE TO MERCURY ION | 7 | 1.83e-02 | -5.15e-01 | 1.60e-01 |
| GOMF HISTONE H2AX KINASE ACTIVITY | 5 | 4.64e-02 | 5.14e-01 | 2.63e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 2.93e-02 | 5.14e-01 | 2.08e-01 |
| GOBP REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 5 | 4.68e-02 | 5.14e-01 | 2.64e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 6 | 2.97e-02 | 5.12e-01 | 2.09e-01 |
| GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS | 5 | 4.76e-02 | -5.12e-01 | 2.66e-01 |
| GOMF UNMETHYLATED CPG BINDING | 10 | 5.16e-03 | 5.11e-01 | 7.39e-02 |
| GOCC CYTOCHROME COMPLEX | 35 | 1.76e-07 | -5.10e-01 | 1.65e-05 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 4.84e-02 | 5.10e-01 | 2.69e-01 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 4.88e-02 | 5.09e-01 | 2.70e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 7 | 1.98e-02 | 5.08e-01 | 1.66e-01 |
| GOBP ECTODERMAL CELL DIFFERENTIATION | 6 | 3.10e-02 | -5.08e-01 | 2.14e-01 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 8 | 1.28e-02 | -5.08e-01 | 1.32e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 5 | 4.92e-02 | -5.08e-01 | 2.71e-01 |
| GOBP RECEPTOR LOCALIZATION TO NON MOTILE CILIUM | 5 | 4.93e-02 | 5.08e-01 | 2.71e-01 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 12 | 2.33e-03 | -5.07e-01 | 4.23e-02 |
| GOMF GLUCOSE BINDING | 11 | 3.60e-03 | -5.07e-01 | 5.74e-02 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 10 | 5.54e-03 | 5.06e-01 | 7.76e-02 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 8.63e-03 | -5.06e-01 | 1.04e-01 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 10 | 5.64e-03 | -5.05e-01 | 7.86e-02 |
| GOBP CELLULAR RESPONSE TO UV B | 12 | 2.51e-03 | -5.04e-01 | 4.44e-02 |
| GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H | 6 | 3.26e-02 | -5.04e-01 | 2.19e-01 |
| GOCC PLATELET DENSE GRANULE LUMEN | 9 | 8.87e-03 | 5.04e-01 | 1.06e-01 |
| GOBP ATRIOVENTRICULAR VALVE FORMATION | 5 | 5.15e-02 | 5.03e-01 | 2.77e-01 |
| GOMF ACETYLATION DEPENDENT PROTEIN BINDING | 24 | 2.04e-05 | 5.02e-01 | 1.05e-03 |
| GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.33e-02 | -5.02e-01 | 2.21e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 5.22e-02 | 5.01e-01 | 2.78e-01 |
| GOBP AMINO ACID NEUROTRANSMITTER REUPTAKE | 6 | 3.35e-02 | -5.01e-01 | 2.22e-01 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 8 | 1.41e-02 | -5.01e-01 | 1.40e-01 |
| GOBP NAD CATABOLIC PROCESS | 19 | 1.57e-04 | -5.01e-01 | 5.54e-03 |
| GOBP ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 5 | 5.25e-02 | -5.01e-01 | 2.78e-01 |
| GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 5 | 5.25e-02 | -5.01e-01 | 2.78e-01 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 9 | 9.47e-03 | 4.99e-01 | 1.09e-01 |
| GOBP REGULATION OF HETEROCHROMATIN FORMATION | 22 | 5.03e-05 | 4.99e-01 | 2.17e-03 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 3.46e-02 | -4.98e-01 | 2.25e-01 |
| GOBP ENERGY COUPLED PROTON TRANSMEMBRANE TRANSPORT AGAINST ELECTROCHEMICAL GRADIENT | 5 | 5.41e-02 | -4.97e-01 | 2.83e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 8 | 1.49e-02 | 4.97e-01 | 1.44e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION | 5 | 5.43e-02 | 4.97e-01 | 2.84e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES | 7 | 2.29e-02 | -4.97e-01 | 1.80e-01 |
| GOBP SEQUESTERING OF METAL ION | 8 | 1.50e-02 | -4.96e-01 | 1.45e-01 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 8 | 1.50e-02 | -4.96e-01 | 1.45e-01 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 3.53e-02 | 4.96e-01 | 2.27e-01 |
| GOBP NOREPINEPHRINE SECRETION | 10 | 6.66e-03 | -4.95e-01 | 8.71e-02 |
| GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY | 9 | 1.01e-02 | -4.95e-01 | 1.14e-01 |
| GOMF GUANYLATE CYCLASE ACTIVITY | 5 | 5.52e-02 | -4.95e-01 | 2.86e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 16 | 6.26e-04 | 4.94e-01 | 1.59e-02 |
| GOBP REGULATION OF INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 5 | 5.59e-02 | 4.94e-01 | 2.88e-01 |
| GOBP INTRACELLULAR GLUTAMATE HOMEOSTASIS | 5 | 5.60e-02 | 4.93e-01 | 2.88e-01 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 5.60e-02 | -4.93e-01 | 2.88e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 14 | 1.39e-03 | 4.93e-01 | 2.94e-02 |
| GOCC PORE COMPLEX | 20 | 1.35e-04 | -4.93e-01 | 4.94e-03 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 7 | 2.39e-02 | 4.93e-01 | 1.85e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 10 | 7.00e-03 | 4.92e-01 | 8.95e-02 |
| GOBP PENILE ERECTION | 5 | 5.66e-02 | -4.92e-01 | 2.89e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 10 | 7.10e-03 | 4.92e-01 | 9.04e-02 |
| GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 6 | 3.71e-02 | -4.91e-01 | 2.34e-01 |
| GOBP NOTOCHORD MORPHOGENESIS | 7 | 2.44e-02 | 4.91e-01 | 1.86e-01 |
| GOCC DENDRITIC SPINE HEAD | 5 | 5.72e-02 | -4.91e-01 | 2.90e-01 |
| GOBP TRACHEA FORMATION | 6 | 3.77e-02 | -4.90e-01 | 2.36e-01 |
| GOBP TRACHEA MORPHOGENESIS | 6 | 3.77e-02 | -4.90e-01 | 2.36e-01 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 6 | 3.84e-02 | -4.88e-01 | 2.38e-01 |
| GOBP LEUKOTRIENE TRANSPORT | 7 | 2.55e-02 | -4.88e-01 | 1.91e-01 |
| GOCC CYTOPLASMIC SIDE OF ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 5 | 5.91e-02 | -4.87e-01 | 2.96e-01 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 8 | 1.72e-02 | 4.86e-01 | 1.55e-01 |
| GOBP REGULATION OF FEVER GENERATION | 8 | 1.73e-02 | -4.86e-01 | 1.55e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 5 | 6.03e-02 | 4.85e-01 | 2.99e-01 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 9 | 1.17e-02 | 4.85e-01 | 1.25e-01 |
| GOMF DNA METHYLTRANSFERASE ACTIVITY | 6 | 3.99e-02 | 4.84e-01 | 2.43e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 11 | 5.42e-03 | -4.84e-01 | 7.71e-02 |
| GOCC NUCLEAR PORE OUTER RING | 10 | 8.16e-03 | 4.83e-01 | 9.97e-02 |
| GOBP ANDROGEN BIOSYNTHETIC PROCESS | 5 | 6.16e-02 | -4.83e-01 | 3.03e-01 |
| GOBP IRON IMPORT INTO CELL | 8 | 1.82e-02 | -4.82e-01 | 1.59e-01 |
| GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY | 7 | 2.72e-02 | -4.82e-01 | 1.99e-01 |
| GOMF CD4 RECEPTOR BINDING | 7 | 2.73e-02 | 4.82e-01 | 1.99e-01 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 10 | 8.36e-03 | -4.82e-01 | 1.01e-01 |
| GOBP REGULATION OF PANCREATIC JUICE SECRETION | 6 | 4.11e-02 | 4.82e-01 | 2.46e-01 |
| GOMF HISTONE H4 DEMETHYLASE ACTIVITY | 5 | 6.33e-02 | 4.80e-01 | 3.08e-01 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 6 | 4.21e-02 | 4.79e-01 | 2.49e-01 |
| GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER | 6 | 4.21e-02 | -4.79e-01 | 2.49e-01 |
| GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY | 9 | 1.29e-02 | -4.79e-01 | 1.32e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 7 | 2.83e-02 | 4.79e-01 | 2.04e-01 |
| GOCC IGD IMMUNOGLOBULIN COMPLEX | 5 | 6.42e-02 | -4.78e-01 | 3.10e-01 |
| GOBP CLUSTERING OF VOLTAGE GATED SODIUM CHANNELS | 5 | 6.43e-02 | 4.78e-01 | 3.10e-01 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 7 | 2.88e-02 | -4.77e-01 | 2.06e-01 |
| GOCC PRP19 COMPLEX | 14 | 1.99e-03 | 4.77e-01 | 3.76e-02 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 16 | 9.51e-04 | -4.77e-01 | 2.21e-02 |
| GOBP POST EMBRYONIC HEMOPOIESIS | 5 | 6.47e-02 | -4.77e-01 | 3.11e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB | 7 | 2.89e-02 | -4.77e-01 | 2.06e-01 |
| GOCC TERTIARY GRANULE LUMEN | 51 | 3.99e-09 | -4.76e-01 | 6.04e-07 |
| GOMF RNA POLYMERASE I GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 6 | 4.36e-02 | 4.76e-01 | 2.54e-01 |
| GOBP OUTER EAR MORPHOGENESIS | 5 | 6.56e-02 | -4.76e-01 | 3.12e-01 |
| GOBP NEGATIVE REGULATION OF SISTER CHROMATID COHESION | 5 | 6.56e-02 | 4.75e-01 | 3.12e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 18 | 4.83e-04 | -4.75e-01 | 1.31e-02 |
| GOBP NEGATIVE REGULATION OF RELAXATION OF MUSCLE | 6 | 4.40e-02 | 4.75e-01 | 2.56e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 7 | 2.97e-02 | 4.74e-01 | 2.09e-01 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 7 | 2.97e-02 | 4.74e-01 | 2.09e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY | 5 | 6.66e-02 | -4.74e-01 | 3.14e-01 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 12 | 4.54e-03 | -4.73e-01 | 6.77e-02 |
| GOBP FIBROBLAST ACTIVATION | 13 | 3.15e-03 | -4.73e-01 | 5.22e-02 |
| GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX | 6 | 4.49e-02 | -4.73e-01 | 2.59e-01 |
| GOCC SERINE TYPE PEPTIDASE COMPLEX | 6 | 4.49e-02 | -4.73e-01 | 2.59e-01 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 2.09e-02 | 4.71e-01 | 1.71e-01 |
| GOBP RANDOM INACTIVATION OF X CHROMOSOME | 8 | 2.10e-02 | 4.71e-01 | 1.71e-01 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 5 | 6.82e-02 | -4.71e-01 | 3.18e-01 |
| GOBP RESPONSE TO DISACCHARIDE | 5 | 6.83e-02 | -4.71e-01 | 3.18e-01 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.60e-02 | -4.70e-01 | 2.62e-01 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 6 | 4.61e-02 | 4.70e-01 | 2.62e-01 |
| GOBP POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS | 7 | 3.22e-02 | -4.68e-01 | 2.17e-01 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 10 | 1.05e-02 | 4.67e-01 | 1.18e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 13 | 3.57e-03 | 4.67e-01 | 5.73e-02 |
| GOBP PROTEIN DEMETHYLATION | 9 | 1.53e-02 | 4.67e-01 | 1.47e-01 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 23 | 1.07e-04 | -4.67e-01 | 4.12e-03 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 6 | 4.81e-02 | 4.66e-01 | 2.69e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 7 | 3.29e-02 | 4.66e-01 | 2.20e-01 |
| GOMF FRUCTOSE BINDING | 6 | 4.83e-02 | -4.66e-01 | 2.69e-01 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 5 | 7.18e-02 | -4.65e-01 | 3.27e-01 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 10 | 1.10e-02 | -4.65e-01 | 1.21e-01 |
| GOMF HEXOKINASE ACTIVITY | 5 | 7.23e-02 | -4.64e-01 | 3.28e-01 |
| GOBP METANEPHRIC GLOMERULUS DEVELOPMENT | 9 | 1.61e-02 | -4.63e-01 | 1.52e-01 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 14 | 2.70e-03 | -4.63e-01 | 4.66e-02 |
| GOMF MUTSALPHA COMPLEX BINDING | 7 | 3.43e-02 | 4.62e-01 | 2.24e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 5 | 7.39e-02 | -4.62e-01 | 3.32e-01 |
| GOMF MICROFIBRIL BINDING | 5 | 7.41e-02 | 4.61e-01 | 3.33e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 9 | 1.67e-02 | -4.61e-01 | 1.53e-01 |
| GOBP PLASMINOGEN ACTIVATION | 19 | 5.16e-04 | -4.60e-01 | 1.37e-02 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 20 | 3.75e-04 | -4.59e-01 | 1.08e-02 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 13 | 4.18e-03 | -4.59e-01 | 6.41e-02 |
| GOBP REGULATION OF RESPIRATORY BURST | 17 | 1.06e-03 | -4.59e-01 | 2.39e-02 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 8 | 2.47e-02 | -4.59e-01 | 1.88e-01 |
| GOMF LIPASE INHIBITOR ACTIVITY | 9 | 1.72e-02 | -4.58e-01 | 1.55e-01 |
| GOMF POTASSIUM ION BINDING | 8 | 2.48e-02 | -4.58e-01 | 1.88e-01 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 6 | 5.24e-02 | 4.57e-01 | 2.78e-01 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 8 | 2.51e-02 | 4.57e-01 | 1.90e-01 |
| GOBP GROWTH HORMONE SECRETION | 9 | 1.76e-02 | -4.57e-01 | 1.57e-01 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 6 | 5.29e-02 | 4.56e-01 | 2.79e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 8 | 2.54e-02 | 4.56e-01 | 1.91e-01 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 6.21e-03 | 4.56e-01 | 8.37e-02 |
| GOBP INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE | 6 | 5.36e-02 | 4.55e-01 | 2.81e-01 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 11 | 8.99e-03 | 4.55e-01 | 1.06e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 1.82e-02 | 4.55e-01 | 1.59e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 12 | 6.42e-03 | -4.54e-01 | 8.51e-02 |
| GOBP UTERINE SMOOTH MUSCLE CONTRACTION | 6 | 5.47e-02 | -4.53e-01 | 2.85e-01 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 7.96e-02 | 4.53e-01 | 3.45e-01 |
| GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT | 5 | 7.97e-02 | -4.53e-01 | 3.45e-01 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 8 | 2.66e-02 | 4.53e-01 | 1.96e-01 |
| GOMF ACETYLCHOLINE GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY | 8 | 2.70e-02 | 4.51e-01 | 1.98e-01 |
| GOCC RESPIRASOME | 95 | 2.98e-14 | -4.51e-01 | 1.85e-11 |
| GOMF FATTY ACID ELONGASE ACTIVITY | 6 | 5.58e-02 | -4.51e-01 | 2.88e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 11 | 9.72e-03 | -4.50e-01 | 1.11e-01 |
| GOBP REGULATION OF HELICASE ACTIVITY | 9 | 1.94e-02 | 4.50e-01 | 1.65e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 10 | 1.40e-02 | 4.49e-01 | 1.39e-01 |
| GOBP DUMP METABOLIC PROCESS | 6 | 5.70e-02 | -4.49e-01 | 2.90e-01 |
| GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION | 6 | 5.71e-02 | -4.49e-01 | 2.90e-01 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 9 | 1.98e-02 | 4.48e-01 | 1.66e-01 |
| GOCC ISWI TYPE COMPLEX | 14 | 3.68e-03 | 4.48e-01 | 5.82e-02 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 8.27e-02 | 4.48e-01 | 3.51e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE | 5 | 8.30e-02 | -4.48e-01 | 3.51e-01 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 5.79e-02 | 4.47e-01 | 2.91e-01 |
| GOCC SYMMETRIC SYNAPSE | 8 | 2.86e-02 | 4.47e-01 | 2.05e-01 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 6 | 5.83e-02 | -4.46e-01 | 2.93e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 22 | 2.90e-04 | 4.46e-01 | 8.96e-03 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 7 | 4.10e-02 | -4.46e-01 | 2.46e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 4.10e-02 | 4.46e-01 | 2.46e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 6 | 5.86e-02 | -4.46e-01 | 2.94e-01 |
| GOMF BUBBLE DNA BINDING | 8 | 2.90e-02 | 4.46e-01 | 2.07e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC SPECIALIZATION MEMBRANE | 5 | 8.44e-02 | 4.46e-01 | 3.54e-01 |
| GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY | 5 | 8.44e-02 | 4.46e-01 | 3.54e-01 |
| GOBP NEUTROPHIL DEGRANULATION | 14 | 3.92e-03 | -4.45e-01 | 6.11e-02 |
| GOBP OSTEOCLAST PROLIFERATION | 8 | 2.93e-02 | -4.45e-01 | 2.08e-01 |
| GOCC PROTEASOME CORE COMPLEX | 19 | 7.84e-04 | -4.45e-01 | 1.89e-02 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 9 | 2.10e-02 | 4.44e-01 | 1.71e-01 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 9 | 2.11e-02 | -4.44e-01 | 1.71e-01 |
| GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY | 9 | 2.11e-02 | -4.44e-01 | 1.71e-01 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 66 | 4.46e-10 | -4.44e-01 | 8.18e-08 |
| GOCC CHROMATOID BODY | 7 | 4.21e-02 | 4.44e-01 | 2.49e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 10 | 1.52e-02 | -4.43e-01 | 1.46e-01 |
| GOMF NADH DEHYDROGENASE UBIQUINONE ACTIVITY | 41 | 8.95e-07 | -4.43e-01 | 7.09e-05 |
| GOBP MDA 5 SIGNALING PATHWAY | 10 | 1.53e-02 | 4.43e-01 | 1.46e-01 |
| GOMF PROTEIN PHOSPHATASE 2B BINDING | 5 | 8.64e-02 | 4.43e-01 | 3.58e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 5 | 8.67e-02 | 4.42e-01 | 3.58e-01 |
| GOBP PROLINE TRANSMEMBRANE TRANSPORT | 8 | 3.03e-02 | 4.42e-01 | 2.11e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 10 | 1.56e-02 | -4.42e-01 | 1.48e-01 |
| GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT | 5 | 8.72e-02 | -4.42e-01 | 3.59e-01 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 9 | 2.18e-02 | 4.42e-01 | 1.75e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 6 | 6.10e-02 | 4.42e-01 | 3.02e-01 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 5 | 8.73e-02 | -4.41e-01 | 3.59e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE | 6 | 6.16e-02 | -4.41e-01 | 3.03e-01 |
| GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION | 7 | 4.35e-02 | -4.41e-01 | 2.54e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 13 | 5.96e-03 | 4.40e-01 | 8.19e-02 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 13 | 6.01e-03 | 4.40e-01 | 8.23e-02 |
| GOBP DETECTION OF CALCIUM ION | 10 | 1.62e-02 | -4.39e-01 | 1.52e-01 |
| GOBP HEAT ACCLIMATION | 6 | 6.27e-02 | 4.39e-01 | 3.06e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 7 | 4.46e-02 | 4.38e-01 | 2.59e-01 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 6 | 6.32e-02 | -4.38e-01 | 3.07e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 9.02e-02 | 4.38e-01 | 3.67e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 16 | 2.45e-03 | 4.37e-01 | 4.38e-02 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 9 | 2.32e-02 | 4.37e-01 | 1.81e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY | 8 | 3.23e-02 | -4.37e-01 | 2.18e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 9 | 2.32e-02 | -4.37e-01 | 1.81e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 8 | 3.24e-02 | 4.37e-01 | 2.18e-01 |
| GOCC NADH DEHYDROGENASE COMPLEX | 50 | 9.27e-08 | -4.36e-01 | 9.51e-06 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 5 | 9.15e-02 | 4.36e-01 | 3.70e-01 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 28 | 6.65e-05 | 4.35e-01 | 2.74e-03 |
| GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 9.19e-02 | -4.35e-01 | 3.70e-01 |
| GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 9.20e-02 | 4.35e-01 | 3.71e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE | 6 | 6.57e-02 | -4.34e-01 | 3.12e-01 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 13 | 6.75e-03 | -4.34e-01 | 8.75e-02 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 10 | 1.77e-02 | 4.33e-01 | 1.57e-01 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 8 | 3.39e-02 | -4.33e-01 | 2.23e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 8 | 3.43e-02 | 4.32e-01 | 2.24e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 14 | 5.13e-03 | -4.32e-01 | 7.38e-02 |
| GOBP CELLULAR RESPONSE TO X RAY | 9 | 2.49e-02 | 4.32e-01 | 1.89e-01 |
| GOMF HISTONE H3K4ME H3K4ME2 H3K4ME3 DEMETHYLASE ACTIVITY | 5 | 9.47e-02 | 4.32e-01 | 3.75e-01 |
| GOCC BRCA1 C COMPLEX | 6 | 6.73e-02 | 4.31e-01 | 3.16e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 33 | 1.81e-05 | 4.31e-01 | 9.53e-04 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ACTIVITY | 6 | 6.75e-02 | -4.31e-01 | 3.16e-01 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 5 | 9.52e-02 | 4.31e-01 | 3.76e-01 |
| GOBP TRIGEMINAL NERVE DEVELOPMENT | 8 | 3.50e-02 | 4.31e-01 | 2.26e-01 |
| GOBP NUCLEOSIDE SALVAGE | 11 | 1.34e-02 | -4.31e-01 | 1.36e-01 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 7 | 4.86e-02 | -4.30e-01 | 2.69e-01 |
| GOBP POSITIVE REGULATION OF CELL FATE COMMITMENT | 8 | 3.50e-02 | 4.30e-01 | 2.26e-01 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 6.90e-02 | 4.29e-01 | 3.20e-01 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 6.90e-02 | -4.29e-01 | 3.20e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 50 | 1.56e-07 | -4.29e-01 | 1.47e-05 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 9 | 2.60e-02 | -4.29e-01 | 1.94e-01 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.96e-02 | 4.28e-01 | 2.72e-01 |
| GOBP MANGANESE ION TRANSPORT | 10 | 1.90e-02 | -4.28e-01 | 1.64e-01 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 93 | 9.66e-13 | -4.28e-01 | 4.11e-10 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 26 | 1.60e-04 | -4.28e-01 | 5.64e-03 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 23 | 3.88e-04 | 4.27e-01 | 1.11e-02 |
| GOBP VITAMIN K METABOLIC PROCESS | 11 | 1.42e-02 | -4.27e-01 | 1.40e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 13 | 7.77e-03 | -4.26e-01 | 9.62e-02 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 9 | 2.69e-02 | 4.26e-01 | 1.97e-01 |
| GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION | 11 | 1.45e-02 | -4.26e-01 | 1.42e-01 |
| GOCC AXONEMAL A TUBULE INNER SHEATH | 6 | 7.13e-02 | -4.25e-01 | 3.26e-01 |
| GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY | 6 | 7.15e-02 | -4.25e-01 | 3.26e-01 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 7 | 5.17e-02 | 4.25e-01 | 2.77e-01 |
| GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 8 | 3.75e-02 | -4.25e-01 | 2.35e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 21 | 7.65e-04 | -4.24e-01 | 1.86e-02 |
| GOMF DEATH DOMAIN BINDING | 10 | 2.03e-02 | -4.24e-01 | 1.68e-01 |
| GOBP PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS | 5 | 1.01e-01 | 4.23e-01 | 3.88e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FUSION | 5 | 1.01e-01 | 4.23e-01 | 3.89e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 15 | 4.55e-03 | 4.23e-01 | 6.78e-02 |
| GOCC RIBBON SYNAPSE | 11 | 1.52e-02 | 4.23e-01 | 1.46e-01 |
| GOBP GABAERGIC NEURON DIFFERENTIATION | 7 | 5.30e-02 | -4.22e-01 | 2.79e-01 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 7.35e-02 | 4.22e-01 | 3.32e-01 |
| GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 1.03e-01 | 4.21e-01 | 3.91e-01 |
| GOBP DENTINOGENESIS | 5 | 1.03e-01 | -4.21e-01 | 3.91e-01 |
| GOCC PHOSPHORYLASE KINASE COMPLEX | 5 | 1.03e-01 | -4.21e-01 | 3.91e-01 |
| GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY | 5 | 1.03e-01 | -4.21e-01 | 3.92e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 22 | 6.31e-04 | 4.21e-01 | 1.60e-02 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 5.39e-02 | -4.21e-01 | 2.82e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 5 | 1.04e-01 | 4.20e-01 | 3.93e-01 |
| GOBP CAMP CATABOLIC PROCESS | 8 | 3.97e-02 | 4.20e-01 | 2.42e-01 |
| GOCC L TYPE VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 7 | 5.43e-02 | -4.20e-01 | 2.84e-01 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 7 | 5.46e-02 | 4.19e-01 | 2.84e-01 |
| GOCC NF KAPPAB COMPLEX | 5 | 1.04e-01 | 4.19e-01 | 3.94e-01 |
| GOBP RESPIRATORY BURST | 36 | 1.33e-05 | -4.19e-01 | 7.47e-04 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 11 | 1.62e-02 | -4.19e-01 | 1.52e-01 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 12 | 1.21e-02 | 4.19e-01 | 1.28e-01 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 7.60e-02 | -4.18e-01 | 3.37e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 8 | 4.05e-02 | -4.18e-01 | 2.45e-01 |
| GOMF MHC CLASS IB RECEPTOR ACTIVITY | 8 | 4.06e-02 | 4.18e-01 | 2.45e-01 |
| GOBP SMOOTH MUSCLE CELL MATRIX ADHESION | 5 | 1.06e-01 | -4.18e-01 | 3.96e-01 |
| GOCC SARCOPLASMIC RETICULUM LUMEN | 5 | 1.06e-01 | 4.18e-01 | 3.96e-01 |
| GOBP RESPONSE TO ERYTHROPOIETIN | 6 | 7.64e-02 | -4.18e-01 | 3.38e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS | 9 | 3.02e-02 | -4.17e-01 | 2.11e-01 |
| GOBP DTMP METABOLIC PROCESS | 6 | 7.69e-02 | -4.17e-01 | 3.40e-01 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 1.07e-01 | 4.17e-01 | 3.98e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CHROMATIN | 45 | 1.31e-06 | -4.17e-01 | 9.78e-05 |
| GOCC AZUROPHIL GRANULE LUMEN | 86 | 2.37e-11 | -4.17e-01 | 6.16e-09 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 13 | 9.34e-03 | -4.16e-01 | 1.09e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 16 | 3.95e-03 | -4.16e-01 | 6.13e-02 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 9 | 3.07e-02 | 4.16e-01 | 2.13e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 11 | 1.70e-02 | 4.16e-01 | 1.54e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 9 | 3.09e-02 | 4.16e-01 | 2.13e-01 |
| GOBP RENAL VESICLE FORMATION | 6 | 7.84e-02 | -4.15e-01 | 3.43e-01 |
| GOMF U6 SNRNA BINDING | 14 | 7.19e-03 | 4.15e-01 | 9.11e-02 |
| GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT | 6 | 7.86e-02 | 4.15e-01 | 3.43e-01 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 2.32e-02 | -4.15e-01 | 1.81e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 12 | 1.29e-02 | 4.14e-01 | 1.33e-01 |
| GOMF TOXIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.76e-02 | 4.14e-01 | 2.91e-01 |
| GOBP DETERMINATION OF LIVER LEFT RIGHT ASYMMETRY | 5 | 1.09e-01 | -4.14e-01 | 4.01e-01 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 10 | 2.33e-02 | -4.14e-01 | 1.82e-01 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 9 | 3.14e-02 | 4.14e-01 | 2.15e-01 |
| GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN | 6 | 7.92e-02 | -4.14e-01 | 3.44e-01 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 1.10e-01 | -4.13e-01 | 4.04e-01 |
| GOBP LIPID GLYCOSYLATION | 8 | 4.32e-02 | -4.13e-01 | 2.53e-01 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 6 | 8.02e-02 | 4.12e-01 | 3.46e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 36 | 1.85e-05 | 4.12e-01 | 9.60e-04 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 6 | 8.04e-02 | 4.12e-01 | 3.46e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 9 | 3.30e-02 | 4.10e-01 | 2.20e-01 |
| GOBP GLYCINE TRANSPORT | 8 | 4.45e-02 | 4.10e-01 | 2.58e-01 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 16 | 4.53e-03 | -4.10e-01 | 6.76e-02 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 9 | 3.33e-02 | -4.10e-01 | 2.21e-01 |
| GOBP PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN | 8 | 4.48e-02 | -4.10e-01 | 2.59e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 8 | 4.54e-02 | 4.09e-01 | 2.60e-01 |
| GOCC TOM COMPLEX | 7 | 6.13e-02 | -4.08e-01 | 3.02e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 8.36e-02 | 4.08e-01 | 3.53e-01 |
| GOBP FORMATE METABOLIC PROCESS | 5 | 1.14e-01 | -4.08e-01 | 4.14e-01 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 1.92e-02 | 4.08e-01 | 1.64e-01 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 39 | 1.09e-05 | 4.07e-01 | 6.23e-04 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 7 | 6.23e-02 | -4.07e-01 | 3.05e-01 |
| GOBP INSEMINATION | 8 | 4.66e-02 | -4.06e-01 | 2.64e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 11 | 1.96e-02 | 4.06e-01 | 1.66e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 11 | 1.97e-02 | -4.06e-01 | 1.66e-01 |
| GOMF SINGLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY | 5 | 1.16e-01 | 4.06e-01 | 4.15e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 14 | 8.64e-03 | 4.05e-01 | 1.04e-01 |
| GOMF G QUADRUPLEX DNA BINDING | 11 | 1.99e-02 | 4.05e-01 | 1.66e-01 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 27 | 2.76e-04 | 4.04e-01 | 8.72e-03 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 6 | 8.65e-02 | -4.04e-01 | 3.58e-01 |
| GOMF DELTA CATENIN BINDING | 7 | 6.42e-02 | -4.04e-01 | 3.10e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 7 | 6.49e-02 | -4.03e-01 | 3.11e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 7 | 6.51e-02 | -4.03e-01 | 3.11e-01 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 11 | 2.08e-02 | 4.02e-01 | 1.71e-01 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 22 | 1.11e-03 | 4.02e-01 | 2.45e-02 |
| GOBP ERBB3 SIGNALING PATHWAY | 9 | 3.69e-02 | -4.02e-01 | 2.33e-01 |
| GOMF PEROXIREDOXIN ACTIVITY | 8 | 4.93e-02 | -4.01e-01 | 2.71e-01 |
| GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 7 | 6.60e-02 | 4.01e-01 | 3.12e-01 |
| GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY | 5 | 1.20e-01 | -4.01e-01 | 4.24e-01 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 16 | 5.51e-03 | -4.01e-01 | 7.74e-02 |
| GOMF INOSITOL PHOSPHATE KINASE ACTIVITY | 9 | 3.74e-02 | 4.01e-01 | 2.35e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 9 | 3.76e-02 | -4.00e-01 | 2.35e-01 |
| GOBP RESPONSE TO L LEUCINE | 14 | 9.51e-03 | 4.00e-01 | 1.09e-01 |
| GOBP REGULATION OF CENTROMERIC SISTER CHROMATID COHESION | 5 | 1.21e-01 | 4.00e-01 | 4.26e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 8 | 5.04e-02 | -3.99e-01 | 2.74e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 9 | 3.80e-02 | 3.99e-01 | 2.37e-01 |
| GOCC MRE11 COMPLEX | 5 | 1.22e-01 | 3.99e-01 | 4.28e-01 |
| GOBP MICROGLIA DIFFERENTIATION | 11 | 2.20e-02 | -3.99e-01 | 1.75e-01 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 38 | 2.14e-05 | -3.98e-01 | 1.10e-03 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 8 | 5.11e-02 | 3.98e-01 | 2.76e-01 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 1.23e-01 | -3.98e-01 | 4.30e-01 |
| GOMF HISTONE KINASE ACTIVITY | 21 | 1.60e-03 | 3.98e-01 | 3.26e-02 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 12 | 1.71e-02 | -3.98e-01 | 1.54e-01 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 8 | 5.17e-02 | -3.97e-01 | 2.77e-01 |
| GOBP RESPONSE TO NEMATODE | 5 | 1.24e-01 | -3.97e-01 | 4.31e-01 |
| GOCC SPECIFIC GRANULE | 156 | 1.03e-17 | -3.97e-01 | 8.77e-15 |
| GOBP REGULATION OF STEM CELL DIVISION | 9 | 3.91e-02 | 3.97e-01 | 2.40e-01 |
| GOMF TOLL LIKE RECEPTOR 4 BINDING | 5 | 1.24e-01 | -3.97e-01 | 4.32e-01 |
| GOBP VOCALIZATION BEHAVIOR | 11 | 2.26e-02 | 3.97e-01 | 1.78e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 15 | 7.78e-03 | -3.97e-01 | 9.62e-02 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 6.90e-02 | -3.97e-01 | 3.20e-01 |
| GOCC COHESIN COMPLEX | 10 | 2.99e-02 | 3.97e-01 | 2.09e-01 |
| GOBP NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION | 5 | 1.25e-01 | -3.97e-01 | 4.32e-01 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 16 | 6.03e-03 | 3.97e-01 | 8.23e-02 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 13 | 1.33e-02 | -3.96e-01 | 1.35e-01 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 6 | 9.29e-02 | 3.96e-01 | 3.72e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 51 | 9.85e-07 | 3.96e-01 | 7.61e-05 |
| GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION | 5 | 1.25e-01 | -3.96e-01 | 4.33e-01 |
| GOCC CONNEXIN COMPLEX | 5 | 1.25e-01 | 3.96e-01 | 4.34e-01 |
| GOCC SPECIFIC GRANULE LUMEN | 61 | 9.36e-08 | -3.95e-01 | 9.51e-06 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 7 | 7.09e-02 | 3.94e-01 | 3.25e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 20 | 2.30e-03 | 3.94e-01 | 4.19e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 21 | 1.82e-03 | -3.93e-01 | 3.57e-02 |
| GOMF DEMETHYLASE ACTIVITY | 36 | 4.51e-05 | 3.93e-01 | 2.03e-03 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 21 | 1.84e-03 | -3.93e-01 | 3.59e-02 |
| GOMF GLYCINE BINDING | 6 | 9.59e-02 | 3.92e-01 | 3.77e-01 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 19 | 3.07e-03 | 3.92e-01 | 5.12e-02 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 20 | 2.39e-03 | -3.92e-01 | 4.31e-02 |
| GOBP REGULATION OF ANGIOTENSIN LEVELS IN BLOOD | 7 | 7.23e-02 | -3.92e-01 | 3.28e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 8 | 5.49e-02 | 3.92e-01 | 2.85e-01 |
| GOCC INTERSTITIAL MATRIX | 5 | 1.29e-01 | 3.92e-01 | 4.40e-01 |
| GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 9 | 4.19e-02 | -3.92e-01 | 2.49e-01 |
| GOCC SPECIFIC GRANULE MEMBRANE | 88 | 2.17e-10 | -3.91e-01 | 4.05e-08 |
| GOBP 4 HYDROXYPROLINE METABOLIC PROCESS | 10 | 3.22e-02 | -3.91e-01 | 2.17e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA ALTERNATIVE NONHOMOLOGOUS END JOINING | 8 | 5.54e-02 | 3.91e-01 | 2.87e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 7.32e-02 | 3.91e-01 | 3.31e-01 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 5 | 1.30e-01 | 3.91e-01 | 4.42e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 22 | 1.54e-03 | -3.90e-01 | 3.16e-02 |
| GOMF OPSONIN BINDING | 12 | 1.94e-02 | -3.90e-01 | 1.65e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 5 | 1.31e-01 | -3.90e-01 | 4.44e-01 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 9 | 4.31e-02 | 3.89e-01 | 2.53e-01 |
| GOBP RNA GUANINE N7 METHYLATION | 6 | 9.87e-02 | 3.89e-01 | 3.84e-01 |
| GOBP P BODY ASSEMBLY | 23 | 1.24e-03 | 3.89e-01 | 2.69e-02 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 7 | 7.47e-02 | 3.89e-01 | 3.34e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION TO ASYMMETRICAL DIMETHYL ARGININE | 7 | 7.48e-02 | 3.89e-01 | 3.34e-01 |
| GOBP PROTEIN O LINKED FUCOSYLATION | 5 | 1.32e-01 | -3.89e-01 | 4.46e-01 |
| GOCC RAGULATOR COMPLEX | 6 | 9.91e-02 | -3.89e-01 | 3.84e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 15 | 9.15e-03 | -3.89e-01 | 1.08e-01 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 9 | 4.35e-02 | 3.89e-01 | 2.54e-01 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 7 | 7.50e-02 | -3.89e-01 | 3.35e-01 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 12 | 1.98e-02 | -3.88e-01 | 1.66e-01 |
| GOMF INTRACELLULARLY CALCIUM GATED CHLORIDE CHANNEL ACTIVITY | 12 | 1.98e-02 | -3.88e-01 | 1.66e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 13 | 1.54e-02 | -3.88e-01 | 1.47e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 24 | 1.01e-03 | 3.88e-01 | 2.31e-02 |
| GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 6 | 1.01e-01 | 3.87e-01 | 3.88e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 15 | 9.49e-03 | -3.87e-01 | 1.09e-01 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 3.45e-02 | 3.86e-01 | 2.25e-01 |
| GOCC GOLGI TRANS CISTERNA | 10 | 3.46e-02 | 3.86e-01 | 2.25e-01 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 14 | 1.24e-02 | -3.86e-01 | 1.30e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 11 | 2.68e-02 | -3.85e-01 | 1.97e-01 |
| GOCC SIGNAL RECOGNITION PARTICLE | 10 | 3.50e-02 | -3.85e-01 | 2.26e-01 |
| GOMF LIGAND GATED MONOATOMIC ANION CHANNEL ACTIVITY | 20 | 2.87e-03 | -3.85e-01 | 4.90e-02 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 9 | 4.55e-02 | 3.85e-01 | 2.60e-01 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 12 | 2.11e-02 | -3.85e-01 | 1.71e-01 |
| GOCC XY BODY | 13 | 1.65e-02 | 3.84e-01 | 1.53e-01 |
| GOMF INOSITOL 1 3 4 5 TETRAKISPHOSPHATE BINDING | 5 | 1.37e-01 | -3.84e-01 | 4.53e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 7 | 7.89e-02 | 3.84e-01 | 3.44e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 11 | 2.77e-02 | -3.83e-01 | 2.01e-01 |
| GOBP QUINOLINATE METABOLIC PROCESS | 5 | 1.38e-01 | 3.83e-01 | 4.55e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 8 | 6.06e-02 | 3.83e-01 | 3.00e-01 |
| GOCC DNA REPLICATION FACTOR A COMPLEX | 12 | 2.16e-02 | 3.83e-01 | 1.73e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 11 | 2.78e-02 | -3.83e-01 | 2.02e-01 |
| GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 5 | 1.39e-01 | 3.82e-01 | 4.57e-01 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 11 | 2.81e-02 | -3.82e-01 | 2.03e-01 |
| GOMF ALPHA CATENIN BINDING | 7 | 7.99e-02 | -3.82e-01 | 3.45e-01 |
| GOBP BLOOD COAGULATION INTRINSIC PATHWAY | 7 | 7.99e-02 | -3.82e-01 | 3.45e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION | 5 | 1.39e-01 | 3.82e-01 | 4.57e-01 |
| GOBP REGULATION OF FEAR RESPONSE | 8 | 6.15e-02 | 3.82e-01 | 3.03e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 29 | 3.74e-04 | 3.82e-01 | 1.08e-02 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 8.07e-02 | 3.81e-01 | 3.47e-01 |
| GOBP PLASMA MEMBRANE FUSION | 12 | 2.22e-02 | -3.81e-01 | 1.76e-01 |
| GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 7 | 8.08e-02 | -3.81e-01 | 3.47e-01 |
| GOCC TERTIARY GRANULE MEMBRANE | 70 | 3.48e-08 | -3.81e-01 | 4.07e-06 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 1.40e-01 | -3.81e-01 | 4.59e-01 |
| GOBP RESPONSE TO CYCLOHEXIMIDE | 5 | 1.41e-01 | -3.80e-01 | 4.60e-01 |
| GOBP CITRULLINE METABOLIC PROCESS | 5 | 1.41e-01 | 3.80e-01 | 4.60e-01 |
| GOMF RETINAL BINDING | 6 | 1.07e-01 | -3.80e-01 | 3.99e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL DEGRANULATION | 12 | 2.28e-02 | -3.80e-01 | 1.79e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 1.42e-01 | -3.79e-01 | 4.61e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 7 | 8.23e-02 | 3.79e-01 | 3.50e-01 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 15 | 1.10e-02 | 3.79e-01 | 1.21e-01 |
| GOBP COPULATION | 13 | 1.79e-02 | -3.79e-01 | 1.58e-01 |
| GOBP CORTICOTROPIN SECRETION | 5 | 1.42e-01 | -3.79e-01 | 4.61e-01 |
| GOCC RSC TYPE COMPLEX | 14 | 1.42e-02 | 3.79e-01 | 1.40e-01 |
| GOBP ATRIOVENTRICULAR NODE DEVELOPMENT | 5 | 1.43e-01 | 3.79e-01 | 4.61e-01 |
| GOCC OMEGASOME | 5 | 1.43e-01 | 3.79e-01 | 4.61e-01 |
| GOBP GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS | 7 | 8.31e-02 | 3.78e-01 | 3.51e-01 |
| GOBP TRABECULA FORMATION | 16 | 8.83e-03 | -3.78e-01 | 1.05e-01 |
| GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 1.43e-01 | 3.78e-01 | 4.63e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 8 | 6.41e-02 | 3.78e-01 | 3.10e-01 |
| GOCC CONDENSIN COMPLEX | 8 | 6.41e-02 | 3.78e-01 | 3.10e-01 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 15 | 1.13e-02 | -3.78e-01 | 1.22e-01 |
| GOBP HRI MEDIATED SIGNALING | 6 | 1.09e-01 | -3.78e-01 | 4.03e-01 |
| GOMF CYCLASE ACTIVITY | 15 | 1.14e-02 | -3.77e-01 | 1.23e-01 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 10 | 3.91e-02 | 3.77e-01 | 2.40e-01 |
| GOCC OXIDOREDUCTASE COMPLEX | 115 | 3.23e-12 | -3.76e-01 | 1.14e-09 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 17 | 7.31e-03 | 3.76e-01 | 9.18e-02 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 10 | 3.97e-02 | 3.76e-01 | 2.42e-01 |
| GOBP AUTOCRINE SIGNALING | 5 | 1.46e-01 | -3.76e-01 | 4.67e-01 |
| GOMF CHLORIDE ION BINDING | 6 | 1.11e-01 | -3.75e-01 | 4.08e-01 |
| GOBP RESPONSE TO SORBITOL | 6 | 1.12e-01 | 3.75e-01 | 4.08e-01 |
| GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 9 | 5.14e-02 | -3.75e-01 | 2.77e-01 |
| GOCC STEREOCILIUM BASE | 6 | 1.12e-01 | -3.75e-01 | 4.08e-01 |
| GOBP DELAMINATION | 5 | 1.47e-01 | -3.75e-01 | 4.69e-01 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 8 | 6.68e-02 | 3.74e-01 | 3.14e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 9 | 5.19e-02 | -3.74e-01 | 2.78e-01 |
| GOBP VACUOLAR TRANSMEMBRANE TRANSPORT | 7 | 8.71e-02 | 3.73e-01 | 3.59e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 10 | 4.11e-02 | -3.73e-01 | 2.46e-01 |
| GOBP MAST CELL DIFFERENTIATION | 5 | 1.49e-01 | -3.73e-01 | 4.74e-01 |
| GOBP GLUCOSE CATABOLIC PROCESS | 23 | 1.98e-03 | -3.73e-01 | 3.75e-02 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 13 | 2.00e-02 | 3.72e-01 | 1.67e-01 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 83 | 4.40e-09 | -3.72e-01 | 6.53e-07 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 9 | 5.30e-02 | 3.72e-01 | 2.79e-01 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 1.50e-01 | 3.72e-01 | 4.75e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 12 | 2.58e-02 | -3.72e-01 | 1.93e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 14 | 1.61e-02 | -3.72e-01 | 1.52e-01 |
| GOCC GAMMA DELTA T CELL RECEPTOR COMPLEX | 6 | 1.15e-01 | 3.71e-01 | 4.15e-01 |
| GOCC THO COMPLEX | 6 | 1.15e-01 | 3.71e-01 | 4.15e-01 |
| GOBP SUPEROXIDE ANION GENERATION | 33 | 2.23e-04 | -3.71e-01 | 7.31e-03 |
| GOCC AXONEMAL OUTER DOUBLET | 11 | 3.31e-02 | -3.71e-01 | 2.21e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 12 | 2.62e-02 | -3.71e-01 | 1.95e-01 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 10 | 4.24e-02 | -3.71e-01 | 2.51e-01 |
| GOBP BLOOD VESSEL MATURATION | 6 | 1.16e-01 | 3.70e-01 | 4.15e-01 |
| GOBP POSITIVE REGULATION OF CORTICOSTEROID HORMONE SECRETION | 5 | 1.52e-01 | -3.70e-01 | 4.76e-01 |
| GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 6 | 1.16e-01 | -3.70e-01 | 4.15e-01 |
| GOBP RRNA 5 END PROCESSING | 5 | 1.52e-01 | 3.70e-01 | 4.77e-01 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 9.04e-02 | 3.70e-01 | 3.67e-01 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 13 | 2.11e-02 | -3.69e-01 | 1.71e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 1.53e-01 | -3.69e-01 | 4.77e-01 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 33 | 2.46e-04 | -3.69e-01 | 7.97e-03 |
| GOCC HOST CELLULAR COMPONENT | 8 | 7.10e-02 | 3.69e-01 | 3.25e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 4.38e-02 | 3.68e-01 | 2.55e-01 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 6 | 1.19e-01 | 3.68e-01 | 4.20e-01 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 5.60e-02 | 3.68e-01 | 2.88e-01 |
| GOBP POSITIVE REGULATION OF STRESS GRANULE ASSEMBLY | 7 | 9.19e-02 | 3.68e-01 | 3.70e-01 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 13 | 2.17e-02 | 3.68e-01 | 1.74e-01 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 74 | 4.57e-08 | -3.67e-01 | 5.09e-06 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 8 | 7.19e-02 | -3.67e-01 | 3.27e-01 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 5 | 1.55e-01 | 3.67e-01 | 4.81e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 14 | 1.74e-02 | 3.67e-01 | 1.55e-01 |
| GOCC SHELTERIN COMPLEX | 6 | 1.20e-01 | 3.67e-01 | 4.23e-01 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 9.34e-02 | -3.66e-01 | 3.73e-01 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 10 | 4.51e-02 | 3.66e-01 | 2.60e-01 |
| GOCC CILIARY TRANSITION FIBER | 7 | 9.40e-02 | 3.66e-01 | 3.74e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 13 | 2.25e-02 | -3.65e-01 | 1.77e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 16 | 1.14e-02 | -3.65e-01 | 1.23e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 1.57e-01 | -3.65e-01 | 4.84e-01 |
| GOBP CHOLESTEROL IMPORT | 7 | 9.42e-02 | -3.65e-01 | 3.75e-01 |
| GOBP L ALANINE TRANSPORT | 8 | 7.37e-02 | 3.65e-01 | 3.32e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT | 7 | 9.47e-02 | -3.65e-01 | 3.75e-01 |
| GOBP REGULATION OF ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 5 | 1.58e-01 | 3.65e-01 | 4.86e-01 |
| GOBP URATE TRANSPORT | 5 | 1.58e-01 | -3.64e-01 | 4.86e-01 |
| GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.58e-01 | -3.64e-01 | 4.86e-01 |
| GOBP UREA TRANSMEMBRANE TRANSPORT | 6 | 1.22e-01 | -3.64e-01 | 4.28e-01 |
| GOMF UREA TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.22e-01 | -3.64e-01 | 4.28e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 20 | 4.79e-03 | 3.64e-01 | 7.05e-02 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 17 | 9.34e-03 | -3.64e-01 | 1.09e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 138 | 1.55e-13 | -3.64e-01 | 8.05e-11 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 24 | 2.04e-03 | -3.64e-01 | 3.83e-02 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 10 | 4.64e-02 | 3.64e-01 | 2.63e-01 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 6 | 1.23e-01 | -3.63e-01 | 4.30e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 12 | 2.93e-02 | 3.63e-01 | 2.08e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 6 | 1.23e-01 | -3.63e-01 | 4.30e-01 |
| GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 12 | 2.94e-02 | -3.63e-01 | 2.08e-01 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 11 | 3.72e-02 | 3.63e-01 | 2.34e-01 |
| GOBP APOPTOTIC CHROMOSOME CONDENSATION | 6 | 1.24e-01 | 3.63e-01 | 4.31e-01 |
| GOBP OTIC VESICLE MORPHOGENESIS | 5 | 1.61e-01 | 3.62e-01 | 4.90e-01 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 1.25e-01 | -3.62e-01 | 4.32e-01 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 9 | 6.07e-02 | 3.61e-01 | 3.01e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 11 | 3.82e-02 | -3.61e-01 | 2.37e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 1.62e-01 | 3.61e-01 | 4.92e-01 |
| GOMF ELECTRON TRANSFER ACTIVITY | 110 | 6.16e-11 | -3.61e-01 | 1.34e-08 |
| GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION | 6 | 1.26e-01 | -3.61e-01 | 4.35e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 15 | 1.57e-02 | -3.60e-01 | 1.49e-01 |
| GOCC TERTIARY GRANULE | 154 | 1.18e-14 | -3.60e-01 | 8.46e-12 |
| GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION | 5 | 1.64e-01 | -3.60e-01 | 4.95e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 12 | 3.12e-02 | 3.59e-01 | 2.14e-01 |
| GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 7 | 9.98e-02 | -3.59e-01 | 3.85e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS | 6 | 1.28e-01 | -3.59e-01 | 4.38e-01 |
| GOCC AZUROPHIL GRANULE | 151 | 2.64e-14 | -3.59e-01 | 1.76e-11 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 2.52e-02 | -3.59e-01 | 1.90e-01 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 1.65e-01 | 3.58e-01 | 4.98e-01 |
| GOMF ANNEALING ACTIVITY | 11 | 3.97e-02 | 3.58e-01 | 2.42e-01 |
| GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY | 6 | 1.29e-01 | 3.58e-01 | 4.39e-01 |
| GOCC MICROFIBRIL | 11 | 3.97e-02 | -3.58e-01 | 2.42e-01 |
| GOBP REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION | 5 | 1.66e-01 | -3.58e-01 | 4.99e-01 |
| GOMF GLUCOSIDASE ACTIVITY | 10 | 5.02e-02 | -3.58e-01 | 2.74e-01 |
| GOBP NUCLEOLUS ORGANIZATION | 18 | 8.61e-03 | 3.58e-01 | 1.04e-01 |
| GOCC SUMO LIGASE COMPLEX | 13 | 2.56e-02 | 3.57e-01 | 1.92e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 8 | 8.01e-02 | -3.57e-01 | 3.46e-01 |
| GOBP REGULATION OF CHROMATIN BINDING | 10 | 5.04e-02 | 3.57e-01 | 2.74e-01 |
| GOBP LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING | 7 | 1.02e-01 | 3.57e-01 | 3.89e-01 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 5.07e-02 | 3.57e-01 | 2.75e-01 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 15 | 1.67e-02 | -3.57e-01 | 1.53e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 17 | 1.09e-02 | 3.57e-01 | 1.20e-01 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 11 | 4.06e-02 | -3.57e-01 | 2.45e-01 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 1.31e-01 | -3.56e-01 | 4.43e-01 |
| GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING | 5 | 1.68e-01 | -3.56e-01 | 5.01e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 10 | 5.11e-02 | -3.56e-01 | 2.76e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 23 | 3.11e-03 | -3.56e-01 | 5.15e-02 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 14 | 2.12e-02 | -3.56e-01 | 1.72e-01 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 23 | 3.17e-03 | -3.55e-01 | 5.23e-02 |
| GOBP MECHANOSENSORY BEHAVIOR | 8 | 8.17e-02 | 3.55e-01 | 3.49e-01 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 6 | 1.32e-01 | -3.55e-01 | 4.45e-01 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 7 | 1.04e-01 | -3.55e-01 | 3.93e-01 |
| GOMF ACTIVIN RECEPTOR BINDING | 7 | 1.04e-01 | -3.55e-01 | 3.94e-01 |
| GOMF C X C CHEMOKINE BINDING | 5 | 1.70e-01 | -3.55e-01 | 5.03e-01 |
| GOCC ACETYLCHOLINE GATED CHANNEL COMPLEX | 8 | 8.24e-02 | 3.55e-01 | 3.50e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 9 | 6.56e-02 | -3.54e-01 | 3.12e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 6 | 1.33e-01 | 3.54e-01 | 4.47e-01 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 1.33e-01 | 3.54e-01 | 4.47e-01 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 6 | 1.33e-01 | -3.54e-01 | 4.48e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 10 | 5.28e-02 | -3.54e-01 | 2.79e-01 |
| GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY | 5 | 1.71e-01 | -3.53e-01 | 5.05e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 8 | 8.35e-02 | 3.53e-01 | 3.53e-01 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 54 | 7.19e-06 | -3.53e-01 | 4.26e-04 |
| GOBP RESPONSE TO ODORANT | 5 | 1.72e-01 | 3.53e-01 | 5.06e-01 |
| GOBP MONOCYTE CHEMOTAXIS | 37 | 2.04e-04 | -3.53e-01 | 6.83e-03 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 11 | 4.28e-02 | 3.53e-01 | 2.52e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 1.06e-01 | 3.53e-01 | 3.97e-01 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 8.41e-02 | -3.53e-01 | 3.54e-01 |
| GOMF MHC CLASS II PROTEIN BINDING | 6 | 1.35e-01 | 3.53e-01 | 4.50e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 8.44e-02 | -3.52e-01 | 3.54e-01 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 6 | 1.35e-01 | -3.52e-01 | 4.51e-01 |
| GOBP PROSTAGLANDIN SECRETION | 12 | 3.47e-02 | -3.52e-01 | 2.25e-01 |
| GOBP IMMATURE T CELL PROLIFERATION | 9 | 6.77e-02 | -3.52e-01 | 3.17e-01 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 12 | 3.49e-02 | -3.52e-01 | 2.26e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL OUTER MEMBRANE | 15 | 1.84e-02 | -3.52e-01 | 1.60e-01 |
| GOBP COBALAMIN METABOLIC PROCESS | 9 | 6.79e-02 | 3.51e-01 | 3.17e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 4.38e-02 | -3.51e-01 | 2.55e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 9 | 6.84e-02 | 3.51e-01 | 3.18e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION | 5 | 1.74e-01 | 3.51e-01 | 5.09e-01 |
| GOMF CUPROUS ION BINDING | 6 | 1.37e-01 | -3.51e-01 | 4.53e-01 |
| GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE | 5 | 1.75e-01 | -3.50e-01 | 5.09e-01 |
| GOMF HEXOSAMINIDASE ACTIVITY | 13 | 2.87e-02 | -3.50e-01 | 2.06e-01 |
| GOBP BONE TRABECULA MORPHOGENESIS | 11 | 4.43e-02 | -3.50e-01 | 2.57e-01 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 45 | 4.78e-05 | -3.50e-01 | 2.09e-03 |
| GOMF PROTON CHANNEL ACTIVITY | 21 | 5.48e-03 | -3.50e-01 | 7.74e-02 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 6 | 1.38e-01 | 3.50e-01 | 4.54e-01 |
| GOMF CASPASE BINDING | 10 | 5.55e-02 | -3.50e-01 | 2.87e-01 |
| GOBP RESPONSE TO LUTEINIZING HORMONE | 5 | 1.76e-01 | 3.50e-01 | 5.10e-01 |
| GOMF UNIPORTER ACTIVITY | 5 | 1.76e-01 | -3.50e-01 | 5.10e-01 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 6 | 1.39e-01 | 3.49e-01 | 4.57e-01 |
| GOBP CENTRIOLE ELONGATION | 8 | 8.73e-02 | 3.49e-01 | 3.59e-01 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 7 | 1.10e-01 | -3.49e-01 | 4.04e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 56 | 6.32e-06 | -3.49e-01 | 3.86e-04 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 5 | 1.77e-01 | 3.49e-01 | 5.12e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 52 | 1.38e-05 | -3.48e-01 | 7.62e-04 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 14 | 2.42e-02 | -3.48e-01 | 1.86e-01 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 12 | 3.69e-02 | 3.48e-01 | 2.33e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 18 | 1.07e-02 | -3.48e-01 | 1.19e-01 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 36 | 3.09e-04 | -3.47e-01 | 9.40e-03 |
| GOBP WNT PROTEIN SECRETION | 6 | 1.41e-01 | -3.47e-01 | 4.60e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 19 | 8.81e-03 | -3.47e-01 | 1.05e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 8 | 8.93e-02 | 3.47e-01 | 3.65e-01 |
| GOBP PRIMITIVE HEMOPOIESIS | 9 | 7.16e-02 | -3.47e-01 | 3.26e-01 |
| GOBP ASPARTATE METABOLIC PROCESS | 6 | 1.42e-01 | -3.46e-01 | 4.60e-01 |
| GOMF QUINONE BINDING | 16 | 1.65e-02 | -3.46e-01 | 1.53e-01 |
| GOMF CTPASE ACTIVITY | 6 | 1.42e-01 | 3.46e-01 | 4.61e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 27 | 1.86e-03 | 3.46e-01 | 3.61e-02 |
| GOBP SKELETAL MYOFIBRIL ASSEMBLY | 7 | 1.13e-01 | -3.46e-01 | 4.12e-01 |
| GOCC U7 SNRNP | 7 | 1.13e-01 | -3.46e-01 | 4.12e-01 |
| GOCC B WICH COMPLEX | 7 | 1.13e-01 | 3.46e-01 | 4.12e-01 |
| GOBP LOOP OF HENLE DEVELOPMENT | 5 | 1.81e-01 | -3.46e-01 | 5.18e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 18 | 1.11e-02 | 3.46e-01 | 1.22e-01 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 1.81e-01 | -3.45e-01 | 5.18e-01 |
| GOMF MRF BINDING | 5 | 1.81e-01 | -3.45e-01 | 5.18e-01 |
| GOBP CELLULAR RESPONSE TO L LEUCINE | 12 | 3.84e-02 | 3.45e-01 | 2.38e-01 |
| GOBP MESODERMAL CELL FATE COMMITMENT | 7 | 1.14e-01 | -3.45e-01 | 4.14e-01 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 6 | 1.44e-01 | 3.44e-01 | 4.65e-01 |
| GOCC METHYLOSOME | 12 | 3.91e-02 | -3.44e-01 | 2.40e-01 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 21 | 6.36e-03 | 3.44e-01 | 8.49e-02 |
| GOMF ACETYLCHOLINE RECEPTOR ACTIVITY | 10 | 5.98e-02 | 3.44e-01 | 2.98e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 24 | 3.59e-03 | -3.43e-01 | 5.74e-02 |
| GOMF LIPOPEPTIDE BINDING | 9 | 7.47e-02 | -3.43e-01 | 3.34e-01 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 7.47e-02 | 3.43e-01 | 3.34e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 8 | 9.32e-02 | 3.43e-01 | 3.73e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 1.17e-01 | -3.42e-01 | 4.16e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 10 | 6.12e-02 | 3.42e-01 | 3.02e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 21 | 6.72e-03 | -3.42e-01 | 8.74e-02 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 11 | 5.01e-02 | -3.41e-01 | 2.74e-01 |
| GOBP NOTCH RECEPTOR PROCESSING | 8 | 9.48e-02 | -3.41e-01 | 3.75e-01 |
| GOBP NADH METABOLIC PROCESS | 30 | 1.22e-03 | -3.41e-01 | 2.66e-02 |
| GOBP ATP BIOSYNTHETIC PROCESS | 92 | 1.56e-08 | -3.41e-01 | 2.05e-06 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 12 | 4.09e-02 | -3.41e-01 | 2.46e-01 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 1.18e-01 | -3.41e-01 | 4.19e-01 |
| GOBP INTESTINE SMOOTH MUSCLE CONTRACTION | 6 | 1.48e-01 | -3.41e-01 | 4.72e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 15 | 2.24e-02 | 3.40e-01 | 1.77e-01 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 11 | 5.06e-02 | 3.40e-01 | 2.75e-01 |
| GOBP RESPONSE TO SYMBIONT | 5 | 1.87e-01 | 3.40e-01 | 5.28e-01 |
| GOCC GLYCOPROTEIN IB IX V COMPLEX | 5 | 1.88e-01 | -3.40e-01 | 5.28e-01 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 8 | 9.56e-02 | 3.40e-01 | 3.77e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 121 | 1.00e-10 | -3.40e-01 | 2.13e-08 |
| GOBP GENOMIC IMPRINTING | 14 | 2.76e-02 | 3.40e-01 | 2.01e-01 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 6 | 1.49e-01 | -3.40e-01 | 4.74e-01 |
| GOMF HISTONE H4K20 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 1.88e-01 | 3.40e-01 | 5.29e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 8 | 9.64e-02 | -3.39e-01 | 3.78e-01 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 6 | 1.50e-01 | 3.39e-01 | 4.75e-01 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 9.67e-02 | -3.39e-01 | 3.79e-01 |
| GOCC POLAR MICROTUBULE | 5 | 1.89e-01 | 3.39e-01 | 5.30e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 11 | 5.16e-02 | 3.39e-01 | 2.77e-01 |
| GOBP REFLEX | 7 | 1.21e-01 | 3.39e-01 | 4.24e-01 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 1.51e-01 | -3.39e-01 | 4.76e-01 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 11 | 5.21e-02 | -3.38e-01 | 2.78e-01 |
| GOMF COMPLEMENT BINDING | 16 | 1.92e-02 | -3.38e-01 | 1.64e-01 |
| GOBP MICROGLIAL CELL MIGRATION | 6 | 1.52e-01 | -3.38e-01 | 4.76e-01 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 8 | 9.85e-02 | -3.37e-01 | 3.83e-01 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 23 | 5.10e-03 | -3.37e-01 | 7.36e-02 |
| GOBP ASTROCYTE DEVELOPMENT | 34 | 6.65e-04 | -3.37e-01 | 1.65e-02 |
| GOCC CHROMATIN SILENCING COMPLEX | 13 | 3.54e-02 | 3.37e-01 | 2.27e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 8 | 9.89e-02 | -3.37e-01 | 3.84e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 9 | 8.02e-02 | 3.37e-01 | 3.46e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 9 | 8.02e-02 | -3.37e-01 | 3.46e-01 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 26 | 2.96e-03 | 3.37e-01 | 5.01e-02 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 38 | 3.31e-04 | -3.36e-01 | 9.89e-03 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 9 | 8.05e-02 | -3.36e-01 | 3.46e-01 |
| GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 1.93e-01 | -3.36e-01 | 5.34e-01 |
| GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT | 10 | 6.56e-02 | 3.36e-01 | 3.12e-01 |
| GOBP FOLIC ACID TRANSPORT | 8 | 9.98e-02 | -3.36e-01 | 3.85e-01 |
| GOBP SENSORY PERCEPTION OF SOUR TASTE | 5 | 1.93e-01 | 3.36e-01 | 5.35e-01 |
| GOMF DNA DNA TETHERING ACTIVITY | 7 | 1.24e-01 | 3.36e-01 | 4.31e-01 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 6.60e-02 | -3.36e-01 | 3.13e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 12 | 4.41e-02 | 3.36e-01 | 2.56e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 22 | 6.42e-03 | 3.36e-01 | 8.51e-02 |
| GOBP CERAMIDE CATABOLIC PROCESS | 17 | 1.66e-02 | -3.36e-01 | 1.53e-01 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 9 | 8.13e-02 | -3.36e-01 | 3.48e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 7 | 1.24e-01 | -3.35e-01 | 4.32e-01 |
| GOCC LAMININ COMPLEX | 7 | 1.24e-01 | -3.35e-01 | 4.32e-01 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 6 | 1.55e-01 | 3.35e-01 | 4.81e-01 |
| GOMF ADENYLATE CYCLASE ACTIVITY | 11 | 5.44e-02 | -3.35e-01 | 2.84e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY | 9 | 8.18e-02 | -3.35e-01 | 3.49e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 46 | 8.46e-05 | -3.35e-01 | 3.35e-03 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 7 | 1.25e-01 | -3.35e-01 | 4.33e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 31 | 1.25e-03 | 3.35e-01 | 2.70e-02 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 27 | 2.64e-03 | -3.34e-01 | 4.60e-02 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 1.56e-01 | -3.34e-01 | 4.82e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 10 | 6.73e-02 | -3.34e-01 | 3.16e-01 |
| GOBP FEVER GENERATION | 9 | 8.26e-02 | -3.34e-01 | 3.50e-01 |
| GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 7 | 1.26e-01 | -3.34e-01 | 4.35e-01 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 8.26e-02 | 3.34e-01 | 3.50e-01 |
| GOBP BRAINSTEM DEVELOPMENT | 5 | 1.96e-01 | 3.34e-01 | 5.38e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 22 | 6.72e-03 | 3.34e-01 | 8.74e-02 |
| GOMF IGE BINDING | 5 | 1.97e-01 | -3.34e-01 | 5.38e-01 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 25 | 3.90e-03 | 3.33e-01 | 6.09e-02 |
| GOBP CHROMATIN LOOPING | 14 | 3.08e-02 | 3.33e-01 | 2.13e-01 |
| GOCC PERINUCLEOLAR COMPARTMENT | 5 | 1.97e-01 | 3.33e-01 | 5.40e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 7 | 1.27e-01 | -3.33e-01 | 4.38e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 25 | 3.99e-03 | -3.33e-01 | 6.17e-02 |
| GOMF UBIQUITIN MODIFIED HISTONE READER ACTIVITY | 7 | 1.28e-01 | 3.33e-01 | 4.38e-01 |
| GOBP REGULATION OF GAP JUNCTION ASSEMBLY | 6 | 1.58e-01 | -3.32e-01 | 4.86e-01 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 1.04e-01 | 3.32e-01 | 3.93e-01 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 6 | 1.59e-01 | 3.32e-01 | 4.87e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 5 | 1.99e-01 | 3.32e-01 | 5.42e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 10 | 6.95e-02 | -3.31e-01 | 3.20e-01 |
| GOBP ICOSANOID CATABOLIC PROCESS | 7 | 1.29e-01 | -3.31e-01 | 4.40e-01 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 8 | 1.05e-01 | 3.31e-01 | 3.95e-01 |
| GOCC HOPS COMPLEX | 14 | 3.19e-02 | 3.31e-01 | 2.16e-01 |
| GOBP RESPONSE TO RAPAMYCIN | 5 | 2.00e-01 | -3.31e-01 | 5.43e-01 |
| GOBP URETER DEVELOPMENT | 7 | 1.29e-01 | -3.31e-01 | 4.40e-01 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 8 | 1.05e-01 | 3.31e-01 | 3.95e-01 |
| GOBP MEIOTIC METAPHASE CHROMOSOME ALIGNMENT | 5 | 2.00e-01 | 3.31e-01 | 5.43e-01 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 10 | 7.00e-02 | -3.31e-01 | 3.21e-01 |
| GOBP INOSITOL METABOLIC PROCESS | 8 | 1.05e-01 | 3.31e-01 | 3.95e-01 |
| GOBP RESPONSE TO HYDROXYUREA | 11 | 5.75e-02 | 3.31e-01 | 2.91e-01 |
| GOBP RESPONSE TO HYPEROXIA | 14 | 3.23e-02 | -3.31e-01 | 2.17e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 17 | 1.83e-02 | 3.30e-01 | 1.60e-01 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 8.61e-02 | 3.30e-01 | 3.58e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 9 | 8.63e-02 | 3.30e-01 | 3.58e-01 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 153 | 1.81e-12 | -3.30e-01 | 7.36e-10 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 11 | 5.82e-02 | -3.30e-01 | 2.93e-01 |
| GOCC MEIOTIC COHESIN COMPLEX | 6 | 1.62e-01 | 3.30e-01 | 4.92e-01 |
| GOBP RESPONSE TO FUNGUS | 48 | 7.78e-05 | -3.30e-01 | 3.12e-03 |
| GOBP GERM CELL MIGRATION | 6 | 1.62e-01 | -3.29e-01 | 4.92e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 2.02e-01 | 3.29e-01 | 5.45e-01 |
| GOCC INTEGRIN COMPLEX | 27 | 3.06e-03 | -3.29e-01 | 5.12e-02 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 13 | 4.01e-02 | -3.29e-01 | 2.44e-01 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 8 | 1.07e-01 | -3.29e-01 | 3.99e-01 |
| GOBP RESPONSE TO UV C | 13 | 4.04e-02 | 3.28e-01 | 2.45e-01 |
| GOMF GAMMA AMINOBUTYRIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.04e-01 | -3.28e-01 | 5.47e-01 |
| GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS | 6 | 1.64e-01 | 3.28e-01 | 4.95e-01 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 75 | 8.85e-07 | -3.28e-01 | 7.07e-05 |
| GOBP REGULATION OF PROTON TRANSPORT | 15 | 2.79e-02 | -3.28e-01 | 2.02e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 6 | 1.64e-01 | 3.28e-01 | 4.96e-01 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 4.93e-02 | 3.28e-01 | 2.71e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 9 | 8.87e-02 | -3.28e-01 | 3.63e-01 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 11 | 5.99e-02 | -3.28e-01 | 2.98e-01 |
| GOBP GTP BIOSYNTHETIC PROCESS | 9 | 8.88e-02 | -3.28e-01 | 3.64e-01 |
| GOBP BRADYKININ CATABOLIC PROCESS | 6 | 1.65e-01 | -3.27e-01 | 4.98e-01 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 19 | 1.35e-02 | -3.27e-01 | 1.36e-01 |
| GOBP NEGATIVE T CELL SELECTION | 12 | 4.99e-02 | 3.27e-01 | 2.73e-01 |
| GOCC PHAGOLYSOSOME | 7 | 1.34e-01 | -3.27e-01 | 4.50e-01 |
| GOBP PONS DEVELOPMENT | 7 | 1.35e-01 | -3.27e-01 | 4.50e-01 |
| GOMF MITOCHONDRION TARGETING SEQUENCE BINDING | 5 | 2.06e-01 | -3.26e-01 | 5.50e-01 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 1.67e-01 | 3.26e-01 | 5.00e-01 |
| GOBP PHAGOSOME ACIDIFICATION | 7 | 1.35e-01 | -3.26e-01 | 4.51e-01 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 5 | 2.07e-01 | 3.26e-01 | 5.52e-01 |
| GOCC NETWORK FORMING COLLAGEN TRIMER | 6 | 1.67e-01 | -3.26e-01 | 5.00e-01 |
| GOBP ASTROCYTE ACTIVATION | 20 | 1.18e-02 | -3.25e-01 | 1.25e-01 |
| GOCC PLATELET ALPHA GRANULE | 74 | 1.35e-06 | -3.25e-01 | 9.87e-05 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 17 | 2.04e-02 | -3.25e-01 | 1.69e-01 |
| GOBP AGGRESOME ASSEMBLY | 5 | 2.09e-01 | -3.25e-01 | 5.54e-01 |
| GOBP GLYCEROL TRANSMEMBRANE TRANSPORT | 6 | 1.68e-01 | -3.25e-01 | 5.02e-01 |
| GOMF GLYCEROL TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.68e-01 | -3.25e-01 | 5.02e-01 |
| GOBP RESPONSE TO SODIUM ARSENITE | 6 | 1.68e-01 | -3.25e-01 | 5.02e-01 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 59 | 1.62e-05 | -3.24e-01 | 8.67e-04 |
| GOBP ELASTIC FIBER ASSEMBLY | 9 | 9.20e-02 | -3.24e-01 | 3.70e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 11 | 6.26e-02 | -3.24e-01 | 3.06e-01 |
| GOBP PROTEIN ACTIVATION CASCADE | 15 | 2.98e-02 | -3.24e-01 | 2.09e-01 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 9 | 9.24e-02 | -3.24e-01 | 3.72e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 11 | 6.29e-02 | -3.24e-01 | 3.07e-01 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 79 | 6.50e-07 | 3.24e-01 | 5.43e-05 |
| GOCC OUTER KINETOCHORE | 19 | 1.46e-02 | 3.24e-01 | 1.42e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 15 | 3.00e-02 | -3.24e-01 | 2.10e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 6 | 1.70e-01 | 3.24e-01 | 5.03e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 6 | 1.70e-01 | 3.23e-01 | 5.04e-01 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 12 | 5.24e-02 | 3.23e-01 | 2.78e-01 |
| GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX | 5 | 2.10e-01 | 3.23e-01 | 5.56e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 12 | 5.24e-02 | -3.23e-01 | 2.78e-01 |
| GOCC IGE IMMUNOGLOBULIN COMPLEX | 5 | 2.11e-01 | -3.23e-01 | 5.56e-01 |
| GOMF SUMO BINDING | 17 | 2.11e-02 | 3.23e-01 | 1.71e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 15 | 3.04e-02 | -3.23e-01 | 2.11e-01 |
| GOBP POSITIVE REGULATION OF FEAR RESPONSE | 5 | 2.12e-01 | 3.23e-01 | 5.58e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 14 | 3.67e-02 | -3.22e-01 | 2.32e-01 |
| GOBP PARTURITION | 10 | 7.76e-02 | -3.22e-01 | 3.41e-01 |
| GOBP GLOMERULUS MORPHOGENESIS | 7 | 1.40e-01 | 3.22e-01 | 4.58e-01 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 14 | 3.69e-02 | -3.22e-01 | 2.33e-01 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 8 | 1.15e-01 | -3.22e-01 | 4.15e-01 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 10 | 7.79e-02 | -3.22e-01 | 3.41e-01 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 9 | 9.46e-02 | 3.22e-01 | 3.75e-01 |
| GOMF SODIUM ION BINDING | 6 | 1.72e-01 | -3.22e-01 | 5.07e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 11 | 6.47e-02 | 3.22e-01 | 3.11e-01 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 6 | 1.72e-01 | -3.22e-01 | 5.07e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 7 | 1.41e-01 | 3.21e-01 | 4.60e-01 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 10 | 7.84e-02 | 3.21e-01 | 3.43e-01 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 30 | 2.31e-03 | -3.21e-01 | 4.20e-02 |
| GOBP AEROBIC RESPIRATION | 183 | 6.57e-14 | -3.21e-01 | 3.61e-11 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 1.74e-01 | 3.20e-01 | 5.09e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 9 | 9.62e-02 | 3.20e-01 | 3.78e-01 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 19 | 1.58e-02 | 3.20e-01 | 1.49e-01 |
| GOCC VESICLE LUMEN | 293 | 4.24e-21 | -3.20e-01 | 6.60e-18 |
| GOBP SYNAPTIC VESICLE UNCOATING | 5 | 2.16e-01 | 3.20e-01 | 5.60e-01 |
| GOCC PLATELET DENSE GRANULE MEMBRANE | 6 | 1.75e-01 | -3.20e-01 | 5.09e-01 |
| GOBP MACROPHAGE MIGRATION | 45 | 2.07e-04 | -3.20e-01 | 6.88e-03 |
| GOCC ELASTIC FIBER | 5 | 2.16e-01 | -3.19e-01 | 5.60e-01 |
| GOMF CELL ADHESIVE PROTEIN BINDING INVOLVED IN BUNDLE OF HIS CELL PURKINJE MYOCYTE COMMUNICATION | 5 | 2.16e-01 | -3.19e-01 | 5.60e-01 |
| GOMF BMP RECEPTOR ACTIVITY | 5 | 2.16e-01 | -3.19e-01 | 5.60e-01 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 18 | 1.91e-02 | -3.19e-01 | 1.64e-01 |
| GOBP ORNITHINE METABOLIC PROCESS | 8 | 1.18e-01 | -3.19e-01 | 4.19e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 5 | 2.17e-01 | -3.19e-01 | 5.61e-01 |
| GOBP OBSERVATIONAL LEARNING | 5 | 2.17e-01 | 3.19e-01 | 5.61e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 48 | 1.32e-04 | -3.19e-01 | 4.89e-03 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 1.44e-01 | -3.19e-01 | 4.64e-01 |
| GOBP FATTY ACID ELONGATION SATURATED FATTY ACID | 7 | 1.44e-01 | -3.19e-01 | 4.64e-01 |
| GOCC CATSPER COMPLEX | 9 | 9.78e-02 | -3.19e-01 | 3.82e-01 |
| GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 8 | 1.19e-01 | -3.18e-01 | 4.20e-01 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 10 | 8.14e-02 | 3.18e-01 | 3.48e-01 |
| GOCC NUCLEAR REPLICATION FORK | 40 | 4.98e-04 | 3.18e-01 | 1.35e-02 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 9 | 9.86e-02 | 3.18e-01 | 3.83e-01 |
| GOBP ARGININE CATABOLIC PROCESS | 7 | 1.45e-01 | -3.18e-01 | 4.66e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 12 | 5.66e-02 | -3.18e-01 | 2.89e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 46 | 1.91e-04 | -3.18e-01 | 6.45e-03 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 78 | 1.22e-06 | 3.18e-01 | 9.27e-05 |
| GOBP DNA REPLICATION SYNTHESIS OF PRIMER | 7 | 1.46e-01 | 3.18e-01 | 4.66e-01 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 9 | 9.92e-02 | 3.17e-01 | 3.84e-01 |
| GOBP MITOCHONDRIAL DNA REPAIR | 6 | 1.78e-01 | 3.17e-01 | 5.14e-01 |
| GOCC BASEMENT MEMBRANE COLLAGEN TRIMER | 5 | 2.19e-01 | -3.17e-01 | 5.64e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 2.20e-01 | 3.17e-01 | 5.64e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 5 | 2.20e-01 | -3.17e-01 | 5.64e-01 |
| GOBP NEURON NEURON SYNAPTIC TRANSMISSION | 6 | 1.79e-01 | -3.17e-01 | 5.16e-01 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 12 | 5.76e-02 | 3.17e-01 | 2.91e-01 |
| GOBP ERYTHROSE 4 PHOSPHATE PHOSPHOENOLPYRUVATE FAMILY AMINO ACID METABOLIC PROCESS | 11 | 6.91e-02 | -3.17e-01 | 3.20e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 5 | 2.20e-01 | -3.16e-01 | 5.66e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS | 5 | 2.20e-01 | 3.16e-01 | 5.66e-01 |
| GOBP DIAPEDESIS | 6 | 1.80e-01 | 3.16e-01 | 5.16e-01 |
| GOBP REGULATION OF WNT PROTEIN SECRETION | 5 | 2.21e-01 | -3.16e-01 | 5.66e-01 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 12 | 5.78e-02 | 3.16e-01 | 2.91e-01 |
| GOBP ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS | 5 | 2.21e-01 | 3.16e-01 | 5.66e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 18 | 2.02e-02 | -3.16e-01 | 1.68e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 21 | 1.21e-02 | 3.16e-01 | 1.28e-01 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 10 | 8.36e-02 | 3.16e-01 | 3.53e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 15 | 3.43e-02 | -3.16e-01 | 2.24e-01 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 53 | 7.05e-05 | -3.16e-01 | 2.87e-03 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 19 | 1.73e-02 | 3.15e-01 | 1.55e-01 |
| GOBP TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION | 7 | 1.49e-01 | -3.15e-01 | 4.73e-01 |
| GOBP L CYSTINE TRANSPORT | 5 | 2.23e-01 | 3.15e-01 | 5.68e-01 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 44 | 3.04e-04 | 3.15e-01 | 9.30e-03 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 45 | 2.61e-04 | -3.15e-01 | 8.30e-03 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 29 | 3.39e-03 | 3.14e-01 | 5.50e-02 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 9 | 1.03e-01 | 3.14e-01 | 3.91e-01 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 26 | 5.54e-03 | -3.14e-01 | 7.76e-02 |
| GOBP REGULATION OF NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 14 | 4.18e-02 | 3.14e-01 | 2.49e-01 |
| GOMF FATTY ACYL COA SYNTHASE ACTIVITY | 5 | 2.24e-01 | -3.14e-01 | 5.69e-01 |
| GOCC HAUS COMPLEX | 8 | 1.25e-01 | 3.14e-01 | 4.32e-01 |
| GOBP FRUCTOSE METABOLIC PROCESS | 13 | 5.03e-02 | -3.14e-01 | 2.74e-01 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 9 | 1.04e-01 | -3.13e-01 | 3.93e-01 |
| GOBP INNER CELL MASS CELL DIFFERENTIATION | 5 | 2.25e-01 | 3.13e-01 | 5.70e-01 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 1.04e-01 | -3.13e-01 | 3.93e-01 |
| GOMF L LEUCINE BINDING | 6 | 1.84e-01 | 3.13e-01 | 5.23e-01 |
| GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 7 | 1.52e-01 | -3.13e-01 | 4.76e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 10 | 8.66e-02 | -3.13e-01 | 3.58e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 12 | 6.06e-02 | -3.13e-01 | 3.00e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 13 | 5.09e-02 | 3.13e-01 | 2.76e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 2.26e-01 | -3.13e-01 | 5.71e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 23 | 9.43e-03 | -3.13e-01 | 1.09e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR BINDING | 7 | 1.52e-01 | -3.13e-01 | 4.77e-01 |
| GOBP REGULATION OF PLASMA CELL DIFFERENTIATION | 5 | 2.26e-01 | -3.13e-01 | 5.71e-01 |
| GOMF RETINOL BINDING | 5 | 2.26e-01 | -3.13e-01 | 5.71e-01 |
| GOBP NITRIC OXIDE CGMP MEDIATED SIGNALING | 7 | 1.52e-01 | -3.13e-01 | 4.77e-01 |
| GOCC TORC2 COMPLEX | 9 | 1.04e-01 | 3.13e-01 | 3.94e-01 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 40 | 6.33e-04 | 3.12e-01 | 1.60e-02 |
| GOMF SODIUM CHANNEL INHIBITOR ACTIVITY | 7 | 1.53e-01 | -3.12e-01 | 4.77e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 8 | 1.27e-01 | -3.12e-01 | 4.36e-01 |
| GOBP COCHLEA MORPHOGENESIS | 9 | 1.05e-01 | 3.12e-01 | 3.95e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 28 | 4.30e-03 | -3.12e-01 | 6.55e-02 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 29 | 3.67e-03 | 3.12e-01 | 5.82e-02 |
| GOMF U2 SNRNA BINDING | 6 | 1.86e-01 | 3.12e-01 | 5.26e-01 |
| GOMF FLIPPASE ACTIVITY | 15 | 3.67e-02 | 3.12e-01 | 2.32e-01 |
| GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY | 5 | 2.28e-01 | -3.11e-01 | 5.73e-01 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 52 | 1.03e-04 | -3.11e-01 | 4.05e-03 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION | 6 | 1.87e-01 | 3.11e-01 | 5.28e-01 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 13 | 5.24e-02 | 3.11e-01 | 2.78e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 19 | 1.90e-02 | 3.11e-01 | 1.64e-01 |
| GOCC CKM COMPLEX | 5 | 2.29e-01 | 3.11e-01 | 5.74e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 17 | 2.66e-02 | 3.11e-01 | 1.96e-01 |
| GOBP RESOLUTION OF DNA RECOMBINATION INTERMEDIATES | 6 | 1.88e-01 | 3.10e-01 | 5.28e-01 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 7 | 1.55e-01 | 3.10e-01 | 4.81e-01 |
| GOMF SIRNA BINDING | 10 | 8.95e-02 | 3.10e-01 | 3.65e-01 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 16 | 3.18e-02 | 3.10e-01 | 2.16e-01 |
| GOMF ACYL COA OXIDASE ACTIVITY | 7 | 1.56e-01 | -3.10e-01 | 4.82e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 115 | 9.70e-09 | -3.10e-01 | 1.31e-06 |
| GOMF INORGANIC DIPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 2.31e-01 | -3.09e-01 | 5.77e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 9 | 1.08e-01 | 3.09e-01 | 4.00e-01 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 12 | 6.35e-02 | 3.09e-01 | 3.08e-01 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 2.31e-01 | 3.09e-01 | 5.78e-01 |
| GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 8 | 1.30e-01 | -3.09e-01 | 4.41e-01 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 2.31e-01 | -3.09e-01 | 5.78e-01 |
| GOBP MATING BEHAVIOR | 22 | 1.21e-02 | -3.09e-01 | 1.28e-01 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 6 | 1.91e-01 | -3.09e-01 | 5.31e-01 |
| GOMF RETINOIC ACID BINDING | 8 | 1.31e-01 | 3.09e-01 | 4.43e-01 |
| GOMF MACROLIDE BINDING | 11 | 7.66e-02 | -3.08e-01 | 3.39e-01 |
| GOBP BASOLATERAL PROTEIN SECRETION | 5 | 2.33e-01 | 3.08e-01 | 5.79e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 9 | 1.09e-01 | -3.08e-01 | 4.03e-01 |
| GOBP NITROGEN CYCLE METABOLIC PROCESS | 8 | 1.31e-01 | -3.08e-01 | 4.43e-01 |
| GOBP UREA CYCLE | 8 | 1.31e-01 | -3.08e-01 | 4.43e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 12 | 6.45e-02 | 3.08e-01 | 3.11e-01 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 15 | 3.88e-02 | -3.08e-01 | 2.39e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 80 | 1.88e-06 | -3.08e-01 | 1.30e-04 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 9.16e-02 | -3.08e-01 | 3.70e-01 |
| GOCC GLYCOGEN GRANULE | 6 | 1.91e-01 | 3.08e-01 | 5.33e-01 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 5 | 2.33e-01 | 3.08e-01 | 5.80e-01 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 12 | 6.51e-02 | -3.08e-01 | 3.11e-01 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 9 | 1.10e-01 | 3.07e-01 | 4.05e-01 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 5 | 2.34e-01 | 3.07e-01 | 5.81e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 31 | 3.04e-03 | -3.07e-01 | 5.12e-02 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 8 | 1.32e-01 | -3.07e-01 | 4.46e-01 |
| GOBP GRANULOCYTE ACTIVATION | 45 | 3.60e-04 | -3.07e-01 | 1.05e-02 |
| GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH | 9 | 1.11e-01 | 3.07e-01 | 4.07e-01 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 9 | 1.11e-01 | 3.07e-01 | 4.07e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 12 | 6.57e-02 | -3.07e-01 | 3.12e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 10 | 9.30e-02 | 3.07e-01 | 3.72e-01 |
| GOBP MUSCLE ATROPHY | 8 | 1.33e-01 | -3.07e-01 | 4.47e-01 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 11 | 7.82e-02 | -3.07e-01 | 3.43e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 12 | 6.59e-02 | 3.07e-01 | 3.12e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 72 | 6.90e-06 | 3.06e-01 | 4.13e-04 |
| GOBP SEGMENT SPECIFICATION | 8 | 1.33e-01 | 3.06e-01 | 4.48e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 12 | 6.62e-02 | -3.06e-01 | 3.13e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 10 | 9.36e-02 | -3.06e-01 | 3.74e-01 |
| GOBP ARGININE METABOLIC PROCESS | 13 | 5.61e-02 | -3.06e-01 | 2.88e-01 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 42 | 6.01e-04 | -3.06e-01 | 1.55e-02 |
| GOCC 3M COMPLEX | 5 | 2.36e-01 | -3.06e-01 | 5.84e-01 |
| GOMF PEPTIDOGLYCAN BINDING | 11 | 7.90e-02 | -3.06e-01 | 3.44e-01 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 23 | 1.12e-02 | -3.06e-01 | 1.22e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 10 | 9.43e-02 | 3.06e-01 | 3.75e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 16 | 3.43e-02 | 3.06e-01 | 2.24e-01 |
| GOBP PROTEIN NITROSYLATION | 13 | 5.67e-02 | -3.05e-01 | 2.89e-01 |
| GOMF DNA TRANSLOCASE ACTIVITY | 5 | 2.37e-01 | 3.05e-01 | 5.85e-01 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 10 | 9.47e-02 | 3.05e-01 | 3.75e-01 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 6 | 1.96e-01 | -3.05e-01 | 5.37e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 6.72e-02 | -3.05e-01 | 3.16e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 1.96e-01 | 3.05e-01 | 5.38e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 20 | 1.82e-02 | -3.05e-01 | 1.60e-01 |
| GOBP PEPTIDE MODIFICATION | 6 | 1.96e-01 | -3.05e-01 | 5.38e-01 |
| GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION | 6 | 1.96e-01 | -3.05e-01 | 5.38e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 1.36e-01 | -3.04e-01 | 4.52e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 27 | 6.20e-03 | -3.04e-01 | 8.36e-02 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 10 | 9.57e-02 | 3.04e-01 | 3.77e-01 |
| GOBP REGULATION OF RESPONSE TO NUTRIENT LEVELS | 22 | 1.35e-02 | -3.04e-01 | 1.36e-01 |
| GOBP GLIAL CELL MIGRATION | 53 | 1.28e-04 | -3.04e-01 | 4.82e-03 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 8 | 1.37e-01 | 3.04e-01 | 4.53e-01 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 6 | 1.97e-01 | 3.04e-01 | 5.40e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 42 | 6.54e-04 | -3.04e-01 | 1.63e-02 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION TO BONE MARROW | 5 | 2.39e-01 | 3.04e-01 | 5.87e-01 |
| GOMF HISTONE READER ACTIVITY | 18 | 2.57e-02 | 3.04e-01 | 1.92e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 14 | 4.92e-02 | 3.04e-01 | 2.71e-01 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 9 | 1.15e-01 | 3.03e-01 | 4.15e-01 |
| GOBP HEPATOCYTE DIFFERENTIATION | 9 | 1.15e-01 | 3.03e-01 | 4.15e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 5 | 2.40e-01 | 3.03e-01 | 5.88e-01 |
| GOCC LAMELLAR BODY | 9 | 1.15e-01 | -3.03e-01 | 4.15e-01 |
| GOBP PEPTIDE CROSS LINKING | 17 | 3.07e-02 | -3.03e-01 | 2.13e-01 |
| GOBP RHOMBOMERE DEVELOPMENT | 5 | 2.41e-01 | -3.03e-01 | 5.89e-01 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 15 | 4.25e-02 | -3.03e-01 | 2.51e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 9 | 1.16e-01 | -3.03e-01 | 4.15e-01 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 8 | 1.39e-01 | 3.02e-01 | 4.57e-01 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 6 | 2.00e-01 | -3.02e-01 | 5.43e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 16 | 3.64e-02 | -3.02e-01 | 2.31e-01 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 13 | 5.95e-02 | 3.02e-01 | 2.97e-01 |
| GOBP RESPONSE TO YEAST | 7 | 1.67e-01 | -3.02e-01 | 5.00e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 28 | 5.69e-03 | -3.02e-01 | 7.92e-02 |
| GOMF ALKALI METAL ION BINDING | 13 | 5.95e-02 | -3.02e-01 | 2.97e-01 |
| GOBP RESPONSE TO GLUCAGON | 13 | 5.95e-02 | 3.02e-01 | 2.97e-01 |
| GOCC MITOTIC SPINDLE POLE | 38 | 1.29e-03 | 3.02e-01 | 2.74e-02 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 6 | 2.01e-01 | 3.02e-01 | 5.43e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 15 | 4.32e-02 | 3.01e-01 | 2.53e-01 |
| GOCC CYTOLYTIC GRANULE | 14 | 5.08e-02 | -3.01e-01 | 2.76e-01 |
| GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 6 | 2.01e-01 | 3.01e-01 | 5.44e-01 |
| GOBP CYCLOOXYGENASE PATHWAY | 9 | 1.17e-01 | -3.01e-01 | 4.17e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR | 13 | 6.02e-02 | -3.01e-01 | 2.99e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT | 6 | 2.02e-01 | -3.01e-01 | 5.45e-01 |
| GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 2.44e-01 | -3.01e-01 | 5.90e-01 |
| GOBP OTIC VESICLE DEVELOPMENT | 8 | 1.41e-01 | 3.01e-01 | 4.60e-01 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 6 | 2.02e-01 | -3.01e-01 | 5.45e-01 |
| GOMF TRANSPORTER INHIBITOR ACTIVITY | 32 | 3.25e-03 | -3.01e-01 | 5.33e-02 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 14 | 5.16e-02 | 3.00e-01 | 2.77e-01 |
| GOBP REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 6 | 2.03e-01 | -3.00e-01 | 5.45e-01 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 8 | 1.41e-01 | 3.00e-01 | 4.60e-01 |
| GOBP HEART VALVE FORMATION | 8 | 1.42e-01 | 3.00e-01 | 4.60e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 25 | 9.41e-03 | 3.00e-01 | 1.09e-01 |
| GOMF CENTROMERIC DNA BINDING | 6 | 2.03e-01 | 3.00e-01 | 5.46e-01 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 25 | 9.53e-03 | 3.00e-01 | 1.09e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 10 | 1.01e-01 | -2.99e-01 | 3.88e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 12 | 7.24e-02 | -2.99e-01 | 3.28e-01 |
| GOBP PERICARDIUM DEVELOPMENT | 8 | 1.43e-01 | 2.99e-01 | 4.61e-01 |
| GOMF CLATHRIN LIGHT CHAIN BINDING | 6 | 2.04e-01 | 2.99e-01 | 5.48e-01 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 17 | 3.26e-02 | -2.99e-01 | 2.19e-01 |
| GOMF RETROMER COMPLEX BINDING | 9 | 1.20e-01 | -2.99e-01 | 4.24e-01 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 8 | 1.43e-01 | 2.99e-01 | 4.63e-01 |
| GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY | 5 | 2.47e-01 | -2.99e-01 | 5.95e-01 |
| GOBP MUCOCILIARY CLEARANCE | 6 | 2.05e-01 | 2.99e-01 | 5.49e-01 |
| GOCC GROWTH FACTOR COMPLEX | 6 | 2.05e-01 | -2.99e-01 | 5.49e-01 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 11 | 8.63e-02 | 2.99e-01 | 3.58e-01 |
| GOMF PROTEIN ANTIGEN BINDING | 8 | 1.44e-01 | 2.99e-01 | 4.63e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 15 | 4.53e-02 | 2.99e-01 | 2.60e-01 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 2.48e-01 | -2.98e-01 | 5.95e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 9 | 1.22e-01 | -2.98e-01 | 4.26e-01 |
| GOCC TUBULAR ENDOSOME | 5 | 2.49e-01 | 2.98e-01 | 5.96e-01 |
| GOBP COPPER ION HOMEOSTASIS | 19 | 2.47e-02 | -2.98e-01 | 1.88e-01 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 8 | 1.45e-01 | 2.98e-01 | 4.66e-01 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 8 | 1.45e-01 | -2.98e-01 | 4.66e-01 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 8 | 1.45e-01 | 2.98e-01 | 4.66e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 7 | 1.73e-01 | 2.97e-01 | 5.08e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 11 | 8.79e-02 | -2.97e-01 | 3.61e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 22 | 1.59e-02 | -2.97e-01 | 1.50e-01 |
| GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY | 7 | 1.74e-01 | -2.97e-01 | 5.08e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 14 | 5.45e-02 | -2.97e-01 | 2.84e-01 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 15 | 4.67e-02 | 2.97e-01 | 2.64e-01 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 9 | 1.23e-01 | -2.97e-01 | 4.30e-01 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 15 | 4.67e-02 | -2.97e-01 | 2.64e-01 |
| GOCC PYRUVATE DEHYDROGENASE COMPLEX | 6 | 2.08e-01 | -2.97e-01 | 5.54e-01 |
| GOBP ADULT HEART DEVELOPMENT | 5 | 2.51e-01 | -2.97e-01 | 5.98e-01 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 2.08e-01 | 2.97e-01 | 5.54e-01 |
| GOMF CHEMOATTRACTANT ACTIVITY | 17 | 3.44e-02 | -2.96e-01 | 2.24e-01 |
| GOBP RIG I SIGNALING PATHWAY | 24 | 1.20e-02 | 2.96e-01 | 1.27e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 13 | 6.44e-02 | -2.96e-01 | 3.11e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 12 | 7.56e-02 | 2.96e-01 | 3.36e-01 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 54 | 1.68e-04 | -2.96e-01 | 5.87e-03 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 78 | 6.43e-06 | 2.95e-01 | 3.90e-04 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 12 | 7.64e-02 | 2.95e-01 | 3.38e-01 |
| GOBP EOSINOPHIL DIFFERENTIATION | 5 | 2.53e-01 | -2.95e-01 | 6.00e-01 |
| GOCC DNA REPAIR COMPLEX | 22 | 1.65e-02 | 2.95e-01 | 1.53e-01 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 47 | 4.62e-04 | 2.95e-01 | 1.26e-02 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 7.66e-02 | -2.95e-01 | 3.39e-01 |
| GOBP ZYMOGEN ACTIVATION | 44 | 7.13e-04 | -2.95e-01 | 1.75e-02 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 1.26e-01 | 2.95e-01 | 4.35e-01 |
| GOBP LOCOMOTOR RHYTHM | 11 | 9.07e-02 | -2.95e-01 | 3.68e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 6 | 2.12e-01 | 2.94e-01 | 5.58e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS VIA UDP GALACTOSE | 5 | 2.54e-01 | -2.94e-01 | 6.02e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 21 | 1.95e-02 | -2.94e-01 | 1.66e-01 |
| GOMF LNCRNA BINDING | 16 | 4.15e-02 | 2.94e-01 | 2.48e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS | 7 | 1.78e-01 | -2.94e-01 | 5.14e-01 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 6 | 2.12e-01 | 2.94e-01 | 5.59e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 1.08e-01 | -2.94e-01 | 4.00e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 15 | 4.88e-02 | -2.94e-01 | 2.70e-01 |
| GOBP DORSAL SPINAL CORD DEVELOPMENT | 8 | 1.50e-01 | -2.94e-01 | 4.75e-01 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 2.13e-01 | -2.94e-01 | 5.59e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DEVELOPMENT | 6 | 2.13e-01 | -2.93e-01 | 5.59e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 9 | 1.27e-01 | 2.93e-01 | 4.38e-01 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 122 | 2.19e-08 | -2.93e-01 | 2.72e-06 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 14 | 5.74e-02 | 2.93e-01 | 2.91e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 9 | 1.28e-01 | 2.93e-01 | 4.38e-01 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 2.56e-01 | 2.93e-01 | 6.04e-01 |
| GOBP MONOACYLGLYCEROL BIOSYNTHETIC PROCESS | 6 | 2.14e-01 | -2.93e-01 | 5.59e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 12 | 7.88e-02 | -2.93e-01 | 3.44e-01 |
| GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY | 6 | 2.14e-01 | 2.93e-01 | 5.59e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 7 | 1.80e-01 | -2.93e-01 | 5.16e-01 |
| GOBP SIRNA PROCESSING | 8 | 1.52e-01 | 2.93e-01 | 4.76e-01 |
| GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 8 | 1.52e-01 | 2.93e-01 | 4.76e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 16 | 4.26e-02 | -2.93e-01 | 2.52e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 19 | 2.72e-02 | -2.93e-01 | 1.99e-01 |
| GOMF NEUREGULIN BINDING | 5 | 2.57e-01 | -2.93e-01 | 6.05e-01 |
| GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION | 8 | 1.52e-01 | -2.93e-01 | 4.76e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY | 6 | 2.14e-01 | -2.93e-01 | 5.59e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 5 | 2.57e-01 | -2.92e-01 | 6.05e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 18 | 3.17e-02 | 2.92e-01 | 2.15e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 18 | 3.17e-02 | -2.92e-01 | 2.15e-01 |
| GOMF HELICASE ACTIVITY | 148 | 8.09e-10 | 2.92e-01 | 1.40e-07 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 1.52e-01 | -2.92e-01 | 4.77e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 11 | 9.32e-02 | 2.92e-01 | 3.73e-01 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 6 | 2.15e-01 | -2.92e-01 | 5.60e-01 |
| GOBP SYNAPTIC VESICLE DOCKING | 6 | 2.15e-01 | 2.92e-01 | 5.60e-01 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 6 | 2.16e-01 | -2.92e-01 | 5.60e-01 |
| GOMF FLOPPASE ACTIVITY | 16 | 4.33e-02 | 2.92e-01 | 2.54e-01 |
| GOBP MICROAUTOPHAGY | 22 | 1.79e-02 | 2.91e-01 | 1.58e-01 |
| GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS | 5 | 2.59e-01 | -2.91e-01 | 6.08e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 21 | 2.08e-02 | 2.91e-01 | 1.71e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 12 | 8.07e-02 | -2.91e-01 | 3.47e-01 |
| GOCC MIGRASOME | 5 | 2.60e-01 | -2.91e-01 | 6.08e-01 |
| GOMF ANKYRIN BINDING | 13 | 6.93e-02 | 2.91e-01 | 3.20e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 2.17e-01 | 2.91e-01 | 5.61e-01 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 12 | 8.11e-02 | 2.91e-01 | 3.47e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 18 | 3.27e-02 | -2.91e-01 | 2.19e-01 |
| GOBP CAMP BIOSYNTHETIC PROCESS | 7 | 1.83e-01 | -2.90e-01 | 5.22e-01 |
| GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 7 | 1.84e-01 | 2.90e-01 | 5.22e-01 |
| GOBP DNA TOPOLOGICAL CHANGE | 9 | 1.32e-01 | 2.90e-01 | 4.45e-01 |
| GOBP SEX DETERMINATION | 10 | 1.12e-01 | -2.90e-01 | 4.09e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 134 | 6.68e-09 | 2.90e-01 | 9.47e-07 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 11 | 9.58e-02 | 2.90e-01 | 3.77e-01 |
| GOBP DIAPHRAGM DEVELOPMENT | 5 | 2.62e-01 | -2.89e-01 | 6.11e-01 |
| GOCC MEDIATOR COMPLEX | 37 | 2.33e-03 | 2.89e-01 | 4.23e-02 |
| GOMF ACETYLESTERASE ACTIVITY | 5 | 2.63e-01 | 2.89e-01 | 6.11e-01 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 5.26e-02 | 2.89e-01 | 2.79e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 10 | 1.14e-01 | -2.89e-01 | 4.13e-01 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 10 | 1.14e-01 | 2.89e-01 | 4.13e-01 |
| GOBP BLASTOCYST GROWTH | 20 | 2.55e-02 | 2.89e-01 | 1.91e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPSE ORGANIZATION | 5 | 2.64e-01 | -2.88e-01 | 6.13e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 21 | 2.22e-02 | 2.88e-01 | 1.76e-01 |
| GOMF PROTEIN GERANYLGERANYLTRANSFERASE ACTIVITY | 5 | 2.64e-01 | 2.88e-01 | 6.13e-01 |
| GOMF LYSOPHOSPHATIDIC ACID PHOSPHATASE ACTIVITY | 5 | 2.65e-01 | 2.88e-01 | 6.13e-01 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 31 | 5.49e-03 | -2.88e-01 | 7.74e-02 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 23 | 1.68e-02 | 2.88e-01 | 1.53e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 21 | 2.23e-02 | -2.88e-01 | 1.76e-01 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 7 | 1.88e-01 | 2.88e-01 | 5.28e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 14 | 6.24e-02 | -2.88e-01 | 3.06e-01 |
| GOBP INTERLEUKIN 1 ALPHA PRODUCTION | 6 | 2.23e-01 | -2.87e-01 | 5.68e-01 |
| GOMF DEATH RECEPTOR ACTIVITY | 12 | 8.48e-02 | -2.87e-01 | 3.55e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 14 | 6.27e-02 | -2.87e-01 | 3.06e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 22 | 1.97e-02 | 2.87e-01 | 1.66e-01 |
| GOBP DNA STRAND INVASION | 5 | 2.66e-01 | 2.87e-01 | 6.15e-01 |
| GOBP CELLULAR RESPONSE TO L GLUTAMATE | 5 | 2.66e-01 | 2.87e-01 | 6.15e-01 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 2.66e-01 | -2.87e-01 | 6.15e-01 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 1.88e-01 | 2.87e-01 | 5.29e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY | 7 | 1.89e-01 | -2.87e-01 | 5.29e-01 |
| GOBP POLYAMINE METABOLIC PROCESS | 18 | 3.51e-02 | -2.87e-01 | 2.26e-01 |
| GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR | 7 | 1.89e-01 | -2.87e-01 | 5.29e-01 |
| GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT | 6 | 2.24e-01 | -2.87e-01 | 5.69e-01 |
| GOCC ASTROCYTE END FOOT | 6 | 2.24e-01 | -2.87e-01 | 5.69e-01 |
| GOCC REPLISOME | 23 | 1.74e-02 | 2.87e-01 | 1.55e-01 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 17 | 4.10e-02 | 2.86e-01 | 2.46e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 17 | 4.10e-02 | 2.86e-01 | 2.46e-01 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 12 | 8.62e-02 | -2.86e-01 | 3.58e-01 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 9 | 1.37e-01 | -2.86e-01 | 4.54e-01 |
| GOMF GPI ANCHOR BINDING | 5 | 2.68e-01 | -2.86e-01 | 6.18e-01 |
| GOBP CGMP MEDIATED SIGNALING | 18 | 3.57e-02 | -2.86e-01 | 2.29e-01 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 17 | 4.12e-02 | 2.86e-01 | 2.47e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 8 | 1.61e-01 | 2.86e-01 | 4.91e-01 |
| GOMF CHONDROITIN SULFATE BINDING | 6 | 2.25e-01 | 2.86e-01 | 5.70e-01 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 12 | 8.66e-02 | -2.86e-01 | 3.58e-01 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 15 | 5.54e-02 | 2.86e-01 | 2.87e-01 |
| GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT | 8 | 1.62e-01 | -2.86e-01 | 4.92e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 14 | 6.43e-02 | 2.86e-01 | 3.10e-01 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 8 | 1.62e-01 | 2.85e-01 | 4.92e-01 |
| GOBP MEMBRANOUS SEPTUM MORPHOGENESIS | 7 | 1.91e-01 | 2.85e-01 | 5.32e-01 |
| GOBP TYROSINE CATABOLIC PROCESS | 5 | 2.69e-01 | -2.85e-01 | 6.19e-01 |
| GOBP REGULATION OF CORE PROMOTER BINDING | 5 | 2.69e-01 | -2.85e-01 | 6.20e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 7 | 1.92e-01 | -2.85e-01 | 5.33e-01 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 7 | 1.92e-01 | -2.85e-01 | 5.33e-01 |
| GOBP VASCULAR WOUND HEALING | 15 | 5.64e-02 | -2.85e-01 | 2.89e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 9 | 1.39e-01 | -2.85e-01 | 4.57e-01 |
| GOBP FOLATE TRANSMEMBRANE TRANSPORT | 5 | 2.71e-01 | -2.85e-01 | 6.21e-01 |
| GOBP COPPER ION IMPORT | 6 | 2.28e-01 | -2.84e-01 | 5.73e-01 |
| GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 5 | 2.71e-01 | -2.84e-01 | 6.22e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 12 | 8.83e-02 | -2.84e-01 | 3.62e-01 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 11 | 1.03e-01 | 2.84e-01 | 3.91e-01 |
| GOBP COBALT ION TRANSPORT | 7 | 1.93e-01 | -2.84e-01 | 5.35e-01 |
| GOBP RENAL WATER ABSORPTION | 5 | 2.72e-01 | -2.84e-01 | 6.22e-01 |
| GOCC ESC E Z COMPLEX | 15 | 5.70e-02 | 2.84e-01 | 2.90e-01 |
| GOBP CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS | 7 | 1.93e-01 | -2.84e-01 | 5.35e-01 |
| GOMF HYDROPEROXY ICOSATETRAENOATE DEHYDRATASE ACTIVITY | 5 | 2.72e-01 | -2.84e-01 | 6.22e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 6 | 2.29e-01 | 2.84e-01 | 5.74e-01 |
| GOBP RESPONSE TO COBALT ION | 10 | 1.21e-01 | 2.83e-01 | 4.26e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 36 | 3.31e-03 | 2.83e-01 | 5.41e-02 |
| GOBP ICOSANOID TRANSPORT | 36 | 3.32e-03 | -2.83e-01 | 5.41e-02 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 6 | 2.31e-01 | 2.83e-01 | 5.77e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR REGULATOR ACTIVITY | 5 | 2.74e-01 | -2.82e-01 | 6.24e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 41 | 1.75e-03 | -2.82e-01 | 3.48e-02 |
| GOBP RESPONSE TO MINERALOCORTICOID | 30 | 7.42e-03 | -2.82e-01 | 9.28e-02 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 7 | 1.96e-01 | 2.82e-01 | 5.38e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 156 | 1.16e-09 | -2.82e-01 | 1.93e-07 |
| GOCC CATENIN COMPLEX | 17 | 4.40e-02 | 2.82e-01 | 2.56e-01 |
| GOCC PHAGOCYTIC CUP | 27 | 1.12e-02 | -2.82e-01 | 1.22e-01 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 11 | 1.06e-01 | 2.82e-01 | 3.96e-01 |
| GOBP SYMPATHETIC GANGLION DEVELOPMENT | 5 | 2.76e-01 | 2.81e-01 | 6.26e-01 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 8 | 1.68e-01 | 2.81e-01 | 5.02e-01 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 30 | 7.69e-03 | -2.81e-01 | 9.55e-02 |
| GOBP RESPONSE TO GRAVITY | 6 | 2.33e-01 | -2.81e-01 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 1.69e-01 | -2.81e-01 | 5.02e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 11 | 1.07e-01 | 2.81e-01 | 3.98e-01 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 9 | 1.45e-01 | -2.81e-01 | 4.65e-01 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 11 | 1.07e-01 | -2.81e-01 | 3.98e-01 |
| GOBP RETINAL METABOLIC PROCESS | 13 | 7.96e-02 | -2.81e-01 | 3.45e-01 |
| GOBP REGULATION OF PINOCYTOSIS | 11 | 1.07e-01 | 2.81e-01 | 3.99e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 8 | 1.69e-01 | 2.81e-01 | 5.03e-01 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 7 | 1.99e-01 | -2.81e-01 | 5.41e-01 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 2.34e-01 | 2.81e-01 | 5.81e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 27 | 1.16e-02 | 2.81e-01 | 1.25e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 17 | 4.52e-02 | 2.81e-01 | 2.60e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 28 | 1.02e-02 | 2.81e-01 | 1.15e-01 |
| GOBP MITOTIC SPINDLE ELONGATION | 11 | 1.07e-01 | 2.81e-01 | 3.99e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 14 | 6.93e-02 | -2.80e-01 | 3.20e-01 |
| GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 5 | 2.78e-01 | -2.80e-01 | 6.27e-01 |
| GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 6 | 2.35e-01 | -2.80e-01 | 5.82e-01 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 11 | 1.08e-01 | -2.80e-01 | 4.00e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 32 | 6.09e-03 | 2.80e-01 | 8.27e-02 |
| GOBP AXIAL MESODERM DEVELOPMENT | 7 | 2.00e-01 | 2.80e-01 | 5.43e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 14 | 6.99e-02 | 2.80e-01 | 3.21e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 16 | 5.28e-02 | -2.80e-01 | 2.79e-01 |
| GOBP PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE | 6 | 2.36e-01 | 2.80e-01 | 5.83e-01 |
| GOBP REGULATION OF ACROSOME REACTION | 7 | 2.00e-01 | 2.80e-01 | 5.43e-01 |
| GOBP PODOSOME ASSEMBLY | 18 | 4.02e-02 | -2.79e-01 | 2.44e-01 |
| GOBP HISTAMINE SECRETION | 12 | 9.40e-02 | -2.79e-01 | 3.74e-01 |
| GOBP COLLAGEN CATABOLIC PROCESS | 31 | 7.13e-03 | -2.79e-01 | 9.07e-02 |
| GOMF GLYCOGEN BINDING | 6 | 2.36e-01 | 2.79e-01 | 5.84e-01 |
| GOCC NUCLEAR OUTER MEMBRANE | 26 | 1.38e-02 | -2.79e-01 | 1.38e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 10 | 1.27e-01 | -2.79e-01 | 4.36e-01 |
| GOBP TRNA TRANSPORT | 5 | 2.80e-01 | -2.79e-01 | 6.29e-01 |
| GOBP LIPID IMPORT INTO CELL | 18 | 4.05e-02 | -2.79e-01 | 2.45e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 6 | 2.37e-01 | -2.79e-01 | 5.85e-01 |
| GOCC INTEGRATOR COMPLEX | 16 | 5.36e-02 | 2.79e-01 | 2.81e-01 |
| GOBP BILE ACID SECRETION | 8 | 1.72e-01 | 2.79e-01 | 5.07e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 11 | 1.10e-01 | -2.79e-01 | 4.03e-01 |
| GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION | 7 | 2.02e-01 | -2.78e-01 | 5.45e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 15 | 6.19e-02 | -2.78e-01 | 3.04e-01 |
| GOBP REGULATION OF HEAT GENERATION | 11 | 1.10e-01 | -2.78e-01 | 4.04e-01 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 8 | 1.73e-01 | -2.78e-01 | 5.07e-01 |
| GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION | 6 | 2.38e-01 | 2.78e-01 | 5.85e-01 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 7 | 2.03e-01 | -2.78e-01 | 5.45e-01 |
| GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY | 8 | 1.73e-01 | -2.78e-01 | 5.08e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 32 | 6.48e-03 | 2.78e-01 | 8.55e-02 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 23 | 2.10e-02 | -2.78e-01 | 1.71e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 8 | 1.74e-01 | -2.78e-01 | 5.08e-01 |
| GOBP INTRACILIARY TRANSPORT | 43 | 1.62e-03 | 2.78e-01 | 3.29e-02 |
| GOBP INTERLEUKIN 17 PRODUCTION | 33 | 5.78e-03 | -2.78e-01 | 8.02e-02 |
| GOBP PEROXISOME FISSION | 10 | 1.29e-01 | -2.78e-01 | 4.39e-01 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 15 | 6.28e-02 | 2.77e-01 | 3.07e-01 |
| GOBP RESPONSE TO GONADOTROPIN RELEASING HORMONE | 6 | 2.39e-01 | -2.77e-01 | 5.87e-01 |
| GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY | 5 | 2.83e-01 | -2.77e-01 | 6.32e-01 |
| GOCC DYNACTIN COMPLEX | 8 | 1.75e-01 | -2.77e-01 | 5.09e-01 |
| GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 2.40e-01 | 2.77e-01 | 5.88e-01 |
| GOCC FICOLIN 1 RICH GRANULE | 179 | 1.67e-10 | -2.77e-01 | 3.31e-08 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 1.66e-02 | -2.77e-01 | 1.53e-01 |
| GOBP BEHAVIORAL RESPONSE TO NICOTINE | 5 | 2.84e-01 | 2.77e-01 | 6.34e-01 |
| GOCC MKS COMPLEX | 13 | 8.42e-02 | 2.77e-01 | 3.54e-01 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 17 | 4.83e-02 | -2.77e-01 | 2.69e-01 |
| GOMF CHEMOKINE ACTIVITY | 23 | 2.17e-02 | -2.77e-01 | 1.74e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 194 | 3.10e-11 | 2.76e-01 | 7.63e-09 |
| GOBP OOCYTE CONSTRUCTION | 5 | 2.85e-01 | 2.76e-01 | 6.34e-01 |
| GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.76e-01 | -2.76e-01 | 5.10e-01 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 5 | 2.85e-01 | -2.76e-01 | 6.34e-01 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 6 | 2.42e-01 | 2.76e-01 | 5.90e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 16 | 5.61e-02 | -2.76e-01 | 2.88e-01 |
| GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY | 8 | 1.77e-01 | -2.76e-01 | 5.12e-01 |
| GOBP DENDRITE ARBORIZATION | 8 | 1.77e-01 | 2.76e-01 | 5.12e-01 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 12 | 9.83e-02 | -2.76e-01 | 3.83e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 11 | 1.14e-01 | -2.76e-01 | 4.12e-01 |
| GOMF COENZYME A DIPHOSPHATASE ACTIVITY | 5 | 2.86e-01 | 2.76e-01 | 6.34e-01 |
| GOBP ISOCITRATE METABOLIC PROCESS | 6 | 2.43e-01 | -2.75e-01 | 5.90e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 14 | 7.47e-02 | -2.75e-01 | 3.34e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 13 | 8.59e-02 | 2.75e-01 | 3.58e-01 |
| GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION | 5 | 2.87e-01 | 2.75e-01 | 6.35e-01 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 15 | 6.53e-02 | 2.75e-01 | 3.12e-01 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 9.93e-02 | 2.75e-01 | 3.85e-01 |
| GOBP DIET INDUCED THERMOGENESIS | 9 | 1.54e-01 | 2.75e-01 | 4.79e-01 |
| GOMF TRNA CYTIDINE METHYLTRANSFERASE ACTIVITY | 10 | 1.33e-01 | 2.75e-01 | 4.47e-01 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 7 | 2.09e-01 | -2.74e-01 | 5.54e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 8 | 1.79e-01 | 2.74e-01 | 5.16e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 51 | 7.06e-04 | -2.74e-01 | 1.74e-02 |
| GOBP TRICARBOXYLIC ACID CYCLE | 28 | 1.20e-02 | -2.74e-01 | 1.28e-01 |
| GOBP DIOL METABOLIC PROCESS | 29 | 1.06e-02 | -2.74e-01 | 1.18e-01 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 21 | 2.97e-02 | 2.74e-01 | 2.09e-01 |
| GOCC SCHMIDT LANTERMAN INCISURE | 9 | 1.55e-01 | -2.74e-01 | 4.81e-01 |
| GOBP BONE GROWTH | 20 | 3.40e-02 | 2.74e-01 | 2.23e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 10 | 1.34e-01 | 2.74e-01 | 4.48e-01 |
| GOBP TOOTH ERUPTION | 5 | 2.89e-01 | -2.74e-01 | 6.37e-01 |
| GOBP CYTOPLASMIC TRANSLATION | 157 | 3.17e-09 | -2.74e-01 | 4.95e-07 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 20 | 3.42e-02 | 2.74e-01 | 2.24e-01 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 42 | 2.17e-03 | -2.73e-01 | 4.00e-02 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 11 | 1.16e-01 | 2.73e-01 | 4.16e-01 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 15 | 6.69e-02 | -2.73e-01 | 3.14e-01 |
| GOBP PROTEIN DESUMOYLATION | 9 | 1.56e-01 | 2.73e-01 | 4.82e-01 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 10 | 1.35e-01 | -2.73e-01 | 4.50e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 13 | 8.82e-02 | -2.73e-01 | 3.62e-01 |
| GOBP ADP TRANSPORT | 10 | 1.35e-01 | -2.73e-01 | 4.50e-01 |
| GOCC CHROMOSOME CENTROMERIC CORE DOMAIN | 9 | 1.56e-01 | -2.73e-01 | 4.82e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 8 | 1.81e-01 | -2.73e-01 | 5.18e-01 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 15 | 6.75e-02 | -2.73e-01 | 3.16e-01 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 1.82e-01 | -2.73e-01 | 5.19e-01 |
| GOCC BORC COMPLEX | 8 | 1.82e-01 | -2.73e-01 | 5.19e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 22 | 2.69e-02 | -2.73e-01 | 1.97e-01 |
| GOBP ATP TRANSPORT | 17 | 5.17e-02 | -2.73e-01 | 2.77e-01 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 6 | 2.48e-01 | 2.72e-01 | 5.95e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 27 | 1.43e-02 | 2.72e-01 | 1.40e-01 |
| GOBP T CELL ANTIGEN PROCESSING AND PRESENTATION | 6 | 2.48e-01 | 2.72e-01 | 5.96e-01 |
| GOMF DNA REPLICATION ORIGIN BINDING | 16 | 5.93e-02 | 2.72e-01 | 2.97e-01 |
| GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 6 | 2.48e-01 | -2.72e-01 | 5.96e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 58 | 3.36e-04 | 2.72e-01 | 9.98e-03 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 16 | 5.98e-02 | 2.72e-01 | 2.98e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 2.93e-01 | 2.72e-01 | 6.41e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 2.93e-01 | 2.72e-01 | 6.41e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 21 | 3.12e-02 | 2.72e-01 | 2.14e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 16 | 6.00e-02 | -2.72e-01 | 2.98e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 10 | 1.37e-01 | -2.72e-01 | 4.53e-01 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 15 | 6.86e-02 | 2.72e-01 | 3.19e-01 |
| GOBP REGULATION OF RNA BINDING | 7 | 2.14e-01 | 2.71e-01 | 5.59e-01 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 2.50e-01 | 2.71e-01 | 5.97e-01 |
| GOMF AMIDINE LYASE ACTIVITY | 6 | 2.50e-01 | -2.71e-01 | 5.98e-01 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 7 | 2.14e-01 | -2.71e-01 | 5.59e-01 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.14e-01 | -2.71e-01 | 5.59e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 15 | 6.93e-02 | 2.71e-01 | 3.20e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 6 | 2.51e-01 | -2.71e-01 | 5.98e-01 |
| GOBP TRNA SURVEILLANCE | 8 | 1.85e-01 | 2.71e-01 | 5.24e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 6 | 2.51e-01 | -2.71e-01 | 5.98e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 17 | 5.35e-02 | -2.71e-01 | 2.81e-01 |
| GOCC CONTRACTILE RING | 11 | 1.20e-01 | 2.71e-01 | 4.24e-01 |
| GOCC SET1C COMPASS COMPLEX | 13 | 9.14e-02 | 2.70e-01 | 3.70e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 2.16e-01 | -2.70e-01 | 5.60e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 30 | 1.04e-02 | 2.70e-01 | 1.17e-01 |
| GOBP EPITHELIAL CELL MATURATION | 18 | 4.73e-02 | -2.70e-01 | 2.66e-01 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 7 | 2.16e-01 | -2.70e-01 | 5.60e-01 |
| GOBP BONE CELL DEVELOPMENT | 18 | 4.74e-02 | -2.70e-01 | 2.66e-01 |
| GOBP SNRNA TRANSCRIPTION | 19 | 4.17e-02 | 2.70e-01 | 2.49e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION | 9 | 1.61e-01 | 2.70e-01 | 4.90e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION | 5 | 2.96e-01 | 2.70e-01 | 6.45e-01 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 39 | 3.58e-03 | -2.70e-01 | 5.74e-02 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 12 | 1.06e-01 | -2.69e-01 | 3.97e-01 |
| GOBP INDOLE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 1.87e-01 | 2.69e-01 | 5.28e-01 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 2.97e-01 | 2.69e-01 | 6.46e-01 |
| GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY | 9 | 1.62e-01 | 2.69e-01 | 4.92e-01 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 15 | 7.10e-02 | 2.69e-01 | 3.25e-01 |
| GOBP ACROSOMAL VESICLE EXOCYTOSIS | 5 | 2.97e-01 | 2.69e-01 | 6.46e-01 |
| GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION | 8 | 1.88e-01 | -2.69e-01 | 5.28e-01 |
| GOBP REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT | 8 | 1.88e-01 | 2.69e-01 | 5.28e-01 |
| GOCC PRESYNAPTIC CYTOSKELETON | 7 | 2.18e-01 | 2.69e-01 | 5.61e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 28 | 1.38e-02 | 2.69e-01 | 1.38e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 5 | 2.98e-01 | -2.69e-01 | 6.47e-01 |
| GOBP UV PROTECTION | 11 | 1.23e-01 | -2.69e-01 | 4.28e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 10 | 1.41e-01 | -2.69e-01 | 4.60e-01 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 8 | 1.88e-01 | 2.69e-01 | 5.29e-01 |
| GOBP REGULATION OF ASPARTIC TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 6 | 2.55e-01 | 2.68e-01 | 6.02e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 10 | 1.42e-01 | 2.68e-01 | 4.60e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 18 | 4.87e-02 | -2.68e-01 | 2.70e-01 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 14 | 8.22e-02 | -2.68e-01 | 3.50e-01 |
| GOMF HISTONE H2A DEUBIQUITINASE ACTIVITY | 6 | 2.55e-01 | 2.68e-01 | 6.03e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 12 | 1.08e-01 | -2.68e-01 | 4.00e-01 |
| GOMF DOUBLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY | 6 | 2.56e-01 | 2.68e-01 | 6.03e-01 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 28 | 1.41e-02 | 2.68e-01 | 1.40e-01 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 1.64e-01 | -2.68e-01 | 4.95e-01 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 31 | 9.80e-03 | -2.68e-01 | 1.12e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 14 | 8.25e-02 | -2.68e-01 | 3.50e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 36 | 5.40e-03 | -2.68e-01 | 7.69e-02 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 13 | 9.44e-02 | -2.68e-01 | 3.75e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 2.56e-01 | 2.68e-01 | 6.04e-01 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 11 | 1.24e-01 | -2.68e-01 | 4.32e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 6 | 2.56e-01 | -2.68e-01 | 6.04e-01 |
| GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 13 | 9.49e-02 | -2.67e-01 | 3.75e-01 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 8 | 1.90e-01 | -2.67e-01 | 5.31e-01 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 30 | 1.12e-02 | -2.67e-01 | 1.22e-01 |
| GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION | 8 | 1.91e-01 | -2.67e-01 | 5.31e-01 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 41 | 3.07e-03 | 2.67e-01 | 5.12e-02 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 9 | 1.65e-01 | -2.67e-01 | 4.98e-01 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 7 | 2.21e-01 | 2.67e-01 | 5.66e-01 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 22 | 3.02e-02 | 2.67e-01 | 2.11e-01 |
| GOCC MICROTUBULE MINUS END | 7 | 2.21e-01 | 2.67e-01 | 5.67e-01 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 3.02e-01 | -2.67e-01 | 6.51e-01 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 7 | 2.22e-01 | -2.67e-01 | 5.67e-01 |
| GOCC TERMINAL BOUTON | 27 | 1.66e-02 | 2.66e-01 | 1.53e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 10 | 1.45e-01 | 2.66e-01 | 4.65e-01 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 15 | 7.41e-02 | 2.66e-01 | 3.33e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 13 | 9.64e-02 | -2.66e-01 | 3.78e-01 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 9 | 1.67e-01 | 2.66e-01 | 5.00e-01 |
| GOMF MAP KINASE ACTIVITY | 14 | 8.46e-02 | -2.66e-01 | 3.55e-01 |
| GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 6 | 2.59e-01 | 2.66e-01 | 6.07e-01 |
| GOBP BASE EXCISION REPAIR | 43 | 2.54e-03 | 2.66e-01 | 4.46e-02 |
| GOBP POSITIVE REGULATION OF COAGULATION | 24 | 2.41e-02 | -2.66e-01 | 1.85e-01 |
| GOBP PRE MIRNA PROCESSING | 15 | 7.46e-02 | 2.66e-01 | 3.34e-01 |
| GOBP GALACTOSE METABOLIC PROCESS | 9 | 1.67e-01 | -2.66e-01 | 5.00e-01 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 2.60e-01 | 2.66e-01 | 6.08e-01 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 2.24e-01 | 2.66e-01 | 5.69e-01 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 8 | 1.93e-01 | -2.66e-01 | 5.35e-01 |
| GOCC ALVEOLAR LAMELLAR BODY | 7 | 2.24e-01 | -2.66e-01 | 5.69e-01 |
| GOBP ADENINE TRANSPORT | 6 | 2.60e-01 | -2.65e-01 | 6.09e-01 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 13 | 9.76e-02 | -2.65e-01 | 3.82e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 25 | 2.17e-02 | -2.65e-01 | 1.74e-01 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 2.61e-01 | 2.65e-01 | 6.09e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION | 9 | 1.69e-01 | 2.65e-01 | 5.02e-01 |
| GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY | 5 | 3.05e-01 | 2.65e-01 | 6.53e-01 |
| GOBP FUCOSE METABOLIC PROCESS | 13 | 9.82e-02 | -2.65e-01 | 3.83e-01 |
| GOBP REGULATION OF MYOBLAST FUSION | 18 | 5.19e-02 | -2.65e-01 | 2.78e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 24 | 2.48e-02 | -2.65e-01 | 1.88e-01 |
| GOMF P53 BINDING | 60 | 3.92e-04 | 2.65e-01 | 1.11e-02 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 27 | 1.73e-02 | -2.65e-01 | 1.55e-01 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 20 | 4.07e-02 | -2.64e-01 | 2.45e-01 |
| GOMF DOUBLE STRANDED RNA BINDING | 70 | 1.31e-04 | 2.64e-01 | 4.89e-03 |
| GOCC MEIOTIC SPINDLE | 9 | 1.70e-01 | 2.64e-01 | 5.03e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 6 | 2.62e-01 | 2.64e-01 | 6.11e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 6 | 2.63e-01 | 2.64e-01 | 6.11e-01 |
| GOBP STRESS GRANULE DISASSEMBLY | 7 | 2.27e-01 | 2.64e-01 | 5.72e-01 |
| GOMF TELOMERIC DNA BINDING | 38 | 4.92e-03 | 2.64e-01 | 7.19e-02 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 17 | 6.00e-02 | -2.63e-01 | 2.98e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 6 | 2.64e-01 | -2.63e-01 | 6.12e-01 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 40 | 3.93e-03 | 2.63e-01 | 6.11e-02 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 48 | 1.60e-03 | 2.63e-01 | 3.26e-02 |
| GOBP RESPONSE TO DIETARY EXCESS | 23 | 2.88e-02 | 2.63e-01 | 2.06e-01 |
| GOBP CYTOLYSIS | 5 | 3.08e-01 | 2.63e-01 | 6.56e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 10 | 1.49e-01 | -2.63e-01 | 4.74e-01 |
| GOMF ORGANOPHOSPHATE PHOSPHATE ANTIPORTER ACTIVITY | 7 | 2.28e-01 | -2.63e-01 | 5.74e-01 |
| GOBP COPPER ION TRANSPORT | 15 | 7.78e-02 | -2.63e-01 | 3.41e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 10 | 1.50e-01 | -2.63e-01 | 4.75e-01 |
| GOCC LATE ENDOSOME LUMEN | 6 | 2.65e-01 | -2.63e-01 | 6.14e-01 |
| GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 5 | 3.09e-01 | 2.63e-01 | 6.56e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 10 | 1.50e-01 | -2.63e-01 | 4.75e-01 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 3.10e-01 | 2.62e-01 | 6.57e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 12 | 1.16e-01 | -2.62e-01 | 4.15e-01 |
| GOBP INTERMEDIATE FILAMENT BUNDLE ASSEMBLY | 5 | 3.10e-01 | -2.62e-01 | 6.57e-01 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 15 | 7.86e-02 | 2.62e-01 | 3.43e-01 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 9 | 1.73e-01 | -2.62e-01 | 5.08e-01 |
| GOBP IRIS MORPHOGENESIS | 6 | 2.66e-01 | -2.62e-01 | 6.15e-01 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 3.10e-01 | -2.62e-01 | 6.57e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 150 | 2.95e-08 | 2.62e-01 | 3.58e-06 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 13 | 1.02e-01 | 2.62e-01 | 3.89e-01 |
| GOCC MLL3 4 COMPLEX | 12 | 1.16e-01 | 2.62e-01 | 4.15e-01 |
| GOBP RESPONSE TO UV B | 19 | 4.80e-02 | -2.62e-01 | 2.68e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 22 | 3.34e-02 | -2.62e-01 | 2.22e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 19 | 4.82e-02 | 2.62e-01 | 2.69e-01 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 10 | 1.52e-01 | -2.62e-01 | 4.76e-01 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 24 | 2.65e-02 | -2.62e-01 | 1.96e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 8 | 2.00e-01 | -2.62e-01 | 5.43e-01 |
| GOBP METANEPHROS DEVELOPMENT | 48 | 1.71e-03 | -2.62e-01 | 3.43e-02 |
| GOCC ENZYME ACTIVATOR COMPLEX | 13 | 1.02e-01 | -2.62e-01 | 3.91e-01 |
| GOBP ASTROCYTE CELL MIGRATION | 8 | 2.00e-01 | -2.61e-01 | 5.43e-01 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 6 | 2.68e-01 | 2.61e-01 | 6.17e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 157 | 1.62e-08 | -2.61e-01 | 2.10e-06 |
| GOCC SWR1 COMPLEX | 13 | 1.03e-01 | 2.61e-01 | 3.92e-01 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 28 | 1.68e-02 | -2.61e-01 | 1.53e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVATOR ACTIVITY | 5 | 3.12e-01 | -2.61e-01 | 6.59e-01 |
| GOBP SPHINGOID METABOLIC PROCESS | 21 | 3.84e-02 | -2.61e-01 | 2.38e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 9 | 1.75e-01 | -2.61e-01 | 5.10e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 118 | 9.76e-07 | 2.61e-01 | 7.60e-05 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 19 | 4.90e-02 | 2.61e-01 | 2.70e-01 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 58 | 5.91e-04 | -2.61e-01 | 1.53e-02 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 13 | 1.04e-01 | -2.61e-01 | 3.93e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 9 | 1.76e-01 | -2.61e-01 | 5.10e-01 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 8 | 2.02e-01 | -2.61e-01 | 5.45e-01 |
| GOMF PROTEIN KINASE C BINDING | 46 | 2.22e-03 | -2.61e-01 | 4.09e-02 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 15 | 8.07e-02 | -2.60e-01 | 3.47e-01 |
| GOBP CUT METABOLIC PROCESS | 5 | 3.13e-01 | 2.60e-01 | 6.60e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 16 | 7.15e-02 | 2.60e-01 | 3.26e-01 |
| GOBP EPIGENETIC PROGRAMMING OF GENE EXPRESSION | 25 | 2.43e-02 | 2.60e-01 | 1.86e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 2.03e-01 | 2.60e-01 | 5.46e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 14 | 9.23e-02 | 2.60e-01 | 3.71e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN LEVELS | 9 | 1.77e-01 | -2.60e-01 | 5.12e-01 |
| GOMF SYNDECAN BINDING | 5 | 3.14e-01 | -2.60e-01 | 6.61e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 10 | 1.55e-01 | 2.60e-01 | 4.81e-01 |
| GOBP OVULATION | 10 | 1.55e-01 | -2.59e-01 | 4.81e-01 |
| GOBP L KYNURENINE METABOLIC PROCESS | 6 | 2.71e-01 | 2.59e-01 | 6.22e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 14 | 9.30e-02 | -2.59e-01 | 3.72e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 7 | 2.35e-01 | -2.59e-01 | 5.82e-01 |
| GOCC GOLGI MEDIAL CISTERNA | 12 | 1.20e-01 | 2.59e-01 | 4.23e-01 |
| GOMF MHC CLASS IB PROTEIN BINDING | 8 | 2.04e-01 | -2.59e-01 | 5.48e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 53 | 1.11e-03 | -2.59e-01 | 2.45e-02 |
| GOBP INNERVATION | 18 | 5.72e-02 | 2.59e-01 | 2.90e-01 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 9 | 1.79e-01 | 2.59e-01 | 5.15e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 189 | 8.34e-10 | 2.59e-01 | 1.42e-07 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 15 | 8.30e-02 | 2.59e-01 | 3.51e-01 |
| GOBP CGMP METABOLIC PROCESS | 10 | 1.57e-01 | -2.58e-01 | 4.84e-01 |
| GOBP PEPTIDYL LYSINE OXIDATION | 5 | 3.17e-01 | -2.58e-01 | 6.64e-01 |
| GOMF PROTEIN LYSINE 6 OXIDASE ACTIVITY | 5 | 3.17e-01 | -2.58e-01 | 6.64e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 22 | 3.59e-02 | -2.58e-01 | 2.30e-01 |
| GOBP AMINO ACID SALVAGE | 5 | 3.17e-01 | -2.58e-01 | 6.64e-01 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 3.17e-01 | -2.58e-01 | 6.64e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 10 | 1.57e-01 | 2.58e-01 | 4.84e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 16 | 7.37e-02 | 2.58e-01 | 3.32e-01 |
| GOMF RETINAL DEHYDROGENASE ACTIVITY | 6 | 2.73e-01 | -2.58e-01 | 6.23e-01 |
| GOBP FAT SOLUBLE VITAMIN CATABOLIC PROCESS | 7 | 2.37e-01 | -2.58e-01 | 5.84e-01 |
| GOBP GLUTATHIONE CATABOLIC PROCESS | 5 | 3.17e-01 | 2.58e-01 | 6.64e-01 |
| GOMF TRNA CYTIDINE 5 METHYLTRANSFERASE ACTIVITY | 5 | 3.18e-01 | 2.58e-01 | 6.64e-01 |
| GOCC PODOSOME | 32 | 1.15e-02 | -2.58e-01 | 1.24e-01 |
| GOMF MONOSACCHARIDE BINDING | 66 | 2.90e-04 | -2.58e-01 | 8.96e-03 |
| GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY | 7 | 2.37e-01 | -2.58e-01 | 5.85e-01 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 43 | 3.43e-03 | -2.58e-01 | 5.56e-02 |
| GOBP NEGATIVE REGULATION OF FILOPODIUM ASSEMBLY | 5 | 3.18e-01 | -2.58e-01 | 6.65e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 49 | 1.80e-03 | 2.58e-01 | 3.54e-02 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 17 | 6.58e-02 | -2.58e-01 | 3.12e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 15 | 8.40e-02 | 2.58e-01 | 3.54e-01 |
| GOBP PERICENTRIC HETEROCHROMATIN FORMATION | 5 | 3.18e-01 | -2.58e-01 | 6.65e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 2.38e-01 | 2.58e-01 | 5.85e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 20 | 4.61e-02 | 2.58e-01 | 2.62e-01 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 7 | 2.38e-01 | -2.58e-01 | 5.85e-01 |
| GOBP PEXOPHAGY | 7 | 2.38e-01 | 2.57e-01 | 5.86e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 14 | 9.55e-02 | -2.57e-01 | 3.77e-01 |
| GOBP HEXOSE PHOSPHATE TRANSPORT | 7 | 2.39e-01 | -2.57e-01 | 5.87e-01 |
| GOBP SECONDARY HEART FIELD SPECIFICATION | 7 | 2.39e-01 | 2.57e-01 | 5.87e-01 |
| GOMF POLY ADP D RIBOSE BINDING | 6 | 2.76e-01 | 2.57e-01 | 6.26e-01 |
| GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 7 | 2.39e-01 | -2.57e-01 | 5.87e-01 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 10 | 1.60e-01 | 2.57e-01 | 4.88e-01 |
| GOBP SISTER CHROMATID COHESION | 55 | 9.86e-04 | 2.57e-01 | 2.28e-02 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 9 | 1.82e-01 | -2.57e-01 | 5.19e-01 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 13 | 1.09e-01 | 2.57e-01 | 4.02e-01 |
| GOBP GLIAL CELL ACTIVATION | 47 | 2.34e-03 | -2.57e-01 | 4.23e-02 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 16 | 7.57e-02 | -2.56e-01 | 3.36e-01 |
| GOMF ACETYLCHOLINE RECEPTOR BINDING | 7 | 2.40e-01 | -2.56e-01 | 5.88e-01 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 2.77e-01 | 2.56e-01 | 6.26e-01 |
| GOBP AMYLOID BETA CLEARANCE | 31 | 1.35e-02 | -2.56e-01 | 1.36e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 14 | 9.68e-02 | 2.56e-01 | 3.79e-01 |
| GOMF OLEATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.21e-01 | -2.56e-01 | 6.67e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 22 | 3.75e-02 | 2.56e-01 | 2.35e-01 |
| GOBP PLATELET AGGREGATION | 65 | 3.55e-04 | -2.56e-01 | 1.04e-02 |
| GOBP HORMONE CATABOLIC PROCESS | 6 | 2.77e-01 | -2.56e-01 | 6.26e-01 |
| GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS | 6 | 2.78e-01 | -2.56e-01 | 6.26e-01 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.84e-01 | 2.56e-01 | 5.23e-01 |
| GOBP GROOMING BEHAVIOR | 9 | 1.84e-01 | -2.56e-01 | 5.23e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 11 | 1.42e-01 | 2.55e-01 | 4.61e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 31 | 1.39e-02 | 2.55e-01 | 1.38e-01 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 14 | 9.81e-02 | 2.55e-01 | 3.83e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 1.85e-01 | 2.55e-01 | 5.24e-01 |
| GOMF 7SK SNRNA BINDING | 9 | 1.85e-01 | 2.55e-01 | 5.24e-01 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 21 | 4.29e-02 | -2.55e-01 | 2.53e-01 |
| GOCC SECRETORY GRANULE | 730 | 6.67e-32 | -2.55e-01 | 1.56e-28 |
| GOBP MESENCHYMAL EPITHELIAL CELL SIGNALING | 5 | 3.23e-01 | -2.55e-01 | 6.69e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 18 | 6.11e-02 | -2.55e-01 | 3.02e-01 |
| GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.24e-01 | -2.55e-01 | 6.69e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 14 | 9.86e-02 | -2.55e-01 | 3.83e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 23 | 3.43e-02 | 2.55e-01 | 2.24e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 28 | 1.96e-02 | -2.55e-01 | 1.66e-01 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 9 | 1.86e-01 | 2.55e-01 | 5.25e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 6 | 2.80e-01 | 2.55e-01 | 6.29e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 30 | 1.57e-02 | 2.55e-01 | 1.49e-01 |
| GOBP PROTEIN REFOLDING | 23 | 3.45e-02 | 2.55e-01 | 2.25e-01 |
| GOBP GALACTOSYLCERAMIDE BIOSYNTHETIC PROCESS | 5 | 3.24e-01 | 2.55e-01 | 6.69e-01 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 6 | 2.80e-01 | -2.55e-01 | 6.29e-01 |
| GOBP AUTOPHAGY OF PEROXISOME | 16 | 7.79e-02 | 2.55e-01 | 3.42e-01 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 20 | 4.88e-02 | -2.55e-01 | 2.70e-01 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 34 | 1.02e-02 | -2.54e-01 | 1.15e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 30 | 1.59e-02 | 2.54e-01 | 1.50e-01 |
| GOBP MICROTUBULE ANCHORING | 25 | 2.77e-02 | 2.54e-01 | 2.01e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 14 | 9.95e-02 | -2.54e-01 | 3.85e-01 |
| GOBP STEROID CATABOLIC PROCESS | 14 | 9.96e-02 | -2.54e-01 | 3.85e-01 |
| GOMF LIPID KINASE ACTIVITY | 39 | 6.02e-03 | 2.54e-01 | 8.23e-02 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 1.28e-01 | 2.54e-01 | 4.38e-01 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 1.79e-02 | -2.54e-01 | 1.58e-01 |
| GOMF HISTONE BINDING | 227 | 4.24e-11 | 2.54e-01 | 9.43e-09 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 9 | 1.87e-01 | -2.54e-01 | 5.28e-01 |
| GOBP NOSE DEVELOPMENT | 8 | 2.14e-01 | 2.54e-01 | 5.59e-01 |
| GOBP THIAMINE TRANSPORT | 6 | 2.82e-01 | 2.54e-01 | 6.31e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 10 | 1.65e-01 | -2.54e-01 | 4.97e-01 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 23 | 3.52e-02 | 2.54e-01 | 2.27e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 34 | 1.05e-02 | 2.54e-01 | 1.18e-01 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 11 | 1.45e-01 | 2.53e-01 | 4.66e-01 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 1.65e-01 | 2.53e-01 | 4.98e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 8 | 2.14e-01 | 2.53e-01 | 5.59e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 25 | 2.83e-02 | -2.53e-01 | 2.04e-01 |
| GOBP REGULATION OF APPETITE | 13 | 1.14e-01 | -2.53e-01 | 4.13e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 8 | 2.15e-01 | -2.53e-01 | 5.60e-01 |
| GOCC AP 1 ADAPTOR COMPLEX | 11 | 1.46e-01 | 2.53e-01 | 4.68e-01 |
| GOMF GLUCOSE SODIUM SYMPORTER ACTIVITY | 5 | 3.28e-01 | 2.53e-01 | 6.73e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 14 | 1.01e-01 | 2.53e-01 | 3.89e-01 |
| GOBP FOLIC ACID METABOLIC PROCESS | 13 | 1.15e-01 | -2.52e-01 | 4.15e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 16 | 8.06e-02 | 2.52e-01 | 3.47e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 33 | 1.21e-02 | 2.52e-01 | 1.28e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 5 | 3.29e-01 | 2.52e-01 | 6.74e-01 |
| GOBP VIRAL GENOME REPLICATION | 119 | 2.02e-06 | 2.52e-01 | 1.37e-04 |
| GOBP RESPONSE TO THYROID HORMONE | 20 | 5.10e-02 | -2.52e-01 | 2.76e-01 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 16 | 8.10e-02 | 2.52e-01 | 3.47e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 51 | 1.86e-03 | 2.52e-01 | 3.60e-02 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 6 | 2.86e-01 | 2.52e-01 | 6.34e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 97 | 1.84e-05 | -2.52e-01 | 9.59e-04 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 2.86e-01 | 2.51e-01 | 6.34e-01 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 20 | 5.15e-02 | -2.51e-01 | 2.77e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 43 | 4.32e-03 | 2.51e-01 | 6.57e-02 |
| GOBP BRANCHIOMOTOR NEURON AXON GUIDANCE | 6 | 2.86e-01 | 2.51e-01 | 6.34e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 28 | 2.13e-02 | 2.51e-01 | 1.72e-01 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 5 | 3.30e-01 | -2.51e-01 | 6.75e-01 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 27 | 2.39e-02 | -2.51e-01 | 1.84e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 5 | 3.31e-01 | 2.51e-01 | 6.75e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 16 | 8.23e-02 | -2.51e-01 | 3.50e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 19 | 5.85e-02 | -2.51e-01 | 2.94e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 3.32e-01 | -2.51e-01 | 6.76e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 31 | 1.57e-02 | 2.51e-01 | 1.49e-01 |
| GOBP CMP METABOLIC PROCESS | 7 | 2.51e-01 | -2.51e-01 | 5.98e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 25 | 3.01e-02 | 2.51e-01 | 2.11e-01 |
| GOMF ARYLSULFATASE ACTIVITY | 10 | 1.70e-01 | -2.50e-01 | 5.04e-01 |
| GOCC CALCINEURIN COMPLEX | 5 | 3.32e-01 | 2.50e-01 | 6.76e-01 |
| GOBP ENERGY HOMEOSTASIS | 59 | 8.84e-04 | 2.50e-01 | 2.11e-02 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 87 | 5.50e-05 | 2.50e-01 | 2.35e-03 |
| GOCC HEMIDESMOSOME | 7 | 2.52e-01 | 2.50e-01 | 5.99e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 21 | 4.73e-02 | 2.50e-01 | 2.66e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 11 | 1.51e-01 | 2.50e-01 | 4.76e-01 |
| GOBP PREPULSE INHIBITION | 7 | 2.52e-01 | 2.50e-01 | 6.00e-01 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 19 | 5.95e-02 | 2.50e-01 | 2.97e-01 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 5 | 3.33e-01 | -2.50e-01 | 6.77e-01 |
| GOBP N ACYLETHANOLAMINE METABOLIC PROCESS | 5 | 3.34e-01 | -2.50e-01 | 6.77e-01 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 1.52e-01 | 2.50e-01 | 4.76e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 24 | 3.43e-02 | -2.50e-01 | 2.24e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 12 | 1.35e-01 | -2.50e-01 | 4.50e-01 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 73 | 2.28e-04 | 2.49e-01 | 7.44e-03 |
| GOBP RNA 3 URIDYLATION | 5 | 3.34e-01 | 2.49e-01 | 6.78e-01 |
| GOBP ICOSANOID METABOLIC PROCESS | 90 | 4.41e-05 | -2.49e-01 | 1.99e-03 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 27 | 2.51e-02 | 2.49e-01 | 1.90e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 7 | 2.54e-01 | -2.49e-01 | 6.02e-01 |
| GOBP ATP METABOLIC PROCESS | 195 | 2.02e-09 | -2.49e-01 | 3.21e-07 |
| GOBP TRNA DECAY | 16 | 8.48e-02 | 2.49e-01 | 3.55e-01 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 3.35e-01 | -2.49e-01 | 6.78e-01 |
| GOBP REGULATION OF IRON ION TRANSPORT | 7 | 2.54e-01 | 2.49e-01 | 6.02e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 9 | 1.96e-01 | 2.49e-01 | 5.38e-01 |
| GOBP G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION | 6 | 2.92e-01 | -2.48e-01 | 6.41e-01 |
| GOCC DNA DEPENDENT PROTEIN KINASE COMPLEX | 5 | 3.36e-01 | 2.48e-01 | 6.79e-01 |
| GOMF LBD DOMAIN BINDING | 5 | 3.36e-01 | -2.48e-01 | 6.79e-01 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 11 | 1.54e-01 | -2.48e-01 | 4.80e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 18 | 6.86e-02 | 2.48e-01 | 3.19e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 10 | 1.75e-01 | -2.48e-01 | 5.09e-01 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 30 | 1.88e-02 | 2.48e-01 | 1.63e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 7 | 2.56e-01 | -2.48e-01 | 6.04e-01 |
| GOBP CLATHRIN COAT ASSEMBLY | 17 | 7.70e-02 | 2.48e-01 | 3.40e-01 |
| GOBP REGULATION OF VESICLE SIZE | 20 | 5.51e-02 | -2.48e-01 | 2.86e-01 |
| GOBP RESPONSE TO HYDROPEROXIDE | 17 | 7.72e-02 | -2.48e-01 | 3.40e-01 |
| GOBP V D J RECOMBINATION | 18 | 6.90e-02 | 2.48e-01 | 3.20e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 28 | 2.34e-02 | -2.48e-01 | 1.82e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 58 | 1.11e-03 | -2.48e-01 | 2.45e-02 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 20 | 5.54e-02 | -2.47e-01 | 2.87e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 11 | 1.56e-01 | 2.47e-01 | 4.81e-01 |
| GOMF PRE MRNA INTRONIC BINDING | 11 | 1.56e-01 | 2.47e-01 | 4.81e-01 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 18 | 6.95e-02 | -2.47e-01 | 3.20e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 23 | 4.03e-02 | -2.47e-01 | 2.45e-01 |
| GOMF PEROXISOME TARGETING SEQUENCE BINDING | 5 | 3.39e-01 | -2.47e-01 | 6.81e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 6 | 2.95e-01 | -2.47e-01 | 6.43e-01 |
| GOBP POSITIVE REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 3.39e-01 | 2.47e-01 | 6.81e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 7 | 2.58e-01 | 2.47e-01 | 6.06e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 12 | 1.39e-01 | 2.47e-01 | 4.57e-01 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 15 | 9.81e-02 | -2.47e-01 | 3.83e-01 |
| GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 5 | 3.40e-01 | 2.47e-01 | 6.81e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 6 | 2.96e-01 | -2.46e-01 | 6.45e-01 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 16 | 8.82e-02 | -2.46e-01 | 3.62e-01 |
| GOMF POLY ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 5 | 3.40e-01 | 2.46e-01 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 22 | 4.56e-02 | -2.46e-01 | 2.61e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 14 | 1.11e-01 | -2.46e-01 | 4.07e-01 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 58 | 1.20e-03 | -2.46e-01 | 2.62e-02 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 3.41e-01 | 2.46e-01 | 6.82e-01 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 5.72e-02 | -2.46e-01 | 2.90e-01 |
| GOCC ALPHA KETOACID DEHYDROGENASE COMPLEX | 15 | 9.95e-02 | -2.46e-01 | 3.85e-01 |
| GOCC CORE MEDIATOR COMPLEX | 26 | 3.02e-02 | 2.46e-01 | 2.11e-01 |
| GOBP REGULATION OF HAIR CYCLE | 17 | 7.97e-02 | 2.46e-01 | 3.45e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 25 | 3.36e-02 | -2.46e-01 | 2.22e-01 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 10 | 1.79e-01 | -2.45e-01 | 5.16e-01 |
| GOCC CILIARY TIP | 41 | 6.56e-03 | 2.45e-01 | 8.62e-02 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 23 | 4.17e-02 | -2.45e-01 | 2.49e-01 |
| GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 3.42e-01 | -2.45e-01 | 6.83e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 19 | 6.47e-02 | 2.45e-01 | 3.11e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION CENTROMERIC | 5 | 3.43e-01 | 2.45e-01 | 6.84e-01 |
| GOBP VERY LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 12 | 1.42e-01 | -2.45e-01 | 4.61e-01 |
| GOBP ENDOTHELIAL CELL MORPHOGENESIS | 6 | 2.99e-01 | 2.45e-01 | 6.49e-01 |
| GOCC FIBRILLAR COLLAGEN TRIMER | 7 | 2.62e-01 | 2.45e-01 | 6.11e-01 |
| GOCC PREFOLDIN COMPLEX | 7 | 2.62e-01 | -2.45e-01 | 6.11e-01 |
| GOMF OLIGOSACCHARIDE BINDING | 9 | 2.04e-01 | -2.45e-01 | 5.47e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 7 | 2.63e-01 | 2.44e-01 | 6.11e-01 |
| GOBP SNRNA 3 END PROCESSING | 21 | 5.25e-02 | 2.44e-01 | 2.78e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 14 | 1.13e-01 | -2.44e-01 | 4.12e-01 |
| GOBP OSTEOBLAST DEVELOPMENT | 9 | 2.04e-01 | -2.44e-01 | 5.48e-01 |
| GOBP NADPH REGENERATION | 21 | 5.27e-02 | -2.44e-01 | 2.79e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 26 | 3.12e-02 | 2.44e-01 | 2.14e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 23 | 4.28e-02 | -2.44e-01 | 2.52e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 1.82e-01 | 2.44e-01 | 5.18e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 27 | 2.82e-02 | 2.44e-01 | 2.04e-01 |
| GOBP REGULATION OF SENSORY PERCEPTION | 12 | 1.44e-01 | -2.44e-01 | 4.64e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 1.82e-01 | 2.44e-01 | 5.19e-01 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 1.62e-01 | 2.44e-01 | 4.92e-01 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 19 | 6.62e-02 | -2.43e-01 | 3.13e-01 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 276 | 3.30e-12 | -2.43e-01 | 1.14e-09 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 8 | 2.33e-01 | -2.43e-01 | 5.80e-01 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 13 | 1.29e-01 | -2.43e-01 | 4.40e-01 |
| GOBP MYOBLAST PROLIFERATION | 18 | 7.41e-02 | -2.43e-01 | 3.33e-01 |
| GOBP L LEUCINE CATABOLIC PROCESS | 5 | 3.47e-01 | -2.43e-01 | 6.86e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 20 | 5.99e-02 | 2.43e-01 | 2.98e-01 |
| GOCC LEWY BODY | 8 | 2.34e-01 | -2.43e-01 | 5.81e-01 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 9 | 2.07e-01 | -2.43e-01 | 5.52e-01 |
| GOMF VASOPRESSIN RECEPTOR ACTIVITY | 5 | 3.47e-01 | -2.43e-01 | 6.87e-01 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 21 | 5.41e-02 | 2.43e-01 | 2.83e-01 |
| GOBP NUCLEOTIDE SALVAGE | 16 | 9.27e-02 | -2.43e-01 | 3.72e-01 |
| GOMF FK506 BINDING | 10 | 1.84e-01 | -2.43e-01 | 5.22e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 23 | 4.39e-02 | -2.43e-01 | 2.56e-01 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 43 | 5.91e-03 | -2.43e-01 | 8.15e-02 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 29 | 2.38e-02 | -2.42e-01 | 1.84e-01 |
| GOBP INTERFERON ALPHA PRODUCTION | 27 | 2.92e-02 | 2.42e-01 | 2.08e-01 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 39 | 8.83e-03 | -2.42e-01 | 1.05e-01 |
| GOCC SITE OF DNA DAMAGE | 126 | 2.63e-06 | 2.42e-01 | 1.75e-04 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 11 | 1.64e-01 | 2.42e-01 | 4.96e-01 |
| GOBP DE NOVO CENTRIOLE ASSEMBLY | 5 | 3.48e-01 | -2.42e-01 | 6.88e-01 |
| GOCC VACUOLAR LUMEN | 150 | 3.07e-07 | -2.42e-01 | 2.73e-05 |
| GOMF UBIQUITIN LIGASE ACTIVATOR ACTIVITY | 9 | 2.09e-01 | 2.42e-01 | 5.54e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 17 | 8.42e-02 | -2.42e-01 | 3.54e-01 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 15 | 1.05e-01 | 2.42e-01 | 3.95e-01 |
| GOCC U4 SNRNP | 10 | 1.86e-01 | -2.42e-01 | 5.25e-01 |
| GOBP ADENOSINE TRANSPORT | 5 | 3.49e-01 | 2.42e-01 | 6.89e-01 |
| GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION | 6 | 3.05e-01 | -2.42e-01 | 6.53e-01 |
| GOBP TRANSITION BETWEEN FAST AND SLOW FIBER | 5 | 3.50e-01 | -2.42e-01 | 6.89e-01 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 9 | 2.10e-01 | -2.42e-01 | 5.55e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 14 | 1.18e-01 | -2.41e-01 | 4.18e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 19 | 6.86e-02 | 2.41e-01 | 3.19e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 16 | 9.47e-02 | -2.41e-01 | 3.75e-01 |
| GOBP TRANSCRIPTION ELONGATION BY RNA POLYMERASE I | 7 | 2.69e-01 | -2.41e-01 | 6.19e-01 |
| GOBP CELLULAR RESPIRATION | 224 | 4.90e-10 | -2.41e-01 | 8.81e-08 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 11 | 1.66e-01 | -2.41e-01 | 5.00e-01 |
| GOBP MRNA MODIFICATION | 19 | 6.92e-02 | 2.41e-01 | 3.20e-01 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 15 | 1.06e-01 | -2.41e-01 | 3.97e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 19 | 6.94e-02 | -2.41e-01 | 3.20e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 11 | 1.67e-01 | -2.41e-01 | 5.00e-01 |
| GOBP VESICLE UNCOATING | 7 | 2.71e-01 | 2.40e-01 | 6.22e-01 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 8 | 2.40e-01 | 2.40e-01 | 5.87e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 9 | 2.12e-01 | 2.40e-01 | 5.59e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 7 | 2.71e-01 | -2.40e-01 | 6.22e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 11 | 1.68e-01 | 2.40e-01 | 5.02e-01 |
| GOCC ZYMOGEN GRANULE | 12 | 1.50e-01 | -2.40e-01 | 4.75e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 7 | 2.72e-01 | -2.40e-01 | 6.22e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 281 | 4.47e-12 | -2.40e-01 | 1.35e-09 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 22 | 5.15e-02 | -2.40e-01 | 2.77e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 2.72e-01 | -2.40e-01 | 6.22e-01 |
| GOBP REGULATION OF TORC2 SIGNALING | 6 | 3.09e-01 | 2.40e-01 | 6.56e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 14 | 1.20e-01 | 2.40e-01 | 4.24e-01 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 2.41e-01 | -2.39e-01 | 5.89e-01 |
| GOCC SCAR COMPLEX | 12 | 1.51e-01 | -2.39e-01 | 4.76e-01 |
| GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 3.54e-01 | 2.39e-01 | 6.93e-01 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 27 | 3.16e-02 | -2.39e-01 | 2.15e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 11 | 1.70e-01 | 2.39e-01 | 5.03e-01 |
| GOBP MIRNA PROCESSING | 42 | 7.36e-03 | 2.39e-01 | 9.23e-02 |
| GOCC BRCA1 A COMPLEX | 8 | 2.42e-01 | 2.39e-01 | 5.90e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 18 | 7.96e-02 | -2.39e-01 | 3.45e-01 |
| GOCC APICAL CORTEX | 6 | 3.11e-01 | -2.39e-01 | 6.58e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 8 | 2.43e-01 | -2.39e-01 | 5.90e-01 |
| GOBP RENAL VESICLE DEVELOPMENT | 10 | 1.92e-01 | -2.38e-01 | 5.33e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 116 | 9.13e-06 | 2.38e-01 | 5.34e-04 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 94 | 6.46e-05 | 2.38e-01 | 2.69e-03 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 57 | 1.85e-03 | -2.38e-01 | 3.60e-02 |
| GOBP PROTEIN LOCALIZATION TO AXON | 8 | 2.43e-01 | 2.38e-01 | 5.90e-01 |
| GOBP TOOTH MINERALIZATION | 19 | 7.25e-02 | -2.38e-01 | 3.29e-01 |
| GOMF FOLIC ACID BINDING | 11 | 1.72e-01 | -2.38e-01 | 5.07e-01 |
| GOCC OXOGLUTARATE DEHYDROGENASE COMPLEX | 10 | 1.94e-01 | -2.37e-01 | 5.35e-01 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 12 | 1.55e-01 | 2.37e-01 | 4.81e-01 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 21 | 5.97e-02 | 2.37e-01 | 2.98e-01 |
| GOBP GRANULOCYTE MIGRATION | 115 | 1.10e-05 | -2.37e-01 | 6.28e-04 |
| GOBP RESPONSE TO FUNGICIDE | 6 | 3.14e-01 | 2.37e-01 | 6.61e-01 |
| GOBP REGULATION OF BARBED END ACTIN FILAMENT CAPPING | 5 | 3.58e-01 | -2.37e-01 | 6.95e-01 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 3.58e-01 | 2.37e-01 | 6.95e-01 |
| GOCC OUTER DYNEIN ARM | 7 | 2.77e-01 | 2.37e-01 | 6.26e-01 |
| GOMF AMP BINDING | 13 | 1.39e-01 | -2.37e-01 | 4.57e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 70 | 6.09e-04 | -2.37e-01 | 1.56e-02 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 10 | 1.95e-01 | -2.37e-01 | 5.37e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 27 | 3.33e-02 | 2.37e-01 | 2.21e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 42 | 8.01e-03 | -2.36e-01 | 9.86e-02 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 2.79e-01 | 2.36e-01 | 6.28e-01 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 13 | 1.40e-01 | -2.36e-01 | 4.58e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 20 | 6.73e-02 | -2.36e-01 | 3.16e-01 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 49 | 4.22e-03 | 2.36e-01 | 6.46e-02 |
| GOBP DETECTION OF CELL DENSITY | 7 | 2.79e-01 | -2.36e-01 | 6.29e-01 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 6 | 3.17e-01 | 2.36e-01 | 6.64e-01 |
| GOMF TRNA URIDINE METHYLTRANSFERASE ACTIVITY | 5 | 3.61e-01 | -2.36e-01 | 6.97e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 14 | 1.26e-01 | 2.36e-01 | 4.36e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 13 | 1.41e-01 | -2.36e-01 | 4.60e-01 |
| GOBP RESPONSE TO GLYCOPROTEIN | 9 | 2.21e-01 | 2.36e-01 | 5.66e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 1.76e-01 | 2.35e-01 | 5.11e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST CELL | 7 | 2.81e-01 | 2.35e-01 | 6.30e-01 |
| GOBP HEMIDESMOSOME ASSEMBLY | 5 | 3.63e-01 | -2.35e-01 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 5 | 3.63e-01 | -2.35e-01 | 6.98e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 23 | 5.10e-02 | 2.35e-01 | 2.76e-01 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 19 | 7.62e-02 | 2.35e-01 | 3.38e-01 |
| GOBP EPITHELIAL CELL CELL ADHESION | 15 | 1.15e-01 | -2.35e-01 | 4.15e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 14 | 1.28e-01 | 2.35e-01 | 4.39e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 38 | 1.23e-02 | -2.35e-01 | 1.29e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 14 | 1.28e-01 | -2.35e-01 | 4.39e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS I PROTEIN COMPLEX | 6 | 3.20e-01 | 2.35e-01 | 6.66e-01 |
| GOCC CCR4 NOT COMPLEX | 16 | 1.04e-01 | 2.35e-01 | 3.94e-01 |
| GOMF STEROL TRANSFER ACTIVITY | 18 | 8.49e-02 | 2.35e-01 | 3.55e-01 |
| GOBP SHORT TERM MEMORY | 8 | 2.51e-01 | 2.35e-01 | 5.98e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 36 | 1.49e-02 | 2.34e-01 | 1.44e-01 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 8 | 2.51e-01 | 2.34e-01 | 5.99e-01 |
| GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE | 6 | 3.21e-01 | -2.34e-01 | 6.67e-01 |
| GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.83e-01 | 2.34e-01 | 6.33e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 6 | 3.21e-01 | 2.34e-01 | 6.67e-01 |
| GOBP REGULATION OF BILE ACID SECRETION | 5 | 3.65e-01 | 2.34e-01 | 6.99e-01 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 15 | 1.17e-01 | 2.34e-01 | 4.16e-01 |
| GOBP MALATE METABOLIC PROCESS | 7 | 2.84e-01 | -2.34e-01 | 6.33e-01 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 13 | 1.44e-01 | -2.34e-01 | 4.64e-01 |
| GOBP VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 5 | 3.65e-01 | -2.34e-01 | 6.99e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 2.67e-02 | 2.34e-01 | 1.96e-01 |
| GOMF THIOREDOXIN DISULFIDE REDUCTASE NADPH ACTIVITY | 6 | 3.21e-01 | -2.34e-01 | 6.67e-01 |
| GOMF FUCOSE BINDING | 6 | 3.21e-01 | -2.34e-01 | 6.67e-01 |
| GOCC DESMOSOME | 18 | 8.61e-02 | -2.34e-01 | 3.58e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 7 | 2.84e-01 | 2.34e-01 | 6.34e-01 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 11 | 1.80e-01 | -2.34e-01 | 5.17e-01 |
| GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 6 | 3.22e-01 | 2.34e-01 | 6.67e-01 |
| GOBP INTEGRIN ACTIVATION | 18 | 8.63e-02 | -2.34e-01 | 3.58e-01 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 14 | 1.30e-01 | 2.33e-01 | 4.43e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 91 | 1.18e-04 | -2.33e-01 | 4.51e-03 |
| GOBP REGULATION OF XENOPHAGY | 9 | 2.25e-01 | -2.33e-01 | 5.70e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 132 | 3.63e-06 | -2.33e-01 | 2.34e-04 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 7 | 2.85e-01 | 2.33e-01 | 6.34e-01 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 19 | 7.85e-02 | 2.33e-01 | 3.43e-01 |
| GOBP ER OVERLOAD RESPONSE | 11 | 1.81e-01 | 2.33e-01 | 5.18e-01 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 12 | 1.62e-01 | -2.33e-01 | 4.92e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 46 | 6.23e-03 | -2.33e-01 | 8.37e-02 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 1.31e-01 | 2.33e-01 | 4.43e-01 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 109 | 2.63e-05 | -2.33e-01 | 1.31e-03 |
| GOCC FILOPODIUM TIP | 17 | 9.64e-02 | 2.33e-01 | 3.78e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 14 | 1.31e-01 | 2.33e-01 | 4.44e-01 |
| GOCC FEMALE GERM CELL NUCLEUS | 10 | 2.02e-01 | 2.33e-01 | 5.45e-01 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 10 | 2.02e-01 | 2.33e-01 | 5.45e-01 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 6 | 3.24e-01 | 2.32e-01 | 6.69e-01 |
| GOMF NEUROPEPTIDE RECEPTOR ACTIVITY | 16 | 1.07e-01 | 2.32e-01 | 4.00e-01 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 7 | 2.87e-01 | -2.32e-01 | 6.35e-01 |
| GOBP LIPID DROPLET DISASSEMBLY | 5 | 3.68e-01 | -2.32e-01 | 7.01e-01 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 143 | 1.62e-06 | -2.32e-01 | 1.14e-04 |
| GOBP RESPONSE TO X RAY | 26 | 4.04e-02 | 2.32e-01 | 2.45e-01 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 7 | 2.88e-01 | 2.32e-01 | 6.35e-01 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 17 | 9.75e-02 | 2.32e-01 | 3.82e-01 |
| GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT | 5 | 3.69e-01 | 2.32e-01 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 5 | 3.69e-01 | 2.32e-01 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 17 | 9.81e-02 | -2.32e-01 | 3.83e-01 |
| GOBP CHORIONIC TROPHOBLAST CELL DIFFERENTIATION | 6 | 3.26e-01 | -2.32e-01 | 6.71e-01 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 9 | 2.29e-01 | 2.32e-01 | 5.74e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 25 | 4.50e-02 | -2.32e-01 | 2.59e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 13 | 1.48e-01 | -2.32e-01 | 4.72e-01 |
| GOMF MORPHOGEN ACTIVITY | 5 | 3.70e-01 | -2.32e-01 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 11 | 1.83e-01 | 2.32e-01 | 5.22e-01 |
| GOBP ELASTIN METABOLIC PROCESS | 6 | 3.26e-01 | 2.32e-01 | 6.71e-01 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 12 | 1.65e-01 | 2.31e-01 | 4.98e-01 |
| GOMF GUANYLATE KINASE ACTIVITY | 9 | 2.30e-01 | -2.31e-01 | 5.75e-01 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 30 | 2.84e-02 | 2.31e-01 | 2.04e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 8 | 2.58e-01 | -2.31e-01 | 6.06e-01 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 13 | 1.49e-01 | 2.31e-01 | 4.74e-01 |
| GOMF DNA HELICASE ACTIVITY | 59 | 2.14e-03 | 2.31e-01 | 3.98e-02 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 17 | 9.91e-02 | 2.31e-01 | 3.84e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 21 | 6.68e-02 | -2.31e-01 | 3.14e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 50 | 4.71e-03 | -2.31e-01 | 6.96e-02 |
| GOBP NEUTROPHIL MIGRATION | 90 | 1.53e-04 | -2.31e-01 | 5.46e-03 |
| GOBP UTP BIOSYNTHETIC PROCESS | 8 | 2.58e-01 | -2.31e-01 | 6.06e-01 |
| GOMF TOLL LIKE RECEPTOR BINDING | 14 | 1.35e-01 | -2.31e-01 | 4.50e-01 |
| GOCC T CELL RECEPTOR COMPLEX | 123 | 9.82e-06 | 2.31e-01 | 5.67e-04 |
| GOBP PROTEIN SUMOYLATION | 62 | 1.69e-03 | 2.31e-01 | 3.40e-02 |
| GOBP RESPONSE TO ETHER | 13 | 1.50e-01 | -2.31e-01 | 4.75e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 14 | 1.35e-01 | -2.30e-01 | 4.51e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND METHYLATION | 14 | 1.35e-01 | 2.30e-01 | 4.51e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 12 | 1.67e-01 | 2.30e-01 | 5.00e-01 |
| GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS | 5 | 3.73e-01 | 2.30e-01 | 7.05e-01 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 16 | 1.11e-01 | -2.30e-01 | 4.07e-01 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 27 | 3.84e-02 | -2.30e-01 | 2.38e-01 |
| GOBP DEMETHYLATION | 37 | 1.54e-02 | 2.30e-01 | 1.47e-01 |
| GOCC TRICARBOXYLIC ACID CYCLE HETEROMERIC ENZYME COMPLEX | 17 | 1.00e-01 | -2.30e-01 | 3.87e-01 |
| GOCC RADIAL SPOKE | 6 | 3.29e-01 | 2.30e-01 | 6.75e-01 |
| GOBP CELL REDOX HOMEOSTASIS | 39 | 1.29e-02 | -2.30e-01 | 1.33e-01 |
| GOBP EPIBOLY | 35 | 1.85e-02 | -2.30e-01 | 1.60e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 62 | 1.73e-03 | 2.30e-01 | 3.45e-02 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 9 | 2.32e-01 | 2.30e-01 | 5.79e-01 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 6 | 3.30e-01 | 2.30e-01 | 6.75e-01 |
| GOCC LATERAL ELEMENT | 11 | 1.87e-01 | 2.30e-01 | 5.28e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 12 | 1.69e-01 | -2.30e-01 | 5.02e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 7 | 2.93e-01 | 2.29e-01 | 6.42e-01 |
| GOBP CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION | 6 | 3.31e-01 | -2.29e-01 | 6.75e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 41 | 1.10e-02 | -2.29e-01 | 1.21e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 8 | 2.61e-01 | -2.29e-01 | 6.10e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 68 | 1.07e-03 | 2.29e-01 | 2.41e-02 |
| GOBP RESPONSE TO COPPER ION | 23 | 5.70e-02 | -2.29e-01 | 2.90e-01 |
| GOBP MEMBRANE DISASSEMBLY | 13 | 1.52e-01 | 2.29e-01 | 4.77e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 9 | 2.34e-01 | -2.29e-01 | 5.80e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 20 | 7.59e-02 | 2.29e-01 | 3.37e-01 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 50 | 5.05e-03 | -2.29e-01 | 7.30e-02 |
| GOBP DETECTION OF BACTERIUM | 15 | 1.24e-01 | -2.29e-01 | 4.32e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 17 | 1.02e-01 | 2.29e-01 | 3.90e-01 |
| GOMF G PROTEIN COUPLED ADENOSINE RECEPTOR ACTIVITY | 5 | 3.75e-01 | -2.29e-01 | 7.07e-01 |
| GOBP AMP SALVAGE | 5 | 3.76e-01 | -2.29e-01 | 7.07e-01 |
| GOBP PIGMENT CATABOLIC PROCESS | 7 | 2.94e-01 | -2.29e-01 | 6.43e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 95 | 1.16e-04 | 2.29e-01 | 4.45e-03 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 14 | 1.38e-01 | 2.29e-01 | 4.57e-01 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 25 | 4.81e-02 | 2.28e-01 | 2.68e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 107 | 4.60e-05 | 2.28e-01 | 2.05e-03 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 3.34e-01 | 2.28e-01 | 6.77e-01 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 39 | 1.38e-02 | 2.28e-01 | 1.38e-01 |
| GOCC UNIPLEX COMPLEX | 6 | 3.34e-01 | -2.28e-01 | 6.77e-01 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 2.65e-01 | -2.28e-01 | 6.13e-01 |
| GOBP CELLULAR RESPONSE TO UV A | 5 | 3.79e-01 | -2.27e-01 | 7.11e-01 |
| GOCC SPECTRIN | 9 | 2.38e-01 | 2.27e-01 | 5.85e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 26 | 4.48e-02 | -2.27e-01 | 2.59e-01 |
| GOMF FATTY ACID DERIVATIVE BINDING | 17 | 1.05e-01 | -2.27e-01 | 3.95e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 10 | 2.13e-01 | -2.27e-01 | 5.59e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 6 | 3.35e-01 | -2.27e-01 | 6.78e-01 |
| GOBP ICOSANOID SECRETION | 26 | 4.50e-02 | -2.27e-01 | 2.59e-01 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 64 | 1.68e-03 | -2.27e-01 | 3.39e-02 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 37 | 1.68e-02 | -2.27e-01 | 1.53e-01 |
| GOBP PROTEIN PALMITOYLATION | 30 | 3.14e-02 | -2.27e-01 | 2.15e-01 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 12 | 1.73e-01 | -2.27e-01 | 5.08e-01 |
| GOBP SULFATION | 13 | 1.57e-01 | -2.27e-01 | 4.83e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 14 | 1.42e-01 | -2.27e-01 | 4.60e-01 |
| GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 8 | 2.67e-01 | -2.27e-01 | 6.15e-01 |
| GOBP REGULATION OF MAST CELL DEGRANULATION | 24 | 5.44e-02 | -2.27e-01 | 2.84e-01 |
| GOBP METANEPHROS MORPHOGENESIS | 17 | 1.06e-01 | -2.27e-01 | 3.96e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 14 | 1.42e-01 | -2.27e-01 | 4.61e-01 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 57 | 3.08e-03 | -2.27e-01 | 5.12e-02 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 9 | 2.39e-01 | -2.27e-01 | 5.87e-01 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 25 | 4.99e-02 | 2.27e-01 | 2.73e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 3.80e-01 | 2.27e-01 | 7.12e-01 |
| GOMF ADENINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.80e-01 | -2.26e-01 | 7.12e-01 |
| GOCC RIBOSOMAL SUBUNIT | 181 | 1.47e-07 | -2.26e-01 | 1.40e-05 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 7 | 3.00e-01 | 2.26e-01 | 6.49e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 1047 | 3.13e-35 | 2.26e-01 | 9.74e-32 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 35 | 2.06e-02 | -2.26e-01 | 1.70e-01 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 15 | 1.29e-01 | 2.26e-01 | 4.40e-01 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 13 | 1.58e-01 | 2.26e-01 | 4.86e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 6 | 3.38e-01 | 2.26e-01 | 6.80e-01 |
| GOMF FMN BINDING | 12 | 1.75e-01 | 2.26e-01 | 5.10e-01 |
| GOBP REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS | 5 | 3.82e-01 | 2.26e-01 | 7.14e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 79 | 5.21e-04 | 2.26e-01 | 1.38e-02 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 143 | 3.21e-06 | 2.26e-01 | 2.10e-04 |
| GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.83e-01 | -2.26e-01 | 7.15e-01 |
| GOBP RESPONSE TO FOOD | 24 | 5.59e-02 | -2.25e-01 | 2.88e-01 |
| GOMF PHOSPHOLIPASE D ACTIVITY | 5 | 3.83e-01 | 2.25e-01 | 7.15e-01 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 10 | 2.18e-01 | 2.25e-01 | 5.61e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 17 | 1.08e-01 | 2.25e-01 | 4.00e-01 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 3.84e-01 | 2.25e-01 | 7.15e-01 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 11 | 1.96e-01 | 2.25e-01 | 5.38e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ANERGY | 5 | 3.84e-01 | 2.25e-01 | 7.15e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 71 | 1.05e-03 | -2.25e-01 | 2.38e-02 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 14 | 1.45e-01 | -2.25e-01 | 4.66e-01 |
| GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 6 | 3.40e-01 | -2.25e-01 | 6.82e-01 |
| GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION | 9 | 2.43e-01 | 2.25e-01 | 5.90e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 23 | 6.22e-02 | -2.25e-01 | 3.05e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 27 | 4.34e-02 | -2.25e-01 | 2.54e-01 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 9 | 2.44e-01 | 2.24e-01 | 5.90e-01 |
| GOCC PINOSOME | 9 | 2.44e-01 | 2.24e-01 | 5.90e-01 |
| GOBP RRNA BASE METHYLATION | 10 | 2.19e-01 | 2.24e-01 | 5.64e-01 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 24 | 5.71e-02 | -2.24e-01 | 2.90e-01 |
| GOBP OMEGA HYDROXYLASE P450 PATHWAY | 6 | 3.41e-01 | -2.24e-01 | 6.82e-01 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 21 | 7.51e-02 | -2.24e-01 | 3.35e-01 |
| GOBP RNA SURVEILLANCE | 18 | 9.96e-02 | 2.24e-01 | 3.85e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 7 | 3.05e-01 | 2.24e-01 | 6.53e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 16 | 1.21e-01 | 2.24e-01 | 4.25e-01 |
| GOBP GRANULOCYTE CHEMOTAXIS | 94 | 1.74e-04 | -2.24e-01 | 6.02e-03 |
| GOBP R LOOP PROCESSING | 9 | 2.45e-01 | 2.24e-01 | 5.91e-01 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 13 | 1.62e-01 | 2.24e-01 | 4.92e-01 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 54 | 4.41e-03 | 2.24e-01 | 6.65e-02 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 15 | 1.33e-01 | -2.24e-01 | 4.48e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVATOR ACTIVITY | 5 | 3.86e-01 | -2.24e-01 | 7.15e-01 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 35 | 2.19e-02 | -2.24e-01 | 1.75e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 45 | 9.40e-03 | 2.24e-01 | 1.09e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 110 | 5.02e-05 | -2.24e-01 | 2.17e-03 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 24 | 5.78e-02 | 2.24e-01 | 2.91e-01 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 15 | 1.34e-01 | 2.24e-01 | 4.48e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 21 | 7.60e-02 | -2.24e-01 | 3.37e-01 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 18 | 1.00e-01 | -2.24e-01 | 3.87e-01 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 8 | 2.74e-01 | 2.24e-01 | 6.24e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 3.06e-01 | -2.24e-01 | 6.53e-01 |
| GOBP PANCREATIC JUICE SECRETION | 9 | 2.46e-01 | 2.23e-01 | 5.93e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 40 | 1.45e-02 | 2.23e-01 | 1.42e-01 |
| GOBP VITAMIN D BIOSYNTHETIC PROCESS | 8 | 2.74e-01 | -2.23e-01 | 6.24e-01 |
| GOMF INTERMEDIATE FILAMENT BINDING | 8 | 2.74e-01 | -2.23e-01 | 6.24e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 15 | 1.34e-01 | 2.23e-01 | 4.50e-01 |
| GOMF N ACYLSPHINGOSINE AMIDOHYDROLASE ACTIVITY | 7 | 3.06e-01 | -2.23e-01 | 6.54e-01 |
| GOCC MMXD COMPLEX | 5 | 3.87e-01 | -2.23e-01 | 7.16e-01 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 35 | 2.23e-02 | -2.23e-01 | 1.76e-01 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 20 | 8.41e-02 | 2.23e-01 | 3.54e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 9 | 2.46e-01 | 2.23e-01 | 5.94e-01 |
| GOCC ENDOPEPTIDASE COMPLEX | 79 | 6.08e-04 | -2.23e-01 | 1.56e-02 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 10 | 2.22e-01 | -2.23e-01 | 5.67e-01 |
| GOCC REPLICATION FORK | 74 | 9.09e-04 | 2.23e-01 | 2.14e-02 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 41 | 1.35e-02 | 2.23e-01 | 1.36e-01 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 11 | 2.00e-01 | -2.23e-01 | 5.43e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 3.45e-01 | 2.23e-01 | 6.85e-01 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 10 | 2.23e-01 | 2.23e-01 | 5.68e-01 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 3.45e-01 | 2.23e-01 | 6.85e-01 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 19 | 9.29e-02 | -2.23e-01 | 3.72e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 32 | 2.93e-02 | -2.23e-01 | 2.08e-01 |
| GOMF HMG BOX DOMAIN BINDING | 9 | 2.47e-01 | -2.23e-01 | 5.95e-01 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 15 | 1.36e-01 | -2.23e-01 | 4.51e-01 |
| GOBP VIRAL RNA GENOME REPLICATION | 28 | 4.16e-02 | 2.22e-01 | 2.48e-01 |
| GOMF OXIDIZED DNA BINDING | 11 | 2.01e-01 | 2.22e-01 | 5.45e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 26 | 4.97e-02 | -2.22e-01 | 2.72e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 10 | 2.23e-01 | -2.22e-01 | 5.69e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 30 | 3.51e-02 | 2.22e-01 | 2.26e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 169 | 6.17e-07 | -2.22e-01 | 5.20e-05 |
| GOBP C TERMINAL PROTEIN LIPIDATION | 9 | 2.48e-01 | 2.22e-01 | 5.96e-01 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 19 | 9.37e-02 | 2.22e-01 | 3.74e-01 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 2.24e-01 | 2.22e-01 | 5.69e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 87 | 3.44e-04 | 2.22e-01 | 1.01e-02 |
| GOBP AMELOGENESIS | 16 | 1.24e-01 | -2.22e-01 | 4.32e-01 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 18 | 1.03e-01 | 2.22e-01 | 3.92e-01 |
| GOCC DENDRITIC GROWTH CONE | 9 | 2.49e-01 | 2.22e-01 | 5.97e-01 |
| GOBP PROTEIN ACETYLATION | 50 | 6.69e-03 | 2.22e-01 | 8.73e-02 |
| GOBP THALAMUS DEVELOPMENT | 9 | 2.50e-01 | 2.22e-01 | 5.98e-01 |
| GOBP CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS | 6 | 3.47e-01 | 2.22e-01 | 6.87e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 55 | 4.47e-03 | 2.22e-01 | 6.70e-02 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 19 | 9.45e-02 | -2.22e-01 | 3.75e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 210 | 3.12e-08 | -2.22e-01 | 3.69e-06 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 6 | 3.48e-01 | 2.21e-01 | 6.87e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 37 | 1.98e-02 | -2.21e-01 | 1.66e-01 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 9 | 2.51e-01 | -2.21e-01 | 5.98e-01 |
| GOCC CYTOSOLIC RIBOSOME | 112 | 5.29e-05 | -2.21e-01 | 2.27e-03 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 29 | 3.93e-02 | 2.21e-01 | 2.41e-01 |
| GOCC PROTEASOME COMPLEX | 61 | 2.82e-03 | -2.21e-01 | 4.83e-02 |
| GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY | 7 | 3.11e-01 | -2.21e-01 | 6.58e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 14 | 1.52e-01 | 2.21e-01 | 4.77e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 3.48e-01 | -2.21e-01 | 6.88e-01 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 9 | 2.51e-01 | -2.21e-01 | 5.98e-01 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 2.51e-01 | -2.21e-01 | 5.98e-01 |
| GOMF ERBB 3 CLASS RECEPTOR BINDING | 5 | 3.92e-01 | -2.21e-01 | 7.21e-01 |
| GOBP PEPTIDE CATABOLIC PROCESS | 17 | 1.15e-01 | -2.21e-01 | 4.15e-01 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 24 | 6.11e-02 | 2.21e-01 | 3.02e-01 |
| GOBP PROTEIN NEDDYLATION | 28 | 4.32e-02 | -2.21e-01 | 2.53e-01 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 12 | 1.86e-01 | -2.21e-01 | 5.25e-01 |
| GOBP MYELOID CELL DEVELOPMENT | 83 | 5.09e-04 | -2.21e-01 | 1.36e-02 |
| GOCC STEREOCILIA COUPLING LINK | 5 | 3.93e-01 | -2.21e-01 | 7.21e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 37 | 2.02e-02 | 2.21e-01 | 1.68e-01 |
| GOMF KINETOCHORE BINDING | 6 | 3.49e-01 | 2.21e-01 | 6.89e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 29 | 3.98e-02 | -2.21e-01 | 2.43e-01 |
| GOBP REGULATION OF MYELOID DENDRITIC CELL ACTIVATION | 5 | 3.93e-01 | -2.21e-01 | 7.21e-01 |
| GOMF FATTY ACID BINDING | 31 | 3.36e-02 | -2.20e-01 | 2.22e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 63 | 2.47e-03 | 2.20e-01 | 4.40e-02 |
| GOMF DYNEIN COMPLEX BINDING | 22 | 7.35e-02 | 2.20e-01 | 3.32e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 16 | 1.27e-01 | -2.20e-01 | 4.37e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 9 | 2.52e-01 | -2.20e-01 | 6.00e-01 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 10 | 2.28e-01 | -2.20e-01 | 5.73e-01 |
| GOBP ACTIN MYOSIN FILAMENT SLIDING | 6 | 3.50e-01 | -2.20e-01 | 6.90e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 23 | 6.78e-02 | -2.20e-01 | 3.17e-01 |
| GOBP REACTIVE GLIOSIS | 5 | 3.94e-01 | -2.20e-01 | 7.21e-01 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 85 | 4.58e-04 | -2.20e-01 | 1.26e-02 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 40 | 1.62e-02 | -2.20e-01 | 1.52e-01 |
| GOCC SECRETORY VESICLE | 858 | 7.95e-28 | -2.20e-01 | 1.49e-24 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 10 | 2.29e-01 | -2.20e-01 | 5.74e-01 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 35 | 2.46e-02 | 2.19e-01 | 1.88e-01 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 40 | 1.64e-02 | -2.19e-01 | 1.53e-01 |
| GOBP PHAGOSOME MATURATION | 27 | 4.86e-02 | -2.19e-01 | 2.69e-01 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 25 | 5.78e-02 | 2.19e-01 | 2.91e-01 |
| GOBP SPINDLE ELONGATION | 13 | 1.71e-01 | 2.19e-01 | 5.05e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 37 | 2.10e-02 | 2.19e-01 | 1.71e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS | 5 | 3.96e-01 | -2.19e-01 | 7.22e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 38 | 1.94e-02 | -2.19e-01 | 1.65e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 16 | 1.29e-01 | 2.19e-01 | 4.40e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 2.25e-03 | 2.19e-01 | 4.13e-02 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 21 | 8.23e-02 | 2.19e-01 | 3.50e-01 |
| GOBP HEART FIELD SPECIFICATION | 9 | 2.55e-01 | 2.19e-01 | 6.03e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 67 | 1.95e-03 | 2.19e-01 | 3.71e-02 |
| GOBP ADP BIOSYNTHETIC PROCESS | 5 | 3.97e-01 | -2.19e-01 | 7.23e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 92 | 2.87e-04 | 2.19e-01 | 8.93e-03 |
| GOMF TPR DOMAIN BINDING | 7 | 3.16e-01 | 2.19e-01 | 6.64e-01 |
| GOBP DETOXIFICATION OF COPPER ION | 6 | 3.54e-01 | -2.19e-01 | 6.93e-01 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 5.90e-03 | 2.19e-01 | 8.15e-02 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 5 | 3.97e-01 | -2.19e-01 | 7.23e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 5 | 3.97e-01 | -2.19e-01 | 7.23e-01 |
| GOMF DNA BINDING BENDING | 13 | 1.72e-01 | 2.19e-01 | 5.07e-01 |
| GOBP REGULATION OF CRISTAE FORMATION | 5 | 3.97e-01 | -2.19e-01 | 7.23e-01 |
| GOBP BOX C D SNORNP ASSEMBLY | 8 | 2.85e-01 | -2.18e-01 | 6.34e-01 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 15 | 1.43e-01 | 2.18e-01 | 4.62e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 17 | 1.19e-01 | 2.18e-01 | 4.20e-01 |
| GOBP CELLULAR RESPONSE TO SALT | 5 | 3.98e-01 | -2.18e-01 | 7.23e-01 |
| GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 3.98e-01 | -2.18e-01 | 7.23e-01 |
| GOCC MULTIVESICULAR BODY LUMEN | 5 | 3.98e-01 | -2.18e-01 | 7.23e-01 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 10 | 2.32e-01 | 2.18e-01 | 5.79e-01 |
| GOBP POLYOL TRANSMEMBRANE TRANSPORT | 9 | 2.57e-01 | -2.18e-01 | 6.05e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 8 | 2.85e-01 | -2.18e-01 | 6.34e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 28 | 4.57e-02 | 2.18e-01 | 2.61e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 13 | 1.73e-01 | 2.18e-01 | 5.08e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 14 | 1.58e-01 | 2.18e-01 | 4.85e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 11 | 2.10e-01 | -2.18e-01 | 5.56e-01 |
| GOCC RISC LOADING COMPLEX | 8 | 2.86e-01 | 2.18e-01 | 6.34e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 8 | 2.86e-01 | 2.18e-01 | 6.34e-01 |
| GOCC MITOTIC SPINDLE MIDZONE | 13 | 1.74e-01 | 2.18e-01 | 5.09e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 92 | 3.10e-04 | 2.18e-01 | 9.40e-03 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 31 | 3.61e-02 | 2.17e-01 | 2.30e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 12 | 1.92e-01 | -2.17e-01 | 5.33e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 11 | 2.12e-01 | -2.17e-01 | 5.58e-01 |
| GOBP ADHERENS JUNCTION MAINTENANCE | 6 | 3.56e-01 | -2.17e-01 | 6.94e-01 |
| GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 11 | 2.12e-01 | -2.17e-01 | 5.58e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 55 | 5.29e-03 | 2.17e-01 | 7.57e-02 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 86 | 4.98e-04 | -2.17e-01 | 1.35e-02 |
| GOBP OXALATE TRANSPORT | 6 | 3.57e-01 | -2.17e-01 | 6.94e-01 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 7 | 3.20e-01 | -2.17e-01 | 6.66e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 12 | 1.93e-01 | -2.17e-01 | 5.34e-01 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 11 | 2.12e-01 | 2.17e-01 | 5.59e-01 |
| GOBP SEMICIRCULAR CANAL DEVELOPMENT | 5 | 4.01e-01 | -2.17e-01 | 7.25e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 45 | 1.18e-02 | -2.17e-01 | 1.25e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION | 10 | 2.35e-01 | -2.17e-01 | 5.82e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 8 | 2.88e-01 | 2.17e-01 | 6.36e-01 |
| GOCC INO80 TYPE COMPLEX | 27 | 5.11e-02 | 2.17e-01 | 2.76e-01 |
| GOBP NEURAL PLATE DEVELOPMENT | 7 | 3.21e-01 | 2.17e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 13 | 1.76e-01 | -2.17e-01 | 5.10e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 144 | 7.15e-06 | 2.17e-01 | 4.26e-04 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 14 | 1.60e-01 | -2.17e-01 | 4.89e-01 |
| GOBP INTERLEUKIN 23 PRODUCTION | 8 | 2.89e-01 | -2.17e-01 | 6.37e-01 |
| GOCC WNT SIGNALOSOME | 12 | 1.94e-01 | 2.17e-01 | 5.36e-01 |
| GOMF IMMUNOGLOBULIN BINDING | 19 | 1.03e-01 | -2.16e-01 | 3.91e-01 |
| GOBP MIGRACYTOSIS | 5 | 4.02e-01 | -2.16e-01 | 7.26e-01 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 4.02e-01 | 2.16e-01 | 7.26e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 20 | 9.41e-02 | 2.16e-01 | 3.75e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 70 | 1.76e-03 | 2.16e-01 | 3.49e-02 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 13 | 1.77e-01 | 2.16e-01 | 5.12e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 22 | 7.93e-02 | -2.16e-01 | 3.44e-01 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 68 | 2.06e-03 | 2.16e-01 | 3.85e-02 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 15 | 1.47e-01 | 2.16e-01 | 4.70e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 1.47e-01 | -2.16e-01 | 4.70e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 41 | 1.67e-02 | 2.16e-01 | 1.53e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 42 | 1.55e-02 | -2.16e-01 | 1.47e-01 |
| GOBP MACROPHAGE DIFFERENTIATION | 52 | 7.07e-03 | -2.16e-01 | 9.03e-02 |
| GOMF GLYCEROL CHANNEL ACTIVITY | 5 | 4.03e-01 | -2.16e-01 | 7.26e-01 |
| GOMF MONOATOMIC ION GATED CHANNEL ACTIVITY | 20 | 9.47e-02 | -2.16e-01 | 3.75e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 50 | 8.30e-03 | -2.16e-01 | 1.01e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 9 | 2.62e-01 | -2.16e-01 | 6.11e-01 |
| GOBP FOREBRAIN MORPHOGENESIS | 9 | 2.62e-01 | -2.16e-01 | 6.11e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 18 | 1.13e-01 | 2.16e-01 | 4.12e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 23 | 7.34e-02 | -2.16e-01 | 3.32e-01 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 11 | 2.16e-01 | 2.15e-01 | 5.60e-01 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 9 | 2.63e-01 | -2.15e-01 | 6.11e-01 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 52 | 7.25e-03 | 2.15e-01 | 9.16e-02 |
| GOMF DIACYLGLYCEROL BINDING | 11 | 2.16e-01 | 2.15e-01 | 5.60e-01 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 75 | 1.28e-03 | -2.15e-01 | 2.74e-02 |
| GOBP METANEPHRIC TUBULE DEVELOPMENT | 14 | 1.64e-01 | -2.15e-01 | 4.95e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS | 6 | 3.62e-01 | -2.15e-01 | 6.98e-01 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 12 | 1.98e-01 | -2.15e-01 | 5.40e-01 |
| GOMF SULFATIDE BINDING | 5 | 4.06e-01 | 2.15e-01 | 7.27e-01 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 3.63e-01 | -2.15e-01 | 6.98e-01 |
| GOCC GABA ERGIC SYNAPSE | 38 | 2.21e-02 | -2.15e-01 | 1.76e-01 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 46 | 1.19e-02 | 2.14e-01 | 1.26e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING | 8 | 2.94e-01 | -2.14e-01 | 6.42e-01 |
| GOCC CORVET COMPLEX | 7 | 3.26e-01 | 2.14e-01 | 6.71e-01 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 8 | 2.94e-01 | -2.14e-01 | 6.42e-01 |
| GOBP STRESS GRANULE ASSEMBLY | 32 | 3.62e-02 | 2.14e-01 | 2.30e-01 |
| GOMF SPHINGOSINE N ACYLTRANSFERASE ACTIVITY | 6 | 3.64e-01 | -2.14e-01 | 6.99e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 10 | 2.42e-01 | 2.14e-01 | 5.89e-01 |
| GOBP FUCOSYLATION | 13 | 1.82e-01 | -2.14e-01 | 5.19e-01 |
| GOBP LYMPHOCYTE ANERGY | 8 | 2.95e-01 | 2.14e-01 | 6.43e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 3.65e-01 | -2.14e-01 | 6.99e-01 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 4.08e-01 | 2.14e-01 | 7.29e-01 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 6 | 3.65e-01 | -2.14e-01 | 6.99e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 39 | 2.10e-02 | -2.14e-01 | 1.71e-01 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 19 | 1.07e-01 | -2.14e-01 | 3.99e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 27 | 5.48e-02 | -2.13e-01 | 2.85e-01 |
| GOBP PHOSPHOLIPID EFFLUX | 7 | 3.28e-01 | 2.13e-01 | 6.74e-01 |
| GOBP SNRNA METABOLIC PROCESS | 56 | 5.75e-03 | 2.13e-01 | 7.99e-02 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 24 | 7.07e-02 | -2.13e-01 | 3.24e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 57 | 5.40e-03 | 2.13e-01 | 7.69e-02 |
| GOBP CELL JUNCTION DISASSEMBLY | 21 | 9.12e-02 | -2.13e-01 | 3.69e-01 |
| GOBP CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION | 6 | 3.67e-01 | -2.13e-01 | 7.00e-01 |
| GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS | 5 | 4.10e-01 | -2.13e-01 | 7.31e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 81 | 9.32e-04 | -2.13e-01 | 2.18e-02 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 3.30e-01 | -2.13e-01 | 6.75e-01 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 23 | 7.75e-02 | -2.13e-01 | 3.41e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 6 | 3.67e-01 | -2.13e-01 | 7.01e-01 |
| GOCC SEX CHROMOSOME | 33 | 3.47e-02 | 2.12e-01 | 2.25e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 88 | 5.75e-04 | -2.12e-01 | 1.50e-02 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 4.11e-01 | 2.12e-01 | 7.31e-01 |
| GOBP EOSINOPHIL ACTIVATION | 9 | 2.70e-01 | -2.12e-01 | 6.21e-01 |
| GOCC AXOLEMMA | 11 | 2.23e-01 | 2.12e-01 | 5.68e-01 |
| GOBP NEUROINFLAMMATORY RESPONSE | 65 | 3.08e-03 | -2.12e-01 | 5.12e-02 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 3.68e-01 | -2.12e-01 | 7.01e-01 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 9 | 2.71e-01 | 2.12e-01 | 6.21e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 19 | 1.10e-01 | -2.12e-01 | 4.04e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 14 | 1.70e-01 | 2.12e-01 | 5.03e-01 |
| GOMF SIALIC ACID BINDING | 17 | 1.30e-01 | -2.12e-01 | 4.43e-01 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 4.12e-01 | 2.12e-01 | 7.32e-01 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 13 | 1.86e-01 | 2.12e-01 | 5.26e-01 |
| GOBP NEUTROPHIL CHEMOTAXIS | 72 | 1.90e-03 | -2.12e-01 | 3.65e-02 |
| GOBP POSITIVE CHEMOTAXIS | 38 | 2.40e-02 | -2.12e-01 | 1.85e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 28 | 5.28e-02 | -2.11e-01 | 2.79e-01 |
| GOCC LATERAL PART OF CELL | 5 | 4.13e-01 | 2.11e-01 | 7.33e-01 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 67 | 2.77e-03 | 2.11e-01 | 4.76e-02 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 8 | 3.01e-01 | 2.11e-01 | 6.51e-01 |
| GOBP LUNG MORPHOGENESIS | 36 | 2.83e-02 | -2.11e-01 | 2.04e-01 |
| GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 8 | 3.01e-01 | -2.11e-01 | 6.51e-01 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 6 | 3.71e-01 | 2.11e-01 | 7.03e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 32 | 3.88e-02 | -2.11e-01 | 2.39e-01 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 10 | 2.48e-01 | -2.11e-01 | 5.95e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1503 | 9.57e-43 | 2.11e-01 | 8.95e-39 |
| GOBP DNA INTEGRATION | 7 | 3.34e-01 | 2.11e-01 | 6.77e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 239 | 1.92e-08 | -2.11e-01 | 2.45e-06 |
| GOCC CHROMOSOMAL REGION | 372 | 2.77e-12 | 2.11e-01 | 1.03e-09 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 30 | 4.56e-02 | -2.11e-01 | 2.61e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 18 | 1.21e-01 | -2.11e-01 | 4.26e-01 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 13 | 1.88e-01 | -2.11e-01 | 5.28e-01 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 10 | 2.49e-01 | -2.11e-01 | 5.96e-01 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 13 | 1.89e-01 | 2.11e-01 | 5.29e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 7 | 3.35e-01 | -2.11e-01 | 6.78e-01 |
| GOMF PROTEIN DISULFIDE REDUCTASE NAD P H ACTIVITY | 8 | 3.03e-01 | -2.11e-01 | 6.52e-01 |
| GOCC GAP JUNCTION | 12 | 2.07e-01 | 2.10e-01 | 5.52e-01 |
| GOBP HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION | 6 | 3.72e-01 | -2.10e-01 | 7.04e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 40 | 2.13e-02 | -2.10e-01 | 1.72e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 1256 | 3.80e-36 | 2.10e-01 | 1.78e-32 |
| GOBP GDP METABOLIC PROCESS | 11 | 2.27e-01 | -2.10e-01 | 5.73e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 13 | 1.90e-01 | 2.10e-01 | 5.30e-01 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 9 | 2.75e-01 | 2.10e-01 | 6.26e-01 |
| GOCC KATANIN COMPLEX | 5 | 4.17e-01 | -2.10e-01 | 7.36e-01 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 9 | 2.76e-01 | -2.10e-01 | 6.26e-01 |
| GOBP ACYLGLYCEROL TRANSPORT | 5 | 4.17e-01 | 2.10e-01 | 7.36e-01 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 13 | 1.91e-01 | 2.10e-01 | 5.31e-01 |
| GOMF CLATHRIN BINDING | 41 | 2.02e-02 | 2.10e-01 | 1.68e-01 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 17 | 1.35e-01 | -2.09e-01 | 4.51e-01 |
| GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION | 8 | 3.05e-01 | -2.09e-01 | 6.53e-01 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 3.38e-01 | -2.09e-01 | 6.80e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 19 | 1.15e-01 | -2.09e-01 | 4.15e-01 |
| GOMF SERINE HYDROLASE ACTIVITY | 112 | 1.32e-04 | -2.09e-01 | 4.89e-03 |
| GOMF MOLECULAR TAG ACTIVITY | 13 | 1.92e-01 | -2.09e-01 | 5.33e-01 |
| GOCC SIN3 TYPE COMPLEX | 22 | 8.98e-02 | 2.09e-01 | 3.66e-01 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 3.76e-01 | -2.09e-01 | 7.07e-01 |
| GOBP AORTA DEVELOPMENT | 44 | 1.66e-02 | -2.09e-01 | 1.53e-01 |
| GOBP RESPONSE TO VITAMIN E | 8 | 3.07e-01 | -2.09e-01 | 6.55e-01 |
| GOCC PLATELET DENSE GRANULE | 16 | 1.49e-01 | 2.09e-01 | 4.73e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 1.16e-01 | 2.08e-01 | 4.15e-01 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 42 | 1.94e-02 | -2.08e-01 | 1.65e-01 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 22 | 9.06e-02 | -2.08e-01 | 3.68e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 36 | 3.05e-02 | -2.08e-01 | 2.12e-01 |
| GOCC SWI SNF COMPLEX | 29 | 5.22e-02 | 2.08e-01 | 2.78e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 66 | 3.44e-03 | 2.08e-01 | 5.57e-02 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 19 | 1.16e-01 | -2.08e-01 | 4.15e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 17 | 1.37e-01 | 2.08e-01 | 4.54e-01 |
| GOCC CORNIFIED ENVELOPE | 25 | 7.17e-02 | -2.08e-01 | 3.26e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 3.40e-01 | 2.08e-01 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS | 5 | 4.21e-01 | -2.08e-01 | 7.39e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 236 | 3.71e-08 | 2.08e-01 | 4.29e-06 |
| GOBP MEMBRANE REPOLARIZATION | 31 | 4.51e-02 | -2.08e-01 | 2.60e-01 |
| GOCC CASPASE COMPLEX | 9 | 2.80e-01 | -2.08e-01 | 6.29e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 57 | 6.64e-03 | 2.08e-01 | 8.70e-02 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION | 9 | 2.81e-01 | 2.08e-01 | 6.30e-01 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 13 | 1.95e-01 | 2.08e-01 | 5.37e-01 |
| GOBP ANIMAL ORGAN MATURATION | 23 | 8.49e-02 | -2.08e-01 | 3.55e-01 |
| GOMF U4 SNRNA BINDING | 6 | 3.79e-01 | 2.07e-01 | 7.11e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 1.08e-01 | -2.07e-01 | 4.01e-01 |
| GOBP RESPONSE TO CADMIUM ION | 48 | 1.29e-02 | -2.07e-01 | 1.33e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 19 | 1.18e-01 | -2.07e-01 | 4.18e-01 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 6 | 3.79e-01 | 2.07e-01 | 7.11e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 14 | 1.79e-01 | -2.07e-01 | 5.16e-01 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 7 | 3.43e-01 | 2.07e-01 | 6.83e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 13 | 1.96e-01 | -2.07e-01 | 5.38e-01 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 24 | 7.91e-02 | 2.07e-01 | 3.44e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 9 | 2.82e-01 | -2.07e-01 | 6.31e-01 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 11 | 2.35e-01 | 2.07e-01 | 5.82e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 47 | 1.41e-02 | -2.07e-01 | 1.40e-01 |
| GOBP UREA TRANSPORT | 8 | 3.11e-01 | -2.07e-01 | 6.58e-01 |
| GOBP NEGATIVE REGULATION OF TUBULIN DEACETYLATION | 5 | 4.23e-01 | 2.07e-01 | 7.41e-01 |
| GOCC CLATHRIN SCULPTED VESICLE | 7 | 3.44e-01 | 2.07e-01 | 6.84e-01 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 31 | 4.63e-02 | 2.07e-01 | 2.63e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 98 | 4.05e-04 | 2.07e-01 | 1.14e-02 |
| GOBP DNA ALKYLATION REPAIR | 12 | 2.15e-01 | 2.07e-01 | 5.60e-01 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 12 | 2.15e-01 | -2.07e-01 | 5.60e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 28 | 5.85e-02 | 2.07e-01 | 2.94e-01 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 6 | 3.81e-01 | 2.07e-01 | 7.13e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 21 | 1.02e-01 | -2.06e-01 | 3.89e-01 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 8 | 3.13e-01 | 2.06e-01 | 6.59e-01 |
| GOMF TELOMERASE RNA BINDING | 22 | 9.42e-02 | 2.06e-01 | 3.75e-01 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 7 | 3.45e-01 | 2.06e-01 | 6.85e-01 |
| GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 2.84e-01 | -2.06e-01 | 6.34e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 63 | 4.69e-03 | 2.06e-01 | 6.93e-02 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 16 | 1.54e-01 | 2.06e-01 | 4.79e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 9 | 2.85e-01 | -2.06e-01 | 6.34e-01 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 3.77e-02 | -2.06e-01 | 2.36e-01 |
| GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 8 | 3.14e-01 | -2.06e-01 | 6.60e-01 |
| GOBP NEURON PROJECTION REGENERATION | 45 | 1.69e-02 | -2.06e-01 | 1.54e-01 |
| GOBP DETECTION OF OTHER ORGANISM | 18 | 1.31e-01 | -2.06e-01 | 4.43e-01 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 31 | 4.74e-02 | -2.06e-01 | 2.66e-01 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 15 | 1.68e-01 | 2.06e-01 | 5.01e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 31 | 4.75e-02 | 2.06e-01 | 2.66e-01 |
| GOBP SEX CHROMOSOME DOSAGE COMPENSATION | 17 | 1.42e-01 | 2.06e-01 | 4.61e-01 |
| GOBP GOLGI DISASSEMBLY | 6 | 3.84e-01 | 2.05e-01 | 7.15e-01 |
| GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 9 | 2.86e-01 | -2.05e-01 | 6.34e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 6 | 3.84e-01 | 2.05e-01 | 7.15e-01 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 10 | 2.61e-01 | 2.05e-01 | 6.09e-01 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 25 | 7.57e-02 | 2.05e-01 | 3.36e-01 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 181 | 1.93e-06 | -2.05e-01 | 1.32e-04 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 23 | 8.89e-02 | -2.05e-01 | 3.64e-01 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 9 | 2.87e-01 | 2.05e-01 | 6.35e-01 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 18 | 1.32e-01 | -2.05e-01 | 4.46e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 29 | 5.64e-02 | -2.05e-01 | 2.89e-01 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 48 | 1.42e-02 | 2.05e-01 | 1.40e-01 |
| GOMF C PALMITOYLTRANSFERASE ACTIVITY | 5 | 4.28e-01 | -2.05e-01 | 7.43e-01 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 14 | 1.85e-01 | 2.05e-01 | 5.24e-01 |
| GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 5 | 4.28e-01 | 2.05e-01 | 7.43e-01 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 10 | 2.63e-01 | 2.04e-01 | 6.11e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 37 | 3.14e-02 | 2.04e-01 | 2.15e-01 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 243 | 4.03e-08 | 2.04e-01 | 4.59e-06 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 13 | 2.02e-01 | -2.04e-01 | 5.45e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 87 | 9.88e-04 | 2.04e-01 | 2.28e-02 |
| GOBP ANTIBACTERIAL INNATE IMMUNE RESPONSE | 7 | 3.49e-01 | -2.04e-01 | 6.89e-01 |
| GOBP MAST CELL PROLIFERATION | 6 | 3.87e-01 | -2.04e-01 | 7.16e-01 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 21 | 1.05e-01 | 2.04e-01 | 3.96e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR | 296 | 1.56e-09 | 2.04e-01 | 2.52e-07 |
| GOBP REGULATION OF CILIUM MOVEMENT | 23 | 9.05e-02 | -2.04e-01 | 3.67e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 50 | 1.26e-02 | -2.04e-01 | 1.31e-01 |
| GOBP PROSTHETIC GROUP METABOLIC PROCESS | 6 | 3.88e-01 | 2.04e-01 | 7.16e-01 |
| GOBP DORSAL AORTA MORPHOGENESIS | 5 | 4.31e-01 | 2.03e-01 | 7.44e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 41 | 2.42e-02 | 2.03e-01 | 1.86e-01 |
| GOBP PUTRESCINE METABOLIC PROCESS | 8 | 3.19e-01 | -2.03e-01 | 6.66e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 10 | 2.66e-01 | -2.03e-01 | 6.15e-01 |
| GOCC INHIBITORY SYNAPSE | 8 | 3.20e-01 | 2.03e-01 | 6.66e-01 |
| GOBP LEUKOCYTE AGGREGATION | 11 | 2.43e-01 | -2.03e-01 | 5.90e-01 |
| GOBP OVIDUCT DEVELOPMENT | 5 | 4.32e-01 | -2.03e-01 | 7.44e-01 |
| GOMF TAT PROTEIN BINDING | 10 | 2.66e-01 | 2.03e-01 | 6.15e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 28 | 6.31e-02 | -2.03e-01 | 3.07e-01 |
| GOMF SINGLE STRANDED RNA BINDING | 74 | 2.54e-03 | 2.03e-01 | 4.46e-02 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 3.20e-01 | 2.03e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 32 | 4.72e-02 | 2.03e-01 | 2.66e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 16 | 1.61e-01 | -2.03e-01 | 4.90e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 14 | 1.90e-01 | -2.02e-01 | 5.30e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 123 | 1.05e-04 | 2.02e-01 | 4.09e-03 |
| GOBP RESPONSE TO INTERFERON BETA | 31 | 5.12e-02 | 2.02e-01 | 2.77e-01 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 24 | 8.63e-02 | -2.02e-01 | 3.58e-01 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA READER ACTIVITY | 11 | 2.46e-01 | 2.02e-01 | 5.93e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 211 | 4.14e-07 | -2.02e-01 | 3.59e-05 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 7 | 3.55e-01 | -2.02e-01 | 6.93e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 56 | 8.92e-03 | -2.02e-01 | 1.06e-01 |
| GOCC TRANSLOCON COMPLEX | 6 | 3.92e-01 | -2.02e-01 | 7.20e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM MEMBRANE | 5 | 4.34e-01 | -2.02e-01 | 7.46e-01 |
| GOBP MICROTUBULE NUCLEATION | 45 | 1.91e-02 | 2.02e-01 | 1.64e-01 |
| GOBP POSITIVE REGULATION OF MRNA CATABOLIC PROCESS | 101 | 4.56e-04 | 2.02e-01 | 1.25e-02 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 9 | 2.95e-01 | -2.02e-01 | 6.43e-01 |
| GOBP NEURAL CREST FORMATION | 10 | 2.69e-01 | 2.02e-01 | 6.19e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 17 | 1.50e-01 | -2.02e-01 | 4.75e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 115 | 1.86e-04 | -2.02e-01 | 6.32e-03 |
| GOBP OLIGODENDROCYTE APOPTOTIC PROCESS | 5 | 4.35e-01 | 2.02e-01 | 7.47e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 183 | 2.51e-06 | 2.02e-01 | 1.68e-04 |
| GOBP PROTEIN DENEDDYLATION | 11 | 2.47e-01 | -2.02e-01 | 5.95e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 49 | 1.47e-02 | 2.01e-01 | 1.43e-01 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 13 | 2.09e-01 | 2.01e-01 | 5.54e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 7 | 3.56e-01 | -2.01e-01 | 6.94e-01 |
| GOCC DENDRITE TERMINUS | 12 | 2.27e-01 | 2.01e-01 | 5.72e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 65 | 5.00e-03 | 2.01e-01 | 7.27e-02 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 13 | 2.09e-01 | 2.01e-01 | 5.54e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 2.96e-01 | -2.01e-01 | 6.45e-01 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 7 | 3.57e-01 | -2.01e-01 | 6.94e-01 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 7 | 3.57e-01 | -2.01e-01 | 6.94e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 6 | 3.94e-01 | 2.01e-01 | 7.21e-01 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 8 | 3.25e-01 | 2.01e-01 | 6.70e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 13 | 2.10e-01 | -2.01e-01 | 5.55e-01 |
| GOMF AMMONIA LYASE ACTIVITY | 5 | 4.36e-01 | -2.01e-01 | 7.48e-01 |
| GOBP REGULATION OF GLOMERULAR FILTRATION | 8 | 3.25e-01 | 2.01e-01 | 6.70e-01 |
| GOBP DETOXIFICATION | 119 | 1.54e-04 | -2.01e-01 | 5.46e-03 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 44 | 2.12e-02 | 2.01e-01 | 1.72e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 41 | 2.61e-02 | -2.01e-01 | 1.95e-01 |
| GOBP OPTIC NERVE MORPHOGENESIS | 5 | 4.37e-01 | 2.01e-01 | 7.49e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 23 | 9.59e-02 | -2.01e-01 | 3.77e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 7 | 3.58e-01 | -2.01e-01 | 6.95e-01 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 17 | 1.52e-01 | -2.01e-01 | 4.77e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 10 | 2.72e-01 | 2.00e-01 | 6.22e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 7 | 3.58e-01 | 2.00e-01 | 6.95e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 12 | 2.29e-01 | -2.00e-01 | 5.74e-01 |
| GOBP EGG ACTIVATION | 7 | 3.59e-01 | -2.00e-01 | 6.95e-01 |
| GOBP HYPOTHALAMUS CELL DIFFERENTIATION | 6 | 3.95e-01 | -2.00e-01 | 7.22e-01 |
| GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE | 6 | 3.95e-01 | -2.00e-01 | 7.22e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 3.59e-01 | 2.00e-01 | 6.95e-01 |
| GOBP TAURINE METABOLIC PROCESS | 6 | 3.96e-01 | 2.00e-01 | 7.22e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 16 | 1.66e-01 | 2.00e-01 | 4.99e-01 |
| GOMF TETRAPYRROLE BINDING | 108 | 3.29e-04 | -2.00e-01 | 9.85e-03 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 6 | 3.97e-01 | -2.00e-01 | 7.23e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 11 | 2.51e-01 | 2.00e-01 | 5.98e-01 |
| GOMF PROTEINASE ACTIVATED RECEPTOR ACTIVITY | 5 | 4.39e-01 | -2.00e-01 | 7.50e-01 |
| GOBP POLYOL CATABOLIC PROCESS | 9 | 3.00e-01 | 2.00e-01 | 6.49e-01 |
| GOBP POSITIVE REGULATION OF AGGREPHAGY | 5 | 4.39e-01 | 2.00e-01 | 7.50e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 17 | 1.54e-01 | -2.00e-01 | 4.80e-01 |
| GOMF RNA STEM LOOP BINDING | 15 | 1.81e-01 | 2.00e-01 | 5.18e-01 |
| GOBP REGULATION OF OPSONIZATION | 5 | 4.40e-01 | 2.00e-01 | 7.50e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 76 | 2.64e-03 | 1.99e-01 | 4.60e-02 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 8 | 3.29e-01 | -1.99e-01 | 6.74e-01 |
| GOBP HEME B METABOLIC PROCESS | 9 | 3.00e-01 | -1.99e-01 | 6.50e-01 |
| GOBP NUCLEOBASE CATABOLIC PROCESS | 6 | 3.98e-01 | -1.99e-01 | 7.23e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 18 | 1.44e-01 | -1.99e-01 | 4.63e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 26 | 7.89e-02 | -1.99e-01 | 3.44e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY | 45 | 2.09e-02 | 1.99e-01 | 1.71e-01 |
| GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 5 | 4.41e-01 | 1.99e-01 | 7.51e-01 |
| GOBP TRANSLATIONAL TERMINATION | 16 | 1.68e-01 | 1.99e-01 | 5.02e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 29 | 6.39e-02 | -1.99e-01 | 3.10e-01 |
| GOCC TROPONIN COMPLEX | 5 | 4.42e-01 | -1.99e-01 | 7.51e-01 |
| GOBP NEURON REMODELING | 10 | 2.76e-01 | -1.99e-01 | 6.26e-01 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 12 | 2.33e-01 | 1.99e-01 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 10 | 2.77e-01 | 1.99e-01 | 6.26e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 35 | 4.20e-02 | 1.99e-01 | 2.49e-01 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 14 | 1.98e-01 | -1.99e-01 | 5.41e-01 |
| GOBP NITRIC OXIDE TRANSPORT | 5 | 4.42e-01 | -1.99e-01 | 7.51e-01 |
| GOBP RENAL SODIUM ION ABSORPTION | 8 | 3.31e-01 | 1.98e-01 | 6.75e-01 |
| GOBP RENAL SODIUM ION TRANSPORT | 8 | 3.31e-01 | 1.98e-01 | 6.75e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 61 | 7.34e-03 | 1.98e-01 | 9.21e-02 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 10 | 2.77e-01 | 1.98e-01 | 6.26e-01 |
| GOCC NUCLEAR CHROMOSOME | 220 | 3.99e-07 | 1.98e-01 | 3.49e-05 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 9 | 3.03e-01 | -1.98e-01 | 6.52e-01 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 22 | 1.08e-01 | 1.98e-01 | 4.00e-01 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 7 | 3.64e-01 | -1.98e-01 | 6.99e-01 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 70 | 4.18e-03 | 1.98e-01 | 6.41e-02 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 27 | 7.50e-02 | 1.98e-01 | 3.34e-01 |
| GOBP VITAMIN CATABOLIC PROCESS | 10 | 2.78e-01 | -1.98e-01 | 6.27e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 21 | 1.16e-01 | 1.98e-01 | 4.16e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 35 | 4.28e-02 | -1.98e-01 | 2.52e-01 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 10 | 2.79e-01 | -1.98e-01 | 6.28e-01 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 31 | 5.67e-02 | -1.98e-01 | 2.89e-01 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.04e-01 | -1.98e-01 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 8 | 3.33e-01 | 1.98e-01 | 6.77e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 89 | 1.27e-03 | 1.98e-01 | 2.73e-02 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 17 | 1.58e-01 | 1.98e-01 | 4.86e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 36 | 4.03e-02 | -1.98e-01 | 2.45e-01 |
| GOMF DIPEPTIDASE ACTIVITY | 13 | 2.18e-01 | -1.97e-01 | 5.61e-01 |
| GOBP REGULATION OF PROTEIN MATURATION | 55 | 1.14e-02 | -1.97e-01 | 1.23e-01 |
| GOBP SOMITE DEVELOPMENT | 54 | 1.21e-02 | 1.97e-01 | 1.28e-01 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 8 | 3.34e-01 | -1.97e-01 | 6.77e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 36 | 4.05e-02 | -1.97e-01 | 2.45e-01 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 14 | 2.01e-01 | 1.97e-01 | 5.44e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 194 | 2.16e-06 | -1.97e-01 | 1.45e-04 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 181 | 4.72e-06 | 1.97e-01 | 3.00e-04 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 8 | 3.34e-01 | 1.97e-01 | 6.78e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 20 | 1.27e-01 | -1.97e-01 | 4.37e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 58 | 9.41e-03 | 1.97e-01 | 1.09e-01 |
| GOBP PROTEIN MONOUBIQUITINATION | 48 | 1.83e-02 | 1.97e-01 | 1.60e-01 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 8 | 3.35e-01 | -1.97e-01 | 6.78e-01 |
| GOMF COLLAGEN RECEPTOR ACTIVITY | 6 | 4.04e-01 | -1.97e-01 | 7.27e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 10 | 2.82e-01 | -1.97e-01 | 6.31e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 9 | 3.07e-01 | 1.97e-01 | 6.55e-01 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 21 | 1.19e-01 | -1.96e-01 | 4.20e-01 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 7 | 3.68e-01 | -1.96e-01 | 7.01e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 11 | 2.59e-01 | -1.96e-01 | 6.08e-01 |
| GOBP PROTEIN DEUBIQUITINATION | 82 | 2.12e-03 | 1.96e-01 | 3.95e-02 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 22 | 1.11e-01 | -1.96e-01 | 4.07e-01 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 4.48e-01 | 1.96e-01 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 6 | 4.06e-01 | -1.96e-01 | 7.28e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 14 | 2.05e-01 | -1.96e-01 | 5.48e-01 |
| GOBP MRNA TRANSPORT | 123 | 1.77e-04 | 1.96e-01 | 6.09e-03 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 17 | 1.63e-01 | -1.96e-01 | 4.92e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 11 | 2.62e-01 | 1.95e-01 | 6.10e-01 |
| GOBP L LEUCINE IMPORT ACROSS PLASMA MEMBRANE | 5 | 4.49e-01 | 1.95e-01 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 36 | 4.24e-02 | -1.95e-01 | 2.51e-01 |
| GOBP OTOLITH DEVELOPMENT | 5 | 4.49e-01 | 1.95e-01 | 7.55e-01 |
| GOBP ACTIN NUCLEATION | 52 | 1.48e-02 | -1.95e-01 | 1.44e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 5 | 4.49e-01 | 1.95e-01 | 7.55e-01 |
| GOBP PLATELET ACTIVATION | 117 | 2.62e-04 | -1.95e-01 | 8.32e-03 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 9 | 3.10e-01 | -1.95e-01 | 6.57e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 108 | 4.54e-04 | -1.95e-01 | 1.25e-02 |
| GOMF COPPER ION BINDING | 47 | 2.06e-02 | -1.95e-01 | 1.69e-01 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 13 | 2.23e-01 | -1.95e-01 | 5.68e-01 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 12 | 2.42e-01 | 1.95e-01 | 5.89e-01 |
| GOBP MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER | 5 | 4.50e-01 | 1.95e-01 | 7.55e-01 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 8 | 3.39e-01 | 1.95e-01 | 6.81e-01 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 10 | 2.85e-01 | -1.95e-01 | 6.34e-01 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 2.85e-01 | 1.95e-01 | 6.34e-01 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 38 | 3.75e-02 | 1.95e-01 | 2.35e-01 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 19 | 1.41e-01 | -1.95e-01 | 4.60e-01 |
| GOBP REGULATION OF COAGULATION | 55 | 1.24e-02 | -1.95e-01 | 1.29e-01 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 9 | 3.11e-01 | 1.95e-01 | 6.58e-01 |
| GOBP L LEUCINE METABOLIC PROCESS | 7 | 3.72e-01 | -1.95e-01 | 7.04e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 11 | 2.63e-01 | -1.95e-01 | 6.11e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 22 | 1.14e-01 | -1.95e-01 | 4.12e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 8 | 3.40e-01 | 1.95e-01 | 6.82e-01 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 13 | 2.24e-01 | -1.95e-01 | 5.69e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 14 | 2.07e-01 | -1.95e-01 | 5.52e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 44 | 2.55e-02 | -1.95e-01 | 1.91e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 70 | 4.87e-03 | -1.95e-01 | 7.15e-02 |
| GOBP ALANINE TRANSPORT | 12 | 2.43e-01 | 1.95e-01 | 5.90e-01 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 125 | 1.72e-04 | 1.95e-01 | 5.98e-03 |
| GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL | 5 | 4.51e-01 | 1.95e-01 | 7.57e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 12 | 2.43e-01 | -1.95e-01 | 5.90e-01 |
| GOMF TRAIL BINDING | 5 | 4.52e-01 | 1.94e-01 | 7.57e-01 |
| GOBP ETHANOL METABOLIC PROCESS | 8 | 3.41e-01 | -1.94e-01 | 6.82e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 29 | 7.01e-02 | 1.94e-01 | 3.22e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 26 | 8.64e-02 | -1.94e-01 | 3.58e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 12 | 2.44e-01 | -1.94e-01 | 5.90e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 25 | 9.27e-02 | -1.94e-01 | 3.72e-01 |
| GOBP NEGATIVE REGULATION OF CELL VOLUME | 5 | 4.52e-01 | -1.94e-01 | 7.57e-01 |
| GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY | 7 | 3.74e-01 | -1.94e-01 | 7.06e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 41 | 3.15e-02 | -1.94e-01 | 2.15e-01 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 153 | 3.43e-05 | 1.94e-01 | 1.64e-03 |
| GOBP AXIS SPECIFICATION | 59 | 9.94e-03 | 1.94e-01 | 1.13e-01 |
| GOBP MITOTIC RECOMBINATION | 23 | 1.07e-01 | 1.94e-01 | 3.99e-01 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 50 | 1.76e-02 | -1.94e-01 | 1.57e-01 |
| GOCC ENDOSOME LUMEN | 29 | 7.07e-02 | -1.94e-01 | 3.24e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 25 | 9.34e-02 | -1.94e-01 | 3.73e-01 |
| GOBP DEFINITIVE HEMOPOIESIS | 19 | 1.44e-01 | -1.94e-01 | 4.64e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 30 | 6.64e-02 | -1.94e-01 | 3.13e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 32 | 5.80e-02 | -1.94e-01 | 2.92e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING | 7 | 3.75e-01 | -1.94e-01 | 7.07e-01 |
| GOMF MONOAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.75e-01 | 1.94e-01 | 7.07e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 58 | 1.07e-02 | 1.94e-01 | 1.19e-01 |
| GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION | 5 | 4.53e-01 | -1.94e-01 | 7.58e-01 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 7 | 3.75e-01 | 1.94e-01 | 7.07e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 15 | 1.94e-01 | -1.94e-01 | 5.36e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 10 | 2.89e-01 | 1.94e-01 | 6.37e-01 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 15 | 1.94e-01 | -1.94e-01 | 5.36e-01 |
| GOBP UBIQUITIN RECYCLING | 13 | 2.27e-01 | 1.94e-01 | 5.72e-01 |
| GOCC CELL BODY MEMBRANE | 18 | 1.55e-01 | -1.94e-01 | 4.81e-01 |
| GOBP REGULATION OF FIBRINOLYSIS | 12 | 2.46e-01 | -1.94e-01 | 5.93e-01 |
| GOCC AP 3 ADAPTOR COMPLEX | 11 | 2.66e-01 | 1.94e-01 | 6.15e-01 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 2.90e-01 | 1.93e-01 | 6.38e-01 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 15 | 1.95e-01 | -1.93e-01 | 5.37e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 8 | 3.44e-01 | -1.93e-01 | 6.84e-01 |
| GOCC FIBRILLAR CENTER | 139 | 8.31e-05 | 1.93e-01 | 3.31e-03 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 16 | 1.81e-01 | -1.93e-01 | 5.18e-01 |
| GOMF 5S RRNA BINDING | 9 | 3.16e-01 | -1.93e-01 | 6.63e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 28 | 7.73e-02 | 1.93e-01 | 3.41e-01 |
| GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 4.55e-01 | 1.93e-01 | 7.60e-01 |
| GOBP ENAMEL MINERALIZATION | 12 | 2.47e-01 | -1.93e-01 | 5.95e-01 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 8 | 3.45e-01 | 1.93e-01 | 6.85e-01 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 12 | 2.48e-01 | -1.93e-01 | 5.96e-01 |
| GOBP ECTODERM DEVELOPMENT | 14 | 2.13e-01 | -1.92e-01 | 5.59e-01 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 53 | 1.54e-02 | -1.92e-01 | 1.47e-01 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 9 | 3.18e-01 | -1.92e-01 | 6.65e-01 |
| GOCC CHROMOSOME PASSENGER COMPLEX | 6 | 4.15e-01 | 1.92e-01 | 7.34e-01 |
| GOMF NADH DEHYDROGENASE ACTIVITY | 11 | 2.70e-01 | -1.92e-01 | 6.20e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 18 | 1.59e-01 | 1.92e-01 | 4.87e-01 |
| GOCC AXONAL GROWTH CONE | 23 | 1.11e-01 | 1.92e-01 | 4.08e-01 |
| GOCC PML BODY | 103 | 7.73e-04 | 1.92e-01 | 1.87e-02 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 17 | 1.71e-01 | 1.92e-01 | 5.05e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 9 | 3.19e-01 | 1.92e-01 | 6.66e-01 |
| GOBP HETEROCHROMATIN FORMATION | 110 | 5.14e-04 | 1.92e-01 | 1.37e-02 |
| GOBP APOPTOTIC CELL CLEARANCE | 42 | 3.17e-02 | -1.92e-01 | 2.15e-01 |
| GOBP CARNITINE METABOLIC PROCESS | 11 | 2.71e-01 | -1.91e-01 | 6.22e-01 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 11 | 2.71e-01 | -1.91e-01 | 6.22e-01 |
| GOBP REGULATION OF ODONTOGENESIS | 9 | 3.20e-01 | -1.91e-01 | 6.66e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 34 | 5.35e-02 | 1.91e-01 | 2.81e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 12 | 2.51e-01 | -1.91e-01 | 5.98e-01 |
| GOMF ARRESTIN FAMILY PROTEIN BINDING | 6 | 4.17e-01 | -1.91e-01 | 7.36e-01 |
| GOBP HISTAMINE TRANSPORT | 13 | 2.33e-01 | -1.91e-01 | 5.80e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 11 | 2.73e-01 | -1.91e-01 | 6.23e-01 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 9 | 3.21e-01 | -1.91e-01 | 6.67e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 33 | 5.76e-02 | -1.91e-01 | 2.91e-01 |
| GOBP SKELETAL MUSCLE FIBER DIFFERENTIATION | 6 | 4.18e-01 | -1.91e-01 | 7.37e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 78 | 3.56e-03 | -1.91e-01 | 5.73e-02 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 12 | 2.52e-01 | 1.91e-01 | 6.00e-01 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 28 | 8.06e-02 | 1.91e-01 | 3.47e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 21 | 1.30e-01 | 1.91e-01 | 4.43e-01 |
| GOBP POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS | 5 | 4.61e-01 | 1.91e-01 | 7.64e-01 |
| GOMF NMDA GLUTAMATE RECEPTOR ACTIVITY | 6 | 4.19e-01 | 1.90e-01 | 7.38e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 27 | 8.68e-02 | 1.90e-01 | 3.58e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 42 | 3.27e-02 | -1.90e-01 | 2.19e-01 |
| GOBP BONE MARROW DEVELOPMENT | 8 | 3.51e-01 | 1.90e-01 | 6.91e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 12 | 2.54e-01 | 1.90e-01 | 6.02e-01 |
| GOMF OLIGOPEPTIDE BINDING | 10 | 2.98e-01 | -1.90e-01 | 6.47e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 46 | 2.57e-02 | -1.90e-01 | 1.92e-01 |
| GOCC PARANODE REGION OF AXON | 10 | 2.98e-01 | 1.90e-01 | 6.47e-01 |
| GOBP PROTEASOME ASSEMBLY | 13 | 2.35e-01 | -1.90e-01 | 5.83e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 9 | 3.24e-01 | 1.90e-01 | 6.69e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 74 | 4.73e-03 | -1.90e-01 | 6.98e-02 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 2.36e-01 | -1.90e-01 | 5.83e-01 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 23 | 1.15e-01 | 1.90e-01 | 4.15e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 13 | 2.36e-01 | -1.90e-01 | 5.83e-01 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 34 | 5.54e-02 | -1.90e-01 | 2.87e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 16 | 1.89e-01 | 1.90e-01 | 5.29e-01 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 23 | 1.15e-01 | 1.90e-01 | 4.15e-01 |
| GOCC CONDENSED CHROMOSOME | 263 | 1.20e-07 | 1.90e-01 | 1.18e-05 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 42 | 3.35e-02 | -1.90e-01 | 2.22e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 14 | 2.20e-01 | 1.90e-01 | 5.64e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 414 | 3.63e-11 | -1.90e-01 | 8.49e-09 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 12 | 2.56e-01 | 1.89e-01 | 6.04e-01 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 7 | 3.85e-01 | -1.89e-01 | 7.15e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 13 | 2.37e-01 | 1.89e-01 | 5.85e-01 |
| GOCC MHC PROTEIN COMPLEX | 24 | 1.08e-01 | 1.89e-01 | 4.01e-01 |
| GOBP DNA CONFORMATION CHANGE | 88 | 2.15e-03 | 1.89e-01 | 3.98e-02 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 7 | 3.86e-01 | 1.89e-01 | 7.15e-01 |
| GOBP CDP CHOLINE PATHWAY | 7 | 3.86e-01 | -1.89e-01 | 7.15e-01 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 20 | 1.43e-01 | -1.89e-01 | 4.62e-01 |
| GOBP ENTERIC NERVOUS SYSTEM DEVELOPMENT | 7 | 3.86e-01 | -1.89e-01 | 7.16e-01 |
| GOBP SOMITOGENESIS | 40 | 3.85e-02 | 1.89e-01 | 2.38e-01 |
| GOCC VOLTAGE GATED SODIUM CHANNEL COMPLEX | 11 | 2.78e-01 | 1.89e-01 | 6.26e-01 |
| GOBP L PHENYLALANINE METABOLIC PROCESS | 6 | 4.23e-01 | -1.89e-01 | 7.41e-01 |
| GOBP CHROMOSOME SEPARATION | 79 | 3.68e-03 | 1.89e-01 | 5.82e-02 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 33 | 6.03e-02 | 1.89e-01 | 2.99e-01 |
| GOBP DNA REPLICATION INITIATION | 35 | 5.30e-02 | 1.89e-01 | 2.79e-01 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 2.21e-01 | 1.89e-01 | 5.66e-01 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 7 | 3.87e-01 | 1.89e-01 | 7.16e-01 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 23 | 1.17e-01 | -1.89e-01 | 4.17e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 12 | 2.58e-01 | 1.89e-01 | 6.06e-01 |
| GOBP SPINDLE ASSEMBLY | 126 | 2.53e-04 | 1.89e-01 | 8.15e-03 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 6 | 4.23e-01 | -1.89e-01 | 7.41e-01 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 32 | 6.46e-02 | -1.89e-01 | 3.11e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 18 | 1.66e-01 | -1.89e-01 | 4.99e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 12 | 2.58e-01 | -1.89e-01 | 6.06e-01 |
| GOBP CORTISOL BIOSYNTHETIC PROCESS | 6 | 4.24e-01 | 1.89e-01 | 7.41e-01 |
| GOBP CORTISOL METABOLIC PROCESS | 6 | 4.24e-01 | 1.89e-01 | 7.41e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 3.88e-01 | 1.89e-01 | 7.16e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 4.66e-01 | -1.88e-01 | 7.67e-01 |
| GOMF ADENYLATE KINASE ACTIVITY | 7 | 3.88e-01 | -1.88e-01 | 7.16e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 14 | 2.23e-01 | -1.88e-01 | 5.68e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 8 | 3.57e-01 | 1.88e-01 | 6.94e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 5 | 4.66e-01 | 1.88e-01 | 7.68e-01 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 7 | 3.89e-01 | 1.88e-01 | 7.17e-01 |
| GOCC CENTRIOLE | 154 | 5.64e-05 | 1.88e-01 | 2.37e-03 |
| GOMF CHROMATIN INSULATOR SEQUENCE BINDING | 5 | 4.67e-01 | 1.88e-01 | 7.68e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 9 | 3.29e-01 | 1.88e-01 | 6.75e-01 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 80 | 3.66e-03 | -1.88e-01 | 5.81e-02 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 58 | 1.33e-02 | -1.88e-01 | 1.35e-01 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 31 | 7.02e-02 | 1.88e-01 | 3.22e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 86 | 2.60e-03 | 1.88e-01 | 4.55e-02 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 11 | 2.81e-01 | -1.88e-01 | 6.30e-01 |
| GOBP GONADOTROPIN SECRETION | 7 | 3.90e-01 | 1.88e-01 | 7.18e-01 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 9 | 3.30e-01 | -1.88e-01 | 6.75e-01 |
| GOBP REGULATORY NCRNA PROCESSING | 58 | 1.35e-02 | 1.88e-01 | 1.36e-01 |
| GOBP POSITIVE REGULATION OF ODONTOGENESIS | 6 | 4.26e-01 | -1.88e-01 | 7.42e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 16 | 1.94e-01 | 1.88e-01 | 5.36e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 11 | 2.82e-01 | -1.88e-01 | 6.30e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 11 | 2.82e-01 | -1.87e-01 | 6.30e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 10 | 3.05e-01 | -1.87e-01 | 6.53e-01 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 9 | 3.30e-01 | -1.87e-01 | 6.75e-01 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 6 | 4.27e-01 | -1.87e-01 | 7.42e-01 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 50 | 2.19e-02 | -1.87e-01 | 1.75e-01 |
| GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.27e-01 | -1.87e-01 | 7.42e-01 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 9 | 3.31e-01 | 1.87e-01 | 6.75e-01 |
| GOBP LONG TERM MEMORY | 27 | 9.24e-02 | 1.87e-01 | 3.72e-01 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 7 | 3.91e-01 | -1.87e-01 | 7.20e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 24 | 1.13e-01 | 1.87e-01 | 4.11e-01 |
| GOBP INTERNAL PEPTIDYL LYSINE ACETYLATION | 7 | 3.92e-01 | 1.87e-01 | 7.20e-01 |
| GOCC GBAF COMPLEX | 13 | 2.43e-01 | 1.87e-01 | 5.90e-01 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 13 | 2.43e-01 | -1.87e-01 | 5.90e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 127 | 2.79e-04 | 1.87e-01 | 8.75e-03 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING | 5 | 4.70e-01 | -1.87e-01 | 7.71e-01 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 14 | 2.27e-01 | -1.87e-01 | 5.72e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 61 | 1.17e-02 | 1.87e-01 | 1.25e-01 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 21 | 1.39e-01 | -1.87e-01 | 4.57e-01 |
| GOBP LOCALIZATION OF CELL | 6 | 4.29e-01 | 1.87e-01 | 7.43e-01 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 13 | 2.44e-01 | -1.87e-01 | 5.91e-01 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 8 | 3.61e-01 | -1.87e-01 | 6.97e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 19 | 1.59e-01 | -1.86e-01 | 4.88e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 303 | 2.35e-08 | -1.86e-01 | 2.89e-06 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 45 | 3.06e-02 | 1.86e-01 | 2.12e-01 |
| GOMF WW DOMAIN BINDING | 19 | 1.60e-01 | 1.86e-01 | 4.88e-01 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 10 | 3.08e-01 | -1.86e-01 | 6.55e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 16 | 1.97e-01 | -1.86e-01 | 5.39e-01 |
| GOMF MEDIUM CHAIN FATTY ACID COA LIGASE ACTIVITY | 8 | 3.62e-01 | -1.86e-01 | 6.98e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 6 | 4.30e-01 | 1.86e-01 | 7.44e-01 |
| GOBP REGULATION OF ACTIN NUCLEATION | 38 | 4.71e-02 | -1.86e-01 | 2.65e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 163 | 4.13e-05 | -1.86e-01 | 1.88e-03 |
| GOBP ACUTE PHASE RESPONSE | 28 | 8.83e-02 | -1.86e-01 | 3.62e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 76 | 5.04e-03 | 1.86e-01 | 7.29e-02 |
| GOMF TITIN BINDING | 10 | 3.08e-01 | -1.86e-01 | 6.56e-01 |
| GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 6 | 4.30e-01 | -1.86e-01 | 7.44e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 19 | 1.61e-01 | -1.86e-01 | 4.90e-01 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 4.72e-01 | -1.86e-01 | 7.72e-01 |
| GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY | 5 | 4.72e-01 | 1.86e-01 | 7.72e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 6 | 4.31e-01 | -1.86e-01 | 7.44e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 11 | 2.86e-01 | 1.86e-01 | 6.34e-01 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 16 | 1.99e-01 | -1.86e-01 | 5.41e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 66 | 9.16e-03 | -1.85e-01 | 1.08e-01 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 10 | 3.10e-01 | -1.85e-01 | 6.57e-01 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 790 | 7.21e-19 | 1.85e-01 | 8.42e-16 |
| GOBP NEPHRIC DUCT DEVELOPMENT | 8 | 3.64e-01 | -1.85e-01 | 6.99e-01 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 22 | 1.32e-01 | -1.85e-01 | 4.46e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 16 | 1.99e-01 | -1.85e-01 | 5.42e-01 |
| GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX | 5 | 4.73e-01 | -1.85e-01 | 7.73e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 752 | 4.94e-18 | -1.85e-01 | 4.61e-15 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 19 | 1.62e-01 | 1.85e-01 | 4.92e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 30 | 7.91e-02 | 1.85e-01 | 3.44e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 61 | 1.24e-02 | 1.85e-01 | 1.29e-01 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 16 | 2.00e-01 | -1.85e-01 | 5.43e-01 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.65e-01 | 1.85e-01 | 6.99e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 277 | 1.15e-07 | 1.85e-01 | 1.14e-05 |
| GOBP RESPONSE TO UV A | 7 | 3.97e-01 | -1.85e-01 | 7.23e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 108 | 8.97e-04 | -1.85e-01 | 2.12e-02 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 3.97e-01 | 1.85e-01 | 7.23e-01 |
| GOBP VIRAL TRANSCRIPTION | 47 | 2.83e-02 | 1.85e-01 | 2.04e-01 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 5 | 4.74e-01 | 1.85e-01 | 7.73e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 18 | 1.74e-01 | -1.85e-01 | 5.09e-01 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 18 | 1.75e-01 | -1.85e-01 | 5.09e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 144 | 1.30e-04 | -1.85e-01 | 4.88e-03 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 15 | 2.16e-01 | 1.84e-01 | 5.60e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 2.69e-01 | -1.84e-01 | 6.18e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 14 | 2.32e-01 | 1.84e-01 | 5.79e-01 |
| GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 6 | 4.34e-01 | 1.84e-01 | 7.46e-01 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 16 | 2.02e-01 | -1.84e-01 | 5.45e-01 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 7 | 3.99e-01 | 1.84e-01 | 7.24e-01 |
| GOBP TELOMERE MAINTENANCE | 156 | 7.15e-05 | 1.84e-01 | 2.89e-03 |
| GOBP REGULATION OF LIGASE ACTIVITY | 9 | 3.39e-01 | -1.84e-01 | 6.81e-01 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 129 | 3.03e-04 | 1.84e-01 | 9.30e-03 |
| GOBP BIOLOGICAL PHASE | 5 | 4.76e-01 | 1.84e-01 | 7.74e-01 |
| GOBP MRNA 3 END PROCESSING | 39 | 4.66e-02 | 1.84e-01 | 2.64e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 22 | 1.35e-01 | -1.84e-01 | 4.50e-01 |
| GOMF GLUTATHIONE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.35e-01 | -1.84e-01 | 7.47e-01 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 4.35e-01 | -1.84e-01 | 7.47e-01 |
| GOMF RNA POLYMERASE BINDING | 56 | 1.72e-02 | 1.84e-01 | 1.55e-01 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 10 | 3.14e-01 | 1.84e-01 | 6.61e-01 |
| GOCC BBSOME | 8 | 3.68e-01 | 1.84e-01 | 7.01e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 19 | 1.65e-01 | -1.84e-01 | 4.98e-01 |
| GOCC IGM IMMUNOGLOBULIN COMPLEX | 9 | 3.40e-01 | -1.84e-01 | 6.81e-01 |
| GOBP TRANSPOSITION | 26 | 1.05e-01 | 1.84e-01 | 3.95e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 67 | 9.28e-03 | -1.84e-01 | 1.09e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 15 | 2.18e-01 | 1.84e-01 | 5.61e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 17 | 1.90e-01 | 1.84e-01 | 5.30e-01 |
| GOBP PYRUVATE FAMILY AMINO ACID CATABOLIC PROCESS | 7 | 4.00e-01 | -1.84e-01 | 7.25e-01 |
| GOBP DECIDUALIZATION | 18 | 1.78e-01 | -1.83e-01 | 5.14e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 22 | 1.36e-01 | -1.83e-01 | 4.53e-01 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 64 | 1.12e-02 | 1.83e-01 | 1.22e-01 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 2.52e-01 | -1.83e-01 | 6.00e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 22 | 1.37e-01 | -1.83e-01 | 4.53e-01 |
| GOBP REGULATION OF SODIUM DEPENDENT PHOSPHATE TRANSPORT | 5 | 4.78e-01 | -1.83e-01 | 7.76e-01 |
| GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT | 5 | 4.78e-01 | -1.83e-01 | 7.76e-01 |
| GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY | 5 | 4.78e-01 | -1.83e-01 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 3.69e-01 | 1.83e-01 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 55 | 1.88e-02 | -1.83e-01 | 1.63e-01 |
| GOBP KYNURENINE METABOLIC PROCESS | 9 | 3.41e-01 | 1.83e-01 | 6.82e-01 |
| GOCC ORIGIN RECOGNITION COMPLEX | 8 | 3.70e-01 | 1.83e-01 | 7.02e-01 |
| GOMF G PROTEIN ACTIVITY | 41 | 4.27e-02 | -1.83e-01 | 2.52e-01 |
| GOBP SYNAPTIC VESICLE COATING | 5 | 4.79e-01 | -1.83e-01 | 7.77e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 4.38e-01 | -1.83e-01 | 7.49e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 18 | 1.79e-01 | 1.83e-01 | 5.16e-01 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 43 | 3.81e-02 | -1.83e-01 | 2.37e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 27 | 1.00e-01 | -1.83e-01 | 3.87e-01 |
| GOBP NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 10 | 3.17e-01 | -1.83e-01 | 6.64e-01 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 8 | 3.71e-01 | -1.83e-01 | 7.03e-01 |
| GOBP MAINTENANCE OF CELL NUMBER | 153 | 9.64e-05 | 1.83e-01 | 3.80e-03 |
| GOMF CHLORIDE CHANNEL ACTIVITY | 44 | 3.61e-02 | -1.83e-01 | 2.30e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 64 | 1.15e-02 | 1.83e-01 | 1.24e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 10 | 3.18e-01 | -1.83e-01 | 6.64e-01 |
| GOBP REGULATION OF VESICLE FUSION | 17 | 1.93e-01 | -1.82e-01 | 5.34e-01 |
| GOBP CARNITINE TRANSPORT | 7 | 4.03e-01 | -1.82e-01 | 7.26e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 6 | 4.39e-01 | -1.82e-01 | 7.50e-01 |
| GOBP ALKANESULFONATE TRANSMEMBRANE TRANSPORT | 6 | 4.40e-01 | -1.82e-01 | 7.50e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION | 8 | 3.73e-01 | 1.82e-01 | 7.05e-01 |
| GOCC ESCRT I COMPLEX | 10 | 3.19e-01 | 1.82e-01 | 6.66e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 48 | 2.92e-02 | 1.82e-01 | 2.08e-01 |
| GOBP CATECHOL CONTAINING COMPOUND CATABOLIC PROCESS | 7 | 4.05e-01 | 1.82e-01 | 7.27e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 88 | 3.21e-03 | 1.82e-01 | 5.29e-02 |
| GOCC EXON EXON JUNCTION COMPLEX | 20 | 1.59e-01 | 1.82e-01 | 4.88e-01 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 45 | 3.50e-02 | -1.82e-01 | 2.26e-01 |
| GOBP EXCRETION | 14 | 2.39e-01 | 1.82e-01 | 5.87e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 62 | 1.34e-02 | 1.82e-01 | 1.36e-01 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 55 | 1.99e-02 | -1.82e-01 | 1.66e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION | 5 | 4.82e-01 | -1.81e-01 | 7.80e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 122 | 5.36e-04 | -1.81e-01 | 1.42e-02 |
| GOBP BONE MATURATION | 20 | 1.60e-01 | -1.81e-01 | 4.89e-01 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 4.82e-01 | 1.81e-01 | 7.80e-01 |
| GOBP RESPONSE TO MAGNESIUM ION | 16 | 2.09e-01 | -1.81e-01 | 5.54e-01 |
| GOBP CATECHOLAMINE SECRETION | 29 | 9.09e-02 | -1.81e-01 | 3.68e-01 |
| GOBP BEHAVIORAL RESPONSE TO ETHANOL | 7 | 4.06e-01 | -1.81e-01 | 7.28e-01 |
| GOBP L AMINO ACID CATABOLIC PROCESS | 50 | 2.66e-02 | -1.81e-01 | 1.96e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 36 | 5.99e-02 | 1.81e-01 | 2.98e-01 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 3.47e-01 | 1.81e-01 | 6.86e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 7 | 4.07e-01 | -1.81e-01 | 7.28e-01 |
| GOBP KINETOCHORE ORGANIZATION | 21 | 1.51e-01 | 1.81e-01 | 4.75e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 13 | 2.58e-01 | -1.81e-01 | 6.07e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 14 | 2.41e-01 | 1.81e-01 | 5.89e-01 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 26 | 1.10e-01 | 1.81e-01 | 4.05e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 2.41e-01 | 1.81e-01 | 5.89e-01 |
| GOBP PROTEIN DELIPIDATION | 5 | 4.84e-01 | 1.81e-01 | 7.81e-01 |
| GOCC GERM CELL NUCLEUS | 52 | 2.41e-02 | 1.81e-01 | 1.85e-01 |
| GOBP RESPONSE TO BILE ACID | 6 | 4.43e-01 | -1.81e-01 | 7.51e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS | 9 | 3.48e-01 | -1.81e-01 | 6.87e-01 |
| GOBP STEM CELL DIVISION | 28 | 9.79e-02 | 1.81e-01 | 3.82e-01 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 14 | 2.42e-01 | 1.81e-01 | 5.90e-01 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 66 | 1.12e-02 | -1.81e-01 | 1.22e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 31 | 8.19e-02 | -1.81e-01 | 3.49e-01 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 7 | 4.08e-01 | 1.81e-01 | 7.29e-01 |
| GOCC LAMELLIPODIUM MEMBRANE | 19 | 1.73e-01 | -1.80e-01 | 5.08e-01 |
| GOBP RETINOL METABOLIC PROCESS | 31 | 8.22e-02 | -1.80e-01 | 3.50e-01 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 59 | 1.66e-02 | 1.80e-01 | 1.53e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 10 | 3.23e-01 | 1.80e-01 | 6.69e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 9.28e-02 | -1.80e-01 | 3.72e-01 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 19 | 1.74e-01 | 1.80e-01 | 5.08e-01 |
| GOMF OSMOSENSOR ACTIVITY | 5 | 4.85e-01 | -1.80e-01 | 7.83e-01 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 8 | 3.78e-01 | -1.80e-01 | 7.10e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 14 | 2.43e-01 | -1.80e-01 | 5.90e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 47 | 3.27e-02 | -1.80e-01 | 2.19e-01 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 20 | 1.63e-01 | -1.80e-01 | 4.94e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 11 | 3.01e-01 | 1.80e-01 | 6.51e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 62 | 1.42e-02 | 1.80e-01 | 1.40e-01 |
| GOBP LEUKOTRIENE D4 METABOLIC PROCESS | 6 | 4.45e-01 | 1.80e-01 | 7.53e-01 |
| GOBP MACROPHAGE PROLIFERATION | 7 | 4.10e-01 | -1.80e-01 | 7.31e-01 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 12 | 2.81e-01 | -1.80e-01 | 6.30e-01 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 14 | 2.44e-01 | 1.80e-01 | 5.90e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 3.78e-01 | -1.80e-01 | 7.11e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 12 | 2.81e-01 | -1.80e-01 | 6.30e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 12 | 2.81e-01 | 1.80e-01 | 6.30e-01 |
| GOBP CHOLINE TRANSPORT | 5 | 4.86e-01 | 1.80e-01 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 10 | 3.26e-01 | -1.79e-01 | 6.71e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 30 | 8.89e-02 | 1.79e-01 | 3.64e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 510 | 3.97e-12 | -1.79e-01 | 1.28e-09 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 11 | 3.03e-01 | -1.79e-01 | 6.53e-01 |
| GOBP PHASIC SMOOTH MUSCLE CONTRACTION | 12 | 2.83e-01 | 1.79e-01 | 6.32e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 8 | 3.80e-01 | 1.79e-01 | 7.12e-01 |
| GOCC SPERM ANNULUS | 6 | 4.47e-01 | 1.79e-01 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 60 | 1.65e-02 | -1.79e-01 | 1.53e-01 |
| GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 10 | 3.27e-01 | 1.79e-01 | 6.72e-01 |
| GOBP CHIASMA ASSEMBLY | 6 | 4.48e-01 | 1.79e-01 | 7.55e-01 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 18 | 1.89e-01 | 1.79e-01 | 5.29e-01 |
| GOBP NAIL DEVELOPMENT | 6 | 4.48e-01 | -1.79e-01 | 7.55e-01 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 4.12e-01 | -1.79e-01 | 7.32e-01 |
| GOCC ENDOLYSOSOME LUMEN | 5 | 4.88e-01 | 1.79e-01 | 7.84e-01 |
| GOBP DEFENSE RESPONSE TO VIRUS | 266 | 5.09e-07 | 1.79e-01 | 4.33e-05 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 50 | 2.88e-02 | 1.79e-01 | 2.06e-01 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 8 | 3.81e-01 | -1.79e-01 | 7.13e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 38 | 5.66e-02 | -1.79e-01 | 2.89e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 29 | 9.59e-02 | -1.79e-01 | 3.77e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 16 | 2.16e-01 | -1.79e-01 | 5.60e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 7 | 4.13e-01 | -1.79e-01 | 7.33e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 104 | 1.65e-03 | -1.79e-01 | 3.33e-02 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 27 | 1.08e-01 | -1.79e-01 | 4.01e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 23 | 1.39e-01 | 1.78e-01 | 4.57e-01 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 25 | 1.23e-01 | -1.78e-01 | 4.28e-01 |
| GOMF MHC PROTEIN COMPLEX BINDING | 35 | 6.78e-02 | 1.78e-01 | 3.17e-01 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 16 | 2.17e-01 | -1.78e-01 | 5.61e-01 |
| GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 7 | 4.14e-01 | 1.78e-01 | 7.33e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 141 | 2.57e-04 | -1.78e-01 | 8.24e-03 |
| GOBP RECEPTOR INTERNALIZATION | 101 | 1.96e-03 | -1.78e-01 | 3.73e-02 |
| GOBP PHENOTYPIC SWITCHING | 6 | 4.50e-01 | 1.78e-01 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 12 | 2.85e-01 | -1.78e-01 | 6.34e-01 |
| GOBP LUNG ASSOCIATED MESENCHYME DEVELOPMENT | 7 | 4.14e-01 | -1.78e-01 | 7.34e-01 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 9 | 3.55e-01 | -1.78e-01 | 6.93e-01 |
| GOBP ANATOMICAL STRUCTURE REGRESSION | 8 | 3.83e-01 | 1.78e-01 | 7.15e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 4.91e-01 | -1.78e-01 | 7.85e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 26 | 1.16e-01 | 1.78e-01 | 4.15e-01 |
| GOCC CORTICAL GRANULE | 5 | 4.91e-01 | -1.78e-01 | 7.85e-01 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 9 | 3.55e-01 | 1.78e-01 | 6.93e-01 |
| GOMF CARGO ADAPTOR ACTIVITY | 21 | 1.58e-01 | 1.78e-01 | 4.86e-01 |
| GOBP MRNA METHYLGUANOSINE CAP DECAPPING | 16 | 2.18e-01 | 1.78e-01 | 5.61e-01 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 4.91e-01 | -1.78e-01 | 7.85e-01 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 11 | 3.07e-01 | 1.78e-01 | 6.55e-01 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 3.56e-01 | 1.78e-01 | 6.94e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 8 | 3.84e-01 | 1.78e-01 | 7.15e-01 |
| GOBP SULFATE TRANSPORT | 11 | 3.08e-01 | -1.78e-01 | 6.56e-01 |
| GOBP REVERSIBLE DIFFERENTIATION | 5 | 4.92e-01 | 1.77e-01 | 7.85e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 139 | 3.04e-04 | -1.77e-01 | 9.30e-03 |
| GOCC ANNULATE LAMELLAE | 5 | 4.92e-01 | 1.77e-01 | 7.85e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 11 | 3.08e-01 | -1.77e-01 | 6.56e-01 |
| GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 5 | 4.92e-01 | -1.77e-01 | 7.85e-01 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 8.25e-02 | -1.77e-01 | 3.50e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 21 | 1.60e-01 | 1.77e-01 | 4.88e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 26 | 1.18e-01 | -1.77e-01 | 4.18e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 17 | 2.06e-01 | -1.77e-01 | 5.50e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 41 | 4.97e-02 | 1.77e-01 | 2.72e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 55 | 2.33e-02 | 1.77e-01 | 1.81e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 76 | 7.67e-03 | -1.77e-01 | 9.55e-02 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 60 | 1.78e-02 | 1.77e-01 | 1.58e-01 |
| GOBP BLASTODERM SEGMENTATION | 14 | 2.52e-01 | 1.77e-01 | 6.00e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 18 | 1.94e-01 | -1.77e-01 | 5.36e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 892 | 3.24e-19 | 1.77e-01 | 4.33e-16 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 6 | 4.54e-01 | 1.77e-01 | 7.59e-01 |
| GOCC COMMITMENT COMPLEX | 5 | 4.94e-01 | -1.76e-01 | 7.88e-01 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 56 | 2.24e-02 | -1.76e-01 | 1.77e-01 |
| GOBP RNA 3 END PROCESSING | 85 | 4.93e-03 | 1.76e-01 | 7.19e-02 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 13 | 2.71e-01 | 1.76e-01 | 6.22e-01 |
| GOBP PROLINE TRANSPORT | 10 | 3.34e-01 | 1.76e-01 | 6.78e-01 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 39 | 5.67e-02 | 1.76e-01 | 2.89e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 3.11e-01 | -1.76e-01 | 6.58e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 13 | 2.72e-01 | -1.76e-01 | 6.22e-01 |
| GOBP POSITIVE REGULATION OF G0 TO G1 TRANSITION | 5 | 4.95e-01 | 1.76e-01 | 7.88e-01 |
| GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS | 8 | 3.88e-01 | -1.76e-01 | 7.17e-01 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 12 | 2.91e-01 | -1.76e-01 | 6.39e-01 |
| GOBP LIPID PHOSPHORYLATION | 9 | 3.61e-01 | 1.76e-01 | 6.97e-01 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 9 | 3.61e-01 | 1.76e-01 | 6.97e-01 |
| GOCC NUCLEAR PORE | 94 | 3.22e-03 | 1.76e-01 | 5.29e-02 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 18 | 1.97e-01 | -1.76e-01 | 5.38e-01 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 16 | 2.24e-01 | -1.76e-01 | 5.69e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 17 | 2.10e-01 | 1.76e-01 | 5.55e-01 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 10 | 3.36e-01 | -1.76e-01 | 6.79e-01 |
| GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 7 | 4.21e-01 | -1.76e-01 | 7.39e-01 |
| GOCC ROD PHOTORECEPTOR OUTER SEGMENT | 5 | 4.97e-01 | 1.76e-01 | 7.88e-01 |
| GOMF DYNACTIN BINDING | 12 | 2.92e-01 | 1.76e-01 | 6.41e-01 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 76 | 8.18e-03 | -1.75e-01 | 9.98e-02 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 7 | 4.22e-01 | -1.75e-01 | 7.40e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 61 | 1.78e-02 | 1.75e-01 | 1.58e-01 |
| GOBP HEME A METABOLIC PROCESS | 10 | 3.37e-01 | -1.75e-01 | 6.79e-01 |
| GOBP REGULATION OF CELL PROJECTION SIZE | 10 | 3.37e-01 | -1.75e-01 | 6.79e-01 |
| GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING | 7 | 4.22e-01 | 1.75e-01 | 7.40e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 96 | 2.99e-03 | -1.75e-01 | 5.04e-02 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 37 | 6.50e-02 | 1.75e-01 | 3.11e-01 |
| GOBP REGULATION OF RRNA PROCESSING | 16 | 2.25e-01 | 1.75e-01 | 5.70e-01 |
| GOBP ABSCISSION | 5 | 4.97e-01 | -1.75e-01 | 7.89e-01 |
| GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 3.37e-01 | -1.75e-01 | 6.79e-01 |
| GOBP WALKING BEHAVIOR | 23 | 1.46e-01 | -1.75e-01 | 4.67e-01 |
| GOBP PROTEIN GERANYLGERANYLATION | 6 | 4.58e-01 | 1.75e-01 | 7.62e-01 |
| GOBP THYMIC T CELL SELECTION | 22 | 1.56e-01 | 1.75e-01 | 4.81e-01 |
| GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT | 7 | 4.23e-01 | -1.75e-01 | 7.41e-01 |
| GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 3.38e-01 | 1.75e-01 | 6.81e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 5 | 4.99e-01 | 1.75e-01 | 7.90e-01 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 11 | 3.15e-01 | 1.75e-01 | 6.63e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 17 | 2.12e-01 | -1.75e-01 | 5.59e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 3.16e-01 | -1.75e-01 | 6.63e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 56 | 2.38e-02 | 1.75e-01 | 1.84e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 13 | 2.76e-01 | -1.75e-01 | 6.26e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 21 | 1.66e-01 | 1.75e-01 | 4.99e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 70 | 1.16e-02 | 1.74e-01 | 1.25e-01 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 17 | 2.13e-01 | -1.74e-01 | 5.59e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 10 | 3.40e-01 | -1.74e-01 | 6.81e-01 |
| GOMF BETA CATENIN BINDING | 77 | 8.16e-03 | 1.74e-01 | 9.97e-02 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 259 | 1.35e-06 | -1.74e-01 | 9.87e-05 |
| GOCC NODE OF RANVIER | 11 | 3.17e-01 | 1.74e-01 | 6.64e-01 |
| GOCC SEC61 TRANSLOCON COMPLEX | 5 | 5.00e-01 | -1.74e-01 | 7.91e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 27 | 1.17e-01 | 1.74e-01 | 4.17e-01 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 51 | 3.14e-02 | -1.74e-01 | 2.15e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 3.40e-01 | -1.74e-01 | 6.82e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 6 | 4.60e-01 | -1.74e-01 | 7.64e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 11 | 3.18e-01 | -1.74e-01 | 6.64e-01 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 35 | 7.48e-02 | 1.74e-01 | 3.34e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 19 | 1.89e-01 | -1.74e-01 | 5.30e-01 |
| GOBP EMBRYONIC CLEAVAGE | 8 | 3.94e-01 | 1.74e-01 | 7.21e-01 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 3.41e-01 | -1.74e-01 | 6.82e-01 |
| GOBP FOREBRAIN NEUROBLAST DIVISION | 5 | 5.01e-01 | 1.74e-01 | 7.91e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 26 | 1.25e-01 | -1.74e-01 | 4.33e-01 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 11 | 3.18e-01 | 1.74e-01 | 6.65e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 121 | 9.64e-04 | 1.74e-01 | 2.24e-02 |
| GOBP TRNA 3 END PROCESSING | 7 | 4.26e-01 | 1.74e-01 | 7.42e-01 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 37 | 6.78e-02 | -1.74e-01 | 3.17e-01 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 12 | 2.98e-01 | -1.74e-01 | 6.47e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 10 | 3.42e-01 | -1.73e-01 | 6.83e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 27 | 1.19e-01 | -1.73e-01 | 4.20e-01 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 9 | 3.68e-01 | -1.73e-01 | 7.01e-01 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 177 | 6.93e-05 | 1.73e-01 | 2.84e-03 |
| GOBP AXONOGENESIS INVOLVED IN INNERVATION | 8 | 3.96e-01 | 1.73e-01 | 7.22e-01 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.96e-01 | 1.73e-01 | 7.22e-01 |
| GOBP METHIONINE METABOLIC PROCESS | 13 | 2.80e-01 | -1.73e-01 | 6.29e-01 |
| GOMF DENEDDYLASE ACTIVITY | 6 | 4.63e-01 | 1.73e-01 | 7.66e-01 |
| GOMF PEPTIDE ANTIGEN BINDING | 46 | 4.22e-02 | 1.73e-01 | 2.50e-01 |
| GOBP LYSINE METABOLIC PROCESS | 7 | 4.28e-01 | 1.73e-01 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 5.03e-01 | -1.73e-01 | 7.92e-01 |
| GOCC CHECKPOINT CLAMP COMPLEX | 5 | 5.03e-01 | 1.73e-01 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 14 | 2.62e-01 | -1.73e-01 | 6.11e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 13 | 2.80e-01 | 1.73e-01 | 6.29e-01 |
| GOBP POSITIVE REGULATION OF ARTERY MORPHOGENESIS | 6 | 4.63e-01 | 1.73e-01 | 7.66e-01 |
| GOBP REGULATION OF ARTERY MORPHOGENESIS | 6 | 4.63e-01 | 1.73e-01 | 7.66e-01 |
| GOBP SYNCYTIUM FORMATION | 52 | 3.10e-02 | -1.73e-01 | 2.14e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 10 | 3.44e-01 | -1.73e-01 | 6.84e-01 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 38 | 6.53e-02 | -1.73e-01 | 3.12e-01 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 8 | 3.98e-01 | 1.73e-01 | 7.23e-01 |
| GOBP RECOMBINATIONAL REPAIR | 183 | 5.60e-05 | 1.73e-01 | 2.37e-03 |
| GOBP COBALAMIN TRANSPORT | 8 | 3.98e-01 | -1.73e-01 | 7.23e-01 |
| GOBP POSTREPLICATION REPAIR | 36 | 7.31e-02 | 1.73e-01 | 3.31e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 24 | 1.44e-01 | -1.72e-01 | 4.63e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 38 | 6.58e-02 | -1.72e-01 | 3.12e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 178 | 7.22e-05 | 1.72e-01 | 2.91e-03 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 21 | 1.71e-01 | -1.72e-01 | 5.06e-01 |
| GOBP CELL CYCLE DNA REPLICATION | 45 | 4.55e-02 | 1.72e-01 | 2.60e-01 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 14 | 2.64e-01 | 1.72e-01 | 6.13e-01 |
| GOBP BLOOD VESSEL REMODELING | 35 | 7.77e-02 | -1.72e-01 | 3.41e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 19 | 1.93e-01 | -1.72e-01 | 5.35e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 29 | 1.08e-01 | 1.72e-01 | 4.01e-01 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 91 | 4.51e-03 | 1.72e-01 | 6.75e-02 |
| GOBP SULFUR AMINO ACID TRANSPORT | 10 | 3.46e-01 | 1.72e-01 | 6.85e-01 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 9 | 3.71e-01 | -1.72e-01 | 7.03e-01 |
| GOBP LACTONE METABOLIC PROCESS | 10 | 3.46e-01 | -1.72e-01 | 6.86e-01 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 16 | 2.33e-01 | 1.72e-01 | 5.80e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 9 | 3.72e-01 | 1.72e-01 | 7.04e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 26 | 1.29e-01 | -1.72e-01 | 4.40e-01 |
| GOBP CELLULAR RESPONSE TO IRON ION | 7 | 4.31e-01 | -1.72e-01 | 7.44e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 3.72e-01 | -1.72e-01 | 7.04e-01 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 22 | 1.63e-01 | -1.72e-01 | 4.94e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 19 | 1.95e-01 | 1.72e-01 | 5.37e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 15 | 2.50e-01 | 1.72e-01 | 5.98e-01 |
| GOMF NUCLEASE INHIBITOR ACTIVITY | 6 | 4.67e-01 | -1.72e-01 | 7.68e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 29 | 1.10e-01 | -1.72e-01 | 4.04e-01 |
| GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN | 5 | 5.07e-01 | -1.71e-01 | 7.95e-01 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 82 | 7.27e-03 | 1.71e-01 | 9.16e-02 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 12 | 3.04e-01 | 1.71e-01 | 6.53e-01 |
| GOBP EOSINOPHIL MIGRATION | 15 | 2.50e-01 | -1.71e-01 | 5.98e-01 |
| GOMF PROTEIN FOLDING CHAPERONE | 58 | 2.40e-02 | 1.71e-01 | 1.85e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 7 | 4.32e-01 | 1.71e-01 | 7.45e-01 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 69 | 1.40e-02 | 1.71e-01 | 1.39e-01 |
| GOBP REGULATION OF DOPAMINE SECRETION | 12 | 3.05e-01 | -1.71e-01 | 6.53e-01 |
| GOBP PHAGOCYTOSIS RECOGNITION | 17 | 2.23e-01 | -1.71e-01 | 5.68e-01 |
| GOBP REGULATION OF DNA LIGATION | 6 | 4.69e-01 | 1.71e-01 | 7.70e-01 |
| GOBP FATTY ACID TRANSPORT | 77 | 9.55e-03 | -1.71e-01 | 1.10e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 46 | 4.50e-02 | -1.71e-01 | 2.59e-01 |
| GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 7 | 4.34e-01 | -1.71e-01 | 7.46e-01 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 19 | 1.98e-01 | 1.71e-01 | 5.40e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE DEPHOSPHORYLATION | 7 | 4.34e-01 | -1.71e-01 | 7.46e-01 |
| GOMF PROTEASOME BINDING | 16 | 2.38e-01 | -1.71e-01 | 5.85e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 18 | 2.10e-01 | 1.71e-01 | 5.56e-01 |
| GOMF IGG BINDING | 8 | 4.04e-01 | -1.70e-01 | 7.27e-01 |
| GOMF FAD BINDING | 36 | 7.68e-02 | -1.70e-01 | 3.39e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 123 | 1.10e-03 | 1.70e-01 | 2.45e-02 |
| GOBP POSITIVE REGULATION OF DNA CATABOLIC PROCESS | 5 | 5.10e-01 | -1.70e-01 | 7.96e-01 |
| GOBP MONOCYTE DIFFERENTIATION | 26 | 1.33e-01 | 1.70e-01 | 4.47e-01 |
| GOMF LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 1.13e-01 | -1.70e-01 | 4.11e-01 |
| GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY | 6 | 4.71e-01 | -1.70e-01 | 7.72e-01 |
| GOCC EKC KEOPS COMPLEX | 5 | 5.10e-01 | 1.70e-01 | 7.96e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 87 | 6.12e-03 | -1.70e-01 | 8.29e-02 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 47 | 4.38e-02 | -1.70e-01 | 2.55e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 20 | 1.88e-01 | -1.70e-01 | 5.29e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 24 | 1.50e-01 | 1.70e-01 | 4.75e-01 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 25 | 1.42e-01 | -1.70e-01 | 4.60e-01 |
| GOCC BRUSH BORDER MEMBRANE | 42 | 5.69e-02 | -1.70e-01 | 2.89e-01 |
| GOBP CHROMOSOME ORGANIZATION | 573 | 3.69e-12 | 1.70e-01 | 1.23e-09 |
| GOBP HAIR FOLLICLE MATURATION | 9 | 3.78e-01 | 1.70e-01 | 7.10e-01 |
| GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 6 | 4.72e-01 | -1.70e-01 | 7.72e-01 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 16 | 2.40e-01 | -1.70e-01 | 5.88e-01 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 11 | 3.30e-01 | -1.70e-01 | 6.75e-01 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 10 | 3.53e-01 | -1.70e-01 | 6.93e-01 |
| GOBP DITERPENOID METABOLIC PROCESS | 51 | 3.63e-02 | -1.69e-01 | 2.31e-01 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 47 | 4.45e-02 | -1.69e-01 | 2.58e-01 |
| GOBP RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 5 | 5.12e-01 | -1.69e-01 | 7.97e-01 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 4.38e-01 | -1.69e-01 | 7.49e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 37 | 7.47e-02 | -1.69e-01 | 3.34e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 13 | 2.91e-01 | -1.69e-01 | 6.39e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 39 | 6.75e-02 | -1.69e-01 | 3.16e-01 |
| GOBP HYDROGEN SULFIDE METABOLIC PROCESS | 5 | 5.13e-01 | -1.69e-01 | 7.97e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 14 | 2.74e-01 | 1.69e-01 | 6.24e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 12 | 3.11e-01 | -1.69e-01 | 6.58e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 4.74e-01 | 1.69e-01 | 7.73e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 24 | 1.52e-01 | -1.69e-01 | 4.77e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 5 | 5.13e-01 | -1.69e-01 | 7.98e-01 |
| GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY | 14 | 2.74e-01 | -1.69e-01 | 6.24e-01 |
| GOMF PROTEASE BINDING | 114 | 1.86e-03 | -1.69e-01 | 3.60e-02 |
| GOCC NEUROMUSCULAR JUNCTION | 58 | 2.62e-02 | -1.69e-01 | 1.95e-01 |
| GOBP DNA REPAIR | 577 | 4.28e-12 | 1.69e-01 | 1.33e-09 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 140 | 5.72e-04 | 1.69e-01 | 1.50e-02 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 75 | 1.16e-02 | -1.69e-01 | 1.25e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 10 | 3.56e-01 | -1.69e-01 | 6.94e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 8 | 4.09e-01 | 1.68e-01 | 7.31e-01 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 43 | 5.60e-02 | -1.68e-01 | 2.88e-01 |
| GOMF SYNTAXIN 1 BINDING | 14 | 2.75e-01 | -1.68e-01 | 6.26e-01 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 5.14e-01 | -1.68e-01 | 7.98e-01 |
| GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY | 6 | 4.75e-01 | 1.68e-01 | 7.74e-01 |
| GOBP DNA RECOMBINATION | 309 | 3.59e-07 | 1.68e-01 | 3.16e-05 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL BUD | 7 | 4.41e-01 | -1.68e-01 | 7.51e-01 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 3.13e-01 | 1.68e-01 | 6.60e-01 |
| GOBP RENAL WATER TRANSPORT | 6 | 4.76e-01 | -1.68e-01 | 7.74e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 16 | 2.44e-01 | 1.68e-01 | 5.91e-01 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 150 | 3.78e-04 | 1.68e-01 | 1.09e-02 |
| GOBP REGULATION OF NEURON MATURATION | 7 | 4.41e-01 | 1.68e-01 | 7.51e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 31 | 1.05e-01 | 1.68e-01 | 3.95e-01 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 28 | 1.24e-01 | -1.68e-01 | 4.31e-01 |
| GOBP DNA STRAND ELONGATION | 37 | 7.68e-02 | 1.68e-01 | 3.39e-01 |
| GOMF NADP BINDING | 46 | 4.85e-02 | -1.68e-01 | 2.69e-01 |
| GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS | 6 | 4.76e-01 | 1.68e-01 | 7.74e-01 |
| GOBP PROLINE METABOLIC PROCESS | 8 | 4.11e-01 | -1.68e-01 | 7.31e-01 |
| GOBP MYOBLAST FUSION | 39 | 6.95e-02 | -1.68e-01 | 3.20e-01 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 458 | 7.11e-10 | 1.68e-01 | 1.25e-07 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 131 | 9.00e-04 | 1.68e-01 | 2.12e-02 |
| GOBP CHROMATIN REMODELING | 569 | 7.28e-12 | 1.68e-01 | 2.13e-09 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 13 | 2.95e-01 | -1.68e-01 | 6.43e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 31 | 1.06e-01 | -1.68e-01 | 3.96e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 35 | 8.59e-02 | -1.68e-01 | 3.58e-01 |
| GOBP CHROMOSOME SEGREGATION | 390 | 1.30e-08 | 1.68e-01 | 1.73e-06 |
| GOBP TRANSLESION SYNTHESIS | 26 | 1.39e-01 | 1.68e-01 | 4.57e-01 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 4.43e-01 | 1.68e-01 | 7.51e-01 |
| GOBP REGULATION OF URINE VOLUME | 14 | 2.78e-01 | -1.68e-01 | 6.26e-01 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 3.59e-01 | 1.68e-01 | 6.95e-01 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 8 | 4.12e-01 | -1.67e-01 | 7.32e-01 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 50 | 4.06e-02 | 1.67e-01 | 2.45e-01 |
| GOBP NEGATIVE CHEMOTAXIS | 34 | 9.15e-02 | -1.67e-01 | 3.70e-01 |
| GOBP RESPONSE TO VITAMIN A | 7 | 4.44e-01 | -1.67e-01 | 7.52e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 96 | 4.65e-03 | -1.67e-01 | 6.90e-02 |
| GOBP AMINO ACID BETAINE TRANSPORT | 12 | 3.16e-01 | -1.67e-01 | 6.63e-01 |
| GOBP MEMBRANE RAFT ASSEMBLY | 9 | 3.85e-01 | -1.67e-01 | 7.15e-01 |
| GOBP GLYCOLIPID TRANSPORT | 8 | 4.13e-01 | -1.67e-01 | 7.33e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 8 | 4.13e-01 | 1.67e-01 | 7.33e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 68 | 1.73e-02 | 1.67e-01 | 1.55e-01 |
| GOBP T CELL CYTOKINE PRODUCTION | 36 | 8.31e-02 | -1.67e-01 | 3.51e-01 |
| GOBP ACTIN FILAMENT SEVERING | 16 | 2.48e-01 | -1.67e-01 | 5.95e-01 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 10 | 3.61e-01 | -1.67e-01 | 6.97e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY | 7 | 4.45e-01 | 1.67e-01 | 7.53e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 13 | 2.98e-01 | -1.67e-01 | 6.47e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 16 | 2.48e-01 | -1.67e-01 | 5.96e-01 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 19 | 2.09e-01 | -1.67e-01 | 5.54e-01 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 111 | 2.43e-03 | 1.67e-01 | 4.34e-02 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 41 | 6.51e-02 | -1.67e-01 | 3.11e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 160 | 2.78e-04 | 1.67e-01 | 8.75e-03 |
| GOMF ACTIN MONOMER BINDING | 25 | 1.50e-01 | 1.66e-01 | 4.75e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 18 | 2.22e-01 | -1.66e-01 | 5.67e-01 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 38 | 7.63e-02 | -1.66e-01 | 3.38e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 16 | 2.50e-01 | -1.66e-01 | 5.98e-01 |
| GOCC CELL POLE | 8 | 4.16e-01 | -1.66e-01 | 7.36e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 32 | 1.04e-01 | 1.66e-01 | 3.94e-01 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 4.47e-01 | -1.66e-01 | 7.55e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 42 | 6.31e-02 | 1.66e-01 | 3.07e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 31 | 1.10e-01 | 1.66e-01 | 4.05e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 15 | 2.67e-01 | -1.66e-01 | 6.15e-01 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 13 | 3.01e-01 | -1.66e-01 | 6.51e-01 |
| GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY | 7 | 4.48e-01 | 1.66e-01 | 7.55e-01 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 8 | 4.17e-01 | -1.66e-01 | 7.36e-01 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 4.17e-01 | -1.66e-01 | 7.36e-01 |
| GOBP RESPONSE TO TESTOSTERONE | 32 | 1.05e-01 | -1.65e-01 | 3.96e-01 |
| GOBP REGULATION OF TOOTH MINERALIZATION | 5 | 5.22e-01 | -1.65e-01 | 8.03e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 11 | 3.42e-01 | -1.65e-01 | 6.83e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 24 | 1.61e-01 | -1.65e-01 | 4.90e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 17 | 2.38e-01 | 1.65e-01 | 5.85e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 9 | 3.91e-01 | -1.65e-01 | 7.19e-01 |
| GOCC CLATHRIN COAT | 46 | 5.25e-02 | 1.65e-01 | 2.78e-01 |
| GOMF DINUCLEOTIDE PHOSPHATASE ACTIVITY | 7 | 4.49e-01 | -1.65e-01 | 7.55e-01 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 17 | 2.38e-01 | -1.65e-01 | 5.86e-01 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 132 | 1.05e-03 | 1.65e-01 | 2.38e-02 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 17 | 2.39e-01 | -1.65e-01 | 5.87e-01 |
| GOBP TORC2 SIGNALING | 13 | 3.03e-01 | 1.65e-01 | 6.52e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 21 | 1.91e-01 | 1.65e-01 | 5.31e-01 |
| GOMF CARDIOLIPIN BINDING | 9 | 3.91e-01 | -1.65e-01 | 7.20e-01 |
| GOBP REGULATION OF RECEPTOR BINDING | 11 | 3.43e-01 | -1.65e-01 | 6.84e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 34 | 9.59e-02 | -1.65e-01 | 3.77e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 62 | 2.47e-02 | -1.65e-01 | 1.88e-01 |
| GOMF GLYCOLIPID BINDING | 23 | 1.71e-01 | -1.65e-01 | 5.05e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 101 | 4.18e-03 | 1.65e-01 | 6.41e-02 |
| GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 8 | 4.20e-01 | 1.65e-01 | 7.38e-01 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 69 | 1.79e-02 | -1.65e-01 | 1.58e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 16 | 2.54e-01 | -1.65e-01 | 6.02e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 420 | 6.88e-09 | -1.65e-01 | 9.60e-07 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 10 | 3.67e-01 | 1.65e-01 | 7.01e-01 |
| GOBP SUCCINATE METABOLIC PROCESS | 5 | 5.24e-01 | -1.65e-01 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 18 | 2.26e-01 | -1.65e-01 | 5.72e-01 |
| GOCC GLYCOPROTEIN COMPLEX | 19 | 2.14e-01 | -1.65e-01 | 5.59e-01 |
| GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY | 6 | 4.85e-01 | -1.65e-01 | 7.82e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 17 | 2.40e-01 | 1.65e-01 | 5.88e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 7 | 4.51e-01 | 1.65e-01 | 7.56e-01 |
| GOMF FRUCTOSE 6 PHOSPHATE BINDING | 5 | 5.24e-01 | -1.65e-01 | 8.05e-01 |
| GOBP REGULATION OF RENAL SYSTEM PROCESS | 13 | 3.04e-01 | 1.64e-01 | 6.53e-01 |
| GOBP MRNA TRANSCRIPTION | 48 | 4.87e-02 | 1.64e-01 | 2.69e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 11 | 3.45e-01 | -1.64e-01 | 6.85e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 12 | 3.24e-01 | -1.64e-01 | 6.69e-01 |
| GOBP SNRNA PROCESSING | 27 | 1.39e-01 | 1.64e-01 | 4.57e-01 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 27 | 1.39e-01 | 1.64e-01 | 4.57e-01 |
| GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 7 | 4.51e-01 | -1.64e-01 | 7.57e-01 |
| GOBP RESPONSE TO SELENIUM ION | 8 | 4.21e-01 | -1.64e-01 | 7.39e-01 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 81 | 1.06e-02 | 1.64e-01 | 1.18e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 13 | 3.05e-01 | -1.64e-01 | 6.53e-01 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 104 | 3.80e-03 | -1.64e-01 | 5.96e-02 |
| GOBP FEMALE MEIOSIS I | 10 | 3.69e-01 | 1.64e-01 | 7.01e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 16 | 2.55e-01 | -1.64e-01 | 6.03e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 590 | 9.30e-12 | 1.64e-01 | 2.56e-09 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 14 | 2.88e-01 | 1.64e-01 | 6.35e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 8 | 4.22e-01 | -1.64e-01 | 7.40e-01 |
| GOMF SODIUM INDEPENDENT ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.25e-01 | -1.64e-01 | 8.05e-01 |
| GOBP RENAL WATER HOMEOSTASIS | 15 | 2.72e-01 | -1.64e-01 | 6.22e-01 |
| GOBP ORGAN INDUCTION | 9 | 3.94e-01 | -1.64e-01 | 7.21e-01 |
| GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION | 6 | 4.87e-01 | -1.64e-01 | 7.83e-01 |
| GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY | 6 | 4.87e-01 | -1.64e-01 | 7.83e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 49 | 4.74e-02 | 1.64e-01 | 2.66e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 53 | 3.93e-02 | -1.64e-01 | 2.41e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 145 | 6.74e-04 | 1.64e-01 | 1.67e-02 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 19 | 2.17e-01 | -1.64e-01 | 5.61e-01 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 19 | 2.17e-01 | 1.64e-01 | 5.61e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 5.27e-01 | 1.63e-01 | 8.06e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 276 | 2.97e-06 | -1.63e-01 | 1.96e-04 |
| GOBP GALACTOLIPID METABOLIC PROCESS | 6 | 4.89e-01 | 1.63e-01 | 7.84e-01 |
| GOBP REGULATION OF GONAD DEVELOPMENT | 8 | 4.24e-01 | -1.63e-01 | 7.41e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 10 | 3.72e-01 | 1.63e-01 | 7.04e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 56 | 3.48e-02 | 1.63e-01 | 2.25e-01 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 39 | 7.81e-02 | 1.63e-01 | 3.42e-01 |
| GOMF CYTOKINE ACTIVITY | 123 | 1.79e-03 | -1.63e-01 | 3.54e-02 |
| GOCC CYTOSOLIC PROTEASOME COMPLEX | 5 | 5.28e-01 | -1.63e-01 | 8.07e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 244 | 1.16e-05 | 1.63e-01 | 6.59e-04 |
| GOBP GERM CELL PROLIFERATION | 9 | 3.97e-01 | -1.63e-01 | 7.23e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 12 | 3.29e-01 | 1.63e-01 | 6.74e-01 |
| GOCC DYSTROGLYCAN COMPLEX | 5 | 5.28e-01 | -1.63e-01 | 8.07e-01 |
| GOBP ADENOSINE METABOLIC PROCESS | 10 | 3.72e-01 | 1.63e-01 | 7.05e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 31 | 1.17e-01 | -1.63e-01 | 4.16e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 602 | 8.64e-12 | -1.63e-01 | 2.45e-09 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 5 | 5.28e-01 | -1.63e-01 | 8.07e-01 |
| GOMF CHEMOKINE RECEPTOR BINDING | 32 | 1.11e-01 | -1.63e-01 | 4.07e-01 |
| GOBP RNA LOCALIZATION | 191 | 1.04e-04 | 1.63e-01 | 4.06e-03 |
| GOMF AMYLOID BETA BINDING | 72 | 1.69e-02 | -1.63e-01 | 1.54e-01 |
| GOBP NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 5 | 5.28e-01 | 1.63e-01 | 8.07e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE | 5 | 5.29e-01 | 1.63e-01 | 8.07e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 11 | 3.50e-01 | 1.63e-01 | 6.90e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 22 | 1.87e-01 | -1.63e-01 | 5.27e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 40 | 7.51e-02 | -1.63e-01 | 3.35e-01 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 79 | 1.25e-02 | 1.63e-01 | 1.30e-01 |
| GOCC NUCLEAR PERIPHERY | 142 | 8.23e-04 | 1.63e-01 | 1.98e-02 |
| GOCC DNA POLYMERASE COMPLEX | 20 | 2.08e-01 | 1.62e-01 | 5.54e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 185 | 1.39e-04 | -1.62e-01 | 5.05e-03 |
| GOBP REGULATION OF TUBE SIZE | 98 | 5.47e-03 | -1.62e-01 | 7.73e-02 |
| GOBP SUCKLING BEHAVIOR | 9 | 3.99e-01 | -1.62e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 33 | 1.07e-01 | -1.62e-01 | 3.98e-01 |
| GOBP RNA CAPPING | 15 | 2.77e-01 | 1.62e-01 | 6.26e-01 |
| GOBP MAGNESIUM ION HOMEOSTASIS | 10 | 3.75e-01 | 1.62e-01 | 7.07e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 26 | 1.52e-01 | -1.62e-01 | 4.77e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 50 | 4.73e-02 | -1.62e-01 | 2.66e-01 |
| GOBP TRANSPORT OF VIRUS | 20 | 2.09e-01 | 1.62e-01 | 5.55e-01 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 19 | 2.21e-01 | -1.62e-01 | 5.67e-01 |
| GOBP REGULATION OF HEART GROWTH | 43 | 6.59e-02 | 1.62e-01 | 3.12e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT | 11 | 3.52e-01 | -1.62e-01 | 6.92e-01 |
| GOCC NUCLEOSOME | 76 | 1.47e-02 | -1.62e-01 | 1.43e-01 |
| GOBP L SERINE METABOLIC PROCESS | 11 | 3.53e-01 | -1.62e-01 | 6.92e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 32 | 1.13e-01 | -1.62e-01 | 4.12e-01 |
| GOCC RIBOSOME | 223 | 3.13e-05 | -1.62e-01 | 1.52e-03 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 13 | 3.13e-01 | 1.62e-01 | 6.59e-01 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 11 | 3.53e-01 | 1.62e-01 | 6.92e-01 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 12 | 3.32e-01 | -1.62e-01 | 6.76e-01 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 10 | 3.76e-01 | 1.62e-01 | 7.08e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 65 | 2.43e-02 | -1.62e-01 | 1.86e-01 |
| GOMF FIBRONECTIN BINDING | 23 | 1.80e-01 | -1.62e-01 | 5.17e-01 |
| GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION | 8 | 4.29e-01 | -1.62e-01 | 7.43e-01 |
| GOBP FATTY ACID BETA OXIDATION | 71 | 1.86e-02 | -1.61e-01 | 1.62e-01 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 26 | 1.54e-01 | 1.61e-01 | 4.80e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY INVOLVED IN REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 26 | 1.55e-01 | 1.61e-01 | 4.81e-01 |
| GOCC SECONDARY LYSOSOME | 21 | 2.01e-01 | -1.61e-01 | 5.44e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 7 | 4.60e-01 | -1.61e-01 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 11 | 3.55e-01 | 1.61e-01 | 6.93e-01 |
| GOBP DNA DEAMINATION | 13 | 3.14e-01 | -1.61e-01 | 6.61e-01 |
| GOMF INTEGRIN BINDING | 119 | 2.39e-03 | -1.61e-01 | 4.31e-02 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 19 | 2.24e-01 | -1.61e-01 | 5.69e-01 |
| GOMF PHOSPHOLIPASE BINDING | 21 | 2.01e-01 | 1.61e-01 | 5.44e-01 |
| GOCC U1 SNRNP | 19 | 2.24e-01 | -1.61e-01 | 5.69e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 51 | 4.67e-02 | -1.61e-01 | 2.64e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 64 | 2.59e-02 | -1.61e-01 | 1.94e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 5 | 5.33e-01 | -1.61e-01 | 8.10e-01 |
| GOCC PRONUCLEUS | 12 | 3.34e-01 | 1.61e-01 | 6.78e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 9 | 4.03e-01 | 1.61e-01 | 7.26e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 12 | 3.35e-01 | -1.61e-01 | 6.78e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 14 | 2.97e-01 | 1.61e-01 | 6.46e-01 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 4.61e-01 | 1.61e-01 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 6 | 4.95e-01 | 1.61e-01 | 7.88e-01 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 223 | 3.52e-05 | -1.61e-01 | 1.67e-03 |
| GOBP CENTROSOME DUPLICATION | 71 | 1.92e-02 | 1.61e-01 | 1.64e-01 |
| GOMF SH2 DOMAIN BINDING | 42 | 7.16e-02 | -1.61e-01 | 3.26e-01 |
| GOBP HEART GROWTH | 63 | 2.75e-02 | 1.61e-01 | 2.01e-01 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 77 | 1.49e-02 | -1.60e-01 | 1.44e-01 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 11 | 3.57e-01 | -1.60e-01 | 6.94e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 28 | 1.42e-01 | 1.60e-01 | 4.60e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 51 | 4.75e-02 | -1.60e-01 | 2.66e-01 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 11 | 3.57e-01 | -1.60e-01 | 6.94e-01 |
| GOCC ASTER | 10 | 3.80e-01 | 1.60e-01 | 7.12e-01 |
| GOMF CARBONATE DEHYDRATASE ACTIVITY | 11 | 3.57e-01 | -1.60e-01 | 6.94e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 102 | 5.14e-03 | 1.60e-01 | 7.38e-02 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 106 | 4.35e-03 | 1.60e-01 | 6.59e-02 |
| GOBP REGULATION OF FLAGELLATED SPERM MOTILITY | 8 | 4.33e-01 | -1.60e-01 | 7.45e-01 |
| GOBP GLUTAMATE SECRETION | 20 | 2.15e-01 | 1.60e-01 | 5.60e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 20 | 2.15e-01 | -1.60e-01 | 5.60e-01 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 7 | 4.63e-01 | 1.60e-01 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 5.35e-01 | 1.60e-01 | 8.12e-01 |
| GOBP VASOCONSTRICTION | 49 | 5.27e-02 | -1.60e-01 | 2.79e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 18 | 2.40e-01 | -1.60e-01 | 5.88e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 7 | 4.64e-01 | 1.60e-01 | 7.66e-01 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 23 | 1.84e-01 | -1.60e-01 | 5.23e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 20 | 2.16e-01 | -1.60e-01 | 5.60e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX CIRCULATING | 11 | 3.59e-01 | 1.60e-01 | 6.95e-01 |
| GOMF PEPTIDE HORMONE BINDING | 29 | 1.36e-01 | -1.60e-01 | 4.52e-01 |
| GOBP MALE SEX DETERMINATION | 6 | 4.98e-01 | -1.60e-01 | 7.89e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 72 | 1.90e-02 | -1.60e-01 | 1.64e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 51 | 4.83e-02 | -1.60e-01 | 2.69e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 20 | 2.16e-01 | -1.60e-01 | 5.60e-01 |
| GOCC GLIAL CELL PROJECTION | 26 | 1.59e-01 | -1.60e-01 | 4.87e-01 |
| GOCC HFE TRANSFERRIN RECEPTOR COMPLEX | 6 | 4.98e-01 | -1.60e-01 | 7.89e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 24 | 1.76e-01 | -1.60e-01 | 5.10e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 14 | 3.01e-01 | -1.60e-01 | 6.51e-01 |
| GOCC BRUSH BORDER | 80 | 1.36e-02 | -1.60e-01 | 1.37e-01 |
| GOMF SINGLE STRANDED DNA BINDING | 117 | 2.88e-03 | 1.59e-01 | 4.90e-02 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 169 | 3.49e-04 | 1.59e-01 | 1.02e-02 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 10 | 3.83e-01 | -1.59e-01 | 7.15e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 32 | 1.19e-01 | -1.59e-01 | 4.20e-01 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 14 | 3.02e-01 | 1.59e-01 | 6.51e-01 |
| GOBP PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS | 9 | 4.08e-01 | -1.59e-01 | 7.29e-01 |
| GOCC PCG PROTEIN COMPLEX | 46 | 6.16e-02 | 1.59e-01 | 3.03e-01 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 13 | 3.20e-01 | 1.59e-01 | 6.67e-01 |
| GOMF BIS 5 ADENOSYL PENTAPHOSPHATASE ACTIVITY | 5 | 5.38e-01 | -1.59e-01 | 8.13e-01 |
| GOBP PROTEIN UNFOLDING | 5 | 5.38e-01 | -1.59e-01 | 8.13e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 76 | 1.65e-02 | 1.59e-01 | 1.53e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 40 | 8.17e-02 | 1.59e-01 | 3.49e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 51 | 4.95e-02 | -1.59e-01 | 2.72e-01 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 5.38e-01 | 1.59e-01 | 8.14e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 59 | 3.48e-02 | -1.59e-01 | 2.25e-01 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 8 | 4.36e-01 | 1.59e-01 | 7.48e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 21 | 2.08e-01 | 1.59e-01 | 5.53e-01 |
| GOCC HETEROCHROMATIN | 76 | 1.67e-02 | 1.59e-01 | 1.53e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 18 | 2.43e-01 | -1.59e-01 | 5.90e-01 |
| GOBP DIADENOSINE POLYPHOSPHATE CATABOLIC PROCESS | 5 | 5.39e-01 | 1.59e-01 | 8.14e-01 |
| GOBP SISTER CHROMATID SEGREGATION | 226 | 3.91e-05 | 1.59e-01 | 1.82e-03 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 18 | 2.44e-01 | -1.59e-01 | 5.90e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 8 | 4.37e-01 | -1.59e-01 | 7.49e-01 |
| GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY | 6 | 5.01e-01 | -1.59e-01 | 7.91e-01 |
| GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY | 7 | 4.67e-01 | 1.59e-01 | 7.68e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 29 | 1.40e-01 | -1.59e-01 | 4.57e-01 |
| GOCC PEPTIDASE COMPLEX | 109 | 4.25e-03 | -1.58e-01 | 6.50e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 12 | 3.42e-01 | -1.58e-01 | 6.83e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 10 | 3.86e-01 | 1.58e-01 | 7.15e-01 |
| GOCC MICROVILLUS MEMBRANE | 25 | 1.70e-01 | -1.58e-01 | 5.04e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 10 | 3.86e-01 | 1.58e-01 | 7.15e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 19 | 2.32e-01 | -1.58e-01 | 5.79e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 33 | 1.15e-01 | -1.58e-01 | 4.15e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 10 | 3.86e-01 | -1.58e-01 | 7.15e-01 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 32 | 1.21e-01 | -1.58e-01 | 4.26e-01 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 9 | 4.11e-01 | -1.58e-01 | 7.31e-01 |
| GOCC OUTER MEMBRANE | 227 | 4.01e-05 | -1.58e-01 | 1.85e-03 |
| GOMF LIPID TRANSFER ACTIVITY | 44 | 6.95e-02 | 1.58e-01 | 3.20e-01 |
| GOBP DITERPENOID BIOSYNTHETIC PROCESS | 6 | 5.02e-01 | -1.58e-01 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 36 | 1.01e-01 | -1.58e-01 | 3.88e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 15 | 2.90e-01 | -1.58e-01 | 6.38e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 100 | 6.37e-03 | 1.58e-01 | 8.49e-02 |
| GOMF TBP CLASS PROTEIN BINDING | 24 | 1.81e-01 | 1.58e-01 | 5.18e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 11 | 3.65e-01 | -1.58e-01 | 6.99e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 13 | 3.25e-01 | -1.58e-01 | 6.70e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 28 | 1.49e-01 | -1.58e-01 | 4.73e-01 |
| GOBP FATTY ACID ELONGATION | 13 | 3.25e-01 | -1.58e-01 | 6.70e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 32 | 1.23e-01 | -1.58e-01 | 4.28e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 12 | 3.44e-01 | -1.58e-01 | 6.85e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 31 | 1.29e-01 | -1.58e-01 | 4.40e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 7 | 4.71e-01 | -1.57e-01 | 7.72e-01 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 42 | 7.74e-02 | -1.57e-01 | 3.41e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES | 7 | 4.71e-01 | -1.57e-01 | 7.72e-01 |
| GOMF PROMOTER ENHANCER LOOP ANCHORING ACTIVITY | 5 | 5.42e-01 | 1.57e-01 | 8.16e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 20 | 2.23e-01 | -1.57e-01 | 5.68e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 19 | 2.35e-01 | -1.57e-01 | 5.83e-01 |
| GOMF NOTCH BINDING | 19 | 2.35e-01 | 1.57e-01 | 5.83e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 11 | 3.67e-01 | 1.57e-01 | 7.00e-01 |
| GOCC KINESIN COMPLEX | 43 | 7.46e-02 | 1.57e-01 | 3.34e-01 |
| GOBP REGULATION OF ICOSANOID SECRETION | 14 | 3.09e-01 | -1.57e-01 | 6.56e-01 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 14 | 3.09e-01 | -1.57e-01 | 6.56e-01 |
| GOBP LIPID OXIDATION | 100 | 6.64e-03 | -1.57e-01 | 8.70e-02 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 35 | 1.08e-01 | -1.57e-01 | 4.00e-01 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 99 | 6.95e-03 | -1.57e-01 | 8.93e-02 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 137 | 1.52e-03 | 1.57e-01 | 3.13e-02 |
| GOMF ARP2 3 COMPLEX BINDING | 14 | 3.09e-01 | -1.57e-01 | 6.56e-01 |
| GOBP STARTLE RESPONSE | 16 | 2.77e-01 | 1.57e-01 | 6.26e-01 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 234 | 3.55e-05 | -1.57e-01 | 1.67e-03 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 4.72e-01 | 1.57e-01 | 7.73e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 25 | 1.75e-01 | 1.57e-01 | 5.09e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 8 | 4.42e-01 | 1.57e-01 | 7.51e-01 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 62 | 3.27e-02 | -1.57e-01 | 2.19e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 28 | 1.51e-01 | 1.57e-01 | 4.76e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 105 | 5.52e-03 | 1.57e-01 | 7.75e-02 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 27 | 1.59e-01 | 1.57e-01 | 4.87e-01 |
| GOMF CARD DOMAIN BINDING | 14 | 3.10e-01 | -1.57e-01 | 6.57e-01 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 39 | 9.06e-02 | -1.57e-01 | 3.68e-01 |
| GOCC CATION TRANSPORTING ATPASE COMPLEX | 11 | 3.69e-01 | -1.57e-01 | 7.01e-01 |
| GOBP SCARNA LOCALIZATION TO CAJAL BODY | 5 | 5.44e-01 | 1.57e-01 | 8.18e-01 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 11 | 3.69e-01 | 1.56e-01 | 7.02e-01 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 7 | 4.73e-01 | 1.56e-01 | 7.73e-01 |
| GOCC APICOLATERAL PLASMA MEMBRANE | 15 | 2.94e-01 | -1.56e-01 | 6.43e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 5 | 5.45e-01 | 1.56e-01 | 8.18e-01 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 17 | 2.64e-01 | -1.56e-01 | 6.13e-01 |
| GOBP CYSTEINE METABOLIC PROCESS | 9 | 4.17e-01 | -1.56e-01 | 7.36e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 108 | 5.02e-03 | -1.56e-01 | 7.28e-02 |
| GOBP HYALURONAN CATABOLIC PROCESS | 14 | 3.12e-01 | -1.56e-01 | 6.59e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 32 | 1.27e-01 | -1.56e-01 | 4.36e-01 |
| GOBP CGAS STING SIGNALING PATHWAY | 18 | 2.52e-01 | -1.56e-01 | 6.00e-01 |
| GOBP REGULATION OF LIPASE ACTIVITY | 46 | 6.72e-02 | -1.56e-01 | 3.16e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 48 | 6.16e-02 | -1.56e-01 | 3.03e-01 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 52 | 5.18e-02 | -1.56e-01 | 2.78e-01 |
| GOBP INTRACELLULAR PHOSPHATE ION HOMEOSTASIS | 6 | 5.08e-01 | -1.56e-01 | 7.96e-01 |
| GOBP ETHER METABOLIC PROCESS | 24 | 1.86e-01 | -1.56e-01 | 5.26e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 10 | 3.94e-01 | 1.56e-01 | 7.21e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 17 | 2.66e-01 | 1.56e-01 | 6.15e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 41 | 8.43e-02 | -1.56e-01 | 3.54e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 19 | 2.40e-01 | 1.56e-01 | 5.88e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 96 | 8.37e-03 | -1.56e-01 | 1.01e-01 |
| GOMF DIACYLGLYCEROL DEPENDENT SERINE THREONINE KINASE ACTIVITY | 14 | 3.13e-01 | 1.56e-01 | 6.60e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 100 | 7.16e-03 | -1.56e-01 | 9.09e-02 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 10 | 3.94e-01 | -1.56e-01 | 7.21e-01 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 12 | 3.51e-01 | 1.56e-01 | 6.90e-01 |
| GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY | 5 | 5.47e-01 | -1.56e-01 | 8.20e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 79 | 1.69e-02 | -1.55e-01 | 1.54e-01 |
| GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT | 6 | 5.10e-01 | -1.55e-01 | 7.96e-01 |
| GOBP NUCLEUS ORGANIZATION | 139 | 1.57e-03 | 1.55e-01 | 3.23e-02 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 34 | 1.17e-01 | -1.55e-01 | 4.17e-01 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 26 | 1.71e-01 | 1.55e-01 | 5.05e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 118 | 3.61e-03 | 1.55e-01 | 5.74e-02 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 28 | 1.56e-01 | 1.55e-01 | 4.81e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 11 | 3.73e-01 | 1.55e-01 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 7 | 4.78e-01 | 1.55e-01 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 40 | 8.99e-02 | 1.55e-01 | 3.66e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 47 | 6.61e-02 | -1.55e-01 | 3.13e-01 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 18 | 2.55e-01 | 1.55e-01 | 6.03e-01 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 59 | 3.96e-02 | 1.55e-01 | 2.42e-01 |
| GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY | 6 | 5.11e-01 | -1.55e-01 | 7.97e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 15 | 2.99e-01 | -1.55e-01 | 6.49e-01 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 18 | 2.56e-01 | -1.55e-01 | 6.03e-01 |
| GOBP CAMP METABOLIC PROCESS | 17 | 2.69e-01 | 1.55e-01 | 6.19e-01 |
| GOBP ERBB2 EGFR SIGNALING PATHWAY | 6 | 5.12e-01 | -1.55e-01 | 7.97e-01 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 5.12e-01 | 1.55e-01 | 7.97e-01 |
| GOMF UBIQUITIN LIKE LIGASE SUBSTRATE ADAPTOR ACTIVITY | 55 | 4.75e-02 | 1.55e-01 | 2.66e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION | 5 | 5.50e-01 | -1.54e-01 | 8.22e-01 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 68 | 2.76e-02 | 1.54e-01 | 2.01e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 33 | 1.25e-01 | -1.54e-01 | 4.32e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 3.35e-01 | 1.54e-01 | 6.78e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 7 | 4.79e-01 | 1.54e-01 | 7.77e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 20 | 2.32e-01 | -1.54e-01 | 5.79e-01 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 9 | 4.23e-01 | 1.54e-01 | 7.41e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 4.23e-01 | -1.54e-01 | 7.41e-01 |
| GOCC INTERCALATED DISC | 39 | 9.55e-02 | -1.54e-01 | 3.77e-01 |
| GOBP SPINDLE ORGANIZATION | 192 | 2.28e-04 | 1.54e-01 | 7.44e-03 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 16 | 2.86e-01 | -1.54e-01 | 6.34e-01 |
| GOBP POSITIVE T CELL SELECTION | 41 | 8.79e-02 | 1.54e-01 | 3.61e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 6 | 5.14e-01 | -1.54e-01 | 7.98e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 143 | 1.48e-03 | -1.54e-01 | 3.08e-02 |
| GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.14e-01 | 1.54e-01 | 7.98e-01 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 28 | 1.59e-01 | -1.54e-01 | 4.87e-01 |
| GOBP CHEMOKINE PRODUCTION | 79 | 1.81e-02 | -1.54e-01 | 1.59e-01 |
| GOBP REGULATION OF DNA DEMETHYLATION | 5 | 5.52e-01 | -1.54e-01 | 8.24e-01 |
| GOCC ARYL HYDROCARBON RECEPTOR COMPLEX | 5 | 5.52e-01 | 1.54e-01 | 8.24e-01 |
| GOCC CALCIUM CHANNEL COMPLEX | 53 | 5.30e-02 | -1.54e-01 | 2.79e-01 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 8 | 4.52e-01 | -1.54e-01 | 7.57e-01 |
| GOMF DNA POLYMERASE ACTIVITY | 28 | 1.59e-01 | 1.54e-01 | 4.88e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 188 | 2.81e-04 | 1.54e-01 | 8.78e-03 |
| GOBP FOCAL ADHESION ASSEMBLY | 72 | 2.42e-02 | -1.54e-01 | 1.86e-01 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 12 | 3.57e-01 | 1.54e-01 | 6.94e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 378 | 2.95e-07 | 1.54e-01 | 2.65e-05 |
| GOMF AMIDE BINDING | 203 | 1.62e-04 | -1.54e-01 | 5.70e-03 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 290 | 6.83e-06 | 1.54e-01 | 4.12e-04 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 14 | 3.20e-01 | -1.53e-01 | 6.67e-01 |
| GOBP DE NOVO PROTEIN FOLDING | 42 | 8.54e-02 | 1.53e-01 | 3.57e-01 |
| GOBP TELOMERE ORGANIZATION | 170 | 5.60e-04 | 1.53e-01 | 1.48e-02 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 15 | 3.04e-01 | -1.53e-01 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 10 | 4.01e-01 | -1.53e-01 | 7.25e-01 |
| GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS | 5 | 5.53e-01 | 1.53e-01 | 8.24e-01 |
| GOBP SERINE TRANSPORT | 9 | 4.26e-01 | 1.53e-01 | 7.42e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 5.16e-01 | 1.53e-01 | 8.00e-01 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 5.53e-01 | 1.53e-01 | 8.24e-01 |
| GOBP DNA REPLICATION | 268 | 1.58e-05 | 1.53e-01 | 8.61e-04 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 8 | 4.53e-01 | -1.53e-01 | 7.58e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 13 | 3.39e-01 | -1.53e-01 | 6.81e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 22 | 2.14e-01 | -1.53e-01 | 5.59e-01 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 17 | 2.75e-01 | -1.53e-01 | 6.25e-01 |
| GOBP GLIOGENESIS | 268 | 1.61e-05 | -1.53e-01 | 8.65e-04 |
| GOBP MONONUCLEAR CELL MIGRATION | 181 | 3.87e-04 | -1.53e-01 | 1.11e-02 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 24 | 1.95e-01 | 1.53e-01 | 5.37e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 14 | 3.22e-01 | 1.53e-01 | 6.67e-01 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 10 | 4.03e-01 | 1.53e-01 | 7.26e-01 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 16 | 2.91e-01 | 1.53e-01 | 6.39e-01 |
| GOCC GOLGI LUMEN | 60 | 4.10e-02 | -1.53e-01 | 2.46e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 121 | 3.78e-03 | -1.52e-01 | 5.94e-02 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 251 | 3.19e-05 | 1.52e-01 | 1.54e-03 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 39 | 9.96e-02 | 1.52e-01 | 3.85e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 89 | 1.30e-02 | -1.52e-01 | 1.33e-01 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 15 | 3.08e-01 | -1.52e-01 | 6.55e-01 |
| GOCC CAVEOLA | 68 | 3.00e-02 | -1.52e-01 | 2.10e-01 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 6 | 5.19e-01 | -1.52e-01 | 8.01e-01 |
| GOBP FACIAL NERVE MORPHOGENESIS | 8 | 4.56e-01 | 1.52e-01 | 7.60e-01 |
| GOBP MRNA SPLICE SITE RECOGNITION | 31 | 1.43e-01 | 1.52e-01 | 4.62e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE | 6 | 5.19e-01 | -1.52e-01 | 8.01e-01 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 9 | 4.30e-01 | 1.52e-01 | 7.44e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 74 | 2.38e-02 | -1.52e-01 | 1.84e-01 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 4.86e-01 | -1.52e-01 | 7.83e-01 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 140 | 1.92e-03 | 1.52e-01 | 3.67e-02 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 78 | 2.04e-02 | -1.52e-01 | 1.69e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 10 | 4.06e-01 | 1.52e-01 | 7.28e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 86 | 1.50e-02 | -1.52e-01 | 1.45e-01 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 4.87e-01 | 1.52e-01 | 7.83e-01 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 5.57e-01 | 1.52e-01 | 8.26e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 19 | 2.52e-01 | 1.52e-01 | 6.00e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 5 | 5.57e-01 | -1.52e-01 | 8.26e-01 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 10 | 4.07e-01 | -1.52e-01 | 7.28e-01 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 11 | 3.84e-01 | 1.51e-01 | 7.15e-01 |
| GOMF HISTONE H3 KINASE ACTIVITY | 11 | 3.84e-01 | 1.51e-01 | 7.15e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 278 | 1.39e-05 | 1.51e-01 | 7.62e-04 |
| GOMF NARROW PORE CHANNEL ACTIVITY | 10 | 4.07e-01 | -1.51e-01 | 7.28e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 35 | 1.21e-01 | 1.51e-01 | 4.25e-01 |
| GOMF ACYL COA BINDING | 19 | 2.53e-01 | -1.51e-01 | 6.01e-01 |
| GOBP DTTP METABOLIC PROCESS | 5 | 5.58e-01 | 1.51e-01 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 43 | 8.64e-02 | 1.51e-01 | 3.58e-01 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 8 | 4.59e-01 | -1.51e-01 | 7.63e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 54 | 5.48e-02 | -1.51e-01 | 2.85e-01 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 14 | 3.28e-01 | -1.51e-01 | 6.73e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 16 | 2.95e-01 | 1.51e-01 | 6.44e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 35 | 1.22e-01 | 1.51e-01 | 4.27e-01 |
| GOBP CENTRIOLE ASSEMBLY | 45 | 7.96e-02 | 1.51e-01 | 3.45e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 5.59e-01 | 1.51e-01 | 8.27e-01 |
| GOBP NUCLEAR BODY ORGANIZATION | 18 | 2.68e-01 | 1.51e-01 | 6.17e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 40 | 9.85e-02 | 1.51e-01 | 3.83e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 26 | 1.83e-01 | -1.51e-01 | 5.20e-01 |
| GOMF GROWTH FACTOR ACTIVITY | 80 | 1.96e-02 | -1.51e-01 | 1.66e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 134 | 2.55e-03 | 1.51e-01 | 4.48e-02 |
| GOBP AMIDE METABOLIC PROCESS | 365 | 7.37e-07 | -1.51e-01 | 5.99e-05 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 11 | 3.87e-01 | -1.51e-01 | 7.16e-01 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 20 | 2.43e-01 | -1.51e-01 | 5.90e-01 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 4.90e-01 | 1.51e-01 | 7.85e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE EXTRAVASATION | 5 | 5.60e-01 | 1.51e-01 | 8.27e-01 |
| GOBP REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 6 | 5.23e-01 | -1.51e-01 | 8.04e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING VIA ENDOSOME | 5 | 5.60e-01 | 1.51e-01 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 8 | 4.61e-01 | -1.51e-01 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION | 5 | 5.60e-01 | -1.51e-01 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 41 | 9.54e-02 | 1.51e-01 | 3.77e-01 |
| GOMF LYSINE N ACETYLTRANSFERASE ACTIVITY ACTING ON ACETYL PHOSPHATE AS DONOR | 5 | 5.60e-01 | 1.50e-01 | 8.27e-01 |
| GOBP REGULATION OF DNA REPAIR | 209 | 1.78e-04 | 1.50e-01 | 6.10e-03 |
| GOBP LIPOPHAGY | 7 | 4.91e-01 | -1.50e-01 | 7.85e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 142 | 1.99e-03 | 1.50e-01 | 3.76e-02 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 13 | 3.48e-01 | -1.50e-01 | 6.88e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 32 | 1.42e-01 | -1.50e-01 | 4.60e-01 |
| GOBP ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT | 6 | 5.24e-01 | -1.50e-01 | 8.05e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 20 | 2.45e-01 | 1.50e-01 | 5.92e-01 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 10 | 4.11e-01 | -1.50e-01 | 7.31e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 32 | 1.42e-01 | 1.50e-01 | 4.61e-01 |
| GOMF RNA POLYMERASE II ACTIVITY | 11 | 3.89e-01 | -1.50e-01 | 7.17e-01 |
| GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING | 6 | 5.25e-01 | -1.50e-01 | 8.05e-01 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 9 | 4.36e-01 | 1.50e-01 | 7.48e-01 |
| GOBP NADP METABOLIC PROCESS | 40 | 1.01e-01 | -1.50e-01 | 3.88e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 18 | 2.71e-01 | 1.50e-01 | 6.22e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 65 | 3.67e-02 | -1.50e-01 | 2.32e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 21 | 2.35e-01 | -1.50e-01 | 5.82e-01 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 12 | 3.69e-01 | 1.50e-01 | 7.02e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 42 | 9.31e-02 | 1.50e-01 | 3.73e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 4.37e-01 | 1.50e-01 | 7.49e-01 |
| GOBP DNA LIGATION | 16 | 3.00e-01 | 1.50e-01 | 6.50e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 82 | 1.91e-02 | -1.50e-01 | 1.64e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 23 | 2.14e-01 | -1.50e-01 | 5.59e-01 |
| GOBP INTERFERON BETA PRODUCTION | 57 | 5.07e-02 | 1.50e-01 | 2.75e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1199 | 2.60e-18 | 1.50e-01 | 2.70e-15 |
| GOCC BBAF COMPLEX | 9 | 4.37e-01 | 1.50e-01 | 7.49e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 12 | 3.70e-01 | -1.49e-01 | 7.02e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 14 | 3.33e-01 | 1.49e-01 | 6.77e-01 |
| GOBP REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 106 | 7.90e-03 | 1.49e-01 | 9.76e-02 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 11 | 3.91e-01 | -1.49e-01 | 7.20e-01 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 24 | 2.05e-01 | -1.49e-01 | 5.49e-01 |
| GOBP PODOCYTE CELL MIGRATION | 7 | 4.94e-01 | -1.49e-01 | 7.87e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 69 | 3.22e-02 | 1.49e-01 | 2.17e-01 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 28 | 1.72e-01 | -1.49e-01 | 5.07e-01 |
| GOBP AMP METABOLIC PROCESS | 21 | 2.37e-01 | -1.49e-01 | 5.85e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 17 | 2.88e-01 | -1.49e-01 | 6.35e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 25 | 1.97e-01 | 1.49e-01 | 5.40e-01 |
| GOBP MRNA METABOLIC PROCESS | 676 | 4.08e-11 | 1.49e-01 | 9.30e-09 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 67 | 3.52e-02 | -1.49e-01 | 2.26e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 19 | 2.62e-01 | 1.49e-01 | 6.10e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 37 | 1.17e-01 | -1.49e-01 | 4.17e-01 |
| GOBP REGULATION OF PHOSPHATE TRANSPORT | 7 | 4.96e-01 | -1.49e-01 | 7.88e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 23 | 2.17e-01 | -1.49e-01 | 5.61e-01 |
| GOCC INNER DYNEIN ARM | 5 | 5.65e-01 | -1.49e-01 | 8.29e-01 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 9 | 4.40e-01 | -1.49e-01 | 7.50e-01 |
| GOMF HYDRO LYASE ACTIVITY | 51 | 6.62e-02 | -1.49e-01 | 3.13e-01 |
| GOBP NEURAL TUBE PATTERNING | 23 | 2.17e-01 | 1.49e-01 | 5.61e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 36 | 1.23e-01 | 1.49e-01 | 4.28e-01 |
| GOBP HEMOSTASIS | 195 | 3.46e-04 | -1.49e-01 | 1.02e-02 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 7 | 4.96e-01 | -1.49e-01 | 7.88e-01 |
| GOBP RESPONSE TO CALCIUM ION | 100 | 1.03e-02 | -1.48e-01 | 1.16e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 55 | 5.68e-02 | -1.48e-01 | 2.89e-01 |
| GOCC PRECATALYTIC SPLICEOSOME | 52 | 6.41e-02 | 1.48e-01 | 3.10e-01 |
| GOBP ISOLEUCINE TRANSPORT | 5 | 5.66e-01 | 1.48e-01 | 8.29e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 46 | 8.17e-02 | 1.48e-01 | 3.49e-01 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 5.66e-01 | -1.48e-01 | 8.29e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 66 | 3.72e-02 | -1.48e-01 | 2.34e-01 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 11 | 3.95e-01 | -1.48e-01 | 7.21e-01 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 13 | 3.55e-01 | 1.48e-01 | 6.93e-01 |
| GOBP GERMINAL CENTER FORMATION | 13 | 3.55e-01 | 1.48e-01 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 9 | 4.41e-01 | 1.48e-01 | 7.51e-01 |
| GOBP ZINC ION TRANSPORT | 22 | 2.29e-01 | 1.48e-01 | 5.74e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 65 | 3.90e-02 | -1.48e-01 | 2.40e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 53 | 6.23e-02 | -1.48e-01 | 3.05e-01 |
| GOBP GLANDULAR EPITHELIAL CELL MATURATION | 7 | 4.98e-01 | -1.48e-01 | 7.89e-01 |
| GOBP COCHLEA DEVELOPMENT | 28 | 1.75e-01 | 1.48e-01 | 5.10e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 192 | 4.10e-04 | -1.48e-01 | 1.15e-02 |
| GOBP SEGMENTATION | 61 | 4.59e-02 | 1.48e-01 | 2.61e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 17 | 2.92e-01 | 1.48e-01 | 6.40e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 15 | 3.22e-01 | 1.48e-01 | 6.67e-01 |
| GOBP SPERM EGG RECOGNITION | 29 | 1.69e-01 | -1.48e-01 | 5.02e-01 |
| GOCC NUCLEAR BODY | 785 | 1.94e-12 | 1.48e-01 | 7.55e-10 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 31 | 1.55e-01 | -1.48e-01 | 4.81e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 119 | 5.42e-03 | 1.48e-01 | 7.71e-02 |
| GOBP INTRACELLULAR MAGNESIUM ION HOMEOSTASIS | 5 | 5.68e-01 | -1.48e-01 | 8.30e-01 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 491 | 2.14e-08 | -1.48e-01 | 2.71e-06 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 22 | 2.31e-01 | -1.47e-01 | 5.78e-01 |
| GOMF DEUBIQUITINASE ACTIVITY | 93 | 1.41e-02 | 1.47e-01 | 1.40e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 13 | 3.58e-01 | -1.47e-01 | 6.95e-01 |
| GOCC ORGANELLAR RIBOSOME | 89 | 1.63e-02 | -1.47e-01 | 1.53e-01 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 19 | 2.67e-01 | -1.47e-01 | 6.15e-01 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 8 | 4.71e-01 | 1.47e-01 | 7.72e-01 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 13 | 3.59e-01 | 1.47e-01 | 6.95e-01 |
| GOBP MRNA PROCESSING | 457 | 7.22e-08 | 1.47e-01 | 7.50e-06 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 13 | 3.59e-01 | -1.47e-01 | 6.95e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 106 | 8.98e-03 | -1.47e-01 | 1.06e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 34 | 1.39e-01 | -1.47e-01 | 4.57e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 9 | 4.46e-01 | -1.47e-01 | 7.53e-01 |
| GOBP OLFACTORY NERVE DEVELOPMENT | 6 | 5.34e-01 | -1.47e-01 | 8.11e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 29 | 1.71e-01 | 1.47e-01 | 5.06e-01 |
| GOMF BITTER TASTE RECEPTOR ACTIVITY | 6 | 5.34e-01 | 1.47e-01 | 8.11e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 10 | 4.22e-01 | 1.47e-01 | 7.40e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 15 | 3.26e-01 | 1.47e-01 | 6.71e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 12 | 3.79e-01 | -1.47e-01 | 7.11e-01 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 59 | 5.16e-02 | 1.47e-01 | 2.77e-01 |
| GOBP INTERLEUKIN 8 PRODUCTION | 68 | 3.67e-02 | -1.46e-01 | 2.32e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 381 | 9.13e-07 | 1.46e-01 | 7.18e-05 |
| GOBP REGULATION OF DNA REPLICATION | 120 | 5.60e-03 | 1.46e-01 | 7.81e-02 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 12 | 3.80e-01 | -1.46e-01 | 7.12e-01 |
| GOBP OVULATION FROM OVARIAN FOLLICLE | 5 | 5.71e-01 | -1.46e-01 | 8.30e-01 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 167 | 1.10e-03 | 1.46e-01 | 2.45e-02 |
| GOMF INSULIN RECEPTOR BINDING | 18 | 2.82e-01 | -1.46e-01 | 6.31e-01 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 31 | 1.58e-01 | -1.46e-01 | 4.86e-01 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 10 | 4.23e-01 | -1.46e-01 | 7.41e-01 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 45 | 8.94e-02 | 1.46e-01 | 3.65e-01 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 11 | 4.01e-01 | -1.46e-01 | 7.25e-01 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 7 | 5.03e-01 | 1.46e-01 | 7.92e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 31 | 1.59e-01 | 1.46e-01 | 4.87e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 98 | 1.24e-02 | -1.46e-01 | 1.29e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 342 | 3.40e-06 | 1.46e-01 | 2.21e-04 |
| GOBP RESPONSE TO GAMMA RADIATION | 46 | 8.64e-02 | 1.46e-01 | 3.58e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 17 | 2.97e-01 | 1.46e-01 | 6.46e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 19 | 2.71e-01 | 1.46e-01 | 6.21e-01 |
| GOBP RESPONSE TO CORTICOSTEROID | 114 | 7.08e-03 | -1.46e-01 | 9.03e-02 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 28 | 1.81e-01 | 1.46e-01 | 5.18e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 262 | 4.76e-05 | -1.46e-01 | 2.09e-03 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 24 | 2.16e-01 | -1.46e-01 | 5.60e-01 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 26 | 1.98e-01 | 1.46e-01 | 5.40e-01 |
| GOBP POLYKETIDE METABOLIC PROCESS | 7 | 5.04e-01 | -1.46e-01 | 7.93e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 47 | 8.36e-02 | -1.46e-01 | 3.53e-01 |
| GOCC HEMOGLOBIN COMPLEX | 10 | 4.25e-01 | -1.46e-01 | 7.42e-01 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 27 | 1.90e-01 | -1.46e-01 | 5.31e-01 |
| GOCC MICOS COMPLEX | 9 | 4.49e-01 | 1.46e-01 | 7.55e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 59 | 5.29e-02 | -1.46e-01 | 2.79e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 7 | 5.04e-01 | -1.46e-01 | 7.93e-01 |
| GOBP HIPPO SIGNALING | 46 | 8.74e-02 | 1.46e-01 | 3.59e-01 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 7 | 5.05e-01 | 1.46e-01 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 29 | 1.75e-01 | -1.46e-01 | 5.09e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 24 | 2.17e-01 | 1.46e-01 | 5.61e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 20 | 2.60e-01 | -1.45e-01 | 6.08e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 14 | 3.46e-01 | 1.45e-01 | 6.86e-01 |
| GOBP NEUTROPHIL HOMEOSTASIS | 20 | 2.60e-01 | 1.45e-01 | 6.09e-01 |
| GOBP COMPLEMENT ACTIVATION | 45 | 9.15e-02 | -1.45e-01 | 3.70e-01 |
| GOBP B CELL HOMEOSTASIS | 34 | 1.43e-01 | 1.45e-01 | 4.61e-01 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.50e-01 | 1.45e-01 | 7.56e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 14 | 3.47e-01 | -1.45e-01 | 6.86e-01 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 9 | 4.51e-01 | -1.45e-01 | 7.56e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 18 | 2.86e-01 | 1.45e-01 | 6.34e-01 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 10 | 4.27e-01 | -1.45e-01 | 7.42e-01 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 8 | 4.77e-01 | 1.45e-01 | 7.76e-01 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 15 | 3.31e-01 | -1.45e-01 | 6.75e-01 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 11 | 4.05e-01 | 1.45e-01 | 7.27e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 10 | 4.27e-01 | -1.45e-01 | 7.42e-01 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 11 | 4.05e-01 | -1.45e-01 | 7.27e-01 |
| GOBP FATTY ACID HOMEOSTASIS | 12 | 3.85e-01 | 1.45e-01 | 7.15e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 29 | 1.77e-01 | -1.45e-01 | 5.12e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 13 | 3.66e-01 | -1.45e-01 | 7.00e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 10 | 4.28e-01 | 1.45e-01 | 7.43e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 15 | 3.32e-01 | 1.45e-01 | 6.76e-01 |
| GOBP POSITIVE REGULATION OF COLLATERAL SPROUTING | 7 | 5.07e-01 | 1.45e-01 | 7.96e-01 |
| GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 6 | 5.39e-01 | -1.45e-01 | 8.14e-01 |
| GOBP REGULATION OF RESTING MEMBRANE POTENTIAL | 7 | 5.08e-01 | -1.45e-01 | 7.96e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 13 | 3.67e-01 | 1.45e-01 | 7.00e-01 |
| GOMF HISTONE DECROTONYLASE ACTIVITY | 5 | 5.76e-01 | 1.45e-01 | 8.33e-01 |
| GOBP DNA DAMAGE RESPONSE | 850 | 8.02e-13 | 1.45e-01 | 3.57e-10 |
| GOBP DETECTION OF BIOTIC STIMULUS | 32 | 1.57e-01 | -1.45e-01 | 4.84e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 39 | 1.18e-01 | -1.44e-01 | 4.19e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 43 | 1.01e-01 | -1.44e-01 | 3.88e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 26 | 2.03e-01 | -1.44e-01 | 5.45e-01 |
| GOBP CARBON DIOXIDE TRANSPORT | 8 | 4.79e-01 | -1.44e-01 | 7.77e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 71 | 3.54e-02 | 1.44e-01 | 2.27e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 8 | 4.80e-01 | 1.44e-01 | 7.77e-01 |
| GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 5 | 5.76e-01 | -1.44e-01 | 8.33e-01 |
| GOBP PROTEIN C LINKED GLYCOSYLATION | 6 | 5.41e-01 | 1.44e-01 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 15 | 3.33e-01 | -1.44e-01 | 6.77e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 21 | 2.53e-01 | -1.44e-01 | 6.00e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 492 | 4.29e-08 | 1.44e-01 | 4.84e-06 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 28 | 1.87e-01 | -1.44e-01 | 5.27e-01 |
| GOBP STEM CELL PROLIFERATION | 76 | 2.98e-02 | 1.44e-01 | 2.09e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 17 | 3.04e-01 | 1.44e-01 | 6.53e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 32 | 1.59e-01 | -1.44e-01 | 4.87e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 120 | 6.45e-03 | 1.44e-01 | 8.53e-02 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 54 | 6.73e-02 | -1.44e-01 | 3.16e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 55 | 6.48e-02 | -1.44e-01 | 3.11e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 10 | 4.31e-01 | -1.44e-01 | 7.44e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 23 | 2.32e-01 | 1.44e-01 | 5.79e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 17 | 3.04e-01 | -1.44e-01 | 6.53e-01 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 8 | 4.81e-01 | 1.44e-01 | 7.79e-01 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 10 | 4.31e-01 | -1.44e-01 | 7.44e-01 |
| GOBP SPERMIDINE METABOLIC PROCESS | 8 | 4.81e-01 | -1.44e-01 | 7.79e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 17 | 3.05e-01 | 1.44e-01 | 6.53e-01 |
| GOBP RENAL TUBULAR SECRETION | 8 | 4.82e-01 | -1.44e-01 | 7.79e-01 |
| GOBP OLIGOPEPTIDE TRANSPORT | 15 | 3.36e-01 | -1.44e-01 | 6.79e-01 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.11e-01 | -1.44e-01 | 7.97e-01 |
| GOCC GRANULAR COMPONENT | 7 | 5.11e-01 | 1.44e-01 | 7.97e-01 |
| GOBP POSITIVE REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 5 | 5.79e-01 | -1.43e-01 | 8.33e-01 |
| GOBP PHOSPHATE ION TRANSPORT | 22 | 2.44e-01 | -1.43e-01 | 5.91e-01 |
| GOBP NEUTROPHIL APOPTOTIC PROCESS | 7 | 5.12e-01 | 1.43e-01 | 7.97e-01 |
| GOBP MONOAMINE TRANSPORT | 49 | 8.29e-02 | -1.43e-01 | 3.51e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 28 | 1.90e-01 | -1.43e-01 | 5.30e-01 |
| GOBP CHONDROCYTE PROLIFERATION | 15 | 3.37e-01 | -1.43e-01 | 6.79e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 158 | 1.90e-03 | 1.43e-01 | 3.65e-02 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 3.22e-01 | 1.43e-01 | 6.67e-01 |
| GOBP MITOCHONDRIAL FISSION | 38 | 1.27e-01 | 1.43e-01 | 4.37e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 47 | 9.02e-02 | -1.43e-01 | 3.67e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 22 | 2.46e-01 | 1.43e-01 | 5.94e-01 |
| GOCC CILIARY TRANSITION ZONE | 68 | 4.19e-02 | 1.43e-01 | 2.49e-01 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 23 | 2.36e-01 | 1.43e-01 | 5.84e-01 |
| GOCC MYOFILAMENT | 18 | 2.95e-01 | -1.43e-01 | 6.43e-01 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 397 | 1.07e-06 | 1.43e-01 | 8.20e-05 |
| GOCC NUCLEAR SPECK | 391 | 1.29e-06 | 1.43e-01 | 9.73e-05 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 200 | 5.07e-04 | 1.43e-01 | 1.36e-02 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 45 | 9.81e-02 | -1.43e-01 | 3.83e-01 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 197 | 5.62e-04 | -1.43e-01 | 1.48e-02 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 13 | 3.74e-01 | -1.42e-01 | 7.06e-01 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 17 | 3.09e-01 | -1.42e-01 | 6.56e-01 |
| GOCC SPERM MIDPIECE | 34 | 1.51e-01 | -1.42e-01 | 4.75e-01 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 89 | 2.02e-02 | -1.42e-01 | 1.68e-01 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 116 | 8.06e-03 | -1.42e-01 | 9.89e-02 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 27 | 2.00e-01 | -1.42e-01 | 5.43e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 27 | 2.01e-01 | -1.42e-01 | 5.43e-01 |
| GOBP SIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION | 5 | 5.82e-01 | -1.42e-01 | 8.35e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 131 | 4.93e-03 | 1.42e-01 | 7.19e-02 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 5.46e-01 | 1.42e-01 | 8.20e-01 |
| GOMF PEPTIDE HORMONE RECEPTOR BINDING | 7 | 5.15e-01 | -1.42e-01 | 7.98e-01 |
| GOBP CELL CHEMOTAXIS | 240 | 1.48e-04 | -1.42e-01 | 5.32e-03 |
| GOMF SPHINGOLIPID TRANSFER ACTIVITY | 8 | 4.86e-01 | 1.42e-01 | 7.83e-01 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 15 | 3.41e-01 | -1.42e-01 | 6.82e-01 |
| GOMF EPHRIN RECEPTOR ACTIVITY | 12 | 3.94e-01 | 1.42e-01 | 7.21e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 7 | 5.15e-01 | -1.42e-01 | 7.98e-01 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 116 | 8.19e-03 | -1.42e-01 | 9.99e-02 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 63 | 5.13e-02 | 1.42e-01 | 2.77e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 223 | 2.59e-04 | 1.42e-01 | 8.26e-03 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 8 | 4.87e-01 | -1.42e-01 | 7.83e-01 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 5 | 5.83e-01 | 1.42e-01 | 8.36e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 7 | 5.16e-01 | 1.42e-01 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 157 | 2.17e-03 | -1.42e-01 | 4.00e-02 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 48 | 8.92e-02 | 1.42e-01 | 3.64e-01 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 73 | 3.62e-02 | 1.42e-01 | 2.30e-01 |
| GOBP ARACHIDONIC ACID SECRETION | 15 | 3.42e-01 | -1.42e-01 | 6.83e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 198 | 5.88e-04 | 1.42e-01 | 1.52e-02 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 24 | 2.30e-01 | 1.42e-01 | 5.75e-01 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 10 | 4.38e-01 | -1.42e-01 | 7.49e-01 |
| GOBP AORTA MORPHOGENESIS | 21 | 2.62e-01 | -1.41e-01 | 6.10e-01 |
| GOMF CHROMATIN BINDING | 524 | 3.04e-08 | 1.41e-01 | 3.65e-06 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 26 | 2.12e-01 | 1.41e-01 | 5.58e-01 |
| GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS | 5 | 5.84e-01 | -1.41e-01 | 8.37e-01 |
| GOBP NK T CELL PROLIFERATION | 8 | 4.89e-01 | -1.41e-01 | 7.85e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 94 | 1.80e-02 | -1.41e-01 | 1.58e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 65 | 4.90e-02 | 1.41e-01 | 2.70e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY TYPE I | 5 | 5.85e-01 | 1.41e-01 | 8.37e-01 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 5.85e-01 | -1.41e-01 | 8.37e-01 |
| GOMF HORMONE BINDING | 57 | 6.54e-02 | -1.41e-01 | 3.12e-01 |
| GOBP GAP JUNCTION ASSEMBLY | 10 | 4.40e-01 | -1.41e-01 | 7.50e-01 |
| GOBP RESPONSE TO STEROL | 28 | 1.96e-01 | 1.41e-01 | 5.38e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 139 | 4.09e-03 | -1.41e-01 | 6.30e-02 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 32 | 1.68e-01 | -1.41e-01 | 5.01e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 5.19e-01 | -1.41e-01 | 8.01e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 8 | 4.90e-01 | 1.41e-01 | 7.85e-01 |
| GOMF GLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 5 | 5.85e-01 | -1.41e-01 | 8.38e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 10 | 4.41e-01 | -1.41e-01 | 7.51e-01 |
| GOBP PRESYNAPSE ORGANIZATION | 31 | 1.75e-01 | -1.41e-01 | 5.09e-01 |
| GOBP REGULATION OF ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 5.86e-01 | 1.41e-01 | 8.38e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 39 | 1.29e-01 | -1.41e-01 | 4.39e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN | 5 | 5.87e-01 | 1.40e-01 | 8.39e-01 |
| GOMF POLY G BINDING | 8 | 4.92e-01 | 1.40e-01 | 7.85e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 112 | 1.03e-02 | -1.40e-01 | 1.16e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 36 | 1.45e-01 | -1.40e-01 | 4.66e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 94 | 1.88e-02 | -1.40e-01 | 1.63e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 14 | 3.64e-01 | 1.40e-01 | 6.99e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 293 | 3.66e-05 | 1.40e-01 | 1.72e-03 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 11 | 4.21e-01 | -1.40e-01 | 7.39e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 14 | 3.64e-01 | -1.40e-01 | 6.99e-01 |
| GOBP BRAIN MORPHOGENESIS | 29 | 1.92e-01 | -1.40e-01 | 5.33e-01 |
| GOCC SPLICEOSOMAL COMPLEX | 195 | 7.43e-04 | 1.40e-01 | 1.81e-02 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 75 | 3.60e-02 | 1.40e-01 | 2.30e-01 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 20 | 2.78e-01 | -1.40e-01 | 6.27e-01 |
| GOCC P BODY | 96 | 1.78e-02 | 1.40e-01 | 1.58e-01 |
| GOCC TOR COMPLEX | 12 | 4.01e-01 | 1.40e-01 | 7.25e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 29 | 1.92e-01 | -1.40e-01 | 5.34e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 9 | 4.68e-01 | -1.40e-01 | 7.68e-01 |
| GOBP WATER TRANSPORT | 14 | 3.65e-01 | -1.40e-01 | 6.99e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 62 | 5.68e-02 | 1.40e-01 | 2.89e-01 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 5 | 5.88e-01 | 1.40e-01 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 6 | 5.53e-01 | 1.40e-01 | 8.24e-01 |
| GOBP IMPORT INTO NUCLEUS | 155 | 2.69e-03 | 1.40e-01 | 4.66e-02 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 79 | 3.19e-02 | 1.40e-01 | 2.16e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 16 | 3.34e-01 | 1.40e-01 | 6.77e-01 |
| GOBP CATECHOLAMINE TRANSPORT | 38 | 1.37e-01 | -1.39e-01 | 4.53e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 39 | 1.32e-01 | -1.39e-01 | 4.45e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 57 | 6.86e-02 | -1.39e-01 | 3.19e-01 |
| GOBP TELOMERE CAPPING | 38 | 1.37e-01 | 1.39e-01 | 4.53e-01 |
| GOMF GALACTOSIDE BINDING | 7 | 5.23e-01 | 1.39e-01 | 8.04e-01 |
| GOMF PH DOMAIN BINDING | 8 | 4.95e-01 | 1.39e-01 | 7.88e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 149 | 3.32e-03 | -1.39e-01 | 5.41e-02 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 7 | 5.23e-01 | 1.39e-01 | 8.04e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 358 | 5.98e-06 | -1.39e-01 | 3.68e-04 |
| GOBP GAS TRANSPORT | 13 | 3.85e-01 | -1.39e-01 | 7.15e-01 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 8 | 4.95e-01 | -1.39e-01 | 7.88e-01 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 5.90e-01 | 1.39e-01 | 8.40e-01 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 10 | 4.46e-01 | 1.39e-01 | 7.54e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 11 | 4.25e-01 | 1.39e-01 | 7.42e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 12 | 4.05e-01 | -1.39e-01 | 7.27e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 197 | 7.79e-04 | 1.39e-01 | 1.88e-02 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 61 | 6.08e-02 | 1.39e-01 | 3.01e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 17 | 3.22e-01 | 1.39e-01 | 6.67e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 11 | 4.26e-01 | -1.39e-01 | 7.42e-01 |
| GOBP UTP METABOLIC PROCESS | 10 | 4.48e-01 | -1.39e-01 | 7.55e-01 |
| GOBP PROSTANOID METABOLIC PROCESS | 40 | 1.29e-01 | -1.39e-01 | 4.40e-01 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 51 | 8.68e-02 | -1.39e-01 | 3.58e-01 |
| GOCC SPINDLE MICROTUBULE | 78 | 3.43e-02 | 1.39e-01 | 2.24e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 16 | 3.37e-01 | -1.39e-01 | 6.79e-01 |
| GOMF SHORT CHAIN CARBOXYLESTERASE ACTIVITY | 6 | 5.57e-01 | 1.39e-01 | 8.26e-01 |
| GOCC SPERM CONNECTING PIECE | 9 | 4.72e-01 | 1.39e-01 | 7.72e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 54 | 7.83e-02 | 1.39e-01 | 3.43e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 19 | 2.96e-01 | -1.38e-01 | 6.45e-01 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 130 | 6.42e-03 | 1.38e-01 | 8.51e-02 |
| GOMF PRIMARY MIRNA BINDING | 9 | 4.72e-01 | 1.38e-01 | 7.73e-01 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 46 | 1.04e-01 | -1.38e-01 | 3.94e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 53 | 8.14e-02 | -1.38e-01 | 3.48e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 30 | 1.90e-01 | 1.38e-01 | 5.30e-01 |
| GOBP CHEMOSENSORY BEHAVIOR | 14 | 3.70e-01 | 1.38e-01 | 7.03e-01 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 13 | 3.88e-01 | -1.38e-01 | 7.16e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 17 | 3.24e-01 | 1.38e-01 | 6.69e-01 |
| GOMF LIGAND GATED SODIUM CHANNEL ACTIVITY | 10 | 4.49e-01 | 1.38e-01 | 7.55e-01 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 7 | 5.27e-01 | -1.38e-01 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT | 5 | 5.93e-01 | -1.38e-01 | 8.42e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 16 | 3.39e-01 | -1.38e-01 | 6.81e-01 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 9 | 4.74e-01 | 1.38e-01 | 7.73e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 48 | 9.84e-02 | 1.38e-01 | 3.83e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS | 5 | 5.93e-01 | -1.38e-01 | 8.42e-01 |
| GOMF E BOX BINDING | 33 | 1.71e-01 | -1.38e-01 | 5.05e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 11 | 4.29e-01 | 1.38e-01 | 7.43e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 5.59e-01 | -1.38e-01 | 8.27e-01 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 92 | 2.24e-02 | -1.38e-01 | 1.77e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 12 | 4.09e-01 | -1.38e-01 | 7.30e-01 |
| GOBP CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 187 | 1.16e-03 | -1.38e-01 | 2.56e-02 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 22 | 2.64e-01 | 1.38e-01 | 6.12e-01 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 66 | 5.31e-02 | -1.38e-01 | 2.79e-01 |
| GOCC APICAL DENDRITE | 13 | 3.90e-01 | -1.38e-01 | 7.18e-01 |
| GOMF NUCLEOSIDE BINDING | 8 | 5.00e-01 | 1.38e-01 | 7.91e-01 |
| GOBP DENDRITIC SPINE MAINTENANCE | 17 | 3.26e-01 | -1.38e-01 | 6.71e-01 |
| GOBP GLIAL CELL DIFFERENTIATION | 196 | 8.97e-04 | -1.38e-01 | 2.12e-02 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 21 | 2.75e-01 | -1.38e-01 | 6.26e-01 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 22 | 2.64e-01 | -1.38e-01 | 6.13e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 17 | 3.26e-01 | -1.38e-01 | 6.72e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 30 | 1.92e-01 | 1.37e-01 | 5.34e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 46 | 1.07e-01 | -1.37e-01 | 3.98e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION | 6 | 5.60e-01 | -1.37e-01 | 8.27e-01 |
| GOBP WOUND HEALING | 339 | 1.38e-05 | -1.37e-01 | 7.62e-04 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 9 | 4.76e-01 | -1.37e-01 | 7.74e-01 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 23 | 2.55e-01 | 1.37e-01 | 6.02e-01 |
| GOCC CILIARY ROOTLET | 14 | 3.74e-01 | -1.37e-01 | 7.06e-01 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 27 | 2.17e-01 | -1.37e-01 | 5.61e-01 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 7 | 5.30e-01 | 1.37e-01 | 8.07e-01 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 119 | 9.78e-03 | -1.37e-01 | 1.12e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 8 | 5.02e-01 | 1.37e-01 | 7.92e-01 |
| GOMF BMP RECEPTOR BINDING | 7 | 5.30e-01 | -1.37e-01 | 8.08e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 34 | 1.67e-01 | -1.37e-01 | 5.00e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 16 | 3.43e-01 | -1.37e-01 | 6.83e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 71 | 4.61e-02 | -1.37e-01 | 2.62e-01 |
| GOBP RNA SPLICING | 425 | 1.32e-06 | 1.37e-01 | 9.79e-05 |
| GOMF HISTONE DEACETYLASE BINDING | 104 | 1.60e-02 | 1.37e-01 | 1.51e-01 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 35 | 1.62e-01 | -1.37e-01 | 4.92e-01 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 6 | 5.62e-01 | -1.37e-01 | 8.28e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 14 | 3.76e-01 | 1.37e-01 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 15 | 3.60e-01 | -1.37e-01 | 6.96e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 18 | 3.16e-01 | -1.37e-01 | 6.63e-01 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 6 | 5.63e-01 | 1.37e-01 | 8.28e-01 |
| GOMF HSP90 PROTEIN BINDING | 38 | 1.45e-01 | 1.36e-01 | 4.66e-01 |
| GOCC EMC COMPLEX | 10 | 4.55e-01 | -1.36e-01 | 7.60e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 290 | 6.48e-05 | -1.36e-01 | 2.69e-03 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 14 | 3.77e-01 | -1.36e-01 | 7.10e-01 |
| GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING | 6 | 5.63e-01 | -1.36e-01 | 8.28e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 12 | 4.14e-01 | 1.36e-01 | 7.33e-01 |
| GOBP FLOOR PLATE DEVELOPMENT | 8 | 5.05e-01 | 1.36e-01 | 7.93e-01 |
| GOCC ORGANELLE ENVELOPE LUMEN | 88 | 2.73e-02 | -1.36e-01 | 1.99e-01 |
| GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION | 5 | 5.98e-01 | 1.36e-01 | 8.45e-01 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 12 | 4.15e-01 | -1.36e-01 | 7.34e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 18 | 3.18e-01 | -1.36e-01 | 6.65e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 52 | 8.99e-02 | 1.36e-01 | 3.66e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 10 | 4.57e-01 | -1.36e-01 | 7.61e-01 |
| GOCC INTERCHROMATIN GRANULE | 5 | 5.99e-01 | 1.36e-01 | 8.46e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 84 | 3.14e-02 | -1.36e-01 | 2.15e-01 |
| GOBP SECRETORY GRANULE LOCALIZATION | 15 | 3.63e-01 | 1.36e-01 | 6.98e-01 |
| GOBP FIBRINOLYSIS | 18 | 3.19e-01 | -1.36e-01 | 6.66e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 10 | 4.58e-01 | 1.36e-01 | 7.62e-01 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 8 | 5.07e-01 | 1.35e-01 | 7.96e-01 |
| GOBP RESPONSE TO NUTRIENT | 122 | 9.82e-03 | -1.35e-01 | 1.12e-01 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 8 | 5.07e-01 | 1.35e-01 | 7.96e-01 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 30 | 2.00e-01 | 1.35e-01 | 5.43e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 56 | 7.99e-02 | 1.35e-01 | 3.45e-01 |
| GOBP RESPONSE TO VITAMIN | 62 | 6.54e-02 | -1.35e-01 | 3.12e-01 |
| GOBP MOLTING CYCLE | 70 | 5.03e-02 | 1.35e-01 | 2.74e-01 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 8 | 5.08e-01 | -1.35e-01 | 7.96e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 9 | 4.83e-01 | -1.35e-01 | 7.80e-01 |
| GOBP CERAMIDE 1 PHOSPHATE TRANSPORT | 6 | 5.67e-01 | 1.35e-01 | 8.29e-01 |
| GOMF CERAMIDE 1 PHOSPHATE TRANSFER ACTIVITY | 6 | 5.67e-01 | 1.35e-01 | 8.29e-01 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 49 | 1.02e-01 | -1.35e-01 | 3.89e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 17 | 3.35e-01 | 1.35e-01 | 6.78e-01 |
| GOBP NEGATIVE REGULATION OF STEROL TRANSPORT | 5 | 6.01e-01 | -1.35e-01 | 8.47e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 21 | 2.84e-01 | -1.35e-01 | 6.34e-01 |
| GOCC CHLORIDE CHANNEL COMPLEX | 28 | 2.16e-01 | -1.35e-01 | 5.60e-01 |
| GOBP THIAMINE CONTAINING COMPOUND METABOLIC PROCESS | 7 | 5.36e-01 | 1.35e-01 | 8.12e-01 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 51 | 9.54e-02 | -1.35e-01 | 3.77e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 13 | 4.00e-01 | -1.35e-01 | 7.24e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 44 | 1.22e-01 | 1.35e-01 | 4.26e-01 |
| GOCC MICROVILLUS | 74 | 4.48e-02 | -1.35e-01 | 2.59e-01 |
| GOBP RETINA LAYER FORMATION | 12 | 4.19e-01 | 1.35e-01 | 7.37e-01 |
| GOBP RESPONSE TO PEPTIDE | 19 | 3.09e-01 | -1.35e-01 | 6.56e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 5 | 6.02e-01 | 1.35e-01 | 8.47e-01 |
| GOCC MON1 CCZ1 COMPLEX | 5 | 6.02e-01 | 1.35e-01 | 8.47e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 8 | 5.09e-01 | 1.35e-01 | 7.96e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 15 | 3.66e-01 | -1.35e-01 | 7.00e-01 |
| GOBP ASYMMETRIC NEUROBLAST DIVISION | 5 | 6.02e-01 | 1.35e-01 | 8.47e-01 |
| GOBP MEIOTIC CELL CYCLE | 218 | 6.12e-04 | 1.35e-01 | 1.56e-02 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 71 | 4.99e-02 | -1.35e-01 | 2.73e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 54 | 8.72e-02 | -1.35e-01 | 3.59e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 33 | 1.81e-01 | -1.35e-01 | 5.18e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 23 | 2.65e-01 | -1.34e-01 | 6.13e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 181 | 1.83e-03 | -1.34e-01 | 3.59e-02 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 22 | 2.77e-01 | 1.34e-01 | 6.26e-01 |
| GOMF SUMO TRANSFERASE ACTIVITY | 24 | 2.56e-01 | 1.34e-01 | 6.04e-01 |
| GOMF COMPLEMENT COMPONENT C1Q COMPLEX BINDING | 5 | 6.04e-01 | -1.34e-01 | 8.48e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 43 | 1.29e-01 | 1.34e-01 | 4.39e-01 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 14 | 3.86e-01 | -1.34e-01 | 7.15e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 13 | 4.03e-01 | -1.34e-01 | 7.26e-01 |
| GOBP ADRENAL GLAND DEVELOPMENT | 17 | 3.39e-01 | -1.34e-01 | 6.81e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 641 | 7.12e-09 | 1.34e-01 | 9.78e-07 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 47 | 1.12e-01 | 1.34e-01 | 4.10e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 16 | 3.54e-01 | 1.34e-01 | 6.93e-01 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 11 | 4.42e-01 | -1.34e-01 | 7.51e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 329 | 3.04e-05 | 1.34e-01 | 1.48e-03 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 6 | 5.71e-01 | 1.34e-01 | 8.30e-01 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 22 | 2.78e-01 | -1.34e-01 | 6.26e-01 |
| GOCC IGG IMMUNOGLOBULIN COMPLEX | 11 | 4.43e-01 | -1.34e-01 | 7.51e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR ACTIVITY | 6 | 5.71e-01 | 1.34e-01 | 8.30e-01 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 16 | 3.55e-01 | 1.34e-01 | 6.93e-01 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 48 | 1.09e-01 | -1.34e-01 | 4.02e-01 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 8 | 5.13e-01 | -1.34e-01 | 7.97e-01 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 10 | 4.64e-01 | -1.34e-01 | 7.66e-01 |
| GOBP NUCLEOPHAGY | 22 | 2.78e-01 | 1.34e-01 | 6.27e-01 |
| GOBP MEIOTIC CHROMOSOME SEPARATION | 8 | 5.13e-01 | -1.34e-01 | 7.97e-01 |
| GOBP SPHINGOID BIOSYNTHETIC PROCESS | 13 | 4.04e-01 | -1.34e-01 | 7.27e-01 |
| GOMF 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE BINDING | 5 | 6.05e-01 | -1.34e-01 | 8.49e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 237 | 3.98e-04 | -1.34e-01 | 1.13e-02 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 24 | 2.57e-01 | -1.34e-01 | 6.06e-01 |
| GOBP HEART TRABECULA FORMATION | 7 | 5.41e-01 | -1.34e-01 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 16 | 3.55e-01 | -1.34e-01 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 4.05e-01 | -1.33e-01 | 7.27e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 320 | 4.06e-05 | 1.33e-01 | 1.86e-03 |
| GOBP MEMBRANE RAFT LOCALIZATION | 7 | 5.41e-01 | 1.33e-01 | 8.15e-01 |
| GOBP RESPONSE TO WOUNDING | 444 | 1.48e-06 | -1.33e-01 | 1.06e-04 |
| GOMF CHEMOKINE BINDING | 31 | 1.99e-01 | -1.33e-01 | 5.42e-01 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 11 | 4.44e-01 | 1.33e-01 | 7.53e-01 |
| GOMF SULFOTRANSFERASE ACTIVITY | 30 | 2.07e-01 | -1.33e-01 | 5.52e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 543 | 1.12e-07 | -1.33e-01 | 1.12e-05 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 11 | 4.45e-01 | 1.33e-01 | 7.53e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING | 6 | 5.73e-01 | -1.33e-01 | 8.31e-01 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 6 | 5.73e-01 | 1.33e-01 | 8.31e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 39 | 1.51e-01 | -1.33e-01 | 4.76e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 20 | 3.04e-01 | -1.33e-01 | 6.53e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 18 | 3.30e-01 | -1.33e-01 | 6.75e-01 |
| GOBP THERMOCEPTION | 5 | 6.08e-01 | -1.33e-01 | 8.51e-01 |
| GOCC CELL SUBSTRATE JUNCTION | 399 | 5.46e-06 | -1.33e-01 | 3.40e-04 |
| GOMF ALPHA GLUCOSIDASE ACTIVITY | 6 | 5.74e-01 | -1.33e-01 | 8.32e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 19 | 3.17e-01 | 1.33e-01 | 6.64e-01 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 4.47e-01 | 1.33e-01 | 7.54e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 18 | 3.30e-01 | 1.33e-01 | 6.75e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 118 | 1.29e-02 | -1.32e-01 | 1.33e-01 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 19 | 3.18e-01 | -1.32e-01 | 6.64e-01 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.92e-01 | -1.32e-01 | 7.85e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 35 | 1.76e-01 | -1.32e-01 | 5.10e-01 |
| GOMF DAMAGED DNA BINDING | 72 | 5.25e-02 | 1.32e-01 | 2.78e-01 |
| GOCC PAR POLARITY COMPLEX | 6 | 5.75e-01 | 1.32e-01 | 8.33e-01 |
| GOCC SPINDLE POLE CENTROSOME | 13 | 4.10e-01 | 1.32e-01 | 7.31e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 215 | 8.44e-04 | 1.32e-01 | 2.02e-02 |
| GOMF SIGNAL SEQUENCE BINDING | 45 | 1.25e-01 | 1.32e-01 | 4.34e-01 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 65 | 6.56e-02 | -1.32e-01 | 3.12e-01 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 30 | 2.11e-01 | 1.32e-01 | 5.56e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 32 | 1.96e-01 | -1.32e-01 | 5.38e-01 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 14 | 3.93e-01 | -1.32e-01 | 7.21e-01 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 522 | 2.46e-07 | -1.32e-01 | 2.26e-05 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 25 | 2.54e-01 | -1.32e-01 | 6.01e-01 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 29 | 2.19e-01 | -1.32e-01 | 5.63e-01 |
| GOBP PROTEIN LINEAR POLYUBIQUITINATION | 5 | 6.10e-01 | 1.32e-01 | 8.52e-01 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 40 | 1.49e-01 | 1.32e-01 | 4.74e-01 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 5.76e-01 | -1.32e-01 | 8.33e-01 |
| GOBP RIBOSOME DISASSEMBLY | 37 | 1.66e-01 | 1.32e-01 | 4.98e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 101 | 2.22e-02 | -1.32e-01 | 1.76e-01 |
| GOCC PRESPLICEOSOME | 17 | 3.47e-01 | 1.32e-01 | 6.87e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 25 | 2.55e-01 | -1.32e-01 | 6.02e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 5.19e-01 | -1.32e-01 | 8.01e-01 |
| GOBP RENAL SODIUM EXCRETION | 6 | 5.77e-01 | -1.32e-01 | 8.33e-01 |
| GOBP BICARBONATE TRANSPORT | 28 | 2.28e-01 | -1.32e-01 | 5.74e-01 |
| GOMF INTRACELLULARLY LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 24 | 2.65e-01 | -1.32e-01 | 6.13e-01 |
| GOBP NUCLEAR TRANSPORT | 312 | 6.43e-05 | 1.32e-01 | 2.69e-03 |
| GOBP REGULATION OF ODONTOBLAST DIFFERENTIATION | 6 | 5.77e-01 | -1.32e-01 | 8.33e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 11 | 4.50e-01 | 1.32e-01 | 7.55e-01 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 16 | 3.63e-01 | 1.31e-01 | 6.98e-01 |
| GOCC LIPID DROPLET | 87 | 3.40e-02 | -1.31e-01 | 2.24e-01 |
| GOCC ACROSOMAL VESICLE | 91 | 3.03e-02 | -1.31e-01 | 2.11e-01 |
| GOBP REGULATION OF ALDOSTERONE METABOLIC PROCESS | 6 | 5.78e-01 | -1.31e-01 | 8.33e-01 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 37 | 1.67e-01 | -1.31e-01 | 5.00e-01 |
| GOMF GROWTH FACTOR BINDING | 107 | 1.90e-02 | -1.31e-01 | 1.64e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 192 | 1.72e-03 | -1.31e-01 | 3.43e-02 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 10 | 4.73e-01 | 1.31e-01 | 7.73e-01 |
| GOCC EUCHROMATIN | 49 | 1.12e-01 | 1.31e-01 | 4.10e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 37 | 1.68e-01 | 1.31e-01 | 5.01e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS | 6 | 5.78e-01 | -1.31e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 66 | 6.57e-02 | 1.31e-01 | 3.12e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 27 | 2.39e-01 | 1.31e-01 | 5.87e-01 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 39 | 1.57e-01 | 1.31e-01 | 4.84e-01 |
| GOBP GOLGI VESICLE BUDDING | 10 | 4.73e-01 | 1.31e-01 | 7.73e-01 |
| GOCC LYSOSOMAL LUMEN | 75 | 5.00e-02 | -1.31e-01 | 2.73e-01 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 269 | 2.20e-04 | 1.31e-01 | 7.28e-03 |
| GOBP ESTROGEN BIOSYNTHETIC PROCESS | 8 | 5.22e-01 | 1.31e-01 | 8.03e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 19 | 3.23e-01 | 1.31e-01 | 6.69e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 35 | 1.81e-01 | -1.31e-01 | 5.18e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 17 | 3.51e-01 | 1.31e-01 | 6.90e-01 |
| GOBP PHENOL CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 5.22e-01 | 1.31e-01 | 8.03e-01 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 174 | 2.92e-03 | -1.31e-01 | 4.95e-02 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 88 | 3.40e-02 | -1.31e-01 | 2.24e-01 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 111 | 1.74e-02 | -1.31e-01 | 1.55e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 9 | 4.97e-01 | -1.31e-01 | 7.89e-01 |
| GOCC WEIBEL PALADE BODY | 5 | 6.13e-01 | 1.31e-01 | 8.53e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 35 | 1.81e-01 | 1.31e-01 | 5.18e-01 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 7 | 5.50e-01 | -1.31e-01 | 8.22e-01 |
| GOBP MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 49 | 1.14e-01 | -1.31e-01 | 4.12e-01 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 29 | 2.23e-01 | -1.31e-01 | 5.69e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP | 5 | 6.13e-01 | 1.30e-01 | 8.53e-01 |
| GOBP PROTEIN PROCESSING | 182 | 2.40e-03 | -1.30e-01 | 4.31e-02 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 17 | 3.52e-01 | -1.30e-01 | 6.91e-01 |
| GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY | 6 | 5.80e-01 | -1.30e-01 | 8.34e-01 |
| GOBP MAST CELL MIGRATION | 10 | 4.75e-01 | 1.30e-01 | 7.74e-01 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 3.52e-01 | 1.30e-01 | 6.91e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 12 | 4.34e-01 | -1.30e-01 | 7.46e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 56 | 9.18e-02 | -1.30e-01 | 3.70e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 14 | 3.99e-01 | -1.30e-01 | 7.24e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 55 | 9.49e-02 | -1.30e-01 | 3.75e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 156 | 5.02e-03 | -1.30e-01 | 7.28e-02 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 96 | 2.76e-02 | 1.30e-01 | 2.01e-01 |
| GOMF ZINC ION BINDING | 683 | 6.68e-09 | 1.30e-01 | 9.47e-07 |
| GOBP CELL CYCLE PROCESS | 1119 | 2.10e-13 | 1.30e-01 | 1.03e-10 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 23 | 2.80e-01 | 1.30e-01 | 6.30e-01 |
| GOBP RESPONSE TO GRAM POSITIVE BACTERIUM | 5 | 6.15e-01 | 1.30e-01 | 8.54e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 21 | 3.03e-01 | 1.30e-01 | 6.52e-01 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 36 | 1.78e-01 | 1.30e-01 | 5.13e-01 |
| GOBP NUCLEAR EXPORT | 161 | 4.47e-03 | 1.30e-01 | 6.70e-02 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 14 | 4.00e-01 | 1.30e-01 | 7.25e-01 |
| GOCC CUTICULAR PLATE | 7 | 5.52e-01 | 1.30e-01 | 8.24e-01 |
| GOMF ALPHA ACTININ BINDING | 18 | 3.41e-01 | -1.30e-01 | 6.82e-01 |
| GOBP TRNA METHYLATION | 40 | 1.56e-01 | 1.30e-01 | 4.82e-01 |
| GOMF AMINE BINDING | 5 | 6.16e-01 | -1.30e-01 | 8.55e-01 |
| GOBP CLEAVAGE FURROW FORMATION | 7 | 5.53e-01 | -1.30e-01 | 8.24e-01 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 73 | 5.57e-02 | -1.30e-01 | 2.88e-01 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 46 | 1.29e-01 | 1.30e-01 | 4.39e-01 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 18 | 3.42e-01 | -1.29e-01 | 6.82e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 11 | 4.57e-01 | 1.29e-01 | 7.61e-01 |
| GOBP PROTEIN LIPOYLATION | 5 | 6.16e-01 | 1.29e-01 | 8.55e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 33 | 1.99e-01 | 1.29e-01 | 5.41e-01 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 26 | 2.54e-01 | -1.29e-01 | 6.02e-01 |
| GOBP ASPARAGINE METABOLIC PROCESS | 5 | 6.17e-01 | -1.29e-01 | 8.55e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 19 | 3.29e-01 | -1.29e-01 | 6.75e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 20 | 3.17e-01 | -1.29e-01 | 6.64e-01 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 15 | 3.87e-01 | -1.29e-01 | 7.16e-01 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 6.17e-01 | -1.29e-01 | 8.55e-01 |
| GOBP RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION | 7 | 5.54e-01 | -1.29e-01 | 8.24e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 10 | 4.80e-01 | -1.29e-01 | 7.78e-01 |
| GOBP SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 17 | 3.57e-01 | 1.29e-01 | 6.94e-01 |
| GOBP DNA METABOLIC PROCESS | 919 | 3.34e-11 | 1.29e-01 | 8.00e-09 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 34 | 1.93e-01 | 1.29e-01 | 5.35e-01 |
| GOMF SNRNA BINDING | 46 | 1.30e-01 | 1.29e-01 | 4.43e-01 |
| GOBP RESPONSE TO LITHIUM ION | 11 | 4.59e-01 | 1.29e-01 | 7.63e-01 |
| GOBP GENITALIA DEVELOPMENT | 27 | 2.47e-01 | -1.29e-01 | 5.94e-01 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 19 | 3.31e-01 | -1.29e-01 | 6.75e-01 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 23 | 2.85e-01 | 1.29e-01 | 6.34e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 8 | 5.28e-01 | -1.29e-01 | 8.07e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 93 | 3.20e-02 | -1.29e-01 | 2.17e-01 |
| GOBP CYTOPLASM ORGANIZATION | 13 | 4.22e-01 | 1.29e-01 | 7.40e-01 |
| GOCC SPECTRIN ASSOCIATED CYTOSKELETON | 8 | 5.29e-01 | 1.29e-01 | 8.07e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 87 | 3.81e-02 | -1.29e-01 | 2.37e-01 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 10 | 4.82e-01 | 1.29e-01 | 7.79e-01 |
| GOCC SARCOLEMMA | 111 | 1.95e-02 | -1.28e-01 | 1.66e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 12 | 4.42e-01 | 1.28e-01 | 7.51e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 17 | 3.60e-01 | -1.28e-01 | 6.96e-01 |
| GOBP RESPONSE TO LECTIN | 23 | 2.87e-01 | 1.28e-01 | 6.35e-01 |
| GOBP RECEPTOR CLUSTERING | 46 | 1.32e-01 | -1.28e-01 | 4.46e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 174 | 3.51e-03 | 1.28e-01 | 5.66e-02 |
| GOBP NETRIN ACTIVATED SIGNALING PATHWAY | 6 | 5.87e-01 | 1.28e-01 | 8.39e-01 |
| GOMF ER RETENTION SEQUENCE BINDING | 5 | 6.20e-01 | -1.28e-01 | 8.56e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 26 | 2.58e-01 | -1.28e-01 | 6.07e-01 |
| GOBP TRANSLATIONAL READTHROUGH | 8 | 5.31e-01 | 1.28e-01 | 8.08e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 11 | 4.62e-01 | 1.28e-01 | 7.66e-01 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 65 | 7.42e-02 | 1.28e-01 | 3.33e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 12 | 4.43e-01 | 1.28e-01 | 7.51e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 31 | 2.17e-01 | -1.28e-01 | 5.61e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 17 | 3.61e-01 | -1.28e-01 | 6.97e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 5 | 6.20e-01 | 1.28e-01 | 8.57e-01 |
| GOBP RRNA CATABOLIC PROCESS | 14 | 4.07e-01 | -1.28e-01 | 7.28e-01 |
| GOMF BMP BINDING | 11 | 4.63e-01 | -1.28e-01 | 7.66e-01 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 21 | 3.10e-01 | -1.28e-01 | 6.58e-01 |
| GOBP NEGATIVE REGULATION OF ACTION POTENTIAL | 6 | 5.88e-01 | 1.28e-01 | 8.39e-01 |
| GOBP REGULATION OF DENDRITE EXTENSION | 17 | 3.62e-01 | 1.28e-01 | 6.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 18 | 3.48e-01 | -1.28e-01 | 6.88e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 17 | 3.62e-01 | -1.28e-01 | 6.98e-01 |
| GOBP CHONDROCYTE HYPERTROPHY | 5 | 6.21e-01 | -1.28e-01 | 8.57e-01 |
| GOBP POTASSIUM ION TRANSPORT | 155 | 6.10e-03 | -1.28e-01 | 8.27e-02 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 60 | 8.73e-02 | -1.28e-01 | 3.59e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 23 | 2.90e-01 | -1.28e-01 | 6.38e-01 |
| GOBP CELL PROLIFERATION IN HINDBRAIN | 9 | 5.08e-01 | -1.28e-01 | 7.96e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 516 | 7.09e-07 | 1.28e-01 | 5.82e-05 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 49 | 1.23e-01 | -1.27e-01 | 4.28e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 134 | 1.08e-02 | -1.27e-01 | 1.20e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 13 | 4.26e-01 | -1.27e-01 | 7.42e-01 |
| GOMF LIGAND ACTIVATED TRANSCRIPTION FACTOR ACTIVITY | 39 | 1.69e-01 | 1.27e-01 | 5.02e-01 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 7 | 5.60e-01 | 1.27e-01 | 8.27e-01 |
| GOMF HORMONE RECEPTOR BINDING | 12 | 4.45e-01 | -1.27e-01 | 7.53e-01 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 10 | 4.86e-01 | -1.27e-01 | 7.83e-01 |
| GOBP GOLGI RIBBON FORMATION | 11 | 4.65e-01 | 1.27e-01 | 7.67e-01 |
| GOBP TOLL LIKE RECEPTOR 8 SIGNALING PATHWAY | 5 | 6.22e-01 | 1.27e-01 | 8.57e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 24 | 2.80e-01 | 1.27e-01 | 6.30e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 10 | 4.86e-01 | -1.27e-01 | 7.83e-01 |
| GOMF PROTEIN KINASE A BINDING | 45 | 1.40e-01 | 1.27e-01 | 4.58e-01 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 39 | 1.69e-01 | 1.27e-01 | 5.03e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 105 | 2.44e-02 | 1.27e-01 | 1.86e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 32 | 2.13e-01 | 1.27e-01 | 5.59e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 11 | 4.66e-01 | -1.27e-01 | 7.67e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 111 | 2.07e-02 | -1.27e-01 | 1.71e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 99 | 2.89e-02 | -1.27e-01 | 2.06e-01 |
| GOBP HEAT GENERATION | 14 | 4.10e-01 | -1.27e-01 | 7.31e-01 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 12 | 4.46e-01 | -1.27e-01 | 7.54e-01 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 8 | 5.34e-01 | 1.27e-01 | 8.11e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 8 | 5.34e-01 | 1.27e-01 | 8.11e-01 |
| GOBP PRIMARY ALCOHOL CATABOLIC PROCESS | 9 | 5.10e-01 | -1.27e-01 | 7.96e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 14 | 4.11e-01 | 1.27e-01 | 7.31e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 14 | 4.11e-01 | -1.27e-01 | 7.31e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 31 | 2.22e-01 | -1.27e-01 | 5.67e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 22 | 3.03e-01 | 1.27e-01 | 6.52e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 11 | 4.67e-01 | 1.27e-01 | 7.68e-01 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 5.91e-01 | -1.27e-01 | 8.40e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 87 | 4.11e-02 | -1.27e-01 | 2.46e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 25 | 2.73e-01 | 1.27e-01 | 6.23e-01 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 6 | 5.91e-01 | -1.27e-01 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 5.91e-01 | -1.27e-01 | 8.41e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 5.11e-01 | -1.27e-01 | 7.97e-01 |
| GOBP OSMOSENSORY SIGNALING PATHWAY | 8 | 5.35e-01 | -1.27e-01 | 8.12e-01 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 16 | 3.81e-01 | -1.26e-01 | 7.13e-01 |
| GOBP THYROID HORMONE GENERATION | 13 | 4.30e-01 | -1.26e-01 | 7.44e-01 |
| GOBP OVULATION CYCLE PROCESS | 33 | 2.09e-01 | 1.26e-01 | 5.54e-01 |
| GOBP LYMPHANGIOGENESIS | 12 | 4.49e-01 | -1.26e-01 | 7.55e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 29 | 2.39e-01 | -1.26e-01 | 5.87e-01 |
| GOCC NPBAF COMPLEX | 14 | 4.13e-01 | 1.26e-01 | 7.33e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 40 | 1.67e-01 | -1.26e-01 | 5.00e-01 |
| GOMF CERAMIDE BINDING | 18 | 3.54e-01 | -1.26e-01 | 6.93e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 12 | 4.49e-01 | -1.26e-01 | 7.55e-01 |
| GOBP REGULATION OF CYTOKINESIS | 80 | 5.11e-02 | 1.26e-01 | 2.76e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 107 | 2.42e-02 | -1.26e-01 | 1.86e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 19 | 3.41e-01 | -1.26e-01 | 6.82e-01 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 13 | 4.31e-01 | -1.26e-01 | 7.44e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 13 | 4.31e-01 | 1.26e-01 | 7.44e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 36 | 1.91e-01 | -1.26e-01 | 5.32e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 34 | 2.04e-01 | -1.26e-01 | 5.47e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 98 | 3.11e-02 | 1.26e-01 | 2.14e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 314 | 1.24e-04 | -1.26e-01 | 4.68e-03 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 7 | 5.64e-01 | 1.26e-01 | 8.29e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 97 | 3.23e-02 | -1.26e-01 | 2.17e-01 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 6.26e-01 | 1.26e-01 | 8.58e-01 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 13 | 4.33e-01 | 1.26e-01 | 7.45e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 51 | 1.20e-01 | 1.26e-01 | 4.24e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 34 | 2.05e-01 | -1.26e-01 | 5.48e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 25 | 2.77e-01 | -1.26e-01 | 6.26e-01 |
| GOMF ODORANT BINDING | 13 | 4.33e-01 | -1.25e-01 | 7.45e-01 |
| GOBP RNA STABILIZATION | 59 | 9.55e-02 | 1.25e-01 | 3.77e-01 |
| GOBP MELANOSOME ASSEMBLY | 19 | 3.44e-01 | 1.25e-01 | 6.84e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 33 | 2.12e-01 | -1.25e-01 | 5.59e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 10 | 4.92e-01 | -1.25e-01 | 7.85e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 49 | 1.29e-01 | 1.25e-01 | 4.40e-01 |
| GOBP TAXIS | 350 | 5.57e-05 | -1.25e-01 | 2.37e-03 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 99 | 3.11e-02 | -1.25e-01 | 2.14e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 49 | 1.29e-01 | 1.25e-01 | 4.40e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 42 | 1.60e-01 | -1.25e-01 | 4.88e-01 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 7 | 5.66e-01 | -1.25e-01 | 8.29e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 21 | 3.20e-01 | 1.25e-01 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 83 | 4.86e-02 | 1.25e-01 | 2.69e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 29 | 2.43e-01 | 1.25e-01 | 5.90e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 14 | 4.17e-01 | -1.25e-01 | 7.36e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL DIFFERENTIATION | 8 | 5.40e-01 | -1.25e-01 | 8.15e-01 |
| GOBP RESPONSE TO FATTY ACID | 43 | 1.55e-01 | -1.25e-01 | 4.81e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 76 | 5.91e-02 | -1.25e-01 | 2.96e-01 |
| GOBP PUTRESCINE BIOSYNTHETIC PROCESS | 5 | 6.28e-01 | -1.25e-01 | 8.58e-01 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 504 | 1.52e-06 | -1.25e-01 | 1.09e-04 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 11 | 4.73e-01 | -1.25e-01 | 7.73e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 38 | 1.82e-01 | -1.25e-01 | 5.19e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 37 | 1.88e-01 | -1.25e-01 | 5.29e-01 |
| GOBP PENTOSE METABOLIC PROCESS | 10 | 4.94e-01 | 1.25e-01 | 7.87e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 5 | 6.29e-01 | -1.25e-01 | 8.59e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 34 | 2.08e-01 | -1.25e-01 | 5.54e-01 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 239 | 8.97e-04 | -1.25e-01 | 2.12e-02 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 9 | 5.17e-01 | -1.25e-01 | 8.01e-01 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 14 | 4.19e-01 | -1.25e-01 | 7.38e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 32 | 2.22e-01 | -1.25e-01 | 5.67e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 5.68e-01 | 1.25e-01 | 8.30e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 13 | 4.36e-01 | -1.25e-01 | 7.48e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 755 | 5.54e-09 | -1.25e-01 | 8.09e-07 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 23 | 3.01e-01 | 1.25e-01 | 6.51e-01 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 18 | 3.60e-01 | -1.25e-01 | 6.97e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 98 | 3.31e-02 | 1.25e-01 | 2.20e-01 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 28 | 2.54e-01 | -1.25e-01 | 6.02e-01 |
| GOMF PHOSPHATE ION BINDING | 10 | 4.95e-01 | -1.25e-01 | 7.88e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 156 | 7.28e-03 | -1.24e-01 | 9.16e-02 |
| GOMF EXONUCLEASE ACTIVITY | 87 | 4.51e-02 | 1.24e-01 | 2.60e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 64 | 8.57e-02 | 1.24e-01 | 3.58e-01 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 12 | 4.56e-01 | 1.24e-01 | 7.60e-01 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 6 | 5.98e-01 | 1.24e-01 | 8.46e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 11 | 4.76e-01 | 1.24e-01 | 7.75e-01 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 7 | 5.70e-01 | -1.24e-01 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 15 | 4.06e-01 | -1.24e-01 | 7.27e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 208 | 2.04e-03 | -1.24e-01 | 3.84e-02 |
| GOBP POSITIVE REGULATION OF SODIUM PROTON ANTIPORTER ACTIVITY | 5 | 6.31e-01 | -1.24e-01 | 8.61e-01 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 8 | 5.44e-01 | -1.24e-01 | 8.18e-01 |
| GOMF FERRIC IRON BINDING | 7 | 5.70e-01 | -1.24e-01 | 8.30e-01 |
| GOBP CHROMOSOME LOCALIZATION | 113 | 2.30e-02 | 1.24e-01 | 1.80e-01 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 7 | 5.71e-01 | -1.24e-01 | 8.30e-01 |
| GOBP STORE OPERATED CALCIUM ENTRY | 19 | 3.50e-01 | -1.24e-01 | 6.90e-01 |
| GOCC RIPOPTOSOME | 6 | 6.00e-01 | 1.24e-01 | 8.46e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 9 | 5.20e-01 | 1.24e-01 | 8.02e-01 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 57 | 1.06e-01 | -1.24e-01 | 3.97e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 90 | 4.25e-02 | 1.24e-01 | 2.51e-01 |
| GOMF CYCLOSPORIN A BINDING | 16 | 3.92e-01 | 1.24e-01 | 7.20e-01 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 25 | 2.85e-01 | -1.24e-01 | 6.34e-01 |
| GOBP SEROTONIN TRANSPORT | 16 | 3.92e-01 | -1.23e-01 | 7.21e-01 |
| GOBP POLY N ACETYLLACTOSAMINE METABOLIC PROCESS | 7 | 5.72e-01 | -1.23e-01 | 8.31e-01 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 106 | 2.82e-02 | -1.23e-01 | 2.04e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 83 | 5.21e-02 | -1.23e-01 | 2.78e-01 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 61 | 9.59e-02 | 1.23e-01 | 3.77e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 5.00e-01 | -1.23e-01 | 7.91e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 5.46e-01 | -1.23e-01 | 8.20e-01 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 4.60e-01 | 1.23e-01 | 7.64e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE A2 ACTIVITY | 6 | 6.01e-01 | -1.23e-01 | 8.47e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 24 | 2.96e-01 | -1.23e-01 | 6.45e-01 |
| GOBP RNA CATABOLIC PROCESS | 278 | 4.09e-04 | 1.23e-01 | 1.15e-02 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 26 | 2.77e-01 | 1.23e-01 | 6.26e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 943 | 1.48e-10 | -1.23e-01 | 3.00e-08 |
| GOCC TRANSPORTER COMPLEX | 336 | 1.06e-04 | -1.23e-01 | 4.10e-03 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 35 | 2.08e-01 | -1.23e-01 | 5.53e-01 |
| GOCC PHAGOCYTIC VESICLE | 138 | 1.26e-02 | -1.23e-01 | 1.31e-01 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 65 | 8.64e-02 | -1.23e-01 | 3.58e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 54 | 1.18e-01 | -1.23e-01 | 4.19e-01 |
| GOBP REGULATION OF CELL CYCLE | 955 | 1.22e-10 | 1.23e-01 | 2.54e-08 |
| GOBP RECEPTOR CATABOLIC PROCESS | 26 | 2.78e-01 | 1.23e-01 | 6.27e-01 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 10 | 5.01e-01 | 1.23e-01 | 7.91e-01 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 10 | 5.01e-01 | -1.23e-01 | 7.91e-01 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 18 | 3.67e-01 | -1.23e-01 | 7.01e-01 |
| GOMF HEPARIN BINDING | 109 | 2.68e-02 | -1.23e-01 | 1.97e-01 |
| GOCC B CELL RECEPTOR COMPLEX | 5 | 6.35e-01 | -1.23e-01 | 8.63e-01 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 6.03e-01 | 1.23e-01 | 8.48e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 34 | 2.16e-01 | -1.23e-01 | 5.60e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 19 | 3.54e-01 | -1.23e-01 | 6.93e-01 |
| GOMF LAMININ BINDING | 23 | 3.09e-01 | -1.23e-01 | 6.56e-01 |
| GOBP CHOLESTEROL CATABOLIC PROCESS | 6 | 6.03e-01 | -1.23e-01 | 8.48e-01 |
| GOBP ACYL COA METABOLIC PROCESS | 84 | 5.23e-02 | -1.23e-01 | 2.78e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 28 | 2.62e-01 | -1.22e-01 | 6.11e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 38 | 1.92e-01 | -1.22e-01 | 5.33e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 9 | 5.25e-01 | -1.22e-01 | 8.05e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 67 | 8.34e-02 | 1.22e-01 | 3.52e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 11 | 4.82e-01 | 1.22e-01 | 7.80e-01 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 8 | 5.49e-01 | 1.22e-01 | 8.22e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 13 | 4.46e-01 | 1.22e-01 | 7.53e-01 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 6 | 6.05e-01 | 1.22e-01 | 8.49e-01 |
| GOCC PLASMA MEMBRANE RAFT | 92 | 4.30e-02 | -1.22e-01 | 2.53e-01 |
| GOBP VACUOLAR ACIDIFICATION | 33 | 2.25e-01 | -1.22e-01 | 5.70e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 20 | 3.45e-01 | -1.22e-01 | 6.85e-01 |
| GOMF TAP BINDING | 7 | 5.76e-01 | 1.22e-01 | 8.33e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 26 | 2.81e-01 | -1.22e-01 | 6.30e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 178 | 4.99e-03 | -1.22e-01 | 7.27e-02 |
| GOCC BASEMENT MEMBRANE | 64 | 9.16e-02 | -1.22e-01 | 3.70e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 6 | 6.05e-01 | -1.22e-01 | 8.49e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 146 | 1.10e-02 | 1.22e-01 | 1.21e-01 |
| GOCC CILIARY PLASM | 123 | 1.96e-02 | 1.22e-01 | 1.66e-01 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 50 | 1.36e-01 | -1.22e-01 | 4.52e-01 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 163 | 7.28e-03 | -1.22e-01 | 9.16e-02 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 7 | 5.77e-01 | 1.22e-01 | 8.33e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 10 | 5.05e-01 | -1.22e-01 | 7.94e-01 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 79 | 6.13e-02 | -1.22e-01 | 3.02e-01 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 24 | 3.02e-01 | 1.22e-01 | 6.51e-01 |
| GOBP PRO B CELL DIFFERENTIATION | 11 | 4.85e-01 | 1.22e-01 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 58 | 1.09e-01 | 1.22e-01 | 4.02e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 4.31e-01 | 1.22e-01 | 7.44e-01 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 99 | 3.65e-02 | 1.22e-01 | 2.31e-01 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 8 | 5.51e-01 | -1.22e-01 | 8.24e-01 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 3.59e-01 | -1.22e-01 | 6.95e-01 |
| GOBP CEREBELLAR GRANULAR LAYER MORPHOGENESIS | 6 | 6.06e-01 | -1.22e-01 | 8.50e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 4.00e-01 | 1.22e-01 | 7.25e-01 |
| GOCC PERICENTRIC HETEROCHROMATIN | 29 | 2.57e-01 | 1.22e-01 | 6.05e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 5 | 6.38e-01 | -1.22e-01 | 8.65e-01 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 14 | 4.31e-01 | 1.21e-01 | 7.44e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 200 | 3.06e-03 | -1.21e-01 | 5.12e-02 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 146 | 1.13e-02 | -1.21e-01 | 1.23e-01 |
| GOBP RESPONSE TO ATP | 27 | 2.75e-01 | -1.21e-01 | 6.25e-01 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 14 | 4.32e-01 | -1.21e-01 | 7.44e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 33 | 2.27e-01 | 1.21e-01 | 5.73e-01 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 8 | 5.52e-01 | 1.21e-01 | 8.24e-01 |
| GOMF ISOPRENOID BINDING | 14 | 4.32e-01 | -1.21e-01 | 7.44e-01 |
| GOBP VACUOLE FUSION | 11 | 4.86e-01 | -1.21e-01 | 7.83e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 7 | 5.78e-01 | 1.21e-01 | 8.33e-01 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 20 | 3.48e-01 | -1.21e-01 | 6.87e-01 |
| GOBP REPLICATIVE SENESCENCE | 16 | 4.01e-01 | 1.21e-01 | 7.25e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 18 | 3.74e-01 | 1.21e-01 | 7.06e-01 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 14 | 4.33e-01 | -1.21e-01 | 7.45e-01 |
| GOBP NEGATIVE REGULATION OF G0 TO G1 TRANSITION | 6 | 6.07e-01 | -1.21e-01 | 8.50e-01 |
| GOBP REGULATION OF CENTROSOME CYCLE | 51 | 1.35e-01 | 1.21e-01 | 4.50e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 29 | 2.59e-01 | -1.21e-01 | 6.08e-01 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 89 | 4.84e-02 | 1.21e-01 | 2.69e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 38 | 1.97e-01 | 1.21e-01 | 5.38e-01 |
| GOBP RESPONSE TO AXON INJURY | 60 | 1.05e-01 | -1.21e-01 | 3.95e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 28 | 2.68e-01 | -1.21e-01 | 6.17e-01 |
| GOCC CENTROSOME | 687 | 6.43e-08 | 1.21e-01 | 6.75e-06 |
| GOMF INSULIN BINDING | 5 | 6.40e-01 | 1.21e-01 | 8.65e-01 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 19 | 3.62e-01 | 1.21e-01 | 6.98e-01 |
| GOBP BLASTOCYST FORMATION | 36 | 2.09e-01 | 1.21e-01 | 5.55e-01 |
| GOMF OXO ACID LYASE ACTIVITY | 5 | 6.40e-01 | -1.21e-01 | 8.65e-01 |
| GOBP RESPONSE TO ESTRADIOL | 84 | 5.56e-02 | -1.21e-01 | 2.87e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 143 | 1.26e-02 | -1.21e-01 | 1.31e-01 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 17 | 3.89e-01 | -1.21e-01 | 7.17e-01 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 62 | 1.00e-01 | 1.21e-01 | 3.87e-01 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 21 | 3.38e-01 | -1.21e-01 | 6.81e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1479 | 8.25e-15 | 1.21e-01 | 6.43e-12 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 78 | 6.56e-02 | 1.21e-01 | 3.12e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 16 | 4.04e-01 | -1.20e-01 | 7.27e-01 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 11 | 4.89e-01 | 1.20e-01 | 7.85e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 11 | 4.89e-01 | 1.20e-01 | 7.85e-01 |
| GOMF KINASE INHIBITOR ACTIVITY | 74 | 7.35e-02 | -1.20e-01 | 3.32e-01 |
| GOCC PROTEASE INHIBITOR COMPLEX | 6 | 6.10e-01 | -1.20e-01 | 8.52e-01 |
| GOBP POSITIVE REGULATION OF COA TRANSFERASE ACTIVITY | 5 | 6.41e-01 | -1.20e-01 | 8.66e-01 |
| GOBP REGULATION OF COA TRANSFERASE ACTIVITY | 5 | 6.41e-01 | -1.20e-01 | 8.66e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 158 | 9.09e-03 | -1.20e-01 | 1.07e-01 |
| GOBP ACROSOME REACTION | 21 | 3.41e-01 | 1.20e-01 | 6.82e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 6.10e-01 | -1.20e-01 | 8.52e-01 |
| GOMF GAMMA TUBULIN BINDING | 33 | 2.32e-01 | 1.20e-01 | 5.79e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 31 | 2.48e-01 | 1.20e-01 | 5.95e-01 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 10 | 5.11e-01 | 1.20e-01 | 7.97e-01 |
| GOBP NEGATIVE REGULATION OF CELL FATE COMMITMENT | 5 | 6.42e-01 | -1.20e-01 | 8.66e-01 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 53 | 1.31e-01 | -1.20e-01 | 4.43e-01 |
| GOBP CIRCADIAN RHYTHM | 158 | 9.32e-03 | 1.20e-01 | 1.09e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 26 | 2.90e-01 | 1.20e-01 | 6.38e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 20 | 3.53e-01 | -1.20e-01 | 6.93e-01 |
| GOCC MALE GERM CELL NUCLEUS | 43 | 1.74e-01 | 1.20e-01 | 5.09e-01 |
| GOBP NUCLEOBASE TRANSPORT | 12 | 4.72e-01 | -1.20e-01 | 7.73e-01 |
| GOBP CELLULAR RESPONSE TO VIRUS | 54 | 1.28e-01 | 1.20e-01 | 4.38e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX 2 | 5 | 6.43e-01 | -1.20e-01 | 8.67e-01 |
| GOBP REGULATORY NCRNA MEDIATED HETEROCHROMATIN FORMATION | 11 | 4.92e-01 | 1.20e-01 | 7.85e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 30 | 2.57e-01 | 1.20e-01 | 6.04e-01 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 172 | 6.78e-03 | -1.20e-01 | 8.76e-02 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 12 | 4.73e-01 | -1.20e-01 | 7.73e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 22 | 3.32e-01 | 1.20e-01 | 6.76e-01 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 7 | 5.84e-01 | -1.20e-01 | 8.37e-01 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 992 | 1.88e-10 | 1.19e-01 | 3.59e-08 |
| GOBP MOLTING CYCLE PROCESS | 59 | 1.12e-01 | 1.19e-01 | 4.10e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 14 | 4.40e-01 | 1.19e-01 | 7.50e-01 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 84 | 5.88e-02 | -1.19e-01 | 2.95e-01 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 6 | 6.13e-01 | -1.19e-01 | 8.53e-01 |
| GOCC VARICOSITY | 6 | 6.13e-01 | -1.19e-01 | 8.53e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 594 | 6.90e-07 | -1.19e-01 | 5.71e-05 |
| GOMF DNA EXONUCLEASE ACTIVITY | 25 | 3.02e-01 | 1.19e-01 | 6.52e-01 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 183 | 5.44e-03 | -1.19e-01 | 7.71e-02 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 8 | 5.60e-01 | -1.19e-01 | 8.27e-01 |
| GOBP FEAR RESPONSE | 32 | 2.44e-01 | 1.19e-01 | 5.90e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 175 | 6.58e-03 | -1.19e-01 | 8.64e-02 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 6 | 6.14e-01 | 1.19e-01 | 8.53e-01 |
| GOBP ORGAN GROWTH | 119 | 2.49e-02 | 1.19e-01 | 1.88e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 9 | 5.36e-01 | -1.19e-01 | 8.12e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 470 | 9.79e-06 | -1.19e-01 | 5.67e-04 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 10 | 5.15e-01 | -1.19e-01 | 7.98e-01 |
| GOBP ENDOCARDIUM DEVELOPMENT | 7 | 5.86e-01 | 1.19e-01 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 24 | 3.13e-01 | -1.19e-01 | 6.60e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 68 | 9.00e-02 | 1.19e-01 | 3.66e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 28 | 2.76e-01 | -1.19e-01 | 6.26e-01 |
| GOCC SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX | 76 | 7.32e-02 | 1.19e-01 | 3.31e-01 |
| GOBP GLUTAMINE TRANSPORT | 8 | 5.61e-01 | -1.19e-01 | 8.27e-01 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 5.61e-01 | -1.19e-01 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 27 | 2.85e-01 | -1.19e-01 | 6.34e-01 |
| GOBP UTERUS DEVELOPMENT | 15 | 4.26e-01 | 1.19e-01 | 7.42e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 27 | 2.85e-01 | -1.19e-01 | 6.34e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 25 | 3.04e-01 | -1.19e-01 | 6.53e-01 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 32 | 2.45e-01 | 1.19e-01 | 5.92e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 74 | 7.76e-02 | 1.19e-01 | 3.41e-01 |
| GOBP EMBRYONIC HEMOPOIESIS | 21 | 3.47e-01 | -1.19e-01 | 6.87e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 131 | 1.92e-02 | -1.19e-01 | 1.64e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 69 | 8.88e-02 | -1.18e-01 | 3.64e-01 |
| GOMF NEUROPEPTIDE BINDING | 13 | 4.60e-01 | 1.18e-01 | 7.64e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 12 | 4.77e-01 | -1.18e-01 | 7.76e-01 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 12 | 4.77e-01 | -1.18e-01 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 19 | 3.71e-01 | -1.18e-01 | 7.04e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 20 | 3.59e-01 | -1.18e-01 | 6.95e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 65 | 9.88e-02 | -1.18e-01 | 3.84e-01 |
| GOCC PSEUDOPODIUM | 16 | 4.12e-01 | -1.18e-01 | 7.32e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 4.43e-01 | 1.18e-01 | 7.51e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 105 | 3.62e-02 | -1.18e-01 | 2.30e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 6 | 6.16e-01 | -1.18e-01 | 8.55e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 205 | 3.50e-03 | -1.18e-01 | 5.65e-02 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 57 | 1.22e-01 | -1.18e-01 | 4.28e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 432 | 2.48e-05 | 1.18e-01 | 1.25e-03 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 18 | 3.85e-01 | 1.18e-01 | 7.15e-01 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 27 | 2.88e-01 | 1.18e-01 | 6.35e-01 |
| GOCC SPINDLE POLE | 171 | 7.68e-03 | 1.18e-01 | 9.55e-02 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 17 | 3.99e-01 | -1.18e-01 | 7.24e-01 |
| GOCC MALE PRONUCLEUS | 7 | 5.88e-01 | 1.18e-01 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 8 | 5.63e-01 | -1.18e-01 | 8.28e-01 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 23 | 3.27e-01 | -1.18e-01 | 6.72e-01 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 18 | 3.86e-01 | 1.18e-01 | 7.15e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 56 | 1.26e-01 | -1.18e-01 | 4.36e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE | 7 | 5.89e-01 | -1.18e-01 | 8.40e-01 |
| GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 6 | 6.17e-01 | -1.18e-01 | 8.55e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 283 | 6.48e-04 | 1.18e-01 | 1.63e-02 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 1.27e-01 | -1.18e-01 | 4.38e-01 |
| GOBP HEART FORMATION | 19 | 3.74e-01 | 1.18e-01 | 7.06e-01 |
| GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE | 5 | 6.49e-01 | -1.18e-01 | 8.69e-01 |
| GOMF CYCLIC NUCLEOTIDE ACTIVATED MONOATOMIC ION CHANNEL ACTIVITY | 6 | 6.18e-01 | -1.18e-01 | 8.56e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 52 | 1.42e-01 | -1.18e-01 | 4.61e-01 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 32 | 2.50e-01 | 1.18e-01 | 5.98e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 8 | 5.65e-01 | 1.18e-01 | 8.29e-01 |
| GOBP LIPID EXPORT FROM CELL | 36 | 2.22e-01 | -1.17e-01 | 5.68e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 7 | 5.90e-01 | -1.17e-01 | 8.40e-01 |
| GOBP IRON ION TRANSPORT | 50 | 1.51e-01 | -1.17e-01 | 4.75e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 17 | 4.02e-01 | -1.17e-01 | 7.26e-01 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 23 | 3.30e-01 | 1.17e-01 | 6.75e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 25 | 3.10e-01 | 1.17e-01 | 6.57e-01 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 20 | 3.64e-01 | 1.17e-01 | 6.99e-01 |
| GOBP ENDOSOMAL VESICLE FUSION | 15 | 4.32e-01 | 1.17e-01 | 7.44e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 33 | 2.44e-01 | 1.17e-01 | 5.90e-01 |
| GOBP RESPONSE TO VIRUS | 349 | 1.69e-04 | 1.17e-01 | 5.91e-03 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 9 | 5.43e-01 | 1.17e-01 | 8.17e-01 |
| GOMF SUMO LIGASE ACTIVITY | 13 | 4.65e-01 | 1.17e-01 | 7.67e-01 |
| GOMF VINCULIN BINDING | 11 | 5.02e-01 | 1.17e-01 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 8 | 5.67e-01 | -1.17e-01 | 8.29e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 77 | 7.59e-02 | 1.17e-01 | 3.37e-01 |
| GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB | 6 | 6.20e-01 | -1.17e-01 | 8.56e-01 |
| GOMF ESTROGEN 16 ALPHA HYDROXYLASE ACTIVITY | 5 | 6.51e-01 | 1.17e-01 | 8.70e-01 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 14 | 4.49e-01 | 1.17e-01 | 7.55e-01 |
| GOBP NEURAL TUBE FORMATION | 86 | 6.09e-02 | 1.17e-01 | 3.01e-01 |
| GOBP RESPONSE TO VITAMIN D | 28 | 2.84e-01 | -1.17e-01 | 6.34e-01 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 11 | 5.02e-01 | -1.17e-01 | 7.92e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 349 | 1.76e-04 | -1.17e-01 | 6.07e-03 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 582 | 1.46e-06 | -1.17e-01 | 1.06e-04 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 9 | 5.44e-01 | -1.17e-01 | 8.18e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 38 | 2.13e-01 | 1.17e-01 | 5.59e-01 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 23 | 3.33e-01 | -1.17e-01 | 6.77e-01 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 173 | 8.09e-03 | -1.17e-01 | 9.91e-02 |
| GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 6.51e-01 | -1.17e-01 | 8.70e-01 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 6 | 6.21e-01 | -1.17e-01 | 8.57e-01 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 358 | 1.48e-04 | -1.17e-01 | 5.32e-03 |
| GOBP EXPLORATION BEHAVIOR | 22 | 3.44e-01 | 1.17e-01 | 6.84e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 68 | 9.63e-02 | 1.17e-01 | 3.78e-01 |
| GOCC CELL CELL CONTACT ZONE | 61 | 1.15e-01 | -1.17e-01 | 4.15e-01 |
| GOBP OSTEOCLAST DIFFERENTIATION | 87 | 6.01e-02 | -1.17e-01 | 2.99e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 81 | 6.99e-02 | 1.17e-01 | 3.21e-01 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1504 | 4.14e-14 | -1.17e-01 | 2.42e-11 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 17 | 4.06e-01 | -1.16e-01 | 7.27e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 29 | 2.78e-01 | -1.16e-01 | 6.26e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 16 | 4.20e-01 | -1.16e-01 | 7.38e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 22 | 3.44e-01 | -1.16e-01 | 6.85e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 25 | 3.14e-01 | -1.16e-01 | 6.61e-01 |
| GOBP HARD PALATE DEVELOPMENT | 5 | 6.52e-01 | -1.16e-01 | 8.70e-01 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 5.94e-01 | -1.16e-01 | 8.42e-01 |
| GOMF ADP PHOSPHATASE ACTIVITY | 6 | 6.22e-01 | -1.16e-01 | 8.57e-01 |
| GOBP URIDINE TRANSMEMBRANE TRANSPORT | 5 | 6.52e-01 | -1.16e-01 | 8.70e-01 |
| GOBP ERYTHROCYTE MATURATION | 19 | 3.80e-01 | -1.16e-01 | 7.12e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 34 | 2.41e-01 | -1.16e-01 | 5.89e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 34 | 2.41e-01 | 1.16e-01 | 5.89e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 14 | 4.51e-01 | 1.16e-01 | 7.57e-01 |
| GOMF CARBOXY LYASE ACTIVITY | 28 | 2.87e-01 | -1.16e-01 | 6.35e-01 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 6.22e-01 | -1.16e-01 | 8.57e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 48 | 1.64e-01 | 1.16e-01 | 4.95e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 6 | 6.22e-01 | -1.16e-01 | 8.57e-01 |
| GOCC MPP7 DLG1 LIN7 COMPLEX | 5 | 6.53e-01 | -1.16e-01 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1197 | 1.31e-11 | 1.16e-01 | 3.50e-09 |
| GOBP LEUKOCYTE MIGRATION | 318 | 3.71e-04 | -1.16e-01 | 1.08e-02 |
| GOBP METANEPHRIC TUBULE MORPHOGENESIS | 6 | 6.22e-01 | -1.16e-01 | 8.57e-01 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 108 | 3.72e-02 | -1.16e-01 | 2.34e-01 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 9 | 5.47e-01 | -1.16e-01 | 8.20e-01 |
| GOMF PROTEIN KINASE B BINDING | 9 | 5.47e-01 | 1.16e-01 | 8.20e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 54 | 1.40e-01 | 1.16e-01 | 4.59e-01 |
| GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 6 | 6.23e-01 | -1.16e-01 | 8.57e-01 |
| GOBP LEUKOTRIENE D4 BIOSYNTHETIC PROCESS | 5 | 6.54e-01 | 1.16e-01 | 8.71e-01 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 72 | 8.92e-02 | -1.16e-01 | 3.64e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 6.54e-01 | -1.16e-01 | 8.71e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 15 | 4.37e-01 | 1.16e-01 | 7.49e-01 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 12 | 4.87e-01 | -1.16e-01 | 7.83e-01 |
| GOBP MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY | 6 | 6.23e-01 | 1.16e-01 | 8.57e-01 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 12 | 4.87e-01 | -1.16e-01 | 7.83e-01 |
| GOCC VESICLE TETHERING COMPLEX | 66 | 1.04e-01 | 1.16e-01 | 3.93e-01 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 5.71e-01 | -1.16e-01 | 8.30e-01 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 5.71e-01 | -1.16e-01 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 7 | 5.96e-01 | -1.16e-01 | 8.44e-01 |
| GOMF RIBONUCLEASE P ACTIVITY | 12 | 4.88e-01 | -1.16e-01 | 7.84e-01 |
| GOMF NAD BINDING | 51 | 1.53e-01 | -1.16e-01 | 4.78e-01 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 6.24e-01 | -1.16e-01 | 8.57e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 52 | 1.50e-01 | -1.15e-01 | 4.75e-01 |
| GOBP REGULATION OF NK T CELL DIFFERENTIATION | 6 | 6.24e-01 | -1.15e-01 | 8.57e-01 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 8 | 5.72e-01 | 1.15e-01 | 8.31e-01 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 18 | 3.97e-01 | -1.15e-01 | 7.23e-01 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 9 | 5.49e-01 | -1.15e-01 | 8.22e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 17 | 4.10e-01 | -1.15e-01 | 7.31e-01 |
| GOCC U2AF COMPLEX | 6 | 6.25e-01 | -1.15e-01 | 8.57e-01 |
| GOBP CD40 SIGNALING PATHWAY | 14 | 4.55e-01 | 1.15e-01 | 7.60e-01 |
| GOBP MITOCHONDRIAL TRANSPORT | 168 | 9.96e-03 | -1.15e-01 | 1.13e-01 |
| GOCC TRAPPII PROTEIN COMPLEX | 12 | 4.90e-01 | 1.15e-01 | 7.85e-01 |
| GOBP VESICLE TRANSPORT ALONG ACTIN FILAMENT | 8 | 5.73e-01 | 1.15e-01 | 8.31e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 159 | 1.23e-02 | 1.15e-01 | 1.29e-01 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 32 | 2.60e-01 | 1.15e-01 | 6.08e-01 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 16 | 4.26e-01 | -1.15e-01 | 7.42e-01 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 291 | 7.38e-04 | 1.15e-01 | 1.80e-02 |
| GOBP PROTEIN POLYUBIQUITINATION | 251 | 1.71e-03 | 1.15e-01 | 3.43e-02 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 5.09e-01 | -1.15e-01 | 7.96e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 7 | 5.99e-01 | -1.15e-01 | 8.46e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 182 | 7.50e-03 | 1.15e-01 | 9.35e-02 |
| GOBP MELANOCYTE DIFFERENTIATION | 16 | 4.26e-01 | -1.15e-01 | 7.42e-01 |
| GOBP ORGANELLE INHERITANCE | 15 | 4.41e-01 | -1.15e-01 | 7.51e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 27 | 3.02e-01 | -1.15e-01 | 6.51e-01 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 22 | 3.52e-01 | -1.15e-01 | 6.91e-01 |
| GOBP CELL MATRIX ADHESION | 191 | 6.25e-03 | -1.15e-01 | 8.38e-02 |
| GOMF MODIFIED AMINO ACID BINDING | 78 | 7.99e-02 | -1.15e-01 | 3.45e-01 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 267 | 1.25e-03 | 1.15e-01 | 2.70e-02 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 6 | 6.27e-01 | -1.15e-01 | 8.58e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 49 | 1.65e-01 | -1.15e-01 | 4.97e-01 |
| GOBP PLACENTA DEVELOPMENT | 112 | 3.61e-02 | -1.15e-01 | 2.30e-01 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 7 | 5.99e-01 | 1.15e-01 | 8.46e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 15 | 4.42e-01 | -1.15e-01 | 7.51e-01 |
| GOBP TISSUE MIGRATION | 252 | 1.73e-03 | -1.15e-01 | 3.45e-02 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 16 | 4.27e-01 | 1.15e-01 | 7.43e-01 |
| GOBP REGULATION OF T CELL EXTRAVASATION | 6 | 6.27e-01 | 1.15e-01 | 8.58e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 6.57e-01 | 1.15e-01 | 8.72e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 57 | 1.35e-01 | 1.14e-01 | 4.50e-01 |
| GOBP CEREBROSPINAL FLUID CIRCULATION | 9 | 5.52e-01 | 1.14e-01 | 8.24e-01 |
| GOBP PIGMENT CELL DIFFERENTIATION | 27 | 3.03e-01 | -1.14e-01 | 6.52e-01 |
| GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 8 | 5.75e-01 | -1.14e-01 | 8.33e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 118 | 3.18e-02 | -1.14e-01 | 2.16e-01 |
| GOMF LRR DOMAIN BINDING | 16 | 4.28e-01 | -1.14e-01 | 7.43e-01 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 9 | 5.52e-01 | -1.14e-01 | 8.24e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 99 | 4.92e-02 | -1.14e-01 | 2.71e-01 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 48 | 1.71e-01 | -1.14e-01 | 5.05e-01 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 16 | 4.29e-01 | 1.14e-01 | 7.43e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 23 | 3.43e-01 | -1.14e-01 | 6.84e-01 |
| GOBP CONVERGENT EXTENSION | 11 | 5.12e-01 | 1.14e-01 | 7.97e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 16 | 4.29e-01 | 1.14e-01 | 7.44e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 120 | 3.08e-02 | -1.14e-01 | 2.13e-01 |
| GOBP LIPID CATABOLIC PROCESS | 269 | 1.28e-03 | -1.14e-01 | 2.74e-02 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 15 | 4.44e-01 | -1.14e-01 | 7.53e-01 |
| GOBP RNA PROCESSING | 927 | 4.01e-09 | 1.14e-01 | 6.04e-07 |
| GOBP CELL CYCLE | 1425 | 5.64e-13 | 1.14e-01 | 2.64e-10 |
| GOBP PROTEIN POLYGLUTAMYLATION | 10 | 5.33e-01 | -1.14e-01 | 8.10e-01 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 15 | 4.45e-01 | -1.14e-01 | 7.53e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 19 | 3.90e-01 | 1.14e-01 | 7.18e-01 |
| GOBP BONE RESORPTION | 51 | 1.59e-01 | -1.14e-01 | 4.88e-01 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 20 | 3.78e-01 | -1.14e-01 | 7.10e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 22 | 3.55e-01 | 1.14e-01 | 6.93e-01 |
| GOCC CILIARY BASE | 38 | 2.25e-01 | 1.14e-01 | 5.70e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 16 | 4.31e-01 | 1.14e-01 | 7.44e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 37 | 2.31e-01 | 1.14e-01 | 5.78e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 16 | 4.31e-01 | -1.14e-01 | 7.44e-01 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 469 | 2.45e-05 | 1.14e-01 | 1.24e-03 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 12 | 4.96e-01 | -1.14e-01 | 7.88e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 121 | 3.09e-02 | 1.14e-01 | 2.13e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 34 | 2.52e-01 | -1.14e-01 | 5.99e-01 |
| GOBP MESODERMAL CELL FATE SPECIFICATION | 5 | 6.60e-01 | -1.14e-01 | 8.73e-01 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 546 | 5.72e-06 | -1.13e-01 | 3.54e-04 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 7 | 6.03e-01 | -1.13e-01 | 8.48e-01 |
| GOCC CIS GOLGI NETWORK | 61 | 1.25e-01 | 1.13e-01 | 4.34e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 19 | 3.92e-01 | 1.13e-01 | 7.21e-01 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 6 | 6.31e-01 | 1.13e-01 | 8.60e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 8 | 5.79e-01 | 1.13e-01 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 7 | 6.04e-01 | 1.13e-01 | 8.48e-01 |
| GOBP PARANODAL JUNCTION ASSEMBLY | 6 | 6.31e-01 | 1.13e-01 | 8.61e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 54 | 1.50e-01 | 1.13e-01 | 4.75e-01 |
| GOCC U2 SNRNP | 25 | 3.27e-01 | 1.13e-01 | 6.73e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 31 | 2.76e-01 | 1.13e-01 | 6.26e-01 |
| GOBP NEGATIVE REGULATION OF BEHAVIOR | 8 | 5.80e-01 | 1.13e-01 | 8.33e-01 |
| GOBP CELLULAR RESPONSE TO PH | 17 | 4.20e-01 | 1.13e-01 | 7.38e-01 |
| GOCC GOLGI CIS CISTERNA | 19 | 3.94e-01 | 1.13e-01 | 7.21e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 15 | 4.49e-01 | -1.13e-01 | 7.55e-01 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 30 | 2.84e-01 | -1.13e-01 | 6.34e-01 |
| GOBP REGULATION OF HIPPO SIGNALING | 33 | 2.61e-01 | 1.13e-01 | 6.10e-01 |
| GOBP NEUTROPHIL DIFFERENTIATION | 10 | 5.37e-01 | 1.13e-01 | 8.12e-01 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 6 | 6.32e-01 | -1.13e-01 | 8.61e-01 |
| GOBP REGULATION OF MICROTUBULE BINDING | 7 | 6.05e-01 | -1.13e-01 | 8.49e-01 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 30 | 2.85e-01 | -1.13e-01 | 6.34e-01 |
| GOMF MYOSIN V BINDING | 14 | 4.65e-01 | -1.13e-01 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 6.32e-01 | 1.13e-01 | 8.62e-01 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 5 | 6.62e-01 | -1.13e-01 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 12 | 4.99e-01 | 1.13e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 70 | 1.03e-01 | 1.13e-01 | 3.92e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 131 | 2.60e-02 | -1.13e-01 | 1.94e-01 |
| GOBP BILE ACID METABOLIC PROCESS | 36 | 2.42e-01 | -1.13e-01 | 5.90e-01 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 90 | 6.49e-02 | -1.13e-01 | 3.11e-01 |
| GOBP REGULATION OF WOUND HEALING | 97 | 5.55e-02 | -1.13e-01 | 2.87e-01 |
| GOBP INTERKINETIC NUCLEAR MIGRATION | 5 | 6.63e-01 | 1.12e-01 | 8.74e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 330 | 4.50e-04 | -1.12e-01 | 1.25e-02 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 56 | 1.46e-01 | 1.12e-01 | 4.67e-01 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 37 | 2.37e-01 | 1.12e-01 | 5.85e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 24 | 3.41e-01 | 1.12e-01 | 6.82e-01 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 9 | 5.60e-01 | -1.12e-01 | 8.27e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 5.01e-01 | 1.12e-01 | 7.91e-01 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 14 | 4.67e-01 | -1.12e-01 | 7.68e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 18 | 4.10e-01 | -1.12e-01 | 7.31e-01 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 11 | 5.19e-01 | -1.12e-01 | 8.02e-01 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 272 | 1.46e-03 | -1.12e-01 | 3.05e-02 |
| GOBP NEUROTRANSMITTER REUPTAKE | 22 | 3.63e-01 | -1.12e-01 | 6.98e-01 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 6.35e-01 | 1.12e-01 | 8.63e-01 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 31 | 2.81e-01 | -1.12e-01 | 6.30e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 46 | 1.90e-01 | 1.12e-01 | 5.30e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 22 | 3.64e-01 | 1.12e-01 | 6.99e-01 |
| GOBP KINETOCHORE ASSEMBLY | 17 | 4.25e-01 | 1.12e-01 | 7.42e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 54 | 1.56e-01 | -1.12e-01 | 4.81e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 34 | 2.60e-01 | 1.12e-01 | 6.08e-01 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 83 | 7.88e-02 | -1.12e-01 | 3.44e-01 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 70 | 1.06e-01 | 1.12e-01 | 3.97e-01 |
| GOCC VACUOLE | 777 | 1.22e-07 | -1.12e-01 | 1.18e-05 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 41 | 2.17e-01 | -1.12e-01 | 5.61e-01 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 22 | 3.65e-01 | 1.11e-01 | 6.99e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 6 | 6.36e-01 | 1.11e-01 | 8.64e-01 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 18 | 4.13e-01 | -1.11e-01 | 7.33e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 22 | 3.66e-01 | -1.11e-01 | 6.99e-01 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 316 | 6.70e-04 | -1.11e-01 | 1.66e-02 |
| GOBP SLEEP | 15 | 4.56e-01 | 1.11e-01 | 7.60e-01 |
| GOBP HORMONE METABOLIC PROCESS | 148 | 1.95e-02 | -1.11e-01 | 1.66e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 15 | 4.56e-01 | 1.11e-01 | 7.60e-01 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 59 | 1.40e-01 | 1.11e-01 | 4.58e-01 |
| GOBP REGULATION OF AXON GUIDANCE | 6 | 6.37e-01 | -1.11e-01 | 8.64e-01 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 25 | 3.36e-01 | 1.11e-01 | 6.79e-01 |
| GOMF HEAT SHOCK PROTEIN BINDING | 117 | 3.78e-02 | 1.11e-01 | 2.36e-01 |
| GOBP PLATELET DEGRANULATION | 7 | 6.11e-01 | -1.11e-01 | 8.52e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 384 | 1.87e-04 | 1.11e-01 | 6.32e-03 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 5.64e-01 | 1.11e-01 | 8.29e-01 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 22 | 3.67e-01 | 1.11e-01 | 7.01e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 27 | 3.18e-01 | 1.11e-01 | 6.65e-01 |
| GOBP DOPAMINE SECRETION | 17 | 4.28e-01 | -1.11e-01 | 7.43e-01 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 10 | 5.43e-01 | -1.11e-01 | 8.18e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 9 | 5.64e-01 | -1.11e-01 | 8.29e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 207 | 5.94e-03 | -1.11e-01 | 8.16e-02 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 65 | 1.22e-01 | -1.11e-01 | 4.28e-01 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 9 | 5.65e-01 | -1.11e-01 | 8.29e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 157 | 1.65e-02 | -1.11e-01 | 1.53e-01 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 25 | 3.37e-01 | 1.11e-01 | 6.79e-01 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 143 | 2.22e-02 | 1.11e-01 | 1.76e-01 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 13 | 4.89e-01 | 1.11e-01 | 7.85e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 7 | 6.12e-01 | 1.11e-01 | 8.53e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 120 | 3.62e-02 | 1.11e-01 | 2.31e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 129 | 2.99e-02 | -1.11e-01 | 2.10e-01 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 30 | 2.94e-01 | 1.11e-01 | 6.43e-01 |
| GOCC LAMIN FILAMENT | 5 | 6.68e-01 | -1.11e-01 | 8.77e-01 |
| GOCC MITOTIC SPINDLE | 170 | 1.28e-02 | 1.11e-01 | 1.32e-01 |
| GOBP MITOTIC NUCLEAR DIVISION | 261 | 2.09e-03 | 1.11e-01 | 3.90e-02 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 27 | 3.20e-01 | -1.11e-01 | 6.66e-01 |
| GOBP TYPE II HYPERSENSITIVITY | 9 | 5.66e-01 | -1.11e-01 | 8.29e-01 |
| GOBP RESPONSE TO ETHANOL | 88 | 7.31e-02 | -1.11e-01 | 3.31e-01 |
| GOBP ORGANELLE FISSION | 422 | 9.82e-05 | 1.11e-01 | 3.86e-03 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 194 | 7.94e-03 | -1.11e-01 | 9.80e-02 |
| GOBP MICROVILLUS ASSEMBLY | 21 | 3.81e-01 | 1.10e-01 | 7.13e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MATURATION | 6 | 6.39e-01 | -1.10e-01 | 8.65e-01 |
| GOMF REGULATORY RNA BINDING | 47 | 1.90e-01 | 1.10e-01 | 5.31e-01 |
| GOMF DNA POLYMERASE BINDING | 20 | 3.93e-01 | 1.10e-01 | 7.21e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 126 | 3.24e-02 | -1.10e-01 | 2.18e-01 |
| GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 11 | 5.26e-01 | -1.10e-01 | 8.06e-01 |
| GOCC PRESYNAPTIC CYTOSOL | 12 | 5.08e-01 | 1.10e-01 | 7.96e-01 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 8 | 5.89e-01 | 1.10e-01 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 138 | 2.53e-02 | 1.10e-01 | 1.90e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 44 | 2.06e-01 | 1.10e-01 | 5.50e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 8 | 5.90e-01 | -1.10e-01 | 8.40e-01 |
| GOMF XMP 5 NUCLEOSIDASE ACTIVITY | 6 | 6.40e-01 | -1.10e-01 | 8.66e-01 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 6.70e-01 | 1.10e-01 | 8.78e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 92 | 6.79e-02 | -1.10e-01 | 3.17e-01 |
| GOBP DOPAMINE METABOLIC PROCESS | 25 | 3.41e-01 | 1.10e-01 | 6.82e-01 |
| GOBP MALE SEX DIFFERENTIATION | 121 | 3.65e-02 | -1.10e-01 | 2.31e-01 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 31 | 2.89e-01 | -1.10e-01 | 6.37e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 23 | 3.61e-01 | -1.10e-01 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 29 | 3.06e-01 | -1.10e-01 | 6.53e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 242 | 3.22e-03 | 1.10e-01 | 5.29e-02 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 33 | 2.75e-01 | -1.10e-01 | 6.25e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 18 | 4.20e-01 | 1.10e-01 | 7.38e-01 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 19 | 4.07e-01 | -1.10e-01 | 7.29e-01 |
| GOMF ALL TRANS RETINOL DEHYDROGENASE NADPPLUS ACTIVITY | 11 | 5.28e-01 | -1.10e-01 | 8.07e-01 |
| GOMF VITAMIN B6 BINDING | 45 | 2.03e-01 | -1.10e-01 | 5.46e-01 |
| GOBP FUCOSE CATABOLIC PROCESS | 6 | 6.42e-01 | -1.10e-01 | 8.66e-01 |
| GOBP LATE ENDOSOME TO GOLGI TRANSPORT | 5 | 6.71e-01 | -1.10e-01 | 8.79e-01 |
| GOBP ATP EXPORT | 6 | 6.42e-01 | -1.10e-01 | 8.66e-01 |
| GOCC GABA RECEPTOR COMPLEX | 6 | 6.42e-01 | -1.10e-01 | 8.66e-01 |
| GOMF GABA RECEPTOR ACTIVITY | 6 | 6.42e-01 | -1.10e-01 | 8.66e-01 |
| GOBP KETONE BODY METABOLIC PROCESS | 7 | 6.15e-01 | -1.10e-01 | 8.55e-01 |
| GOBP TRNA MODIFICATION | 92 | 6.92e-02 | 1.10e-01 | 3.20e-01 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 235 | 3.82e-03 | 1.10e-01 | 5.98e-02 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 5.70e-01 | -1.09e-01 | 8.30e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 13 | 4.94e-01 | 1.09e-01 | 7.88e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR II BINDING | 6 | 6.42e-01 | 1.09e-01 | 8.66e-01 |
| GOBP TOLERANCE INDUCTION TO SELF ANTIGEN | 6 | 6.43e-01 | 1.09e-01 | 8.66e-01 |
| GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 6.43e-01 | -1.09e-01 | 8.66e-01 |
| GOBP RESPONSE TO SALT | 21 | 3.86e-01 | -1.09e-01 | 7.15e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 127 | 3.35e-02 | -1.09e-01 | 2.22e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 49 | 1.86e-01 | -1.09e-01 | 5.26e-01 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 6.43e-01 | -1.09e-01 | 8.67e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 9 | 5.71e-01 | 1.09e-01 | 8.30e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 34 | 2.71e-01 | 1.09e-01 | 6.22e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 51 | 1.78e-01 | -1.09e-01 | 5.14e-01 |
| GOCC SPERM PRINCIPAL PIECE | 22 | 3.76e-01 | -1.09e-01 | 7.08e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 21 | 3.87e-01 | 1.09e-01 | 7.16e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 53 | 1.70e-01 | 1.09e-01 | 5.03e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 30 | 3.02e-01 | 1.09e-01 | 6.51e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 13 | 4.97e-01 | -1.09e-01 | 7.88e-01 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 13 | 4.97e-01 | -1.09e-01 | 7.88e-01 |
| GOCC FILTRATION DIAPHRAGM | 7 | 6.18e-01 | -1.09e-01 | 8.56e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 11 | 5.32e-01 | 1.09e-01 | 8.09e-01 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 10 | 5.51e-01 | 1.09e-01 | 8.24e-01 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 5.32e-01 | 1.09e-01 | 8.09e-01 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 122 | 3.80e-02 | 1.09e-01 | 2.37e-01 |
| GOMF DYSTROGLYCAN BINDING | 9 | 5.72e-01 | 1.09e-01 | 8.31e-01 |
| GOBP ERYTHROCYTE DEVELOPMENT | 39 | 2.40e-01 | -1.09e-01 | 5.88e-01 |
| GOBP PURINE NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 5 | 6.74e-01 | -1.09e-01 | 8.81e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE CONTACT SITE | 20 | 4.00e-01 | 1.09e-01 | 7.25e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 30 | 3.03e-01 | 1.09e-01 | 6.52e-01 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 41 | 2.29e-01 | -1.09e-01 | 5.74e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 25 | 3.48e-01 | -1.09e-01 | 6.87e-01 |
| GOCC CLEAVAGE FURROW | 51 | 1.80e-01 | 1.08e-01 | 5.17e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 6 | 6.46e-01 | -1.08e-01 | 8.68e-01 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 5.53e-01 | -1.08e-01 | 8.24e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 38 | 2.47e-01 | -1.08e-01 | 5.95e-01 |
| GOCC CHROMOCENTER | 13 | 4.99e-01 | 1.08e-01 | 7.90e-01 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 9 | 5.73e-01 | -1.08e-01 | 8.32e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 35 | 2.68e-01 | 1.08e-01 | 6.17e-01 |
| GOBP STEROL METABOLIC PROCESS | 113 | 4.68e-02 | -1.08e-01 | 2.64e-01 |
| GOCC TRANSFERASE COMPLEX | 794 | 2.12e-07 | 1.08e-01 | 1.97e-05 |
| GOBP OLIGODENDROCYTE PROGENITOR PROLIFERATION | 5 | 6.75e-01 | -1.08e-01 | 8.81e-01 |
| GOBP SUCCINATE TRANSMEMBRANE TRANSPORT | 5 | 6.75e-01 | 1.08e-01 | 8.81e-01 |
| GOMF SUCCINATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.75e-01 | 1.08e-01 | 8.81e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 28 | 3.22e-01 | -1.08e-01 | 6.67e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 99 | 6.29e-02 | -1.08e-01 | 3.07e-01 |
| GOBP DETERMINATION OF DIGESTIVE TRACT LEFT RIGHT ASYMMETRY | 5 | 6.75e-01 | -1.08e-01 | 8.81e-01 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 18 | 4.27e-01 | 1.08e-01 | 7.42e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 311 | 1.05e-03 | -1.08e-01 | 2.38e-02 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 8 | 5.97e-01 | -1.08e-01 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 6.76e-01 | 1.08e-01 | 8.82e-01 |
| GOBP HEART TRABECULA MORPHOGENESIS | 20 | 4.04e-01 | 1.08e-01 | 7.27e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 99 | 6.39e-02 | 1.08e-01 | 3.09e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 30 | 3.07e-01 | -1.08e-01 | 6.55e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 20 | 4.04e-01 | -1.08e-01 | 7.27e-01 |
| GOCC PIGMENT GRANULE | 103 | 5.88e-02 | -1.08e-01 | 2.95e-01 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 9 | 5.76e-01 | 1.08e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 14 | 4.85e-01 | 1.08e-01 | 7.83e-01 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 52 | 1.80e-01 | -1.08e-01 | 5.16e-01 |
| GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION | 12 | 5.19e-01 | -1.08e-01 | 8.01e-01 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 25 | 3.52e-01 | 1.08e-01 | 6.91e-01 |
| GOCC EXOCYST | 16 | 4.57e-01 | 1.07e-01 | 7.61e-01 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 3.53e-01 | -1.07e-01 | 6.92e-01 |
| GOCC DENDRITE CYTOPLASM | 24 | 3.62e-01 | 1.07e-01 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 217 | 6.42e-03 | 1.07e-01 | 8.51e-02 |
| GOCC AP 2 ADAPTOR COMPLEX | 9 | 5.77e-01 | 1.07e-01 | 8.33e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 140 | 2.84e-02 | -1.07e-01 | 2.04e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 191 | 1.05e-02 | -1.07e-01 | 1.18e-01 |
| GOBP DENSE CORE GRANULE TRANSPORT | 8 | 5.99e-01 | -1.07e-01 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 117 | 4.51e-02 | -1.07e-01 | 2.60e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 22 | 3.84e-01 | -1.07e-01 | 7.15e-01 |
| GOBP VIRAL LIFE CYCLE | 279 | 2.06e-03 | 1.07e-01 | 3.85e-02 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 2.72e-01 | -1.07e-01 | 6.22e-01 |
| GOBP VIRAL GENE EXPRESSION | 96 | 6.97e-02 | 1.07e-01 | 3.21e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 59 | 1.55e-01 | 1.07e-01 | 4.81e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 6 | 6.50e-01 | -1.07e-01 | 8.69e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 50 | 1.91e-01 | -1.07e-01 | 5.31e-01 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 7 | 6.24e-01 | -1.07e-01 | 8.57e-01 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 17 | 4.45e-01 | -1.07e-01 | 7.53e-01 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 19 | 4.20e-01 | -1.07e-01 | 7.38e-01 |
| GOMF CHLORIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 71 | 1.19e-01 | -1.07e-01 | 4.22e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 72 | 1.17e-01 | -1.07e-01 | 4.17e-01 |
| GOCC NURD COMPLEX | 16 | 4.59e-01 | 1.07e-01 | 7.63e-01 |
| GOMF INTRAMOLECULAR PHOSPHOTRANSFERASE ACTIVITY | 9 | 5.79e-01 | -1.07e-01 | 8.33e-01 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 215 | 6.94e-03 | -1.07e-01 | 8.93e-02 |
| GOCC ACETYLTRANSFERASE COMPLEX | 95 | 7.20e-02 | 1.07e-01 | 3.27e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 15 | 4.74e-01 | -1.07e-01 | 7.73e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION | 9 | 5.79e-01 | 1.07e-01 | 8.33e-01 |
| GOBP TISSUE REGENERATION | 55 | 1.71e-01 | -1.07e-01 | 5.05e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 323 | 9.87e-04 | -1.07e-01 | 2.28e-02 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 53 | 1.79e-01 | -1.07e-01 | 5.16e-01 |
| GOBP RESPONSE TO KETONE | 162 | 1.93e-02 | -1.07e-01 | 1.65e-01 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 14 | 4.90e-01 | 1.07e-01 | 7.85e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 22 | 3.87e-01 | -1.07e-01 | 7.16e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 134 | 3.33e-02 | -1.06e-01 | 2.21e-01 |
| GOCC NSL COMPLEX | 11 | 5.41e-01 | 1.06e-01 | 8.15e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 5.60e-01 | -1.06e-01 | 8.27e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 15 | 4.76e-01 | 1.06e-01 | 7.74e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 79 | 1.02e-01 | -1.06e-01 | 3.90e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 108 | 5.62e-02 | -1.06e-01 | 2.88e-01 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 33 | 2.90e-01 | -1.06e-01 | 6.39e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 45 | 2.17e-01 | 1.06e-01 | 5.61e-01 |
| GOBP REGULATION OF CELLULAR PH REDUCTION | 6 | 6.52e-01 | -1.06e-01 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 8 | 6.03e-01 | -1.06e-01 | 8.48e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 11 | 5.42e-01 | -1.06e-01 | 8.16e-01 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 21 | 3.99e-01 | -1.06e-01 | 7.24e-01 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 8 | 6.03e-01 | -1.06e-01 | 8.48e-01 |
| GOBP ACTIN MODIFICATION | 5 | 6.81e-01 | -1.06e-01 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 15 | 4.76e-01 | -1.06e-01 | 7.75e-01 |
| GOBP RESPONSE TO CHEMOKINE | 69 | 1.27e-01 | -1.06e-01 | 4.37e-01 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 13 | 5.08e-01 | -1.06e-01 | 7.96e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 17 | 4.49e-01 | 1.06e-01 | 7.55e-01 |
| GOCC SPINDLE | 397 | 2.86e-04 | 1.06e-01 | 8.93e-03 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 21 | 4.00e-01 | -1.06e-01 | 7.25e-01 |
| GOCC ACROSOMAL MEMBRANE | 19 | 4.24e-01 | -1.06e-01 | 7.41e-01 |
| GOBP RESPONSE TO STEROL DEPLETION | 16 | 4.64e-01 | -1.06e-01 | 7.66e-01 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 48 | 2.05e-01 | -1.06e-01 | 5.48e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 59 | 1.60e-01 | 1.06e-01 | 4.88e-01 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 7 | 6.28e-01 | 1.06e-01 | 8.58e-01 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 30 | 3.16e-01 | -1.06e-01 | 6.63e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 28 | 3.33e-01 | 1.06e-01 | 6.77e-01 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 8 | 6.05e-01 | -1.06e-01 | 8.49e-01 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 109 | 5.67e-02 | -1.06e-01 | 2.89e-01 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 5 | 6.82e-01 | 1.06e-01 | 8.84e-01 |
| GOBP PANTOTHENATE METABOLIC PROCESS | 7 | 6.28e-01 | -1.06e-01 | 8.59e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 57 | 1.68e-01 | 1.06e-01 | 5.02e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 15 | 4.80e-01 | -1.05e-01 | 7.77e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 152 | 2.49e-02 | -1.05e-01 | 1.88e-01 |
| GOCC SODIUM CHANNEL COMPLEX | 18 | 4.39e-01 | 1.05e-01 | 7.50e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 12 | 5.27e-01 | 1.05e-01 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 73 | 1.20e-01 | -1.05e-01 | 4.23e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 14 | 4.95e-01 | 1.05e-01 | 7.88e-01 |
| GOBP RHYTHMIC PROCESS | 227 | 6.28e-03 | 1.05e-01 | 8.40e-02 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 9 | 5.84e-01 | -1.05e-01 | 8.37e-01 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 12 | 5.28e-01 | 1.05e-01 | 8.07e-01 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 5.46e-01 | 1.05e-01 | 8.20e-01 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 15 | 4.81e-01 | -1.05e-01 | 7.79e-01 |
| GOBP GENITALIA MORPHOGENESIS | 8 | 6.07e-01 | 1.05e-01 | 8.50e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 39 | 2.56e-01 | -1.05e-01 | 6.04e-01 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 31 | 3.12e-01 | -1.05e-01 | 6.58e-01 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 25 | 3.63e-01 | -1.05e-01 | 6.98e-01 |
| GOCC ORGANELLE ENVELOPE | 1177 | 1.27e-09 | -1.05e-01 | 2.09e-07 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 24 | 3.73e-01 | -1.05e-01 | 7.05e-01 |
| GOBP EXOCYTIC PROCESS | 66 | 1.40e-01 | -1.05e-01 | 4.59e-01 |
| GOBP REGULATION OF POSTSYNAPSE ASSEMBLY | 5 | 6.84e-01 | 1.05e-01 | 8.85e-01 |
| GOMF THIAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.85e-01 | 1.05e-01 | 8.85e-01 |
| GOBP RESPONSE TO PH | 26 | 3.55e-01 | 1.05e-01 | 6.93e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 140 | 3.22e-02 | -1.05e-01 | 2.17e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 32 | 3.05e-01 | -1.05e-01 | 6.53e-01 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 5.66e-01 | -1.05e-01 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 45 | 2.24e-01 | -1.05e-01 | 5.69e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 10 | 5.66e-01 | -1.05e-01 | 8.29e-01 |
| GOCC CTF18 RFC LIKE COMPLEX | 8 | 6.08e-01 | -1.05e-01 | 8.51e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 21 | 4.06e-01 | 1.05e-01 | 7.28e-01 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 10 | 5.67e-01 | 1.05e-01 | 8.29e-01 |
| GOCC ACTIN FILAMENT | 97 | 7.53e-02 | -1.05e-01 | 3.35e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 129 | 4.04e-02 | 1.05e-01 | 2.45e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 195 | 1.19e-02 | 1.04e-01 | 1.26e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 12 | 5.31e-01 | -1.04e-01 | 8.08e-01 |
| GOBP HYPOTONIC RESPONSE | 10 | 5.68e-01 | -1.04e-01 | 8.30e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 52 | 1.93e-01 | -1.04e-01 | 5.35e-01 |
| GOCC SNARE COMPLEX | 43 | 2.37e-01 | -1.04e-01 | 5.84e-01 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 6 | 6.58e-01 | -1.04e-01 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 6.33e-01 | 1.04e-01 | 8.62e-01 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 25 | 3.67e-01 | -1.04e-01 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 44 | 2.32e-01 | -1.04e-01 | 5.79e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 343 | 9.18e-04 | -1.04e-01 | 2.15e-02 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 10 | 5.69e-01 | 1.04e-01 | 8.30e-01 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 83 | 1.01e-01 | -1.04e-01 | 3.89e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 37 | 2.74e-01 | -1.04e-01 | 6.24e-01 |
| GOMF NUCLEOSOMAL DNA BINDING | 45 | 2.28e-01 | -1.04e-01 | 5.73e-01 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 17 | 4.58e-01 | -1.04e-01 | 7.62e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 328 | 1.22e-03 | 1.04e-01 | 2.66e-02 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 221 | 7.77e-03 | -1.04e-01 | 9.62e-02 |
| GOBP I KAPPAB PHOSPHORYLATION | 14 | 5.01e-01 | -1.04e-01 | 7.91e-01 |
| GOBP DENDRITE SELF AVOIDANCE | 7 | 6.34e-01 | -1.04e-01 | 8.63e-01 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 49 | 2.09e-01 | -1.04e-01 | 5.54e-01 |
| GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 6.88e-01 | 1.04e-01 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 48 | 2.14e-01 | 1.04e-01 | 5.59e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 23 | 3.90e-01 | -1.04e-01 | 7.18e-01 |
| GOBP CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 157 | 2.50e-02 | 1.04e-01 | 1.89e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 13 | 5.18e-01 | -1.04e-01 | 8.01e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 15 | 4.88e-01 | 1.03e-01 | 7.84e-01 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 11 | 5.52e-01 | 1.03e-01 | 8.24e-01 |
| GOBP RELAXATION OF MUSCLE | 26 | 3.61e-01 | -1.03e-01 | 6.97e-01 |
| GOBP REGULATION OF RNA SPLICING | 169 | 2.03e-02 | 1.03e-01 | 1.68e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 50 | 2.06e-01 | -1.03e-01 | 5.50e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 25 | 3.71e-01 | 1.03e-01 | 7.03e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 85 | 9.92e-02 | -1.03e-01 | 3.84e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 41 | 2.52e-01 | -1.03e-01 | 5.99e-01 |
| GOBP MACROPINOCYTOSIS | 10 | 5.71e-01 | -1.03e-01 | 8.30e-01 |
| GOBP FIBROBLAST MIGRATION | 51 | 2.02e-01 | -1.03e-01 | 5.45e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 85 | 9.96e-02 | -1.03e-01 | 3.85e-01 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 12 | 5.35e-01 | 1.03e-01 | 8.12e-01 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 214 | 9.19e-03 | -1.03e-01 | 1.08e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 20 | 4.24e-01 | 1.03e-01 | 7.41e-01 |
| GOCC AXON INITIAL SEGMENT | 13 | 5.19e-01 | 1.03e-01 | 8.01e-01 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 11 | 5.53e-01 | -1.03e-01 | 8.24e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 47 | 2.21e-01 | 1.03e-01 | 5.66e-01 |
| GOMF ADENYLATE CYCLASE BINDING | 9 | 5.92e-01 | -1.03e-01 | 8.41e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 66 | 1.47e-01 | -1.03e-01 | 4.70e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 7 | 6.36e-01 | 1.03e-01 | 8.64e-01 |
| GOMF HYALURONIC ACID BINDING | 17 | 4.62e-01 | 1.03e-01 | 7.65e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 31 | 3.21e-01 | 1.03e-01 | 6.67e-01 |
| GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS | 10 | 5.72e-01 | -1.03e-01 | 8.31e-01 |
| GOCC EARLY PHAGOSOME | 11 | 5.54e-01 | -1.03e-01 | 8.24e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 18 | 4.49e-01 | -1.03e-01 | 7.55e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 12 | 5.37e-01 | 1.03e-01 | 8.12e-01 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 16 | 4.76e-01 | -1.03e-01 | 7.74e-01 |
| GOBP PLASMA MEMBRANE RAFT ASSEMBLY | 5 | 6.90e-01 | 1.03e-01 | 8.88e-01 |
| GOBP ZYMOGEN INHIBITION | 7 | 6.37e-01 | -1.03e-01 | 8.64e-01 |
| GOBP NAD METABOLIC PROCESS | 58 | 1.75e-01 | -1.03e-01 | 5.10e-01 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 6 | 6.63e-01 | 1.03e-01 | 8.74e-01 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 21 | 4.15e-01 | 1.03e-01 | 7.34e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE | 45 | 2.33e-01 | 1.03e-01 | 5.80e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 21 | 4.15e-01 | 1.03e-01 | 7.34e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 21 | 4.15e-01 | -1.03e-01 | 7.34e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 299 | 2.26e-03 | -1.03e-01 | 4.13e-02 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 9 | 5.94e-01 | 1.03e-01 | 8.42e-01 |
| GOBP VIRAL PROTEIN PROCESSING | 31 | 3.23e-01 | 1.03e-01 | 6.68e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 22 | 4.05e-01 | -1.03e-01 | 7.27e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL ACTIVATION | 6 | 6.63e-01 | -1.03e-01 | 8.74e-01 |
| GOBP AORTIC VALVE MORPHOGENESIS | 23 | 3.94e-01 | -1.03e-01 | 7.21e-01 |
| GOBP INHIBITORY SYNAPSE ASSEMBLY | 12 | 5.38e-01 | 1.03e-01 | 8.14e-01 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 25 | 3.75e-01 | 1.02e-01 | 7.07e-01 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 18 | 4.52e-01 | -1.02e-01 | 7.57e-01 |
| GOBP EPITHELIAL TUBE FORMATION | 104 | 7.12e-02 | 1.02e-01 | 3.25e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 71 | 1.36e-01 | -1.02e-01 | 4.52e-01 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 5.75e-01 | -1.02e-01 | 8.33e-01 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 14 | 5.08e-01 | 1.02e-01 | 7.96e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 805 | 8.11e-07 | 1.02e-01 | 6.53e-05 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 7 | 6.39e-01 | 1.02e-01 | 8.65e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 70 | 1.39e-01 | 1.02e-01 | 4.57e-01 |
| GOMF COA LIGASE ACTIVITY | 23 | 3.96e-01 | -1.02e-01 | 7.22e-01 |
| GOCC NUCLEOLUS | 988 | 5.40e-08 | 1.02e-01 | 5.87e-06 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 8 | 6.17e-01 | 1.02e-01 | 8.55e-01 |
| GOBP VIRAL PROCESS | 378 | 6.49e-04 | 1.02e-01 | 1.63e-02 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 21 | 4.18e-01 | -1.02e-01 | 7.37e-01 |
| GOCC GOLGI STACK | 129 | 4.53e-02 | 1.02e-01 | 2.60e-01 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 11 | 5.58e-01 | -1.02e-01 | 8.27e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 47 | 2.26e-01 | -1.02e-01 | 5.72e-01 |
| GOBP PHOTOPERIODISM | 24 | 3.87e-01 | 1.02e-01 | 7.16e-01 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 6 | 6.65e-01 | 1.02e-01 | 8.76e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 55 | 1.91e-01 | -1.02e-01 | 5.32e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 41 | 2.59e-01 | -1.02e-01 | 6.07e-01 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 14 | 5.09e-01 | -1.02e-01 | 7.96e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 60 | 1.72e-01 | -1.02e-01 | 5.07e-01 |
| GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 9 | 5.97e-01 | 1.02e-01 | 8.44e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 192 | 1.50e-02 | -1.02e-01 | 1.45e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 30 | 3.35e-01 | 1.02e-01 | 6.78e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 33 | 3.12e-01 | 1.02e-01 | 6.58e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 151 | 3.09e-02 | -1.02e-01 | 2.13e-01 |
| GOCC CAJAL BODY | 61 | 1.69e-01 | 1.02e-01 | 5.03e-01 |
| GOBP VITAMIN METABOLIC PROCESS | 91 | 9.35e-02 | -1.02e-01 | 3.73e-01 |
| GOMF CALCIUM ION BINDING | 480 | 1.35e-04 | -1.02e-01 | 4.94e-03 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 11 | 5.59e-01 | -1.02e-01 | 8.27e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 20 | 4.31e-01 | 1.02e-01 | 7.44e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND DEMETHYLATION | 13 | 5.26e-01 | 1.02e-01 | 8.06e-01 |
| GOCC CILIARY BASAL BODY | 153 | 3.01e-02 | 1.02e-01 | 2.11e-01 |
| GOBP REGULATION OF OSSIFICATION | 88 | 9.96e-02 | -1.02e-01 | 3.85e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 16 | 4.82e-01 | -1.02e-01 | 7.80e-01 |
| GOCC MITOCHONDRIAL CRISTA | 8 | 6.19e-01 | 1.01e-01 | 8.56e-01 |
| GOBP MITOTIC CELL CYCLE PROCESS | 699 | 4.84e-06 | 1.01e-01 | 3.06e-04 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 138 | 3.96e-02 | 1.01e-01 | 2.42e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 177 | 1.99e-02 | -1.01e-01 | 1.66e-01 |
| GOBP URATE METABOLIC PROCESS | 8 | 6.19e-01 | -1.01e-01 | 8.56e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 132 | 4.42e-02 | -1.01e-01 | 2.57e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 24 | 3.90e-01 | 1.01e-01 | 7.18e-01 |
| GOBP BONE MORPHOGENESIS | 66 | 1.55e-01 | 1.01e-01 | 4.81e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 20 | 4.33e-01 | -1.01e-01 | 7.45e-01 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 98 | 8.34e-02 | 1.01e-01 | 3.52e-01 |
| GOBP PHAGOCYTOSIS | 209 | 1.17e-02 | -1.01e-01 | 1.25e-01 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 27 | 3.63e-01 | 1.01e-01 | 6.98e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 27 | 3.63e-01 | -1.01e-01 | 6.98e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 322 | 1.82e-03 | -1.01e-01 | 3.57e-02 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 120 | 5.58e-02 | -1.01e-01 | 2.88e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 53 | 2.03e-01 | -1.01e-01 | 5.46e-01 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 16 | 4.84e-01 | -1.01e-01 | 7.82e-01 |
| GOBP NEUROBLAST PROLIFERATION | 53 | 2.03e-01 | 1.01e-01 | 5.46e-01 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 97 | 8.57e-02 | -1.01e-01 | 3.58e-01 |
| GOBP PARACRINE SIGNALING | 5 | 6.96e-01 | -1.01e-01 | 8.91e-01 |
| GOCC FEMALE PRONUCLEUS | 9 | 6.00e-01 | 1.01e-01 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 23 | 4.02e-01 | 1.01e-01 | 7.26e-01 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 6.44e-01 | 1.01e-01 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 78 | 1.24e-01 | -1.01e-01 | 4.31e-01 |
| GOBP SEROTONIN UPTAKE | 10 | 5.81e-01 | 1.01e-01 | 8.35e-01 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 24 | 3.93e-01 | 1.01e-01 | 7.21e-01 |
| GOBP CELL DIVISION | 575 | 3.69e-05 | 1.01e-01 | 1.72e-03 |
| GOBP CELLULAR RESPONSE TO CAMP | 38 | 2.83e-01 | -1.01e-01 | 6.33e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 8 | 6.22e-01 | -1.01e-01 | 8.57e-01 |
| GOCC GOLGI CISTERNA | 99 | 8.38e-02 | 1.01e-01 | 3.53e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 150 | 3.35e-02 | 1.01e-01 | 2.22e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 958 | 1.36e-07 | 1.01e-01 | 1.31e-05 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 26 | 3.75e-01 | -1.01e-01 | 7.07e-01 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 25 | 3.85e-01 | 1.00e-01 | 7.15e-01 |
| GOBP POLY A DEPENDENT SNORNA 3 END PROCESSING | 8 | 6.23e-01 | -1.00e-01 | 8.57e-01 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 22 | 4.15e-01 | -1.00e-01 | 7.34e-01 |
| GOBP REGULATION OF CELL KILLING | 98 | 8.60e-02 | 1.00e-01 | 3.58e-01 |
| GOBP T CELL EXTRAVASATION | 13 | 5.31e-01 | 1.00e-01 | 8.08e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 6.98e-01 | 1.00e-01 | 8.91e-01 |
| GOCC ANKYRIN 1 COMPLEX | 5 | 6.98e-01 | -1.00e-01 | 8.91e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 56 | 1.95e-01 | 1.00e-01 | 5.37e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 273 | 4.39e-03 | 1.00e-01 | 6.64e-02 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 12 | 5.48e-01 | 1.00e-01 | 8.21e-01 |
| GOMF SPLICING FACTOR BINDING | 6 | 6.71e-01 | 1.00e-01 | 8.79e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 38 | 2.86e-01 | -1.00e-01 | 6.34e-01 |
| GOBP OVULATION CYCLE | 49 | 2.26e-01 | 1.00e-01 | 5.71e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 14 | 5.17e-01 | 1.00e-01 | 8.01e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 20 | 4.39e-01 | -1.00e-01 | 7.50e-01 |
| GOMF GLYCOSPHINGOLIPID BINDING | 8 | 6.24e-01 | -9.99e-02 | 8.57e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 14 | 5.18e-01 | -9.98e-02 | 8.01e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 20 | 4.40e-01 | -9.98e-02 | 7.50e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 62 | 1.75e-01 | -9.97e-02 | 5.09e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 37 | 2.95e-01 | 9.95e-02 | 6.43e-01 |
| GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS | 6 | 6.73e-01 | 9.95e-02 | 8.80e-01 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 29 | 3.54e-01 | -9.95e-02 | 6.93e-01 |
| GOBP CORTICOSPINAL TRACT MORPHOGENESIS | 6 | 6.73e-01 | 9.95e-02 | 8.80e-01 |
| GOMF GATED CHANNEL ACTIVITY | 195 | 1.66e-02 | -9.95e-02 | 1.53e-01 |
| GOCC CENTRIOLAR SATELLITE | 117 | 6.32e-02 | 9.94e-02 | 3.07e-01 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 11 | 5.68e-01 | -9.94e-02 | 8.30e-01 |
| GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT | 7 | 6.49e-01 | -9.94e-02 | 8.69e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 61 | 1.79e-01 | 9.94e-02 | 5.16e-01 |
| GOCC PROTEIN DNA COMPLEX | 1051 | 5.19e-08 | 9.94e-02 | 5.71e-06 |
| GOBP TOXIN METABOLIC PROCESS | 8 | 6.27e-01 | 9.93e-02 | 8.58e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 18 | 4.66e-01 | 9.93e-02 | 7.67e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 41 | 2.71e-01 | -9.93e-02 | 6.22e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 7.01e-01 | -9.93e-02 | 8.92e-01 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 55 | 2.03e-01 | 9.93e-02 | 5.46e-01 |
| GOBP REGULATION OF T CELL COSTIMULATION | 5 | 7.01e-01 | -9.92e-02 | 8.92e-01 |
| GOMF ACTIN FILAMENT BINDING | 179 | 2.20e-02 | -9.92e-02 | 1.75e-01 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 14 | 5.21e-01 | 9.92e-02 | 8.02e-01 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 6.50e-01 | -9.92e-02 | 8.69e-01 |
| GOBP FAT CELL PROLIFERATION | 10 | 5.87e-01 | -9.91e-02 | 8.39e-01 |
| GOBP RNA 5 END PROCESSING | 37 | 2.97e-01 | 9.91e-02 | 6.46e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 89 | 1.06e-01 | -9.91e-02 | 3.97e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 116 | 6.53e-02 | -9.91e-02 | 3.12e-01 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 6.50e-01 | -9.90e-02 | 8.69e-01 |
| GOMF KERATIN FILAMENT BINDING | 5 | 7.01e-01 | 9.90e-02 | 8.92e-01 |
| GOBP UBIQUINONE METABOLIC PROCESS | 18 | 4.67e-01 | -9.90e-02 | 7.68e-01 |
| GOBP REGULATION OF AXON EXTENSION | 64 | 1.71e-01 | 9.90e-02 | 5.05e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 63 | 1.74e-01 | -9.89e-02 | 5.09e-01 |
| GOMF MIRNA BINDING | 38 | 2.91e-01 | 9.89e-02 | 6.40e-01 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 71 | 1.50e-01 | -9.89e-02 | 4.75e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 86 | 1.13e-01 | 9.89e-02 | 4.12e-01 |
| GOBP FAS SIGNALING PATHWAY | 6 | 6.75e-01 | -9.89e-02 | 8.81e-01 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 36 | 3.05e-01 | 9.88e-02 | 6.53e-01 |
| GOBP MEMBRANE INVAGINATION | 61 | 1.82e-01 | -9.88e-02 | 5.19e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 7 | 6.51e-01 | 9.88e-02 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 12 | 5.54e-01 | -9.87e-02 | 8.24e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 130 | 5.20e-02 | -9.87e-02 | 2.78e-01 |
| GOBP BILE ACID SIGNALING PATHWAY | 7 | 6.51e-01 | 9.87e-02 | 8.70e-01 |
| GOBP RESPONSE TO MANGANESE ION | 16 | 4.94e-01 | -9.87e-02 | 7.88e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 89 | 1.08e-01 | -9.86e-02 | 4.00e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 11 | 5.71e-01 | -9.86e-02 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 15 | 5.09e-01 | 9.85e-02 | 7.96e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 31 | 3.43e-01 | 9.85e-02 | 6.83e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 80 | 1.28e-01 | -9.85e-02 | 4.38e-01 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 50 | 2.28e-01 | -9.85e-02 | 5.74e-01 |
| GOCC BLOC COMPLEX | 19 | 4.58e-01 | 9.84e-02 | 7.62e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 21 | 4.35e-01 | -9.84e-02 | 7.47e-01 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 106 | 8.02e-02 | 9.84e-02 | 3.46e-01 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 15 | 5.10e-01 | 9.83e-02 | 7.96e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 18 | 4.70e-01 | 9.83e-02 | 7.72e-01 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 10 | 5.90e-01 | -9.83e-02 | 8.40e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 45 | 2.54e-01 | 9.83e-02 | 6.02e-01 |
| GOBP VITAMIN B6 METABOLIC PROCESS | 5 | 7.04e-01 | -9.82e-02 | 8.94e-01 |
| GOBP L AMINO ACID BIOSYNTHETIC PROCESS | 49 | 2.34e-01 | -9.82e-02 | 5.81e-01 |
| GOMF INTRACELLULARLY GATED CALCIUM CHANNEL ACTIVITY | 17 | 4.84e-01 | -9.81e-02 | 7.81e-01 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 7 | 6.53e-01 | 9.80e-02 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 158 | 3.36e-02 | -9.79e-02 | 2.22e-01 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 405 | 7.22e-04 | 9.79e-02 | 1.77e-02 |
| GOBP AMINE METABOLIC PROCESS | 82 | 1.25e-01 | -9.79e-02 | 4.34e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 88 | 1.13e-01 | 9.79e-02 | 4.11e-01 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 26 | 3.88e-01 | -9.79e-02 | 7.16e-01 |
| GOMF ACID THIOL LIGASE ACTIVITY | 27 | 3.79e-01 | -9.79e-02 | 7.11e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 10 | 5.92e-01 | 9.78e-02 | 8.41e-01 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 11 | 5.74e-01 | 9.78e-02 | 8.32e-01 |
| GOBP T CELL SELECTION | 54 | 2.14e-01 | 9.77e-02 | 5.59e-01 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 11 | 5.75e-01 | -9.77e-02 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 122 | 6.26e-02 | 9.76e-02 | 3.06e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 30 | 3.55e-01 | 9.76e-02 | 6.93e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 97 | 9.67e-02 | -9.76e-02 | 3.79e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 9 | 6.12e-01 | 9.75e-02 | 8.53e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 24 | 4.08e-01 | -9.75e-02 | 7.29e-01 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 7 | 6.55e-01 | 9.75e-02 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 47 | 2.48e-01 | -9.75e-02 | 5.95e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 156 | 3.56e-02 | -9.75e-02 | 2.29e-01 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 11 | 5.76e-01 | 9.74e-02 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 6 | 6.79e-01 | -9.74e-02 | 8.83e-01 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 7.06e-01 | 9.74e-02 | 8.95e-01 |
| GOCC FILAMENTOUS ACTIN | 25 | 3.99e-01 | -9.74e-02 | 7.24e-01 |
| GOBP RNA MODIFICATION | 163 | 3.19e-02 | 9.74e-02 | 2.16e-01 |
| GOCC MITOCHONDRION | 1541 | 1.70e-10 | -9.74e-02 | 3.31e-08 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 34 | 3.26e-01 | 9.73e-02 | 6.71e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 133 | 5.26e-02 | -9.73e-02 | 2.79e-01 |
| GOCC MAIN AXON | 49 | 2.39e-01 | 9.73e-02 | 5.87e-01 |
| GOCC LAMELLIPODIUM | 182 | 2.36e-02 | -9.73e-02 | 1.83e-01 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 219 | 1.31e-02 | -9.73e-02 | 1.34e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 38 | 3.00e-01 | 9.73e-02 | 6.49e-01 |
| GOBP REGULATION OF NUCLEAR DIVISION | 122 | 6.37e-02 | 9.72e-02 | 3.09e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 41 | 2.82e-01 | 9.72e-02 | 6.30e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 177 | 2.57e-02 | 9.72e-02 | 1.93e-01 |
| GOCC CMG COMPLEX | 11 | 5.77e-01 | -9.71e-02 | 8.33e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 14 | 5.29e-01 | -9.71e-02 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 6.56e-01 | 9.71e-02 | 8.72e-01 |
| GOCC CELL SURFACE | 673 | 1.75e-05 | -9.71e-02 | 9.28e-04 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 23 | 4.20e-01 | -9.71e-02 | 7.39e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MIGRATION | 5 | 7.07e-01 | 9.70e-02 | 8.95e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION | 6 | 6.81e-01 | -9.70e-02 | 8.84e-01 |
| GOMF VITAMIN BINDING | 111 | 7.74e-02 | -9.70e-02 | 3.41e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 89 | 1.14e-01 | -9.70e-02 | 4.13e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 7 | 6.57e-01 | -9.70e-02 | 8.72e-01 |
| GOCC RNA POLYMERASE COMPLEX | 100 | 9.39e-02 | 9.70e-02 | 3.74e-01 |
| GOBP RESPONSE TO AMPHETAMINE | 25 | 4.02e-01 | -9.69e-02 | 7.25e-01 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 32 | 3.43e-01 | 9.69e-02 | 6.83e-01 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 8 | 6.35e-01 | -9.69e-02 | 8.63e-01 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 7 | 6.57e-01 | 9.68e-02 | 8.72e-01 |
| GOBP COPII COATED VESICLE CARGO LOADING | 18 | 4.78e-01 | 9.67e-02 | 7.76e-01 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 467 | 3.43e-04 | -9.67e-02 | 1.01e-02 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 9 | 6.16e-01 | 9.67e-02 | 8.55e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 112 | 7.73e-02 | -9.66e-02 | 3.41e-01 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 121 | 6.66e-02 | -9.65e-02 | 3.14e-01 |
| GOCC ASTROCYTE PROJECTION | 11 | 5.79e-01 | -9.65e-02 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 27 | 3.85e-01 | 9.65e-02 | 7.15e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 16 | 5.04e-01 | -9.65e-02 | 7.93e-01 |
| GOBP OOCYTE DIFFERENTIATION | 45 | 2.63e-01 | 9.65e-02 | 6.11e-01 |
| GOBP MINERALOCORTICOID BIOSYNTHETIC PROCESS | 8 | 6.37e-01 | -9.64e-02 | 8.64e-01 |
| GOBP MINERALOCORTICOID METABOLIC PROCESS | 8 | 6.37e-01 | -9.64e-02 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 72 | 1.57e-01 | -9.64e-02 | 4.84e-01 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 6 | 6.83e-01 | -9.63e-02 | 8.84e-01 |
| GOCC MICROTUBULE BUNDLE | 6 | 6.83e-01 | 9.63e-02 | 8.84e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 49 | 2.44e-01 | -9.63e-02 | 5.90e-01 |
| GOBP LIPID DROPLET FORMATION | 12 | 5.64e-01 | -9.63e-02 | 8.29e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 184 | 2.43e-02 | -9.62e-02 | 1.86e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 119 | 6.99e-02 | 9.62e-02 | 3.21e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 7 | 6.59e-01 | 9.62e-02 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 9 | 6.18e-01 | 9.61e-02 | 8.56e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 174 | 2.88e-02 | 9.61e-02 | 2.06e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 104 | 9.06e-02 | 9.60e-02 | 3.68e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 15 | 5.20e-01 | -9.60e-02 | 8.02e-01 |
| GOBP POTASSIUM ION HOMEOSTASIS | 24 | 4.15e-01 | 9.60e-02 | 7.34e-01 |
| GOBP REGULATION OF BODY FLUID LEVELS | 283 | 5.44e-03 | -9.60e-02 | 7.71e-02 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 7 | 6.60e-01 | 9.60e-02 | 8.73e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 15 | 5.20e-01 | -9.60e-02 | 8.02e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 372 | 1.49e-03 | 9.59e-02 | 3.08e-02 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 11 | 5.82e-01 | 9.59e-02 | 8.35e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 15 | 5.20e-01 | -9.59e-02 | 8.02e-01 |
| GOBP FILOPODIUM ASSEMBLY | 57 | 2.11e-01 | 9.58e-02 | 5.56e-01 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 18 | 4.82e-01 | 9.58e-02 | 7.79e-01 |
| GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 6 | 6.85e-01 | -9.58e-02 | 8.85e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 17 | 4.94e-01 | 9.58e-02 | 7.88e-01 |
| GOCC INO80 COMPLEX | 16 | 5.07e-01 | 9.57e-02 | 7.96e-01 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 8 | 6.39e-01 | -9.57e-02 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 88 | 1.21e-01 | -9.57e-02 | 4.24e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 9 | 6.19e-01 | -9.57e-02 | 8.56e-01 |
| GOBP PANCREATIC A CELL DIFFERENTIATION | 5 | 7.11e-01 | 9.57e-02 | 8.97e-01 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 7.11e-01 | -9.57e-02 | 8.97e-01 |
| GOCC MULTIVESICULAR BODY | 53 | 2.29e-01 | -9.56e-02 | 5.74e-01 |
| GOBP NUCLEIC ACID CATABOLIC PROCESS | 661 | 2.76e-05 | 9.56e-02 | 1.36e-03 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 6.85e-01 | -9.56e-02 | 8.86e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 55 | 2.20e-01 | -9.56e-02 | 5.66e-01 |
| GOBP NEURAL RETINA DEVELOPMENT | 46 | 2.62e-01 | 9.56e-02 | 6.11e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 100 | 9.88e-02 | -9.55e-02 | 3.84e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 6.01e-01 | 9.55e-02 | 8.47e-01 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 47 | 2.57e-01 | 9.55e-02 | 6.05e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 56 | 2.16e-01 | -9.55e-02 | 5.60e-01 |
| GOBP SYNAPSE MATURATION | 24 | 4.18e-01 | -9.55e-02 | 7.37e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 8 | 6.40e-01 | -9.55e-02 | 8.66e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 21 | 4.49e-01 | 9.54e-02 | 7.55e-01 |
| GOBP REGULATION OF MICROVILLUS ASSEMBLY | 6 | 6.86e-01 | -9.54e-02 | 8.86e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 11 | 5.84e-01 | 9.54e-02 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 106 | 8.96e-02 | -9.54e-02 | 3.65e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 76 | 1.51e-01 | 9.54e-02 | 4.75e-01 |
| GOCC MEMBRANE COAT | 92 | 1.14e-01 | 9.54e-02 | 4.13e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 25 | 4.10e-01 | 9.53e-02 | 7.31e-01 |
| GOBP CHLORIDE TRANSPORT | 78 | 1.46e-01 | -9.53e-02 | 4.66e-01 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 13 | 5.52e-01 | -9.53e-02 | 8.24e-01 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 110 | 8.44e-02 | -9.52e-02 | 3.54e-01 |
| GOBP RNA DECAPPING | 19 | 4.73e-01 | 9.52e-02 | 7.73e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 252 | 9.27e-03 | -9.52e-02 | 1.09e-01 |
| GOBP AMINE CATABOLIC PROCESS | 16 | 5.10e-01 | -9.52e-02 | 7.96e-01 |
| GOCC ADHERENS JUNCTION | 155 | 4.08e-02 | -9.52e-02 | 2.46e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION | 5 | 7.12e-01 | 9.52e-02 | 8.97e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 39 | 3.04e-01 | -9.52e-02 | 6.53e-01 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 13 | 5.52e-01 | 9.52e-02 | 8.24e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 82 | 1.36e-01 | 9.51e-02 | 4.53e-01 |
| GOBP B CELL CHEMOTAXIS | 6 | 6.87e-01 | 9.51e-02 | 8.86e-01 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 11 | 5.85e-01 | -9.50e-02 | 8.38e-01 |
| GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL | 5 | 7.13e-01 | -9.50e-02 | 8.98e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 41 | 2.93e-01 | -9.50e-02 | 6.41e-01 |
| GOMF DYNEIN LIGHT CHAIN BINDING | 8 | 6.42e-01 | -9.50e-02 | 8.66e-01 |
| GOMF NEUROPEPTIDE RECEPTOR BINDING | 12 | 5.69e-01 | 9.50e-02 | 8.30e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 5.69e-01 | -9.49e-02 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 6.42e-01 | -9.49e-02 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 12 | 5.69e-01 | 9.49e-02 | 8.30e-01 |
| GOBP THYROID HORMONE TRANSPORT | 7 | 6.64e-01 | 9.48e-02 | 8.74e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 54 | 2.28e-01 | 9.48e-02 | 5.74e-01 |
| GOBP PARAXIAL MESODERM MORPHOGENESIS | 7 | 6.64e-01 | -9.48e-02 | 8.74e-01 |
| GOBP MANNOSYLATION | 26 | 4.03e-01 | 9.48e-02 | 7.26e-01 |
| GOBP OSTEOCLAST FUSION | 5 | 7.14e-01 | -9.48e-02 | 8.98e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 13 | 5.55e-01 | -9.47e-02 | 8.24e-01 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 25 | 4.13e-01 | -9.46e-02 | 7.33e-01 |
| GOCC POSTSYNAPTIC ENDOSOME MEMBRANE | 5 | 7.14e-01 | 9.46e-02 | 8.98e-01 |
| GOMF CARGO RECEPTOR ACTIVITY | 66 | 1.84e-01 | -9.46e-02 | 5.22e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 6 | 6.88e-01 | -9.46e-02 | 8.87e-01 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 56 | 2.21e-01 | -9.46e-02 | 5.66e-01 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 15 | 5.26e-01 | 9.46e-02 | 8.06e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 886 | 1.80e-06 | 9.45e-02 | 1.26e-04 |
| GOBP TRANSMEMBRANE TRANSPORT | 1163 | 5.50e-08 | -9.45e-02 | 5.91e-06 |
| GOMF HORMONE ACTIVITY | 43 | 2.84e-01 | -9.45e-02 | 6.33e-01 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 9 | 6.23e-01 | -9.45e-02 | 8.57e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 22 | 4.43e-01 | -9.45e-02 | 7.51e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 9 | 6.24e-01 | 9.45e-02 | 8.57e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 103 | 9.79e-02 | 9.44e-02 | 3.82e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 38 | 3.14e-01 | 9.43e-02 | 6.61e-01 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 6.44e-01 | -9.43e-02 | 8.67e-01 |
| GOBP METHYLATION | 201 | 2.12e-02 | 9.42e-02 | 1.72e-01 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 323 | 3.60e-03 | -9.42e-02 | 5.74e-02 |
| GOBP REGULATION OF OPSIN MEDIATED SIGNALING PATHWAY | 7 | 6.66e-01 | -9.42e-02 | 8.76e-01 |
| GOBP VACUOLAR LOCALIZATION | 77 | 1.53e-01 | -9.42e-02 | 4.78e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 28 | 3.89e-01 | -9.41e-02 | 7.17e-01 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 38 | 3.15e-01 | -9.41e-02 | 6.63e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 8 | 6.45e-01 | 9.41e-02 | 8.68e-01 |
| GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 7 | 6.67e-01 | 9.41e-02 | 8.76e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 22 | 4.45e-01 | 9.40e-02 | 7.53e-01 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 35 | 3.36e-01 | -9.40e-02 | 6.79e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 890 | 2.00e-06 | -9.39e-02 | 1.36e-04 |
| GOMF GLUTAMATE BINDING | 5 | 7.16e-01 | -9.39e-02 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 5 | 7.16e-01 | 9.39e-02 | 8.99e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 7 | 6.67e-01 | -9.39e-02 | 8.77e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 15 | 5.29e-01 | -9.38e-02 | 8.07e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 8 | 6.46e-01 | 9.38e-02 | 8.69e-01 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 9 | 6.26e-01 | 9.38e-02 | 8.58e-01 |
| GOMF DEAMINASE ACTIVITY | 29 | 3.82e-01 | 9.37e-02 | 7.14e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 18 | 4.91e-01 | 9.37e-02 | 7.85e-01 |
| GOBP ARTERY DEVELOPMENT | 72 | 1.69e-01 | -9.37e-02 | 5.03e-01 |
| GOBP PROTEIN HYDROXYLATION | 22 | 4.47e-01 | -9.36e-02 | 7.55e-01 |
| GOBP INFLAMMATORY RESPONSE | 662 | 3.96e-05 | -9.36e-02 | 1.83e-03 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 32 | 3.59e-01 | -9.36e-02 | 6.96e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 59 | 2.14e-01 | -9.36e-02 | 5.59e-01 |
| GOBP KETONE CATABOLIC PROCESS | 14 | 5.44e-01 | -9.36e-02 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 5 | 7.17e-01 | 9.35e-02 | 9.00e-01 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 6 | 6.92e-01 | 9.35e-02 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 29 | 3.84e-01 | 9.34e-02 | 7.15e-01 |
| GOCC BLEB | 9 | 6.28e-01 | -9.34e-02 | 8.58e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 17 | 5.05e-01 | 9.33e-02 | 7.94e-01 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 110 | 9.08e-02 | -9.33e-02 | 3.68e-01 |
| GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 17 | 5.05e-01 | -9.33e-02 | 7.94e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 4.01e-01 | -9.33e-02 | 7.25e-01 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 25 | 4.19e-01 | 9.33e-02 | 7.38e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 51 | 2.49e-01 | 9.33e-02 | 5.97e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 120 | 7.76e-02 | -9.33e-02 | 3.41e-01 |
| GOBP PEPTIDYL SERINE MODIFICATION | 227 | 1.55e-02 | 9.32e-02 | 1.48e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 28 | 3.93e-01 | -9.32e-02 | 7.21e-01 |
| GOBP CELLULAR RESPONSE TO MAGNESIUM ION | 6 | 6.93e-01 | -9.32e-02 | 8.90e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 29 | 3.85e-01 | -9.31e-02 | 7.15e-01 |
| GOBP RESPONSE TO REDOX STATE | 13 | 5.61e-01 | -9.31e-02 | 8.27e-01 |
| GOBP RESPONSE TO ZINC ION | 32 | 3.62e-01 | -9.31e-02 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 26 | 4.11e-01 | -9.31e-02 | 7.31e-01 |
| GOBP NEUROTRANSMITTER UPTAKE | 31 | 3.70e-01 | -9.31e-02 | 7.02e-01 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 74 | 1.67e-01 | 9.30e-02 | 5.00e-01 |
| GOMF SULFUR COMPOUND BINDING | 192 | 2.63e-02 | -9.30e-02 | 1.95e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 28 | 3.94e-01 | -9.30e-02 | 7.21e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 13 | 5.62e-01 | 9.30e-02 | 8.28e-01 |
| GOCC PARANODAL JUNCTION | 8 | 6.49e-01 | -9.30e-02 | 8.69e-01 |
| GOBP OPTIC NERVE DEVELOPMENT | 15 | 5.33e-01 | -9.29e-02 | 8.10e-01 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 38 | 3.22e-01 | 9.29e-02 | 6.67e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 69 | 1.82e-01 | 9.29e-02 | 5.19e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 11 | 5.94e-01 | 9.29e-02 | 8.42e-01 |
| GOBP LATERAL MESODERM DEVELOPMENT | 12 | 5.78e-01 | -9.29e-02 | 8.33e-01 |
| GOBP WNT SIGNALING PATHWAY | 355 | 2.65e-03 | 9.28e-02 | 4.60e-02 |
| GOBP MAINTENANCE OF LENS TRANSPARENCY | 7 | 6.71e-01 | -9.28e-02 | 8.79e-01 |
| GOBP LEYDIG CELL DIFFERENTIATION | 7 | 6.71e-01 | 9.28e-02 | 8.79e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 58 | 2.22e-01 | -9.27e-02 | 5.67e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR BINDING | 8 | 6.50e-01 | 9.27e-02 | 8.69e-01 |
| GOBP RESPONSE TO METAL ION | 262 | 9.79e-03 | -9.27e-02 | 1.12e-01 |
| GOBP NEGATIVE REGULATION OF HEART RATE | 8 | 6.50e-01 | 9.26e-02 | 8.69e-01 |
| GOBP CIRCULATORY SYSTEM PROCESS | 422 | 1.10e-03 | -9.26e-02 | 2.45e-02 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 15 | 5.34e-01 | -9.26e-02 | 8.11e-01 |
| GOBP O GLYCAN PROCESSING | 36 | 3.36e-01 | -9.26e-02 | 6.79e-01 |
| GOBP MITOTIC DNA REPLICATION | 17 | 5.09e-01 | -9.26e-02 | 7.96e-01 |
| GOBP INORGANIC ANION TRANSPORT | 116 | 8.50e-02 | -9.26e-02 | 3.55e-01 |
| GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE | 8 | 6.50e-01 | -9.26e-02 | 8.69e-01 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 23 | 4.42e-01 | 9.26e-02 | 7.51e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 130 | 6.84e-02 | -9.26e-02 | 3.18e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 39 | 3.17e-01 | 9.26e-02 | 6.64e-01 |
| GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 7.20e-01 | 9.25e-02 | 9.01e-01 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 186 | 2.97e-02 | -9.25e-02 | 2.09e-01 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 7 | 6.72e-01 | -9.25e-02 | 8.80e-01 |
| GOBP PROTEIN UFMYLATION | 6 | 6.95e-01 | -9.24e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF CELL MATURATION | 6 | 6.95e-01 | 9.24e-02 | 8.91e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 293 | 6.51e-03 | 9.24e-02 | 8.59e-02 |
| GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING | 7 | 6.72e-01 | 9.24e-02 | 8.80e-01 |
| GOBP REGULATION OF CHEMOTAXIS | 157 | 4.58e-02 | -9.24e-02 | 2.61e-01 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 77 | 1.61e-01 | -9.23e-02 | 4.91e-01 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 152 | 4.96e-02 | -9.23e-02 | 2.72e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 87 | 1.37e-01 | -9.22e-02 | 4.53e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 7.21e-01 | -9.22e-02 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 5 | 7.21e-01 | -9.22e-02 | 9.01e-01 |
| GOBP CARNITINE TRANSMEMBRANE TRANSPORT | 5 | 7.21e-01 | -9.22e-02 | 9.01e-01 |
| GOCC ENDONUCLEASE COMPLEX | 40 | 3.13e-01 | 9.21e-02 | 6.60e-01 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 10 | 6.14e-01 | -9.21e-02 | 8.54e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 52 | 2.51e-01 | -9.21e-02 | 5.98e-01 |
| GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 5.97e-01 | -9.21e-02 | 8.44e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 72 | 1.77e-01 | 9.20e-02 | 5.12e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 373 | 2.28e-03 | -9.20e-02 | 4.16e-02 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 14 | 5.51e-01 | -9.20e-02 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 50 | 2.61e-01 | -9.20e-02 | 6.09e-01 |
| GOBP LIPOPROTEIN LOCALIZATION | 18 | 4.99e-01 | 9.19e-02 | 7.90e-01 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 30 | 3.83e-01 | 9.19e-02 | 7.15e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 36 | 3.40e-01 | 9.19e-02 | 6.81e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 15 | 5.38e-01 | 9.19e-02 | 8.13e-01 |
| GOCC STEREOCILIUM TIP | 17 | 5.12e-01 | 9.19e-02 | 7.97e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 6 | 6.97e-01 | -9.19e-02 | 8.91e-01 |
| GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 6 | 6.97e-01 | -9.18e-02 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 21 | 4.66e-01 | 9.18e-02 | 7.68e-01 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 49 | 2.66e-01 | 9.18e-02 | 6.15e-01 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 9 | 6.33e-01 | -9.18e-02 | 8.62e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY | 5 | 7.22e-01 | 9.18e-02 | 9.02e-01 |
| GOBP ORGANIC ANION TRANSPORT | 320 | 4.78e-03 | -9.17e-02 | 7.04e-02 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 144 | 5.75e-02 | 9.17e-02 | 2.91e-01 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 14 | 5.53e-01 | -9.17e-02 | 8.24e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 14 | 5.53e-01 | -9.17e-02 | 8.24e-01 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 13 | 5.67e-01 | -9.16e-02 | 8.29e-01 |
| GOMF PROLINE RICH REGION BINDING | 16 | 5.26e-01 | 9.16e-02 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 28 | 4.02e-01 | -9.16e-02 | 7.25e-01 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 19 | 4.89e-01 | -9.16e-02 | 7.85e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 146 | 5.62e-02 | -9.16e-02 | 2.88e-01 |
| GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY | 6 | 6.98e-01 | 9.16e-02 | 8.91e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 15 | 5.39e-01 | -9.15e-02 | 8.14e-01 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 21 | 4.68e-01 | -9.15e-02 | 7.69e-01 |
| GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY | 5 | 7.23e-01 | 9.15e-02 | 9.03e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 19 | 4.90e-01 | 9.15e-02 | 7.85e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 36 | 3.42e-01 | 9.15e-02 | 6.83e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 25 | 4.29e-01 | -9.15e-02 | 7.43e-01 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 29 | 3.94e-01 | -9.14e-02 | 7.21e-01 |
| GOBP REGULATION OF TELOMERE CAPPING | 25 | 4.29e-01 | 9.14e-02 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 7 | 6.75e-01 | 9.14e-02 | 8.81e-01 |
| GOBP RESPONSE TO ALCOHOL | 197 | 2.70e-02 | -9.14e-02 | 1.98e-01 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 38 | 3.30e-01 | -9.13e-02 | 6.75e-01 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 11 | 6.00e-01 | -9.12e-02 | 8.46e-01 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 33 | 3.64e-01 | -9.12e-02 | 6.99e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 21 | 4.69e-01 | 9.12e-02 | 7.71e-01 |
| GOBP REGULATION OF CELL DIVISION | 147 | 5.65e-02 | 9.11e-02 | 2.89e-01 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 47 | 2.80e-01 | 9.11e-02 | 6.29e-01 |
| GOMF CORECEPTOR ACTIVITY | 49 | 2.70e-01 | 9.11e-02 | 6.20e-01 |
| GOCC CYTOPLASMIC REGION | 231 | 1.71e-02 | 9.11e-02 | 1.54e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 20 | 4.81e-01 | 9.11e-02 | 7.79e-01 |
| GOBP ALCOHOL METABOLIC PROCESS | 284 | 8.27e-03 | -9.11e-02 | 1.01e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 11 | 6.01e-01 | -9.11e-02 | 8.47e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 8 | 6.56e-01 | 9.10e-02 | 8.71e-01 |
| GOMF WNT RECEPTOR ACTIVITY | 14 | 5.56e-01 | 9.10e-02 | 8.25e-01 |
| GOCC FC RECEPTOR COMPLEX | 5 | 7.25e-01 | 9.09e-02 | 9.03e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 186 | 3.25e-02 | -9.09e-02 | 2.19e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 123 | 8.17e-02 | -9.09e-02 | 3.49e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 25 | 4.32e-01 | 9.09e-02 | 7.44e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 36 | 3.45e-01 | -9.09e-02 | 6.85e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 1075 | 4.82e-07 | 9.09e-02 | 4.14e-05 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 28 | 4.06e-01 | -9.08e-02 | 7.27e-01 |
| GOBP THYROID GLAND DEVELOPMENT | 19 | 4.93e-01 | -9.08e-02 | 7.86e-01 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 9 | 6.37e-01 | -9.07e-02 | 8.64e-01 |
| GOBP GLUTATHIONE TRANSPORT | 8 | 6.57e-01 | -9.07e-02 | 8.72e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 132 | 7.19e-02 | 9.07e-02 | 3.27e-01 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 316 | 5.56e-03 | -9.07e-02 | 7.78e-02 |
| GOBP CELL FATE SPECIFICATION | 52 | 2.58e-01 | 9.07e-02 | 6.06e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 28 | 4.07e-01 | 9.06e-02 | 7.28e-01 |
| GOBP INTERLEUKIN 6 PRODUCTION | 131 | 7.35e-02 | -9.06e-02 | 3.32e-01 |
| GOBP ERBB4 SIGNALING PATHWAY | 6 | 7.01e-01 | -9.06e-02 | 8.92e-01 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 48 | 2.78e-01 | -9.05e-02 | 6.27e-01 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 7.01e-01 | -9.05e-02 | 8.92e-01 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 16 | 5.31e-01 | 9.05e-02 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 40 | 3.22e-01 | 9.05e-02 | 6.67e-01 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 6.39e-01 | -9.04e-02 | 8.65e-01 |
| GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 8 | 6.58e-01 | -9.04e-02 | 8.72e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 5 | 7.26e-01 | -9.04e-02 | 9.03e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 170 | 4.21e-02 | -9.04e-02 | 2.49e-01 |
| GOBP STEM CELL DIFFERENTIATION | 176 | 3.87e-02 | 9.03e-02 | 2.39e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 35 | 3.55e-01 | 9.03e-02 | 6.93e-01 |
| GOBP POINTED END ACTIN FILAMENT CAPPING | 5 | 7.27e-01 | 9.03e-02 | 9.03e-01 |
| GOMF RS DOMAIN BINDING | 5 | 7.27e-01 | 9.03e-02 | 9.03e-01 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 22 | 4.64e-01 | -9.03e-02 | 7.66e-01 |
| GOCC WASH COMPLEX | 14 | 5.59e-01 | 9.02e-02 | 8.27e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 33 | 3.70e-01 | 9.02e-02 | 7.02e-01 |
| GOBP PRENYLATION | 10 | 6.22e-01 | 9.01e-02 | 8.57e-01 |
| GOBP GMP METABOLIC PROCESS | 26 | 4.27e-01 | -9.01e-02 | 7.42e-01 |
| GOBP VIRAL TRANSLATION | 19 | 4.97e-01 | -9.00e-02 | 7.89e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 125 | 8.22e-02 | -9.00e-02 | 3.50e-01 |
| GOCC ANCHORING JUNCTION | 744 | 2.91e-05 | -9.00e-02 | 1.42e-03 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY | 6 | 7.03e-01 | 9.00e-02 | 8.93e-01 |
| GOBP MONOATOMIC CATION TRANSPORT | 753 | 2.64e-05 | -9.00e-02 | 1.31e-03 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 40 | 3.25e-01 | -9.00e-02 | 6.70e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 81 | 1.62e-01 | -9.00e-02 | 4.91e-01 |
| GOCC MICROBODY LUMEN | 44 | 3.02e-01 | -9.00e-02 | 6.51e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 7 | 6.80e-01 | 8.99e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 21 | 4.76e-01 | -8.99e-02 | 7.74e-01 |
| GOMF GLUTAMATE RECEPTOR BINDING | 34 | 3.65e-01 | -8.99e-02 | 6.99e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 29 | 4.03e-01 | 8.98e-02 | 7.26e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 84 | 1.55e-01 | -8.98e-02 | 4.81e-01 |
| GOBP CEREBELLAR CORTEX FORMATION | 18 | 5.10e-01 | 8.98e-02 | 7.96e-01 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 23 | 4.56e-01 | 8.97e-02 | 7.60e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 44 | 3.03e-01 | 8.97e-02 | 6.52e-01 |
| GOBP RESPONSE TO L GLUTAMATE | 15 | 5.48e-01 | 8.97e-02 | 8.21e-01 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 8 | 6.61e-01 | -8.97e-02 | 8.74e-01 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 74 | 1.82e-01 | -8.97e-02 | 5.19e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 38 | 3.39e-01 | -8.97e-02 | 6.81e-01 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 12 | 5.91e-01 | 8.96e-02 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 710 | 4.73e-05 | 8.96e-02 | 2.09e-03 |
| GOBP OLFACTORY BEHAVIOR | 8 | 6.61e-01 | 8.95e-02 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF NEUROEPITHELIAL CELL DIFFERENTIATION | 6 | 7.04e-01 | 8.95e-02 | 8.94e-01 |
| GOBP REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 12 | 5.91e-01 | 8.95e-02 | 8.41e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 123 | 8.67e-02 | -8.94e-02 | 3.58e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 13 | 5.77e-01 | 8.93e-02 | 8.33e-01 |
| GOCC MEMBRANE MICRODOMAIN | 244 | 1.63e-02 | -8.93e-02 | 1.52e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 5.12e-01 | 8.93e-02 | 7.97e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 3.54e-01 | 8.93e-02 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 49 | 2.79e-01 | -8.93e-02 | 6.29e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 112 | 1.03e-01 | -8.93e-02 | 3.91e-01 |
| GOBP DNA BIOSYNTHETIC PROCESS | 175 | 4.16e-02 | 8.93e-02 | 2.48e-01 |
| GOMF PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 5.50e-01 | -8.92e-02 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 122 | 8.89e-02 | 8.92e-02 | 3.64e-01 |
| GOBP CILIUM ORGANIZATION | 374 | 3.06e-03 | 8.92e-02 | 5.12e-02 |
| GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 12 | 5.93e-01 | 8.92e-02 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 6 | 7.05e-01 | -8.91e-02 | 8.95e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 12 | 5.93e-01 | 8.91e-02 | 8.42e-01 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 414 | 1.87e-03 | -8.91e-02 | 3.61e-02 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 6 | 7.06e-01 | 8.91e-02 | 8.95e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 6 | 7.06e-01 | -8.90e-02 | 8.95e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 8 | 6.63e-01 | -8.90e-02 | 8.74e-01 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 165 | 4.85e-02 | -8.90e-02 | 2.69e-01 |
| GOMF CHEMOREPELLENT ACTIVITY | 21 | 4.80e-01 | -8.90e-02 | 7.78e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 20 | 4.91e-01 | -8.90e-02 | 7.85e-01 |
| GOBP REGULATION OF CALCIUM IMPORT INTO THE MITOCHONDRION | 6 | 7.06e-01 | 8.90e-02 | 8.95e-01 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 93 | 1.38e-01 | -8.89e-02 | 4.57e-01 |
| GOBP SECONDARY METABOLIC PROCESS | 35 | 3.63e-01 | 8.89e-02 | 6.98e-01 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 12 | 5.94e-01 | 8.89e-02 | 8.42e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 78 | 1.75e-01 | 8.89e-02 | 5.09e-01 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 20 | 4.92e-01 | 8.88e-02 | 7.85e-01 |
| GOCC FLOTILLIN COMPLEX | 8 | 6.64e-01 | 8.88e-02 | 8.74e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 11 | 6.10e-01 | 8.87e-02 | 8.52e-01 |
| GOBP SNRNA TRANSPORT | 6 | 7.07e-01 | -8.87e-02 | 8.95e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 753 | 3.49e-05 | 8.86e-02 | 1.67e-03 |
| GOBP PEPTIDE METABOLIC PROCESS | 64 | 2.20e-01 | -8.86e-02 | 5.66e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 14 | 5.66e-01 | -8.86e-02 | 8.29e-01 |
| GOMF MANNOSE BINDING | 19 | 5.04e-01 | -8.85e-02 | 7.93e-01 |
| GOBP L AMINO ACID METABOLIC PROCESS | 144 | 6.67e-02 | -8.85e-02 | 3.14e-01 |
| GOBP REGULATION OF STEROL TRANSPORT | 42 | 3.21e-01 | 8.85e-02 | 6.67e-01 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 105 | 1.17e-01 | 8.85e-02 | 4.17e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 157 | 5.57e-02 | -8.85e-02 | 2.88e-01 |
| GOBP LIVER MORPHOGENESIS | 18 | 5.16e-01 | 8.84e-02 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 32 | 3.87e-01 | 8.84e-02 | 7.16e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 15 | 5.53e-01 | -8.84e-02 | 8.24e-01 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 22 | 4.73e-01 | 8.84e-02 | 7.73e-01 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 16 | 5.41e-01 | -8.83e-02 | 8.15e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 254 | 1.55e-02 | 8.82e-02 | 1.48e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 29 | 4.11e-01 | -8.82e-02 | 7.31e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 38 | 3.47e-01 | -8.82e-02 | 6.87e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 892 | 7.91e-06 | -8.82e-02 | 4.65e-04 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 322 | 6.53e-03 | -8.82e-02 | 8.60e-02 |
| GOCC RNA POLYMERASE I COMPLEX | 13 | 5.82e-01 | -8.81e-02 | 8.36e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 23 | 4.64e-01 | -8.81e-02 | 7.66e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 21 | 4.85e-01 | -8.81e-02 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 26 | 4.37e-01 | 8.80e-02 | 7.49e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN PARTURITION | 5 | 7.33e-01 | -8.80e-02 | 9.06e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 14 | 5.69e-01 | 8.80e-02 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 115 | 1.03e-01 | 8.80e-02 | 3.92e-01 |
| GOBP CELL CELL RECOGNITION | 46 | 3.02e-01 | -8.80e-02 | 6.51e-01 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 6 | 7.09e-01 | 8.80e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 35 | 3.68e-01 | 8.79e-02 | 7.01e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 11 | 6.14e-01 | -8.79e-02 | 8.53e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 38 | 3.48e-01 | 8.79e-02 | 6.88e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 11 | 6.14e-01 | -8.79e-02 | 8.54e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 68 | 2.10e-01 | -8.78e-02 | 5.56e-01 |
| GOBP NK T CELL ACTIVATION | 13 | 5.83e-01 | 8.78e-02 | 8.36e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 39 | 3.43e-01 | -8.77e-02 | 6.84e-01 |
| GOBP MAMMALIAN OOGENESIS STAGE | 9 | 6.49e-01 | 8.77e-02 | 8.69e-01 |
| GOCC DEUTEROSOME | 5 | 7.34e-01 | -8.77e-02 | 9.07e-01 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 7 | 6.88e-01 | 8.76e-02 | 8.87e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 31 | 3.98e-01 | 8.76e-02 | 7.24e-01 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 11 | 6.15e-01 | -8.76e-02 | 8.55e-01 |
| GOBP CELL RECOGNITION | 101 | 1.28e-01 | -8.76e-02 | 4.39e-01 |
| GOBP RESPONSE TO BACTERIUM | 528 | 5.74e-04 | -8.76e-02 | 1.50e-02 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 7.10e-01 | 8.76e-02 | 8.97e-01 |
| GOBP SECRETION BY TISSUE | 30 | 4.07e-01 | 8.76e-02 | 7.28e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 8 | 6.68e-01 | -8.75e-02 | 8.77e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 99 | 1.32e-01 | -8.75e-02 | 4.46e-01 |
| GOBP REGULATION OF INSULIN SECRETION | 127 | 8.90e-02 | -8.74e-02 | 3.64e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 176 | 4.57e-02 | -8.73e-02 | 2.61e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 12 | 6.00e-01 | -8.73e-02 | 8.47e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 10 | 6.33e-01 | 8.73e-02 | 8.62e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 13 | 5.86e-01 | -8.73e-02 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 9 | 6.50e-01 | -8.73e-02 | 8.69e-01 |
| GOMF T CELL RECEPTOR BINDING | 11 | 6.16e-01 | 8.73e-02 | 8.55e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 27 | 4.33e-01 | 8.72e-02 | 7.45e-01 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 16 | 5.46e-01 | -8.72e-02 | 8.20e-01 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 851 | 1.56e-05 | 8.72e-02 | 8.54e-04 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 9 | 6.51e-01 | 8.71e-02 | 8.70e-01 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 617 | 2.22e-04 | -8.71e-02 | 7.30e-03 |
| GOBP RNA METHYLATION | 78 | 1.84e-01 | 8.70e-02 | 5.22e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 30 | 4.09e-01 | -8.70e-02 | 7.31e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 9 | 6.51e-01 | 8.70e-02 | 8.70e-01 |
| GOBP CELL MATURATION | 132 | 8.45e-02 | -8.70e-02 | 3.54e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 129 | 8.82e-02 | 8.69e-02 | 3.62e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 12 | 6.02e-01 | -8.69e-02 | 8.47e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 17 | 5.35e-01 | -8.69e-02 | 8.12e-01 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 168 | 5.21e-02 | 8.69e-02 | 2.78e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 456 | 1.49e-03 | 8.68e-02 | 3.09e-02 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 14 | 5.74e-01 | 8.68e-02 | 8.32e-01 |
| GOCC MYOSIN FILAMENT | 12 | 6.03e-01 | 8.68e-02 | 8.48e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 30 | 4.11e-01 | -8.67e-02 | 7.31e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 41 | 3.37e-01 | -8.67e-02 | 6.79e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 15 | 5.61e-01 | -8.67e-02 | 8.27e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 138 | 7.87e-02 | 8.67e-02 | 3.43e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 308 | 8.88e-03 | -8.67e-02 | 1.06e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 7.37e-01 | -8.67e-02 | 9.08e-01 |
| GOMF SNAP RECEPTOR ACTIVITY | 35 | 3.75e-01 | -8.67e-02 | 7.07e-01 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 10 | 6.35e-01 | 8.66e-02 | 8.64e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 8 | 6.72e-01 | 8.66e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 105 | 1.26e-01 | -8.65e-02 | 4.34e-01 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 26 | 4.45e-01 | -8.65e-02 | 7.53e-01 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 15 | 5.62e-01 | -8.65e-02 | 8.28e-01 |
| GOMF PROFILIN BINDING | 9 | 6.53e-01 | 8.65e-02 | 8.71e-01 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 13 | 5.90e-01 | 8.64e-02 | 8.40e-01 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 138 | 7.97e-02 | -8.64e-02 | 3.45e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 100 | 1.35e-01 | -8.64e-02 | 4.51e-01 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 261 | 1.63e-02 | -8.64e-02 | 1.53e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 46 | 3.11e-01 | -8.63e-02 | 6.58e-01 |
| GOMF ACTININ BINDING | 24 | 4.64e-01 | -8.63e-02 | 7.66e-01 |
| GOBP REGULATION OF T CELL MIGRATION | 41 | 3.39e-01 | -8.63e-02 | 6.81e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 53 | 2.77e-01 | -8.63e-02 | 6.26e-01 |
| GOBP TRYPTOPHAN TRANSPORT | 6 | 7.14e-01 | 8.63e-02 | 8.98e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 85 | 1.69e-01 | 8.63e-02 | 5.03e-01 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 6.37e-01 | -8.63e-02 | 8.64e-01 |
| GOBP LIPID MODIFICATION | 167 | 5.45e-02 | -8.63e-02 | 2.84e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 38 | 3.58e-01 | -8.62e-02 | 6.95e-01 |
| GOCC AXONEMAL MICROTUBULE | 23 | 4.75e-01 | -8.61e-02 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 5 | 7.39e-01 | -8.60e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 29 | 4.23e-01 | -8.60e-02 | 7.41e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 67 | 2.24e-01 | -8.60e-02 | 5.69e-01 |
| GOMF LYASE ACTIVITY | 171 | 5.25e-02 | -8.59e-02 | 2.78e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 240 | 2.19e-02 | -8.59e-02 | 1.75e-01 |
| GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 6 | 7.16e-01 | 8.59e-02 | 8.99e-01 |
| GOCC GARP COMPLEX | 5 | 7.39e-01 | -8.59e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 34 | 3.86e-01 | 8.59e-02 | 7.15e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 14 | 5.78e-01 | 8.59e-02 | 8.33e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 19 | 5.17e-01 | -8.59e-02 | 8.01e-01 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 73 | 2.05e-01 | 8.59e-02 | 5.48e-01 |
| GOBP TONGUE MORPHOGENESIS | 5 | 7.40e-01 | -8.58e-02 | 9.08e-01 |
| GOBP EATING BEHAVIOR | 20 | 5.06e-01 | 8.58e-02 | 7.95e-01 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 18 | 5.29e-01 | 8.58e-02 | 8.07e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 113 | 1.15e-01 | 8.58e-02 | 4.15e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 244 | 2.11e-02 | -8.57e-02 | 1.71e-01 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 12 | 6.08e-01 | 8.56e-02 | 8.51e-01 |
| GOCC SPINDLE MIDZONE | 34 | 3.88e-01 | 8.55e-02 | 7.16e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 21 | 4.97e-01 | -8.55e-02 | 7.89e-01 |
| GOBP VASODILATION | 37 | 3.68e-01 | -8.55e-02 | 7.01e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 49 | 3.01e-01 | 8.54e-02 | 6.51e-01 |
| GOBP L ASPARTATE IMPORT ACROSS PLASMA MEMBRANE | 5 | 7.41e-01 | -8.54e-02 | 9.09e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 48 | 3.06e-01 | 8.54e-02 | 6.54e-01 |
| GOCC COLLAGEN TRIMER | 48 | 3.06e-01 | -8.54e-02 | 6.54e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 10 | 6.40e-01 | -8.53e-02 | 8.66e-01 |
| GOBP REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION | 5 | 7.41e-01 | 8.53e-02 | 9.09e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 9 | 6.58e-01 | 8.52e-02 | 8.72e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 29 | 4.27e-01 | 8.52e-02 | 7.42e-01 |
| GOBP AGGREPHAGY | 16 | 5.55e-01 | 8.52e-02 | 8.25e-01 |
| GOBP TONGUE DEVELOPMENT | 11 | 6.25e-01 | 8.51e-02 | 8.57e-01 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 26 | 4.52e-01 | -8.51e-02 | 7.57e-01 |
| GOMF U3 SNORNA BINDING | 10 | 6.42e-01 | 8.50e-02 | 8.66e-01 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 6 | 7.18e-01 | -8.50e-02 | 9.00e-01 |
| GOMF COLLAGEN BINDING | 56 | 2.72e-01 | -8.49e-02 | 6.22e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 35 | 3.85e-01 | -8.49e-02 | 7.15e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 142 | 8.09e-02 | -8.48e-02 | 3.47e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 83 | 1.82e-01 | -8.48e-02 | 5.18e-01 |
| GOMF MHC CLASS I PROTEIN BINDING | 20 | 5.12e-01 | -8.48e-02 | 7.97e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE | 8 | 6.78e-01 | 8.47e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 33 | 4.00e-01 | -8.47e-02 | 7.24e-01 |
| GOBP MISMATCH REPAIR | 33 | 4.00e-01 | 8.47e-02 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF GROWTH | 185 | 4.69e-02 | 8.47e-02 | 2.64e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 34 | 3.93e-01 | 8.47e-02 | 7.21e-01 |
| GOBP CRISTAE FORMATION | 19 | 5.23e-01 | -8.47e-02 | 8.04e-01 |
| GOBP CELL SUBSTRATE ADHESION | 293 | 1.26e-02 | -8.47e-02 | 1.31e-01 |
| GOMF SHORT CHAIN FATTY ACYL COA DEHYDROGENASE ACTIVITY | 5 | 7.43e-01 | -8.46e-02 | 9.09e-01 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 114 | 1.19e-01 | -8.46e-02 | 4.20e-01 |
| GOBP RESPONSE TO COLD | 36 | 3.80e-01 | 8.46e-02 | 7.12e-01 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 154 | 6.99e-02 | 8.46e-02 | 3.21e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 16 | 5.58e-01 | 8.46e-02 | 8.27e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 46 | 3.21e-01 | -8.46e-02 | 6.67e-01 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 15 | 5.71e-01 | -8.46e-02 | 8.30e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 7.20e-01 | 8.45e-02 | 9.01e-01 |
| GOBP PLASMA MEMBRANE TUBULATION | 18 | 5.35e-01 | 8.45e-02 | 8.11e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 22 | 4.93e-01 | -8.45e-02 | 7.86e-01 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 12 | 6.13e-01 | 8.44e-02 | 8.53e-01 |
| GOMF G QUADRUPLEX RNA BINDING | 8 | 6.79e-01 | 8.44e-02 | 8.83e-01 |
| GOBP REGULATION OF MYELINATION | 38 | 3.68e-01 | 8.44e-02 | 7.01e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY | 7 | 6.99e-01 | -8.43e-02 | 8.92e-01 |
| GOBP MOTOR NEURON MIGRATION | 7 | 6.99e-01 | -8.43e-02 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 19 | 5.25e-01 | 8.42e-02 | 8.05e-01 |
| GOBP RETICULOPHAGY | 20 | 5.15e-01 | 8.41e-02 | 7.98e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 59 | 2.64e-01 | -8.41e-02 | 6.12e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 24 | 4.76e-01 | 8.41e-02 | 7.74e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 132 | 9.54e-02 | -8.41e-02 | 3.77e-01 |
| GOBP NEURON RECOGNITION | 30 | 4.26e-01 | -8.41e-02 | 7.42e-01 |
| GOMF BETA TUBULIN BINDING | 36 | 3.83e-01 | -8.40e-02 | 7.15e-01 |
| GOBP REGULATION OF GLUCOSE IMPORT | 45 | 3.30e-01 | -8.40e-02 | 6.75e-01 |
| GOBP RESPONSE TO DSRNA | 36 | 3.83e-01 | -8.40e-02 | 7.15e-01 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 11 | 6.30e-01 | -8.39e-02 | 8.60e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 19 | 5.27e-01 | -8.39e-02 | 8.06e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING | 6 | 7.22e-01 | 8.38e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 15 | 5.74e-01 | -8.38e-02 | 8.32e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 315 | 1.05e-02 | 8.38e-02 | 1.18e-01 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 24 | 4.78e-01 | -8.38e-02 | 7.76e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 28 | 4.43e-01 | 8.37e-02 | 7.51e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 330 | 8.99e-03 | 8.37e-02 | 1.06e-01 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 9 | 6.64e-01 | -8.37e-02 | 8.74e-01 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 7 | 7.02e-01 | 8.36e-02 | 8.93e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 7.23e-01 | -8.36e-02 | 9.02e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 16 | 5.63e-01 | 8.36e-02 | 8.28e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 525 | 1.06e-03 | -8.35e-02 | 2.39e-02 |
| GOBP PHOSPHATE ION HOMEOSTASIS | 12 | 6.16e-01 | -8.35e-02 | 8.55e-01 |
| GOBP MITOTIC CELL CYCLE | 822 | 4.81e-05 | 8.34e-02 | 2.09e-03 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 18 | 5.40e-01 | 8.34e-02 | 8.15e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 45 | 3.33e-01 | 8.34e-02 | 6.77e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 77 | 2.06e-01 | -8.34e-02 | 5.50e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1514 | 5.90e-08 | -8.34e-02 | 6.27e-06 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 16 | 5.64e-01 | 8.34e-02 | 8.29e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 28 | 4.45e-01 | -8.33e-02 | 7.53e-01 |
| GOMF ALDO KETO REDUCTASE NADPH ACTIVITY | 24 | 4.80e-01 | -8.33e-02 | 7.78e-01 |
| GOBP AMINO ACID BETAINE BIOSYNTHETIC PROCESS | 5 | 7.47e-01 | -8.32e-02 | 9.11e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 42 | 3.51e-01 | -8.32e-02 | 6.90e-01 |
| GOMF TRIPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.03e-01 | -8.31e-02 | 8.94e-01 |
| GOCC RNA POLYMERASE III COMPLEX | 18 | 5.42e-01 | -8.31e-02 | 8.16e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 35 | 3.95e-01 | -8.31e-02 | 7.22e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 7 | 7.04e-01 | -8.30e-02 | 8.94e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 77 | 2.08e-01 | -8.30e-02 | 5.53e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 226 | 3.15e-02 | -8.30e-02 | 2.15e-01 |
| GOBP TONIC SMOOTH MUSCLE CONTRACTION | 6 | 7.25e-01 | 8.30e-02 | 9.03e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 370 | 6.13e-03 | -8.30e-02 | 8.30e-02 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 26 | 4.64e-01 | 8.30e-02 | 7.66e-01 |
| GOCC CLATHRIN VESICLE COAT | 31 | 4.24e-01 | 8.30e-02 | 7.41e-01 |
| GOMF KINESIN BINDING | 39 | 3.70e-01 | 8.29e-02 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 19 | 5.31e-01 | 8.29e-02 | 8.08e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 22 | 5.01e-01 | 8.29e-02 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 6.67e-01 | 8.29e-02 | 8.76e-01 |
| GOBP POLYOL METABOLIC PROCESS | 88 | 1.79e-01 | -8.29e-02 | 5.16e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 16 | 5.66e-01 | -8.29e-02 | 8.29e-01 |
| GOBP TRABECULA MORPHOGENESIS | 32 | 4.17e-01 | -8.29e-02 | 7.36e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 21 | 5.11e-01 | -8.29e-02 | 7.97e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 10 | 6.50e-01 | -8.28e-02 | 8.69e-01 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 34 | 4.03e-01 | 8.28e-02 | 7.26e-01 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 111 | 1.32e-01 | -8.28e-02 | 4.45e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 82 | 1.95e-01 | 8.27e-02 | 5.37e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 16 | 5.67e-01 | 8.27e-02 | 8.29e-01 |
| GOMF TRANSPORTER ACTIVITY | 893 | 2.77e-05 | -8.27e-02 | 1.36e-03 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 22 | 5.02e-01 | -8.26e-02 | 7.92e-01 |
| GOBP REGULATION OF PH | 82 | 1.96e-01 | -8.26e-02 | 5.38e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 33 | 4.12e-01 | -8.26e-02 | 7.32e-01 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 46 | 3.33e-01 | 8.26e-02 | 6.77e-01 |
| GOMF GTPASE BINDING | 297 | 1.44e-02 | 8.25e-02 | 1.41e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 952 | 1.60e-05 | 8.25e-02 | 8.65e-04 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 11 | 6.36e-01 | -8.25e-02 | 8.64e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 168 | 6.50e-02 | -8.25e-02 | 3.11e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 253 | 2.38e-02 | -8.25e-02 | 1.84e-01 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 21 | 5.13e-01 | 8.25e-02 | 7.97e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 127 | 1.09e-01 | -8.24e-02 | 4.01e-01 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 17 | 5.57e-01 | -8.24e-02 | 8.26e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 6.36e-01 | -8.24e-02 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 21 | 5.14e-01 | 8.23e-02 | 7.98e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 11 | 6.37e-01 | 8.22e-02 | 8.64e-01 |
| GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 5 | 7.50e-01 | -8.22e-02 | 9.12e-01 |
| GOBP SNO S RNA PROCESSING | 12 | 6.22e-01 | 8.21e-02 | 8.57e-01 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 19 | 5.35e-01 | -8.21e-02 | 8.12e-01 |
| GOBP TISSUE HOMEOSTASIS | 197 | 4.69e-02 | -8.21e-02 | 2.64e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 43 | 3.52e-01 | -8.21e-02 | 6.91e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 7.51e-01 | 8.21e-02 | 9.12e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 214 | 3.86e-02 | 8.21e-02 | 2.38e-01 |
| GOMF SELENIUM BINDING | 8 | 6.88e-01 | 8.20e-02 | 8.87e-01 |
| GOMF JUN KINASE BINDING | 11 | 6.38e-01 | -8.20e-02 | 8.64e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 75 | 2.20e-01 | 8.20e-02 | 5.64e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 38 | 3.82e-01 | -8.20e-02 | 7.14e-01 |
| GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX | 8 | 6.88e-01 | -8.19e-02 | 8.87e-01 |
| GOBP G2 MI TRANSITION OF MEIOTIC CELL CYCLE | 6 | 7.28e-01 | -8.19e-02 | 9.03e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 89 | 1.82e-01 | -8.19e-02 | 5.19e-01 |
| GOMF AMINOACYLASE ACTIVITY | 5 | 7.51e-01 | -8.19e-02 | 9.13e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 71 | 2.33e-01 | 8.18e-02 | 5.80e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 817 | 7.04e-05 | -8.18e-02 | 2.87e-03 |
| GOBP CAMP MEDIATED SIGNALING | 42 | 3.59e-01 | 8.18e-02 | 6.95e-01 |
| GOBP RESPONSE TO IRON ION | 23 | 4.97e-01 | -8.18e-02 | 7.89e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 31 | 4.31e-01 | 8.18e-02 | 7.44e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 34 | 4.10e-01 | -8.17e-02 | 7.31e-01 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 80 | 2.07e-01 | 8.17e-02 | 5.51e-01 |
| GOMF AROMATASE ACTIVITY | 12 | 6.24e-01 | -8.16e-02 | 8.57e-01 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 188 | 5.36e-02 | -8.16e-02 | 2.81e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 193 | 5.06e-02 | 8.16e-02 | 2.75e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 805 | 8.27e-05 | 8.16e-02 | 3.31e-03 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 7.52e-01 | 8.16e-02 | 9.13e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 371 | 6.99e-03 | -8.15e-02 | 8.95e-02 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 52 | 3.09e-01 | 8.15e-02 | 6.56e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 12 | 6.25e-01 | 8.15e-02 | 8.57e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 56 | 2.91e-01 | -8.15e-02 | 6.40e-01 |
| GOMF S100 PROTEIN BINDING | 12 | 6.25e-01 | -8.15e-02 | 8.57e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 21 | 5.18e-01 | 8.15e-02 | 8.01e-01 |
| GOBP NEUROBLAST DIVISION | 13 | 6.11e-01 | 8.14e-02 | 8.53e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 10 | 6.56e-01 | 8.14e-02 | 8.71e-01 |
| GOMF CARBOHYDRATE BINDING | 218 | 3.83e-02 | -8.14e-02 | 2.38e-01 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 22 | 5.08e-01 | 8.14e-02 | 7.96e-01 |
| GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS | 5 | 7.53e-01 | 8.14e-02 | 9.13e-01 |
| GOMF PRE MRNA 3 SPLICE SITE BINDING | 6 | 7.30e-01 | -8.14e-02 | 9.04e-01 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.09e-01 | -8.14e-02 | 8.97e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 31 | 4.33e-01 | 8.14e-02 | 7.45e-01 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 10 | 6.56e-01 | 8.14e-02 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 12 | 6.25e-01 | 8.14e-02 | 8.58e-01 |
| GOBP SPERMINE METABOLIC PROCESS | 5 | 7.53e-01 | -8.14e-02 | 9.13e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 41 | 3.67e-01 | -8.14e-02 | 7.01e-01 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 29 | 4.48e-01 | -8.14e-02 | 7.55e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 47 | 3.35e-01 | 8.13e-02 | 6.78e-01 |
| GOBP REGULATION OF NEURON MIGRATION | 33 | 4.19e-01 | 8.13e-02 | 7.37e-01 |
| GOBP FORELIMB MORPHOGENESIS | 20 | 5.29e-01 | -8.13e-02 | 8.07e-01 |
| GOBP NUCLEAR MIGRATION | 24 | 4.91e-01 | -8.13e-02 | 7.85e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 11 | 6.41e-01 | -8.12e-02 | 8.66e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 413 | 4.67e-03 | 8.11e-02 | 6.92e-02 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 6.57e-01 | 8.11e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 44 | 3.52e-01 | -8.11e-02 | 6.92e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 83 | 2.02e-01 | 8.10e-02 | 5.45e-01 |
| GOMF 7S RNA BINDING | 7 | 7.11e-01 | -8.10e-02 | 8.97e-01 |
| GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS | 5 | 7.54e-01 | -8.09e-02 | 9.13e-01 |
| GOBP FLUID TRANSPORT | 20 | 5.31e-01 | -8.09e-02 | 8.08e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 34 | 4.15e-01 | -8.08e-02 | 7.34e-01 |
| GOBP CYTOKINETIC PROCESS | 46 | 3.43e-01 | -8.07e-02 | 6.84e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 7 | 7.12e-01 | -8.07e-02 | 8.97e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 133 | 1.08e-01 | -8.07e-02 | 4.00e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 147 | 9.12e-02 | 8.07e-02 | 3.69e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 179 | 6.26e-02 | -8.07e-02 | 3.06e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 270 | 2.25e-02 | -8.07e-02 | 1.77e-01 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 205 | 4.65e-02 | -8.06e-02 | 2.64e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 20 | 5.33e-01 | 8.06e-02 | 8.10e-01 |
| GOMF C X C CHEMOKINE RECEPTOR ACTIVITY | 8 | 6.93e-01 | -8.06e-02 | 8.90e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 228 | 3.61e-02 | 8.06e-02 | 2.30e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 11 | 6.44e-01 | -8.05e-02 | 8.67e-01 |
| GOBP ENDOCRINE PROCESS | 61 | 2.77e-01 | -8.05e-02 | 6.26e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 116 | 1.34e-01 | 8.05e-02 | 4.50e-01 |
| GOCC CHITOSOME | 16 | 5.78e-01 | -8.04e-02 | 8.33e-01 |
| GOBP NON PROTEINOGENIC AMINO ACID METABOLIC PROCESS | 57 | 2.94e-01 | -8.04e-02 | 6.42e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 70 | 2.45e-01 | -8.04e-02 | 5.92e-01 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 48 | 3.35e-01 | 8.04e-02 | 6.78e-01 |
| GOBP ODONTOGENESIS | 80 | 2.14e-01 | -8.04e-02 | 5.59e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION | 5 | 7.56e-01 | -8.03e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 13 | 6.16e-01 | 8.03e-02 | 8.55e-01 |
| GOBP NECROPTOTIC PROCESS | 39 | 3.86e-01 | 8.03e-02 | 7.15e-01 |
| GOBP LOCOMOTION | 965 | 2.43e-05 | -8.02e-02 | 1.23e-03 |
| GOBP ANOIKIS | 29 | 4.55e-01 | -8.02e-02 | 7.59e-01 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 150 | 8.99e-02 | -8.02e-02 | 3.66e-01 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 30 | 4.47e-01 | 8.02e-02 | 7.55e-01 |
| GOBP CAMP PKA SIGNAL TRANSDUCTION | 5 | 7.56e-01 | 8.02e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 76 | 2.27e-01 | -8.02e-02 | 5.72e-01 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 7.56e-01 | 8.01e-02 | 9.14e-01 |
| GOBP LIPID STORAGE | 74 | 2.33e-01 | -8.01e-02 | 5.80e-01 |
| GOMF MICROTUBULE BINDING | 255 | 2.77e-02 | 8.01e-02 | 2.01e-01 |
| GOCC CATION CHANNEL COMPLEX | 137 | 1.06e-01 | -8.00e-02 | 3.96e-01 |
| GOBP MESENCHYME MORPHOGENESIS | 33 | 4.26e-01 | 8.00e-02 | 7.42e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 28 | 4.64e-01 | 8.00e-02 | 7.66e-01 |
| GOBP EPOXYGENASE P450 PATHWAY | 9 | 6.78e-01 | -7.99e-02 | 8.83e-01 |
| GOBP MITOCHONDRION ORGANIZATION | 485 | 2.58e-03 | -7.99e-02 | 4.51e-02 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 155 | 8.61e-02 | 7.99e-02 | 3.58e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 58 | 2.93e-01 | -7.99e-02 | 6.41e-01 |
| GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS | 8 | 6.96e-01 | 7.99e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 59 | 2.89e-01 | -7.98e-02 | 6.37e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 52 | 3.19e-01 | -7.98e-02 | 6.66e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 33 | 4.27e-01 | -7.98e-02 | 7.43e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 22 | 5.17e-01 | -7.98e-02 | 8.01e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 32 | 4.35e-01 | -7.98e-02 | 7.47e-01 |
| GOMF PHOSPHATASE BINDING | 169 | 7.35e-02 | 7.98e-02 | 3.32e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 31 | 4.42e-01 | -7.98e-02 | 7.51e-01 |
| GOCC EARLY ENDOSOME MEMBRANE | 174 | 6.95e-02 | 7.98e-02 | 3.20e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 110 | 1.49e-01 | -7.97e-02 | 4.73e-01 |
| GOMF IRON ION BINDING | 110 | 1.49e-01 | -7.97e-02 | 4.73e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 15 | 5.93e-01 | -7.97e-02 | 8.42e-01 |
| GOBP RESPONSE TO LIPID | 705 | 3.14e-04 | -7.96e-02 | 9.46e-03 |
| GOBP EYE MORPHOGENESIS | 101 | 1.67e-01 | 7.96e-02 | 5.00e-01 |
| GOBP NEURAL PLATE PATTERN SPECIFICATION | 8 | 6.97e-01 | 7.95e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 34 | 4.22e-01 | 7.95e-02 | 7.40e-01 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 232 | 3.69e-02 | -7.95e-02 | 2.33e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 37 | 4.03e-01 | -7.95e-02 | 7.26e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 14 | 6.07e-01 | -7.95e-02 | 8.50e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 79 | 2.22e-01 | -7.95e-02 | 5.67e-01 |
| GOBP REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY | 6 | 7.36e-01 | -7.95e-02 | 9.08e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 21 | 5.28e-01 | -7.95e-02 | 8.07e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 30 | 4.51e-01 | 7.95e-02 | 7.57e-01 |
| GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 6 | 7.36e-01 | -7.94e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 10 | 6.64e-01 | 7.94e-02 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 7 | 7.16e-01 | -7.94e-02 | 8.99e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 78 | 2.26e-01 | -7.94e-02 | 5.71e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 36 | 4.10e-01 | -7.94e-02 | 7.31e-01 |
| GOBP MUSCLE CONTRACTION | 238 | 3.50e-02 | -7.93e-02 | 2.26e-01 |
| GOBP CATECHOLAMINE UPTAKE | 9 | 6.80e-01 | -7.93e-02 | 8.84e-01 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 9 | 6.80e-01 | -7.93e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 130 | 1.19e-01 | -7.93e-02 | 4.20e-01 |
| GOBP THYMOCYTE MIGRATION | 6 | 7.37e-01 | 7.93e-02 | 9.08e-01 |
| GOCC POSTSYNAPTIC ENDOSOME | 12 | 6.35e-01 | -7.92e-02 | 8.63e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 9 | 6.81e-01 | -7.92e-02 | 8.84e-01 |
| GOBP REGULATION OF GLIOGENESIS | 79 | 2.24e-01 | -7.92e-02 | 5.69e-01 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 13 | 6.21e-01 | -7.92e-02 | 8.57e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 17 | 5.72e-01 | -7.92e-02 | 8.31e-01 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 7 | 7.17e-01 | -7.91e-02 | 9.00e-01 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 59 | 2.93e-01 | -7.91e-02 | 6.42e-01 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 8 | 6.99e-01 | 7.91e-02 | 8.92e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 84 | 2.11e-01 | 7.90e-02 | 5.56e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 16 | 5.84e-01 | -7.90e-02 | 8.37e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 133 | 1.16e-01 | -7.89e-02 | 4.15e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 17 | 5.73e-01 | -7.89e-02 | 8.32e-01 |
| GOMF RNA POLYMERASE I ACTIVITY | 10 | 6.66e-01 | -7.89e-02 | 8.76e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 221 | 4.35e-02 | -7.88e-02 | 2.54e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 18 | 5.63e-01 | 7.88e-02 | 8.28e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 133 | 1.17e-01 | -7.88e-02 | 4.16e-01 |
| GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION | 5 | 7.60e-01 | -7.88e-02 | 9.16e-01 |
| GOBP AMINE TRANSPORT | 57 | 3.04e-01 | -7.88e-02 | 6.53e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 483 | 3.04e-03 | -7.87e-02 | 5.12e-02 |
| GOBP LYTIC VACUOLE ORGANIZATION | 100 | 1.74e-01 | -7.87e-02 | 5.08e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 61 | 2.88e-01 | -7.87e-02 | 6.35e-01 |
| GOCC T TUBULE | 38 | 4.01e-01 | -7.87e-02 | 7.25e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 87 | 2.05e-01 | 7.87e-02 | 5.48e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 5 | 7.61e-01 | -7.87e-02 | 9.16e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 79 | 2.27e-01 | 7.87e-02 | 5.72e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 12 | 6.37e-01 | -7.87e-02 | 8.64e-01 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 13 | 6.24e-01 | -7.86e-02 | 8.57e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL ELONGATION | 5 | 7.61e-01 | -7.86e-02 | 9.16e-01 |
| GOBP MITOCHONDRIAL TRANSLATION | 130 | 1.22e-01 | -7.85e-02 | 4.28e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 173 | 7.50e-02 | -7.85e-02 | 3.34e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 375 | 9.09e-03 | -7.84e-02 | 1.07e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 728 | 3.13e-04 | -7.84e-02 | 9.46e-03 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 8 | 7.01e-01 | -7.84e-02 | 8.92e-01 |
| GOBP AMINO ACID ACTIVATION | 45 | 3.63e-01 | 7.84e-02 | 6.98e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 9 | 6.84e-01 | 7.84e-02 | 8.85e-01 |
| GOMF PYRUVATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 7.61e-01 | -7.84e-02 | 9.17e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 79 | 2.28e-01 | 7.84e-02 | 5.74e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 12 | 6.38e-01 | -7.83e-02 | 8.65e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 6.25e-01 | -7.83e-02 | 8.57e-01 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 38 | 4.04e-01 | -7.82e-02 | 7.27e-01 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 63 | 2.83e-01 | 7.82e-02 | 6.32e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 16 | 5.88e-01 | -7.82e-02 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 83 | 2.18e-01 | 7.82e-02 | 5.61e-01 |
| GOBP FACE DEVELOPMENT | 39 | 3.98e-01 | -7.82e-02 | 7.23e-01 |
| GOBP INTERLEUKIN 2 PRODUCTION | 60 | 2.95e-01 | 7.81e-02 | 6.43e-01 |
| GOBP TUBE FORMATION | 116 | 1.46e-01 | 7.81e-02 | 4.67e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 22 | 5.26e-01 | 7.81e-02 | 8.06e-01 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 10 | 6.69e-01 | -7.81e-02 | 8.77e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 513 | 2.46e-03 | 7.81e-02 | 4.38e-02 |
| GOMF STEROID HORMONE BINDING | 5 | 7.62e-01 | 7.81e-02 | 9.17e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 17 | 5.77e-01 | -7.81e-02 | 8.33e-01 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 40 | 3.93e-01 | -7.81e-02 | 7.21e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY | 11 | 6.54e-01 | -7.80e-02 | 8.71e-01 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 7.03e-01 | 7.80e-02 | 8.93e-01 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 6 | 7.41e-01 | 7.79e-02 | 9.09e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 11 | 6.55e-01 | 7.79e-02 | 8.71e-01 |
| GOBP CARDIAC CONDUCTION | 64 | 2.82e-01 | -7.78e-02 | 6.30e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 40 | 3.94e-01 | -7.78e-02 | 7.21e-01 |
| GOMF RDNA BINDING | 9 | 6.86e-01 | -7.78e-02 | 8.86e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 24 | 5.09e-01 | 7.78e-02 | 7.96e-01 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 19 | 5.57e-01 | 7.78e-02 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 11 | 6.55e-01 | 7.78e-02 | 8.71e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 63 | 2.86e-01 | -7.78e-02 | 6.34e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 9 | 6.86e-01 | 7.77e-02 | 8.86e-01 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 22 | 5.28e-01 | 7.77e-02 | 8.07e-01 |
| GOBP DNA CYTOSINE DEAMINATION | 9 | 6.86e-01 | -7.77e-02 | 8.86e-01 |
| GOBP GLUCOSE IMPORT | 58 | 3.06e-01 | -7.77e-02 | 6.54e-01 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 42 | 3.84e-01 | 7.77e-02 | 7.15e-01 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 7 | 7.22e-01 | -7.77e-02 | 9.02e-01 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 11 | 6.56e-01 | 7.76e-02 | 8.71e-01 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 28 | 4.78e-01 | -7.75e-02 | 7.76e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 21 | 5.39e-01 | -7.74e-02 | 8.14e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 30 | 4.63e-01 | -7.74e-02 | 7.66e-01 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 277 | 2.68e-02 | -7.73e-02 | 1.97e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 91 | 2.03e-01 | -7.73e-02 | 5.45e-01 |
| GOMF TUBULIN BINDING | 344 | 1.38e-02 | 7.73e-02 | 1.38e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 108 | 1.65e-01 | -7.72e-02 | 4.98e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 346 | 1.36e-02 | -7.72e-02 | 1.37e-01 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 54 | 3.27e-01 | 7.72e-02 | 6.72e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 21 | 5.40e-01 | -7.72e-02 | 8.15e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 166 | 8.63e-02 | -7.72e-02 | 3.58e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 114 | 1.55e-01 | 7.72e-02 | 4.81e-01 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 11 | 6.58e-01 | -7.71e-02 | 8.72e-01 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 9 | 6.89e-01 | 7.71e-02 | 8.87e-01 |
| GOCC CONTRACTILE MUSCLE FIBER | 180 | 7.45e-02 | -7.71e-02 | 3.34e-01 |
| GOCC 90S PRERIBOSOME | 26 | 4.96e-01 | 7.70e-02 | 7.88e-01 |
| GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS | 5 | 7.65e-01 | -7.70e-02 | 9.18e-01 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 38 | 4.11e-01 | -7.70e-02 | 7.31e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 36 | 4.24e-01 | -7.70e-02 | 7.41e-01 |
| GOCC CELL DIVISION SITE | 70 | 2.65e-01 | 7.70e-02 | 6.14e-01 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 17 | 5.83e-01 | -7.69e-02 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 14 | 6.18e-01 | 7.69e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 14 | 6.18e-01 | 7.69e-02 | 8.56e-01 |
| GOBP CELL CELL ADHESION | 728 | 4.10e-04 | -7.69e-02 | 1.15e-02 |
| GOCC MICROTUBULE CYTOSKELETON | 1248 | 4.89e-06 | 7.69e-02 | 3.07e-04 |
| GOMF TRANSCRIPTION FACTOR BINDING | 520 | 2.70e-03 | 7.69e-02 | 4.66e-02 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 15 | 6.06e-01 | 7.69e-02 | 8.50e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 12 | 6.45e-01 | -7.68e-02 | 8.68e-01 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 7 | 7.25e-01 | -7.68e-02 | 9.03e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 32 | 4.52e-01 | -7.68e-02 | 7.57e-01 |
| GOBP PROTEIN TETRAMERIZATION | 80 | 2.35e-01 | 7.68e-02 | 5.82e-01 |
| GOCC SIDE OF MEMBRANE | 586 | 1.49e-03 | -7.68e-02 | 3.08e-02 |
| GOBP SINGLE FERTILIZATION | 96 | 1.94e-01 | -7.67e-02 | 5.36e-01 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 44 | 3.79e-01 | -7.67e-02 | 7.11e-01 |
| GOMF ORGANIC ACID BINDING | 142 | 1.15e-01 | -7.66e-02 | 4.15e-01 |
| GOBP L SERINE BIOSYNTHETIC PROCESS | 6 | 7.45e-01 | -7.66e-02 | 9.10e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 9 | 6.91e-01 | -7.66e-02 | 8.88e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 76 | 2.48e-01 | 7.66e-02 | 5.96e-01 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 49 | 3.54e-01 | -7.65e-02 | 6.93e-01 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 13 | 6.33e-01 | -7.65e-02 | 8.62e-01 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 45 | 3.75e-01 | -7.64e-02 | 7.07e-01 |
| GOMF CGMP BINDING | 10 | 6.76e-01 | -7.64e-02 | 8.81e-01 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 66 | 2.83e-01 | -7.63e-02 | 6.33e-01 |
| GOBP VALINE METABOLIC PROCESS | 7 | 7.27e-01 | 7.63e-02 | 9.03e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 40 | 4.04e-01 | -7.63e-02 | 7.26e-01 |
| GOBP TRNA TRANSCRIPTION | 13 | 6.34e-01 | 7.63e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 12 | 6.47e-01 | 7.62e-02 | 8.69e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 13 | 6.34e-01 | -7.62e-02 | 8.63e-01 |
| GOBP CELL ADHESION | 1152 | 1.29e-05 | -7.62e-02 | 7.25e-04 |
| GOBP SPERM AXONEME ASSEMBLY | 23 | 5.27e-01 | -7.62e-02 | 8.06e-01 |
| GOCC DENDRITIC SPINE MEMBRANE | 9 | 6.92e-01 | -7.62e-02 | 8.89e-01 |
| GOCC FILOPODIUM MEMBRANE | 15 | 6.09e-01 | -7.62e-02 | 8.52e-01 |
| GOCC GAMMA TUBULIN COMPLEX | 19 | 5.65e-01 | 7.62e-02 | 8.29e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 36 | 4.29e-01 | -7.62e-02 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 59 | 3.12e-01 | 7.62e-02 | 6.58e-01 |
| GOMF IGG RECEPTOR ACTIVITY | 6 | 7.47e-01 | -7.62e-02 | 9.11e-01 |
| GOBP REGULATION OF MRNA CIS SPLICING VIA SPLICEOSOME | 5 | 7.68e-01 | 7.61e-02 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 60 | 3.08e-01 | -7.61e-02 | 6.55e-01 |
| GOCC MRNA EDITING COMPLEX | 5 | 7.68e-01 | 7.61e-02 | 9.20e-01 |
| GOMF UBIQUINONE BINDING | 6 | 7.47e-01 | 7.61e-02 | 9.11e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 25 | 5.10e-01 | -7.61e-02 | 7.97e-01 |
| GOBP VESICLE CARGO LOADING | 32 | 4.57e-01 | 7.60e-02 | 7.61e-01 |
| GOBP VASCULOGENESIS | 56 | 3.25e-01 | 7.60e-02 | 6.71e-01 |
| GOBP EPITHELIAL FLUID TRANSPORT | 5 | 7.69e-01 | -7.59e-02 | 9.20e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 44 | 3.84e-01 | -7.59e-02 | 7.15e-01 |
| GOCC POSTSYNAPTIC ACTIN CYTOSKELETON | 7 | 7.28e-01 | 7.59e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 42 | 3.95e-01 | 7.59e-02 | 7.22e-01 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 18 | 5.77e-01 | 7.59e-02 | 8.33e-01 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 48 | 3.63e-01 | -7.58e-02 | 6.98e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 24 | 5.20e-01 | 7.58e-02 | 8.02e-01 |
| GOBP MAST CELL ACTIVATION | 61 | 3.06e-01 | -7.58e-02 | 6.54e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 5.89e-01 | 7.58e-02 | 8.40e-01 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 65 | 2.91e-01 | -7.57e-02 | 6.39e-01 |
| GOBP SNRNA MODIFICATION | 7 | 7.29e-01 | 7.57e-02 | 9.03e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 42 | 3.96e-01 | -7.57e-02 | 7.22e-01 |
| GOBP B CELL PROLIFERATION | 79 | 2.45e-01 | 7.57e-02 | 5.92e-01 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 8 | 7.11e-01 | -7.56e-02 | 8.97e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 26 | 5.04e-01 | 7.56e-02 | 7.93e-01 |
| GOCC CELL TRAILING EDGE | 15 | 6.12e-01 | -7.56e-02 | 8.53e-01 |
| GOBP PROTEIN OXIDATION | 10 | 6.79e-01 | -7.56e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 231 | 4.79e-02 | -7.55e-02 | 2.68e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 19 | 5.69e-01 | 7.55e-02 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 18 | 5.79e-01 | -7.55e-02 | 8.33e-01 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 5.22e-01 | -7.55e-02 | 8.03e-01 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 44 | 3.87e-01 | 7.55e-02 | 7.16e-01 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 11 | 6.65e-01 | 7.54e-02 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 140 | 1.24e-01 | -7.53e-02 | 4.31e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 81 | 2.42e-01 | 7.53e-02 | 5.89e-01 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 43 | 3.93e-01 | -7.52e-02 | 7.21e-01 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 47 | 3.73e-01 | 7.52e-02 | 7.05e-01 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 7.50e-01 | -7.52e-02 | 9.12e-01 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 6 | 7.50e-01 | -7.51e-02 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 17 | 5.92e-01 | -7.51e-02 | 8.41e-01 |
| GOCC GAMMA TUBULIN RING COMPLEX | 9 | 6.97e-01 | -7.50e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 51 | 3.54e-01 | -7.50e-02 | 6.93e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION | 8 | 7.14e-01 | 7.49e-02 | 8.98e-01 |
| GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY | 8 | 7.14e-01 | 7.49e-02 | 8.98e-01 |
| GOMF SULFATE BINDING | 6 | 7.51e-01 | 7.49e-02 | 9.12e-01 |
| GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT | 5 | 7.72e-01 | -7.49e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 21 | 5.52e-01 | 7.49e-02 | 8.24e-01 |
| GOBP CHOLANGIOCYTE PROLIFERATION | 5 | 7.72e-01 | -7.49e-02 | 9.22e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 150 | 1.14e-01 | -7.48e-02 | 4.12e-01 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 40 | 4.13e-01 | -7.48e-02 | 7.33e-01 |
| GOMF CYTOKINE BINDING | 121 | 1.55e-01 | -7.48e-02 | 4.81e-01 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 10 | 6.82e-01 | 7.47e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 14 | 6.28e-01 | -7.47e-02 | 8.59e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 338 | 1.83e-02 | -7.47e-02 | 1.60e-01 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 16 | 6.05e-01 | 7.47e-02 | 8.49e-01 |
| GOCC BASAL PART OF CELL | 232 | 5.02e-02 | -7.46e-02 | 2.74e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 461 | 6.05e-03 | -7.46e-02 | 8.24e-02 |
| GOBP TRNA METABOLIC PROCESS | 200 | 6.90e-02 | 7.46e-02 | 3.20e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 39 | 4.20e-01 | -7.45e-02 | 7.39e-01 |
| GOBP CELLULAR SENESCENCE | 93 | 2.15e-01 | 7.45e-02 | 5.59e-01 |
| GOMF CAMP BINDING | 19 | 5.74e-01 | 7.44e-02 | 8.32e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 15 | 6.18e-01 | 7.44e-02 | 8.56e-01 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 7.52e-01 | -7.44e-02 | 9.13e-01 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 10 | 6.84e-01 | -7.44e-02 | 8.85e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 163 | 1.01e-01 | -7.44e-02 | 3.88e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 5 | 7.73e-01 | 7.44e-02 | 9.22e-01 |
| GOBP NEURONAL ACTION POTENTIAL | 20 | 5.65e-01 | -7.44e-02 | 8.29e-01 |
| GOBP REGULATION OF T CELL PROLIFERATION | 153 | 1.13e-01 | -7.43e-02 | 4.11e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 276 | 3.37e-02 | 7.43e-02 | 2.22e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 58 | 3.28e-01 | 7.42e-02 | 6.74e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 51 | 3.59e-01 | 7.42e-02 | 6.96e-01 |
| GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY | 7 | 7.34e-01 | 7.42e-02 | 9.07e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 19 | 5.76e-01 | -7.41e-02 | 8.33e-01 |
| GOBP LEUKOCYTE HOMEOSTASIS | 101 | 1.98e-01 | 7.41e-02 | 5.41e-01 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 7.53e-01 | 7.41e-02 | 9.13e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 7.53e-01 | 7.41e-02 | 9.13e-01 |
| GOBP MYELIN MAINTENANCE | 16 | 6.08e-01 | -7.40e-02 | 8.51e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 24 | 5.30e-01 | 7.40e-02 | 8.08e-01 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 110 | 1.80e-01 | 7.40e-02 | 5.17e-01 |
| GOMF FRIZZLED BINDING | 26 | 5.14e-01 | -7.40e-02 | 7.98e-01 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 23 | 5.39e-01 | -7.39e-02 | 8.14e-01 |
| GOCC CIA COMPLEX | 5 | 7.75e-01 | -7.39e-02 | 9.23e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS | 6 | 7.54e-01 | 7.39e-02 | 9.13e-01 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 33 | 4.63e-01 | -7.38e-02 | 7.66e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 6.09e-01 | 7.38e-02 | 8.52e-01 |
| GOBP MUSCLE HYPERTROPHY | 67 | 2.96e-01 | 7.38e-02 | 6.45e-01 |
| GOBP CALCIUM ION HOMEOSTASIS | 240 | 4.90e-02 | -7.38e-02 | 2.70e-01 |
| GOBP STEROL HOMEOSTASIS | 66 | 3.00e-01 | 7.37e-02 | 6.50e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 34 | 4.57e-01 | -7.37e-02 | 7.61e-01 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 7.76e-01 | -7.36e-02 | 9.23e-01 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 9 | 7.02e-01 | 7.36e-02 | 8.93e-01 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 11 | 6.73e-01 | 7.36e-02 | 8.80e-01 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 18 | 5.89e-01 | -7.36e-02 | 8.40e-01 |
| GOBP TISSUE REMODELING | 128 | 1.51e-01 | -7.35e-02 | 4.75e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 50 | 3.68e-01 | 7.35e-02 | 7.01e-01 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 37 | 4.39e-01 | 7.35e-02 | 7.50e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 21 | 5.60e-01 | -7.34e-02 | 8.27e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 69 | 2.92e-01 | -7.34e-02 | 6.40e-01 |
| GOCC FLEMMING BODY | 31 | 4.79e-01 | 7.34e-02 | 7.77e-01 |
| GOBP PIGMENT ACCUMULATION | 10 | 6.88e-01 | -7.34e-02 | 8.87e-01 |
| GOBP PIGMENT GRANULE MATURATION | 10 | 6.88e-01 | -7.34e-02 | 8.87e-01 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 5 | 7.76e-01 | -7.34e-02 | 9.23e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING PHOSPHATASE ACTIVITY | 5 | 7.76e-01 | 7.34e-02 | 9.23e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 564 | 2.90e-03 | 7.34e-02 | 4.92e-02 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 61 | 3.22e-01 | 7.33e-02 | 6.67e-01 |
| GOBP RRNA METHYLATION | 24 | 5.34e-01 | 7.33e-02 | 8.11e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 29 | 4.95e-01 | -7.33e-02 | 7.88e-01 |
| GOBP DORSAL AORTA DEVELOPMENT | 7 | 7.37e-01 | -7.33e-02 | 9.08e-01 |
| GOBP BONE REMODELING | 65 | 3.07e-01 | -7.33e-02 | 6.55e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 6.74e-01 | -7.32e-02 | 8.81e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 23 | 5.43e-01 | -7.32e-02 | 8.18e-01 |
| GOBP TRNA 5 END PROCESSING | 16 | 6.12e-01 | -7.32e-02 | 8.53e-01 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 156 | 1.15e-01 | -7.32e-02 | 4.15e-01 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 15 | 6.24e-01 | 7.31e-02 | 8.57e-01 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 7 | 7.38e-01 | 7.31e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 41 | 4.18e-01 | 7.31e-02 | 7.37e-01 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 19 | 5.81e-01 | -7.31e-02 | 8.35e-01 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 12 | 6.61e-01 | -7.31e-02 | 8.74e-01 |
| GOCC NEURON PROJECTION TERMINUS | 83 | 2.50e-01 | 7.31e-02 | 5.98e-01 |
| GOBP POSITIVE REGULATION OF HYPERSENSITIVITY | 6 | 7.57e-01 | -7.31e-02 | 9.14e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 26 | 5.19e-01 | -7.30e-02 | 8.01e-01 |
| GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION | 39 | 4.30e-01 | -7.30e-02 | 7.44e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 74 | 2.78e-01 | -7.30e-02 | 6.26e-01 |
| GOMF ADP BINDING | 36 | 4.49e-01 | -7.30e-02 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 10 | 6.89e-01 | -7.30e-02 | 8.87e-01 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 6 | 7.57e-01 | -7.29e-02 | 9.14e-01 |
| GOBP COLLATERAL SPROUTING | 24 | 5.36e-01 | 7.29e-02 | 8.12e-01 |
| GOBP VITAMIN TRANSPORT | 35 | 4.56e-01 | -7.29e-02 | 7.60e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 30 | 4.90e-01 | -7.28e-02 | 7.85e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 217 | 6.50e-02 | 7.27e-02 | 3.11e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 318 | 2.59e-02 | 7.27e-02 | 1.93e-01 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 13 | 6.50e-01 | 7.27e-02 | 8.69e-01 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 13 | 6.50e-01 | 7.27e-02 | 8.69e-01 |
| GOBP MITOPHAGY | 66 | 3.07e-01 | -7.27e-02 | 6.55e-01 |
| GOBP RENAL ABSORPTION | 22 | 5.55e-01 | 7.26e-02 | 8.25e-01 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 6 | 7.58e-01 | 7.26e-02 | 9.15e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 12 | 6.63e-01 | 7.26e-02 | 8.74e-01 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 34 | 4.64e-01 | 7.25e-02 | 7.66e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 34 | 4.64e-01 | -7.25e-02 | 7.66e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 14 | 6.39e-01 | -7.25e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 7 | 7.40e-01 | 7.25e-02 | 9.08e-01 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 274 | 3.90e-02 | 7.24e-02 | 2.40e-01 |
| GOBP BONE MINERALIZATION | 91 | 2.33e-01 | -7.24e-02 | 5.79e-01 |
| GOMF CHITIN BINDING | 7 | 7.40e-01 | -7.24e-02 | 9.08e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 84 | 2.52e-01 | 7.24e-02 | 5.99e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 8 | 7.23e-01 | -7.24e-02 | 9.03e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 18 | 5.95e-01 | -7.23e-02 | 8.43e-01 |
| GOCC CYTOPLASMIC STRESS GRANULE | 82 | 2.58e-01 | 7.23e-02 | 6.06e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 11 | 6.78e-01 | -7.22e-02 | 8.83e-01 |
| GOCC MITOCHONDRIAL MATRIX | 476 | 6.98e-03 | -7.22e-02 | 8.95e-02 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 29 | 5.01e-01 | -7.22e-02 | 7.91e-01 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 37 | 4.48e-01 | -7.21e-02 | 7.55e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 6 | 7.60e-01 | 7.21e-02 | 9.16e-01 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 121 | 1.71e-01 | 7.21e-02 | 5.05e-01 |
| GOMF HEMOGLOBIN BINDING | 7 | 7.41e-01 | 7.21e-02 | 9.09e-01 |
| GOMF UBIQUITIN LIKE PROTEIN READER ACTIVITY | 20 | 5.77e-01 | 7.21e-02 | 8.33e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 100 | 2.13e-01 | -7.21e-02 | 5.59e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 120 | 1.73e-01 | -7.20e-02 | 5.08e-01 |
| GOBP PML BODY ORGANIZATION | 7 | 7.42e-01 | -7.20e-02 | 9.09e-01 |
| GOBP DOPAMINE TRANSPORT | 25 | 5.33e-01 | -7.19e-02 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 676 | 1.43e-03 | 7.19e-02 | 3.01e-02 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 19 | 5.87e-01 | -7.19e-02 | 8.39e-01 |
| GOBP FLAVIN CONTAINING COMPOUND METABOLIC PROCESS | 5 | 7.81e-01 | -7.19e-02 | 9.26e-01 |
| GOMF RNA POLYMERASE ACTIVITY | 32 | 4.82e-01 | 7.19e-02 | 7.79e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 14 | 6.42e-01 | -7.19e-02 | 8.66e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 17 | 6.08e-01 | -7.19e-02 | 8.51e-01 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 56 | 3.52e-01 | -7.18e-02 | 6.92e-01 |
| GOBP PANCREAS DEVELOPMENT | 46 | 3.99e-01 | -7.18e-02 | 7.24e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 634 | 2.03e-03 | 7.18e-02 | 3.83e-02 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 30 | 4.96e-01 | -7.18e-02 | 7.88e-01 |
| GOBP TRANSCYTOSIS | 17 | 6.09e-01 | 7.17e-02 | 8.51e-01 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 28 | 5.11e-01 | 7.17e-02 | 7.97e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 48 | 3.90e-01 | -7.17e-02 | 7.18e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 83 | 2.59e-01 | -7.17e-02 | 6.07e-01 |
| GOMF LONG CHAIN FATTY ACYL COA HYDROLASE ACTIVITY | 13 | 6.55e-01 | -7.17e-02 | 8.71e-01 |
| GOCC SMN COMPLEX | 11 | 6.81e-01 | 7.17e-02 | 8.84e-01 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 174 | 1.03e-01 | -7.17e-02 | 3.91e-01 |
| GOBP SPERM CAPACITATION | 11 | 6.81e-01 | -7.16e-02 | 8.84e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 20 | 5.79e-01 | -7.16e-02 | 8.33e-01 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 28 | 5.12e-01 | -7.16e-02 | 7.97e-01 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 10 | 6.95e-01 | 7.15e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 26 | 5.28e-01 | -7.15e-02 | 8.07e-01 |
| GOCC ACTIN CYTOSKELETON | 428 | 1.12e-02 | -7.15e-02 | 1.22e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 14 | 6.43e-01 | 7.15e-02 | 8.67e-01 |
| GOBP CRANIAL SUTURE MORPHOGENESIS | 5 | 7.82e-01 | -7.15e-02 | 9.26e-01 |
| GOMF ARGININE BINDING | 7 | 7.43e-01 | 7.15e-02 | 9.09e-01 |
| GOBP ENDOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 39 | 4.40e-01 | -7.14e-02 | 7.50e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 30 | 4.99e-01 | 7.13e-02 | 7.90e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 35 | 4.66e-01 | -7.12e-02 | 7.67e-01 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 17 | 6.11e-01 | 7.12e-02 | 8.53e-01 |
| GOMF RNA NUCLEASE ACTIVITY | 118 | 1.81e-01 | 7.12e-02 | 5.18e-01 |
| GOBP CELLULAR RESPONSE TO ATP | 17 | 6.11e-01 | 7.12e-02 | 8.53e-01 |
| GOBP REGULATED EXOCYTOSIS | 178 | 1.02e-01 | -7.11e-02 | 3.89e-01 |
| GOBP POSITIVE REGULATION OF ANOIKIS | 5 | 7.83e-01 | 7.11e-02 | 9.27e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 37 | 4.54e-01 | -7.11e-02 | 7.59e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 8 | 7.28e-01 | -7.11e-02 | 9.03e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 35 | 4.67e-01 | -7.11e-02 | 7.68e-01 |
| GOMF 5 N 7 METHYLGUANOSINE 5 TRIPHOSPHO MRNA HYDROLASE ACTIVITY | 10 | 6.97e-01 | 7.10e-02 | 8.91e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 65 | 3.22e-01 | 7.10e-02 | 6.67e-01 |
| GOBP DIGESTION | 78 | 2.78e-01 | 7.10e-02 | 6.27e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 29 | 5.08e-01 | -7.09e-02 | 7.96e-01 |
| GOBP CELLULAR DEFENSE RESPONSE | 45 | 4.11e-01 | -7.09e-02 | 7.31e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 68 | 3.12e-01 | -7.09e-02 | 6.59e-01 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 8 | 7.29e-01 | -7.08e-02 | 9.03e-01 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 8 | 7.29e-01 | 7.08e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 39 | 4.44e-01 | -7.08e-02 | 7.53e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 63 | 3.32e-01 | -7.07e-02 | 6.76e-01 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 36 | 4.63e-01 | -7.07e-02 | 7.66e-01 |
| GOBP RESPONSE TO ACIDIC PH | 17 | 6.14e-01 | 7.06e-02 | 8.54e-01 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 228 | 6.63e-02 | -7.06e-02 | 3.13e-01 |
| GOCC MITOCHONDRIAL CRISTA JUNCTION | 8 | 7.30e-01 | -7.06e-02 | 9.03e-01 |
| GOBP REGULATION OF MACROPHAGE PROLIFERATION | 5 | 7.85e-01 | -7.06e-02 | 9.28e-01 |
| GOBP ORGANELLE ASSEMBLY | 898 | 3.36e-04 | 7.05e-02 | 9.98e-03 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 10 | 6.99e-01 | 7.05e-02 | 8.92e-01 |
| GOCC SYNAPTIC CLEFT | 11 | 6.86e-01 | -7.04e-02 | 8.86e-01 |
| GOCC AXONEMAL DYNEIN COMPLEX | 16 | 6.26e-01 | 7.04e-02 | 8.58e-01 |
| GOBP NUCLEUS LOCALIZATION | 29 | 5.12e-01 | -7.04e-02 | 7.97e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 21 | 5.76e-01 | -7.04e-02 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 46 | 4.09e-01 | -7.04e-02 | 7.30e-01 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 8 | 7.31e-01 | 7.03e-02 | 9.04e-01 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 12 | 6.73e-01 | -7.03e-02 | 8.80e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 56 | 3.63e-01 | -7.03e-02 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 99 | 2.27e-01 | 7.03e-02 | 5.72e-01 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 67 | 3.20e-01 | -7.03e-02 | 6.66e-01 |
| GOBP MATURATION OF LSU RRNA | 24 | 5.51e-01 | 7.02e-02 | 8.24e-01 |
| GOBP B CELL APOPTOTIC PROCESS | 25 | 5.44e-01 | -7.02e-02 | 8.18e-01 |
| GOBP REGULATION OF CENTROMERE COMPLEX ASSEMBLY | 6 | 7.66e-01 | -7.01e-02 | 9.18e-01 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 12 | 6.74e-01 | -7.01e-02 | 8.81e-01 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 37 | 4.60e-01 | 7.01e-02 | 7.64e-01 |
| GOBP CERAMIDE TRANSPORT | 15 | 6.38e-01 | 7.01e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 28 | 5.21e-01 | -7.01e-02 | 8.02e-01 |
| GOBP NON PROTEINOGENIC AMINO ACID BIOSYNTHETIC PROCESS | 14 | 6.50e-01 | -7.00e-02 | 8.69e-01 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 13 | 6.62e-01 | 7.00e-02 | 8.74e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 881 | 4.20e-04 | 7.00e-02 | 1.17e-02 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 43 | 4.27e-01 | 7.00e-02 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 13 | 6.62e-01 | -7.00e-02 | 8.74e-01 |
| GOBP COENZYME A METABOLIC PROCESS | 18 | 6.07e-01 | 7.00e-02 | 8.50e-01 |
| GOMF ENZYME INHIBITOR ACTIVITY | 281 | 4.35e-02 | -7.00e-02 | 2.54e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 194 | 9.29e-02 | -7.00e-02 | 3.72e-01 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 20 | 5.88e-01 | 6.99e-02 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 101 | 2.25e-01 | 6.98e-02 | 5.70e-01 |
| GOCC ENDOLYSOSOME | 28 | 5.23e-01 | 6.98e-02 | 8.04e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 8 | 7.32e-01 | -6.98e-02 | 9.06e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 236 | 6.48e-02 | -6.98e-02 | 3.11e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 13 | 6.63e-01 | 6.97e-02 | 8.74e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 99 | 2.31e-01 | -6.97e-02 | 5.77e-01 |
| GOBP REGULATION OF SPINDLE CHECKPOINT | 23 | 5.63e-01 | 6.97e-02 | 8.28e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 80 | 2.81e-01 | -6.97e-02 | 6.30e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 19 | 5.99e-01 | -6.97e-02 | 8.46e-01 |
| GOBP EMBRYONIC SKELETAL JOINT DEVELOPMENT | 6 | 7.68e-01 | 6.97e-02 | 9.20e-01 |
| GOCC VESICLE COAT | 59 | 3.55e-01 | 6.96e-02 | 6.93e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE MODULATING SYNAPTIC TRANSMISSION | 6 | 7.68e-01 | 6.96e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 55 | 3.72e-01 | -6.96e-02 | 7.04e-01 |
| GOMF TELOMERASE INHIBITOR ACTIVITY | 5 | 7.87e-01 | 6.96e-02 | 9.28e-01 |
| GOMF G PROTEIN COUPLED NEUROTRANSMITTER RECEPTOR ACTIVITY | 5 | 7.88e-01 | 6.96e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 22 | 5.72e-01 | 6.96e-02 | 8.31e-01 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 30 | 5.10e-01 | 6.96e-02 | 7.96e-01 |
| GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 7.88e-01 | 6.95e-02 | 9.28e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 9 | 7.18e-01 | 6.95e-02 | 9.00e-01 |
| GOMF CO SMAD BINDING | 9 | 7.18e-01 | 6.95e-02 | 9.00e-01 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 65 | 3.33e-01 | 6.95e-02 | 6.77e-01 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 8 | 7.34e-01 | -6.95e-02 | 9.07e-01 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 8 | 7.34e-01 | -6.94e-02 | 9.07e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 13 | 6.65e-01 | -6.94e-02 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 11 | 6.90e-01 | -6.93e-02 | 8.88e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 49 | 4.01e-01 | -6.93e-02 | 7.25e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 18 | 6.11e-01 | -6.93e-02 | 8.52e-01 |
| GOMF I SMAD BINDING | 16 | 6.32e-01 | 6.92e-02 | 8.61e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 41 | 4.44e-01 | -6.92e-02 | 7.52e-01 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 13 | 6.66e-01 | -6.92e-02 | 8.76e-01 |
| GOBP STEROID METABOLIC PROCESS | 228 | 7.21e-02 | -6.91e-02 | 3.28e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 6.79e-01 | 6.91e-02 | 8.83e-01 |
| GOCC PWP2P CONTAINING SUBCOMPLEX OF 90S PRERIBOSOME | 5 | 7.89e-01 | 6.91e-02 | 9.29e-01 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 39 | 4.55e-01 | -6.91e-02 | 7.60e-01 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 7 | 7.52e-01 | 6.90e-02 | 9.13e-01 |
| GOMF TOXIC SUBSTANCE BINDING | 6 | 7.70e-01 | -6.90e-02 | 9.21e-01 |
| GOBP REGULATION OF CELL SHAPE | 120 | 1.92e-01 | -6.90e-02 | 5.33e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 14 | 6.55e-01 | -6.90e-02 | 8.71e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 226 | 7.43e-02 | -6.89e-02 | 3.34e-01 |
| GOMF NAD DEPENDENT PROTEIN LYSINE DEACETYLASE ACTIVITY | 7 | 7.52e-01 | -6.89e-02 | 9.13e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 18 | 6.13e-01 | 6.89e-02 | 8.53e-01 |
| GOMF MRNA 5 UTR BINDING | 22 | 5.76e-01 | -6.88e-02 | 8.33e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 14 | 6.56e-01 | -6.88e-02 | 8.71e-01 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 21 | 5.85e-01 | 6.88e-02 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 31 | 5.07e-01 | 6.88e-02 | 7.96e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 25 | 5.52e-01 | -6.88e-02 | 8.24e-01 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 48 | 4.10e-01 | -6.87e-02 | 7.31e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 480 | 9.90e-03 | -6.87e-02 | 1.12e-01 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 32 | 5.01e-01 | 6.87e-02 | 7.91e-01 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 19 | 6.05e-01 | 6.86e-02 | 8.49e-01 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 8 | 7.37e-01 | -6.86e-02 | 9.08e-01 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 200 | 9.45e-02 | 6.86e-02 | 3.75e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 63 | 3.47e-01 | 6.86e-02 | 6.86e-01 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 6.57e-01 | -6.85e-02 | 8.72e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 120 | 1.95e-01 | -6.85e-02 | 5.37e-01 |
| GOMF TRNA BINDING | 78 | 2.96e-01 | 6.85e-02 | 6.44e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 15 | 6.46e-01 | 6.85e-02 | 8.69e-01 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 193 | 1.01e-01 | -6.85e-02 | 3.88e-01 |
| GOBP DIRECT OSSIFICATION | 5 | 7.91e-01 | 6.84e-02 | 9.30e-01 |
| GOBP VESICLE TETHERING | 32 | 5.03e-01 | 6.84e-02 | 7.92e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 12 | 6.82e-01 | 6.84e-02 | 8.84e-01 |
| GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS | 6 | 7.72e-01 | -6.84e-02 | 9.22e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 218 | 8.20e-02 | -6.83e-02 | 3.50e-01 |
| GOMF CARBON CARBON LYASE ACTIVITY | 44 | 4.33e-01 | -6.83e-02 | 7.45e-01 |
| GOMF METAL ION SENSOR ACTIVITY | 6 | 7.72e-01 | -6.82e-02 | 9.22e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 43 | 4.39e-01 | -6.82e-02 | 7.50e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 34 | 4.91e-01 | 6.82e-02 | 7.85e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 68 | 3.31e-01 | -6.82e-02 | 6.75e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 45 | 4.29e-01 | 6.82e-02 | 7.43e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 6 | 7.73e-01 | 6.81e-02 | 9.22e-01 |
| GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 6 | 7.73e-01 | -6.81e-02 | 9.22e-01 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 600 | 4.41e-03 | -6.81e-02 | 6.65e-02 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 26 | 5.48e-01 | 6.80e-02 | 8.21e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATION | 114 | 2.10e-01 | 6.80e-02 | 5.55e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 32 | 5.06e-01 | -6.79e-02 | 7.95e-01 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 9 | 7.24e-01 | -6.78e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 21 | 5.91e-01 | -6.78e-02 | 8.40e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 20 | 6.00e-01 | -6.78e-02 | 8.46e-01 |
| GOBP CHORION DEVELOPMENT | 9 | 7.25e-01 | -6.78e-02 | 9.03e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 49 | 4.12e-01 | -6.78e-02 | 7.32e-01 |
| GOBP B CELL LINEAGE COMMITMENT | 5 | 7.93e-01 | -6.78e-02 | 9.30e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 10 | 7.11e-01 | 6.78e-02 | 8.97e-01 |
| GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION | 5 | 7.93e-01 | -6.78e-02 | 9.30e-01 |
| GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 10 | 7.11e-01 | 6.77e-02 | 8.97e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 6 | 7.74e-01 | -6.77e-02 | 9.22e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 461 | 1.27e-02 | -6.77e-02 | 1.32e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE CHECKPOINT | 13 | 6.73e-01 | 6.77e-02 | 8.80e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 109 | 2.22e-01 | 6.77e-02 | 5.67e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 422 | 1.71e-02 | 6.77e-02 | 1.54e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 15 | 6.50e-01 | 6.76e-02 | 8.69e-01 |
| GOCC DYNEIN AXONEMAL PARTICLE | 14 | 6.62e-01 | -6.75e-02 | 8.74e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 6.51e-01 | 6.75e-02 | 8.70e-01 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 224 | 8.18e-02 | 6.75e-02 | 3.49e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 7.57e-01 | -6.75e-02 | 9.14e-01 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 8 | 7.41e-01 | 6.74e-02 | 9.09e-01 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 7.94e-01 | 6.74e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 84 | 2.86e-01 | -6.74e-02 | 6.34e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 231 | 7.77e-02 | -6.74e-02 | 3.41e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 65 | 3.48e-01 | 6.74e-02 | 6.87e-01 |
| GOMF ISOMERASE ACTIVITY | 154 | 1.49e-01 | -6.73e-02 | 4.74e-01 |
| GOBP MESENCHYMAL CELL MIGRATION | 36 | 4.85e-01 | 6.73e-02 | 7.82e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 35 | 4.91e-01 | 6.72e-02 | 7.85e-01 |
| GOMF PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ACTIVITY | 6 | 7.76e-01 | 6.72e-02 | 9.23e-01 |
| GOBP NEURAL PLATE REGIONALIZATION | 6 | 7.76e-01 | -6.72e-02 | 9.23e-01 |
| GOBP SPHINGOMYELIN CATABOLIC PROCESS | 7 | 7.58e-01 | -6.72e-02 | 9.15e-01 |
| GOMF MICROTUBULE PLUS END BINDING | 21 | 5.94e-01 | 6.72e-02 | 8.42e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 23 | 5.78e-01 | -6.71e-02 | 8.33e-01 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 97 | 2.54e-01 | 6.71e-02 | 6.01e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 54 | 3.94e-01 | -6.71e-02 | 7.21e-01 |
| GOBP DIACYLGLYCEROL CATABOLIC PROCESS | 5 | 7.95e-01 | 6.70e-02 | 9.31e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 503 | 1.01e-02 | 6.70e-02 | 1.14e-01 |
| GOMF COLLAGEN BINDING INVOLVED IN CELL MATRIX ADHESION | 5 | 7.95e-01 | 6.70e-02 | 9.31e-01 |
| GOBP PIGMENT GRANULE ORGANIZATION | 36 | 4.87e-01 | 6.70e-02 | 7.83e-01 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 31 | 5.19e-01 | -6.70e-02 | 8.01e-01 |
| GOMF TRANSITION METAL ION BINDING | 889 | 7.04e-04 | 6.70e-02 | 1.74e-02 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 25 | 5.62e-01 | 6.70e-02 | 8.28e-01 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 10 | 7.14e-01 | -6.70e-02 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 12 | 6.88e-01 | 6.69e-02 | 8.87e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 11 | 7.01e-01 | -6.69e-02 | 8.92e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 213 | 9.25e-02 | -6.69e-02 | 3.72e-01 |
| GOBP CELL KILLING | 176 | 1.26e-01 | -6.69e-02 | 4.35e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 23 | 5.79e-01 | 6.68e-02 | 8.33e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 212 | 9.41e-02 | 6.67e-02 | 3.75e-01 |
| GOBP CELLULAR RESPONSE TO ANGIOTENSIN | 26 | 5.56e-01 | -6.67e-02 | 8.25e-01 |
| GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 6 | 7.77e-01 | -6.67e-02 | 9.24e-01 |
| GOBP ORGANIC ACID TRANSPORT | 241 | 7.45e-02 | -6.67e-02 | 3.34e-01 |
| GOCC EXORIBONUCLEASE COMPLEX | 25 | 5.64e-01 | 6.67e-02 | 8.29e-01 |
| GOBP RETINAL CONE CELL DIFFERENTIATION | 8 | 7.44e-01 | 6.66e-02 | 9.10e-01 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 41 | 4.60e-01 | -6.66e-02 | 7.64e-01 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 24 | 5.72e-01 | -6.66e-02 | 8.31e-01 |
| GOBP REGULATION OF PROTEOLYSIS | 499 | 1.09e-02 | -6.66e-02 | 1.20e-01 |
| GOBP REGULATION OF BONE RESORPTION | 32 | 5.14e-01 | -6.66e-02 | 7.98e-01 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 7 | 7.60e-01 | 6.66e-02 | 9.16e-01 |
| GOBP REPLACEMENT OSSIFICATION | 23 | 5.81e-01 | -6.66e-02 | 8.34e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 173 | 1.31e-01 | -6.65e-02 | 4.43e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 47 | 4.30e-01 | -6.65e-02 | 7.44e-01 |
| GOBP GLOMERULUS DEVELOPMENT | 53 | 4.03e-01 | -6.65e-02 | 7.26e-01 |
| GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 7 | 7.61e-01 | -6.65e-02 | 9.16e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 10 | 7.16e-01 | -6.64e-02 | 8.99e-01 |
| GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 7.97e-01 | -6.63e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 5.58e-01 | -6.63e-02 | 8.27e-01 |
| GOBP TRNA PROCESSING | 135 | 1.84e-01 | 6.63e-02 | 5.22e-01 |
| GOBP TRANSLATIONAL ELONGATION | 67 | 3.48e-01 | 6.63e-02 | 6.88e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 26 | 5.59e-01 | 6.62e-02 | 8.27e-01 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 8 | 7.46e-01 | 6.62e-02 | 9.10e-01 |
| GOBP MESODERM MORPHOGENESIS | 49 | 4.24e-01 | -6.61e-02 | 7.41e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 105 | 2.42e-01 | -6.60e-02 | 5.90e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 63 | 3.65e-01 | -6.60e-02 | 6.99e-01 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 8 | 7.47e-01 | 6.60e-02 | 9.11e-01 |
| GOBP L LYSINE TRANSMEMBRANE TRANSPORT | 5 | 7.98e-01 | -6.59e-02 | 9.33e-01 |
| GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 7.98e-01 | -6.59e-02 | 9.33e-01 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 13 | 6.81e-01 | 6.59e-02 | 8.84e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 16 | 6.49e-01 | 6.58e-02 | 8.69e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 31 | 5.26e-01 | 6.58e-02 | 8.06e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 21 | 6.02e-01 | 6.58e-02 | 8.47e-01 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 25 | 5.69e-01 | -6.57e-02 | 8.30e-01 |
| GOMF SODIUM PHOSPHATE SYMPORTER ACTIVITY | 7 | 7.63e-01 | -6.57e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 6.49e-01 | -6.57e-02 | 8.69e-01 |
| GOMF U1 SNRNA BINDING | 8 | 7.48e-01 | -6.57e-02 | 9.11e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 11 | 7.06e-01 | -6.57e-02 | 8.95e-01 |
| GOBP MAINTENANCE OF LOCATION | 274 | 6.14e-02 | -6.57e-02 | 3.02e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 5.86e-01 | 6.57e-02 | 8.38e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 113 | 2.28e-01 | 6.57e-02 | 5.73e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 7 | 7.64e-01 | -6.56e-02 | 9.18e-01 |
| GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 7 | 7.64e-01 | 6.56e-02 | 9.18e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 221 | 9.28e-02 | 6.56e-02 | 3.72e-01 |
| GOBP CHROMOSOME CONDENSATION | 37 | 4.90e-01 | 6.56e-02 | 7.85e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 14 | 6.71e-01 | -6.56e-02 | 8.79e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 22 | 5.94e-01 | 6.56e-02 | 8.42e-01 |
| GOBP XENOBIOTIC TRANSPORT | 40 | 4.73e-01 | -6.56e-02 | 7.73e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 17 | 6.40e-01 | -6.55e-02 | 8.65e-01 |
| GOBP AXONAL FASCICULATION | 16 | 6.50e-01 | -6.55e-02 | 8.69e-01 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 174 | 1.36e-01 | 6.55e-02 | 4.52e-01 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 5.02e-01 | -6.55e-02 | 7.92e-01 |
| GOCC MLL1 2 COMPLEX | 32 | 5.21e-01 | 6.55e-02 | 8.03e-01 |
| GOMF KINASE ACTIVITY | 652 | 4.34e-03 | 6.55e-02 | 6.58e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 110 | 2.36e-01 | -6.55e-02 | 5.83e-01 |
| GOCC MIDBODY | 195 | 1.15e-01 | 6.54e-02 | 4.15e-01 |
| GOBP CYTIDINE TO URIDINE EDITING | 11 | 7.07e-01 | 6.54e-02 | 8.95e-01 |
| GOBP INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION | 5 | 8.00e-01 | 6.54e-02 | 9.34e-01 |
| GOBP CELLULAR RESPONSE TO ALDOSTERONE | 6 | 7.81e-01 | 6.54e-02 | 9.26e-01 |
| GOMF RRNA BINDING | 64 | 3.65e-01 | -6.54e-02 | 6.99e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 18 | 6.31e-01 | -6.53e-02 | 8.61e-01 |
| GOMF SPHINGOLIPID BINDING | 26 | 5.64e-01 | -6.53e-02 | 8.29e-01 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 26 | 5.64e-01 | -6.53e-02 | 8.29e-01 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 85 | 2.98e-01 | 6.53e-02 | 6.47e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 11 | 7.08e-01 | 6.53e-02 | 8.96e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY | 7 | 7.65e-01 | 6.52e-02 | 9.18e-01 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 25 | 5.73e-01 | -6.52e-02 | 8.31e-01 |
| GOMF GTPASE INHIBITOR ACTIVITY | 11 | 7.08e-01 | -6.51e-02 | 8.96e-01 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 44 | 4.55e-01 | -6.51e-02 | 7.59e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 33 | 5.18e-01 | -6.50e-02 | 8.01e-01 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 73 | 3.38e-01 | 6.48e-02 | 6.80e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 408 | 2.47e-02 | 6.48e-02 | 1.88e-01 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 48 | 4.38e-01 | 6.48e-02 | 7.49e-01 |
| GOBP REGULATION OF BONE REMODELING | 36 | 5.01e-01 | -6.47e-02 | 7.91e-01 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 7 | 7.67e-01 | -6.47e-02 | 9.19e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 32 | 5.26e-01 | -6.47e-02 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 14 | 6.75e-01 | 6.47e-02 | 8.81e-01 |
| GOBP REGULATION OF HEMOPOIESIS | 359 | 3.53e-02 | -6.47e-02 | 2.27e-01 |
| GOBP IODIDE TRANSPORT | 5 | 8.02e-01 | -6.46e-02 | 9.35e-01 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 9 | 7.37e-01 | -6.46e-02 | 9.08e-01 |
| GOBP INORGANIC ION HOMEOSTASIS | 401 | 2.64e-02 | -6.46e-02 | 1.95e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 75 | 3.33e-01 | -6.46e-02 | 6.77e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 51 | 4.25e-01 | 6.46e-02 | 7.42e-01 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 8 | 7.52e-01 | 6.46e-02 | 9.13e-01 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 164 | 1.54e-01 | 6.46e-02 | 4.79e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 42 | 4.69e-01 | -6.45e-02 | 7.71e-01 |
| GOBP RESPONSE TO TYPE II INTERFERON | 105 | 2.53e-01 | 6.45e-02 | 6.01e-01 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 250 | 7.90e-02 | 6.45e-02 | 3.44e-01 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 51 | 4.26e-01 | 6.44e-02 | 7.42e-01 |
| GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER | 6 | 7.85e-01 | 6.44e-02 | 9.28e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 5 | 8.03e-01 | -6.44e-02 | 9.36e-01 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 278 | 6.47e-02 | 6.44e-02 | 3.11e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 39 | 4.87e-01 | -6.44e-02 | 7.83e-01 |
| GOBP OOGENESIS | 72 | 3.45e-01 | 6.44e-02 | 6.85e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 75 | 3.35e-01 | 6.43e-02 | 6.78e-01 |
| GOBP REGENERATION | 153 | 1.70e-01 | -6.43e-02 | 5.03e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 10 | 7.25e-01 | 6.43e-02 | 9.03e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 183 | 1.34e-01 | -6.43e-02 | 4.48e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1438 | 4.55e-05 | 6.42e-02 | 2.04e-03 |
| GOBP SULFUR COMPOUND TRANSPORT | 48 | 4.42e-01 | -6.41e-02 | 7.51e-01 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 37 | 5.00e-01 | -6.41e-02 | 7.91e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 9 | 7.39e-01 | 6.41e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 20 | 6.20e-01 | 6.41e-02 | 8.56e-01 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 10 | 7.26e-01 | 6.41e-02 | 9.03e-01 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 15 | 6.68e-01 | 6.40e-02 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 50 | 4.33e-01 | 6.40e-02 | 7.46e-01 |
| GOBP POSITIVE REGULATION OF CATECHOLAMINE SECRETION | 6 | 7.86e-01 | -6.40e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 9 | 7.40e-01 | -6.40e-02 | 9.08e-01 |
| GOBP REGULATION OF APOPTOTIC CELL CLEARANCE | 9 | 7.40e-01 | 6.40e-02 | 9.08e-01 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 9 | 7.40e-01 | -6.40e-02 | 9.08e-01 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 9 | 7.40e-01 | 6.40e-02 | 9.08e-01 |
| GOBP DAMP METABOLIC PROCESS | 6 | 7.86e-01 | 6.40e-02 | 9.28e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 30 | 5.44e-01 | -6.39e-02 | 8.18e-01 |
| GOBP DIENCEPHALON DEVELOPMENT | 40 | 4.84e-01 | 6.39e-02 | 7.82e-01 |
| GOBP LEUKOCYTE PROLIFERATION | 286 | 6.29e-02 | -6.39e-02 | 3.07e-01 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 9 | 7.40e-01 | 6.39e-02 | 9.08e-01 |
| GOBP LEUKOTRIENE SIGNALING PATHWAY | 5 | 8.05e-01 | -6.38e-02 | 9.37e-01 |
| GOBP TRANSLATION | 616 | 6.83e-03 | -6.38e-02 | 8.81e-02 |
| GOBP CELLULAR RESPONSE TO UV | 82 | 3.18e-01 | -6.38e-02 | 6.65e-01 |
| GOCC INTERCELLULAR CANALICULUS | 6 | 7.87e-01 | 6.37e-02 | 9.28e-01 |
| GOBP VASCULATURE DEVELOPMENT | 569 | 9.37e-03 | -6.37e-02 | 1.09e-01 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 6 | 7.87e-01 | 6.37e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 13 | 6.91e-01 | -6.37e-02 | 8.88e-01 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 33 | 5.27e-01 | -6.36e-02 | 8.06e-01 |
| GOBP GTP METABOLIC PROCESS | 22 | 6.05e-01 | -6.36e-02 | 8.49e-01 |
| GOBP RESPONSE TO GROWTH HORMONE | 29 | 5.53e-01 | 6.36e-02 | 8.24e-01 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 7 | 7.71e-01 | 6.36e-02 | 9.22e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 124 | 2.21e-01 | -6.36e-02 | 5.66e-01 |
| GOBP FRUCTOSE 2 6 BISPHOSPHATE METABOLIC PROCESS | 5 | 8.05e-01 | -6.36e-02 | 9.37e-01 |
| GOMF FRUCTOSE 2 6 BISPHOSPHATE 2 PHOSPHATASE ACTIVITY | 5 | 8.05e-01 | -6.36e-02 | 9.37e-01 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 7.71e-01 | 6.36e-02 | 9.22e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 83 | 3.17e-01 | 6.36e-02 | 6.64e-01 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 9 | 7.41e-01 | -6.36e-02 | 9.09e-01 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 10 | 7.28e-01 | 6.36e-02 | 9.03e-01 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 7.28e-01 | -6.35e-02 | 9.03e-01 |
| GOMF RIBONUCLEASE P RNA BINDING | 10 | 7.28e-01 | -6.35e-02 | 9.03e-01 |
| GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 8 | 7.56e-01 | 6.35e-02 | 9.14e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 7 | 7.71e-01 | 6.35e-02 | 9.22e-01 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 13 | 6.92e-01 | -6.35e-02 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 16 | 6.60e-01 | -6.35e-02 | 8.73e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 45 | 4.61e-01 | -6.35e-02 | 7.65e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 16 | 6.60e-01 | 6.35e-02 | 8.73e-01 |
| GOBP MIDDLE EAR MORPHOGENESIS | 9 | 7.42e-01 | 6.34e-02 | 9.09e-01 |
| GOBP REGULATION OF CD40 SIGNALING PATHWAY | 5 | 8.06e-01 | 6.34e-02 | 9.37e-01 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 8 | 7.56e-01 | 6.34e-02 | 9.14e-01 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 40 | 4.88e-01 | 6.34e-02 | 7.84e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 18 | 6.41e-01 | 6.34e-02 | 8.66e-01 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 10 | 7.28e-01 | -6.34e-02 | 9.03e-01 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 12 | 7.04e-01 | -6.34e-02 | 8.94e-01 |
| GOCC POLYPRENYL DIPHOSPHATE SYNTHASE COMPLEX | 11 | 7.16e-01 | -6.34e-02 | 8.99e-01 |
| GOMF GLUTAMATE GATED RECEPTOR ACTIVITY | 11 | 7.16e-01 | 6.34e-02 | 8.99e-01 |
| GOBP RESPONSE TO ZINC ION STARVATION | 8 | 7.56e-01 | -6.34e-02 | 9.14e-01 |
| GOBP PROTEIN TRIMERIZATION | 15 | 6.71e-01 | -6.33e-02 | 8.79e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 239 | 9.17e-02 | 6.33e-02 | 3.70e-01 |
| GOCC VESICLE MEMBRANE | 1075 | 4.55e-04 | -6.33e-02 | 1.25e-02 |
| GOBP FOREBRAIN REGIONALIZATION | 10 | 7.29e-01 | -6.33e-02 | 9.03e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 24 | 5.92e-01 | -6.33e-02 | 8.41e-01 |
| GOBP STEM CELL DEVELOPMENT | 58 | 4.05e-01 | -6.32e-02 | 7.27e-01 |
| GOBP ACID SECRETION | 30 | 5.49e-01 | 6.32e-02 | 8.22e-01 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 79 | 3.31e-01 | 6.32e-02 | 6.76e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 27 | 5.70e-01 | -6.32e-02 | 8.30e-01 |
| GOBP MICROTUBULE POLYMERIZATION | 88 | 3.05e-01 | 6.32e-02 | 6.53e-01 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 6.82e-01 | -6.32e-02 | 8.84e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 402 | 2.98e-02 | -6.31e-02 | 2.09e-01 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 7.72e-01 | 6.31e-02 | 9.22e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 7.72e-01 | 6.31e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 36 | 5.12e-01 | -6.31e-02 | 7.97e-01 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 43 | 4.74e-01 | 6.31e-02 | 7.73e-01 |
| GOBP ANIMAL ORGAN FORMATION | 39 | 4.95e-01 | -6.31e-02 | 7.88e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 13 | 6.94e-01 | -6.30e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 56 | 4.15e-01 | -6.30e-02 | 7.34e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 31 | 5.44e-01 | 6.30e-02 | 8.18e-01 |
| GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 16 | 6.63e-01 | 6.30e-02 | 8.74e-01 |
| GOCC VACUOLAR MEMBRANE | 460 | 2.09e-02 | -6.29e-02 | 1.71e-01 |
| GOCC PROXIMAL DENDRITE | 5 | 8.08e-01 | 6.28e-02 | 9.38e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 7.58e-01 | -6.28e-02 | 9.15e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 28 | 5.65e-01 | -6.28e-02 | 8.29e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 68 | 3.71e-01 | -6.27e-02 | 7.03e-01 |
| GOMF ANTIPORTER ACTIVITY | 111 | 2.54e-01 | -6.27e-02 | 6.02e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 26 | 5.80e-01 | -6.26e-02 | 8.34e-01 |
| GOMF MISFOLDED PROTEIN BINDING | 15 | 6.75e-01 | 6.25e-02 | 8.81e-01 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 60 | 4.02e-01 | 6.25e-02 | 7.26e-01 |
| GOBP XMP METABOLIC PROCESS | 7 | 7.75e-01 | 6.25e-02 | 9.23e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 141 | 2.00e-01 | 6.25e-02 | 5.43e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 21 | 6.20e-01 | 6.25e-02 | 8.56e-01 |
| GOBP ARTERY MORPHOGENESIS | 45 | 4.68e-01 | -6.25e-02 | 7.69e-01 |
| GOBP CELL MOTILITY | 1316 | 1.40e-04 | -6.25e-02 | 5.06e-03 |
| GOBP EPITHELIAL CELL PROLIFERATION | 317 | 5.57e-02 | -6.25e-02 | 2.88e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 13 | 6.97e-01 | -6.25e-02 | 8.91e-01 |
| GOMF GAMMA CATENIN BINDING | 8 | 7.60e-01 | 6.24e-02 | 9.16e-01 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 7 | 7.75e-01 | 6.24e-02 | 9.23e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 268 | 7.86e-02 | -6.24e-02 | 3.43e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 25 | 5.90e-01 | -6.23e-02 | 8.40e-01 |
| GOBP L HISTIDINE TRANSMEMBRANE TRANSPORT | 5 | 8.09e-01 | 6.23e-02 | 9.38e-01 |
| GOBP BODY FLUID SECRETION | 62 | 3.96e-01 | 6.23e-02 | 7.22e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 21 | 6.21e-01 | 6.23e-02 | 8.57e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING | 6 | 7.92e-01 | -6.23e-02 | 9.30e-01 |
| GOBP REGULATION OF FERTILIZATION | 10 | 7.33e-01 | -6.23e-02 | 9.06e-01 |
| GOBP LIPID METABOLIC PROCESS | 1088 | 5.20e-04 | -6.23e-02 | 1.38e-02 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 8.09e-01 | -6.23e-02 | 9.38e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 195 | 1.34e-01 | -6.23e-02 | 4.48e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 50 | 4.46e-01 | -6.23e-02 | 7.54e-01 |
| GOCC U6 SNRNP | 8 | 7.60e-01 | 6.23e-02 | 9.16e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 8 | 7.60e-01 | 6.23e-02 | 9.16e-01 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 5.55e-01 | 6.23e-02 | 8.25e-01 |
| GOBP TELOMERASE RNA LOCALIZATION | 19 | 6.38e-01 | -6.23e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 325 | 5.37e-02 | 6.23e-02 | 2.81e-01 |
| GOBP NEUROENDOCRINE CELL DIFFERENTIATION | 8 | 7.60e-01 | 6.23e-02 | 9.16e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 17 | 6.57e-01 | -6.22e-02 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 27 | 5.76e-01 | 6.22e-02 | 8.33e-01 |
| GOBP METALLO SULFUR CLUSTER ASSEMBLY | 28 | 5.69e-01 | -6.21e-02 | 8.30e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 60 | 4.05e-01 | -6.21e-02 | 7.27e-01 |
| GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY | 6 | 7.92e-01 | 6.21e-02 | 9.30e-01 |
| GOMF VIRION BINDING | 7 | 7.76e-01 | 6.21e-02 | 9.23e-01 |
| GOMF ATPASE BINDING | 70 | 3.69e-01 | -6.20e-02 | 7.02e-01 |
| GOCC SYNAPSE | 1108 | 5.04e-04 | -6.19e-02 | 1.36e-02 |
| GOBP PROTEIN ACYLATION | 86 | 3.21e-01 | 6.19e-02 | 6.67e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 100 | 2.85e-01 | -6.18e-02 | 6.34e-01 |
| GOBP HORMONE TRANSPORT | 232 | 1.05e-01 | -6.18e-02 | 3.95e-01 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 12 | 7.11e-01 | -6.18e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 49 | 4.54e-01 | 6.18e-02 | 7.59e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 13 | 7.00e-01 | -6.18e-02 | 8.92e-01 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 14 | 6.89e-01 | 6.17e-02 | 8.87e-01 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 179 | 1.54e-01 | -6.17e-02 | 4.80e-01 |
| GOBP T CELL PROLIFERATION | 186 | 1.47e-01 | -6.17e-02 | 4.69e-01 |
| GOCC I BAND | 104 | 2.77e-01 | -6.17e-02 | 6.26e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 400 | 3.46e-02 | -6.16e-02 | 2.25e-01 |
| GOCC DENDRITIC SHAFT | 32 | 5.47e-01 | -6.15e-02 | 8.21e-01 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 10 | 7.36e-01 | 6.15e-02 | 9.08e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 41 | 4.96e-01 | 6.14e-02 | 7.88e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 18 | 6.52e-01 | 6.14e-02 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF FIBRINOLYSIS | 9 | 7.50e-01 | -6.14e-02 | 9.12e-01 |
| GOMF LIPID BINDING | 670 | 6.70e-03 | -6.14e-02 | 8.73e-02 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 99 | 2.91e-01 | -6.14e-02 | 6.39e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 28 | 5.74e-01 | 6.14e-02 | 8.32e-01 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 7.64e-01 | 6.14e-02 | 9.18e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 160 | 1.80e-01 | 6.14e-02 | 5.17e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 23 | 6.10e-01 | -6.14e-02 | 8.52e-01 |
| GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 7 | 7.79e-01 | 6.13e-02 | 9.25e-01 |
| GOBP CELLULAR RESPONSE TO HEAT | 57 | 4.24e-01 | 6.13e-02 | 7.41e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 18 | 6.53e-01 | 6.13e-02 | 8.70e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 5 | 8.12e-01 | 6.13e-02 | 9.39e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 29 | 5.68e-01 | -6.12e-02 | 8.30e-01 |
| GOBP CELLULAR RESPONSE TO CGMP | 6 | 7.95e-01 | 6.12e-02 | 9.31e-01 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 10 | 7.38e-01 | 6.11e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 11 | 7.26e-01 | -6.11e-02 | 9.03e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 17 | 6.63e-01 | -6.11e-02 | 8.74e-01 |
| GOBP T CELL TOLERANCE INDUCTION | 15 | 6.82e-01 | 6.11e-02 | 8.84e-01 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 11 | 7.26e-01 | 6.10e-02 | 9.03e-01 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 13 | 7.04e-01 | 6.09e-02 | 8.94e-01 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 224 | 1.16e-01 | -6.09e-02 | 4.15e-01 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 9 | 7.52e-01 | 6.08e-02 | 9.13e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 140 | 2.15e-01 | -6.08e-02 | 5.59e-01 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 19 | 6.47e-01 | -6.08e-02 | 8.69e-01 |
| GOCC ENDOCYTIC VESICLE | 305 | 6.81e-02 | -6.07e-02 | 3.18e-01 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 6 | 7.97e-01 | 6.07e-02 | 9.32e-01 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 34 | 5.40e-01 | -6.07e-02 | 8.15e-01 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 7.97e-01 | 6.06e-02 | 9.32e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 17 | 6.65e-01 | -6.06e-02 | 8.75e-01 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 27 | 5.86e-01 | -6.06e-02 | 8.38e-01 |
| GOCC MICROTUBULE PLUS END | 22 | 6.23e-01 | -6.06e-02 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 5 | 8.14e-01 | -6.06e-02 | 9.39e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 37 | 5.24e-01 | 6.06e-02 | 8.05e-01 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 16 | 6.75e-01 | -6.05e-02 | 8.81e-01 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 20 | 6.39e-01 | 6.05e-02 | 8.65e-01 |
| GOMF MHC PROTEIN BINDING | 41 | 5.02e-01 | 6.05e-02 | 7.92e-01 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 26 | 5.93e-01 | -6.05e-02 | 8.42e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 49 | 4.64e-01 | -6.05e-02 | 7.66e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 36 | 5.30e-01 | -6.04e-02 | 8.08e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 13 | 7.06e-01 | -6.03e-02 | 8.95e-01 |
| GOCC AMPHISOME | 13 | 7.06e-01 | -6.03e-02 | 8.95e-01 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 7 | 7.82e-01 | 6.03e-02 | 9.26e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 24 | 6.09e-01 | 6.03e-02 | 8.52e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 13 | 7.07e-01 | -6.03e-02 | 8.95e-01 |
| GOMF LONG CHAIN FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 7.07e-01 | -6.03e-02 | 8.95e-01 |
| GOBP REGULATION OF BEHAVIOR | 50 | 4.61e-01 | 6.02e-02 | 7.65e-01 |
| GOBP TRANSLATIONAL INITIATION | 114 | 2.67e-01 | -6.02e-02 | 6.16e-01 |
| GOBP CELLULAR HOMEOSTASIS | 646 | 9.06e-03 | -6.02e-02 | 1.07e-01 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 12 | 7.18e-01 | -6.01e-02 | 9.00e-01 |
| GOBP DEVELOPMENTAL GROWTH | 486 | 2.32e-02 | 6.01e-02 | 1.81e-01 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 507 | 2.05e-02 | 6.01e-02 | 1.69e-01 |
| GOCC MEMBRANE PROTEIN COMPLEX | 1129 | 6.60e-04 | -6.01e-02 | 1.65e-02 |
| GOBP SIGNAL RELEASE | 353 | 5.25e-02 | -6.01e-02 | 2.78e-01 |
| GOBP GOLGI ORGANIZATION | 145 | 2.12e-01 | 6.01e-02 | 5.58e-01 |
| GOBP INSULIN SECRETION | 149 | 2.06e-01 | -6.00e-02 | 5.51e-01 |
| GOBP L AMINO ACID TRANSPORT | 72 | 3.79e-01 | 6.00e-02 | 7.11e-01 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 16 | 6.78e-01 | 5.99e-02 | 8.83e-01 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 16 | 6.78e-01 | 5.99e-02 | 8.83e-01 |
| GOBP REGULATION OF TOLL SIGNALING PATHWAY | 5 | 8.17e-01 | 5.99e-02 | 9.40e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 16 | 6.78e-01 | 5.99e-02 | 8.83e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 15 | 6.88e-01 | 5.99e-02 | 8.87e-01 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 20 | 6.43e-01 | -5.99e-02 | 8.67e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 36 | 5.34e-01 | 5.99e-02 | 8.11e-01 |
| GOBP MEIOTIC CELL CYCLE PHASE TRANSITION | 11 | 7.31e-01 | -5.98e-02 | 9.05e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 10 | 7.43e-01 | 5.98e-02 | 9.09e-01 |
| GOBP RESPONSE TO GONADOTROPIN | 20 | 6.43e-01 | -5.98e-02 | 8.67e-01 |
| GOMF SMAD BINDING | 65 | 4.05e-01 | 5.98e-02 | 7.27e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 53 | 4.52e-01 | -5.98e-02 | 7.57e-01 |
| GOBP RESPONSE TO NUTRIENT LEVELS | 381 | 4.53e-02 | -5.97e-02 | 2.60e-01 |
| GOCC TRAPP COMPLEX | 17 | 6.70e-01 | 5.97e-02 | 8.78e-01 |
| GOCC PHOSPHATASE COMPLEX | 50 | 4.65e-01 | 5.97e-02 | 7.67e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 10 | 7.44e-01 | -5.97e-02 | 9.09e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 23 | 6.21e-01 | -5.96e-02 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 48 | 4.76e-01 | -5.95e-02 | 7.74e-01 |
| GOBP MANCHETTE ASSEMBLY | 7 | 7.85e-01 | 5.95e-02 | 9.28e-01 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 19 | 6.54e-01 | -5.95e-02 | 8.71e-01 |
| GOBP GLYCOSYLATION | 213 | 1.35e-01 | -5.94e-02 | 4.50e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 33 | 5.55e-01 | 5.94e-02 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF NEURON MIGRATION | 6 | 8.01e-01 | 5.94e-02 | 9.35e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 5 | 8.18e-01 | 5.93e-02 | 9.41e-01 |
| GOMF AMINO ACID BINDING | 32 | 5.61e-01 | 5.93e-02 | 8.28e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 16 | 6.81e-01 | 5.93e-02 | 8.84e-01 |
| GOBP HAIR CELL DIFFERENTIATION | 35 | 5.44e-01 | -5.93e-02 | 8.18e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 45 | 4.92e-01 | -5.93e-02 | 7.85e-01 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 13 | 7.12e-01 | -5.92e-02 | 8.97e-01 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 511 | 2.20e-02 | 5.92e-02 | 1.75e-01 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 7 | 7.86e-01 | -5.92e-02 | 9.28e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 115 | 2.73e-01 | -5.92e-02 | 6.23e-01 |
| GOBP PROTEASOME MEDIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 377 | 4.85e-02 | 5.92e-02 | 2.69e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 18 | 6.64e-01 | -5.92e-02 | 8.74e-01 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 10 | 7.46e-01 | 5.91e-02 | 9.10e-01 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 11 | 7.34e-01 | 5.91e-02 | 9.07e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 116 | 2.71e-01 | 5.91e-02 | 6.22e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 100 | 3.07e-01 | -5.91e-02 | 6.55e-01 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 237 | 1.17e-01 | 5.91e-02 | 4.17e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 98 | 3.12e-01 | 5.91e-02 | 6.59e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 55 | 4.48e-01 | 5.91e-02 | 7.55e-01 |
| GOBP MUSCLE CELL MIGRATION | 69 | 3.96e-01 | -5.91e-02 | 7.22e-01 |
| GOMF L ASCORBIC ACID BINDING | 19 | 6.56e-01 | -5.91e-02 | 8.71e-01 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 59 | 4.33e-01 | -5.90e-02 | 7.45e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 12 | 7.23e-01 | 5.90e-02 | 9.03e-01 |
| GOBP MESENDODERM DEVELOPMENT | 6 | 8.02e-01 | -5.90e-02 | 9.35e-01 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 52 | 4.62e-01 | -5.90e-02 | 7.65e-01 |
| GOBP CHITIN METABOLIC PROCESS | 5 | 8.19e-01 | 5.89e-02 | 9.41e-01 |
| GOMF CHITINASE ACTIVITY | 5 | 8.19e-01 | 5.89e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 97 | 3.16e-01 | 5.89e-02 | 6.63e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 41 | 5.14e-01 | 5.89e-02 | 7.98e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 18 | 6.66e-01 | 5.88e-02 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 37 | 5.36e-01 | -5.88e-02 | 8.12e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 24 | 6.18e-01 | 5.88e-02 | 8.56e-01 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 10 | 7.48e-01 | 5.88e-02 | 9.11e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 37 | 5.36e-01 | -5.88e-02 | 8.12e-01 |
| GOCC MICROBODY | 130 | 2.47e-01 | -5.88e-02 | 5.95e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 166 | 1.92e-01 | -5.87e-02 | 5.33e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 32 | 5.66e-01 | 5.87e-02 | 8.29e-01 |
| GOBP EXIT FROM MITOSIS | 28 | 5.91e-01 | -5.86e-02 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINESIS | 6 | 8.04e-01 | -5.86e-02 | 9.36e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 13 | 7.14e-01 | -5.86e-02 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 74 | 3.84e-01 | -5.86e-02 | 7.15e-01 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 470 | 2.96e-02 | -5.86e-02 | 2.09e-01 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 12 | 7.25e-01 | -5.86e-02 | 9.03e-01 |
| GOBP RESPONSE TO PROGESTERONE | 32 | 5.66e-01 | -5.86e-02 | 8.29e-01 |
| GOCC RIBONUCLEASE MRP COMPLEX | 9 | 7.61e-01 | -5.85e-02 | 9.16e-01 |
| GOCC IKAPPAB KINASE COMPLEX | 7 | 7.89e-01 | 5.85e-02 | 9.29e-01 |
| GOBP TUBULIN DEACETYLATION | 22 | 6.35e-01 | 5.85e-02 | 8.63e-01 |
| GOBP LYMPHOCYTE AGGREGATION | 5 | 8.21e-01 | 5.85e-02 | 9.42e-01 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 187 | 1.68e-01 | -5.85e-02 | 5.02e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST | 10 | 7.49e-01 | 5.85e-02 | 9.12e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 388 | 4.81e-02 | -5.84e-02 | 2.69e-01 |
| GOCC RECYCLING ENDOSOME | 187 | 1.68e-01 | -5.84e-02 | 5.02e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 103 | 3.06e-01 | -5.84e-02 | 6.53e-01 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 78 | 3.73e-01 | -5.84e-02 | 7.05e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 74 | 3.85e-01 | 5.84e-02 | 7.15e-01 |
| GOBP ACTIN FILAMENT NETWORK FORMATION | 8 | 7.75e-01 | -5.83e-02 | 9.23e-01 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 474 | 2.96e-02 | -5.83e-02 | 2.09e-01 |
| GOBP CALCIUM ION TRANSPORT | 323 | 7.16e-02 | -5.83e-02 | 3.26e-01 |
| GOMF TRANSPORTER REGULATOR ACTIVITY | 113 | 2.84e-01 | -5.83e-02 | 6.34e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 18 | 6.69e-01 | -5.83e-02 | 8.77e-01 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 117 | 2.76e-01 | 5.83e-02 | 6.26e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 8 | 7.75e-01 | -5.82e-02 | 9.23e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 37 | 5.40e-01 | 5.82e-02 | 8.15e-01 |
| GOBP CELLULAR CATABOLIC PROCESS | 995 | 1.90e-03 | -5.82e-02 | 3.65e-02 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 7 | 7.90e-01 | 5.82e-02 | 9.29e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 108 | 2.97e-01 | 5.81e-02 | 6.45e-01 |
| GOBP CYTOKINESIS | 169 | 1.93e-01 | 5.81e-02 | 5.34e-01 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 11 | 7.39e-01 | 5.80e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 144 | 2.30e-01 | -5.80e-02 | 5.75e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 12 | 7.28e-01 | -5.80e-02 | 9.03e-01 |
| GOBP AMP BIOSYNTHETIC PROCESS | 13 | 7.17e-01 | -5.80e-02 | 9.00e-01 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 7 | 7.91e-01 | 5.80e-02 | 9.30e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 630 | 1.30e-02 | 5.79e-02 | 1.33e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 31 | 5.77e-01 | -5.79e-02 | 8.33e-01 |
| GOBP MEMORY | 92 | 3.37e-01 | 5.79e-02 | 6.79e-01 |
| GOBP FATTY ACID ALPHA OXIDATION | 6 | 8.06e-01 | -5.79e-02 | 9.37e-01 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 9 | 7.64e-01 | 5.79e-02 | 9.18e-01 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 33 | 5.65e-01 | 5.78e-02 | 8.29e-01 |
| GOCC COPI VESICLE COAT | 13 | 7.18e-01 | 5.78e-02 | 9.00e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 583 | 1.71e-02 | -5.78e-02 | 1.54e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 7 | 7.91e-01 | -5.78e-02 | 9.30e-01 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 31 | 5.78e-01 | 5.77e-02 | 8.33e-01 |
| GOBP LAMELLIPODIUM ORGANIZATION | 81 | 3.70e-01 | -5.77e-02 | 7.02e-01 |
| GOCC CHYLOMICRON | 5 | 8.23e-01 | -5.76e-02 | 9.42e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 92 | 3.40e-01 | 5.76e-02 | 6.81e-01 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 282 | 9.61e-02 | -5.76e-02 | 3.78e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 106 | 3.06e-01 | -5.76e-02 | 6.54e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 9 | 7.65e-01 | 5.75e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 560 | 2.00e-02 | -5.75e-02 | 1.67e-01 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 14 | 7.10e-01 | -5.75e-02 | 8.97e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 14 | 7.10e-01 | -5.75e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 112 | 2.94e-01 | -5.74e-02 | 6.42e-01 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 96 | 3.31e-01 | -5.74e-02 | 6.75e-01 |
| GOMF NADPLUS NUCLEOTIDASE CYCLIC ADP RIBOSE GENERATING | 13 | 7.20e-01 | -5.74e-02 | 9.01e-01 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 94 | 3.37e-01 | -5.74e-02 | 6.79e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 48 | 4.92e-01 | -5.73e-02 | 7.85e-01 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 20 | 6.57e-01 | -5.73e-02 | 8.72e-01 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 34 | 5.63e-01 | -5.73e-02 | 8.28e-01 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 8 | 7.79e-01 | -5.73e-02 | 9.25e-01 |
| GOCC CHROMAFFIN GRANULE | 11 | 7.42e-01 | -5.73e-02 | 9.09e-01 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 13 | 7.21e-01 | 5.72e-02 | 9.01e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 14 | 7.11e-01 | 5.72e-02 | 8.97e-01 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 24 | 6.28e-01 | -5.72e-02 | 8.58e-01 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 7.93e-01 | -5.72e-02 | 9.31e-01 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 53 | 4.72e-01 | 5.71e-02 | 7.72e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 318 | 8.00e-02 | -5.71e-02 | 3.45e-01 |
| GOBP MATURATION OF 5 8S RRNA | 35 | 5.59e-01 | 5.71e-02 | 8.27e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 68 | 4.16e-01 | 5.70e-02 | 7.35e-01 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 8.09e-01 | 5.70e-02 | 9.38e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 118 | 2.85e-01 | 5.70e-02 | 6.34e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 164 | 2.08e-01 | -5.69e-02 | 5.54e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 10 | 7.55e-01 | 5.69e-02 | 9.14e-01 |
| GOBP FAT CELL DIFFERENTIATION | 180 | 1.88e-01 | -5.69e-02 | 5.28e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 29 | 5.96e-01 | 5.69e-02 | 8.44e-01 |
| GOBP MACROPHAGE ACTIVATION | 92 | 3.46e-01 | -5.69e-02 | 6.86e-01 |
| GOMF PHOSPHATASE ACTIVITY | 231 | 1.37e-01 | -5.68e-02 | 4.53e-01 |
| GOBP ENDODERM FORMATION | 47 | 5.01e-01 | -5.67e-02 | 7.91e-01 |
| GOCC SORTING ENDOSOME | 5 | 8.26e-01 | -5.67e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 19 | 6.69e-01 | 5.67e-02 | 8.77e-01 |
| GOCC NEURON TO NEURON SYNAPSE | 280 | 1.02e-01 | -5.67e-02 | 3.91e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 12 | 7.34e-01 | 5.67e-02 | 9.07e-01 |
| GOBP RENAL PROTEIN ABSORPTION | 6 | 8.10e-01 | 5.67e-02 | 9.38e-01 |
| GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 7.34e-01 | 5.67e-02 | 9.07e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 43 | 5.20e-01 | -5.67e-02 | 8.02e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 52 | 4.80e-01 | 5.67e-02 | 7.78e-01 |
| GOBP VESICLE COATING | 39 | 5.40e-01 | 5.67e-02 | 8.15e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN | 27 | 6.11e-01 | -5.66e-02 | 8.52e-01 |
| GOBP REGULATION OF CELL SIZE | 151 | 2.30e-01 | 5.66e-02 | 5.76e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 170 | 2.03e-01 | -5.66e-02 | 5.46e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 221 | 1.48e-01 | 5.65e-02 | 4.71e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 82 | 3.77e-01 | -5.64e-02 | 7.09e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 173 | 2.00e-01 | 5.64e-02 | 5.43e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 16 | 6.96e-01 | 5.64e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 18 | 6.79e-01 | 5.63e-02 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 36 | 5.59e-01 | -5.63e-02 | 8.27e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 21 | 6.55e-01 | 5.63e-02 | 8.71e-01 |
| GOBP FEEDING BEHAVIOR | 51 | 4.87e-01 | -5.63e-02 | 7.83e-01 |
| GOBP LUNG CELL DIFFERENTIATION | 17 | 6.88e-01 | 5.63e-02 | 8.87e-01 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 11 | 7.47e-01 | 5.62e-02 | 9.11e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 7 | 7.97e-01 | -5.62e-02 | 9.32e-01 |
| GOBP PHOTOTRANSDUCTION | 27 | 6.13e-01 | 5.62e-02 | 8.53e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 238 | 1.35e-01 | -5.62e-02 | 4.51e-01 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 179 | 1.95e-01 | -5.62e-02 | 5.37e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 19 | 6.72e-01 | -5.61e-02 | 8.80e-01 |
| GOBP REGULATION OF MITOPHAGY | 35 | 5.66e-01 | -5.61e-02 | 8.29e-01 |
| GOMF NFAT PROTEIN BINDING | 5 | 8.28e-01 | 5.60e-02 | 9.43e-01 |
| GOBP MITOTIC CYTOKINESIS | 88 | 3.64e-01 | 5.60e-02 | 6.99e-01 |
| GOBP DEVELOPMENTAL MATURATION | 233 | 1.41e-01 | -5.60e-02 | 4.60e-01 |
| GOBP RESPONSE TO OXYGEN LEVELS | 267 | 1.15e-01 | -5.60e-02 | 4.15e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 33 | 5.78e-01 | 5.60e-02 | 8.33e-01 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 22 | 6.50e-01 | 5.59e-02 | 8.69e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 184 | 1.91e-01 | -5.59e-02 | 5.32e-01 |
| GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX | 9 | 7.72e-01 | -5.58e-02 | 9.22e-01 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 7.60e-01 | -5.58e-02 | 9.16e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 41 | 5.37e-01 | -5.58e-02 | 8.12e-01 |
| GOBP L PROLINE BIOSYNTHETIC PROCESS | 6 | 8.13e-01 | -5.58e-02 | 9.39e-01 |
| GOCC SAGA TYPE COMPLEX | 37 | 5.57e-01 | 5.57e-02 | 8.26e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 45 | 5.18e-01 | -5.57e-02 | 8.01e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 621 | 1.78e-02 | 5.57e-02 | 1.58e-01 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 69 | 4.24e-01 | -5.57e-02 | 7.41e-01 |
| GOCC ENDOLYSOSOME MEMBRANE | 19 | 6.74e-01 | 5.57e-02 | 8.81e-01 |
| GOBP AMIDE TRANSPORT | 235 | 1.42e-01 | -5.57e-02 | 4.60e-01 |
| GOBP RIBOSOME ASSEMBLY | 58 | 4.64e-01 | -5.57e-02 | 7.66e-01 |
| GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY | 8 | 7.85e-01 | 5.56e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 65 | 4.38e-01 | 5.56e-02 | 7.49e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 69 | 4.24e-01 | -5.56e-02 | 7.41e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 8 | 7.85e-01 | 5.56e-02 | 9.28e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 27 | 6.17e-01 | 5.56e-02 | 8.55e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 25 | 6.31e-01 | -5.55e-02 | 8.60e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 99 | 3.40e-01 | -5.55e-02 | 6.81e-01 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 16 | 7.01e-01 | -5.55e-02 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 64 | 4.43e-01 | 5.54e-02 | 7.51e-01 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 181 | 1.99e-01 | -5.54e-02 | 5.41e-01 |
| GOBP TYPE 2 IMMUNE RESPONSE | 39 | 5.50e-01 | -5.53e-02 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 15 | 7.11e-01 | -5.53e-02 | 8.97e-01 |
| GOBP CELLULAR RESPONSE TO COCAINE | 7 | 8.00e-01 | -5.53e-02 | 9.34e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 119 | 2.98e-01 | 5.53e-02 | 6.47e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS | 6 | 8.15e-01 | 5.53e-02 | 9.39e-01 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 10 | 7.62e-01 | -5.53e-02 | 9.17e-01 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 8 | 7.87e-01 | -5.53e-02 | 9.28e-01 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 9 | 7.74e-01 | -5.52e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 46 | 5.17e-01 | 5.52e-02 | 8.01e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 50 | 5.00e-01 | -5.51e-02 | 7.91e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 348 | 7.78e-02 | 5.50e-02 | 3.41e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 133 | 2.73e-01 | -5.50e-02 | 6.23e-01 |
| GOCC RNA POLYMERASE II HOLOENZYME | 70 | 4.26e-01 | 5.50e-02 | 7.42e-01 |
| GOCC MSL COMPLEX | 5 | 8.31e-01 | -5.50e-02 | 9.44e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 104 | 3.33e-01 | -5.50e-02 | 6.77e-01 |
| GOBP RESPONSE TO LEPTIN | 17 | 6.95e-01 | 5.49e-02 | 8.91e-01 |
| GOBP KERATINIZATION | 23 | 6.48e-01 | 5.49e-02 | 8.69e-01 |
| GOCC POSTSYNAPTIC CYTOSOL | 12 | 7.42e-01 | 5.49e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 7 | 8.02e-01 | 5.48e-02 | 9.35e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 55 | 4.82e-01 | -5.48e-02 | 7.79e-01 |
| GOBP MYELOID CELL HOMEOSTASIS | 164 | 2.26e-01 | -5.48e-02 | 5.71e-01 |
| GOBP RESPONSE TO RADIATION | 362 | 7.35e-02 | 5.48e-02 | 3.32e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 27 | 6.22e-01 | -5.47e-02 | 8.57e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 135 | 2.72e-01 | -5.47e-02 | 6.22e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 718 | 1.25e-02 | 5.47e-02 | 1.30e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 195 | 1.88e-01 | -5.47e-02 | 5.28e-01 |
| GOCC PARASPECKLES | 9 | 7.76e-01 | 5.47e-02 | 9.23e-01 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 100 | 3.45e-01 | -5.46e-02 | 6.85e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 126 | 2.90e-01 | 5.45e-02 | 6.39e-01 |
| GOBP EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION | 8 | 7.90e-01 | -5.45e-02 | 9.29e-01 |
| GOCC TORC1 COMPLEX | 6 | 8.17e-01 | -5.44e-02 | 9.40e-01 |
| GOBP ENDOCYTIC RECYCLING | 81 | 3.97e-01 | 5.44e-02 | 7.23e-01 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 34 | 5.83e-01 | -5.44e-02 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 6 | 8.17e-01 | -5.44e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 13 | 7.34e-01 | 5.44e-02 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 169 | 2.23e-01 | -5.44e-02 | 5.68e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 97 | 3.55e-01 | 5.43e-02 | 6.93e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 41 | 5.47e-01 | -5.43e-02 | 8.21e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 29 | 6.13e-01 | 5.43e-02 | 8.53e-01 |
| GOBP HEPARIN METABOLIC PROCESS | 13 | 7.35e-01 | -5.43e-02 | 9.07e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 38 | 5.63e-01 | -5.43e-02 | 8.28e-01 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 119 | 3.07e-01 | -5.42e-02 | 6.55e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 21 | 6.67e-01 | -5.42e-02 | 8.77e-01 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 21 | 6.67e-01 | 5.42e-02 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 463 | 4.56e-02 | -5.42e-02 | 2.61e-01 |
| GOBP MICROTUBULE BASED PROCESS | 794 | 9.43e-03 | 5.42e-02 | 1.09e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 28 | 6.20e-01 | -5.42e-02 | 8.56e-01 |
| GOBP VIRION ASSEMBLY | 33 | 5.90e-01 | 5.42e-02 | 8.40e-01 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 24 | 6.46e-01 | 5.42e-02 | 8.69e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 7.45e-01 | 5.41e-02 | 9.10e-01 |
| GOBP GLUCOCORTICOID SECRETION | 9 | 7.79e-01 | 5.41e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 55 | 4.88e-01 | -5.41e-02 | 7.84e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 99 | 3.53e-01 | 5.41e-02 | 6.92e-01 |
| GOCC EXOCYTIC VESICLE | 178 | 2.14e-01 | -5.40e-02 | 5.59e-01 |
| GOBP NEGATIVE REGULATION OF CGAS STING SIGNALING PATHWAY | 12 | 7.46e-01 | -5.40e-02 | 9.10e-01 |
| GOBP REGULATION OF LOCOMOTION | 824 | 8.43e-03 | -5.40e-02 | 1.02e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 119 | 3.09e-01 | 5.40e-02 | 6.56e-01 |
| GOMF CYCLIN BINDING | 31 | 6.03e-01 | 5.40e-02 | 8.48e-01 |
| GOMF DEATH RECEPTOR BINDING | 17 | 7.00e-01 | -5.40e-02 | 8.92e-01 |
| GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY | 8 | 7.92e-01 | -5.40e-02 | 9.30e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 496 | 3.97e-02 | 5.39e-02 | 2.42e-01 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 10 | 7.68e-01 | 5.39e-02 | 9.20e-01 |
| GOBP OSSIFICATION | 305 | 1.05e-01 | -5.39e-02 | 3.96e-01 |
| GOMF ALDOSE REDUCTASE NADPH ACTIVITY | 8 | 7.92e-01 | -5.39e-02 | 9.30e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 163 | 2.36e-01 | -5.38e-02 | 5.83e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 60 | 4.71e-01 | 5.38e-02 | 7.72e-01 |
| GOMF LIGASE ACTIVITY | 158 | 2.44e-01 | -5.38e-02 | 5.90e-01 |
| GOBP INTERLEUKIN 18 PRODUCTION | 11 | 7.58e-01 | 5.38e-02 | 9.15e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 60 | 4.72e-01 | 5.37e-02 | 7.72e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 55 | 4.91e-01 | -5.37e-02 | 7.85e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 88 | 3.84e-01 | -5.36e-02 | 7.15e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 28 | 6.24e-01 | 5.36e-02 | 8.57e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 9 | 7.81e-01 | -5.35e-02 | 9.26e-01 |
| GOBP B 1 B CELL DIFFERENTIATION | 5 | 8.36e-01 | -5.35e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 318 | 1.01e-01 | -5.35e-02 | 3.88e-01 |
| GOMF POLY PURINE TRACT BINDING | 26 | 6.37e-01 | 5.35e-02 | 8.64e-01 |
| GOMF SPECTRIN BINDING | 25 | 6.44e-01 | 5.34e-02 | 8.67e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 19 | 6.87e-01 | -5.34e-02 | 8.86e-01 |
| GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 6 | 8.21e-01 | 5.34e-02 | 9.42e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 10 | 7.70e-01 | 5.34e-02 | 9.21e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 53 | 5.02e-01 | 5.33e-02 | 7.92e-01 |
| GOCC RNA CAP BINDING COMPLEX | 15 | 7.21e-01 | -5.33e-02 | 9.01e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 23 | 6.58e-01 | -5.33e-02 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 9 | 7.82e-01 | 5.32e-02 | 9.26e-01 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 38 | 5.70e-01 | -5.32e-02 | 8.30e-01 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 10 | 7.71e-01 | 5.32e-02 | 9.22e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 45 | 5.37e-01 | -5.32e-02 | 8.12e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 88 | 3.89e-01 | 5.32e-02 | 7.17e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 39 | 5.66e-01 | 5.31e-02 | 8.29e-01 |
| GOCC COSTAMERE | 15 | 7.22e-01 | -5.31e-02 | 9.02e-01 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 18 | 6.96e-01 | -5.31e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 8 | 7.95e-01 | -5.31e-02 | 9.31e-01 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 18 | 6.96e-01 | 5.31e-02 | 8.91e-01 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 62 | 4.70e-01 | 5.31e-02 | 7.71e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 245 | 1.52e-01 | -5.31e-02 | 4.77e-01 |
| GOMF CHROMATIN DNA BINDING | 111 | 3.34e-01 | 5.31e-02 | 6.77e-01 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 24 | 6.53e-01 | -5.31e-02 | 8.70e-01 |
| GOCC NUCLEAR ENVELOPE LUMEN | 10 | 7.71e-01 | -5.31e-02 | 9.22e-01 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 1042 | 3.79e-03 | -5.31e-02 | 5.96e-02 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 121 | 3.14e-01 | 5.30e-02 | 6.60e-01 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 9 | 7.83e-01 | 5.30e-02 | 9.27e-01 |
| GOCC GTPASE COMPLEX | 34 | 5.93e-01 | -5.30e-02 | 8.42e-01 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 30 | 6.16e-01 | 5.30e-02 | 8.55e-01 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 91 | 3.83e-01 | 5.29e-02 | 7.15e-01 |
| GOCC AMINOACYL TRNA SYNTHETASE MULTIENZYME COMPLEX | 11 | 7.62e-01 | -5.28e-02 | 9.17e-01 |
| GOBP DEHYDROASCORBIC ACID TRANSPORT | 7 | 8.09e-01 | -5.28e-02 | 9.38e-01 |
| GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.09e-01 | -5.28e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 342 | 9.36e-02 | -5.28e-02 | 3.74e-01 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 7 | 8.09e-01 | 5.27e-02 | 9.38e-01 |
| GOMF LIPOPROTEIN LIPASE ACTIVITY | 6 | 8.23e-01 | -5.27e-02 | 9.42e-01 |
| GOBP DENDRITIC TRANSPORT | 11 | 7.62e-01 | 5.27e-02 | 9.17e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 20 | 6.84e-01 | -5.26e-02 | 8.85e-01 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 13 | 7.43e-01 | -5.26e-02 | 9.09e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 76 | 4.28e-01 | 5.26e-02 | 7.43e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 88 | 3.94e-01 | -5.26e-02 | 7.21e-01 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 10 | 7.74e-01 | -5.25e-02 | 9.22e-01 |
| GOBP ENDOCRINE HORMONE SECRETION | 39 | 5.71e-01 | -5.25e-02 | 8.30e-01 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 27 | 6.37e-01 | 5.25e-02 | 8.64e-01 |
| GOBP G0 TO G1 TRANSITION | 37 | 5.81e-01 | 5.25e-02 | 8.34e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 50 | 5.21e-01 | 5.25e-02 | 8.02e-01 |
| GOCC PRE SNORNP COMPLEX | 7 | 8.10e-01 | -5.25e-02 | 9.38e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 21 | 6.78e-01 | -5.24e-02 | 8.83e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 25 | 6.50e-01 | -5.24e-02 | 8.69e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 11 | 7.63e-01 | -5.24e-02 | 9.18e-01 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 13 | 7.44e-01 | 5.24e-02 | 9.09e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 113 | 3.36e-01 | -5.24e-02 | 6.79e-01 |
| GOBP CELL PROJECTION ASSEMBLY | 547 | 3.64e-02 | 5.23e-02 | 2.31e-01 |
| GOBP REGULATION OF MEMBRANE LIPID METABOLIC PROCESS | 14 | 7.35e-01 | -5.23e-02 | 9.07e-01 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 44 | 5.49e-01 | -5.22e-02 | 8.22e-01 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 262 | 1.46e-01 | -5.22e-02 | 4.66e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 156 | 2.60e-01 | -5.22e-02 | 6.09e-01 |
| GOBP TRIPEPTIDE TRANSMEMBRANE TRANSPORT | 8 | 7.98e-01 | 5.22e-02 | 9.33e-01 |
| GOBP FACIAL NERVE STRUCTURAL ORGANIZATION | 7 | 8.11e-01 | 5.21e-02 | 9.38e-01 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 9 | 7.87e-01 | 5.21e-02 | 9.28e-01 |
| GOBP DNA PROTECTION | 6 | 8.25e-01 | -5.21e-02 | 9.43e-01 |
| GOBP SPINDLE LOCALIZATION | 50 | 5.24e-01 | 5.21e-02 | 8.05e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 37 | 5.84e-01 | -5.21e-02 | 8.36e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 100 | 3.68e-01 | 5.21e-02 | 7.01e-01 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 18 | 7.02e-01 | -5.21e-02 | 8.93e-01 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 13 | 7.45e-01 | 5.20e-02 | 9.10e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 26 | 6.46e-01 | -5.20e-02 | 8.69e-01 |
| GOCC MYOSIN II COMPLEX | 14 | 7.36e-01 | 5.20e-02 | 9.08e-01 |
| GOMF RIBOSOME BINDING | 101 | 3.67e-01 | 5.20e-02 | 7.00e-01 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1271 | 1.84e-03 | -5.20e-02 | 3.60e-02 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 131 | 3.04e-01 | -5.20e-02 | 6.53e-01 |
| GOBP REGULATION OF CELL ADHESION | 655 | 2.34e-02 | -5.19e-02 | 1.82e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SKIN EPIDERMIS | 14 | 7.37e-01 | 5.19e-02 | 9.08e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 227 | 1.78e-01 | 5.19e-02 | 5.14e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 402 | 7.41e-02 | -5.19e-02 | 3.33e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 11 | 7.66e-01 | -5.19e-02 | 9.18e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 81 | 4.20e-01 | -5.19e-02 | 7.38e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 18 | 7.03e-01 | -5.19e-02 | 8.94e-01 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 155 | 2.65e-01 | 5.18e-02 | 6.14e-01 |
| GOBP RESPONSE TO UV | 141 | 2.89e-01 | 5.18e-02 | 6.36e-01 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 202 | 2.05e-01 | 5.17e-02 | 5.48e-01 |
| GOBP SEX DIFFERENTIATION | 191 | 2.18e-01 | -5.17e-02 | 5.61e-01 |
| GOMF ROUNDABOUT BINDING | 5 | 8.41e-01 | 5.17e-02 | 9.48e-01 |
| GOBP RESPONSE TO CGMP | 7 | 8.13e-01 | 5.17e-02 | 9.39e-01 |
| GOCC BOX C D RNP COMPLEX | 5 | 8.42e-01 | -5.16e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 207 | 2.00e-01 | -5.16e-02 | 5.43e-01 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 8 | 8.00e-01 | -5.16e-02 | 9.34e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 29 | 6.30e-01 | -5.16e-02 | 8.60e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 27 | 6.43e-01 | -5.16e-02 | 8.66e-01 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 13 | 7.47e-01 | 5.16e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 33 | 6.08e-01 | 5.16e-02 | 8.51e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 446 | 6.20e-02 | 5.15e-02 | 3.05e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 252 | 1.59e-01 | -5.15e-02 | 4.87e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 35 | 5.98e-01 | 5.15e-02 | 8.45e-01 |
| GOBP LENS FIBER CELL DEVELOPMENT | 10 | 7.78e-01 | -5.15e-02 | 9.24e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 20 | 6.90e-01 | 5.15e-02 | 8.88e-01 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 135 | 3.02e-01 | 5.15e-02 | 6.51e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 12 | 7.58e-01 | 5.15e-02 | 9.15e-01 |
| GOMF NUCLEASE ACTIVITY | 205 | 2.04e-01 | 5.14e-02 | 5.48e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 142 | 2.90e-01 | -5.14e-02 | 6.38e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 22 | 6.76e-01 | -5.14e-02 | 8.82e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 30 | 6.26e-01 | -5.14e-02 | 8.58e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 8.14e-01 | 5.13e-02 | 9.39e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 167 | 2.53e-01 | 5.12e-02 | 6.01e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 30 | 6.28e-01 | -5.12e-02 | 8.58e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 69 | 4.63e-01 | 5.11e-02 | 7.66e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 17 | 7.15e-01 | 5.11e-02 | 8.99e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 35 | 6.01e-01 | 5.11e-02 | 8.47e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 350 | 1.01e-01 | -5.10e-02 | 3.88e-01 |
| GOMF INTERLEUKIN 1 BINDING | 8 | 8.03e-01 | 5.10e-02 | 9.36e-01 |
| GOMF OXYGEN CARRIER ACTIVITY | 10 | 7.80e-01 | -5.10e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 40 | 5.77e-01 | -5.10e-02 | 8.33e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 177 | 2.42e-01 | -5.10e-02 | 5.90e-01 |
| GOMF FERROUS IRON BINDING | 21 | 6.86e-01 | -5.09e-02 | 8.86e-01 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 7 | 8.16e-01 | 5.09e-02 | 9.39e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 107 | 3.63e-01 | 5.09e-02 | 6.98e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 400 | 8.09e-02 | 5.09e-02 | 3.47e-01 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 12 | 7.60e-01 | -5.08e-02 | 9.16e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 21 | 6.87e-01 | 5.08e-02 | 8.86e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 26 | 6.54e-01 | 5.08e-02 | 8.71e-01 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 18 | 7.09e-01 | -5.08e-02 | 8.97e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 220 | 1.95e-01 | -5.07e-02 | 5.37e-01 |
| GOBP TRNA 5 LEADER REMOVAL | 13 | 7.51e-01 | -5.07e-02 | 9.13e-01 |
| GOBP EXOCYTOSIS | 287 | 1.39e-01 | -5.07e-02 | 4.57e-01 |
| GOBP NADH OXIDATION | 6 | 8.30e-01 | -5.07e-02 | 9.44e-01 |
| GOBP LYMPH VESSEL DEVELOPMENT | 20 | 6.95e-01 | -5.07e-02 | 8.91e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 246 | 1.71e-01 | -5.06e-02 | 5.06e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 30 | 6.31e-01 | -5.06e-02 | 8.61e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 78 | 4.40e-01 | 5.06e-02 | 7.50e-01 |
| GOMF GABA A RECEPTOR ACTIVITY | 5 | 8.45e-01 | 5.06e-02 | 9.49e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 9 | 7.93e-01 | 5.06e-02 | 9.30e-01 |
| GOBP SPROUTING ANGIOGENESIS | 102 | 3.78e-01 | -5.06e-02 | 7.10e-01 |
| GOBP INTERLEUKIN 4 PRODUCTION | 31 | 6.26e-01 | 5.06e-02 | 8.58e-01 |
| GOCC NEURON SPINE | 135 | 3.11e-01 | -5.05e-02 | 6.58e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 22 | 6.82e-01 | -5.05e-02 | 8.84e-01 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 62 | 4.92e-01 | -5.05e-02 | 7.85e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 135 | 3.11e-01 | -5.05e-02 | 6.58e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 27 | 6.50e-01 | 5.05e-02 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 22 | 6.82e-01 | -5.04e-02 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 435 | 7.13e-02 | -5.04e-02 | 3.26e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 17 | 7.19e-01 | -5.04e-02 | 9.00e-01 |
| GOBP GOLGI LOCALIZATION | 13 | 7.53e-01 | -5.04e-02 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 14 | 7.44e-01 | -5.04e-02 | 9.10e-01 |
| GOBP PROTEIN FOLDING | 195 | 2.25e-01 | 5.04e-02 | 5.70e-01 |
| GOCC COPII VESICLE COAT | 16 | 7.27e-01 | 5.04e-02 | 9.03e-01 |
| GOCC NUCLEAR MEMBRANE | 283 | 1.45e-01 | 5.04e-02 | 4.66e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 104 | 3.75e-01 | 5.03e-02 | 7.07e-01 |
| GOBP REGULATION OF TRANSLATION AT POSTSYNAPSE | 5 | 8.46e-01 | 5.03e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 9 | 7.94e-01 | 5.03e-02 | 9.31e-01 |
| GOCC CELL CELL JUNCTION | 394 | 8.69e-02 | -5.03e-02 | 3.58e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 37 | 5.98e-01 | -5.01e-02 | 8.45e-01 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 48 | 5.48e-01 | 5.01e-02 | 8.21e-01 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 7.95e-01 | 5.00e-02 | 9.31e-01 |
| GOBP INTRACELLULAR TRANSPORT | 1257 | 2.85e-03 | 5.00e-02 | 4.86e-02 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 77 | 4.48e-01 | 5.00e-02 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 34 | 6.14e-01 | 4.99e-02 | 8.54e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 42 | 5.76e-01 | -4.99e-02 | 8.33e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 10 | 7.85e-01 | -4.99e-02 | 9.28e-01 |
| GOMF EXTRACELLULAR MATRIX BINDING | 46 | 5.58e-01 | -4.99e-02 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 15 | 7.38e-01 | -4.98e-02 | 9.08e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 34 | 6.15e-01 | -4.98e-02 | 8.55e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 474 | 6.33e-02 | 4.98e-02 | 3.07e-01 |
| GOCC DENDRITE MEMBRANE | 20 | 7.00e-01 | -4.98e-02 | 8.92e-01 |
| GOBP BRUSH BORDER ASSEMBLY | 5 | 8.47e-01 | 4.98e-02 | 9.49e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 52 | 5.35e-01 | -4.97e-02 | 8.12e-01 |
| GOBP CYTOSOL TO ENDOPLASMIC RETICULUM TRANSPORT | 5 | 8.47e-01 | 4.97e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 671 | 2.82e-02 | -4.97e-02 | 2.04e-01 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 18 | 7.15e-01 | 4.96e-02 | 8.99e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 74 | 4.60e-01 | 4.96e-02 | 7.64e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 185 | 2.44e-01 | 4.96e-02 | 5.91e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 23 | 6.81e-01 | 4.96e-02 | 8.84e-01 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 494 | 5.91e-02 | 4.96e-02 | 2.96e-01 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 27 | 6.56e-01 | -4.95e-02 | 8.71e-01 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 77 | 4.52e-01 | -4.95e-02 | 7.57e-01 |
| GOMF PURINE NUCLEOTIDE BINDING | 1735 | 6.10e-04 | 4.95e-02 | 1.56e-02 |
| GOBP UDP N ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORT | 5 | 8.48e-01 | 4.95e-02 | 9.49e-01 |
| GOMF UDP N ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.48e-01 | 4.95e-02 | 9.49e-01 |
| GOBP LYSOSOMAL TRANSPORT | 123 | 3.44e-01 | 4.94e-02 | 6.84e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 34 | 6.18e-01 | -4.94e-02 | 8.56e-01 |
| GOBP RESPONSE TO INACTIVITY | 10 | 7.87e-01 | -4.94e-02 | 9.28e-01 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 60 | 5.08e-01 | -4.94e-02 | 7.96e-01 |
| GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE | 6 | 8.34e-01 | 4.93e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 83 | 4.38e-01 | -4.93e-02 | 7.49e-01 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 25 | 6.70e-01 | 4.92e-02 | 8.78e-01 |
| GOBP MICROVILLUS ORGANIZATION | 28 | 6.52e-01 | 4.92e-02 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 84 | 4.35e-01 | -4.92e-02 | 7.47e-01 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 71 | 4.73e-01 | -4.92e-02 | 7.73e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 45 | 5.68e-01 | 4.92e-02 | 8.30e-01 |
| GOBP RESPONSE TO AMINE | 37 | 6.05e-01 | -4.92e-02 | 8.49e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 7 | 8.22e-01 | -4.92e-02 | 9.42e-01 |
| GOBP EPOXIDE METABOLIC PROCESS | 5 | 8.49e-01 | -4.91e-02 | 9.49e-01 |
| GOBP AXIS ELONGATION | 16 | 7.34e-01 | -4.91e-02 | 9.07e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 289 | 1.51e-01 | 4.91e-02 | 4.75e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 23 | 6.83e-01 | -4.91e-02 | 8.85e-01 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 17 | 7.26e-01 | 4.91e-02 | 9.03e-01 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 35 | 6.15e-01 | -4.91e-02 | 8.55e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 21 | 6.97e-01 | 4.91e-02 | 8.91e-01 |
| GOBP RETINAL CELL PROGRAMMED CELL DEATH | 5 | 8.49e-01 | -4.90e-02 | 9.50e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 186 | 2.49e-01 | -4.90e-02 | 5.96e-01 |
| GOBP PROSTATE GLAND GROWTH | 7 | 8.22e-01 | 4.90e-02 | 9.42e-01 |
| GOCC 9PLUS2 MOTILE CILIUM | 121 | 3.52e-01 | -4.90e-02 | 6.91e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 84 | 4.38e-01 | -4.90e-02 | 7.49e-01 |
| GOBP MACROMOLECULE METHYLATION | 122 | 3.50e-01 | 4.90e-02 | 6.90e-01 |
| GOBP FOREBRAIN DEVELOPMENT | 290 | 1.51e-01 | 4.90e-02 | 4.76e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 22 | 6.91e-01 | 4.89e-02 | 8.88e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 47 | 5.62e-01 | -4.89e-02 | 8.28e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 10 | 7.89e-01 | 4.89e-02 | 9.29e-01 |
| GOBP REGULATION OF CELL MATURATION | 14 | 7.52e-01 | 4.89e-02 | 9.13e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 77 | 4.59e-01 | -4.88e-02 | 7.63e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT | 8 | 8.11e-01 | 4.88e-02 | 9.38e-01 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 10 | 7.89e-01 | -4.88e-02 | 9.29e-01 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 33 | 6.28e-01 | 4.88e-02 | 8.58e-01 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 46 | 5.67e-01 | 4.88e-02 | 8.29e-01 |
| GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE | 5 | 8.50e-01 | -4.88e-02 | 9.50e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 21 | 6.99e-01 | -4.87e-02 | 8.92e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 45 | 5.72e-01 | 4.87e-02 | 8.31e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 24 | 6.80e-01 | -4.86e-02 | 8.84e-01 |
| GOBP GLAND MORPHOGENESIS | 86 | 4.36e-01 | 4.86e-02 | 7.48e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 576 | 4.61e-02 | -4.86e-02 | 2.62e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 1030 | 8.39e-03 | -4.86e-02 | 1.01e-01 |
| GOBP CHOLESTEROL EFFLUX | 40 | 5.95e-01 | 4.86e-02 | 8.43e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 14 | 7.53e-01 | -4.86e-02 | 9.13e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1646 | 1.04e-03 | 4.85e-02 | 2.37e-02 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 58 | 5.23e-01 | 4.85e-02 | 8.04e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 190 | 2.49e-01 | 4.85e-02 | 5.97e-01 |
| GOBP DISTAL TUBULE DEVELOPMENT | 7 | 8.24e-01 | -4.84e-02 | 9.43e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 15 | 7.45e-01 | 4.84e-02 | 9.10e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 69 | 4.87e-01 | -4.84e-02 | 7.83e-01 |
| GOBP HEME TRANSPORT | 9 | 8.02e-01 | 4.84e-02 | 9.35e-01 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 8.02e-01 | 4.84e-02 | 9.35e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 15 | 7.46e-01 | -4.84e-02 | 9.10e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 18 | 7.23e-01 | -4.83e-02 | 9.02e-01 |
| GOMF RETINYL PALMITATE ESTERASE ACTIVITY | 5 | 8.52e-01 | -4.82e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 8 | 8.13e-01 | 4.82e-02 | 9.39e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 474 | 7.23e-02 | -4.82e-02 | 3.28e-01 |
| GOBP CELLULAR RESPONSE TO WATER STIMULUS | 5 | 8.52e-01 | -4.81e-02 | 9.50e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 35 | 6.23e-01 | -4.81e-02 | 8.57e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 19 | 7.17e-01 | 4.81e-02 | 9.00e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 48 | 5.65e-01 | 4.80e-02 | 8.29e-01 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 10 | 7.93e-01 | -4.80e-02 | 9.30e-01 |
| GOBP FERTILIZATION | 127 | 3.50e-01 | -4.80e-02 | 6.90e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 15 | 7.48e-01 | 4.80e-02 | 9.11e-01 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 7 | 8.26e-01 | 4.80e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 8.53e-01 | 4.80e-02 | 9.50e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 11 | 7.83e-01 | 4.80e-02 | 9.27e-01 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 9 | 8.03e-01 | -4.79e-02 | 9.36e-01 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 107 | 3.92e-01 | 4.79e-02 | 7.20e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 309 | 1.47e-01 | -4.79e-02 | 4.70e-01 |
| GOMF GTPASE ACTIVITY | 287 | 1.62e-01 | -4.79e-02 | 4.92e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 57 | 5.32e-01 | -4.79e-02 | 8.09e-01 |
| GOBP PROTEIN AUTOPROCESSING | 16 | 7.40e-01 | -4.78e-02 | 9.08e-01 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 8 | 8.15e-01 | -4.78e-02 | 9.39e-01 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 220 | 2.22e-01 | -4.78e-02 | 5.67e-01 |
| GOCC EARP COMPLEX | 5 | 8.53e-01 | -4.78e-02 | 9.50e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 47 | 5.71e-01 | 4.77e-02 | 8.30e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 43 | 5.89e-01 | -4.77e-02 | 8.40e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 175 | 2.77e-01 | -4.77e-02 | 6.26e-01 |
| GOBP HEAD MORPHOGENESIS | 29 | 6.57e-01 | 4.76e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 452 | 8.31e-02 | 4.76e-02 | 3.51e-01 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 8.54e-01 | -4.76e-02 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF SECRETION | 126 | 3.57e-01 | -4.75e-02 | 6.94e-01 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 10 | 7.95e-01 | 4.75e-02 | 9.31e-01 |
| GOBP RESPONSE TO ACETYLCHOLINE | 28 | 6.64e-01 | 4.75e-02 | 8.74e-01 |
| GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 9 | 8.05e-01 | -4.75e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 697 | 3.28e-02 | -4.75e-02 | 2.19e-01 |
| GOBP N GLYCAN PROCESSING | 15 | 7.50e-01 | 4.74e-02 | 9.12e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 45 | 5.82e-01 | 4.74e-02 | 8.36e-01 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 48 | 5.70e-01 | 4.74e-02 | 8.30e-01 |
| GOBP T CELL MIGRATION | 62 | 5.19e-01 | -4.74e-02 | 8.01e-01 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 66 | 5.06e-01 | -4.74e-02 | 7.94e-01 |
| GOMF STEROL BINDING | 59 | 5.29e-01 | 4.74e-02 | 8.07e-01 |
| GOBP EXPORT FROM CELL | 693 | 3.36e-02 | -4.74e-02 | 2.22e-01 |
| GOMF GUANYL RIBONUCLEOTIDE BINDING | 341 | 1.33e-01 | -4.73e-02 | 4.48e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 161 | 3.01e-01 | -4.73e-02 | 6.51e-01 |
| GOCC SPERMATOPROTEASOME COMPLEX | 5 | 8.55e-01 | 4.73e-02 | 9.50e-01 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 63 | 5.17e-01 | -4.72e-02 | 8.00e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 130 | 3.52e-01 | 4.72e-02 | 6.92e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 851 | 1.94e-02 | -4.72e-02 | 1.65e-01 |
| GOBP CELL JUNCTION ORGANIZATION | 555 | 5.72e-02 | -4.72e-02 | 2.90e-01 |
| GOBP SKIN DEVELOPMENT | 189 | 2.63e-01 | 4.72e-02 | 6.11e-01 |
| GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 6 | 8.41e-01 | 4.72e-02 | 9.48e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 84 | 4.55e-01 | -4.72e-02 | 7.60e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 674 | 3.69e-02 | -4.71e-02 | 2.33e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 125 | 3.63e-01 | -4.71e-02 | 6.98e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 61 | 5.25e-01 | 4.71e-02 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 215 | 2.34e-01 | -4.71e-02 | 5.81e-01 |
| GOBP PROTEIN MATURATION | 456 | 8.50e-02 | -4.71e-02 | 3.55e-01 |
| GOBP ESTROGEN METABOLIC PROCESS | 23 | 6.96e-01 | -4.70e-02 | 8.91e-01 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 21 | 7.09e-01 | -4.70e-02 | 8.97e-01 |
| GOBP ACTION POTENTIAL | 113 | 3.89e-01 | -4.69e-02 | 7.17e-01 |
| GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS | 6 | 8.42e-01 | 4.69e-02 | 9.48e-01 |
| GOMF U1 SNRNP BINDING | 6 | 8.42e-01 | 4.69e-02 | 9.48e-01 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 8.18e-01 | -4.69e-02 | 9.41e-01 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 15 | 7.53e-01 | 4.69e-02 | 9.13e-01 |
| GOBP MAGNESIUM ION TRANSPORT | 17 | 7.38e-01 | 4.69e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 5 | 8.56e-01 | 4.68e-02 | 9.51e-01 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 68 | 5.04e-01 | -4.68e-02 | 7.93e-01 |
| GOBP MEMBRANE FUSION | 145 | 3.31e-01 | -4.68e-02 | 6.75e-01 |
| GOCC CELL PROJECTION MEMBRANE | 284 | 1.75e-01 | -4.68e-02 | 5.10e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 426 | 9.80e-02 | -4.67e-02 | 3.83e-01 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 46 | 5.83e-01 | -4.67e-02 | 8.36e-01 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 120 | 3.77e-01 | -4.67e-02 | 7.10e-01 |
| GOBP MUSCLE ADAPTATION | 80 | 4.71e-01 | 4.67e-02 | 7.72e-01 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 53 | 5.57e-01 | 4.66e-02 | 8.26e-01 |
| GOBP RETINA HOMEOSTASIS | 38 | 6.19e-01 | -4.66e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 531 | 6.63e-02 | -4.66e-02 | 3.13e-01 |
| GOBP REGULATION OF CORTISOL BIOSYNTHETIC PROCESS | 5 | 8.57e-01 | 4.66e-02 | 9.51e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 30 | 6.59e-01 | -4.65e-02 | 8.73e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 11 | 7.89e-01 | 4.65e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 291 | 1.72e-01 | 4.65e-02 | 5.07e-01 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 12 | 7.81e-01 | -4.64e-02 | 9.26e-01 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 15 | 7.56e-01 | -4.64e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 45 | 5.90e-01 | 4.64e-02 | 8.40e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 293 | 1.72e-01 | -4.64e-02 | 5.07e-01 |
| GOBP DIGESTIVE SYSTEM PROCESS | 70 | 5.03e-01 | 4.63e-02 | 7.92e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 84 | 4.63e-01 | 4.63e-02 | 7.66e-01 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 44 | 5.95e-01 | 4.63e-02 | 8.43e-01 |
| GOBP NODAL SIGNALING PATHWAY | 12 | 7.81e-01 | 4.63e-02 | 9.26e-01 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 12 | 7.82e-01 | -4.62e-02 | 9.26e-01 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 21 | 7.14e-01 | -4.61e-02 | 8.98e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 97 | 4.32e-01 | -4.61e-02 | 7.45e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 17 | 7.42e-01 | -4.61e-02 | 9.09e-01 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 8 | 8.22e-01 | -4.61e-02 | 9.42e-01 |
| GOBP MAPK CASCADE | 589 | 5.61e-02 | -4.61e-02 | 2.88e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 65 | 5.21e-01 | -4.61e-02 | 8.02e-01 |
| GOBP GROWTH | 697 | 3.83e-02 | 4.60e-02 | 2.38e-01 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 8 | 8.22e-01 | -4.60e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 165 | 3.09e-01 | -4.59e-02 | 6.56e-01 |
| GOBP AMINO ACID METABOLIC PROCESS | 252 | 2.10e-01 | -4.59e-02 | 5.55e-01 |
| GOMF TROPOMYOSIN BINDING | 12 | 7.83e-01 | -4.58e-02 | 9.27e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 19 | 7.30e-01 | -4.58e-02 | 9.03e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 14 | 7.67e-01 | -4.58e-02 | 9.19e-01 |
| GOBP REGULATION OF GAMMA AMINOBUTYRIC ACID SECRETION | 6 | 8.46e-01 | 4.57e-02 | 9.49e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION MICROTUBULE MEDIATED | 23 | 7.05e-01 | -4.57e-02 | 8.94e-01 |
| GOCC GID COMPLEX | 5 | 8.60e-01 | 4.56e-02 | 9.52e-01 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 9 | 8.13e-01 | -4.56e-02 | 9.39e-01 |
| GOBP TOLERANCE INDUCTION | 28 | 6.76e-01 | -4.56e-02 | 8.82e-01 |
| GOBP T CELL DIFFERENTIATION | 283 | 1.88e-01 | 4.55e-02 | 5.28e-01 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 10 | 8.03e-01 | -4.55e-02 | 9.36e-01 |
| GOBP PERICYTE CELL DIFFERENTIATION | 7 | 8.35e-01 | -4.55e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 1022 | 1.40e-02 | -4.54e-02 | 1.39e-01 |
| GOBP LIVER REGENERATION | 26 | 6.88e-01 | 4.54e-02 | 8.87e-01 |
| GOCC A BAND | 30 | 6.67e-01 | 4.54e-02 | 8.77e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 69 | 5.15e-01 | -4.54e-02 | 7.98e-01 |
| GOMF WNT PROTEIN BINDING | 21 | 7.19e-01 | 4.54e-02 | 9.00e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 65 | 5.27e-01 | -4.54e-02 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 29 | 6.72e-01 | 4.54e-02 | 8.80e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 43 | 6.07e-01 | -4.53e-02 | 8.50e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 19 | 7.33e-01 | 4.53e-02 | 9.06e-01 |
| GOBP PROTEIN POLYMERIZATION | 258 | 2.10e-01 | -4.53e-02 | 5.56e-01 |
| GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY | 6 | 8.48e-01 | -4.53e-02 | 9.49e-01 |
| GOBP REGULATION OF ACTION POTENTIAL | 42 | 6.12e-01 | -4.53e-02 | 8.53e-01 |
| GOCC PLASMA MEMBRANE REGION | 911 | 2.06e-02 | -4.53e-02 | 1.69e-01 |
| GOBP RETINAL CONE CELL DEVELOPMENT | 6 | 8.48e-01 | -4.52e-02 | 9.49e-01 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 24 | 7.02e-01 | -4.52e-02 | 8.93e-01 |
| GOBP APPENDAGE DEVELOPMENT | 120 | 3.93e-01 | 4.52e-02 | 7.21e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 32 | 6.58e-01 | -4.52e-02 | 8.73e-01 |
| GOBP CELL AGGREGATION | 10 | 8.05e-01 | -4.52e-02 | 9.37e-01 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 25 | 6.96e-01 | -4.51e-02 | 8.91e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 76 | 4.97e-01 | -4.51e-02 | 7.88e-01 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 9 | 8.15e-01 | -4.51e-02 | 9.39e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 69 | 5.17e-01 | -4.51e-02 | 8.01e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 7 | 8.36e-01 | 4.51e-02 | 9.47e-01 |
| GOMF MRNA BINDING | 307 | 1.75e-01 | 4.50e-02 | 5.09e-01 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 8 | 8.25e-01 | -4.50e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 80 | 4.86e-01 | 4.50e-02 | 7.83e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 17 | 7.48e-01 | 4.50e-02 | 9.11e-01 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 67 | 5.24e-01 | 4.50e-02 | 8.05e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 60 | 5.47e-01 | -4.50e-02 | 8.20e-01 |
| GOBP MESODERM DEVELOPMENT | 87 | 4.68e-01 | -4.50e-02 | 7.70e-01 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 7 | 8.37e-01 | -4.49e-02 | 9.47e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT | 5 | 8.62e-01 | 4.49e-02 | 9.53e-01 |
| GOBP NON PROTEINOGENIC AMINO ACID CATABOLIC PROCESS | 14 | 7.71e-01 | -4.49e-02 | 9.22e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 16 | 7.56e-01 | -4.48e-02 | 9.14e-01 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 1075 | 1.31e-02 | 4.48e-02 | 1.34e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 99 | 4.41e-01 | 4.48e-02 | 7.51e-01 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 52 | 5.76e-01 | -4.48e-02 | 8.33e-01 |
| GOBP NUCLEOSIDE TRANSPORT | 9 | 8.16e-01 | 4.47e-02 | 9.40e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 330 | 1.63e-01 | 4.47e-02 | 4.93e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 10 | 8.07e-01 | -4.47e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 20 | 7.29e-01 | -4.47e-02 | 9.03e-01 |
| GOBP THYMUS DEVELOPMENT | 39 | 6.29e-01 | -4.47e-02 | 8.59e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 95 | 4.52e-01 | -4.46e-02 | 7.57e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 47 | 5.97e-01 | -4.46e-02 | 8.44e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 48 | 5.94e-01 | -4.45e-02 | 8.42e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 25 | 7.00e-01 | -4.45e-02 | 8.92e-01 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 8.50e-01 | 4.45e-02 | 9.50e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 55 | 5.68e-01 | 4.45e-02 | 8.30e-01 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 102 | 4.38e-01 | -4.44e-02 | 7.49e-01 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 13 | 7.81e-01 | -4.44e-02 | 9.26e-01 |
| GOBP IMPORT INTO THE MITOCHONDRION | 49 | 5.91e-01 | -4.44e-02 | 8.40e-01 |
| GOMF METALLOPEPTIDASE ACTIVITY | 131 | 3.80e-01 | -4.44e-02 | 7.12e-01 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 59 | 5.55e-01 | 4.44e-02 | 8.25e-01 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 8 | 8.28e-01 | -4.44e-02 | 9.43e-01 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 48 | 5.95e-01 | -4.43e-02 | 8.43e-01 |
| GOMF GDP BINDING | 63 | 5.43e-01 | -4.43e-02 | 8.18e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 87 | 4.76e-01 | -4.42e-02 | 7.75e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 828 | 3.10e-02 | -4.41e-02 | 2.14e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 22 | 7.20e-01 | 4.41e-02 | 9.01e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 80 | 4.95e-01 | 4.41e-02 | 7.88e-01 |
| GOCC SYNAPSE ASSOCIATED EXTRACELLULAR MATRIX | 6 | 8.52e-01 | 4.41e-02 | 9.50e-01 |
| GOCC RETROMER COMPLEX | 20 | 7.33e-01 | 4.41e-02 | 9.06e-01 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 9 | 8.19e-01 | -4.40e-02 | 9.41e-01 |
| GOBP SELF PROTEOLYSIS | 9 | 8.19e-01 | 4.40e-02 | 9.41e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 15 | 7.68e-01 | -4.39e-02 | 9.20e-01 |
| GOBP AUTOPHAGOSOME MATURATION | 65 | 5.41e-01 | 4.39e-02 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 8.30e-01 | -4.38e-02 | 9.44e-01 |
| GOBP MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS | 583 | 7.07e-02 | 4.38e-02 | 3.24e-01 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 167 | 3.29e-01 | 4.38e-02 | 6.75e-01 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 93 | 4.66e-01 | 4.37e-02 | 7.67e-01 |
| GOCC EXCITATORY SYNAPSE | 34 | 6.59e-01 | 4.37e-02 | 8.73e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 63 | 5.48e-01 | -4.37e-02 | 8.21e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 8 | 8.30e-01 | 4.37e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 75 | 5.13e-01 | -4.37e-02 | 7.97e-01 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 8 | 8.30e-01 | -4.37e-02 | 9.44e-01 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 60 | 5.58e-01 | 4.37e-02 | 8.27e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 9 | 8.21e-01 | 4.37e-02 | 9.42e-01 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 26 | 7.00e-01 | 4.37e-02 | 8.92e-01 |
| GOMF PRE MRNA BINDING | 37 | 6.46e-01 | -4.36e-02 | 8.69e-01 |
| GOMF LIM DOMAIN BINDING | 6 | 8.53e-01 | 4.36e-02 | 9.50e-01 |
| GOMF UBIQUITIN BINDING | 102 | 4.47e-01 | 4.36e-02 | 7.55e-01 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 8.42e-01 | -4.35e-02 | 9.48e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 97 | 4.59e-01 | -4.35e-02 | 7.63e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 70 | 5.29e-01 | 4.35e-02 | 8.07e-01 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 7 | 8.42e-01 | -4.35e-02 | 9.48e-01 |
| GOMF LIPASE ACTIVITY | 101 | 4.51e-01 | -4.34e-02 | 7.56e-01 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 8.67e-01 | 4.34e-02 | 9.55e-01 |
| GOBP SMOOTH MUSCLE CONTRACTION | 68 | 5.36e-01 | -4.33e-02 | 8.12e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 28 | 6.92e-01 | -4.33e-02 | 8.89e-01 |
| GOBP L LEUCINE TRANSPORT | 9 | 8.22e-01 | 4.33e-02 | 9.42e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 16 | 7.65e-01 | -4.33e-02 | 9.18e-01 |
| GOBP SKELETAL MUSCLE CONTRACTION | 33 | 6.67e-01 | -4.32e-02 | 8.77e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 49 | 6.01e-01 | 4.32e-02 | 8.47e-01 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 23 | 7.20e-01 | -4.32e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 50 | 5.98e-01 | -4.32e-02 | 8.45e-01 |
| GOBP MEMBRANE TUBULATION | 5 | 8.67e-01 | 4.31e-02 | 9.56e-01 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 8.23e-01 | 4.31e-02 | 9.42e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 109 | 4.37e-01 | -4.31e-02 | 7.49e-01 |
| GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 7 | 8.44e-01 | -4.30e-02 | 9.49e-01 |
| GOCC AUTOPHAGOSOME | 108 | 4.40e-01 | 4.30e-02 | 7.50e-01 |
| GOBP REGULATION OF CELL GROWTH | 319 | 1.88e-01 | 4.29e-02 | 5.28e-01 |
| GOMF BILE ACID BINDING | 6 | 8.56e-01 | 4.29e-02 | 9.51e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 18 | 7.53e-01 | -4.29e-02 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY | 9 | 8.24e-01 | 4.29e-02 | 9.42e-01 |
| GOBP COPII COATED VESICLE BUDDING | 44 | 6.23e-01 | 4.28e-02 | 8.57e-01 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 27 | 7.00e-01 | 4.28e-02 | 8.92e-01 |
| GOBP POLYAMINE TRANSPORT | 13 | 7.89e-01 | 4.28e-02 | 9.29e-01 |
| GOCC PROTEIN KINASE COMPLEX | 138 | 3.86e-01 | 4.27e-02 | 7.15e-01 |
| GOCC CLATHRIN COMPLEX | 7 | 8.45e-01 | 4.27e-02 | 9.49e-01 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 18 | 7.54e-01 | 4.27e-02 | 9.13e-01 |
| GOBP DENDRITE MORPHOGENESIS | 112 | 4.35e-01 | 4.27e-02 | 7.47e-01 |
| GOCC DENSE CORE GRANULE | 18 | 7.54e-01 | -4.27e-02 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 12 | 7.98e-01 | -4.27e-02 | 9.33e-01 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 5 | 8.69e-01 | 4.27e-02 | 9.56e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 651 | 6.32e-02 | -4.27e-02 | 3.07e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 283 | 2.17e-01 | -4.27e-02 | 5.61e-01 |
| GOBP POST EMBRYONIC DEVELOPMENT | 77 | 5.17e-01 | 4.27e-02 | 8.01e-01 |
| GOBP CRANIAL NERVE DEVELOPMENT | 43 | 6.29e-01 | -4.26e-02 | 8.59e-01 |
| GOCC GATOR1 COMPLEX | 5 | 8.69e-01 | 4.26e-02 | 9.56e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 46 | 6.17e-01 | -4.26e-02 | 8.55e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 10 | 8.16e-01 | 4.26e-02 | 9.39e-01 |
| GOBP COLLECTING DUCT DEVELOPMENT | 7 | 8.45e-01 | -4.26e-02 | 9.49e-01 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 25 | 7.13e-01 | -4.25e-02 | 8.97e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PEROXISOME | 20 | 7.42e-01 | -4.25e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 20 | 7.42e-01 | -4.25e-02 | 9.09e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 21 | 7.36e-01 | -4.25e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 24 | 7.19e-01 | 4.25e-02 | 9.00e-01 |
| GOCC NON MOTILE CILIUM | 124 | 4.14e-01 | 4.25e-02 | 7.34e-01 |
| GOBP RESPONSE TO CAMP | 62 | 5.63e-01 | -4.25e-02 | 8.28e-01 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 8 | 8.35e-01 | 4.24e-02 | 9.46e-01 |
| GOBP PROTEIN STABILIZATION | 189 | 3.14e-01 | 4.24e-02 | 6.61e-01 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 31 | 6.83e-01 | 4.24e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 44 | 6.27e-01 | -4.24e-02 | 8.58e-01 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 8 | 8.36e-01 | 4.23e-02 | 9.46e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 662 | 6.34e-02 | -4.23e-02 | 3.08e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 213 | 2.88e-01 | -4.23e-02 | 6.35e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 58 | 5.78e-01 | 4.22e-02 | 8.33e-01 |
| GOBP RECEPTOR RECYCLING | 42 | 6.36e-01 | -4.22e-02 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 56 | 5.86e-01 | -4.21e-02 | 8.38e-01 |
| GOBP B CELL ACTIVATION | 240 | 2.61e-01 | 4.21e-02 | 6.10e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 31 | 6.85e-01 | -4.21e-02 | 8.86e-01 |
| GOMF RNA CAP BINDING | 18 | 7.57e-01 | -4.21e-02 | 9.14e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 12 | 8.01e-01 | 4.21e-02 | 9.35e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 912 | 3.13e-02 | -4.20e-02 | 2.15e-01 |
| GOBP HOMEOSTATIC PROCESS | 1346 | 9.72e-03 | -4.20e-02 | 1.11e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 25 | 7.16e-01 | -4.20e-02 | 8.99e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 20 | 7.45e-01 | -4.20e-02 | 9.10e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 425 | 1.38e-01 | 4.20e-02 | 4.55e-01 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 28 | 7.01e-01 | -4.20e-02 | 8.92e-01 |
| GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 8.71e-01 | -4.20e-02 | 9.57e-01 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 9 | 8.28e-01 | -4.19e-02 | 9.43e-01 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 7.40e-01 | -4.19e-02 | 9.08e-01 |
| GOBP DEPYRIMIDINATION | 8 | 8.37e-01 | 4.19e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 8.59e-01 | 4.18e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 9 | 8.28e-01 | -4.18e-02 | 9.43e-01 |
| GOBP DETECTION OF LIGHT STIMULUS | 42 | 6.39e-01 | 4.18e-02 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 25 | 7.18e-01 | 4.18e-02 | 9.00e-01 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 11 | 8.11e-01 | 4.17e-02 | 9.38e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 47 | 6.21e-01 | 4.17e-02 | 8.57e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 16 | 7.73e-01 | 4.17e-02 | 9.22e-01 |
| GOBP CELL FATE DETERMINATION | 24 | 7.24e-01 | -4.17e-02 | 9.03e-01 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 30 | 6.93e-01 | -4.17e-02 | 8.90e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 34 | 6.74e-01 | 4.16e-02 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 22 | 7.36e-01 | -4.16e-02 | 9.07e-01 |
| GOBP TRANSFERRIN TRANSPORT | 9 | 8.29e-01 | 4.16e-02 | 9.44e-01 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 24 | 7.25e-01 | 4.15e-02 | 9.03e-01 |
| GOBP FACE MORPHOGENESIS | 24 | 7.25e-01 | -4.15e-02 | 9.03e-01 |
| GOBP PROTEIN TARGETING | 303 | 2.14e-01 | -4.15e-02 | 5.59e-01 |
| GOBP REGULATION OF SYNAPSE MATURATION | 15 | 7.81e-01 | 4.15e-02 | 9.26e-01 |
| GOCC ACTOMYOSIN | 77 | 5.30e-01 | -4.14e-02 | 8.08e-01 |
| GOCC NEUROFIBRILLARY TANGLE | 5 | 8.73e-01 | -4.14e-02 | 9.57e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 41 | 6.47e-01 | 4.14e-02 | 8.69e-01 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 8.73e-01 | 4.13e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 137 | 4.04e-01 | 4.13e-02 | 7.26e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 18 | 7.62e-01 | -4.13e-02 | 9.17e-01 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 40 | 6.51e-01 | 4.13e-02 | 8.70e-01 |
| GOCC MULTIVESICULAR BODY INTERNAL VESICLE | 5 | 8.73e-01 | 4.13e-02 | 9.57e-01 |
| GOCC X CHROMOSOME | 13 | 7.97e-01 | 4.12e-02 | 9.32e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 84 | 5.14e-01 | -4.12e-02 | 7.98e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 18 | 7.63e-01 | -4.11e-02 | 9.17e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 36 | 6.70e-01 | 4.11e-02 | 8.78e-01 |
| GOBP PALLIUM DEVELOPMENT | 144 | 3.95e-01 | 4.11e-02 | 7.21e-01 |
| GOMF CILIARY NEUROTROPHIC FACTOR RECEPTOR BINDING | 5 | 8.74e-01 | -4.11e-02 | 9.57e-01 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 10 | 8.22e-01 | 4.11e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 11 | 8.14e-01 | 4.11e-02 | 9.39e-01 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 12 | 8.05e-01 | -4.11e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 27 | 7.12e-01 | -4.11e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 89 | 5.03e-01 | 4.10e-02 | 7.92e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 10 | 8.23e-01 | -4.10e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 80 | 5.27e-01 | 4.09e-02 | 8.06e-01 |
| GOBP WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 38 | 6.62e-01 | -4.09e-02 | 8.74e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 16 | 7.77e-01 | 4.09e-02 | 9.24e-01 |
| GOBP MALE GAMETE GENERATION | 421 | 1.50e-01 | 4.09e-02 | 4.75e-01 |
| GOBP SYNAPSE ASSEMBLY | 134 | 4.14e-01 | -4.09e-02 | 7.33e-01 |
| GOCC BLOOD MICROPARTICLE | 107 | 4.65e-01 | -4.09e-02 | 7.67e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 18 | 7.64e-01 | -4.08e-02 | 9.18e-01 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 5 | 8.74e-01 | -4.08e-02 | 9.57e-01 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 58 | 5.91e-01 | -4.08e-02 | 8.40e-01 |
| GOBP TESTOSTERONE BIOSYNTHETIC PROCESS | 7 | 8.52e-01 | 4.08e-02 | 9.50e-01 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 10 | 8.23e-01 | 4.08e-02 | 9.42e-01 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 12 | 8.07e-01 | -4.07e-02 | 9.38e-01 |
| GOCC SARCOPLASM | 73 | 5.48e-01 | 4.07e-02 | 8.21e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 18 | 7.65e-01 | 4.07e-02 | 9.18e-01 |
| GOBP RESPONSE TO BLUE LIGHT | 5 | 8.75e-01 | -4.06e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 22 | 7.42e-01 | 4.06e-02 | 9.09e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 28 | 7.10e-01 | -4.06e-02 | 8.97e-01 |
| GOBP CELLULAR PIGMENTATION | 56 | 6.00e-01 | 4.06e-02 | 8.46e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 23 | 7.37e-01 | -4.05e-02 | 9.08e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 119 | 4.46e-01 | 4.05e-02 | 7.53e-01 |
| GOBP REGULATION OF SECRETION | 450 | 1.41e-01 | -4.05e-02 | 4.60e-01 |
| GOBP SPONTANEOUS NEUROTRANSMITTER SECRETION | 6 | 8.64e-01 | -4.04e-02 | 9.54e-01 |
| GOBP SEXUAL REPRODUCTION | 747 | 6.05e-02 | 4.03e-02 | 3.00e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING | 70 | 5.60e-01 | 4.03e-02 | 8.27e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 17 | 7.74e-01 | -4.03e-02 | 9.22e-01 |
| GOMF FILAMIN BINDING | 10 | 8.25e-01 | 4.03e-02 | 9.43e-01 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 11 | 8.17e-01 | 4.02e-02 | 9.40e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 12 | 8.09e-01 | 4.02e-02 | 9.38e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 46 | 6.37e-01 | 4.02e-02 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 8.65e-01 | -4.02e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 8.76e-01 | 4.02e-02 | 9.58e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 54 | 6.10e-01 | 4.02e-02 | 8.52e-01 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 10 | 8.26e-01 | 4.02e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 31 | 6.99e-01 | 4.01e-02 | 8.92e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 10 | 8.26e-01 | -4.01e-02 | 9.43e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 470 | 1.36e-01 | 4.01e-02 | 4.53e-01 |
| GOBP VAGINA DEVELOPMENT | 7 | 8.54e-01 | -4.00e-02 | 9.50e-01 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 8.10e-01 | -4.00e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 8.55e-01 | 4.00e-02 | 9.50e-01 |
| GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE | 8 | 8.45e-01 | 4.00e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 16 | 7.82e-01 | -4.00e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 480 | 1.34e-01 | 4.00e-02 | 4.48e-01 |
| GOBP RESPONSE TO EPINEPHRINE | 11 | 8.19e-01 | 3.99e-02 | 9.41e-01 |
| GOBP REGULATION OF GROWTH | 455 | 1.44e-01 | 3.99e-02 | 4.64e-01 |
| GOBP CALCIUM MEDIATED SIGNALING | 181 | 3.55e-01 | -3.99e-02 | 6.93e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 80 | 5.38e-01 | -3.99e-02 | 8.13e-01 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 22 | 7.46e-01 | -3.99e-02 | 9.11e-01 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 233 | 2.95e-01 | -3.99e-02 | 6.43e-01 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 7.96e-01 | 3.98e-02 | 9.32e-01 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 41 | 6.59e-01 | 3.98e-02 | 8.73e-01 |
| GOBP STRESS FIBER ASSEMBLY | 95 | 5.03e-01 | 3.98e-02 | 7.92e-01 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 14 | 7.97e-01 | -3.97e-02 | 9.32e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 59 | 5.98e-01 | -3.97e-02 | 8.45e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 139 | 4.19e-01 | -3.97e-02 | 7.38e-01 |
| GOBP MEMBRANE RAFT ORGANIZATION | 23 | 7.42e-01 | -3.97e-02 | 9.09e-01 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 8.37e-01 | -3.97e-02 | 9.47e-01 |
| GOMF CO RECEPTOR BINDING | 5 | 8.78e-01 | 3.97e-02 | 9.59e-01 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 77 | 5.47e-01 | 3.97e-02 | 8.21e-01 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 8 | 8.46e-01 | 3.96e-02 | 9.49e-01 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 12 | 8.12e-01 | -3.96e-02 | 9.39e-01 |
| GOBP NEURON FATE COMMITMENT | 29 | 7.12e-01 | -3.96e-02 | 8.97e-01 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 76 | 5.51e-01 | 3.96e-02 | 8.24e-01 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 22 | 7.48e-01 | -3.96e-02 | 9.11e-01 |
| GOBP ERBB SIGNALING PATHWAY | 108 | 4.78e-01 | -3.95e-02 | 7.76e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 7.66e-01 | -3.95e-02 | 9.18e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 83 | 5.34e-01 | -3.95e-02 | 8.11e-01 |
| GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 14 | 7.98e-01 | -3.95e-02 | 9.33e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 13 | 8.05e-01 | 3.95e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 239 | 2.93e-01 | -3.95e-02 | 6.42e-01 |
| GOBP MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 6 | 8.67e-01 | -3.95e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 33 | 6.95e-01 | 3.95e-02 | 8.91e-01 |
| GOBP MEMBRANE HYPERPOLARIZATION | 6 | 8.67e-01 | -3.95e-02 | 9.56e-01 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 8.79e-01 | 3.95e-02 | 9.59e-01 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 8.47e-01 | -3.94e-02 | 9.49e-01 |
| GOMF CERAMIDE 1 PHOSPHATE BINDING | 7 | 8.57e-01 | 3.94e-02 | 9.51e-01 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 8.29e-01 | 3.94e-02 | 9.44e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 169 | 3.78e-01 | 3.93e-02 | 7.10e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 464 | 1.47e-01 | -3.93e-02 | 4.69e-01 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 8 | 8.48e-01 | 3.93e-02 | 9.49e-01 |
| GOCC ATPASE COMPLEX | 142 | 4.19e-01 | 3.92e-02 | 7.38e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 15 | 7.93e-01 | 3.92e-02 | 9.30e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 33 | 6.97e-01 | -3.92e-02 | 8.91e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 21 | 7.56e-01 | -3.92e-02 | 9.14e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 86 | 5.30e-01 | -3.92e-02 | 8.08e-01 |
| GOBP CELL PROLIFERATION IN BONE MARROW | 6 | 8.68e-01 | 3.91e-02 | 9.56e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 95 | 5.10e-01 | 3.91e-02 | 7.96e-01 |
| GOCC SPERM HEAD | 7 | 8.58e-01 | -3.91e-02 | 9.52e-01 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 8 | 8.48e-01 | 3.91e-02 | 9.49e-01 |
| GOBP CHEMICAL HOMEOSTASIS | 786 | 6.27e-02 | -3.90e-02 | 3.06e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 77 | 5.54e-01 | -3.90e-02 | 8.24e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 9 | 8.40e-01 | 3.90e-02 | 9.48e-01 |
| GOCC AGGRESOME | 30 | 7.12e-01 | -3.90e-02 | 8.97e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 64 | 5.90e-01 | -3.90e-02 | 8.40e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 8.31e-01 | -3.90e-02 | 9.44e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 181 | 3.66e-01 | 3.89e-02 | 7.00e-01 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 91 | 5.21e-01 | -3.89e-02 | 8.02e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 38 | 6.78e-01 | -3.89e-02 | 8.83e-01 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 13 | 8.08e-01 | 3.89e-02 | 9.38e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 46 | 6.48e-01 | 3.89e-02 | 8.69e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 10 | 8.31e-01 | 3.89e-02 | 9.44e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 50 | 6.35e-01 | -3.89e-02 | 8.63e-01 |
| GOBP TOLL SIGNALING PATHWAY | 11 | 8.23e-01 | -3.88e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 13 | 8.08e-01 | 3.88e-02 | 9.38e-01 |
| GOCC SEPTIN CYTOSKELETON | 15 | 7.95e-01 | -3.88e-02 | 9.31e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 309 | 2.41e-01 | -3.88e-02 | 5.88e-01 |
| GOBP RUFFLE ASSEMBLY | 40 | 6.71e-01 | 3.88e-02 | 8.79e-01 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 148 | 4.15e-01 | -3.88e-02 | 7.34e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 9 | 8.40e-01 | 3.88e-02 | 9.48e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 17 | 7.82e-01 | -3.87e-02 | 9.26e-01 |
| GOBP LIPID LOCALIZATION | 356 | 2.10e-01 | -3.87e-02 | 5.55e-01 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 174 | 3.78e-01 | 3.87e-02 | 7.11e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 17 | 7.82e-01 | 3.87e-02 | 9.26e-01 |
| GOBP SENSORY PERCEPTION OF PAIN | 53 | 6.26e-01 | -3.87e-02 | 8.58e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 90 | 5.26e-01 | 3.87e-02 | 8.06e-01 |
| GOBP SODIUM ION HOMEOSTASIS | 29 | 7.19e-01 | -3.87e-02 | 9.00e-01 |
| GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 7 | 8.59e-01 | 3.86e-02 | 9.52e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 249 | 2.94e-01 | -3.86e-02 | 6.42e-01 |
| GOBP QUINONE METABOLIC PROCESS | 22 | 7.54e-01 | -3.86e-02 | 9.13e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 194 | 3.54e-01 | 3.86e-02 | 6.93e-01 |
| GOBP SPERMATID DIFFERENTIATION | 143 | 4.26e-01 | 3.86e-02 | 7.42e-01 |
| GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE | 8 | 8.50e-01 | -3.86e-02 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 11 | 8.25e-01 | -3.86e-02 | 9.43e-01 |
| GOBP LACTATE METABOLIC PROCESS | 15 | 7.96e-01 | -3.86e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 81 | 5.49e-01 | 3.85e-02 | 8.22e-01 |
| GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT | 7 | 8.60e-01 | -3.85e-02 | 9.52e-01 |
| GOBP RECEPTOR METABOLIC PROCESS | 66 | 5.89e-01 | 3.85e-02 | 8.40e-01 |
| GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS | 7 | 8.60e-01 | 3.85e-02 | 9.52e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 8.33e-01 | -3.85e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 26 | 7.34e-01 | -3.85e-02 | 9.07e-01 |
| GOBP MITRAL VALVE DEVELOPMENT | 11 | 8.25e-01 | -3.84e-02 | 9.43e-01 |
| GOBP REGULATION OF PIGMENTATION | 13 | 8.11e-01 | 3.84e-02 | 9.38e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME | 10 | 8.34e-01 | 3.83e-02 | 9.45e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 291 | 2.61e-01 | -3.83e-02 | 6.09e-01 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 329 | 2.34e-01 | -3.82e-02 | 5.80e-01 |
| GOCC CLATHRIN COATED PIT | 69 | 5.83e-01 | 3.82e-02 | 8.36e-01 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 22 | 7.57e-01 | -3.82e-02 | 9.14e-01 |
| GOBP PEROXISOME ORGANIZATION | 37 | 6.89e-01 | -3.81e-02 | 8.87e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 54 | 6.29e-01 | -3.81e-02 | 8.59e-01 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 47 | 6.52e-01 | 3.81e-02 | 8.70e-01 |
| GOCC MYELIN SHEATH | 40 | 6.77e-01 | -3.80e-02 | 8.82e-01 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 9 | 8.43e-01 | -3.80e-02 | 9.49e-01 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 600 | 1.12e-01 | -3.80e-02 | 4.08e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 33 | 7.05e-01 | -3.80e-02 | 8.95e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 177 | 3.83e-01 | 3.80e-02 | 7.15e-01 |
| GOBP AXON EXTENSION | 86 | 5.42e-01 | 3.80e-02 | 8.17e-01 |
| GOMF DIOXYGENASE ACTIVITY | 81 | 5.54e-01 | 3.80e-02 | 8.24e-01 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 18 | 7.80e-01 | -3.80e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 28 | 7.28e-01 | -3.80e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 47 | 6.53e-01 | -3.80e-02 | 8.70e-01 |
| GOBP CELL PROJECTION MORPHOGENESIS | 488 | 1.51e-01 | 3.79e-02 | 4.76e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 113 | 4.86e-01 | -3.79e-02 | 7.83e-01 |
| GOBP RESPONSE TO FRUCTOSE | 9 | 8.44e-01 | -3.79e-02 | 9.49e-01 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 8.44e-01 | 3.79e-02 | 9.49e-01 |
| GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 5 | 8.83e-01 | -3.79e-02 | 9.61e-01 |
| GOCC MIB COMPLEX | 13 | 8.13e-01 | -3.78e-02 | 9.39e-01 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 14 | 8.07e-01 | 3.78e-02 | 9.38e-01 |
| GOBP INSULIN METABOLIC PROCESS | 11 | 8.28e-01 | 3.78e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 279 | 2.77e-01 | -3.78e-02 | 6.26e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 205 | 3.51e-01 | 3.78e-02 | 6.91e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 64 | 6.01e-01 | 3.78e-02 | 8.47e-01 |
| GOBP SODIUM ION TRANSPORT | 169 | 3.97e-01 | -3.77e-02 | 7.23e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 123 | 4.71e-01 | -3.77e-02 | 7.72e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 99 | 5.17e-01 | -3.77e-02 | 8.01e-01 |
| GOBP REGULATION OF PROTEIN TARGETING | 73 | 5.78e-01 | -3.76e-02 | 8.33e-01 |
| GOCC AXON | 479 | 1.58e-01 | 3.76e-02 | 4.86e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 104 | 5.08e-01 | 3.76e-02 | 7.96e-01 |
| GOBP PROTEIN DESTABILIZATION | 48 | 6.53e-01 | 3.75e-02 | 8.70e-01 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 7 | 8.64e-01 | -3.75e-02 | 9.54e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 12 | 8.22e-01 | -3.75e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 7 | 8.64e-01 | 3.75e-02 | 9.54e-01 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 17 | 7.89e-01 | -3.75e-02 | 9.29e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 12 | 8.22e-01 | -3.75e-02 | 9.42e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 13 | 8.15e-01 | 3.74e-02 | 9.39e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 6 | 8.74e-01 | -3.74e-02 | 9.57e-01 |
| GOMF SNORNA BINDING | 32 | 7.14e-01 | 3.74e-02 | 8.98e-01 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 8 | 8.55e-01 | 3.74e-02 | 9.50e-01 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 12 | 8.23e-01 | -3.74e-02 | 9.42e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 40 | 6.83e-01 | -3.74e-02 | 8.84e-01 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 114 | 4.91e-01 | 3.74e-02 | 7.85e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE TRANSPORT | 5 | 8.85e-01 | -3.73e-02 | 9.62e-01 |
| GOBP REGULATION OF TRANSPORT | 1255 | 2.64e-02 | -3.73e-02 | 1.95e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 40 | 6.83e-01 | -3.73e-02 | 8.85e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 59 | 6.21e-01 | -3.72e-02 | 8.57e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 64 | 6.07e-01 | -3.72e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 32 | 7.16e-01 | -3.72e-02 | 8.99e-01 |
| GOBP CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE | 5 | 8.86e-01 | -3.71e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 6 | 8.75e-01 | -3.71e-02 | 9.57e-01 |
| GOCC STEREOCILIUM BUNDLE | 50 | 6.50e-01 | -3.71e-02 | 8.69e-01 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 6 | 8.75e-01 | 3.71e-02 | 9.57e-01 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 34 | 7.08e-01 | -3.71e-02 | 8.96e-01 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 10 | 8.39e-01 | -3.71e-02 | 9.48e-01 |
| GOCC CATALYTIC COMPLEX | 1601 | 1.33e-02 | 3.71e-02 | 1.35e-01 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 8.75e-01 | 3.71e-02 | 9.57e-01 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 27 | 7.39e-01 | 3.70e-02 | 9.08e-01 |
| GOCC RUFFLE | 169 | 4.07e-01 | -3.70e-02 | 7.28e-01 |
| GOBP VACUOLAR TRANSPORT | 156 | 4.26e-01 | 3.70e-02 | 7.42e-01 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 9 | 8.48e-01 | 3.70e-02 | 9.49e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 47 | 6.61e-01 | 3.69e-02 | 8.74e-01 |
| GOBP RESPONSE TO HEAT | 85 | 5.56e-01 | 3.69e-02 | 8.26e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 342 | 2.41e-01 | 3.69e-02 | 5.89e-01 |
| GOBP REGULATION OF P38MAPK CASCADE | 34 | 7.10e-01 | -3.69e-02 | 8.97e-01 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 9 | 8.48e-01 | 3.69e-02 | 9.49e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 89 | 5.48e-01 | 3.69e-02 | 8.21e-01 |
| GOMF GLUTAMATE GATED CALCIUM ION CHANNEL ACTIVITY | 5 | 8.87e-01 | 3.69e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 37 | 6.98e-01 | -3.68e-02 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 8.25e-01 | -3.68e-02 | 9.43e-01 |
| GOBP CELL ACTIVATION | 959 | 5.38e-02 | -3.68e-02 | 2.82e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 181 | 3.93e-01 | -3.68e-02 | 7.21e-01 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 14 | 8.12e-01 | -3.68e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 8.76e-01 | -3.67e-02 | 9.58e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 34 | 7.11e-01 | 3.67e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 12 | 8.26e-01 | -3.67e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 22 | 7.66e-01 | 3.67e-02 | 9.18e-01 |
| GOMF PRE MIRNA BINDING | 9 | 8.49e-01 | 3.67e-02 | 9.49e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 399 | 2.09e-01 | -3.67e-02 | 5.54e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 12 | 8.26e-01 | 3.67e-02 | 9.43e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 47 | 6.64e-01 | -3.67e-02 | 8.74e-01 |
| GOBP NEPHRON TUBULE FORMATION | 8 | 8.58e-01 | -3.66e-02 | 9.52e-01 |
| GOCC MYOSIN COMPLEX | 40 | 6.89e-01 | 3.66e-02 | 8.87e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 32 | 7.20e-01 | -3.66e-02 | 9.01e-01 |
| GOBP RRNA PROCESSING | 218 | 3.54e-01 | 3.65e-02 | 6.93e-01 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 10 | 8.42e-01 | 3.65e-02 | 9.48e-01 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 12 | 8.27e-01 | -3.64e-02 | 9.43e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 25 | 7.53e-01 | -3.64e-02 | 9.13e-01 |
| GOCC KINOCILIUM | 8 | 8.59e-01 | 3.63e-02 | 9.52e-01 |
| GOBP REGULATION OF KINASE ACTIVITY | 430 | 1.97e-01 | -3.63e-02 | 5.38e-01 |
| GOCC POSTSYNAPSE | 494 | 1.67e-01 | -3.63e-02 | 5.00e-01 |
| GOBP TYPE II INTERFERON PRODUCTION | 105 | 5.21e-01 | -3.63e-02 | 8.02e-01 |
| GOMF BENZODIAZEPINE RECEPTOR BINDING | 5 | 8.89e-01 | 3.62e-02 | 9.63e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 69 | 6.04e-01 | -3.61e-02 | 8.48e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 9 | 8.51e-01 | 3.61e-02 | 9.50e-01 |
| GOBP PYROPTOSIS | 33 | 7.19e-01 | -3.61e-02 | 9.01e-01 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 19 | 7.85e-01 | -3.61e-02 | 9.28e-01 |
| GOMF ARYL SULFOTRANSFERASE ACTIVITY | 5 | 8.89e-01 | -3.61e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE MATURATION | 5 | 8.89e-01 | -3.61e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 649 | 1.17e-01 | -3.61e-02 | 4.17e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 83 | 5.70e-01 | 3.61e-02 | 8.30e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 17 | 7.97e-01 | 3.60e-02 | 9.32e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 15 | 8.09e-01 | -3.60e-02 | 9.38e-01 |
| GOBP INTERLEUKIN 10 MEDIATED SIGNALING PATHWAY | 11 | 8.36e-01 | -3.60e-02 | 9.47e-01 |
| GOBP LATERAL SPROUTING FROM AN EPITHELIUM | 5 | 8.89e-01 | -3.60e-02 | 9.64e-01 |
| GOMF MALATE DEHYDROGENASE ACTIVITY | 6 | 8.79e-01 | -3.60e-02 | 9.59e-01 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 9 | 8.52e-01 | 3.59e-02 | 9.50e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 70 | 6.04e-01 | -3.59e-02 | 8.48e-01 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 54 | 6.48e-01 | 3.59e-02 | 8.69e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 12 | 8.30e-01 | 3.59e-02 | 9.44e-01 |
| GOBP STRIATUM DEVELOPMENT | 18 | 7.92e-01 | 3.58e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 21 | 7.76e-01 | 3.58e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 8.79e-01 | 3.58e-02 | 9.59e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 28 | 7.43e-01 | 3.57e-02 | 9.09e-01 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 32 | 7.26e-01 | 3.57e-02 | 9.03e-01 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 167 | 4.26e-01 | -3.57e-02 | 7.42e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 60 | 6.33e-01 | -3.57e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 7 | 8.70e-01 | 3.56e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF MYELINATION | 16 | 8.05e-01 | 3.56e-02 | 9.37e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 347 | 2.55e-01 | -3.56e-02 | 6.03e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 534 | 1.60e-01 | -3.56e-02 | 4.88e-01 |
| GOMF NEUROPEPTIDE ACTIVITY | 10 | 8.46e-01 | 3.55e-02 | 9.49e-01 |
| GOBP REGULATION OF HYPERSENSITIVITY | 10 | 8.46e-01 | -3.55e-02 | 9.49e-01 |
| GOBP SENSORY PERCEPTION OF TASTE | 27 | 7.49e-01 | 3.55e-02 | 9.12e-01 |
| GOBP LYMPHOCYTE MIGRATION | 89 | 5.62e-01 | -3.55e-02 | 8.28e-01 |
| GOBP EAR DEVELOPMENT | 132 | 4.81e-01 | 3.55e-02 | 7.79e-01 |
| GOMF ALCOHOL BINDING | 68 | 6.13e-01 | -3.55e-02 | 8.53e-01 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1495 | 2.18e-02 | 3.55e-02 | 1.75e-01 |
| GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 13 | 8.25e-01 | -3.55e-02 | 9.43e-01 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 21 | 7.79e-01 | 3.55e-02 | 9.25e-01 |
| GOMF ALPHA N ACETYLGALACTOSAMINIDE ALPHA 2 6 SIALYLTRANSFERASE ACTIVITY | 5 | 8.91e-01 | -3.54e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 63 | 6.27e-01 | -3.54e-02 | 8.58e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 123 | 4.98e-01 | -3.54e-02 | 7.89e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 36 | 7.13e-01 | -3.54e-02 | 8.98e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 79 | 5.87e-01 | 3.54e-02 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 11 | 8.39e-01 | -3.54e-02 | 9.48e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 8.81e-01 | -3.53e-02 | 9.60e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 24 | 7.65e-01 | 3.53e-02 | 9.18e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 837 | 8.29e-02 | -3.53e-02 | 3.51e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 9 | 8.55e-01 | -3.52e-02 | 9.50e-01 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 25 | 7.61e-01 | -3.52e-02 | 9.16e-01 |
| GOBP REGULATION OF EOSINOPHIL MIGRATION | 5 | 8.92e-01 | 3.52e-02 | 9.65e-01 |
| GOBP MOTOR BEHAVIOR | 19 | 7.91e-01 | 3.52e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 56 | 6.49e-01 | -3.51e-02 | 8.69e-01 |
| GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING | 5 | 8.92e-01 | 3.51e-02 | 9.65e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 54 | 6.55e-01 | 3.51e-02 | 8.71e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 328 | 2.75e-01 | 3.51e-02 | 6.25e-01 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 92 | 5.61e-01 | 3.51e-02 | 8.27e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 9 | 8.55e-01 | -3.51e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 119 | 5.09e-01 | -3.51e-02 | 7.96e-01 |
| GOBP SECRETION | 724 | 1.08e-01 | -3.51e-02 | 4.01e-01 |
| GOBP B CELL DIFFERENTIATION | 125 | 4.99e-01 | 3.50e-02 | 7.90e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 84 | 5.79e-01 | -3.50e-02 | 8.33e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 12 | 8.34e-01 | 3.50e-02 | 9.45e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 446 | 2.06e-01 | 3.50e-02 | 5.49e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE FROM INNER SIDE | 5 | 8.92e-01 | -3.50e-02 | 9.65e-01 |
| GOBP RESPONSE TO STEROID HORMONE | 259 | 3.33e-01 | -3.49e-02 | 6.77e-01 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 6 | 8.82e-01 | 3.49e-02 | 9.61e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 295 | 3.02e-01 | -3.49e-02 | 6.51e-01 |
| GOBP CRANIAL NERVE FORMATION | 7 | 8.73e-01 | 3.49e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 89 | 5.70e-01 | -3.49e-02 | 8.30e-01 |
| GOBP PIGMENTATION | 89 | 5.70e-01 | 3.49e-02 | 8.30e-01 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 8.93e-01 | -3.49e-02 | 9.65e-01 |
| GOBP REGULATION OF GTPASE ACTIVITY | 234 | 3.58e-01 | 3.48e-02 | 6.95e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 851 | 8.44e-02 | 3.48e-02 | 3.54e-01 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 16 | 8.09e-01 | -3.48e-02 | 9.38e-01 |
| GOBP REGULATION OF CELL DEVELOPMENT | 659 | 1.28e-01 | -3.48e-02 | 4.38e-01 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 20 | 7.88e-01 | 3.48e-02 | 9.28e-01 |
| GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS | 5 | 8.93e-01 | -3.47e-02 | 9.65e-01 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 23 | 7.73e-01 | 3.47e-02 | 9.22e-01 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 12 | 8.35e-01 | 3.47e-02 | 9.46e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 38 | 7.12e-01 | 3.47e-02 | 8.97e-01 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 708 | 1.16e-01 | 3.47e-02 | 4.15e-01 |
| GOBP SPLEEN DEVELOPMENT | 30 | 7.43e-01 | -3.46e-02 | 9.09e-01 |
| GOBP OOCYTE MATURATION | 24 | 7.69e-01 | 3.46e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 99 | 5.52e-01 | -3.46e-02 | 8.24e-01 |
| GOCC APICAL JUNCTION COMPLEX | 115 | 5.22e-01 | -3.45e-02 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 15 | 8.17e-01 | -3.45e-02 | 9.40e-01 |
| GOBP SYNAPSE ORGANIZATION | 345 | 2.72e-01 | -3.45e-02 | 6.22e-01 |
| GOMF DOUBLE STRANDED METHYLATED DNA BINDING | 5 | 8.94e-01 | -3.44e-02 | 9.65e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 118 | 5.18e-01 | 3.44e-02 | 8.01e-01 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 8.94e-01 | 3.44e-02 | 9.65e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 107 | 5.39e-01 | -3.44e-02 | 8.14e-01 |
| GOBP RESPONSE TO NICOTINE | 30 | 7.45e-01 | 3.43e-02 | 9.10e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 13 | 8.30e-01 | -3.43e-02 | 9.44e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 13 | 8.31e-01 | -3.42e-02 | 9.44e-01 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 76 | 6.07e-01 | 3.42e-02 | 8.50e-01 |
| GOBP GANGLION DEVELOPMENT | 8 | 8.67e-01 | 3.42e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 8.76e-01 | 3.41e-02 | 9.58e-01 |
| GOBP PSEUDOPODIUM ORGANIZATION | 14 | 8.25e-01 | 3.41e-02 | 9.43e-01 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 56 | 6.59e-01 | 3.41e-02 | 8.73e-01 |
| GOBP CELL SURFACE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 486 | 1.98e-01 | -3.41e-02 | 5.41e-01 |
| GOBP PROTEIN DEACETYLATION | 41 | 7.06e-01 | 3.40e-02 | 8.95e-01 |
| GOBP MITOCHONDRIAL FUSION | 35 | 7.28e-01 | -3.40e-02 | 9.03e-01 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 7 | 8.76e-01 | 3.40e-02 | 9.58e-01 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 25 | 7.68e-01 | 3.40e-02 | 9.20e-01 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 259 | 3.46e-01 | 3.40e-02 | 6.86e-01 |
| GOMF HSP70 PROTEIN BINDING | 45 | 6.93e-01 | 3.40e-02 | 8.90e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 13 | 8.32e-01 | -3.40e-02 | 9.44e-01 |
| GOBP PROTEIN HEXAMERIZATION | 9 | 8.60e-01 | -3.40e-02 | 9.52e-01 |
| GOBP NEURON PROJECTION GUIDANCE | 150 | 4.73e-01 | -3.39e-02 | 7.73e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 15 | 8.20e-01 | -3.39e-02 | 9.42e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 43 | 7.01e-01 | -3.39e-02 | 8.92e-01 |
| GOBP ERAD PATHWAY | 105 | 5.49e-01 | 3.39e-02 | 8.22e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 25 | 7.70e-01 | -3.38e-02 | 9.21e-01 |
| GOBP TRNA THIO MODIFICATION | 5 | 8.96e-01 | -3.38e-02 | 9.65e-01 |
| GOBP RESPONSE TO TYPE III INTERFERON | 8 | 8.68e-01 | -3.38e-02 | 9.56e-01 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 28 | 7.57e-01 | 3.38e-02 | 9.14e-01 |
| GOBP FLAVONOID METABOLIC PROCESS | 5 | 8.96e-01 | -3.38e-02 | 9.65e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 5 | 8.96e-01 | -3.37e-02 | 9.65e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 29 | 7.53e-01 | -3.37e-02 | 9.13e-01 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 57 | 6.60e-01 | 3.37e-02 | 8.73e-01 |
| GOBP NON LYTIC VIRAL RELEASE | 14 | 8.27e-01 | -3.37e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 64 | 6.41e-01 | -3.37e-02 | 8.66e-01 |
| GOBP PIGMENT GRANULE LOCALIZATION | 20 | 7.95e-01 | 3.36e-02 | 9.31e-01 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 13 | 8.34e-01 | 3.36e-02 | 9.45e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 681 | 1.35e-01 | -3.36e-02 | 4.50e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 168 | 4.52e-01 | 3.36e-02 | 7.57e-01 |
| GOBP MAMMARY GLAND INVOLUTION | 5 | 8.96e-01 | -3.36e-02 | 9.65e-01 |
| GOBP RESPONSE TO INSULIN | 226 | 3.84e-01 | -3.36e-02 | 7.15e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 21 | 7.90e-01 | -3.36e-02 | 9.29e-01 |
| GOBP DEPHOSPHORYLATION | 246 | 3.65e-01 | -3.35e-02 | 6.99e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 27 | 7.63e-01 | 3.35e-02 | 9.18e-01 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 16 | 8.17e-01 | -3.35e-02 | 9.40e-01 |
| GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 8.78e-01 | 3.34e-02 | 9.59e-01 |
| GOBP HEMOPOIESIS | 824 | 1.03e-01 | -3.34e-02 | 3.92e-01 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 58 | 6.60e-01 | -3.34e-02 | 8.73e-01 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 52 | 6.77e-01 | 3.34e-02 | 8.83e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 15 | 8.23e-01 | 3.34e-02 | 9.42e-01 |
| GOMF ALPHA TUBULIN BINDING | 38 | 7.22e-01 | 3.34e-02 | 9.02e-01 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 298 | 3.22e-01 | -3.34e-02 | 6.67e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 8 | 8.70e-01 | 3.33e-02 | 9.57e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 64 | 6.45e-01 | -3.33e-02 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 6 | 8.88e-01 | -3.33e-02 | 9.63e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 9 | 8.63e-01 | -3.33e-02 | 9.53e-01 |
| GOBP NUCLEAR MIGRATION ALONG MICROTUBULE | 5 | 8.97e-01 | -3.33e-02 | 9.66e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 475 | 2.14e-01 | -3.33e-02 | 5.59e-01 |
| GOCC AXON CYTOPLASM | 60 | 6.56e-01 | 3.33e-02 | 8.71e-01 |
| GOBP SPERM DNA CONDENSATION | 11 | 8.49e-01 | -3.33e-02 | 9.49e-01 |
| GOBP METAPHASE ANAPHASE TRANSITION OF MEIOTIC CELL CYCLE | 5 | 8.98e-01 | -3.32e-02 | 9.66e-01 |
| GOMF MYOSIN II BINDING | 11 | 8.49e-01 | 3.32e-02 | 9.49e-01 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 14 | 8.30e-01 | -3.32e-02 | 9.44e-01 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 8.24e-01 | 3.32e-02 | 9.42e-01 |
| GOMF ACYL COA HYDROLASE ACTIVITY | 21 | 7.92e-01 | -3.32e-02 | 9.30e-01 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 171 | 4.54e-01 | -3.32e-02 | 7.59e-01 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 202 | 4.17e-01 | -3.31e-02 | 7.36e-01 |
| GOMF HAPTOGLOBIN BINDING | 8 | 8.71e-01 | -3.31e-02 | 9.57e-01 |
| GOMF PRERIBOSOME BINDING | 6 | 8.88e-01 | -3.31e-02 | 9.63e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 146 | 4.91e-01 | 3.30e-02 | 7.85e-01 |
| GOBP SCHWANN CELL MIGRATION | 5 | 8.98e-01 | -3.30e-02 | 9.66e-01 |
| GOMF BIOTIN BINDING | 5 | 8.99e-01 | 3.28e-02 | 9.66e-01 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 9 | 8.65e-01 | 3.28e-02 | 9.54e-01 |
| GOBP G1 TO G0 TRANSITION | 19 | 8.05e-01 | 3.28e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 48 | 6.95e-01 | -3.28e-02 | 8.91e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 24 | 7.81e-01 | 3.27e-02 | 9.26e-01 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 118 | 5.39e-01 | 3.27e-02 | 8.14e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 10 | 8.58e-01 | 3.27e-02 | 9.52e-01 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 8 | 8.73e-01 | -3.27e-02 | 9.57e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 15 | 8.27e-01 | -3.26e-02 | 9.43e-01 |
| GOMF INTRACELLULARLY CAMP ACTIVATED CATION CHANNEL ACTIVITY | 5 | 9.00e-01 | 3.26e-02 | 9.66e-01 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 107 | 5.60e-01 | -3.26e-02 | 8.27e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 75 | 6.26e-01 | 3.25e-02 | 8.58e-01 |
| GOCC PRC1 COMPLEX | 16 | 8.22e-01 | 3.25e-02 | 9.42e-01 |
| GOBP GAMETE GENERATION | 544 | 1.95e-01 | 3.25e-02 | 5.37e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 1284 | 5.05e-02 | 3.25e-02 | 2.75e-01 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 48 | 6.97e-01 | -3.25e-02 | 8.91e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 57 | 6.72e-01 | 3.25e-02 | 8.79e-01 |
| GOBP SENSORY PERCEPTION OF BITTER TASTE | 16 | 8.22e-01 | 3.25e-02 | 9.42e-01 |
| GOCC U5 SNRNP | 19 | 8.07e-01 | -3.25e-02 | 9.38e-01 |
| GOBP EMBRYO DEVELOPMENT | 836 | 1.11e-01 | 3.24e-02 | 4.08e-01 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 43 | 7.13e-01 | -3.24e-02 | 8.98e-01 |
| GOBP GLYCOPHAGY | 12 | 8.46e-01 | 3.24e-02 | 9.49e-01 |
| GOBP HEART PROCESS | 174 | 4.62e-01 | -3.23e-02 | 7.65e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 9 | 8.67e-01 | -3.23e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 18 | 8.13e-01 | 3.22e-02 | 9.39e-01 |
| GOBP REGULATION OF PHOSPHORYLATION | 771 | 1.28e-01 | -3.22e-02 | 4.39e-01 |
| GOBP ENDOSOMAL TRANSPORT | 272 | 3.61e-01 | 3.22e-02 | 6.97e-01 |
| GOCC MUSCLE MYOSIN COMPLEX | 6 | 8.91e-01 | -3.22e-02 | 9.65e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 65 | 6.54e-01 | 3.22e-02 | 8.71e-01 |
| GOBP CARTILAGE DEVELOPMENT | 133 | 5.22e-01 | -3.22e-02 | 8.03e-01 |
| GOBP FOREGUT MORPHOGENESIS | 6 | 8.92e-01 | 3.21e-02 | 9.65e-01 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 529 | 2.06e-01 | -3.21e-02 | 5.50e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 10 | 8.61e-01 | -3.21e-02 | 9.53e-01 |
| GOMF STEROL ESTERASE ACTIVITY | 7 | 8.83e-01 | -3.20e-02 | 9.61e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 39 | 7.29e-01 | -3.20e-02 | 9.03e-01 |
| GOCC ATAC COMPLEX | 14 | 8.36e-01 | 3.20e-02 | 9.46e-01 |
| GOBP ENDOSOME ORGANIZATION | 95 | 5.90e-01 | -3.20e-02 | 8.40e-01 |
| GOBP CELL FATE COMMITMENT | 166 | 4.78e-01 | 3.19e-02 | 7.76e-01 |
| GOCC RECEPTOR COMPLEX | 399 | 2.74e-01 | 3.19e-02 | 6.24e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 12 | 8.48e-01 | -3.19e-02 | 9.49e-01 |
| GOCC AUTOLYSOSOME | 14 | 8.36e-01 | -3.19e-02 | 9.47e-01 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 8 | 8.76e-01 | -3.18e-02 | 9.58e-01 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 18 | 8.15e-01 | 3.18e-02 | 9.39e-01 |
| GOMF C C CHEMOKINE BINDING | 23 | 7.92e-01 | -3.18e-02 | 9.30e-01 |
| GOBP KIDNEY MORPHOGENESIS | 62 | 6.65e-01 | -3.18e-02 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 8 | 8.76e-01 | 3.18e-02 | 9.58e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 19 | 8.11e-01 | -3.18e-02 | 9.38e-01 |
| GOBP INTRACELLULAR CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 11 | 8.55e-01 | -3.18e-02 | 9.51e-01 |
| GOBP RRNA METABOLIC PROCESS | 259 | 3.79e-01 | 3.17e-02 | 7.11e-01 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 58 | 6.76e-01 | -3.17e-02 | 8.81e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 54 | 6.87e-01 | -3.17e-02 | 8.86e-01 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 8.93e-01 | -3.17e-02 | 9.65e-01 |
| GOBP RESPONSE TO CATECHOLAMINE | 42 | 7.22e-01 | -3.17e-02 | 9.02e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 159 | 4.91e-01 | -3.17e-02 | 7.85e-01 |
| GOBP CELL GROWTH | 379 | 2.90e-01 | 3.17e-02 | 6.38e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 8 | 8.77e-01 | -3.16e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 560 | 2.01e-01 | -3.16e-02 | 5.44e-01 |
| GOCC PERIKARYON | 103 | 5.80e-01 | 3.16e-02 | 8.33e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 42 | 7.23e-01 | 3.16e-02 | 9.03e-01 |
| GOBP RENAL SYSTEM PROCESS | 83 | 6.19e-01 | 3.16e-02 | 8.56e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 28 | 7.73e-01 | -3.16e-02 | 9.22e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 81 | 6.24e-01 | -3.15e-02 | 8.57e-01 |
| GOBP NEURON PROJECTION MAINTENANCE | 10 | 8.63e-01 | -3.15e-02 | 9.54e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 93 | 5.99e-01 | 3.15e-02 | 8.46e-01 |
| GOCC CILIUM | 572 | 1.98e-01 | 3.15e-02 | 5.40e-01 |
| GOBP T HELPER 2 CELL CYTOKINE PRODUCTION | 11 | 8.57e-01 | -3.15e-02 | 9.51e-01 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 73 | 6.42e-01 | -3.15e-02 | 8.66e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 540 | 2.11e-01 | -3.15e-02 | 5.57e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 80 | 6.27e-01 | 3.14e-02 | 8.58e-01 |
| GOBP HYALURONAN METABOLIC PROCESS | 29 | 7.70e-01 | -3.14e-02 | 9.21e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 13 | 8.45e-01 | 3.14e-02 | 9.49e-01 |
| GOBP FAT PAD DEVELOPMENT | 9 | 8.71e-01 | 3.14e-02 | 9.57e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 175 | 4.74e-01 | 3.14e-02 | 7.73e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 337 | 3.23e-01 | 3.14e-02 | 6.68e-01 |
| GOBP IMP METABOLIC PROCESS | 16 | 8.28e-01 | -3.13e-02 | 9.43e-01 |
| GOBP LACTATE TRANSMEMBRANE TRANSPORT | 6 | 8.94e-01 | -3.13e-02 | 9.65e-01 |
| GOBP REGULATION OF CELL CELL ADHESION | 415 | 2.74e-01 | -3.13e-02 | 6.24e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 8.57e-01 | -3.13e-02 | 9.51e-01 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 136 | 5.28e-01 | -3.13e-02 | 8.07e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 42 | 7.25e-01 | -3.13e-02 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 21 | 8.04e-01 | 3.13e-02 | 9.36e-01 |
| GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 12 | 8.51e-01 | -3.13e-02 | 9.50e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 7.87e-01 | 3.12e-02 | 9.28e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 11 | 8.58e-01 | -3.12e-02 | 9.52e-01 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 7.83e-01 | -3.12e-02 | 9.27e-01 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 20 | 8.10e-01 | 3.11e-02 | 9.38e-01 |
| GOCC MOTILE CILIUM | 181 | 4.72e-01 | -3.10e-02 | 7.72e-01 |
| GOBP ENDOCYTOSIS | 592 | 1.98e-01 | -3.10e-02 | 5.40e-01 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 49 | 7.07e-01 | 3.10e-02 | 8.95e-01 |
| GOCC SEX CHROMATIN | 6 | 8.95e-01 | -3.10e-02 | 9.65e-01 |
| GOBP GLYCINE METABOLIC PROCESS | 9 | 8.72e-01 | 3.10e-02 | 9.57e-01 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 122 | 5.55e-01 | 3.09e-02 | 8.25e-01 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 16 | 8.31e-01 | 3.09e-02 | 9.44e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 303 | 3.56e-01 | 3.08e-02 | 6.94e-01 |
| GOBP VESICLE DOCKING | 50 | 7.06e-01 | 3.08e-02 | 8.95e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 209 | 4.43e-01 | 3.08e-02 | 7.51e-01 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 51 | 7.04e-01 | -3.08e-02 | 8.94e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 483 | 2.46e-01 | 3.08e-02 | 5.94e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 676 | 1.73e-01 | -3.08e-02 | 5.07e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 5 | 9.05e-01 | -3.08e-02 | 9.68e-01 |
| GOBP URONIC ACID METABOLIC PROCESS | 9 | 8.73e-01 | 3.07e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 9 | 8.73e-01 | 3.07e-02 | 9.57e-01 |
| GOBP T CELL HOMEOSTASIS | 43 | 7.28e-01 | -3.07e-02 | 9.03e-01 |
| GOCC SMALL SUBUNIT PROCESSOME | 72 | 6.53e-01 | -3.07e-02 | 8.70e-01 |
| GOBP REGULATION OF B CELL ACTIVATION | 123 | 5.57e-01 | 3.07e-02 | 8.26e-01 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 7 | 8.88e-01 | -3.06e-02 | 9.63e-01 |
| GOBP RETINAL ROD CELL DEVELOPMENT | 5 | 9.06e-01 | 3.06e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 7 | 8.88e-01 | -3.06e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 28 | 7.79e-01 | 3.06e-02 | 9.25e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 31 | 7.68e-01 | -3.06e-02 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 20 | 8.13e-01 | 3.06e-02 | 9.39e-01 |
| GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 7 | 8.89e-01 | -3.05e-02 | 9.63e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1307 | 6.38e-02 | -3.05e-02 | 3.09e-01 |
| GOMF LAMIN BINDING | 14 | 8.43e-01 | 3.05e-02 | 9.49e-01 |
| GOBP JNK CASCADE | 154 | 5.13e-01 | 3.05e-02 | 7.98e-01 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 83 | 6.31e-01 | 3.05e-02 | 8.61e-01 |
| GOBP CELL MIGRATION IN HINDBRAIN | 14 | 8.43e-01 | 3.05e-02 | 9.49e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 119 | 5.66e-01 | -3.05e-02 | 8.29e-01 |
| GOMF STAT FAMILY PROTEIN BINDING | 10 | 8.68e-01 | 3.05e-02 | 9.56e-01 |
| GOBP SPERM MOTILITY | 84 | 6.29e-01 | -3.05e-02 | 8.59e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 39 | 7.42e-01 | -3.04e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 11 | 8.61e-01 | -3.04e-02 | 9.53e-01 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 9 | 8.75e-01 | 3.04e-02 | 9.57e-01 |
| GOBP RESPONSE TO WATER | 11 | 8.62e-01 | 3.04e-02 | 9.53e-01 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 22 | 8.06e-01 | -3.03e-02 | 9.37e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 119 | 5.68e-01 | 3.03e-02 | 8.30e-01 |
| GOMF HISTONE CHAPERONE ACTIVITY | 11 | 8.62e-01 | 3.03e-02 | 9.53e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 38 | 7.47e-01 | -3.03e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 8.98e-01 | -3.02e-02 | 9.66e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 47 | 7.20e-01 | -3.02e-02 | 9.01e-01 |
| GOBP NEURON FATE SPECIFICATION | 11 | 8.62e-01 | 3.02e-02 | 9.53e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 15 | 8.40e-01 | -3.02e-02 | 9.48e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 255 | 4.07e-01 | -3.01e-02 | 7.29e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 17 | 8.30e-01 | 3.01e-02 | 9.44e-01 |
| GOBP INCLUSION BODY ASSEMBLY | 20 | 8.16e-01 | 3.01e-02 | 9.39e-01 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 59 | 6.89e-01 | -3.01e-02 | 8.87e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 14 | 8.45e-01 | -3.01e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 22 | 8.07e-01 | -3.00e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 130 | 5.55e-01 | 3.00e-02 | 8.25e-01 |
| GOBP HEART MORPHOGENESIS | 173 | 4.97e-01 | 3.00e-02 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 420 | 2.92e-01 | -3.00e-02 | 6.41e-01 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 23 | 8.04e-01 | 3.00e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 5 | 9.08e-01 | -3.00e-02 | 9.69e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 850 | 1.39e-01 | -2.99e-02 | 4.57e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 15 | 8.41e-01 | -2.98e-02 | 9.48e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 28 | 7.85e-01 | 2.98e-02 | 9.28e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 99 | 6.08e-01 | 2.98e-02 | 8.51e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 18 | 8.27e-01 | -2.98e-02 | 9.43e-01 |
| GOCC NUCLEAR ENVELOPE | 451 | 2.79e-01 | 2.98e-02 | 6.27e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 57 | 6.98e-01 | -2.98e-02 | 8.91e-01 |
| GOBP NEURON PROJECTION EXTENSION | 126 | 5.64e-01 | 2.98e-02 | 8.29e-01 |
| GOMF METAL CLUSTER BINDING | 72 | 6.63e-01 | 2.97e-02 | 8.74e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 78 | 6.50e-01 | 2.97e-02 | 8.69e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 260 | 4.09e-01 | -2.97e-02 | 7.31e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 65 | 6.79e-01 | -2.97e-02 | 8.83e-01 |
| GOBP ESTABLISHMENT OF LOCALIZATION IN CELL | 1724 | 4.05e-02 | 2.97e-02 | 2.45e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 14 | 8.48e-01 | 2.96e-02 | 9.49e-01 |
| GOBP DESMOSOME ORGANIZATION | 8 | 8.85e-01 | 2.96e-02 | 9.62e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 228 | 4.42e-01 | 2.96e-02 | 7.51e-01 |
| GOBP REGULATION OF CELL POPULATION PROLIFERATION | 1287 | 7.52e-02 | -2.95e-02 | 3.35e-01 |
| GOBP DENDRITIC CELL MIGRATION | 29 | 7.84e-01 | -2.95e-02 | 9.27e-01 |
| GOBP DENDRITE DEVELOPMENT | 191 | 4.83e-01 | 2.95e-02 | 7.80e-01 |
| GOBP NEGATIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 22 | 8.11e-01 | -2.94e-02 | 9.38e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 39 | 7.51e-01 | 2.94e-02 | 9.12e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 6 | 9.01e-01 | -2.94e-02 | 9.67e-01 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 13 | 8.55e-01 | -2.93e-02 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 14 | 8.50e-01 | 2.93e-02 | 9.50e-01 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 7 | 8.93e-01 | 2.93e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 8.86e-01 | -2.93e-02 | 9.62e-01 |
| GOBP T CELL ACTIVATION | 505 | 2.61e-01 | 2.92e-02 | 6.09e-01 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 8.93e-01 | 2.92e-02 | 9.65e-01 |
| GOBP NEURON APOPTOTIC PROCESS | 220 | 4.56e-01 | -2.92e-02 | 7.60e-01 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 49 | 7.24e-01 | 2.91e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 224 | 4.53e-01 | 2.91e-02 | 7.58e-01 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 1123 | 1.00e-01 | -2.91e-02 | 3.87e-01 |
| GOCC MICROTUBULE | 396 | 3.22e-01 | 2.90e-02 | 6.67e-01 |
| GOBP CELLULAR EXTRAVASATION | 62 | 6.93e-01 | -2.90e-02 | 8.90e-01 |
| GOMF POLYSACCHARIDE BINDING | 20 | 8.23e-01 | 2.90e-02 | 9.42e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 51 | 7.21e-01 | 2.90e-02 | 9.01e-01 |
| GOBP DEFENSE RESPONSE | 1421 | 6.77e-02 | -2.89e-02 | 3.17e-01 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 17 | 8.37e-01 | -2.89e-02 | 9.47e-01 |
| GOBP P38MAPK CASCADE | 46 | 7.35e-01 | -2.88e-02 | 9.07e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 11 | 8.69e-01 | -2.88e-02 | 9.56e-01 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 5 | 9.11e-01 | -2.88e-02 | 9.70e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 34 | 7.71e-01 | -2.88e-02 | 9.22e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 49 | 7.27e-01 | -2.88e-02 | 9.03e-01 |
| GOCC BASAL CORTEX | 5 | 9.11e-01 | -2.88e-02 | 9.70e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 10 | 8.75e-01 | -2.88e-02 | 9.57e-01 |
| GOMF MANGANESE ION BINDING | 61 | 6.98e-01 | -2.87e-02 | 8.92e-01 |
| GOBP REGULATION OF GASTRIC ACID SECRETION | 5 | 9.12e-01 | 2.87e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 42 | 7.48e-01 | 2.87e-02 | 9.11e-01 |
| GOBP PROTEIN IMPORT | 9 | 8.82e-01 | -2.86e-02 | 9.60e-01 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 213 | 4.71e-01 | -2.86e-02 | 7.72e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 8.58e-01 | -2.86e-02 | 9.52e-01 |
| GOMF MISMATCHED DNA BINDING | 14 | 8.53e-01 | 2.86e-02 | 9.50e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 8 | 8.89e-01 | -2.86e-02 | 9.63e-01 |
| GOCC APICAL PART OF CELL | 320 | 3.80e-01 | -2.86e-02 | 7.12e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 11 | 8.70e-01 | -2.86e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 68 | 6.84e-01 | 2.86e-02 | 8.85e-01 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 15 | 8.48e-01 | 2.85e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 18 | 8.34e-01 | -2.85e-02 | 9.45e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 20 | 8.25e-01 | 2.85e-02 | 9.43e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 71 | 6.78e-01 | 2.85e-02 | 8.83e-01 |
| GOBP STEROID HORMONE SECRETION | 19 | 8.30e-01 | -2.85e-02 | 9.44e-01 |
| GOBP NK T CELL DIFFERENTIATION | 11 | 8.70e-01 | 2.85e-02 | 9.57e-01 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 54 | 7.17e-01 | -2.85e-02 | 9.00e-01 |
| GOMF CARBOXYLESTERASE ACTIVITY | 5 | 9.12e-01 | 2.85e-02 | 9.71e-01 |
| GOMF OXYSTEROL BINDING | 15 | 8.49e-01 | -2.85e-02 | 9.49e-01 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 24 | 8.09e-01 | -2.85e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 85 | 6.50e-01 | -2.85e-02 | 8.69e-01 |
| GOBP TUBE MORPHOGENESIS | 659 | 2.13e-01 | -2.85e-02 | 5.59e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 14 | 8.54e-01 | 2.84e-02 | 9.50e-01 |
| GOBP HEAD DEVELOPMENT | 570 | 2.46e-01 | 2.84e-02 | 5.94e-01 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 20 | 8.26e-01 | 2.84e-02 | 9.43e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 9 | 8.83e-01 | 2.83e-02 | 9.61e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 148 | 5.53e-01 | -2.83e-02 | 8.24e-01 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 63 | 6.98e-01 | -2.83e-02 | 8.91e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 1083 | 1.16e-01 | -2.83e-02 | 4.15e-01 |
| GOCC GATOR2 COMPLEX | 10 | 8.77e-01 | 2.82e-02 | 9.58e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 171 | 5.25e-01 | 2.82e-02 | 8.05e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 19 | 8.31e-01 | -2.82e-02 | 9.44e-01 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 35 | 7.73e-01 | -2.82e-02 | 9.22e-01 |
| GOBP TUBE DEVELOPMENT | 812 | 1.72e-01 | -2.82e-02 | 5.07e-01 |
| GOBP ORGANELLE FUSION | 145 | 5.58e-01 | -2.82e-02 | 8.27e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 15 | 8.50e-01 | -2.82e-02 | 9.50e-01 |
| GOBP AXONAL TRANSPORT | 63 | 7.00e-01 | 2.81e-02 | 8.92e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 78 | 6.68e-01 | -2.81e-02 | 8.77e-01 |
| GOBP RIBOSOME BIOGENESIS | 306 | 3.99e-01 | 2.81e-02 | 7.24e-01 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 61 | 7.05e-01 | -2.80e-02 | 8.94e-01 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 8.91e-01 | -2.80e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING | 7 | 8.98e-01 | -2.80e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 175 | 5.23e-01 | -2.80e-02 | 8.04e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 19 | 8.33e-01 | 2.79e-02 | 9.45e-01 |
| GOCC PRERIBOSOME | 105 | 6.21e-01 | -2.79e-02 | 8.57e-01 |
| GOBP AMINO ACID TRANSPORT | 113 | 6.08e-01 | 2.79e-02 | 8.51e-01 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 183 | 5.15e-01 | -2.79e-02 | 7.98e-01 |
| GOBP PEPTIDE TRANSPORT | 189 | 5.08e-01 | -2.79e-02 | 7.96e-01 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 881 | 1.60e-01 | -2.79e-02 | 4.89e-01 |
| GOBP REGULATION OF GROWTH RATE | 5 | 9.14e-01 | -2.79e-02 | 9.71e-01 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 18 | 8.38e-01 | 2.79e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 102 | 6.27e-01 | -2.79e-02 | 8.58e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 170 | 5.31e-01 | 2.78e-02 | 8.08e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 28 | 7.99e-01 | 2.78e-02 | 9.33e-01 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 242 | 4.56e-01 | 2.78e-02 | 7.60e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 13 | 8.62e-01 | 2.78e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 12 | 8.68e-01 | -2.78e-02 | 9.56e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 34 | 7.79e-01 | -2.78e-02 | 9.25e-01 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 33 | 7.83e-01 | -2.77e-02 | 9.27e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 48 | 7.40e-01 | -2.77e-02 | 9.08e-01 |
| GOBP EPITHELIUM DEVELOPMENT | 829 | 1.76e-01 | -2.77e-02 | 5.10e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 116 | 6.07e-01 | -2.77e-02 | 8.50e-01 |
| GOCC PRESYNAPSE | 416 | 3.33e-01 | -2.76e-02 | 6.77e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 27 | 8.04e-01 | -2.76e-02 | 9.36e-01 |
| GOBP VESICLE TARGETING | 65 | 7.01e-01 | 2.76e-02 | 8.92e-01 |
| GOMF ENDOPEPTIDASE ACTIVITY | 267 | 4.39e-01 | -2.75e-02 | 7.50e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 33 | 7.84e-01 | 2.75e-02 | 9.28e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 9 | 8.86e-01 | -2.75e-02 | 9.62e-01 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 16 | 8.49e-01 | 2.75e-02 | 9.49e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 107 | 6.23e-01 | -2.75e-02 | 8.57e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 337 | 3.87e-01 | 2.74e-02 | 7.16e-01 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 9.07e-01 | 2.74e-02 | 9.69e-01 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 25 | 8.13e-01 | 2.74e-02 | 9.39e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 1243 | 1.05e-01 | -2.73e-02 | 3.95e-01 |
| GOBP STEROL TRANSPORT | 85 | 6.63e-01 | 2.73e-02 | 8.74e-01 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 847 | 1.78e-01 | 2.73e-02 | 5.14e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 9 | 8.87e-01 | -2.72e-02 | 9.63e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 40 | 7.66e-01 | -2.72e-02 | 9.18e-01 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 201 | 5.06e-01 | -2.72e-02 | 7.94e-01 |
| GOBP TORC1 SIGNALING | 100 | 6.38e-01 | -2.72e-02 | 8.65e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 76 | 6.82e-01 | 2.72e-02 | 8.84e-01 |
| GOBP DETERMINATION OF LEFT RIGHT ASYMMETRY IN LATERAL MESODERM | 7 | 9.01e-01 | -2.71e-02 | 9.67e-01 |
| GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY | 5 | 9.17e-01 | -2.71e-02 | 9.72e-01 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 20 | 8.34e-01 | -2.70e-02 | 9.45e-01 |
| GOBP MIRNA METABOLIC PROCESS | 92 | 6.54e-01 | 2.70e-02 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 8 | 8.95e-01 | 2.70e-02 | 9.65e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1254 | 1.09e-01 | 2.69e-02 | 4.01e-01 |
| GOBP ALLANTOIN METABOLIC PROCESS | 6 | 9.09e-01 | 2.69e-02 | 9.69e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 527 | 2.91e-01 | -2.69e-02 | 6.39e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 36 | 7.80e-01 | -2.69e-02 | 9.26e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION | 72 | 6.94e-01 | 2.69e-02 | 8.90e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 137 | 5.87e-01 | -2.68e-02 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 21 | 8.32e-01 | -2.68e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE | 7 | 9.02e-01 | 2.68e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 61 | 7.17e-01 | 2.68e-02 | 9.00e-01 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 24 | 8.20e-01 | 2.68e-02 | 9.42e-01 |
| GOBP RESPONSE TO CAFFEINE | 13 | 8.67e-01 | -2.68e-02 | 9.56e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 317 | 4.13e-01 | -2.68e-02 | 7.33e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 19 | 8.40e-01 | 2.67e-02 | 9.48e-01 |
| GOBP IMPORT INTO CELL | 741 | 2.16e-01 | -2.67e-02 | 5.60e-01 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 10 | 8.84e-01 | -2.67e-02 | 9.61e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 64 | 7.12e-01 | -2.67e-02 | 8.97e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 137 | 5.90e-01 | -2.66e-02 | 8.40e-01 |
| GOBP REGULATION OF IMMUNE RESPONSE | 841 | 1.90e-01 | 2.66e-02 | 5.30e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 28 | 8.07e-01 | 2.66e-02 | 9.38e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 67 | 7.06e-01 | 2.66e-02 | 8.95e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 702 | 2.30e-01 | -2.66e-02 | 5.76e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 18 | 8.45e-01 | -2.66e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 38 | 7.77e-01 | 2.66e-02 | 9.24e-01 |
| GOBP AXO DENDRITIC TRANSPORT | 74 | 6.93e-01 | 2.65e-02 | 8.90e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 20 | 8.37e-01 | 2.65e-02 | 9.47e-01 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 49 | 7.48e-01 | 2.65e-02 | 9.11e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 885 | 1.82e-01 | -2.65e-02 | 5.19e-01 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 5 | 9.18e-01 | -2.64e-02 | 9.73e-01 |
| GOBP FEMALE GAMETE GENERATION | 111 | 6.30e-01 | 2.64e-02 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 14 | 8.64e-01 | 2.64e-02 | 9.54e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 28 | 8.09e-01 | 2.64e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 113 | 6.28e-01 | 2.64e-02 | 8.58e-01 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 8.17e-01 | -2.63e-02 | 9.40e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 304 | 4.31e-01 | -2.63e-02 | 7.44e-01 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 9.19e-01 | -2.63e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 33 | 7.94e-01 | -2.62e-02 | 9.31e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1273 | 1.16e-01 | -2.62e-02 | 4.15e-01 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 41 | 7.72e-01 | -2.62e-02 | 9.22e-01 |
| GOBP RESPONSE TO POTASSIUM ION | 16 | 8.56e-01 | -2.62e-02 | 9.51e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 8 | 8.98e-01 | 2.61e-02 | 9.66e-01 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 9 | 8.92e-01 | 2.61e-02 | 9.65e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT | 5 | 9.19e-01 | -2.61e-02 | 9.73e-01 |
| GOCC COPI COATED VESICLE MEMBRANE | 18 | 8.49e-01 | -2.60e-02 | 9.49e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 9.05e-01 | 2.60e-02 | 9.68e-01 |
| GOCC BLOC 1 COMPLEX | 14 | 8.66e-01 | 2.60e-02 | 9.55e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 81 | 6.86e-01 | -2.60e-02 | 8.86e-01 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 87 | 6.76e-01 | -2.60e-02 | 8.81e-01 |
| GOMF DEACETYLASE ACTIVITY | 35 | 7.91e-01 | 2.59e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 61 | 7.27e-01 | 2.59e-02 | 9.03e-01 |
| GOBP DENDRITE EXTENSION | 26 | 8.19e-01 | 2.59e-02 | 9.41e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 15 | 8.62e-01 | 2.59e-02 | 9.53e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 94 | 6.66e-01 | 2.58e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 125 | 6.19e-01 | -2.58e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 7 | 9.06e-01 | 2.58e-02 | 9.68e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 910 | 1.88e-01 | 2.58e-02 | 5.28e-01 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 16 | 8.58e-01 | 2.58e-02 | 9.52e-01 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 140 | 5.99e-01 | 2.57e-02 | 8.46e-01 |
| GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 5 | 9.21e-01 | -2.57e-02 | 9.74e-01 |
| GOCC MICROBODY MEMBRANE | 62 | 7.26e-01 | -2.57e-02 | 9.03e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 126 | 6.19e-01 | -2.57e-02 | 8.56e-01 |
| GOBP MALE MEIOSIS I | 17 | 8.55e-01 | -2.57e-02 | 9.50e-01 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 9.13e-01 | 2.56e-02 | 9.71e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 70 | 7.11e-01 | 2.56e-02 | 8.97e-01 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 18 | 8.51e-01 | -2.56e-02 | 9.50e-01 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 80 | 6.93e-01 | -2.56e-02 | 8.90e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 27 | 8.18e-01 | -2.56e-02 | 9.41e-01 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 35 | 7.94e-01 | -2.55e-02 | 9.31e-01 |
| GOMF RISC COMPLEX BINDING | 5 | 9.21e-01 | -2.55e-02 | 9.74e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 20 | 8.43e-01 | 2.55e-02 | 9.49e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 138 | 6.05e-01 | 2.55e-02 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 10 | 8.89e-01 | -2.55e-02 | 9.63e-01 |
| GOBP VESICLE ORGANIZATION | 330 | 4.27e-01 | -2.55e-02 | 7.42e-01 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 9.22e-01 | 2.54e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 26 | 8.22e-01 | 2.54e-02 | 9.42e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 18 | 8.52e-01 | -2.54e-02 | 9.50e-01 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 15 | 8.65e-01 | -2.54e-02 | 9.54e-01 |
| GOBP NEPHRON DEVELOPMENT | 109 | 6.47e-01 | -2.54e-02 | 8.69e-01 |
| GOCC NBAF COMPLEX | 15 | 8.65e-01 | -2.53e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 24 | 8.30e-01 | -2.53e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF GROWTH | 177 | 5.62e-01 | -2.53e-02 | 8.28e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 304 | 4.49e-01 | 2.52e-02 | 7.55e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 58 | 7.40e-01 | 2.52e-02 | 9.08e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 109 | 6.49e-01 | 2.52e-02 | 8.69e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 13 | 8.75e-01 | 2.52e-02 | 9.57e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 49 | 7.60e-01 | 2.52e-02 | 9.16e-01 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 46 | 7.68e-01 | -2.51e-02 | 9.20e-01 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 17 | 8.58e-01 | -2.51e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 89 | 6.83e-01 | -2.51e-02 | 8.84e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 49 | 7.62e-01 | 2.51e-02 | 9.17e-01 |
| GOCC LATE ENDOSOME | 280 | 4.71e-01 | -2.50e-02 | 7.72e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 37 | 7.92e-01 | -2.50e-02 | 9.30e-01 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 189 | 5.54e-01 | 2.50e-02 | 8.24e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 74 | 7.10e-01 | -2.50e-02 | 8.97e-01 |
| GOBP CYTOSOLIC TRANSPORT | 133 | 6.19e-01 | 2.50e-02 | 8.56e-01 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 13 | 8.76e-01 | 2.49e-02 | 9.58e-01 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 527 | 3.28e-01 | -2.49e-02 | 6.74e-01 |
| GOMF NADPLUS BINDING | 17 | 8.59e-01 | 2.49e-02 | 9.52e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 31 | 8.11e-01 | -2.48e-02 | 9.38e-01 |
| GOMF ACTIVIN BINDING | 10 | 8.92e-01 | 2.47e-02 | 9.65e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 49 | 7.65e-01 | -2.47e-02 | 9.18e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 44 | 7.77e-01 | -2.47e-02 | 9.24e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 80 | 7.03e-01 | -2.47e-02 | 8.93e-01 |
| GOCC NUCLEAR LAMINA | 12 | 8.82e-01 | -2.47e-02 | 9.61e-01 |
| GOMF GROWTH HORMONE RECEPTOR BINDING | 5 | 9.24e-01 | -2.47e-02 | 9.75e-01 |
| GOBP CALCIUM ION IMPORT | 59 | 7.43e-01 | -2.47e-02 | 9.09e-01 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 18 | 8.56e-01 | -2.46e-02 | 9.51e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 131 | 6.27e-01 | -2.46e-02 | 8.58e-01 |
| GOBP LUTEINIZATION | 10 | 8.93e-01 | -2.45e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 35 | 8.02e-01 | 2.45e-02 | 9.35e-01 |
| GOBP ENSHEATHMENT OF NEURONS | 134 | 6.24e-01 | -2.45e-02 | 8.57e-01 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 241 | 5.12e-01 | 2.45e-02 | 7.97e-01 |
| GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 9.05e-01 | 2.45e-02 | 9.68e-01 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 10 | 8.93e-01 | -2.45e-02 | 9.65e-01 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 6 | 9.17e-01 | -2.45e-02 | 9.72e-01 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 57 | 7.50e-01 | 2.44e-02 | 9.12e-01 |
| GOBP FERROPTOSIS | 10 | 8.94e-01 | -2.44e-02 | 9.65e-01 |
| GOBP TOR SIGNALING | 154 | 6.01e-01 | 2.44e-02 | 8.47e-01 |
| GOBP CARTILAGE CONDENSATION | 8 | 9.05e-01 | 2.44e-02 | 9.68e-01 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 17 | 8.62e-01 | 2.44e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 12 | 8.84e-01 | 2.44e-02 | 9.61e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 197 | 5.55e-01 | -2.44e-02 | 8.25e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 551 | 3.28e-01 | -2.44e-02 | 6.74e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 22 | 8.43e-01 | -2.43e-02 | 9.49e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 368 | 4.23e-01 | 2.43e-02 | 7.41e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 44 | 7.80e-01 | 2.43e-02 | 9.26e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 8.04e-01 | 2.43e-02 | 9.36e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 16 | 8.67e-01 | -2.43e-02 | 9.55e-01 |
| GOCC TRANSPORT VESICLE | 344 | 4.39e-01 | -2.43e-02 | 7.50e-01 |
| GOCC PROTEIN LIPID COMPLEX | 23 | 8.40e-01 | -2.43e-02 | 9.48e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN D | 5 | 9.25e-01 | -2.42e-02 | 9.75e-01 |
| GOBP GLUCAN METABOLIC PROCESS | 70 | 7.26e-01 | -2.42e-02 | 9.03e-01 |
| GOBP BLEB ASSEMBLY | 11 | 8.90e-01 | -2.41e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 7 | 9.12e-01 | 2.41e-02 | 9.71e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 21 | 8.48e-01 | 2.41e-02 | 9.49e-01 |
| GOBP GLAND DEVELOPMENT | 314 | 4.63e-01 | 2.41e-02 | 7.66e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 106 | 6.69e-01 | -2.41e-02 | 8.77e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 17 | 8.64e-01 | -2.41e-02 | 9.54e-01 |
| GOMF TRANSPORTER ACTIVATOR ACTIVITY | 6 | 9.19e-01 | -2.40e-02 | 9.73e-01 |
| GOBP PHAGOSOME LYSOSOME FUSION | 12 | 8.85e-01 | 2.40e-02 | 9.62e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 107 | 6.68e-01 | -2.40e-02 | 8.77e-01 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 11 | 8.90e-01 | 2.40e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 6 | 9.19e-01 | 2.40e-02 | 9.73e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 338 | 4.49e-01 | 2.39e-02 | 7.55e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 19 | 8.57e-01 | -2.39e-02 | 9.51e-01 |
| GOBP REGULATION OF GTP BINDING | 8 | 9.07e-01 | 2.39e-02 | 9.69e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 15 | 8.73e-01 | 2.39e-02 | 9.57e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 28 | 8.27e-01 | 2.39e-02 | 9.43e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 9 | 9.02e-01 | 2.38e-02 | 9.67e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 23 | 8.43e-01 | -2.38e-02 | 9.49e-01 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 9.13e-01 | -2.38e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 5 | 9.27e-01 | 2.38e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 146 | 6.20e-01 | 2.37e-02 | 8.57e-01 |
| GOMF ACTIN BINDING | 365 | 4.36e-01 | -2.37e-02 | 7.48e-01 |
| GOCC POSTSYNAPTIC CYTOSKELETON | 11 | 8.92e-01 | -2.37e-02 | 9.65e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 30 | 8.22e-01 | -2.37e-02 | 9.42e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 1060 | 1.92e-01 | 2.37e-02 | 5.34e-01 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 31 | 8.20e-01 | 2.37e-02 | 9.42e-01 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 45 | 7.84e-01 | 2.36e-02 | 9.27e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 71 | 7.31e-01 | -2.36e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 8 | 9.08e-01 | 2.36e-02 | 9.69e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 906 | 2.28e-01 | -2.36e-02 | 5.74e-01 |
| GOBP REGULATION OF MACROAUTOPHAGY | 172 | 5.94e-01 | 2.35e-02 | 8.42e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 9.03e-01 | 2.35e-02 | 9.67e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 35 | 8.10e-01 | -2.35e-02 | 9.38e-01 |
| GOBP RESPONSE TO HORMONE | 664 | 3.01e-01 | -2.35e-02 | 6.51e-01 |
| GOCC M BAND | 22 | 8.49e-01 | -2.35e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 19 | 8.59e-01 | -2.35e-02 | 9.52e-01 |
| GOCC CELL LEADING EDGE | 370 | 4.40e-01 | -2.34e-02 | 7.50e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 171 | 5.98e-01 | -2.34e-02 | 8.45e-01 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 11 | 8.93e-01 | -2.34e-02 | 9.65e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 33 | 8.16e-01 | -2.34e-02 | 9.40e-01 |
| GOCC GEMINI OF COILED BODIES | 12 | 8.89e-01 | 2.33e-02 | 9.63e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 101 | 6.86e-01 | 2.33e-02 | 8.86e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 23 | 8.47e-01 | 2.32e-02 | 9.49e-01 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 44 | 7.90e-01 | -2.32e-02 | 9.29e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 74 | 7.30e-01 | -2.32e-02 | 9.04e-01 |
| GOCC COMPACT MYELIN | 12 | 8.89e-01 | -2.32e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 303 | 4.88e-01 | -2.31e-02 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 37 | 8.08e-01 | -2.31e-02 | 9.38e-01 |
| GOBP RRNA MODIFICATION | 33 | 8.18e-01 | 2.31e-02 | 9.41e-01 |
| GOBP RRNA 3 END PROCESSING | 10 | 9.00e-01 | -2.30e-02 | 9.66e-01 |
| GOCC DNA DEPENDENT PROTEIN KINASE DNA LIGASE 4 COMPLEX | 7 | 9.16e-01 | 2.30e-02 | 9.72e-01 |
| GOBP RESPONSE TO ALDOSTERONE | 16 | 8.73e-01 | -2.30e-02 | 9.57e-01 |
| GOBP REGULATION OF HEART RATE | 65 | 7.48e-01 | -2.30e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 72 | 7.36e-01 | -2.30e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 45 | 7.90e-01 | -2.30e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 6 | 9.22e-01 | 2.30e-02 | 9.74e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 9 | 9.05e-01 | 2.29e-02 | 9.68e-01 |
| GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 11 | 8.95e-01 | 2.29e-02 | 9.65e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 181 | 5.95e-01 | -2.29e-02 | 8.43e-01 |
| GOCC LATE ENDOSOME MEMBRANE | 161 | 6.16e-01 | -2.29e-02 | 8.55e-01 |
| GOBP OXYGEN TRANSPORT | 11 | 8.95e-01 | -2.29e-02 | 9.65e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 543 | 3.63e-01 | 2.28e-02 | 6.98e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 165 | 6.13e-01 | -2.28e-02 | 8.53e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 320 | 4.83e-01 | -2.28e-02 | 7.80e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 171 | 6.07e-01 | -2.28e-02 | 8.50e-01 |
| GOCC DISTAL AXON | 201 | 5.78e-01 | 2.28e-02 | 8.33e-01 |
| GOMF CADHERIN BINDING | 297 | 5.00e-01 | -2.28e-02 | 7.91e-01 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 116 | 6.73e-01 | 2.27e-02 | 8.80e-01 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 14 | 8.83e-01 | -2.27e-02 | 9.61e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 63 | 7.56e-01 | -2.26e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 13 | 8.88e-01 | 2.26e-02 | 9.63e-01 |
| GOMF OPSIN BINDING | 5 | 9.30e-01 | -2.26e-02 | 9.76e-01 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 87 | 7.16e-01 | 2.26e-02 | 8.99e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 1206 | 1.88e-01 | -2.25e-02 | 5.28e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 22 | 8.55e-01 | 2.25e-02 | 9.50e-01 |
| GOBP TRIPEPTIDE TRANSPORT | 9 | 9.07e-01 | -2.25e-02 | 9.69e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 18 | 8.69e-01 | -2.24e-02 | 9.56e-01 |
| GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 9.18e-01 | 2.24e-02 | 9.73e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 131 | 6.58e-01 | 2.24e-02 | 8.72e-01 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 736 | 3.03e-01 | -2.23e-02 | 6.52e-01 |
| GOBP SKIN MORPHOGENESIS | 10 | 9.03e-01 | 2.23e-02 | 9.67e-01 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 130 | 6.61e-01 | -2.23e-02 | 8.74e-01 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 8 | 9.13e-01 | -2.23e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 82 | 7.28e-01 | -2.23e-02 | 9.03e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 92 | 7.12e-01 | 2.23e-02 | 8.97e-01 |
| GOBP SUBPALLIUM DEVELOPMENT | 19 | 8.67e-01 | 2.22e-02 | 9.56e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 111 | 6.87e-01 | -2.22e-02 | 8.86e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 43 | 8.02e-01 | 2.21e-02 | 9.35e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 67 | 7.54e-01 | -2.21e-02 | 9.13e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 69 | 7.51e-01 | 2.21e-02 | 9.13e-01 |
| GOBP CHOLESTEROL STORAGE | 21 | 8.61e-01 | 2.21e-02 | 9.53e-01 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 6 | 9.25e-01 | -2.21e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 17 | 8.75e-01 | 2.21e-02 | 9.57e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 10 | 9.04e-01 | 2.20e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 24 | 8.52e-01 | 2.20e-02 | 9.50e-01 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 19 | 8.68e-01 | -2.20e-02 | 9.56e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 11 | 9.00e-01 | -2.20e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 602 | 3.58e-01 | 2.19e-02 | 6.95e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 312 | 5.06e-01 | -2.19e-02 | 7.94e-01 |
| GOBP RESPONSE TO HISTAMINE | 6 | 9.26e-01 | 2.19e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 115 | 6.85e-01 | -2.19e-02 | 8.86e-01 |
| GOMF MAGNESIUM ION BINDING | 212 | 5.83e-01 | 2.19e-02 | 8.36e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 32 | 8.30e-01 | -2.19e-02 | 9.44e-01 |
| GOBP ORGANIC CATION TRANSPORT | 80 | 7.35e-01 | 2.19e-02 | 9.07e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 90 | 7.20e-01 | -2.19e-02 | 9.01e-01 |
| GOBP T CELL CHEMOTAXIS | 20 | 8.66e-01 | -2.19e-02 | 9.55e-01 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 177 | 6.16e-01 | -2.18e-02 | 8.55e-01 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 448 | 4.28e-01 | 2.18e-02 | 7.43e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 24 | 8.53e-01 | 2.18e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 663 | 3.38e-01 | -2.18e-02 | 6.81e-01 |
| GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION | 8 | 9.15e-01 | -2.18e-02 | 9.72e-01 |
| GOCC CELL CORTEX | 270 | 5.38e-01 | -2.18e-02 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 25 | 8.51e-01 | -2.17e-02 | 9.50e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 124 | 6.77e-01 | -2.17e-02 | 8.82e-01 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 7 | 9.21e-01 | 2.17e-02 | 9.74e-01 |
| GOBP RESPONSE TO IRON II ION | 5 | 9.33e-01 | 2.17e-02 | 9.78e-01 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 99 | 7.10e-01 | 2.16e-02 | 8.97e-01 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 11 | 9.01e-01 | -2.16e-02 | 9.67e-01 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 41 | 8.11e-01 | 2.16e-02 | 9.38e-01 |
| GOBP REGULATION OF ANOIKIS | 19 | 8.71e-01 | -2.16e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 124 | 6.78e-01 | -2.16e-02 | 8.83e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 15 | 8.85e-01 | -2.15e-02 | 9.62e-01 |
| GOCC PERICHROMATIN FIBRILS | 6 | 9.27e-01 | -2.15e-02 | 9.75e-01 |
| GOBP MYOBLAST MIGRATION | 9 | 9.11e-01 | -2.15e-02 | 9.70e-01 |
| GOMF MAP KINASE KINASE ACTIVITY | 14 | 8.90e-01 | 2.14e-02 | 9.64e-01 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 152 | 6.49e-01 | 2.14e-02 | 8.69e-01 |
| GOMF NADPH BINDING | 16 | 8.82e-01 | -2.14e-02 | 9.61e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 69 | 7.59e-01 | 2.14e-02 | 9.16e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 5 | 9.34e-01 | -2.13e-02 | 9.78e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 618 | 3.65e-01 | 2.13e-02 | 6.99e-01 |
| GOBP T CELL MEDIATED IMMUNITY | 122 | 6.85e-01 | -2.13e-02 | 8.85e-01 |
| GOMF EPOXIDE HYDROLASE ACTIVITY | 8 | 9.17e-01 | 2.13e-02 | 9.72e-01 |
| GOBP PROTEOLYSIS | 1320 | 1.95e-01 | -2.12e-02 | 5.37e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 118 | 6.91e-01 | 2.12e-02 | 8.88e-01 |
| GOBP CELL MORPHOGENESIS | 735 | 3.28e-01 | 2.12e-02 | 6.73e-01 |
| GOCC MANCHETTE | 19 | 8.73e-01 | -2.12e-02 | 9.57e-01 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 194 | 6.11e-01 | -2.12e-02 | 8.53e-01 |
| GOCC CLATHRIN COATED VESICLE | 180 | 6.25e-01 | 2.11e-02 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 60 | 7.77e-01 | 2.11e-02 | 9.24e-01 |
| GOMF ARACHIDONIC ACID MONOOXYGENASE ACTIVITY | 7 | 9.23e-01 | -2.11e-02 | 9.74e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 655 | 3.57e-01 | -2.11e-02 | 6.94e-01 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 512 | 4.15e-01 | -2.11e-02 | 7.34e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 13 | 8.95e-01 | 2.10e-02 | 9.65e-01 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 196 | 6.12e-01 | 2.10e-02 | 8.53e-01 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 68 | 7.65e-01 | 2.10e-02 | 9.18e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 162 | 6.45e-01 | 2.10e-02 | 8.68e-01 |
| GOMF ALDEHYDE LYASE ACTIVITY | 8 | 9.18e-01 | -2.10e-02 | 9.73e-01 |
| GOCC ESCRT COMPLEX | 27 | 8.51e-01 | -2.10e-02 | 9.50e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 8 | 9.18e-01 | -2.09e-02 | 9.73e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 169 | 6.39e-01 | 2.09e-02 | 8.65e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION | 5 | 9.35e-01 | 2.09e-02 | 9.78e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 49 | 8.00e-01 | -2.09e-02 | 9.34e-01 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 14 | 8.92e-01 | 2.09e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 21 | 8.69e-01 | 2.09e-02 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 7 | 9.24e-01 | -2.08e-02 | 9.75e-01 |
| GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX | 8 | 9.19e-01 | 2.08e-02 | 9.73e-01 |
| GOMF PEPTIDASE ACTIVITY | 428 | 4.61e-01 | -2.08e-02 | 7.65e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 96 | 7.25e-01 | 2.08e-02 | 9.03e-01 |
| GOBP ADULT BEHAVIOR | 96 | 7.25e-01 | 2.07e-02 | 9.03e-01 |
| GOBP INNATE IMMUNE RESPONSE | 786 | 3.23e-01 | 2.07e-02 | 6.68e-01 |
| GOCC IMMUNOLOGICAL SYNAPSE | 45 | 8.10e-01 | 2.07e-02 | 9.38e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI MEMBRANE | 5 | 9.36e-01 | 2.07e-02 | 9.78e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 261 | 5.66e-01 | 2.07e-02 | 8.29e-01 |
| GOBP PROTEIN METHYLATION | 46 | 8.09e-01 | -2.06e-02 | 9.38e-01 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 20 | 8.73e-01 | 2.06e-02 | 9.57e-01 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 16 | 8.86e-01 | -2.06e-02 | 9.62e-01 |
| GOMF DNA CLAMP LOADER ACTIVITY | 9 | 9.15e-01 | 2.06e-02 | 9.71e-01 |
| GOBP REGULATION OF MUCUS SECRETION | 8 | 9.20e-01 | -2.06e-02 | 9.73e-01 |
| GOBP METANEPHRIC NEPHRON TUBULE MORPHOGENESIS | 5 | 9.36e-01 | -2.06e-02 | 9.78e-01 |
| GOCC CALYX OF HELD | 12 | 9.02e-01 | -2.06e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 120 | 6.97e-01 | 2.06e-02 | 8.91e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 1536 | 1.79e-01 | -2.05e-02 | 5.15e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 223 | 5.99e-01 | 2.05e-02 | 8.46e-01 |
| GOCC SARCOPLASMIC RETICULUM | 58 | 7.88e-01 | 2.05e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 45 | 8.13e-01 | 2.04e-02 | 9.39e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 20 | 8.75e-01 | 2.04e-02 | 9.57e-01 |
| GOBP L GLUTAMATE IMPORT | 32 | 8.42e-01 | 2.04e-02 | 9.48e-01 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 7 | 9.26e-01 | -2.04e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 195 | 6.24e-01 | -2.03e-02 | 8.57e-01 |
| GOMF POLY A BINDING | 20 | 8.75e-01 | -2.03e-02 | 9.57e-01 |
| GOCC KERATIN FILAMENT | 19 | 8.78e-01 | 2.03e-02 | 9.59e-01 |
| GOBP SKELETAL MUSCLE ADAPTATION | 11 | 9.07e-01 | -2.03e-02 | 9.69e-01 |
| GOMF COBALAMIN BINDING | 9 | 9.16e-01 | -2.03e-02 | 9.72e-01 |
| GOBP APOPTOTIC PROCESS | 1560 | 1.81e-01 | -2.03e-02 | 5.18e-01 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 15 | 8.92e-01 | -2.02e-02 | 9.65e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 75 | 7.62e-01 | -2.02e-02 | 9.17e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 539 | 4.22e-01 | 2.02e-02 | 7.40e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 17 | 8.85e-01 | -2.02e-02 | 9.62e-01 |
| GOBP PINOCYTOSIS | 20 | 8.76e-01 | -2.02e-02 | 9.58e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 115 | 7.09e-01 | -2.01e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 100 | 7.28e-01 | 2.01e-02 | 9.03e-01 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 9.32e-01 | -2.01e-02 | 9.77e-01 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 37 | 8.32e-01 | -2.01e-02 | 9.45e-01 |
| GOBP DNA DEMETHYLATION | 20 | 8.76e-01 | 2.01e-02 | 9.58e-01 |
| GOBP BODY MORPHOGENESIS | 40 | 8.26e-01 | 2.01e-02 | 9.43e-01 |
| GOBP MESENCHYME DEVELOPMENT | 219 | 6.10e-01 | -2.00e-02 | 8.52e-01 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 48 | 8.10e-01 | -2.00e-02 | 9.38e-01 |
| GOBP IMMUNE EFFECTOR PROCESS | 597 | 4.04e-01 | -2.00e-02 | 7.26e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 26 | 8.60e-01 | 2.00e-02 | 9.52e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 19 | 8.80e-01 | -2.00e-02 | 9.60e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 76 | 7.64e-01 | -1.99e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 969 | 2.94e-01 | -1.99e-02 | 6.43e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 455 | 4.67e-01 | -1.99e-02 | 7.68e-01 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 38 | 8.32e-01 | 1.99e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 14 | 8.97e-01 | 1.99e-02 | 9.66e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 76 | 7.65e-01 | 1.99e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 601 | 4.05e-01 | -1.99e-02 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 928 | 3.05e-01 | 1.99e-02 | 6.53e-01 |
| GOBP MEMBRANE ORGANIZATION | 698 | 3.75e-01 | -1.97e-02 | 7.07e-01 |
| GOMF TRNA PSEUDOURIDINE SYNTHASE ACTIVITY | 8 | 9.23e-01 | -1.97e-02 | 9.74e-01 |
| GOBP CENTROSOME SEPARATION | 15 | 8.95e-01 | 1.96e-02 | 9.65e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 50 | 8.10e-01 | -1.96e-02 | 9.38e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 55 | 8.01e-01 | 1.96e-02 | 9.35e-01 |
| GOBP MEMBRANE FISSION | 42 | 8.26e-01 | 1.96e-02 | 9.43e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 73 | 7.73e-01 | -1.95e-02 | 9.22e-01 |
| GOMF PDZ DOMAIN BINDING | 69 | 7.79e-01 | 1.95e-02 | 9.25e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 31 | 8.51e-01 | -1.95e-02 | 9.50e-01 |
| GOBP CELL CELL SIGNALING | 867 | 3.30e-01 | -1.95e-02 | 6.75e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 18 | 8.86e-01 | -1.95e-02 | 9.62e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 141 | 6.90e-01 | -1.95e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1297 | 2.39e-01 | -1.95e-02 | 5.87e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 252 | 5.95e-01 | -1.94e-02 | 8.43e-01 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 11 | 9.11e-01 | -1.94e-02 | 9.70e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 29 | 8.57e-01 | -1.94e-02 | 9.51e-01 |
| GOMF SNARE BINDING | 87 | 7.55e-01 | -1.94e-02 | 9.14e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 14 | 9.00e-01 | -1.94e-02 | 9.66e-01 |
| GOCC BRAHMA COMPLEX | 13 | 9.04e-01 | 1.93e-02 | 9.68e-01 |
| GOMF SCAFFOLD PROTEIN BINDING | 60 | 7.96e-01 | 1.93e-02 | 9.31e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 40 | 8.33e-01 | -1.93e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 13 | 9.04e-01 | 1.93e-02 | 9.68e-01 |
| GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 9 | 9.20e-01 | -1.92e-02 | 9.74e-01 |
| GOBP GLIAL CELL PROLIFERATION | 44 | 8.25e-01 | -1.92e-02 | 9.43e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 36 | 8.42e-01 | 1.92e-02 | 9.48e-01 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 44 | 8.26e-01 | -1.92e-02 | 9.43e-01 |
| GOBP PARENTAL BEHAVIOR | 7 | 9.30e-01 | 1.91e-02 | 9.76e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 33 | 8.49e-01 | 1.91e-02 | 9.49e-01 |
| GOBP CILIUM MOVEMENT | 132 | 7.05e-01 | -1.91e-02 | 8.94e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 449 | 4.88e-01 | 1.91e-02 | 7.84e-01 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 12 | 9.09e-01 | 1.91e-02 | 9.69e-01 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 37 | 8.41e-01 | 1.91e-02 | 9.48e-01 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 9.30e-01 | 1.91e-02 | 9.76e-01 |
| GOBP RESPONSE TO INDOLE 3 METHANOL | 6 | 9.36e-01 | 1.91e-02 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 80 | 7.69e-01 | -1.90e-02 | 9.20e-01 |
| GOBP AXONEME ASSEMBLY | 68 | 7.86e-01 | 1.90e-02 | 9.28e-01 |
| GOBP RESPONSE TO HYDROSTATIC PRESSURE | 7 | 9.31e-01 | -1.90e-02 | 9.76e-01 |
| GOCC MICROTUBULE END | 31 | 8.55e-01 | 1.90e-02 | 9.50e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX | 112 | 7.28e-01 | -1.90e-02 | 9.03e-01 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 24 | 8.72e-01 | 1.90e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 5 | 9.41e-01 | 1.90e-02 | 9.80e-01 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 90 | 7.56e-01 | -1.90e-02 | 9.14e-01 |
| GOMF OLFACTORY RECEPTOR ACTIVITY | 51 | 8.15e-01 | 1.89e-02 | 9.39e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 20 | 8.84e-01 | 1.89e-02 | 9.61e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 14 | 9.02e-01 | 1.89e-02 | 9.67e-01 |
| GOBP REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 45 | 8.26e-01 | -1.89e-02 | 9.43e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 9.26e-01 | 1.89e-02 | 9.75e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 25 | 8.70e-01 | -1.89e-02 | 9.57e-01 |
| GOBP SPINAL CORD PATTERNING | 8 | 9.26e-01 | -1.89e-02 | 9.75e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 131 | 7.10e-01 | -1.88e-02 | 8.97e-01 |
| GOBP ADAPTIVE IMMUNE MEMORY RESPONSE | 6 | 9.36e-01 | 1.88e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 12 | 9.10e-01 | -1.88e-02 | 9.70e-01 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 9.22e-01 | -1.88e-02 | 9.74e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 7 | 9.31e-01 | -1.88e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 69 | 7.87e-01 | 1.88e-02 | 9.28e-01 |
| GOBP MULTICELLULAR ORGANISMAL REPRODUCTIVE PROCESS | 640 | 4.18e-01 | 1.88e-02 | 7.37e-01 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 6 | 9.37e-01 | -1.87e-02 | 9.78e-01 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 335 | 5.56e-01 | -1.87e-02 | 8.25e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 15 | 9.00e-01 | 1.87e-02 | 9.66e-01 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 12 | 9.11e-01 | 1.87e-02 | 9.70e-01 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 102 | 7.44e-01 | -1.87e-02 | 9.10e-01 |
| GOBP GASTRULATION | 146 | 6.97e-01 | -1.87e-02 | 8.91e-01 |
| GOCC ENDOSOME MEMBRANE | 519 | 4.67e-01 | -1.87e-02 | 7.68e-01 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 805 | 3.68e-01 | -1.87e-02 | 7.01e-01 |
| GOBP RESPONSE TO TUMOR CELL | 40 | 8.38e-01 | 1.87e-02 | 9.47e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 12 | 9.11e-01 | -1.87e-02 | 9.70e-01 |
| GOBP MIRNA CATABOLIC PROCESS | 16 | 8.97e-01 | 1.86e-02 | 9.66e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 8.60e-01 | -1.86e-02 | 9.52e-01 |
| GOBP DEDIFFERENTIATION | 6 | 9.37e-01 | -1.85e-02 | 9.78e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT LEVELS | 207 | 6.47e-01 | -1.85e-02 | 8.69e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 22 | 8.81e-01 | 1.85e-02 | 9.60e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 168 | 6.81e-01 | -1.84e-02 | 8.84e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 40 | 8.40e-01 | 1.84e-02 | 9.48e-01 |
| GOBP VISUAL BEHAVIOR | 45 | 8.31e-01 | 1.84e-02 | 9.44e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 70 | 7.91e-01 | -1.84e-02 | 9.30e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 728 | 4.00e-01 | -1.83e-02 | 7.25e-01 |
| GOBP MICROTUBULE SEVERING | 8 | 9.29e-01 | 1.83e-02 | 9.76e-01 |
| GOBP NOREPINEPHRINE METABOLIC PROCESS | 8 | 9.29e-01 | 1.83e-02 | 9.76e-01 |
| GOCC SAGA COMPLEX | 23 | 8.79e-01 | 1.83e-02 | 9.59e-01 |
| GOMF ENZYME REGULATOR ACTIVITY | 1111 | 3.03e-01 | -1.83e-02 | 6.53e-01 |
| GOBP REPRODUCTIVE PROCESS | 1036 | 3.20e-01 | 1.83e-02 | 6.66e-01 |
| GOBP DETECTION OF VISIBLE LIGHT | 32 | 8.58e-01 | -1.83e-02 | 9.52e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 313 | 5.79e-01 | -1.82e-02 | 8.33e-01 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 9.44e-01 | 1.82e-02 | 9.81e-01 |
| GOBP RESPONSE TO LEAD ION | 19 | 8.91e-01 | 1.82e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 120 | 7.30e-01 | -1.82e-02 | 9.04e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 9.13e-01 | 1.82e-02 | 9.71e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION | 78 | 7.82e-01 | 1.82e-02 | 9.26e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 61 | 8.07e-01 | -1.81e-02 | 9.38e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 41 | 8.41e-01 | -1.81e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 104 | 7.50e-01 | 1.81e-02 | 9.12e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 26 | 8.73e-01 | 1.80e-02 | 9.57e-01 |
| GOBP VIRAL BUDDING | 24 | 8.78e-01 | 1.80e-02 | 9.59e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 22 | 8.84e-01 | 1.80e-02 | 9.61e-01 |
| GOMF PHOSPHODIESTERASE I ACTIVITY | 5 | 9.44e-01 | -1.80e-02 | 9.82e-01 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 8 | 9.30e-01 | -1.80e-02 | 9.76e-01 |
| GOBP PLATELET MORPHOGENESIS | 26 | 8.74e-01 | -1.79e-02 | 9.57e-01 |
| GOBP PRIMARY MIRNA PROCESSING | 17 | 8.98e-01 | -1.79e-02 | 9.66e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 42 | 8.41e-01 | -1.79e-02 | 9.48e-01 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 7 | 9.35e-01 | -1.79e-02 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 25 | 8.77e-01 | -1.79e-02 | 9.58e-01 |
| GOCC MISMATCH REPAIR COMPLEX | 10 | 9.22e-01 | -1.79e-02 | 9.74e-01 |
| GOBP STRIATED MUSCLE ADAPTATION | 30 | 8.66e-01 | 1.78e-02 | 9.55e-01 |
| GOCC INNER KINETOCHORE | 19 | 8.93e-01 | -1.78e-02 | 9.65e-01 |
| GOCC JUNCTIONAL SARCOPLASMIC RETICULUM MEMBRANE | 6 | 9.40e-01 | -1.78e-02 | 9.79e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 117 | 7.40e-01 | -1.77e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 37 | 8.52e-01 | -1.77e-02 | 9.50e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 12 | 9.15e-01 | -1.77e-02 | 9.72e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 290 | 6.05e-01 | -1.77e-02 | 8.49e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 131 | 7.27e-01 | -1.77e-02 | 9.03e-01 |
| GOBP REGULATION OF PROTEIN TRANSPORT | 352 | 5.70e-01 | -1.76e-02 | 8.30e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 248 | 6.33e-01 | -1.76e-02 | 8.62e-01 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 14 | 9.09e-01 | -1.76e-02 | 9.69e-01 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 124 | 7.35e-01 | -1.76e-02 | 9.07e-01 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 91 | 7.72e-01 | -1.76e-02 | 9.22e-01 |
| GOBP XENOPHAGY | 14 | 9.09e-01 | -1.76e-02 | 9.69e-01 |
| GOBP CELL MIGRATION INVOLVED IN GASTRULATION | 8 | 9.32e-01 | 1.75e-02 | 9.77e-01 |
| GOBP PROTEIN TRANSPORT | 1241 | 3.01e-01 | 1.75e-02 | 6.51e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 121 | 7.40e-01 | -1.75e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 15 | 9.07e-01 | -1.74e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 5 | 9.46e-01 | 1.74e-02 | 9.82e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 113 | 7.50e-01 | 1.74e-02 | 9.12e-01 |
| GOBP RESPONSE TO FORSKOLIN | 10 | 9.24e-01 | -1.74e-02 | 9.75e-01 |
| GOBP LEARNING | 111 | 7.52e-01 | -1.74e-02 | 9.13e-01 |
| GOCC COPI COATED VESICLE | 25 | 8.81e-01 | -1.73e-02 | 9.60e-01 |
| GOMF PHOSPHOLIPID BINDING | 400 | 5.53e-01 | -1.73e-02 | 8.24e-01 |
| GOBP DETECTION OF STIMULUS | 206 | 6.70e-01 | -1.72e-02 | 8.78e-01 |
| GOCC ENDOCYTIC VESICLE LUMEN | 19 | 8.97e-01 | -1.72e-02 | 9.65e-01 |
| GOBP RESPONSE TO COCAINE | 35 | 8.60e-01 | 1.72e-02 | 9.52e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 16 | 9.05e-01 | -1.72e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 24 | 8.84e-01 | 1.72e-02 | 9.62e-01 |
| GOBP CELL CYCLE DNA REPLICATION INITIATION | 5 | 9.47e-01 | -1.71e-02 | 9.82e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 41 | 8.50e-01 | -1.71e-02 | 9.50e-01 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 218 | 6.64e-01 | 1.71e-02 | 8.75e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 651 | 4.58e-01 | -1.71e-02 | 7.62e-01 |
| GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER | 5 | 9.47e-01 | -1.70e-02 | 9.82e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 424 | 5.48e-01 | 1.70e-02 | 8.21e-01 |
| GOBP THIAMINE DIPHOSPHATE METABOLIC PROCESS | 5 | 9.48e-01 | -1.70e-02 | 9.82e-01 |
| GOBP MEMBRANE BIOGENESIS | 54 | 8.29e-01 | 1.70e-02 | 9.44e-01 |
| GOBP MYOBLAST DIFFERENTIATION | 83 | 7.90e-01 | -1.69e-02 | 9.29e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 57 | 8.25e-01 | -1.69e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 18 | 9.01e-01 | -1.69e-02 | 9.67e-01 |
| GOBP EMBRYO IMPLANTATION | 43 | 8.49e-01 | -1.68e-02 | 9.49e-01 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 79 | 7.97e-01 | -1.68e-02 | 9.32e-01 |
| GOBP COMPLEMENT ACTIVATION LECTIN PATHWAY | 5 | 9.48e-01 | 1.67e-02 | 9.82e-01 |
| GOCC LEADING EDGE MEMBRANE | 145 | 7.28e-01 | -1.67e-02 | 9.03e-01 |
| GOMF SUPERCOILED DNA BINDING | 6 | 9.43e-01 | 1.67e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 21 | 8.94e-01 | 1.67e-02 | 9.65e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 92 | 7.82e-01 | -1.67e-02 | 9.26e-01 |
| GOCC DYNEIN COMPLEX | 46 | 8.45e-01 | -1.67e-02 | 9.49e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 13 | 9.17e-01 | 1.67e-02 | 9.72e-01 |
| GOCC NUCLEOID | 46 | 8.45e-01 | 1.66e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 148 | 7.28e-01 | 1.66e-02 | 9.03e-01 |
| GOBP REGULATION OF JNK CASCADE | 123 | 7.51e-01 | 1.66e-02 | 9.13e-01 |
| GOCC TRAPPIII PROTEIN COMPLEX | 12 | 9.21e-01 | 1.65e-02 | 9.74e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 191 | 6.94e-01 | -1.65e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 69 | 8.13e-01 | -1.64e-02 | 9.39e-01 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 7 | 9.40e-01 | -1.64e-02 | 9.79e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 11 | 9.25e-01 | -1.64e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 72 | 8.10e-01 | -1.64e-02 | 9.38e-01 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 10 | 9.28e-01 | -1.64e-02 | 9.76e-01 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 62 | 8.23e-01 | 1.64e-02 | 9.42e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 12 | 9.22e-01 | -1.64e-02 | 9.74e-01 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 15 | 9.13e-01 | 1.64e-02 | 9.71e-01 |
| GOMF METHYL CPG BINDING | 22 | 8.94e-01 | -1.64e-02 | 9.65e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 266 | 6.47e-01 | 1.63e-02 | 8.69e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY VIA STAT | 121 | 7.57e-01 | -1.63e-02 | 9.14e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 37 | 8.64e-01 | 1.63e-02 | 9.54e-01 |
| GOCC SYNAPTIC MEMBRANE | 247 | 6.60e-01 | -1.63e-02 | 8.73e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 18 | 9.05e-01 | -1.63e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF FERROPTOSIS | 8 | 9.37e-01 | 1.62e-02 | 9.78e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 62 | 8.25e-01 | -1.62e-02 | 9.43e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 12 | 9.23e-01 | 1.61e-02 | 9.74e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 277 | 6.45e-01 | -1.61e-02 | 8.68e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1191 | 3.50e-01 | 1.61e-02 | 6.90e-01 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 9 | 9.34e-01 | -1.61e-02 | 9.78e-01 |
| GOMF SNRNP BINDING | 9 | 9.34e-01 | 1.61e-02 | 9.78e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 143 | 7.41e-01 | 1.60e-02 | 9.09e-01 |
| GOBP GASTRIC ACID SECRETION | 9 | 9.34e-01 | -1.60e-02 | 9.78e-01 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 316 | 6.26e-01 | -1.60e-02 | 8.58e-01 |
| GOBP NERVE DEVELOPMENT | 63 | 8.27e-01 | -1.59e-02 | 9.43e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 13 | 9.21e-01 | 1.59e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 19 | 9.04e-01 | -1.59e-02 | 9.68e-01 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 83 | 8.02e-01 | -1.59e-02 | 9.35e-01 |
| GOMF RECEPTOR ANTAGONIST ACTIVITY | 8 | 9.38e-01 | -1.59e-02 | 9.78e-01 |
| GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 9.42e-01 | -1.59e-02 | 9.81e-01 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 107 | 7.77e-01 | -1.58e-02 | 9.24e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 21 | 9.00e-01 | 1.58e-02 | 9.66e-01 |
| GOCC SUPER ELONGATION COMPLEX | 6 | 9.47e-01 | -1.58e-02 | 9.82e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 166 | 7.26e-01 | -1.58e-02 | 9.03e-01 |
| GOCC ZONULA ADHERENS | 8 | 9.39e-01 | 1.57e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 7 | 9.43e-01 | -1.57e-02 | 9.81e-01 |
| GOCC ENDOSOME | 938 | 4.14e-01 | -1.57e-02 | 7.34e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 16 | 9.14e-01 | -1.57e-02 | 9.71e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 60 | 8.34e-01 | -1.56e-02 | 9.45e-01 |
| GOBP NEURON CELL CELL ADHESION | 9 | 9.35e-01 | -1.56e-02 | 9.78e-01 |
| GOBP TRACHEA DEVELOPMENT | 12 | 9.26e-01 | -1.56e-02 | 9.75e-01 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 7 | 9.43e-01 | -1.56e-02 | 9.81e-01 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 339 | 6.22e-01 | -1.56e-02 | 8.57e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 54 | 8.43e-01 | -1.56e-02 | 9.49e-01 |
| GOBP REGULATION OF ENDODERMAL CELL DIFFERENTIATION | 5 | 9.52e-01 | -1.56e-02 | 9.84e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 17 | 9.12e-01 | -1.56e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 12 | 9.26e-01 | 1.56e-02 | 9.75e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 54 | 8.44e-01 | -1.55e-02 | 9.49e-01 |
| GOBP EAR MORPHOGENESIS | 70 | 8.23e-01 | 1.55e-02 | 9.42e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 10 | 9.32e-01 | -1.55e-02 | 9.77e-01 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 9 | 9.36e-01 | -1.55e-02 | 9.78e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 453 | 5.74e-01 | 1.54e-02 | 8.32e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 11 | 9.30e-01 | 1.54e-02 | 9.76e-01 |
| GOBP RESPONSE TO SALT STRESS | 19 | 9.08e-01 | 1.53e-02 | 9.69e-01 |
| GOBP REGULATION OF GASTRULATION | 13 | 9.24e-01 | -1.53e-02 | 9.75e-01 |
| GOBP AXON DEVELOPMENT | 363 | 6.16e-01 | 1.53e-02 | 8.55e-01 |
| GOBP LYMPHOCYTE ACTIVATION | 707 | 4.88e-01 | 1.53e-02 | 7.84e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 160 | 7.39e-01 | -1.53e-02 | 9.08e-01 |
| GOMF ADENOSINE RECEPTOR BINDING | 7 | 9.44e-01 | 1.53e-02 | 9.82e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 24 | 8.97e-01 | -1.53e-02 | 9.66e-01 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 9.53e-01 | -1.52e-02 | 9.84e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 344 | 6.27e-01 | -1.52e-02 | 8.58e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 25 | 8.95e-01 | -1.52e-02 | 9.65e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 106 | 7.87e-01 | 1.52e-02 | 9.28e-01 |
| GOBP REGULATION OF AUTOPHAGY | 335 | 6.33e-01 | 1.52e-02 | 8.62e-01 |
| GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY | 5 | 9.53e-01 | 1.51e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 13 | 9.25e-01 | 1.51e-02 | 9.75e-01 |
| GOBP NEURONAL SIGNAL TRANSDUCTION | 5 | 9.53e-01 | 1.51e-02 | 9.84e-01 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 8 | 9.41e-01 | -1.51e-02 | 9.80e-01 |
| GOBP PROTEIN CATABOLIC PROCESS | 906 | 4.41e-01 | 1.51e-02 | 7.51e-01 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 9.49e-01 | -1.51e-02 | 9.83e-01 |
| GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 7 | 9.45e-01 | -1.51e-02 | 9.82e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY | 5 | 9.53e-01 | -1.51e-02 | 9.84e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 20 | 9.07e-01 | 1.51e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 110 | 7.86e-01 | -1.50e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 6 | 9.49e-01 | -1.50e-02 | 9.83e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 13 | 9.26e-01 | 1.49e-02 | 9.75e-01 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 190 | 7.24e-01 | 1.49e-02 | 9.03e-01 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 6 | 9.50e-01 | 1.48e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 25 | 8.98e-01 | 1.48e-02 | 9.66e-01 |
| GOBP PORE COMPLEX ASSEMBLY | 20 | 9.09e-01 | 1.48e-02 | 9.69e-01 |
| GOCC RUFFLE MEMBRANE | 91 | 8.08e-01 | 1.48e-02 | 9.38e-01 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 129 | 7.72e-01 | 1.48e-02 | 9.22e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 25 | 8.99e-01 | -1.47e-02 | 9.66e-01 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 9.36e-01 | 1.47e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE | 17 | 9.17e-01 | 1.47e-02 | 9.72e-01 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 40 | 8.73e-01 | 1.47e-02 | 9.57e-01 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 6 | 9.50e-01 | 1.47e-02 | 9.83e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 22 | 9.05e-01 | -1.46e-02 | 9.68e-01 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 174 | 7.40e-01 | 1.46e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 5 | 9.55e-01 | 1.46e-02 | 9.84e-01 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 18 | 9.15e-01 | -1.46e-02 | 9.71e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 15 | 9.22e-01 | -1.45e-02 | 9.74e-01 |
| GOBP REGULATION OF MOLECULAR FUNCTION | 1593 | 3.35e-01 | -1.45e-02 | 6.78e-01 |
| GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS | 7 | 9.47e-01 | 1.44e-02 | 9.82e-01 |
| GOBP COGNITION | 233 | 7.05e-01 | 1.44e-02 | 8.94e-01 |
| GOCC NEURON PROJECTION | 973 | 4.47e-01 | 1.44e-02 | 7.55e-01 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 12 | 9.31e-01 | 1.44e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 335 | 6.51e-01 | -1.44e-02 | 8.70e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 14 | 9.26e-01 | -1.44e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 701 | 5.17e-01 | -1.44e-02 | 8.00e-01 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 74 | 8.31e-01 | -1.44e-02 | 9.44e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 118 | 7.88e-01 | -1.43e-02 | 9.28e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 97 | 8.08e-01 | 1.43e-02 | 9.38e-01 |
| GOBP RESPONSE TO ISCHEMIA | 50 | 8.61e-01 | -1.43e-02 | 9.53e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 13 | 9.29e-01 | 1.43e-02 | 9.76e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 255 | 6.95e-01 | -1.43e-02 | 8.91e-01 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 43 | 8.72e-01 | -1.42e-02 | 9.57e-01 |
| GOBP SENSORY PERCEPTION | 380 | 6.35e-01 | -1.42e-02 | 8.63e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 132 | 7.79e-01 | -1.42e-02 | 9.25e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 54 | 8.57e-01 | -1.42e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 13 | 9.30e-01 | 1.42e-02 | 9.76e-01 |
| GOBP MYELIN ASSEMBLY | 21 | 9.11e-01 | -1.41e-02 | 9.70e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 26 | 9.01e-01 | 1.41e-02 | 9.67e-01 |
| GOBP KERATINOCYTE MIGRATION | 15 | 9.25e-01 | -1.41e-02 | 9.75e-01 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 100 | 8.08e-01 | 1.41e-02 | 9.38e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 20 | 9.13e-01 | -1.41e-02 | 9.71e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 293 | 6.79e-01 | 1.41e-02 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 13 | 9.30e-01 | 1.40e-02 | 9.76e-01 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 120 | 7.91e-01 | 1.40e-02 | 9.30e-01 |
| GOBP REGULATION OF MICROVILLUS LENGTH | 6 | 9.53e-01 | 1.40e-02 | 9.84e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 190 | 7.40e-01 | 1.40e-02 | 9.08e-01 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 29 | 8.96e-01 | -1.40e-02 | 9.65e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 125 | 7.88e-01 | -1.40e-02 | 9.28e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 9 | 9.42e-01 | -1.39e-02 | 9.81e-01 |
| GOMF CHOLESTEROL BINDING | 45 | 8.72e-01 | 1.39e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 1016 | 4.53e-01 | -1.39e-02 | 7.58e-01 |
| GOBP HINDBRAIN MORPHOGENESIS | 37 | 8.84e-01 | 1.39e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 20 | 9.14e-01 | 1.39e-02 | 9.71e-01 |
| GOBP SALIVARY GLAND DEVELOPMENT | 29 | 8.97e-01 | -1.39e-02 | 9.66e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 90 | 8.21e-01 | 1.38e-02 | 9.42e-01 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1342 | 3.96e-01 | -1.38e-02 | 7.22e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 176 | 7.53e-01 | 1.38e-02 | 9.13e-01 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 41 | 8.79e-01 | 1.38e-02 | 9.59e-01 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 75 | 8.37e-01 | 1.38e-02 | 9.47e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 852 | 4.95e-01 | -1.38e-02 | 7.88e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 71 | 8.41e-01 | -1.37e-02 | 9.48e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 177 | 7.53e-01 | -1.37e-02 | 9.13e-01 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 9 | 9.43e-01 | -1.37e-02 | 9.81e-01 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 9 | 9.43e-01 | -1.37e-02 | 9.81e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 72 | 8.40e-01 | -1.37e-02 | 9.48e-01 |
| GOMF MANNOSIDASE ACTIVITY | 15 | 9.27e-01 | -1.37e-02 | 9.75e-01 |
| GOBP VACUOLE ORGANIZATION | 219 | 7.27e-01 | -1.37e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 9.58e-01 | -1.37e-02 | 9.84e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 306 | 6.81e-01 | -1.37e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 533 | 5.90e-01 | -1.37e-02 | 8.40e-01 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 34 | 8.90e-01 | 1.37e-02 | 9.64e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 86 | 8.27e-01 | -1.36e-02 | 9.43e-01 |
| GOBP LYMPHOCYTE DIFFERENTIATION | 379 | 6.49e-01 | 1.36e-02 | 8.69e-01 |
| GOBP MAST CELL CHEMOTAXIS | 8 | 9.47e-01 | 1.36e-02 | 9.82e-01 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 25 | 9.06e-01 | -1.36e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 64 | 8.51e-01 | 1.36e-02 | 9.50e-01 |
| GOBP HINDBRAIN DEVELOPMENT | 122 | 7.95e-01 | 1.36e-02 | 9.31e-01 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 33 | 8.93e-01 | 1.36e-02 | 9.65e-01 |
| GOBP NEURONAL ACTION POTENTIAL PROPAGATION | 6 | 9.54e-01 | -1.36e-02 | 9.84e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 10 | 9.41e-01 | -1.35e-02 | 9.80e-01 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 77 | 8.37e-01 | -1.35e-02 | 9.47e-01 |
| GOCC GROWTH CONE MEMBRANE | 6 | 9.54e-01 | 1.35e-02 | 9.84e-01 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 10 | 9.41e-01 | 1.35e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF KIDNEY DEVELOPMENT | 7 | 9.51e-01 | -1.35e-02 | 9.83e-01 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 83 | 8.32e-01 | 1.35e-02 | 9.44e-01 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 269 | 7.04e-01 | -1.34e-02 | 8.94e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 7 | 9.51e-01 | -1.34e-02 | 9.83e-01 |
| GOBP SYNAPTIC VESICLE MATURATION | 22 | 9.14e-01 | -1.34e-02 | 9.71e-01 |
| GOMF STEROID BINDING | 82 | 8.35e-01 | 1.33e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 39 | 8.86e-01 | 1.33e-02 | 9.62e-01 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 11 | 9.39e-01 | -1.33e-02 | 9.79e-01 |
| GOBP REGULATION OF LYMPHANGIOGENESIS | 5 | 9.59e-01 | -1.33e-02 | 9.85e-01 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 111 | 8.09e-01 | -1.33e-02 | 9.38e-01 |
| GOBP MONOSACCHARIDE TRANSMEMBRANE TRANSPORT | 96 | 8.23e-01 | -1.32e-02 | 9.42e-01 |
| GOCC NLRP1 INFLAMMASOME COMPLEX | 5 | 9.59e-01 | -1.32e-02 | 9.85e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 536 | 6.00e-01 | -1.32e-02 | 8.46e-01 |
| GOBP CELL SURFACE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 273 | 7.07e-01 | -1.32e-02 | 8.95e-01 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 55 | 8.66e-01 | -1.32e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 948 | 4.92e-01 | 1.32e-02 | 7.85e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 44 | 8.80e-01 | 1.32e-02 | 9.59e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 69 | 8.50e-01 | -1.31e-02 | 9.50e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 19 | 9.21e-01 | -1.31e-02 | 9.74e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 108 | 8.15e-01 | 1.31e-02 | 9.39e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 16 | 9.28e-01 | -1.30e-02 | 9.76e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 21 | 9.18e-01 | -1.30e-02 | 9.73e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 72 | 8.49e-01 | 1.30e-02 | 9.49e-01 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 40 | 8.87e-01 | -1.30e-02 | 9.63e-01 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 63 | 8.59e-01 | -1.30e-02 | 9.52e-01 |
| GOCC CILIARY MEMBRANE | 65 | 8.57e-01 | 1.29e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TRANSPORT | 208 | 7.48e-01 | -1.29e-02 | 9.11e-01 |
| GOCC FAR SIN STRIPAK COMPLEX | 17 | 9.27e-01 | 1.29e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 842 | 5.25e-01 | -1.29e-02 | 8.05e-01 |
| GOBP RHYTHMIC BEHAVIOR | 30 | 9.03e-01 | 1.29e-02 | 9.67e-01 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 28 | 9.06e-01 | -1.29e-02 | 9.68e-01 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 9 | 9.47e-01 | -1.29e-02 | 9.82e-01 |
| GOBP GENERATION OF NEURONS | 1078 | 4.76e-01 | 1.29e-02 | 7.74e-01 |
| GOMF AXON GUIDANCE RECEPTOR ACTIVITY | 7 | 9.53e-01 | 1.28e-02 | 9.84e-01 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 14 | 9.34e-01 | -1.28e-02 | 9.78e-01 |
| GOBP RESPONSE TO OXYGEN RADICAL | 22 | 9.18e-01 | -1.27e-02 | 9.73e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 628 | 5.89e-01 | 1.26e-02 | 8.40e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 16 | 9.30e-01 | 1.26e-02 | 9.76e-01 |
| GOCC COMPLEX OF COLLAGEN TRIMERS | 14 | 9.35e-01 | -1.26e-02 | 9.78e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 35 | 8.97e-01 | -1.26e-02 | 9.66e-01 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 15 | 9.33e-01 | 1.26e-02 | 9.78e-01 |
| GOBP NITROGEN COMPOUND TRANSPORT | 1606 | 4.03e-01 | 1.25e-02 | 7.26e-01 |
| GOBP ASSOCIATIVE LEARNING | 63 | 8.64e-01 | 1.25e-02 | 9.54e-01 |
| GOBP DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS | 7 | 9.54e-01 | -1.25e-02 | 9.84e-01 |
| GOBP CELL VOLUME HOMEOSTASIS | 31 | 9.05e-01 | -1.24e-02 | 9.68e-01 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 46 | 8.85e-01 | 1.24e-02 | 9.62e-01 |
| GOMF DEOXYRIBONUCLEASE I ACTIVITY | 5 | 9.62e-01 | 1.23e-02 | 9.86e-01 |
| GOMF SYNTAXIN BINDING | 51 | 8.79e-01 | -1.23e-02 | 9.59e-01 |
| GOBP ENDODERM DEVELOPMENT | 64 | 8.65e-01 | 1.23e-02 | 9.54e-01 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 7 | 9.55e-01 | -1.23e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF BINDING | 98 | 8.34e-01 | -1.23e-02 | 9.45e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 434 | 6.61e-01 | 1.23e-02 | 8.74e-01 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 20 | 9.24e-01 | -1.23e-02 | 9.75e-01 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 24 | 9.17e-01 | 1.22e-02 | 9.72e-01 |
| GOBP SARCOMERE ORGANIZATION | 31 | 9.06e-01 | -1.22e-02 | 9.68e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 443 | 6.62e-01 | -1.21e-02 | 8.74e-01 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 96 | 8.38e-01 | -1.21e-02 | 9.47e-01 |
| GOCC NEUROFILAMENT | 5 | 9.63e-01 | 1.21e-02 | 9.86e-01 |
| GOBP LIPID HOMEOSTASIS | 127 | 8.14e-01 | 1.21e-02 | 9.39e-01 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 575 | 6.21e-01 | -1.21e-02 | 8.57e-01 |
| GOBP NEGATIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 5 | 9.63e-01 | -1.21e-02 | 9.86e-01 |
| GOBP MUCUS SECRETION | 13 | 9.40e-01 | -1.21e-02 | 9.79e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 16 | 9.33e-01 | -1.21e-02 | 9.78e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 28 | 9.12e-01 | 1.20e-02 | 9.71e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 47 | 8.87e-01 | 1.20e-02 | 9.62e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLIPPASE ACTIVITY | 5 | 9.63e-01 | 1.20e-02 | 9.86e-01 |
| GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 11 | 9.45e-01 | 1.20e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 52 | 8.81e-01 | 1.20e-02 | 9.60e-01 |
| GOBP CELLULAR RESPONSE TO STARVATION | 150 | 8.00e-01 | 1.20e-02 | 9.34e-01 |
| GOBP SYMBIONT ENTRY INTO HOST | 135 | 8.10e-01 | 1.20e-02 | 9.38e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 72 | 8.61e-01 | -1.20e-02 | 9.53e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 11 | 9.45e-01 | -1.19e-02 | 9.82e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 34 | 9.04e-01 | -1.19e-02 | 9.68e-01 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 60 | 8.74e-01 | -1.19e-02 | 9.57e-01 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 266 | 7.39e-01 | -1.19e-02 | 9.08e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 25 | 9.18e-01 | -1.19e-02 | 9.73e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 24 | 9.20e-01 | -1.19e-02 | 9.73e-01 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 8 | 9.54e-01 | -1.19e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF MUCUS SECRETION | 5 | 9.63e-01 | -1.18e-02 | 9.86e-01 |
| GOCC CELL BODY | 407 | 6.82e-01 | -1.18e-02 | 8.84e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 257 | 7.45e-01 | -1.18e-02 | 9.10e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 22 | 9.24e-01 | 1.18e-02 | 9.75e-01 |
| GOCC MCM COMPLEX | 11 | 9.46e-01 | 1.17e-02 | 9.82e-01 |
| GOBP HEART DEVELOPMENT | 431 | 6.76e-01 | 1.17e-02 | 8.81e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 22 | 9.24e-01 | -1.17e-02 | 9.75e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 138 | 8.12e-01 | 1.17e-02 | 9.38e-01 |
| GOCC LSM2 8 COMPLEX | 7 | 9.57e-01 | -1.17e-02 | 9.84e-01 |
| GOBP REGULATION OF SYSTEM PROCESS | 378 | 6.95e-01 | 1.17e-02 | 8.91e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 34 | 9.06e-01 | 1.17e-02 | 9.68e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 281 | 7.36e-01 | -1.17e-02 | 9.08e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 52 | 8.84e-01 | -1.17e-02 | 9.61e-01 |
| GOCC TIGHT JUNCTION | 98 | 8.42e-01 | -1.17e-02 | 9.48e-01 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 16 | 9.36e-01 | -1.17e-02 | 9.78e-01 |
| GOBP REGULATION OF OVARIAN FOLLICLE DEVELOPMENT | 6 | 9.61e-01 | 1.16e-02 | 9.85e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 57 | 8.79e-01 | 1.16e-02 | 9.59e-01 |
| GOBP REGULATION OF FEMALE GONAD DEVELOPMENT | 5 | 9.64e-01 | 1.16e-02 | 9.86e-01 |
| GOBP CARDIOBLAST PROLIFERATION | 6 | 9.61e-01 | -1.16e-02 | 9.85e-01 |
| GOBP INNER EAR MORPHOGENESIS | 59 | 8.78e-01 | -1.15e-02 | 9.59e-01 |
| GOBP RESPONSE TO LIGHT INTENSITY | 14 | 9.40e-01 | -1.15e-02 | 9.80e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 36 | 9.05e-01 | 1.15e-02 | 9.68e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 45 | 8.94e-01 | -1.15e-02 | 9.65e-01 |
| GOBP CILIUM DISASSEMBLY | 6 | 9.61e-01 | -1.15e-02 | 9.85e-01 |
| GOCC BRISC COMPLEX | 6 | 9.61e-01 | -1.15e-02 | 9.85e-01 |
| GOBP NEURON MIGRATION | 128 | 8.22e-01 | -1.15e-02 | 9.42e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 94 | 8.47e-01 | 1.15e-02 | 9.49e-01 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 592 | 6.33e-01 | 1.15e-02 | 8.62e-01 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 9.39e-01 | -1.15e-02 | 9.79e-01 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 10 | 9.50e-01 | -1.14e-02 | 9.83e-01 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 9.55e-01 | -1.14e-02 | 9.84e-01 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 9.31e-01 | -1.14e-02 | 9.77e-01 |
| GOBP CYTOSKELETON ORGANIZATION | 1242 | 4.99e-01 | 1.14e-02 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 119 | 8.30e-01 | 1.14e-02 | 9.44e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 280 | 7.43e-01 | -1.14e-02 | 9.09e-01 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 9.65e-01 | 1.14e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 48 | 8.92e-01 | 1.14e-02 | 9.65e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING | 8 | 9.56e-01 | 1.13e-02 | 9.84e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 9 | 9.53e-01 | -1.13e-02 | 9.84e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 61 | 8.79e-01 | -1.13e-02 | 9.59e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 16 | 9.38e-01 | -1.13e-02 | 9.78e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 110 | 8.38e-01 | 1.13e-02 | 9.47e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 92 | 8.52e-01 | -1.13e-02 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 65 | 8.76e-01 | -1.12e-02 | 9.58e-01 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 9 | 9.54e-01 | 1.11e-02 | 9.84e-01 |
| GOCC BARR BODY | 8 | 9.57e-01 | -1.11e-02 | 9.84e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 231 | 7.72e-01 | -1.11e-02 | 9.22e-01 |
| GOBP REGULATION OF NEUROGENESIS | 280 | 7.50e-01 | -1.11e-02 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 7 | 9.60e-01 | -1.10e-02 | 9.85e-01 |
| GOBP RESPONSE TO PROTOZOAN | 27 | 9.21e-01 | 1.10e-02 | 9.74e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 152 | 8.14e-01 | 1.10e-02 | 9.39e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 14 | 9.43e-01 | -1.10e-02 | 9.81e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 18 | 9.36e-01 | 1.10e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 23 | 9.27e-01 | -1.10e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 48 | 8.96e-01 | -1.09e-02 | 9.65e-01 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 154 | 8.15e-01 | 1.09e-02 | 9.39e-01 |
| GOMF GABA RECEPTOR BINDING | 11 | 9.50e-01 | -1.09e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 412 | 7.04e-01 | 1.09e-02 | 8.94e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 12 | 9.48e-01 | -1.09e-02 | 9.82e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 74 | 8.72e-01 | -1.09e-02 | 9.57e-01 |
| GOBP PIRNA PROCESSING | 12 | 9.48e-01 | -1.09e-02 | 9.82e-01 |
| GOBP THREONINE METABOLIC PROCESS | 5 | 9.67e-01 | 1.08e-02 | 9.87e-01 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 78 | 8.69e-01 | -1.08e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 7 | 9.61e-01 | -1.08e-02 | 9.85e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 102 | 8.51e-01 | 1.08e-02 | 9.50e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 7 | 9.61e-01 | -1.07e-02 | 9.85e-01 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 29 | 9.20e-01 | 1.07e-02 | 9.74e-01 |
| GOBP REGULATION OF BONE DEVELOPMENT | 7 | 9.61e-01 | -1.07e-02 | 9.85e-01 |
| GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 7 | 9.61e-01 | -1.07e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT | 9 | 9.56e-01 | 1.06e-02 | 9.84e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 50 | 8.97e-01 | 1.06e-02 | 9.65e-01 |
| GOMF SYMPORTER ACTIVITY | 105 | 8.51e-01 | 1.06e-02 | 9.50e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 545 | 6.72e-01 | -1.06e-02 | 8.80e-01 |
| GOBP RESPONSE TO VASOPRESSIN | 6 | 9.64e-01 | -1.06e-02 | 9.86e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 20 | 9.35e-01 | 1.05e-02 | 9.78e-01 |
| GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS | 5 | 9.68e-01 | -1.05e-02 | 9.88e-01 |
| GOBP NEUROTRANSMITTER SECRETION | 109 | 8.50e-01 | 1.05e-02 | 9.50e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 16 | 9.42e-01 | -1.05e-02 | 9.81e-01 |
| GOBP REGULATION OF BINDING | 199 | 7.99e-01 | 1.05e-02 | 9.33e-01 |
| GOBP REGULATION OF MONOCYTE EXTRAVASATION | 6 | 9.65e-01 | 1.05e-02 | 9.86e-01 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 14 | 9.46e-01 | -1.04e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 6 | 9.65e-01 | -1.04e-02 | 9.86e-01 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 9 | 9.57e-01 | -1.04e-02 | 9.84e-01 |
| GOBP NERVOUS SYSTEM PROCESS | 757 | 6.28e-01 | 1.03e-02 | 8.58e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 24 | 9.30e-01 | -1.03e-02 | 9.76e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 25 | 9.29e-01 | -1.03e-02 | 9.76e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 128 | 8.41e-01 | -1.02e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 25 | 9.29e-01 | 1.02e-02 | 9.76e-01 |
| GOBP VASCULAR TRANSPORT | 67 | 8.85e-01 | 1.02e-02 | 9.62e-01 |
| GOCC ANAPHASE PROMOTING COMPLEX | 22 | 9.34e-01 | -1.02e-02 | 9.78e-01 |
| GOBP REGULATION OF LIPID STORAGE | 42 | 9.09e-01 | -1.02e-02 | 9.69e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 33 | 9.19e-01 | -1.02e-02 | 9.73e-01 |
| GOBP MEMBRANE DOCKING | 75 | 8.79e-01 | -1.02e-02 | 9.59e-01 |
| GOMF COPPER CHAPERONE ACTIVITY | 7 | 9.63e-01 | -1.01e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 81 | 8.75e-01 | 1.01e-02 | 9.57e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 108 | 8.56e-01 | 1.01e-02 | 9.51e-01 |
| GOBP PHOSPHORYLATION | 1132 | 5.67e-01 | 1.01e-02 | 8.29e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 84 | 8.73e-01 | -1.01e-02 | 9.57e-01 |
| GOMF ANTIGEN BINDING | 152 | 8.30e-01 | 1.01e-02 | 9.44e-01 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 49 | 9.03e-01 | -1.01e-02 | 9.68e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 422 | 7.25e-01 | 1.00e-02 | 9.03e-01 |
| GOBP HETEROCHROMATIN ORGANIZATION | 11 | 9.54e-01 | -9.97e-03 | 9.84e-01 |
| GOBP RESPONSE TO DEXAMETHASONE | 32 | 9.22e-01 | -9.95e-03 | 9.74e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 5 | 9.69e-01 | 9.92e-03 | 9.89e-01 |
| GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING | 13 | 9.51e-01 | 9.91e-03 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 10 | 9.57e-01 | 9.87e-03 | 9.84e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 153 | 8.33e-01 | -9.87e-03 | 9.45e-01 |
| GOCC EARLY ENDOSOME | 389 | 7.38e-01 | 9.86e-03 | 9.08e-01 |
| GOBP NEUTROPHIL EXTRAVASATION | 13 | 9.51e-01 | 9.84e-03 | 9.83e-01 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 24 | 9.34e-01 | 9.81e-03 | 9.78e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 30 | 9.26e-01 | -9.76e-03 | 9.75e-01 |
| GOMF PROTEIN RNA ADAPTOR ACTIVITY | 20 | 9.40e-01 | 9.75e-03 | 9.79e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 79 | 8.81e-01 | 9.71e-03 | 9.60e-01 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 15 | 9.48e-01 | 9.67e-03 | 9.82e-01 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 52 | 9.04e-01 | 9.65e-03 | 9.68e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 27 | 9.31e-01 | -9.63e-03 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 10 | 9.58e-01 | -9.55e-03 | 9.85e-01 |
| GOBP NEUTROPHIL CLEARANCE | 6 | 9.68e-01 | -9.51e-03 | 9.88e-01 |
| GOBP RESPONSE TO ESTROGEN | 48 | 9.09e-01 | -9.50e-03 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 34 | 9.25e-01 | -9.38e-03 | 9.75e-01 |
| GOBP RESPONSE TO CYTOKINE | 749 | 6.63e-01 | -9.36e-03 | 8.74e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 60 | 9.00e-01 | -9.34e-03 | 9.67e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 37 | 9.22e-01 | 9.34e-03 | 9.74e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 43 | 9.16e-01 | 9.30e-03 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 34 | 9.25e-01 | -9.29e-03 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 25 | 9.36e-01 | 9.29e-03 | 9.78e-01 |
| GOBP MEIOTIC CYTOKINESIS | 6 | 9.69e-01 | -9.28e-03 | 9.88e-01 |
| GOCC COATED VESICLE | 278 | 7.90e-01 | 9.26e-03 | 9.30e-01 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 280 | 7.90e-01 | 9.26e-03 | 9.29e-01 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 10 | 9.60e-01 | -9.20e-03 | 9.85e-01 |
| GOMF PEPTIDE BINDING | 218 | 8.15e-01 | -9.19e-03 | 9.39e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 333 | 7.73e-01 | -9.19e-03 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 9 | 9.62e-01 | -9.17e-03 | 9.86e-01 |
| GOBP INTRACELLULAR SIGNALING CASSETTE | 1580 | 5.44e-01 | -9.14e-03 | 8.18e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 17 | 9.48e-01 | -9.14e-03 | 9.82e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 32 | 9.29e-01 | 9.10e-03 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 14 | 9.53e-01 | -9.08e-03 | 9.84e-01 |
| GOBP RESPONSE TO ACTIVITY | 60 | 9.04e-01 | -9.02e-03 | 9.68e-01 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 21 | 9.43e-01 | -9.01e-03 | 9.81e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 55 | 9.08e-01 | -8.99e-03 | 9.69e-01 |
| GOBP SKELETAL MUSCLE TISSUE GROWTH | 6 | 9.70e-01 | 8.92e-03 | 9.89e-01 |
| GOMF TASTE RECEPTOR ACTIVITY | 9 | 9.63e-01 | 8.91e-03 | 9.86e-01 |
| GOCC CORTICAL CYTOSKELETON | 94 | 8.82e-01 | 8.86e-03 | 9.61e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 27 | 9.37e-01 | 8.85e-03 | 9.78e-01 |
| GOBP NEURON MATURATION | 36 | 9.27e-01 | -8.84e-03 | 9.75e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 29 | 9.34e-01 | -8.84e-03 | 9.78e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 23 | 9.42e-01 | -8.73e-03 | 9.81e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 360 | 7.77e-01 | -8.69e-03 | 9.24e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 29 | 9.36e-01 | -8.68e-03 | 9.78e-01 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 40 | 9.25e-01 | 8.62e-03 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 11 | 9.61e-01 | 8.58e-03 | 9.85e-01 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 12 | 9.59e-01 | 8.58e-03 | 9.85e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 21 | 9.46e-01 | -8.55e-03 | 9.82e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 169 | 8.48e-01 | 8.53e-03 | 9.49e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 54 | 9.14e-01 | -8.53e-03 | 9.71e-01 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 13 | 9.58e-01 | 8.50e-03 | 9.84e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 14 | 9.56e-01 | 8.48e-03 | 9.84e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 9.56e-01 | 8.48e-03 | 9.84e-01 |
| GOBP RESPONSE TO ALKALOID | 71 | 9.02e-01 | 8.46e-03 | 9.67e-01 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 6 | 9.72e-01 | 8.37e-03 | 9.89e-01 |
| GOBP LIPID DIGESTION | 12 | 9.60e-01 | 8.31e-03 | 9.85e-01 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 9 | 9.66e-01 | 8.29e-03 | 9.86e-01 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 53 | 9.17e-01 | -8.26e-03 | 9.72e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 9 | 9.66e-01 | -8.25e-03 | 9.86e-01 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 18 | 9.52e-01 | -8.22e-03 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 185 | 8.49e-01 | 8.13e-03 | 9.49e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 22 | 9.47e-01 | 8.13e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 182 | 8.52e-01 | 8.04e-03 | 9.50e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 216 | 8.39e-01 | -8.01e-03 | 9.48e-01 |
| GOBP ACROSOME ASSEMBLY | 18 | 9.54e-01 | -7.92e-03 | 9.84e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 143 | 8.70e-01 | -7.90e-03 | 9.57e-01 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 8 | 9.69e-01 | 7.90e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 172 | 8.58e-01 | 7.90e-03 | 9.52e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 669 | 7.28e-01 | 7.87e-03 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 217 | 8.42e-01 | 7.87e-03 | 9.48e-01 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 22 | 9.49e-01 | 7.82e-03 | 9.83e-01 |
| GOBP NEURON DEVELOPMENT | 850 | 6.99e-01 | 7.81e-03 | 8.92e-01 |
| GOBP RENAL FILTRATION | 25 | 9.46e-01 | -7.81e-03 | 9.82e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 11 | 9.64e-01 | 7.79e-03 | 9.86e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 89 | 8.99e-01 | 7.77e-03 | 9.66e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 151 | 8.69e-01 | -7.75e-03 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 70 | 9.11e-01 | -7.75e-03 | 9.70e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 554 | 7.57e-01 | 7.70e-03 | 9.14e-01 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 227 | 8.43e-01 | -7.65e-03 | 9.49e-01 |
| GOCC COP9 SIGNALOSOME | 36 | 9.37e-01 | -7.64e-03 | 9.78e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 76 | 9.09e-01 | -7.60e-03 | 9.69e-01 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 21 | 9.52e-01 | -7.60e-03 | 9.84e-01 |
| GOBP ESTROUS CYCLE | 12 | 9.64e-01 | -7.59e-03 | 9.86e-01 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 10 | 9.67e-01 | 7.58e-03 | 9.87e-01 |
| GOBP HYPERSENSITIVITY | 17 | 9.57e-01 | 7.50e-03 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 74 | 9.11e-01 | -7.47e-03 | 9.70e-01 |
| GOBP CARDIOBLAST DIFFERENTIATION | 11 | 9.66e-01 | -7.46e-03 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 32 | 9.42e-01 | -7.44e-03 | 9.81e-01 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 9.71e-01 | 7.43e-03 | 9.89e-01 |
| GOBP RRNA TRANSCRIPTION | 40 | 9.35e-01 | 7.40e-03 | 9.78e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 27 | 9.47e-01 | 7.38e-03 | 9.82e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 36 | 9.39e-01 | -7.37e-03 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 80 | 9.10e-01 | -7.34e-03 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF CILIUM MOVEMENT | 5 | 9.77e-01 | -7.33e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 41 | 9.35e-01 | 7.31e-03 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 40 | 9.36e-01 | 7.29e-03 | 9.78e-01 |
| GOMF NUCLEOSOME BINDING | 76 | 9.13e-01 | 7.28e-03 | 9.71e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 96 | 9.02e-01 | -7.26e-03 | 9.67e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 28 | 9.47e-01 | 7.24e-03 | 9.82e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 12 | 9.65e-01 | -7.23e-03 | 9.86e-01 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 26 | 9.49e-01 | 7.20e-03 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 13 | 9.64e-01 | 7.18e-03 | 9.86e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 70 | 9.17e-01 | 7.18e-03 | 9.72e-01 |
| GOMF PHOTORECEPTOR ACTIVITY | 8 | 9.72e-01 | -7.14e-03 | 9.90e-01 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 9 | 9.71e-01 | -7.11e-03 | 9.89e-01 |
| GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 6 | 9.76e-01 | 7.10e-03 | 9.91e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 59 | 9.25e-01 | 7.07e-03 | 9.75e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 10 | 9.69e-01 | 7.06e-03 | 9.89e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1391 | 6.60e-01 | -7.04e-03 | 8.73e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM AXON ENSHEATHMENT | 24 | 9.53e-01 | 7.01e-03 | 9.84e-01 |
| GOBP MIDBODY ABSCISSION | 17 | 9.60e-01 | 7.00e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 50 | 9.32e-01 | -6.97e-03 | 9.77e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 24 | 9.53e-01 | 6.96e-03 | 9.84e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 24 | 9.53e-01 | 6.93e-03 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 951 | 7.17e-01 | -6.93e-03 | 9.00e-01 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 43 | 9.38e-01 | 6.91e-03 | 9.78e-01 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 8 | 9.73e-01 | 6.90e-03 | 9.90e-01 |
| GOBP REGULATION OF LIPID LOCALIZATION | 125 | 8.94e-01 | -6.89e-03 | 9.65e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 29 | 9.49e-01 | 6.87e-03 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 14 | 9.65e-01 | 6.84e-03 | 9.86e-01 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 21 | 9.57e-01 | 6.81e-03 | 9.84e-01 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 10 | 9.70e-01 | 6.80e-03 | 9.89e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 95 | 9.09e-01 | -6.80e-03 | 9.69e-01 |
| GOBP RESPONSE TO PAIN | 22 | 9.56e-01 | -6.77e-03 | 9.84e-01 |
| GOBP NEUROMUSCULAR PROCESS | 113 | 9.01e-01 | -6.75e-03 | 9.67e-01 |
| GOMF PROTEOGLYCAN BINDING | 28 | 9.51e-01 | -6.70e-03 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 28 | 9.51e-01 | 6.68e-03 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 12 | 9.68e-01 | 6.66e-03 | 9.88e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 427 | 8.14e-01 | -6.63e-03 | 9.39e-01 |
| GOBP FIBROBLAST PROLIFERATION | 92 | 9.13e-01 | 6.62e-03 | 9.71e-01 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 9.78e-01 | -6.62e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 33 | 9.48e-01 | -6.62e-03 | 9.82e-01 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 135 | 8.96e-01 | 6.54e-03 | 9.65e-01 |
| GOBP LIMB BUD FORMATION | 5 | 9.80e-01 | -6.54e-03 | 9.93e-01 |
| GOCC POLE PLASM | 16 | 9.64e-01 | -6.54e-03 | 9.86e-01 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 16 | 9.64e-01 | -6.52e-03 | 9.86e-01 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 751 | 7.62e-01 | -6.49e-03 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 23 | 9.57e-01 | 6.49e-03 | 9.84e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1334 | 6.91e-01 | -6.48e-03 | 8.88e-01 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 339 | 8.38e-01 | -6.44e-03 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 24 | 9.57e-01 | -6.43e-03 | 9.84e-01 |
| GOCC SITE OF POLARIZED GROWTH | 140 | 8.96e-01 | 6.42e-03 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 11 | 9.71e-01 | 6.41e-03 | 9.89e-01 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 9 | 9.74e-01 | -6.38e-03 | 9.90e-01 |
| GOBP DNA MODIFICATION | 40 | 9.45e-01 | -6.32e-03 | 9.82e-01 |
| GOBP MITOCHONDRION DISTRIBUTION | 18 | 9.63e-01 | 6.30e-03 | 9.86e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 33 | 9.50e-01 | -6.29e-03 | 9.83e-01 |
| GOCC GOLGI APPARATUS | 1397 | 6.95e-01 | -6.27e-03 | 8.91e-01 |
| GOCC GOLGI MEMBRANE | 606 | 7.95e-01 | -6.19e-03 | 9.31e-01 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 25 | 9.57e-01 | -6.18e-03 | 9.84e-01 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 242 | 8.69e-01 | 6.16e-03 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 1148 | 7.25e-01 | 6.15e-03 | 9.03e-01 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1509 | 6.90e-01 | 6.15e-03 | 8.88e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 68 | 9.30e-01 | 6.14e-03 | 9.76e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 99 | 9.16e-01 | 6.13e-03 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 9 | 9.75e-01 | -6.09e-03 | 9.91e-01 |
| GOBP REGULATION OF TRANSLATION | 334 | 8.48e-01 | 6.09e-03 | 9.49e-01 |
| GOCC CELL CORTEX REGION | 27 | 9.56e-01 | -6.09e-03 | 9.84e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 555 | 8.10e-01 | -5.96e-03 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 13 | 9.70e-01 | 5.94e-03 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 84 | 9.25e-01 | -5.92e-03 | 9.75e-01 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 668 | 7.96e-01 | -5.88e-03 | 9.31e-01 |
| GOBP TISSUE MORPHOGENESIS | 421 | 8.37e-01 | -5.84e-03 | 9.47e-01 |
| GOCC CELL TIP | 6 | 9.80e-01 | 5.84e-03 | 9.93e-01 |
| GOCC KINETOCHORE MICROTUBULE | 19 | 9.65e-01 | -5.82e-03 | 9.86e-01 |
| GOBP REGULATION OF T CIRCLE FORMATION | 7 | 9.79e-01 | -5.80e-03 | 9.93e-01 |
| GOBP REGULATION OF AGGREPHAGY | 7 | 9.79e-01 | -5.78e-03 | 9.93e-01 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 10 | 9.75e-01 | 5.78e-03 | 9.91e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 14 | 9.70e-01 | 5.75e-03 | 9.89e-01 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.82e-01 | -5.74e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 131 | 9.10e-01 | 5.73e-03 | 9.70e-01 |
| GOMF POTASSIUM ION LEAK CHANNEL ACTIVITY | 8 | 9.78e-01 | 5.73e-03 | 9.92e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 352 | 8.54e-01 | 5.71e-03 | 9.50e-01 |
| GOMF TAU PROTEIN BINDING | 42 | 9.49e-01 | 5.69e-03 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 27 | 9.59e-01 | -5.68e-03 | 9.85e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 368 | 8.53e-01 | -5.63e-03 | 9.50e-01 |
| GOBP NEPHRON MORPHOGENESIS | 48 | 9.46e-01 | -5.63e-03 | 9.82e-01 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 99 | 9.23e-01 | 5.60e-03 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 246 | 8.81e-01 | 5.56e-03 | 9.60e-01 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 295 | 8.71e-01 | 5.51e-03 | 9.57e-01 |
| GOBP ORGANELLE LOCALIZATION | 540 | 8.28e-01 | 5.48e-03 | 9.43e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 106 | 9.23e-01 | 5.44e-03 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 89 | 9.29e-01 | -5.44e-03 | 9.76e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 7 | 9.80e-01 | -5.43e-03 | 9.93e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 27 | 9.61e-01 | -5.39e-03 | 9.85e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 35 | 9.56e-01 | 5.35e-03 | 9.84e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 166 | 9.06e-01 | -5.33e-03 | 9.68e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 19 | 9.68e-01 | 5.32e-03 | 9.88e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 136 | 9.15e-01 | 5.28e-03 | 9.72e-01 |
| GOBP HEART VALVE DEVELOPMENT | 49 | 9.50e-01 | -5.21e-03 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 8 | 9.80e-01 | -5.16e-03 | 9.93e-01 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 347 | 8.71e-01 | -5.06e-03 | 9.57e-01 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 9.84e-01 | -5.06e-03 | 9.94e-01 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 9 | 9.79e-01 | -5.06e-03 | 9.93e-01 |
| GOMF R SMAD BINDING | 22 | 9.68e-01 | 5.00e-03 | 9.88e-01 |
| GOBP MACROAUTOPHAGY | 344 | 8.74e-01 | -4.98e-03 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 18 | 9.71e-01 | -4.97e-03 | 9.89e-01 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 15 | 9.74e-01 | 4.91e-03 | 9.90e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 66 | 9.45e-01 | 4.91e-03 | 9.82e-01 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 13 | 9.76e-01 | 4.86e-03 | 9.91e-01 |
| GOBP VESICLE LOCALIZATION | 197 | 9.07e-01 | -4.83e-03 | 9.69e-01 |
| GOBP BONE DEVELOPMENT | 154 | 9.18e-01 | -4.82e-03 | 9.73e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 53 | 9.52e-01 | -4.81e-03 | 9.84e-01 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 10 | 9.79e-01 | -4.76e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 6 | 9.84e-01 | 4.71e-03 | 9.94e-01 |
| GOCC TRANS GOLGI NETWORK | 238 | 9.01e-01 | 4.69e-03 | 9.67e-01 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 139 | 9.24e-01 | 4.66e-03 | 9.75e-01 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 56 | 9.52e-01 | 4.62e-03 | 9.84e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1502 | 7.65e-01 | 4.61e-03 | 9.18e-01 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 16 | 9.75e-01 | 4.60e-03 | 9.91e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 1175 | 7.96e-01 | -4.48e-03 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 16 | 9.75e-01 | -4.45e-03 | 9.91e-01 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 14 | 9.77e-01 | -4.40e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 140 | 9.29e-01 | -4.38e-03 | 9.76e-01 |
| GOBP DGMP METABOLIC PROCESS | 5 | 9.87e-01 | -4.36e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 44 | 9.60e-01 | 4.34e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 23 | 9.72e-01 | 4.30e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 73 | 9.49e-01 | -4.30e-03 | 9.83e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 13 | 9.79e-01 | -4.27e-03 | 9.93e-01 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 79 | 9.48e-01 | 4.25e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 17 | 9.76e-01 | 4.24e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 116 | 9.37e-01 | -4.23e-03 | 9.78e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 9.72e-01 | -4.21e-03 | 9.90e-01 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 818 | 8.38e-01 | 4.20e-03 | 9.47e-01 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 26 | 9.70e-01 | -4.20e-03 | 9.89e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 59 | 9.56e-01 | 4.18e-03 | 9.84e-01 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 95 | 9.44e-01 | 4.16e-03 | 9.82e-01 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 23 | 9.73e-01 | 4.14e-03 | 9.90e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 8 | 9.84e-01 | -4.13e-03 | 9.94e-01 |
| GOMF MYOSIN BINDING | 58 | 9.57e-01 | 4.12e-03 | 9.84e-01 |
| GOMF KINASE BINDING | 696 | 8.53e-01 | -4.11e-03 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 369 | 8.94e-01 | -4.05e-03 | 9.65e-01 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 22 | 9.74e-01 | 4.02e-03 | 9.90e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 194 | 9.23e-01 | 4.01e-03 | 9.74e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 30 | 9.70e-01 | -3.97e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 5 | 9.88e-01 | -3.94e-03 | 9.96e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 50 | 9.62e-01 | 3.93e-03 | 9.86e-01 |
| GOBP PROTEIN DE ADP RIBOSYLATION | 5 | 9.88e-01 | -3.91e-03 | 9.96e-01 |
| GOMF LYSOPHOSPHATIDIC ACID BINDING | 5 | 9.88e-01 | -3.91e-03 | 9.96e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 73 | 9.54e-01 | -3.90e-03 | 9.84e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE | 682 | 8.64e-01 | 3.86e-03 | 9.54e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 64 | 9.57e-01 | 3.86e-03 | 9.84e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 21 | 9.76e-01 | 3.82e-03 | 9.91e-01 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 11 | 9.83e-01 | 3.81e-03 | 9.94e-01 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 908 | 8.46e-01 | 3.79e-03 | 9.49e-01 |
| GOMF THIOESTERASE BINDING | 10 | 9.83e-01 | 3.78e-03 | 9.94e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 47 | 9.65e-01 | -3.74e-03 | 9.86e-01 |
| GOBP EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 91 | 9.51e-01 | -3.72e-03 | 9.83e-01 |
| GOCC ENDODEOXYRIBONUCLEASE COMPLEX | 5 | 9.88e-01 | 3.72e-03 | 9.96e-01 |
| GOBP INTERLEUKIN 12 PRODUCTION | 57 | 9.62e-01 | -3.68e-03 | 9.86e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 9 | 9.85e-01 | 3.65e-03 | 9.94e-01 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 35 | 9.70e-01 | -3.62e-03 | 9.89e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 35 | 9.71e-01 | 3.60e-03 | 9.89e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 55 | 9.63e-01 | 3.57e-03 | 9.86e-01 |
| GOMF APOLIPOPROTEIN BINDING | 12 | 9.83e-01 | 3.56e-03 | 9.94e-01 |
| GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY | 6 | 9.88e-01 | -3.49e-03 | 9.96e-01 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 33 | 9.72e-01 | -3.48e-03 | 9.90e-01 |
| GOBP EPIDERMIS MORPHOGENESIS | 21 | 9.78e-01 | -3.45e-03 | 9.93e-01 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 12 | 9.83e-01 | -3.45e-03 | 9.94e-01 |
| GOMF MRNA 3 UTR BINDING | 90 | 9.55e-01 | -3.45e-03 | 9.84e-01 |
| GOCC DENDRITIC TREE | 460 | 8.99e-01 | 3.44e-03 | 9.66e-01 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 8 | 9.87e-01 | -3.38e-03 | 9.96e-01 |
| GOBP REGULATION OF DNA BINDING | 64 | 9.63e-01 | 3.36e-03 | 9.86e-01 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 86 | 9.57e-01 | 3.35e-03 | 9.84e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 19 | 9.80e-01 | -3.35e-03 | 9.93e-01 |
| GOBP SALIVA SECRETION | 6 | 9.89e-01 | 3.26e-03 | 9.96e-01 |
| GOBP PEROXISOMAL TRANSPORT | 22 | 9.79e-01 | 3.23e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 5 | 9.90e-01 | 3.21e-03 | 9.97e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 207 | 9.37e-01 | -3.20e-03 | 9.78e-01 |
| GOCC INCLUSION BODY | 65 | 9.65e-01 | 3.18e-03 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 9.87e-01 | -3.18e-03 | 9.96e-01 |
| GOBP RESPONSE TO BMP | 107 | 9.55e-01 | 3.17e-03 | 9.84e-01 |
| GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 10 | 9.86e-01 | -3.16e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF VESICLE TRANSPORT ALONG MICROTUBULE | 5 | 9.90e-01 | 3.14e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 8 | 9.88e-01 | -3.09e-03 | 9.96e-01 |
| GOBP ORGANELLE DISASSEMBLY | 171 | 9.45e-01 | -3.08e-03 | 9.82e-01 |
| GOBP LACTATION | 30 | 9.77e-01 | 3.06e-03 | 9.92e-01 |
| GOBP SNORNA LOCALIZATION | 6 | 9.90e-01 | -3.06e-03 | 9.97e-01 |
| GOBP CYTOKINE PRODUCTION | 674 | 8.94e-01 | -3.02e-03 | 9.65e-01 |
| GOBP BEHAVIOR | 447 | 9.13e-01 | -3.01e-03 | 9.71e-01 |
| GOMF OXYGEN BINDING | 14 | 9.84e-01 | 3.00e-03 | 9.94e-01 |
| GOCC COATED VESICLE MEMBRANE | 176 | 9.46e-01 | -2.95e-03 | 9.82e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 9.89e-01 | 2.92e-03 | 9.97e-01 |
| GOBP NEURON PROJECTION ORGANIZATION | 79 | 9.65e-01 | 2.82e-03 | 9.86e-01 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 19 | 9.83e-01 | -2.82e-03 | 9.94e-01 |
| GOMF KINASE ACTIVATOR ACTIVITY | 124 | 9.57e-01 | -2.78e-03 | 9.84e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 41 | 9.76e-01 | -2.74e-03 | 9.91e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 64 | 9.70e-01 | -2.72e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 154 | 9.54e-01 | 2.72e-03 | 9.84e-01 |
| GOBP RUFFLE ORGANIZATION | 51 | 9.74e-01 | 2.66e-03 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 15 | 9.86e-01 | -2.65e-03 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 9 | 9.89e-01 | 2.65e-03 | 9.96e-01 |
| GOBP MATURE B CELL DIFFERENTIATION | 32 | 9.79e-01 | 2.64e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 24 | 9.82e-01 | -2.61e-03 | 9.94e-01 |
| GOMF NF KAPPAB BINDING | 29 | 9.81e-01 | 2.58e-03 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 137 | 9.59e-01 | 2.56e-03 | 9.85e-01 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 49 | 9.75e-01 | 2.56e-03 | 9.91e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 34 | 9.79e-01 | -2.55e-03 | 9.93e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 28 | 9.82e-01 | -2.50e-03 | 9.94e-01 |
| GOBP SYNAPTIC SIGNALING | 533 | 9.22e-01 | 2.49e-03 | 9.74e-01 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 14 | 9.87e-01 | -2.46e-03 | 9.96e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 324 | 9.40e-01 | -2.45e-03 | 9.79e-01 |
| GOBP RESPONSE TO MUSCLE INACTIVITY | 8 | 9.90e-01 | 2.45e-03 | 9.97e-01 |
| GOBP OPSONIZATION | 8 | 9.91e-01 | -2.42e-03 | 9.97e-01 |
| GOMF SH3 DOMAIN BINDING | 110 | 9.65e-01 | 2.41e-03 | 9.86e-01 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 9.89e-01 | -2.39e-03 | 9.96e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 976 | 8.99e-01 | -2.39e-03 | 9.66e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 63 | 9.74e-01 | -2.38e-03 | 9.90e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 9.92e-01 | -2.32e-03 | 9.97e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 46 | 9.78e-01 | -2.32e-03 | 9.93e-01 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 11 | 9.89e-01 | -2.32e-03 | 9.97e-01 |
| GOCC MICROVESICLE | 5 | 9.93e-01 | 2.30e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 490 | 9.33e-01 | 2.21e-03 | 9.78e-01 |
| GOBP CARDIOCYTE DIFFERENTIATION | 104 | 9.69e-01 | 2.21e-03 | 9.89e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 37 | 9.82e-01 | -2.19e-03 | 9.94e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 422 | 9.39e-01 | 2.17e-03 | 9.79e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 14 | 9.89e-01 | -2.16e-03 | 9.96e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 86 | 9.73e-01 | 2.13e-03 | 9.90e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 31 | 9.84e-01 | -2.08e-03 | 9.94e-01 |
| GOBP PYRUVATE TRANSPORT | 6 | 9.93e-01 | -2.07e-03 | 9.98e-01 |
| GOCC LUMENAL SIDE OF MEMBRANE | 41 | 9.82e-01 | -2.03e-03 | 9.94e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 78 | 9.75e-01 | 2.01e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 5 | 9.94e-01 | 2.00e-03 | 9.98e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 52 | 9.80e-01 | 1.99e-03 | 9.93e-01 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 9 | 9.92e-01 | -1.97e-03 | 9.97e-01 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 121 | 9.70e-01 | 1.96e-03 | 9.89e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 11 | 9.91e-01 | 1.93e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 20 | 9.88e-01 | -1.93e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 8 | 9.93e-01 | -1.85e-03 | 9.98e-01 |
| GOBP MATURATION OF SSU RRNA | 52 | 9.82e-01 | 1.83e-03 | 9.94e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 53 | 9.82e-01 | -1.79e-03 | 9.94e-01 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 34 | 9.86e-01 | -1.79e-03 | 9.95e-01 |
| GOBP GOLGI LUMEN ACIDIFICATION | 13 | 9.91e-01 | -1.76e-03 | 9.97e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 46 | 9.84e-01 | -1.75e-03 | 9.94e-01 |
| GOBP REGULATION OF CYTOKINETIC PROCESS | 7 | 9.94e-01 | 1.74e-03 | 9.98e-01 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 44 | 9.84e-01 | 1.73e-03 | 9.94e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 17 | 9.90e-01 | -1.73e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 9.95e-01 | 1.73e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1370 | 9.15e-01 | -1.73e-03 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 71 | 9.80e-01 | -1.68e-03 | 9.93e-01 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 8 | 9.94e-01 | 1.64e-03 | 9.98e-01 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 35 | 9.87e-01 | 1.59e-03 | 9.96e-01 |
| GOBP MACROMOLECULE DEACYLATION | 56 | 9.84e-01 | -1.57e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 254 | 9.66e-01 | 1.56e-03 | 9.86e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 108 | 9.78e-01 | -1.54e-03 | 9.93e-01 |
| GOBP STABILIZATION OF MEMBRANE POTENTIAL | 9 | 9.94e-01 | 1.51e-03 | 9.98e-01 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 94 | 9.80e-01 | -1.47e-03 | 9.93e-01 |
| GOCC CYTOSOLIC REGION | 19 | 9.91e-01 | -1.46e-03 | 9.97e-01 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 108 | 9.80e-01 | -1.38e-03 | 9.93e-01 |
| GOBP NEUROGENESIS | 1273 | 9.37e-01 | -1.31e-03 | 9.78e-01 |
| GOCC FILOPODIUM | 88 | 9.83e-01 | 1.31e-03 | 9.94e-01 |
| GOBP MONOCYTE EXTRAVASATION | 10 | 9.94e-01 | -1.27e-03 | 9.98e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1383 | 9.38e-01 | 1.25e-03 | 9.78e-01 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 30 | 9.91e-01 | 1.22e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS | 6 | 9.96e-01 | 1.20e-03 | 9.98e-01 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 699 | 9.59e-01 | 1.14e-03 | 9.85e-01 |
| GOCC INTERCELLULAR BRIDGE | 79 | 9.86e-01 | -1.13e-03 | 9.95e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 100 | 9.85e-01 | -1.11e-03 | 9.94e-01 |
| GOBP DNA CATABOLIC PROCESS | 28 | 9.92e-01 | -1.09e-03 | 9.97e-01 |
| GOCC SMAD PROTEIN COMPLEX | 8 | 9.96e-01 | -1.09e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 34 | 9.92e-01 | -1.05e-03 | 9.97e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 5 | 9.97e-01 | -1.05e-03 | 9.98e-01 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 13 | 9.95e-01 | -1.05e-03 | 9.98e-01 |
| GOMF PHOSPHATIDIC ACID BINDING | 21 | 9.93e-01 | -1.03e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1419 | 9.49e-01 | -1.01e-03 | 9.83e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 235 | 9.79e-01 | -9.90e-04 | 9.93e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 500 | 9.70e-01 | -9.89e-04 | 9.89e-01 |
| GOBP PROTEIN LOCALIZATION TO MOTILE CILIUM | 5 | 9.97e-01 | -9.79e-04 | 9.98e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 65 | 9.90e-01 | 9.33e-04 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL | 8 | 9.96e-01 | 9.15e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 15 | 9.95e-01 | 8.88e-04 | 9.98e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 47 | 9.92e-01 | 8.73e-04 | 9.97e-01 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 406 | 9.76e-01 | 8.70e-04 | 9.91e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 12 | 9.96e-01 | -8.69e-04 | 9.98e-01 |
| GOMF ACID PHOSPHATASE ACTIVITY | 8 | 9.97e-01 | 8.69e-04 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 31 | 9.93e-01 | 8.61e-04 | 9.98e-01 |
| GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 7 | 9.97e-01 | 8.43e-04 | 9.98e-01 |
| GOMF PHOSPHOPROTEIN BINDING | 88 | 9.89e-01 | 8.41e-04 | 9.96e-01 |
| GOBP INTESTINAL ABSORPTION | 30 | 9.94e-01 | -8.39e-04 | 9.98e-01 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 7 | 9.97e-01 | 8.04e-04 | 9.98e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 16 | 9.96e-01 | 7.89e-04 | 9.98e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 43 | 9.93e-01 | 7.77e-04 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 21 | 9.95e-01 | -7.30e-04 | 9.98e-01 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 13 | 9.96e-01 | -7.07e-04 | 9.98e-01 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 7 | 9.97e-01 | -6.99e-04 | 9.98e-01 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 411 | 9.82e-01 | 6.52e-04 | 9.94e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 329 | 9.84e-01 | 6.51e-04 | 9.94e-01 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 10 | 9.97e-01 | -6.50e-04 | 9.98e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 108 | 9.91e-01 | -6.25e-04 | 9.97e-01 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 16 | 9.97e-01 | 6.12e-04 | 9.98e-01 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 63 | 9.94e-01 | 5.73e-04 | 9.98e-01 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 36 | 9.95e-01 | -5.70e-04 | 9.98e-01 |
| GOCC CHOLINERGIC SYNAPSE | 7 | 9.98e-01 | -5.29e-04 | 9.98e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 8 | 9.98e-01 | -5.26e-04 | 9.98e-01 |
| GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION | 6 | 9.98e-01 | -5.18e-04 | 9.99e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 49 | 9.95e-01 | 5.06e-04 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 27 | 9.97e-01 | -4.73e-04 | 9.98e-01 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 23 | 9.97e-01 | -3.92e-04 | 9.98e-01 |
| GOBP MAMMARY GLAND DEVELOPMENT | 98 | 9.95e-01 | 3.84e-04 | 9.98e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 1003 | 9.84e-01 | -3.80e-04 | 9.94e-01 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 26 | 9.98e-01 | -2.96e-04 | 9.98e-01 |
| GOBP SENSORY PERCEPTION OF SMELL | 68 | 9.97e-01 | 2.81e-04 | 9.98e-01 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 685 | 9.91e-01 | -2.61e-04 | 9.97e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 224 | 9.95e-01 | -2.61e-04 | 9.98e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 43 | 9.98e-01 | -2.46e-04 | 9.98e-01 |
| GOBP REGULATION OF AXONOGENESIS | 114 | 9.96e-01 | -2.41e-04 | 9.98e-01 |
| GOMF CALMODULIN BINDING | 155 | 9.97e-01 | -1.92e-04 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION | 5 | 9.99e-01 | -1.74e-04 | 1.00e+00 |
| GOBP RESPONSE TO STARVATION | 184 | 9.98e-01 | 1.31e-04 | 9.98e-01 |
| GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 7 | 1.00e+00 | 5.88e-05 | 1.00e+00 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 475 | 1.00e+00 | -3.44e-06 | 1.00e+00 |
Detailed Gene set reports
GOBP LIPOXYGENASE PATHWAY
| set | GOBP LIPOXYGENASE PATHWAY |
| setSize | 9 |
| pANOVA | 4.4e-06 |
| s.dist | -0.884 |
| p.adjustANOVA | 0.000282 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ALOX5 | -10673 |
| HPGD | -10510 |
| GPX1 | -10479 |
| ALOX15B | -10350 |
| ALOX15 | -9878 |
| ALOX12B | -9721 |
| ALOX5AP | -9681 |
| ALOX12 | -8085 |
| GPX4 | -5552 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ALOX5 | -10673 |
| HPGD | -10510 |
| GPX1 | -10479 |
| ALOX15B | -10350 |
| ALOX15 | -9878 |
| ALOX12B | -9721 |
| ALOX5AP | -9681 |
| ALOX12 | -8085 |
| GPX4 | -5552 |
GOBP LIPOXIN METABOLIC PROCESS
| set | GOBP LIPOXIN METABOLIC PROCESS |
| setSize | 5 |
| pANOVA | 0.000638 |
| s.dist | -0.882 |
| p.adjustANOVA | 0.0161 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ALOX5 | -10673 |
| ALOX15B | -10350 |
| ALOX15 | -9878 |
| PTGR1 | -8103 |
| ALOX12 | -8085 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ALOX5 | -10673 |
| ALOX15B | -10350 |
| ALOX15 | -9878 |
| PTGR1 | -8103 |
| ALOX12 | -8085 |
GOMF COMPLEMENT COMPONENT C3B BINDING
| set | GOMF COMPLEMENT COMPONENT C3B BINDING |
| setSize | 5 |
| pANOVA | 0.00134 |
| s.dist | -0.828 |
| p.adjustANOVA | 0.0285 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| VSIG4 | -10595 |
| CFH | -10507 |
| ITGAM | -10123 |
| CR1 | -7796 |
| ITGB2 | -5129 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| VSIG4 | -10595 |
| CFH | -10507 |
| ITGAM | -10123 |
| CR1 | -7796 |
| ITGB2 | -5129 |
GOMF ICOSANOID BINDING
| set | GOMF ICOSANOID BINDING |
| setSize | 7 |
| pANOVA | 0.000233 |
| s.dist | -0.803 |
| p.adjustANOVA | 0.00756 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| S100A9 | -10671 |
| S100A8 | -10617 |
| ALOX5AP | -9681 |
| STX3 | -9634 |
| PPARG | -9600 |
| OXER1 | -7305 |
| TMEM175 | -2396 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| S100A9 | -10671 |
| S100A8 | -10617 |
| ALOX5AP | -9681 |
| STX3 | -9634 |
| PPARG | -9600 |
| OXER1 | -7305 |
| TMEM175 | -2396 |
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB
| set | GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB |
| setSize | 5 |
| pANOVA | 0.00249 |
| s.dist | -0.781 |
| p.adjustANOVA | 0.0441 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CD1D | -10338 |
| CD1B | -9980 |
| CD1E | -8285 |
| CD1C | -8271 |
| CD1A | -4711 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CD1D | -10338 |
| CD1B | -9980 |
| CD1E | -8285 |
| CD1C | -8271 |
| CD1A | -4711 |
GOMF LIPID ANTIGEN BINDING
| set | GOMF LIPID ANTIGEN BINDING |
| setSize | 5 |
| pANOVA | 0.00249 |
| s.dist | -0.781 |
| p.adjustANOVA | 0.0441 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CD1D | -10338 |
| CD1B | -9980 |
| CD1E | -8285 |
| CD1C | -8271 |
| CD1A | -4711 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CD1D | -10338 |
| CD1B | -9980 |
| CD1E | -8285 |
| CD1C | -8271 |
| CD1A | -4711 |
GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY
| set | GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY |
| setSize | 8 |
| pANOVA | 0.000139 |
| s.dist | 0.778 |
| p.adjustANOVA | 0.00505 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DDX60 | 10905 |
| OASL | 10748 |
| DHX58 | 10547 |
| ZCCHC3 | 9988 |
| PUM2 | 9418 |
| ANKRD17 | 9407 |
| PUM1 | 8254 |
| USP15 | 513 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| DDX60 | 10905 |
| OASL | 10748 |
| DHX58 | 10547 |
| ZCCHC3 | 9988 |
| PUM2 | 9418 |
| ANKRD17 | 9407 |
| PUM1 | 8254 |
| USP15 | 513 |
GOMF DNA RNA HYBRID BINDING
| set | GOMF DNA RNA HYBRID BINDING |
| setSize | 5 |
| pANOVA | 0.00272 |
| s.dist | 0.774 |
| p.adjustANOVA | 0.0468 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| POLR1B | 11070 |
| POLR3B | 10788 |
| POLR3A | 10678 |
| PRIM2 | 6168 |
| POLR1A | 4721 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| POLR1B | 11070 |
| POLR3B | 10788 |
| POLR3A | 10678 |
| PRIM2 | 6168 |
| POLR1A | 4721 |
GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION
| set | GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION |
| setSize | 7 |
| pANOVA | 0.00039 |
| s.dist | 0.774 |
| p.adjustANOVA | 0.0111 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NIPBL | 10708 |
| STAG1 | 9865 |
| STAG2 | 9393 |
| SMC3 | 9277 |
| NAA50 | 8441 |
| SMC1A | 7186 |
| RAD21 | 5911 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NIPBL | 10708 |
| STAG1 | 9865 |
| STAG2 | 9393 |
| SMC3 | 9277 |
| NAA50 | 8441 |
| SMC1A | 7186 |
| RAD21 | 5911 |
GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY
| set | GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY |
| setSize | 10 |
| pANOVA | 2.27e-05 |
| s.dist | -0.773 |
| p.adjustANOVA | 0.00116 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NCF1C | -10589 |
| SH3PXD2B | -10568 |
| NCF1 | -10360 |
| NCF4 | -10214 |
| NCF1B | -10211 |
| NOXA1 | -7195 |
| SH3PXD2A | -6876 |
| PDGFB | -6128 |
| NCF2 | -5331 |
| NOXO1 | -4845 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NCF1C | -10589 |
| SH3PXD2B | -10568 |
| NCF1 | -10360 |
| NCF4 | -10214 |
| NCF1B | -10211 |
| NOXA1 | -7195 |
| SH3PXD2A | -6876 |
| PDGFB | -6128 |
| NCF2 | -5331 |
| NOXO1 | -4845 |
GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY
| set | GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00278 |
| s.dist | 0.772 |
| p.adjustANOVA | 0.0476 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SENP2 | 10951 |
| SENP5 | 10032 |
| SENP6 | 8471 |
| SENP1 | 7856 |
| SENP7 | 6027 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SENP2 | 10951 |
| SENP5 | 10032 |
| SENP6 | 8471 |
| SENP1 | 7856 |
| SENP7 | 6027 |
GOMF ANKYRIN REPEAT BINDING
| set | GOMF ANKYRIN REPEAT BINDING |
| setSize | 6 |
| pANOVA | 0.00111 |
| s.dist | 0.769 |
| p.adjustANOVA | 0.0245 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SHANK1 | 10370 |
| TNKS1BP1 | 10156 |
| TERF1 | 9237 |
| RELA | 8242 |
| HIF1AN | 8201 |
| KIF21A | 5558 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SHANK1 | 10370 |
| TNKS1BP1 | 10156 |
| TERF1 | 9237 |
| RELA | 8242 |
| HIF1AN | 8201 |
| KIF21A | 5558 |
GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE
| set | GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE |
| setSize | 6 |
| pANOVA | 0.00125 |
| s.dist | -0.761 |
| p.adjustANOVA | 0.027 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| S100A9 | -10671 |
| NCF1 | -10360 |
| DUSP10 | -9382 |
| GRN | -8616 |
| SLAMF8 | -8161 |
| RPS19 | -1375 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| S100A9 | -10671 |
| NCF1 | -10360 |
| DUSP10 | -9382 |
| GRN | -8616 |
| SLAMF8 | -8161 |
| RPS19 | -1375 |
GOMF NERVE GROWTH FACTOR BINDING
| set | GOMF NERVE GROWTH FACTOR BINDING |
| setSize | 6 |
| pANOVA | 0.00173 |
| s.dist | -0.738 |
| p.adjustANOVA | 0.0345 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NGFR | -10612 |
| NTRK1 | -10322 |
| SORT1 | -10072 |
| PCSK6 | -9386 |
| A2M | -5850 |
| FURIN | -856 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NGFR | -10612 |
| NTRK1 | -10322 |
| SORT1 | -10072 |
| PCSK6 | -9386 |
| A2M | -5850 |
| FURIN | -856 |
GOBP SYNAPSE PRUNING
| set | GOBP SYNAPSE PRUNING |
| setSize | 9 |
| pANOVA | 0.000134 |
| s.dist | -0.735 |
| p.adjustANOVA | 0.00493 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| C1QB | -10574 |
| C1QC | -10504 |
| ITGAM | -10123 |
| ITGB1 | -9923 |
| C1QA | -9898 |
| PLXNC1 | -6337 |
| C3 | -5253 |
| EPHA4 | -5175 |
| CX3CR1 | -2520 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| C1QB | -10574 |
| C1QC | -10504 |
| ITGAM | -10123 |
| ITGB1 | -9923 |
| C1QA | -9898 |
| PLXNC1 | -6337 |
| C3 | -5253 |
| EPHA4 | -5175 |
| CX3CR1 | -2520 |
GOCC PHAGOCYTIC VESICLE LUMEN
| set | GOCC PHAGOCYTIC VESICLE LUMEN |
| setSize | 5 |
| pANOVA | 0.00445 |
| s.dist | -0.735 |
| p.adjustANOVA | 0.0668 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MPO | -10488 |
| PGLYRP1 | -10287 |
| LTF | -10051 |
| HGS | -5068 |
| GNLY | -3144 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MPO | -10488 |
| PGLYRP1 | -10287 |
| LTF | -10051 |
| HGS | -5068 |
| GNLY | -3144 |
GOBP PROTEIN REPAIR
| set | GOBP PROTEIN REPAIR |
| setSize | 7 |
| pANOVA | 0.000897 |
| s.dist | -0.725 |
| p.adjustANOVA | 0.0212 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MSRB2 | -9933 |
| MSRA | -9085 |
| PCMT1 | -8983 |
| MSRB1 | -8274 |
| PARK7 | -6674 |
| MSRB3 | -5800 |
| FN3K | -5153 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MSRB2 | -9933 |
| MSRA | -9085 |
| PCMT1 | -8983 |
| MSRB1 | -8274 |
| PARK7 | -6674 |
| MSRB3 | -5800 |
| FN3K | -5153 |
GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL
| set | GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL |
| setSize | 5 |
| pANOVA | 0.00513 |
| s.dist | -0.723 |
| p.adjustANOVA | 0.0738 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CXCL8 | -10680 |
| FUCA2 | -8233 |
| ITGAV | -7840 |
| EXOC2 | -6303 |
| EXOC7 | -5332 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CXCL8 | -10680 |
| FUCA2 | -8233 |
| ITGAV | -7840 |
| EXOC2 | -6303 |
| EXOC7 | -5332 |
GOBP INNATE IMMUNE RESPONSE IN MUCOSA
| set | GOBP INNATE IMMUNE RESPONSE IN MUCOSA |
| setSize | 17 |
| pANOVA | 2.88e-07 |
| s.dist | -0.719 |
| p.adjustANOVA | 2.61e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| H2BC12 | -10667 |
| DEFA4 | -10436 |
| H2BC8 | -10326 |
| DEFA1 | -10309 |
| DEFA3 | -10130 |
| LTF | -10051 |
| CAMP | -10047 |
| H2BC11 | -10012 |
| RNASE3 | -9781 |
| H2BC21 | -8891 |
| NOD2 | -8349 |
| DEFA1B | -7844 |
| RNASE2 | -5416 |
| RPL39 | -5188 |
| FAU | -3185 |
| H2BC7 | -183 |
| H2BC4 | 1117 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| H2BC12 | -10667 |
| DEFA4 | -10436 |
| H2BC8 | -10326 |
| DEFA1 | -10309 |
| DEFA3 | -10130 |
| LTF | -10051 |
| CAMP | -10047 |
| H2BC11 | -10012 |
| RNASE3 | -9781 |
| H2BC21 | -8891 |
| NOD2 | -8349 |
| DEFA1B | -7844 |
| RNASE2 | -5416 |
| RPL39 | -5188 |
| FAU | -3185 |
| H2BC7 | -183 |
| H2BC4 | 1117 |
GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY
| set | GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY |
| setSize | 7 |
| pANOVA | 0.00102 |
| s.dist | -0.717 |
| p.adjustANOVA | 0.0232 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ANXA4 | -9988 |
| ANXA3 | -9267 |
| ANXA1 | -8784 |
| ANXA5 | -7835 |
| ANXA2 | -7443 |
| PINLYP | -5979 |
| SNCA | -4023 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ANXA4 | -9988 |
| ANXA3 | -9267 |
| ANXA1 | -8784 |
| ANXA5 | -7835 |
| ANXA2 | -7443 |
| PINLYP | -5979 |
| SNCA | -4023 |
GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION
| set | GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION |
| setSize | 5 |
| pANOVA | 0.00582 |
| s.dist | 0.712 |
| p.adjustANOVA | 0.0806 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ABCA1 | 11154 |
| APOE | 10212 |
| RALBP1 | 8788 |
| NRP1 | 8025 |
| ABL1 | 1858 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ABCA1 | 11154 |
| APOE | 10212 |
| RALBP1 | 8788 |
| NRP1 | 8025 |
| ABL1 | 1858 |
GOBP PEPTIDOGLYCAN METABOLIC PROCESS
| set | GOBP PEPTIDOGLYCAN METABOLIC PROCESS |
| setSize | 5 |
| pANOVA | 0.00592 |
| s.dist | -0.711 |
| p.adjustANOVA | 0.0815 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PGLYRP1 | -10287 |
| PGLYRP2 | -8903 |
| PGLYRP3 | -7012 |
| LYG1 | -6236 |
| LYG2 | -5296 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PGLYRP1 | -10287 |
| PGLYRP2 | -8903 |
| PGLYRP3 | -7012 |
| LYG1 | -6236 |
| LYG2 | -5296 |
GOMF HISTONE H3K9 TRIMETHYLTRANSFERASE ACTIVITY
| set | GOMF HISTONE H3K9 TRIMETHYLTRANSFERASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00606 |
| s.dist | 0.709 |
| p.adjustANOVA | 0.0825 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PRDM2 | 10418 |
| PRDM9 | 8542 |
| SUV39H1 | 7972 |
| SUV39H2 | 7742 |
| SETDB1 | 5177 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PRDM2 | 10418 |
| PRDM9 | 8542 |
| SUV39H1 | 7972 |
| SUV39H2 | 7742 |
| SETDB1 | 5177 |
GOMF MHC CLASS I PROTEIN COMPLEX BINDING
| set | GOMF MHC CLASS I PROTEIN COMPLEX BINDING |
| setSize | 7 |
| pANOVA | 0.00119 |
| s.dist | 0.707 |
| p.adjustANOVA | 0.0261 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| KLRC1 | 10735 |
| TAPBPL | 10184 |
| TAPBP | 7966 |
| CD160 | 7604 |
| KLRD1 | 7046 |
| KLRC2 | 6302 |
| CD8A | 5849 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| KLRC1 | 10735 |
| TAPBPL | 10184 |
| TAPBP | 7966 |
| CD160 | 7604 |
| KLRD1 | 7046 |
| KLRC2 | 6302 |
| CD8A | 5849 |
GOBP HEPOXILIN METABOLIC PROCESS
| set | GOBP HEPOXILIN METABOLIC PROCESS |
| setSize | 7 |
| pANOVA | 0.00122 |
| s.dist | -0.706 |
| p.adjustANOVA | 0.0266 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ALOX15B | -10350 |
| ALOX15 | -9878 |
| ALOX12B | -9721 |
| ALOX12 | -8085 |
| GSTP1 | -5828 |
| GSTM1 | -5089 |
| GSTM2 | -3496 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ALOX15B | -10350 |
| ALOX15 | -9878 |
| ALOX12B | -9721 |
| ALOX12 | -8085 |
| GSTP1 | -5828 |
| GSTM1 | -5089 |
| GSTM2 | -3496 |
GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION
| set | GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION |
| setSize | 5 |
| pANOVA | 0.00643 |
| s.dist | 0.704 |
| p.adjustANOVA | 0.0851 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| JPX | 9796 |
| DYRK1A | 9694 |
| KMT2A | 6903 |
| PHF8 | 6898 |
| PHF2 | 6288 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| JPX | 9796 |
| DYRK1A | 9694 |
| KMT2A | 6903 |
| PHF8 | 6898 |
| PHF2 | 6288 |
GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY
| set | GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY |
| setSize | 7 |
| pANOVA | 0.00132 |
| s.dist | -0.701 |
| p.adjustANOVA | 0.0281 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| UQCRH | -8619 |
| UQCRFS1P1 | -8478 |
| UQCR10 | -7914 |
| UQCRFS1 | -7613 |
| CYC1 | -7309 |
| MT-CYB | -6171 |
| UQCRC1 | -5973 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| UQCRH | -8619 |
| UQCRFS1P1 | -8478 |
| UQCR10 | -7914 |
| UQCRFS1 | -7613 |
| CYC1 | -7309 |
| MT-CYB | -6171 |
| UQCRC1 | -5973 |
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY
| set | GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY |
| setSize | 7 |
| pANOVA | 0.00134 |
| s.dist | 0.7 |
| p.adjustANOVA | 0.0285 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PIK3CG | 10835 |
| PIK3CD | 10183 |
| PIK3C2A | 9179 |
| PIK3CA | 8985 |
| PIK3C2B | 8956 |
| PIK3CB | 5442 |
| PIK3C2G | 1528 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PIK3CG | 10835 |
| PIK3CD | 10183 |
| PIK3C2A | 9179 |
| PIK3CA | 8985 |
| PIK3C2B | 8956 |
| PIK3CB | 5442 |
| PIK3C2G | 1528 |
GOCC RDNA HETEROCHROMATIN
| set | GOCC RDNA HETEROCHROMATIN |
| setSize | 5 |
| pANOVA | 0.00695 |
| s.dist | 0.697 |
| p.adjustANOVA | 0.0893 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RRP8 | 10742 |
| BAZ2A | 8627 |
| SUV39H1 | 7972 |
| NOP53 | 6469 |
| SIRT1 | 5401 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| RRP8 | 10742 |
| BAZ2A | 8627 |
| SUV39H1 | 7972 |
| NOP53 | 6469 |
| SIRT1 | 5401 |
GOBP RESPONSE TO CORTICOSTERONE
| set | GOBP RESPONSE TO CORTICOSTERONE |
| setSize | 11 |
| pANOVA | 6.5e-05 |
| s.dist | -0.695 |
| p.adjustANOVA | 0.00269 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FOS | -10000 |
| FOSL1 | -9984 |
| CDKN1A | -9808 |
| NEFL | -9137 |
| FOSB | -9077 |
| AANAT | -8401 |
| COMT | -7745 |
| HDAC6 | -6604 |
| FOXO3 | -5920 |
| MAOB | -5385 |
| AVPR1A | 910 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FOS | -10000 |
| FOSL1 | -9984 |
| CDKN1A | -9808 |
| NEFL | -9137 |
| FOSB | -9077 |
| AANAT | -8401 |
| COMT | -7745 |
| HDAC6 | -6604 |
| FOXO3 | -5920 |
| MAOB | -5385 |
| AVPR1A | 910 |
GOBP REGULATION OF INTESTINAL ABSORPTION
| set | GOBP REGULATION OF INTESTINAL ABSORPTION |
| setSize | 6 |
| pANOVA | 0.0032 |
| s.dist | 0.695 |
| p.adjustANOVA | 0.0528 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ABCG8 | 11073 |
| EPB41 | 10439 |
| HAMP | 9774 |
| LPCAT3 | 9355 |
| PRAP1 | 6259 |
| APOA2 | 7 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ABCG8 | 11073 |
| EPB41 | 10439 |
| HAMP | 9774 |
| LPCAT3 | 9355 |
| PRAP1 | 6259 |
| APOA2 | 7 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS
| set | GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS |
| setSize | 9 |
| pANOVA | 0.000328 |
| s.dist | -0.691 |
| p.adjustANOVA | 0.00985 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LACC1 | -10029 |
| UQCRH | -8619 |
| UQCRFS1P1 | -8478 |
| UQCR10 | -7914 |
| UQCRFS1 | -7613 |
| CYC1 | -7309 |
| MT-CYB | -6171 |
| UQCRC1 | -5973 |
| NQO2 | -3899 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| LACC1 | -10029 |
| UQCRH | -8619 |
| UQCRFS1P1 | -8478 |
| UQCR10 | -7914 |
| UQCRFS1 | -7613 |
| CYC1 | -7309 |
| MT-CYB | -6171 |
| UQCRC1 | -5973 |
| NQO2 | -3899 |
GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION
| set | GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION |
| setSize | 5 |
| pANOVA | 0.00747 |
| s.dist | -0.691 |
| p.adjustANOVA | 0.0932 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HK2 | -9773 |
| PINK1 | -8769 |
| TSPO | -7849 |
| HK1 | -7678 |
| AKT1 | -2579 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HK2 | -9773 |
| PINK1 | -8769 |
| TSPO | -7849 |
| HK1 | -7678 |
| AKT1 | -2579 |
GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT
| set | GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT |
| setSize | 5 |
| pANOVA | 0.00799 |
| s.dist | 0.685 |
| p.adjustANOVA | 0.0985 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RIPK1 | 10891 |
| TCAF2 | 8707 |
| ABCB1 | 6859 |
| GOPC | 6512 |
| TCAF1 | 5582 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| RIPK1 | 10891 |
| TCAF2 | 8707 |
| ABCB1 | 6859 |
| GOPC | 6512 |
| TCAF1 | 5582 |
GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL
| set | GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL |
| setSize | 5 |
| pANOVA | 0.00828 |
| s.dist | 0.682 |
| p.adjustANOVA | 0.101 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NTSR1 | 10908 |
| CHRNA2 | 9830 |
| NLGN2 | 7842 |
| ABAT | 4963 |
| UNC13B | 4841 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NTSR1 | 10908 |
| CHRNA2 | 9830 |
| NLGN2 | 7842 |
| ABAT | 4963 |
| UNC13B | 4841 |
GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE
| set | GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE |
| setSize | 5 |
| pANOVA | 0.0088 |
| s.dist | -0.676 |
| p.adjustANOVA | 0.105 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RGS9 | -10691 |
| CALM2 | -9906 |
| CALM1 | -8530 |
| YWHAE | -3563 |
| CALM3 | -3174 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| RGS9 | -10691 |
| CALM2 | -9906 |
| CALM1 | -8530 |
| YWHAE | -3563 |
| CALM3 | -3174 |
GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE
| set | GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE |
| setSize | 8 |
| pANOVA | 0.00111 |
| s.dist | -0.666 |
| p.adjustANOVA | 0.0245 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| S100A9 | -10671 |
| NCF1 | -10360 |
| DUSP10 | -9382 |
| GRN | -8616 |
| PRDX2 | -8442 |
| SLAMF8 | -8161 |
| RPS19 | -1375 |
| LIPA | 552 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| S100A9 | -10671 |
| NCF1 | -10360 |
| DUSP10 | -9382 |
| GRN | -8616 |
| PRDX2 | -8442 |
| SLAMF8 | -8161 |
| RPS19 | -1375 |
| LIPA | 552 |
GOBP ANTERIOR COMMISSURE MORPHOGENESIS
| set | GOBP ANTERIOR COMMISSURE MORPHOGENESIS |
| setSize | 5 |
| pANOVA | 0.0105 |
| s.dist | 0.66 |
| p.adjustANOVA | 0.118 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DRAXIN | 9690 |
| TSKU | 9372 |
| FBXO45 | 8686 |
| WDR47 | 5108 |
| PLXNA4 | 4355 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| DRAXIN | 9690 |
| TSKU | 9372 |
| FBXO45 | 8686 |
| WDR47 | 5108 |
| PLXNA4 | 4355 |
GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY
| set | GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY |
| setSize | 7 |
| pANOVA | 0.00253 |
| s.dist | 0.659 |
| p.adjustANOVA | 0.0446 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MX1 | 11057 |
| OAS2 | 10999 |
| OASL | 10748 |
| OAS1 | 9580 |
| STAT1 | 7768 |
| IL6ST | 4936 |
| IL27RA | -3095 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MX1 | 11057 |
| OAS2 | 10999 |
| OASL | 10748 |
| OAS1 | 9580 |
| STAT1 | 7768 |
| IL6ST | 4936 |
| IL27RA | -3095 |
GOBP ANTIBACTERIAL PEPTIDE PRODUCTION
| set | GOBP ANTIBACTERIAL PEPTIDE PRODUCTION |
| setSize | 5 |
| pANOVA | 0.0108 |
| s.dist | -0.658 |
| p.adjustANOVA | 0.12 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| EVPL | -10698 |
| ELANE | -10154 |
| NOD2 | -8349 |
| LGALS4 | -5886 |
| MMP7 | 226 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| EVPL | -10698 |
| ELANE | -10154 |
| NOD2 | -8349 |
| LGALS4 | -5886 |
| MMP7 | 226 |
GOBP ANTIMICROBIAL PEPTIDE PRODUCTION
| set | GOBP ANTIMICROBIAL PEPTIDE PRODUCTION |
| setSize | 5 |
| pANOVA | 0.0108 |
| s.dist | -0.658 |
| p.adjustANOVA | 0.12 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| EVPL | -10698 |
| ELANE | -10154 |
| NOD2 | -8349 |
| LGALS4 | -5886 |
| MMP7 | 226 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| EVPL | -10698 |
| ELANE | -10154 |
| NOD2 | -8349 |
| LGALS4 | -5886 |
| MMP7 | 226 |
GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY
| set | GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0111 |
| s.dist | -0.656 |
| p.adjustANOVA | 0.121 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SCPEP1 | -10371 |
| CTSA | -9260 |
| CPD | -8856 |
| CPVL | -5892 |
| PRCP | -371 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SCPEP1 | -10371 |
| CTSA | -9260 |
| CPD | -8856 |
| CPVL | -5892 |
| PRCP | -371 |
GOBP RESPONSE TO INTERFERON ALPHA
| set | GOBP RESPONSE TO INTERFERON ALPHA |
| setSize | 18 |
| pANOVA | 1.59e-06 |
| s.dist | 0.653 |
| p.adjustANOVA | 0.000113 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MX2 | 11124 |
| TPR | 10984 |
| ADAR | 10939 |
| EIF2AK2 | 10595 |
| LAMP3 | 10354 |
| IFNAR2 | 10008 |
| IFNAR1 | 9525 |
| IFITM1 | 8984 |
| BST2 | 8573 |
| RO60 | 8041 |
| PDE12 | 6947 |
| IFITM3 | 6566 |
| IFITM2 | 5885 |
| PYHIN1 | 5111 |
| GAS6 | 5046 |
| KLHL20 | 4181 |
| AXL | 4089 |
| GATA3 | -4479 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MX2 | 11124 |
| TPR | 10984 |
| ADAR | 10939 |
| EIF2AK2 | 10595 |
| LAMP3 | 10354 |
| IFNAR2 | 10008 |
| IFNAR1 | 9525 |
| IFITM1 | 8984 |
| BST2 | 8573 |
| RO60 | 8041 |
| PDE12 | 6947 |
| IFITM3 | 6566 |
| IFITM2 | 5885 |
| PYHIN1 | 5111 |
| GAS6 | 5046 |
| KLHL20 | 4181 |
| AXL | 4089 |
| GATA3 | -4479 |
GOMF PRIMARY AMINE OXIDASE ACTIVITY
| set | GOMF PRIMARY AMINE OXIDASE ACTIVITY |
| setSize | 6 |
| pANOVA | 0.00592 |
| s.dist | -0.649 |
| p.adjustANOVA | 0.0815 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AOC2 | -10663 |
| AOC1 | -10301 |
| AOC3 | -9941 |
| DDO | -6361 |
| MAOB | -5385 |
| IL4I1 | 1433 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| AOC2 | -10663 |
| AOC1 | -10301 |
| AOC3 | -9941 |
| DDO | -6361 |
| MAOB | -5385 |
| IL4I1 | 1433 |
GOMF DNA TOPOISOMERASE ACTIVITY
| set | GOMF DNA TOPOISOMERASE ACTIVITY |
| setSize | 6 |
| pANOVA | 0.00603 |
| s.dist | 0.647 |
| p.adjustANOVA | 0.0823 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TOP3A | 10701 |
| TOP2B | 10067 |
| TOP1 | 9392 |
| TOP2A | 8369 |
| TOP3B | 3392 |
| TOP1MT | 1873 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TOP3A | 10701 |
| TOP2B | 10067 |
| TOP1 | 9392 |
| TOP2A | 8369 |
| TOP3B | 3392 |
| TOP1MT | 1873 |
GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION
| set | GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION |
| setSize | 6 |
| pANOVA | 0.00617 |
| s.dist | -0.646 |
| p.adjustANOVA | 0.0834 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FBN2 | -10205 |
| FBN1 | -9461 |
| LTBP1 | -9440 |
| NBL1 | -5864 |
| NRROS | -5737 |
| MICOS10-NBL1 | -299 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| FBN2 | -10205 |
| FBN1 | -9461 |
| LTBP1 | -9440 |
| NBL1 | -5864 |
| NRROS | -5737 |
| MICOS10-NBL1 | -299 |
GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY
| set | GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY |
| setSize | 6 |
| pANOVA | 0.00623 |
| s.dist | -0.645 |
| p.adjustANOVA | 0.0837 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NCF1 | -10360 |
| NOX5 | -7391 |
| CYBB | -7005 |
| CYBA | -5970 |
| NCF2 | -5331 |
| DUOX1 | -4905 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NCF1 | -10360 |
| NOX5 | -7391 |
| CYBB | -7005 |
| CYBA | -5970 |
| NCF2 | -5331 |
| DUOX1 | -4905 |
GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT
| set | GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT |
| setSize | 7 |
| pANOVA | 0.00339 |
| s.dist | 0.639 |
| p.adjustANOVA | 0.055 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NOG | 11046 |
| GATA6 | 10722 |
| MESP1 | 10258 |
| TREX1 | 8071 |
| BVES | 4319 |
| GJB6 | 3859 |
| ENG | 2217 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NOG | 11046 |
| GATA6 | 10722 |
| MESP1 | 10258 |
| TREX1 | 8071 |
| BVES | 4319 |
| GJB6 | 3859 |
| ENG | 2217 |
GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION
| set | GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION |
| setSize | 5 |
| pANOVA | 0.0134 |
| s.dist | -0.638 |
| p.adjustANOVA | 0.136 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| BCL6 | -10513 |
| HLX | -9561 |
| ANXA1 | -8784 |
| ASCL2 | -5475 |
| SOCS5 | 546 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| BCL6 | -10513 |
| HLX | -9561 |
| ANXA1 | -8784 |
| ASCL2 | -5475 |
| SOCS5 | 546 |
GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS
| set | GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS |
| setSize | 10 |
| pANOVA | 0.000475 |
| s.dist | 0.638 |
| p.adjustANOVA | 0.0129 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ABCG8 | 11073 |
| SCT | 10907 |
| HAMP | 9774 |
| DCANP1 | 9758 |
| WNK3 | 9499 |
| NR1H3 | 9105 |
| TIFAB | 8212 |
| STK39 | 5951 |
| WNK1 | 1311 |
| PTGER3 | -3619 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ABCG8 | 11073 |
| SCT | 10907 |
| HAMP | 9774 |
| DCANP1 | 9758 |
| WNK3 | 9499 |
| NR1H3 | 9105 |
| TIFAB | 8212 |
| STK39 | 5951 |
| WNK1 | 1311 |
| PTGER3 | -3619 |
Network diagram
Only used for one-dimensional analysis.
Here, the network diagram is used to depict the similarity between
some of the top ranked gene sets. It makes separate charts for up and
downregulated sets. It works best when prioritisation is done by effect
size during the mitch_calc() step. By default, we only show
the top 20 genes, but you can use the networkplot() command
yourself with other options. See ?networkplot for more
detail. There is an element of stochasticity with regard to the network
projection, so if you see a lot of overlapping labels or labels getting
cut off, you could repeat the chart generation until you get a nice
layout. See ?networkplot for more detail.
Below the network diagrams, you will see lists of genes that make up the up and downregulated sets respectively. For upregulated genes the score needs to be >2 and for downregulated genes it needs to be < -2. This is to remove genes that have uninteresting differential expression and do not contribute enrichment.
if (d==1) {
networkplot(eres=res,FDR=0.05,n_sets=20)
network_genes(eres=res,FDR=0.05,n_sets=20)
} else {
message("Network charts only generated in one-dimensional analysis.")
}
## [[1]]
## [[1]]$`UP genesets.GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS`
## character(0)
##
## [[1]]$`UP genesets.GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION`
## character(0)
##
## [[1]]$`UP genesets.GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY`
## [1] "MX1" "OAS2"
##
## [[1]]$`UP genesets.GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY`
## character(0)
##
## [[1]]$`UP genesets.GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS`
## [1] "ABCG8" "SCT"
##
## [[1]]$`UP genesets.GOBP NOTOCHORD DEVELOPMENT`
## [1] "COL18A1" "EPHA2" "ID3" "NOG"
##
## [[1]]$`UP genesets.GOBP NUCLEAR PORE COMPLEX ASSEMBLY`
## [1] "AHCTF1" "TPR"
##
## [[1]]$`UP genesets.GOBP NUCLEAR PORE ORGANIZATION`
## [1] "AHCTF1" "TPR"
##
## [[1]]$`UP genesets.GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION`
## [1] "ZNF304"
##
## [[1]]$`UP genesets.GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY`
## [1] "DDX60"
##
## [[1]]$`UP genesets.GOBP PROTEIN POLY ADP RIBOSYLATION`
## character(0)
##
## [[1]]$`UP genesets.GOBP RESPONSE TO INTERFERON ALPHA`
## [1] "ADAR" "MX2" "TPR"
##
## [[1]]$`UP genesets.GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY`
## [1] "PIK3CG"
##
## [[1]]$`UP genesets.GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY`
## [1] "PIK3CG"
##
## [[1]]$`UP genesets.GOMF ANKYRIN REPEAT BINDING`
## character(0)
##
## [[1]]$`UP genesets.GOMF DNA RNA HYBRID BINDING`
## [1] "POLR1B" "POLR3B"
##
## [[1]]$`UP genesets.GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY`
## character(0)
##
## [[1]]$`UP genesets.GOMF MHC CLASS I PROTEIN COMPLEX BINDING`
## character(0)
##
## [[1]]$`UP genesets.GOMF MISMATCH REPAIR COMPLEX BINDING`
## [1] "WRN"
##
## [[1]]$`UP genesets.GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY`
## [1] "SENP2"
##
## [[1]]$`DOWN genesets.GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB`
## [1] "CD1A" "CD1B" "CD1C" "CD1D" "CD1E"
##
## [[1]]$`DOWN genesets.GOBP HEPOXILIN METABOLIC PROCESS`
## [1] "ALOX12" "ALOX12B" "ALOX15" "ALOX15B" "GSTM1" "GSTM2" "GSTP1"
##
## [[1]]$`DOWN genesets.GOBP INNATE IMMUNE RESPONSE IN MUCOSA`
## [1] "CAMP" "DEFA1" "DEFA1B" "DEFA3" "DEFA4" "FAU" "H2BC11" "H2BC12"
## [9] "H2BC21" "H2BC4" "H2BC7" "H2BC8" "LTF" "NOD2" "RNASE2" "RNASE3"
## [17] "RPL39"
##
## [[1]]$`DOWN genesets.GOBP LIPOXIN METABOLIC PROCESS`
## [1] "ALOX12" "ALOX15" "ALOX15B" "ALOX5" "PTGR1"
##
## [[1]]$`DOWN genesets.GOBP LIPOXYGENASE PATHWAY`
## [1] "ALOX12" "ALOX12B" "ALOX15" "ALOX15B" "ALOX5" "ALOX5AP" "GPX1"
## [8] "GPX4" "HPGD"
##
## [[1]]$`DOWN genesets.GOBP PROTEIN REPAIR`
## [1] "FN3K" "MSRA" "MSRB1" "MSRB2" "MSRB3" "PARK7" "PCMT1"
##
## [[1]]$`DOWN genesets.GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE`
## [1] "DUSP10" "GRN" "NCF1" "RPS19" "S100A9" "SLAMF8"
##
## [[1]]$`DOWN genesets.GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE`
## [1] "DUSP10" "GRN" "LIPA" "NCF1" "PRDX2" "RPS19" "S100A9" "SLAMF8"
##
## [[1]]$`DOWN genesets.GOBP RESPONSE TO CORTICOSTERONE`
## [1] "AANAT" "AVPR1A" "CDKN1A" "COMT" "FOS" "FOSB" "FOSL1" "FOXO3"
## [9] "HDAC6" "MAOB" "NEFL"
##
## [[1]]$`DOWN genesets.GOBP SYNAPSE PRUNING`
## [1] "C1QA" "C1QB" "C1QC" "C3" "CX3CR1" "EPHA4" "ITGAM" "ITGB1"
## [9] "PLXNC1"
##
## [[1]]$`DOWN genesets.GOCC NADPH OXIDASE COMPLEX`
## [1] "CYBA" "CYBB" "DUOX1" "NCF1" "NCF1B" "NCF1C" "NCF2" "NCF4" "NOX5"
## [10] "NOXA1" "NOXO1" "RAC1" "RAC2" "RAC3"
##
## [[1]]$`DOWN genesets.GOMF COMPLEMENT COMPONENT C3B BINDING`
## [1] "CFH" "CR1" "ITGAM" "ITGB2" "VSIG4"
##
## [[1]]$`DOWN genesets.GOMF ICOSANOID BINDING`
## [1] "ALOX5AP" "OXER1" "PPARG" "S100A8" "S100A9" "STX3" "TMEM175"
##
## [[1]]$`DOWN genesets.GOMF LIPID ANTIGEN BINDING`
## [1] "CD1A" "CD1B" "CD1C" "CD1D" "CD1E"
##
## [[1]]$`DOWN genesets.GOMF NERVE GROWTH FACTOR BINDING`
## [1] "A2M" "FURIN" "NGFR" "NTRK1" "PCSK6" "SORT1"
##
## [[1]]$`DOWN genesets.GOMF NEUROTROPHIN BINDING`
## [1] "A2M" "FSTL4" "FURIN" "HAP1" "NGFR" "NTRK1" "PCSK6" "SORT1"
##
## [[1]]$`DOWN genesets.GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS`
## [1] "CYC1" "LACC1" "MT-CYB" "NQO2" "UQCR10" "UQCRC1"
## [7] "UQCRFS1" "UQCRFS1P1" "UQCRH"
##
## [[1]]$`DOWN genesets.GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY`
## [1] "ANXA1" "ANXA2" "ANXA3" "ANXA4" "ANXA5" "PINLYP" "SNCA"
##
## [[1]]$`DOWN genesets.GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY`
## [1] "NCF1" "NCF1B" "NCF1C" "NCF2" "NCF4" "NOXA1"
## [7] "NOXO1" "PDGFB" "SH3PXD2A" "SH3PXD2B"
##
## [[1]]$`DOWN genesets.GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY`
## [1] "CYC1" "MT-CYB" "UQCR10" "UQCRC1" "UQCRFS1" "UQCRFS1P1"
## [7] "UQCRH"Session information
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.5.2 (2025-10-31)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 24.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.26.so; LAPACK version 3.12.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=en_US.UTF-8
## [9] LC_ADDRESS=en_US.UTF-8 LC_TELEPHONE=en_US.UTF-8
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=en_US.UTF-8
##
## time zone: Etc/UTC
## tzcode source: system (glibc)
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] gtools_3.9.5 xlsx_0.6.5
## [3] DT_0.34.0 ggplot2_4.0.3
## [5] kableExtra_1.4.0 limma_3.66.0
## [7] RhpcBLASctl_0.23-42 beeswarm_0.4.0
## [9] eulerr_7.1.0 MASS_7.3-65
## [11] mitch_1.22.1 DESeq2_1.50.2
## [13] SummarizedExperiment_1.40.0 Biobase_2.70.0
## [15] MatrixGenerics_1.22.0 matrixStats_1.5.0
## [17] GenomicRanges_1.62.1 Seqinfo_1.0.0
## [19] IRanges_2.44.0 S4Vectors_0.48.1
## [21] BiocGenerics_0.56.0 generics_0.1.4
## [23] dplyr_1.2.1 WGCNA_1.74
## [25] fastcluster_1.3.0 dynamicTreeCut_1.63-1
## [27] reshape2_1.4.5 gplots_3.3.0
##
## loaded via a namespace (and not attached):
## [1] RColorBrewer_1.1-3 rstudioapi_0.17.1 jsonlite_2.0.0
## [4] magrittr_2.0.4 farver_2.1.2 rmarkdown_2.30
## [7] vctrs_0.7.3 base64enc_0.1-3 progress_1.2.3
## [10] htmltools_0.5.8.1 S4Arrays_1.10.1 SparseArray_1.10.10
## [13] Formula_1.2-5 sass_0.4.10 KernSmooth_2.23-26
## [16] bslib_0.9.0 htmlwidgets_1.6.4 plyr_1.8.9
## [19] echarts4r_0.5.0 impute_1.84.0 cachem_1.1.0
## [22] mime_0.13 lifecycle_1.0.5 iterators_1.0.14
## [25] pkgconfig_2.0.3 Matrix_1.7-4 R6_2.6.1
## [28] fastmap_1.2.0 shiny_1.11.1 digest_0.6.39
## [31] colorspace_2.1-2 GGally_2.4.0 textshaping_1.0.4
## [34] Hmisc_5.2-5 labeling_0.4.3 polyclip_1.10-7
## [37] abind_1.4-8 compiler_4.5.2 withr_3.0.2
## [40] doParallel_1.0.17 htmlTable_2.5.0 S7_0.2.2
## [43] backports_1.5.1 BiocParallel_1.44.0 ggstats_0.13.0
## [46] DelayedArray_0.36.1 caTools_1.18.3 tools_4.5.2
## [49] foreign_0.8-90 otel_0.2.0 httpuv_1.6.16
## [52] nnet_7.3-20 glue_1.8.0 promises_1.5.0
## [55] grid_4.5.2 polylabelr_1.0.0 checkmate_2.3.4
## [58] cluster_2.1.8.1 gtable_0.3.6 preprocessCore_1.72.0
## [61] tidyr_1.3.2 hms_1.1.4 data.table_1.18.4
## [64] xml2_1.5.1 XVector_0.50.0 foreach_1.5.2
## [67] pillar_1.11.1 stringr_1.6.0 later_1.4.4
## [70] rJava_1.0-18 splines_4.5.2 lattice_0.22-7
## [73] survival_3.8-3 tidyselect_1.2.1 locfit_1.5-9.12
## [76] knitr_1.50 gridExtra_2.3 svglite_2.2.2
## [79] xfun_0.54 statmod_1.5.2 stringi_1.8.7
## [82] statnet.common_4.13.0 yaml_2.3.11 evaluate_1.0.5
## [85] codetools_0.2-20 xlsxjars_0.9.0 tibble_3.3.0
## [88] cli_3.6.5 rpart_4.1.24 xtable_1.8-4
## [91] systemfonts_1.3.1 jquerylib_0.1.4 network_1.20.0
## [94] Rcpp_1.1.1-1.1 coda_0.19-4.1 parallel_4.5.2
## [97] prettyunits_1.2.0 bitops_1.0-9 viridisLite_0.4.3
## [100] scales_1.4.0 crayon_1.5.3 purrr_1.2.0
## [103] rlang_1.2.0END of report